https://gpcardio.org/de/
https://gpcardio.org/de/2014-05-28_praktischer-leitfaden-fur-hausarztinnen-und-hausarzte-zur-anwendung-von-statinen-bei-menschen-mit-diabetesrisiko/
https://gpcardio.org/de/2015-01-07_das-epccs-leitliniendokument-zur-schlaganfallpravention-bei-vorhofflimmern-1/
https://gpcardio.org/de/2015-09-29_lebhafte-debatte-bei-der-jahrlichen-epccs-clinical-masterclass-fuhrt-zu-praktischer-anleitung/
https://gpcardio.org/de/2015-10-02_was-ist-die-evidenzbasis-fur-die-blutdruckmodifikation-in-den-leitlinienaktualisierungen/
https://gpcardio.org/de/2015-10-02_was-ist-die-evidenzbasis-fur-die-modifikation-des-gesundheitsverhaltens-in-den-leitlinienaktualisierungen/
https://gpcardio.org/de/2015-10-12_was-ist-die-evidenzbasis-fur-die-lipidmodifikation-in-den-leitlinienaktualisierungen/
https://gpcardio.org/de/2015-10-14_was-ist-die-evidenzbasis-fur-die-diagnose-und-das-management-der-herzinsuffizienz-in-den-leitlinienaktualisierungen/
https://gpcardio.org/de/2016-03-15_was-ist-die-evidenzbasis-fur-die-lipidmodifikation-in-den-leitlinienaktualisierungen/
https://gpcardio.org/de/2016-04-15_identifikation-und-behandlung-von-patientinnen-und-patienten-mit-echter-hypertonie/
https://gpcardio.org/de/2016-05-26_die-evidenzbasis-fur-verhaltensanderungen-im-gesundheitsbereich/
https://gpcardio.org/de/2016-09-06_epccs-konsensusleitfaden-zur-schlaganfallpravention-bei-vorhofflimmern-spaf-in-der-hausarztlichen-versorgung/
https://gpcardio.org/de/2016-09-28_epccs-leitliniendokumente/
https://gpcardio.org/de/2017-03-30_leitfaden-zur-veranderung-des-gesundheitsverhaltens-was-zeigt-die-evidenz-was-wird-empfohlen-und-stimme-ich-zu/
https://gpcardio.org/de/2017-04-20_kontroversen-bei-hypertonie-welche-implikationen-hat-sprint-im-kontext-aktueller-behandlungsstudien/
https://gpcardio.org/de/2017-04-20_kontroversen-bei-lipiden-ist-die-rolle-der-statine-jetzt-geklart-gibt-es-alternativen-und-was-ist-in-der-pipeline/
https://gpcardio.org/de/2017-04-20_leitfaden-zur-veranderung-des-gesundheitsverhaltens-was-zeigt-die-evidenz-was-wird-empfohlen-und-stimme-ich-zu/
https://gpcardio.org/de/2017-04-20_lipidmanagement-was-sagen-die-leitlinien-und-welche-implikationen-ergeben-sich-fur-die-primarversorgung/
https://gpcardio.org/de/2017-04-20_management-des-vorhofflimmerns-was-sagen-die-leitlinien-und-welche-implikationen-ergeben-sich-fur-die-primarversorgung/
https://gpcardio.org/de/2017-04-20_was-ist-die-neue-evidenzbasis-fur-die-diagnose-und-das-management-der-herzinsuffizienz/
https://gpcardio.org/de/2017-06-05_bestandteile-wirksamer-strategien-zur-forderung-von-verhaltensanderungen/
https://gpcardio.org/de/2017-06-22_wie-wirken-sich-die-neuesten-leitlinienanderungen-auf-das-management-der-dyslipidamie-in-der-primarversorgung-aus/
https://gpcardio.org/de/2017-07-01_epccs-leitlinie-zur-herzinsuffizienz-als-clinical-intelligence-im-br-j-gen-prac-veroffentlicht/
https://gpcardio.org/de/2017-07-18_diagnose-und-management-der-herzinsuffizienz-variieren-erheblich-zwischen-europaischen-landern/
https://gpcardio.org/de/2017-09-13_was-konnen-wir-aus-den-neuesten-hypertonie-studien-lernen/
https://gpcardio.org/de/2017-12-10_epccs-praktische-anleitung-zur-diagnose-und-zum-management-der-herzinsuffizienz-in-der-primarversorgung/
https://gpcardio.org/de/2018-02-06_wie-kann-die-epccs-besser-mit-hausarztinnen-und-hausarzten-in-verschiedenen-europaischen-landern-im-bereich-der-kardiovaskularen-aufklarung-zusammenarbeiten/
https://gpcardio.org/de/2018-02-06_wie-kann-die-epccs-ihre-mitgliederzahl-erweitern/
https://gpcardio.org/de/2018-02-19_chronische-herzinsuffizienz/
https://gpcardio.org/de/2018-02-19_praktische-anleitung-zur-diagnose-und-zum-management-der-herzinsuffizienz-in-der-primarversorgung/
https://gpcardio.org/de/2018-02-19_pravention-des-schlaganfalls-bei-patientinnen-und-patienten-mit-vorhofflimmern/
https://gpcardio.org/de/2018-02-22_forderung-von-verhaltensanderungen-zur-reduktion-des-kardiovaskularen-risikos-in-der-primarversorgung/
https://gpcardio.org/de/2018-02-25_folien-organisation-der-primarversorgung-in-den-niederlanden/
https://gpcardio.org/de/2018-02-26_folien-organisation-der-primarversorgung-in-der-slowakei/
https://gpcardio.org/de/2018-02-26_folien-primarversorgung-in-bulgarien-nagpb/
https://gpcardio.org/de/2018-02-26_niederlande-uberblick-kardiovaskulare-primarversorgung/
https://gpcardio.org/de/2018-02-26_slowakei-uberblick-kardiovaskulare-primarversorgung/
https://gpcardio.org/de/2018-02-27_folien-kardiovaskulare-primarversorgung-in-spanien/
https://gpcardio.org/de/2018-02-27_folien-organisation-der-primarversorgung-in-portugal/
https://gpcardio.org/de/2018-02-28_bulgarien-kardiovaskulare-primarversorgung/
https://gpcardio.org/de/2018-02-28_folien-kardiovaskulare-primarversorgung-in-frankreich/
https://gpcardio.org/de/2018-02-28_portugal-uberblick-kardiovaskulare-primarversorgung/
https://gpcardio.org/de/2018-02-28_spanien-uberblick-kardiovaskulare-primarversorgung/
https://gpcardio.org/de/2018-03-01_folien-kardiovaskulare-primarversorgung-in-griechenland/
https://gpcardio.org/de/2018-03-01_folien-kardiovaskulare-primarversorgung-in-rumanien/
https://gpcardio.org/de/2018-03-01_frankreich-uberblick-kardiovaskulare-primarversorgung/
https://gpcardio.org/de/2018-03-01_griechenland-uberblick-kardiovaskulare-primarversorgung/
https://gpcardio.org/de/2018-03-01_rumanien-uberblick-kardiovaskulare-primarversorgung/
https://gpcardio.org/de/2018-03-02_deutschland-uberblick-kardiovaskulare-primarversorgung/
https://gpcardio.org/de/2018-03-02_folien-kardiovaskulare-primarversorgung-in-deutschland/
https://gpcardio.org/de/2018-03-13_abgestimmte-epccs-leitlinie-zur-schlaganfallpravention-bei-vorhofflimmern-in-der-primaren-gesundheitsversorgung/
https://gpcardio.org/de/2018-03-27_forderung-von-gesundheitsverhaltensanderungen-zur-senkung-des-kardiovaskularen-risikos-in-der-primaren-gesundheitsversorgung/
https://gpcardio.org/de/2018-03-27_periphere-arterielle-verschlusskrankheit-eine-vernachlassigte-schwere-cv-erkrankung/
https://gpcardio.org/de/2018-03-28_diabetes-und-vaskulare-erkrankung-epidemiologie-und-behandlungsoptionen/
https://gpcardio.org/de/2018-04-04_folien-arterienerkrankung-der-unteren-extremitat-eine-vernachlassigte-bedeutende-kardiovaskulare-erkrankung-diagnose-und-klinisches-management-in-der-hausarztlichen-versorgung/
https://gpcardio.org/de/2018-04-04_folien-hypertonie-konnen-wir-uns-auf-diagnostische-und-therapeutische-schwellenwerte-einigen/
https://gpcardio.org/de/2018-04-04_folien-lipidsenkung-die-evidenz-die-leitlinien-die-klinische-realitat/
https://gpcardio.org/de/2018-04-04_folien-management-komplexer-herzinsuffizienz-eine-facharztliche-perspektive-auf-die-schnittstelle-zwischen-primar-und-sekundarversorgung/
https://gpcardio.org/de/2018-04-04_folien-management-von-herzinsuffizienz-in-der-hausarztlichen-versorgung-die-perspektive-der-hausarztin-des-hausarztes/
https://gpcardio.org/de/2018-04-04_folien-praktischer-workshop-zu-abpm/
https://gpcardio.org/de/2018-04-04_folien-update-zu-typ-2-diabetes-und-kardiovaskularer-erkrankung/
https://gpcardio.org/de/2018-04-04_management-erhohter-lipide-und-statine-das-gute-das-schlechte-und-das-hassliche/
https://gpcardio.org/de/2018-04-10_hypertonie-konnen-wir-uns-auf-diagnostische-und-therapeutische-schwellenwerte-einigen/
https://gpcardio.org/de/2018-04-10_komplexitaten-im-management-von-herzinsuffizienz-in-der-hausarztlichen-versorgung/
https://gpcardio.org/de/2018-04-24_management-des-mit-t2dm-einhergehenden-kardiovaskularen-risikos-im-licht-neuer-behandlungsoptionen/
https://gpcardio.org/de/2018-05-16_folien-hausarztliche-versorgung-in-italien/
https://gpcardio.org/de/2018-05-16_kardiovaskulare-hausarztliche-versorgung-in-italien/
https://gpcardio.org/de/2018-05-22_lipidsenkung-die-evidenz-die-leitlinien-die-klinische-realitat/
https://gpcardio.org/de/2018-06-15_semergen-die-dekanin-der-familienmedizin-in-spanien/
https://gpcardio.org/de/2018-06-15_semergen-spanische-gesellschaft-fur-hausarztinnen-und-hausarzte/
https://gpcardio.org/de/2018-06-19_spanien-epccs-einfuhrung/
https://gpcardio.org/de/2018-07-18_komplexitaten-im-management-von-herzinsuffizienz/
https://gpcardio.org/de/2018-08-16_hypertonie-konnen-wir-uns-auf-diagnostische-und-therapeutische-schwellenwerte-einigen/
https://gpcardio.org/de/2018-08-22_management-erhohter-lipide-in-der-hausarztlichen-versorgung/
https://gpcardio.org/de/2018-10-22_forderung-von-lebensstilanderungen-zur-senkung-des-kardiovaskularen-risikos-in-der-pzz/
https://gpcardio.org/de/2018-10-22_hausarztin-hausarzt-in-danemark/
https://gpcardio.org/de/2018-10-22_management-der-dyslipidamie-in-der-primaren-gesundheitsversorgung/
https://gpcardio.org/de/2018-10-22_praktische-leitlinie-zur-diagnose-und-behandlung-von-herzinsuffizienz-in-der-primaren-gesundheitsversorgung/
https://gpcardio.org/de/2018-10-23_pravention-nichtubertragbarer-kardiovaskularer-erkrankungen-in-der-hausarztlichen-versorgung-in-russland/
https://gpcardio.org/de/2018-10-25_management-erhohter-lipide-in-der-primaren-gesundheitsversorgung/
https://gpcardio.org/de/2018-10-30_wege-zur-forderung-von-verhaltensanderungen-zur-senkung-des-kardiovaskularen-risikos-in-der-hausarztlichen-versorgung/
https://gpcardio.org/de/2018-12-03_hausarztliche-kardiovaskulare-versorgung-in-serbien-englisch/
https://gpcardio.org/de/2018-12-04_hausarztliche-kardiovaskulare-versorgung-in-der-tschechischen-republik-englisch/
https://gpcardio.org/de/2018-12-04_hausarztliche-kardiovaskulare-versorgung-in-der-tschechischen-republik-tschechisch/
https://gpcardio.org/de/2018-12-04_hausarztliche-kardiovaskulare-versorgung-in-der-ukraine-englisch/
https://gpcardio.org/de/2018-12-04_hausarztliche-kardiovaskulare-versorgung-in-der-ukraine-ukrainisch/
https://gpcardio.org/de/2018-12-04_hausarztliche-kardiovaskulare-versorgung-in-montenegro-englisch/
https://gpcardio.org/de/2018-12-04_hausarztliche-kardiovaskulare-versorgung-in-serbien-serbisch/
https://gpcardio.org/de/2018-12-05_hausarztliche-kardiovaskulare-versorgung-in-belgien-englisch/
https://gpcardio.org/de/2018-12-05_hausarztliche-kardiovaskulare-versorgung-in-belgien-flamisch/
https://gpcardio.org/de/2018-12-05_hausarztliche-kardiovaskulare-versorgung-in-der-slowakei-englisch/
https://gpcardio.org/de/2018-12-05_hausarztliche-kardiovaskulare-versorgung-in-der-slowakei-slowakisch/
https://gpcardio.org/de/2018-12-05_hausarztliche-kardiovaskulare-versorgung-in-polen-englisch/
https://gpcardio.org/de/2018-12-05_hausarztliche-kardiovaskulare-versorgung-in-polen-polnisch/
https://gpcardio.org/de/2018-12-07_hausarztliche-kardiovaskulare-versorgung-in-deutschland-deutsch/
https://gpcardio.org/de/2018-12-07_hausarztliche-kardiovaskulare-versorgung-in-deutschland-englisch/
https://gpcardio.org/de/2018-12-10_hausarztliche-kardiovaskulare-versorgung-in-der-turkei-turkisch/
https://gpcardio.org/de/2018-12-10_hausarztliche-kardiovaskulare-versorgung-in-irland-englisch/
https://gpcardio.org/de/2018-12-13_hausarztliche-kardiovaskulare-versorgung-in-der-turkei-englisch/
https://gpcardio.org/de/2018-12-17_hausarztliche-kardiovaskulare-versorgung-in-danemark-danisch/
https://gpcardio.org/de/2018-12-17_hausarztliche-kardiovaskulare-versorgung-in-danemark-englisch/
https://gpcardio.org/de/2018-12-17_hausarztliche-kardiovaskulare-versorgung-in-montenegro-montenegrinisch/
https://gpcardio.org/de/2018-12-17_hausarztliche-kardiovaskulare-versorgung-in-rumanien-rumanisch/
https://gpcardio.org/de/2018-12-17_hausarztliche-kardiovaskulare-versorgung-in-spanien-englisch/
https://gpcardio.org/de/2018-12-17_hausarztliche-kardiovaskulare-versorgung-in-spanien-spanisch/
https://gpcardio.org/de/2018-12-18_folien-kernbotschaften-der-epccs-leitlinie-zum-management-erhohter-lipide-in-der-hausarztlichen-versorgung/
https://gpcardio.org/de/2019-01-10_hausarztliche-kardiovaskulare-versorgung-in-spanien-englisch/
https://gpcardio.org/de/2019-01-10_hausarztliche-kardiovaskulare-versorgung-in-spanien-spanisch/
https://gpcardio.org/de/2019-02-07_epccs-gesellschaft-was-steht-mitgliedern-zur-verfugung/
https://gpcardio.org/de/2019-02-25_aktuelles-management-von-diabetes-und-kardiovaskularem-risiko-in-der-hausarztlichen-versorgung/
https://gpcardio.org/de/2019-03-28_diabetes-und-kardiovaskulares-risiko/
https://gpcardio.org/de/2019-03-28_update-zur-schlaganfallpravention-bei-vorhofflimmern/
https://gpcardio.org/de/2019-03-28_wie-geht-man-mit-den-herausforderungen-der-multimorbiditat-in-der-hausarztlichen-praxis-um/
https://gpcardio.org/de/2019-04-02_folien-aktuelle-updates-zu-den-internationalen-hypertonie-leitlinien-wo-unterscheiden-sie-sich-und-worauf-sollten-wir-uns-in-der-hausarztlichen-versorgung-einigen/
https://gpcardio.org/de/2019-04-02_folien-cvd-und-psychische-gesundheit/
https://gpcardio.org/de/2019-04-02_folien-diabetes-und-kardiovaskulares-risiko/
https://gpcardio.org/de/2019-04-02_folien-komplexitaten-im-management-von-herzinsuffizienz/
https://gpcardio.org/de/2019-04-02_folien-multimorbiditat-kardiovaskulare-erkrankung-und-polypharmazie/
https://gpcardio.org/de/2019-04-02_folien-update-zur-schlaganfallpravention-bei-vorhofflimmern/
https://gpcardio.org/de/2019-04-02_folien-welche-evidenz-gibt-es-dafur-dass-diabetes-mit-dem-cvd-risiko-verknupft-ist/
https://gpcardio.org/de/2019-04-03_komplexitaten-im-management-von-herzinsuffizienz/
https://gpcardio.org/de/2019-04-24_aktuelle-updates-zu-den-internationalen-hypertonie-leitlinien-wo-unterscheiden-sie-sich-und-worauf-sollten-wir-uns-in-der-hausarztlichen-versorgung-einigen/
https://gpcardio.org/de/2019-04-25_bildung-austausch-anleitung-und-interaktion-beim-epccs-summit-2019/
https://gpcardio.org/de/2019-05-02_folien-cvd-bei-diabetes-ins-visier-nehmen-neuartige-strategien-zur-bewaltigung-des-risikos/
https://gpcardio.org/de/2019-05-02_folien-management-von-diabetes-in-der-taglichen-kardiovaskularen-praxis-ein-multidisziplinarer-ansatz/
https://gpcardio.org/de/2019-05-02_folien-typ-2-diabetes-und-kardiovaskulare-outcomes-mehr-als-glukosemanagement-erkenntnisse-aus-glp1-ra-studien/
https://gpcardio.org/de/2019-05-07_schlaganfallpravention-bei-vorhofflimmern/
https://gpcardio.org/de/2019-05-21_update-zum-management-des-kardiovaskularen-risikos-bei-diabetes-was-zeigt-die-evidenz/
https://gpcardio.org/de/2019-06-18_neuer-diagnostischer-algorithmus-und-therapeutische-optionen-im-hf-management/
https://gpcardio.org/de/2019-08-13_folien-kernbotschaften-der-epccs-leitlinie-zum-aktuellen-management-von-diabetes-und-kardiovaskularem-risiko-in-der-hausarztlichen-versorgung/
https://gpcardio.org/de/2019-08-29_diagnose-und-management-von-hypertonie-in-der-hausarztlichen-versorgung/
https://gpcardio.org/de/2019-10-02_ausweitung-der-epccs-auf-europaische-lander-was-geplant-ist/
https://gpcardio.org/de/2019-10-03_epccs-und-hausarztliche-kardiovaskulare-versorgung-in-der-slowakei-englisch/
https://gpcardio.org/de/2019-10-03_epccs-und-hausarztliche-kardiovaskulare-versorgung-in-der-slowakei-slowakisch/
https://gpcardio.org/de/2019-10-03_epccs-und-hausarztliche-kardiovaskulare-versorgung-in-serbien/
https://gpcardio.org/de/2019-10-03_epccs-und-hausarztliche-kardiovaskulare-versorgung-in-spanien-englisch/
https://gpcardio.org/de/2019-10-03_epccs-und-hausarztliche-kardiovaskulare-versorgung-in-spanien-spanisch/
https://gpcardio.org/de/2019-10-03_wie-die-epccs-hausarztlichem-fachpersonal-in-ganz-europa-helfen-mochte-kardiovaskulares-risiko-zu-erkennen-und-zu-managen-griechisch/
https://gpcardio.org/de/2019-10-09_wie-die-epccs-hausarztlichem-fachpersonal-in-ganz-europa-helfen-mochte-kardiovaskulares-risiko-zu-erkennen-und-zu-managen-englisch/
https://gpcardio.org/de/2019-10-29_diagnose-und-behandlung-von-hypertonie-in-der-primaren-gesundheitsversorgung-serbische-zusammenfassung-der-epccs-leitlinie-zu-hypertonie/
https://gpcardio.org/de/2019-10-29_diagnose-und-management-von-hypertonie-in-der-hausarztlichen-versorgung-franzosische-zusammenfassung/
https://gpcardio.org/de/2019-10-29_diagnose-und-management-von-hypertonie-in-der-hausarztlichen-versorgung-griechische-zusammenfassung/
https://gpcardio.org/de/2019-10-29_diagnose-und-management-von-hypertonie-in-der-hausarztlichen-versorgung-ukrainische-zusammenfassung/
https://gpcardio.org/de/2019-10-29_griechische-gesellschaften-im-bereich-der-hausarztlichen-versorgung/
https://gpcardio.org/de/2019-10-29_societe-francaise-de-medecine-generale-sfmg/
https://gpcardio.org/de/2019-11-04_epccs-und-hausarztliche-kardiovaskulare-versorgung-in-der-turkei/
https://gpcardio.org/de/2019-11-04_epccs-und-hausarztliche-kardiovaskulare-versorgung-in-der-ukraine/
https://gpcardio.org/de/2019-11-04_epccs-und-hausarztliche-kardiovaskulare-versorgung-in-frankreich/
https://gpcardio.org/de/2019-11-04_epccs-und-hausarztliche-kardiovaskulare-versorgung-in-irland/
https://gpcardio.org/de/2019-11-04_epccs-und-hausarztliche-kardiovaskulare-versorgung-in-polen-englisch/
https://gpcardio.org/de/2019-11-04_epccs-und-hausarztliche-kardiovaskulare-versorgung-in-polen-polnisch/
https://gpcardio.org/de/2019-11-12_herzinsuffizienz-und-komorbiditaten-nierenerkrankung-und-krebs/
https://gpcardio.org/de/2020-04-09_initiale-invasive-oder-konservative-strategie-bei-stabiler-koronarer-herzkrankheit/
https://gpcardio.org/de/2020-04-14_wirkung-von-dapagliflozin-auf-die-verschlechterung-der-herzinsuffizienz-und-den-kardiovaskularen-tod-bei-patienten-mit-herzinsuffizienz-mit-und-ohne-diabetes/
https://gpcardio.org/de/2020-04-16_inclisiran-zur-behandlung-der-heterozygoten-familiaren-hypercholesterinamie/
https://gpcardio.org/de/2020-04-16_zwei-phase-3-studien-zu-inclisiran-bei-patienten-mit-erhohtem-ldl-cholesterin/
https://gpcardio.org/de/2020-04-23_management-der-koronaren-herzkrankheit-bei-patienten-mit-fortgeschrittener-nierenerkrankung/
https://gpcardio.org/de/2020-04-25_clopidogrel-versus-ticagrelor-oder-prasugrel-bei-patienten-im-alter-von-70-jahren-oder-alter-mit-nicht-st-streckenhebungs-akutem-koronarsyndrom-popular-age/
https://gpcardio.org/de/2020-05-01_optimale-antithrombotische-regime-fur-patienten-mit-vorhofflimmern-die-sich-einer-perkutanen-koronarintervention-unterziehen/
https://gpcardio.org/de/2020-05-02_wirksamkeit-der-kathetergestutzten-renalen-denervierung-ohne-antihypertensive-medikamente-spyral-htn-off-med-pivotal/
https://gpcardio.org/de/2020-05-05_zehn-jahres-ergebnisse-nach-medikamentenbeschichteten-stents-versus-koronarer-bypass-operation-bei-linker-hauptstamm-koronarerkrankung/
https://gpcardio.org/de/2020-05-09_monotherapie-mit-einem-p2y12-hemmer-oder-aspirin-zur-sekundarpravention-bei-patienten-mit-etablierter-atherosklerose/
https://gpcardio.org/de/2020-05-12_klinisches-management-der-stabilen-koronaren-herzkrankheit-bei-patienten-mit-typ-2-diabetes-mellitus/
https://gpcardio.org/de/2020-05-14_vericiguat-bei-patienten-mit-herzinsuffizienz-und-reduzierter-ejektionsfraktion/
https://gpcardio.org/de/2020-05-19_zusammenhang-zwischen-blutdrucksenkung-und-inzidenter-demenz-oder-kognitiver-beeintrachtigung/
https://gpcardio.org/de/2020-05-26_weltweite-pravalenz-der-familiaren-hypercholesterinamie/
https://gpcardio.org/de/2020-05-26_wirkung-der-reduktion-antihypertensiver-medikation-versus-ublicher-versorgung-auf-die-kurzfristige-blutdruckkontrolle-bei-patienten-mit-hypertonie-im-alter-von-80-jahren-und-alter/
https://gpcardio.org/de/2020-06-16_wirkung-von-ticagrelor-monotherapie-versus-ticagrelor-mit-aspirin-auf-schwere-blutungen-und-kardiovaskulare-ereignisse-bei-patienten-mit-akutem-koronarsyndrom/
https://gpcardio.org/de/2020-07-07_erkennung-prognose-und-therapie-der-systemischen-amyloidose/
https://gpcardio.org/de/2020-07-11_schatzung-des-lebenszeitnutzens-umfassender-krankheitsmodifizierender-pharmakologischer-therapien-bei-patienten-mit-herzinsuffizienz-mit-reduzierter-ejektionsfraktion/
https://gpcardio.org/de/2020-07-14_vergleichende-wirksamkeit-und-sicherheit-oraler-p2y12-hemmer-bei-akutem-koronarsyndrom/
https://gpcardio.org/de/2020-07-14_zusammenhang-zwischen-radialarterien-graft-versus-vena-saphena-graft-und-langfristigen-kardiovaskularen-endpunkten-bei-patienten-mit-koronarer-bypass-operation/
https://gpcardio.org/de/2020-08-01_vollstandige-versus-nur-auf-die-culprit-lasion-beschrankte-revaskularisation-bei-st-hebungsinfarkt/
https://gpcardio.org/de/2020-08-04_acc-expertenkonsens-2020-entscheidungspfad-zum-management-von-blutungen-bei-patienten-unter-oralen-antikoagulanzien/
https://gpcardio.org/de/2020-08-07_integriertes-management-von-vorhofflimmern-in-der-hausarztlichen-versorgung/
https://gpcardio.org/de/2020-08-11_sicherheit-und-wirksamkeit-des-absetzens-von-aspirin-unter-fortgesetzter-p2y12-hemmer-therapie-bei-patienten-nach-perkutaner-koronarintervention/
https://gpcardio.org/de/2020-08-20_evinacumab-bei-homozygoter-familiarer-hypercholesterinamie/
https://gpcardio.org/de/2020-08-25_wirkung-der-genotypgesteuerten-auswahl-oraler-p2y12-hemmer-versus-konventioneller-clopidogrel-therapie-auf-ischamische-endpunkte-nach-perkutaner-koronarintervention/
https://gpcardio.org/de/2020-09-01_expertenkonsens-2020-entscheidungspfad-zu-neuartigen-therapien-zur-kardiovaskularen-risikoreduktion-bei-patienten-mit-typ-2-diabetes/
https://gpcardio.org/de/2020-09-07_mortalitat-nach-medikamentenfreisetzenden-stents-versus-koronarer-bypass-operation-bei-erkrankung-des-linken-hauptstamms/
https://gpcardio.org/de/2020-09-14_wirkungen-von-glucagon-like-peptide-1-rezeptoragonisten-auf-schwerwiegende-kardiovaskulare-ereignisse-bei-patienten-mit-typ-2-diabetes-mellitus-mit-oder-ohne-etablierte-kardiovaskulare-erkrankung/
https://gpcardio.org/de/2020-09-19_sglt2-hemmer-bei-patienten-mit-herzinsuffizienz-mit-reduzierter-ejektionsfraktion/
https://gpcardio.org/de/2020-10-01_evolocumab-bei-padiatrischer-heterozygoter-familiarer-hypercholesterinamie/
https://gpcardio.org/de/2020-10-01_fruhe-rhythmuskontrolltherapie-bei-patienten-mit-vorhofflimmern/
https://gpcardio.org/de/2020-10-01_naturlicher-verlauf-der-asymptomatischen-schweren-aortenklappenstenose-und-zusammenhang-zwischen-fruher-intervention-und-endpunkten/
https://gpcardio.org/de/2020-10-08_dapagliflozin-bei-patienten-mit-chronischer-nierenerkrankung/
https://gpcardio.org/de/2020-10-08_kardiovaskulare-endpunkte-unter-ertugliflozin-bei-typ-2-diabetes/
https://gpcardio.org/de/2020-10-08_kardiovaskulare-und-renale-endpunkte-unter-empagliflozin-bei-herzinsuffizienz/
https://gpcardio.org/de/2020-10-10_prasugrel-basierte-deeskalation-der-dualen-thrombozytenaggregationshemmung-nach-perkutaner-koronarintervention-bei-patienten-mit-akutem-koronarsyndrom-host-reduce-polytech-acs/
https://gpcardio.org/de/2020-10-13_duale-thrombozytenaggregationshemmung-nach-perkutaner-koronarintervention-und-medikamentenfreisetzenden-stents/
https://gpcardio.org/de/2020-10-29_niedrig-dosiertes-edoxaban-bei-sehr-alten-patienten-mit-vorhofflimmern/
https://gpcardio.org/de/2020-10-31_neuentwicklung-und-validierung-des-syntax-score-ii-zur-individualisierung-der-entscheidungsfindung-zwischen-perkutaner-und-chirurgischer-revaskularisation-bei-patienten-mit-komplexer-koronarer-herzkra/
https://gpcardio.org/de/2020-11-07_vollstandige-revaskularisation-reduziert-kardiovaskularen-tod-bei-patienten-mit-st-hebungsinfarkt-und-mehrgefaserkrankung/
https://gpcardio.org/de/2020-11-10_screening-auf-bluthochdruck-bei-kindern-und-jugendlichen/
https://gpcardio.org/de/2020-11-17_colchicin-bei-patienten-mit-akutem-koronarsyndrom/
https://gpcardio.org/de/2020-11-21_die-senkung-des-lipoprotein-a-durch-alirocumab-reduziert-die-gesamtlast-kardiovaskularer-ereignisse-unabhangig-von-der-senkung-des-ldl-cholesterins/
https://gpcardio.org/de/2020-11-21_wirksamkeit-und-sicherheit-der-senkung-des-ldl-cholesterins-bei-alteren-patienten/
https://gpcardio.org/de/2020-11-26_n-of-1-studie-mit-statin-placebo-oder-keiner-behandlung-zur-beurteilung-von-nebenwirkungen/
https://gpcardio.org/de/2020-11-26_rivaroxaban-bei-patienten-mit-vorhofflimmern-und-biologischer-mitralklappenprothese/
https://gpcardio.org/de/2020-12-08_wirkung-hochdosierter-omega-3-fettsauren-versus-maiskeimol-auf-schwerwiegende-unerwunschte-kardiovaskulare-ereignisse-bei-patienten-mit-hohem-kardiovaskularem-risiko/
https://gpcardio.org/de/2020-12-10_evinacumab-bei-patienten-mit-therapierefraktarer-hypercholesterinamie/
https://gpcardio.org/de/2020-12-12_eisencarboxymaltose-bei-eisenmangel-zum-entlassungszeitpunkt-nach-akuter-herzinsuffizienz/
https://gpcardio.org/de/2020-12-22_wirkung-von-digoxin-versus-bisoprolol-zur-frequenzkontrolle-bei-vorhofflimmern-auf-die-von-patienten-berichtete-lebensqualitat/
https://gpcardio.org/de/2021-01-14_aktivierung-des-kardialen-myosins-mit-omecamtiv-mecarbil-bei-systolischer-herzinsuffizienz/
https://gpcardio.org/de/2021-01-14_sotagliflozin-bei-patienten-mit-diabetes-und-chronischer-nierenerkrankung/
https://gpcardio.org/de/2021-01-14_sotagliflozin-bei-patienten-mit-diabetes-und-kurzlicher-verschlechterung-der-herzinsuffizienz/
https://gpcardio.org/de/2021-01-21_kurze-duale-thrombozytenaggregationshemmung-gefolgt-von-p2y12-hemmer-monotherapie-versus-verlangerte-duale-thrombozytenaggregationshemmung-nach-perkutaner-koronarintervention-mit-medikamentenfreisetze/
https://gpcardio.org/de/2021-01-21_polypille-mit-oder-ohne-aspirin-bei-personen-ohne-kardiovaskulare-erkrankung/
https://gpcardio.org/de/2021-01-26_randomisierte-studie-zu-empagliflozin-bei-nicht-diabetischen-patienten-mit-herzinsuffizienz-und-reduzierter-ejektionsfraktion/
https://gpcardio.org/de/2021-01-28_inhaliertes-treprostinil-bei-pulmonaler-hypertonie-infolge-interstitieller-lungenerkrankung/
https://gpcardio.org/de/2021-01-28_kryoablation-oder-medikamententherapie-zur-initialen-behandlung-von-vorhofflimmern/
https://gpcardio.org/de/2021-01-28_kryoballon-ablation-als-initiale-therapie-bei-vorhofflimmern/
https://gpcardio.org/de/2021-02-01_zusammenhang-zwischen-sglt2-hemmern-und-kardiovaskularen-sowie-renalen-endpunkten-bei-patienten-mit-typ-2-diabetes/
https://gpcardio.org/de/2021-02-09_acc-expertenkonsens-2020-entscheidungspfad-fur-die-antikoagulative-und-antithrombozytare-therapie-bei-patienten-mit-vorhofflimmern-oder-venoser-thromboembolie-die-sich-einer-perkutanen-koronarinterven/
https://gpcardio.org/de/2021-02-09_finerenon-und-kardiovaskulare-endpunkte-bei-patienten-mit-chronischer-nierenerkrankung-und-typ-2-diabetes/
https://gpcardio.org/de/2021-02-09_wirkung-von-hochintensivem-intervalltraining-moderatem-kontinuierlichem-training-oder-leitlinienbasierter-beratung-zu-korperlicher-aktivitat-auf-die-spitzensauerstoffaufnahme-bei-patienten-mit-herzins/
https://gpcardio.org/de/2021-02-16_aktualisierung-2021-zum-acc-expertenkonsens-entscheidungspfad-2017-zur-optimierung-der-herzinsuffizienztherapie/
https://gpcardio.org/de/2021-03-02_3-jahres-ergebnisse-der-transkatheter-mitralklappenreparatur-bei-patienten-mit-herzinsuffizienz/
https://gpcardio.org/de/2021-03-16_wirkung-der-supplementierung-mit-marinen-omega-3-fettsauren-und-vitamin-d-auf-neu-aufgetretenes-vorhofflimmern/
https://gpcardio.org/de/2021-03-31_wirkungen-von-dapagliflozin-auf-die-mortalitat-bei-patienten-mit-chronischer-nierenerkrankung/
https://gpcardio.org/de/2021-04-07_esc-leitlinien-2020-fur-das-management-des-akuten-koronarsyndroms-bei-patienten-ohne-persistierende-st-streckenhebung/
https://gpcardio.org/de/2021-04-17_gesteuerte-versus-standardmasige-thrombozytenaggregationshemmer-therapie-bei-patienten-mit-perkutaner-koronarintervention/
https://gpcardio.org/de/2021-05-01_pharmakologische-blutdrucksenkung-zur-primar-und-sekundarpravention-kardiovaskularer-erkrankungen-uber-verschiedene-blutdruckniveaus-hinweg/
https://gpcardio.org/de/2021-05-05_verursachen-betablocker-depressionen/
https://gpcardio.org/de/2021-05-20_abschlussbericht-einer-studie-zur-intensiven-versus-standardmasigen-blutdruckkontrolle/
https://gpcardio.org/de/2021-05-27_vergleichende-wirksamkeit-der-aspirin-dosierung-bei-kardiovaskularer-erkrankung/
https://gpcardio.org/de/2021-06-01_bewertung-der-katheterablation-oder-antiarrhythmischer-medikamente-als-erstlinientherapie-bei-vorhofflimmern/
https://gpcardio.org/de/2021-06-03_verschluss-des-linken-vorhofohrs-wahrend-einer-herzoperation-zur-schlaganfallpravention/
https://gpcardio.org/de/2021-06-26_aspirin-versus-clopidogrel-fur-die-chronische-erhaltungsmonotherapie-nach-perkutaner-koronarintervention-host-exam/
https://gpcardio.org/de/2021-06-26_ultraschallbasierte-renale-denervation-bei-hypertonie-die-gegenuber-einer-dreifachkombinationstablette-resistent-ist-radiance-htn-trio/
https://gpcardio.org/de/2021-07-10_wirksamkeit-und-sicherheit-des-neuartigen-dualen-gip-und-glp-1-rezeptoragonisten-tirzepatid-bei-patienten-mit-typ-2-diabetes-surpass-1/
https://gpcardio.org/de/2021-07-15_korperliche-rehabilitation-fur-altere-patienten-die-wegen-herzinsuffizienz-hospitalisiert-wurden/
https://gpcardio.org/de/2021-07-21_wirksamkeit-und-sicherheit-von-niedrig-dosiertem-colchicin-bei-patienten-mit-koronarer-herzerkrankung/
https://gpcardio.org/de/2021-07-22_multivessel-pci-gesteuert-durch-ffr-oder-angiographie-bei-myokardinfarkt/
https://gpcardio.org/de/2021-08-05_milrinon-im-vergleich-zu-dobutamin-bei-der-behandlung-des-kardiogenen-schocks/
https://gpcardio.org/de/2021-08-14_einmal-wochentliche-tirzepatid-gabe-versus-einmal-tagliches-insulin-degludec-als-zusatztherapie-zu-metformin-mit-oder-ohne-sglt2-hemmer-bei-patienten-mit-typ-2-diabetes-surpass-3/
https://gpcardio.org/de/2021-08-17_senkung-von-cholesterin-blutdruck-oder-beidem-zur-pravention-kardiovaskularer-ereignisse/
https://gpcardio.org/de/2021-08-31_acc-expertenkonsens-2021-entscheidungspfad-fur-das-management-der-ascvd-risikoreduktion-bei-patienten-mit-persistierender-hypertriglyzeridamie/
https://gpcardio.org/de/2021-09-02_kardiovaskulare-und-renale-endpunkte-unter-efpeglenatid-bei-typ-2-diabetes/
https://gpcardio.org/de/2021-09-11_hamodynamisch-gefuhrtes-management-der-herzinsuffizienz-guide-hf/
https://gpcardio.org/de/2021-09-16_wirkung-des-salzersatzes-auf-kardiovaskulare-ereignisse-und-tod/
https://gpcardio.org/de/2021-09-18_initiale-behandlung-mit-einer-einzeltablette-die-eine-vierfachkombination-aus-viertel-dosen-von-blutdruckmedikamenten-enthalt-versus-standarddosis-monotherapie-bei-patienten-mit-hypertonie-quartet/
https://gpcardio.org/de/2021-09-30_studie-zur-intensiven-blutdruckkontrolle-bei-alteren-patienten-mit-hypertonie/
https://gpcardio.org/de/2021-10-09_ungesteuerte-deeskalation-von-ticagrelor-auf-clopidogrel-bei-stabilisierten-patienten-mit-akutem-myokardinfarkt-nach-perkutaner-koronarintervention-talos-ami/
https://gpcardio.org/de/2021-10-14_empagliflozin-bei-herzinsuffizienz-mit-erhaltener-ejektionsfraktion/
https://gpcardio.org/de/2021-10-14_empagliflozin-und-wichtige-renale-endpunkte-bei-herzinsuffizienz/
https://gpcardio.org/de/2021-10-19_wirkung-von-empagliflozin-auf-ereignisse-der-verschlechterung-der-herzinsuffizienz-bei-patienten-mit-herzinsuffizienz-und-erhaltener-ejektionsfraktion/
https://gpcardio.org/de/2021-10-23_klinische-endpunkte-beim-systematischen-screening-auf-vorhofflimmern-strokestop/
https://gpcardio.org/de/2021-10-28_duale-thrombozytenaggregationshemmung-nach-pci-bei-patienten-mit-hohem-blutungsrisiko/
https://gpcardio.org/de/2021-11-02_influenza-impfung-nach-myokardinfarkt/
https://gpcardio.org/de/2021-11-11_angiotensin-rezeptor-neprilysin-inhibition-bei-akutem-myokardinfarkt/
https://gpcardio.org/de/2021-11-13_blutdrucksenkung-und-risiko-fur-neu-auftretenden-typ-2-diabetes/
https://gpcardio.org/de/2021-11-13_tirzepatid-versus-insulin-glargin-bei-typ-2-diabetes-und-erhohtem-kardiovaskularem-risiko-surpass-4/
https://gpcardio.org/de/2021-12-02_edoxaban-versus-vitamin-k-antagonist-bei-vorhofflimmern-nach-tavr/
https://gpcardio.org/de/2021-12-04_posteriore-linke-perikardiotomie-zur-pravention-von-vorhofflimmern-nach-herzoperation/
https://gpcardio.org/de/2021-12-07_av-knoten-ablation-und-kardiale-resynchronisation-bei-patienten-mit-permanentem-vorhofflimmern-und-schmalem-qrs-komplex/
https://gpcardio.org/de/2021-12-09_kardiovaskulare-ereignisse-unter-finerenon-bei-nierenerkrankung-und-typ-2-diabetes/
https://gpcardio.org/de/2021-12-11_angiographisch-quantitativer-flow-ratio-gesteuerte-koronare-intervention-favor-iii-china/
https://gpcardio.org/de/2021-12-18_perkutane-koronarintervention-mit-medikamentenfreisetzenden-stents-versus-koronare-bypass-operation-bei-hauptstammstenose-der-linken-koronararterie/
https://gpcardio.org/de/2021-12-21_wirkung-einer-langfristigen-supplementierung-mit-marinen-omega-3-fettsauren-auf-das-risiko-fur-vorhofflimmern-in-randomisierten-kontrollierten-studien-zu-kardiovaskularen-endpunkten/
https://gpcardio.org/de/2021-12-30_angiographie-nach-auserklinischem-herzstillstand-ohne-st-strecken-hebung/
https://gpcardio.org/de/2021-12-30_chlortalidon-bei-hypertonie-im-rahmen-fortgeschrittener-chronischer-nierenerkrankung/
https://gpcardio.org/de/2022-01-13_durch-fraktionelle-flussreserve-gesteuerte-pci-im-vergleich-zur-koronaren-bypass-operation/
https://gpcardio.org/de/2022-01-18_leitlinie-2021-des-acc-aha-scai-zur-koronaren-revaskularisation/
https://gpcardio.org/de/2022-01-25_direkte-orale-antikoagulanzien-versus-warfarin-bei-patienten-mit-vorhofflimmern/
https://gpcardio.org/de/2022-01-25_screening-auf-vorhofflimmern/
https://gpcardio.org/de/2022-02-08_finerenon-senkt-das-risiko-einer-neu-auftretenden-herzinsuffizienz-bei-patienten-mit-chronischer-nierenerkrankung-und-typ-2-diabetes/
https://gpcardio.org/de/2022-02-10_kardiovaskulare-und-renale-endpunkte-unter-finerenon-bei-patienten-mit-typ-2-diabetes-und-chronischer-nierenerkrankung/
https://gpcardio.org/de/2022-03-07_vergleichende-effekte-einer-gesteuerten-versus-einer-potenten-p2y12-hemmer-therapie-beim-akuten-koronarsyndrom/
https://gpcardio.org/de/2022-03-21_systematische-fruhe-rhythmuskontrollstrategie-bei-vorhofflimmern-bei-patienten-mit-oder-ohne-symptome/
https://gpcardio.org/de/2022-04-09_reduktion-der-nahrungsnatriumzufuhr-auf-unter-100-mmol-bei-herzinsuffizienz-sodium-hf/
https://gpcardio.org/de/2022-04-09_sicherheit-des-oralen-faktor-xia-inhibitors-asundexian-im-vergleich-zu-apixaban-bei-patienten-mit-vorhofflimmern-pacific-af/
https://gpcardio.org/de/2022-04-26_aspirin-einnahme-zur-pravention-kardiovaskularer-erkrankungen/
https://gpcardio.org/de/2022-05-03_leitlinie-2022-der-aha-acc-hfsa-zum-management-der-herzinsuffizienz/
https://gpcardio.org/de/2022-05-03_leitlinie-2022-der-aha-acc-hfsa-zum-management-der-herzinsuffizienz/
https://gpcardio.org/de/2022-05-03_leitlinie-2022-der-aha-acc-hfsa-zum-management-der-herzinsuffizienz/
https://gpcardio.org/de/2022-05-10_wirkung-von-alirocumab-als-zusatz-zu-einer-hochintensiven-statintherapie-auf-die-koronare-atherosklerose-bei-patienten-mit-akutem-myokardinfarkt/
https://gpcardio.org/de/2022-05-12_behandlung-leichter-chronischer-hypertonie-in-der-schwangerschaft/
https://gpcardio.org/de/2022-05-21_bariatrische-chirurgie-und-kardiovaskulare-erkrankungen/
https://gpcardio.org/de/2022-05-31_auswirkungen-langfristiger-metformin-und-lebensstilinterventionen-auf-kardiovaskulare-ereignisse-im-diabetes-prevention-program-und-seiner-outcome-studie/
https://gpcardio.org/de/2022-06-02_notwendigkeit-eines-neustarts-und-aufholens-bei-der-cvd-pravention-in-zeiten-von-covid-19/
https://gpcardio.org/de/2022-06-07_randomisierte-studie-zu-ablationsbasierter-rhythmuskontrolle-versus-frequenzkontrolle-bei-patienten-mit-herzinsuffizienz-und-vorhofflimmern/
https://gpcardio.org/de/2022-06-21_beeinflusst-der-zeitpunkt-der-katheterablation-bei-ventrikularer-tachykardie-die-prognose-bei-patienten-mit-implantierbarem-kardioverter-defibrillator-ergebnisse-der-multizentrischen-randomisierten-pa/
https://gpcardio.org/de/2022-06-21_wirkung-mrt-gesteuerter-fibroseablation-im-vergleich-zur-konventionellen-katheterablation-auf-das-wiederauftreten-atrialer-arrhythmien-bei-patienten-mit-persistierendem-vorhofflimmern/
https://gpcardio.org/de/2022-07-19_wirkung-von-omecamtiv-mecarbil-auf-die-belastungskapazitat-bei-chronischer-herzinsuffizienz-mit-reduzierter-ejektionsfraktion/
https://gpcardio.org/de/2022-07-26_verhaltensberatungsinterventionen-zur-forderung-einer-gesunden-ernahrung-und-korperlicher-aktivitat-zur-kardiovaskularen-pravention-bei-erwachsenen-ohne-kardiovaskulare-risikofaktoren/
https://gpcardio.org/de/2022-07-26_wirkungen-eines-fruhen-beginns-von-empagliflozin-auf-diurese-und-nierenfunktion-bei-patienten-mit-akut-dekompensierter-herzinsuffizienz-empag-hf/
https://gpcardio.org/de/2022-07-26_wirkungen-von-empagliflozin-auf-symptome-korperliche-einschrankungen-und-lebensqualitat-bei-patienten-die-wegen-akuter-herzinsuffizienz-hospitalisiert-wurden/
https://gpcardio.org/de/2022-07-30_langfristige-wirksamkeit-und-sicherheit-einer-kombinationstherapie-aus-mittelintensivem-statin-mit-ezetimib-versus-hochintensiver-statin-monotherapie-bei-patienten-mit-atherosklerotischer-kardiovaskul/
https://gpcardio.org/de/2022-08-09_anfanglicher-abfall-dip-der-geschatzten-glomerularen-filtrationsrate-nach-beginn-von-dapagliflozin-bei-patienten-mit-herzinsuffizienz-und-reduzierter-ejektionsfraktion/
https://gpcardio.org/de/2022-08-23_statin-einnahme-zur-primaren-pravention-kardiovaskularer-erkrankungen-bei-erwachsenen/
https://gpcardio.org/de/2022-08-23_statin-einnahme-zur-primaren-pravention-kardiovaskularer-erkrankungen-bei-erwachsenen/
https://gpcardio.org/de/2022-08-30_empagliflozin-bei-herzinsuffizienz-mit-erhaltener-linksventrikularer-ejektionsfraktion-mit-und-ohne-diabetes/
https://gpcardio.org/de/2022-09-01_fraktionelle-flussreserve-oder-intravaskulare-ultraschalluntersuchung-zur-steuerung-der-pci/
https://gpcardio.org/de/2022-09-03_sglt-2-hemmer-bei-patienten-mit-herzinsuffizienz/
https://gpcardio.org/de/2022-09-07_pravalenz-der-statinunvertraglichkeit/
https://gpcardio.org/de/2022-09-08_routinemasige-funktionstestung-oder-standardversorgung-bei-hochrisikopatienten-nach-pci/
https://gpcardio.org/de/2022-09-10_wirkung-der-statintherapie-auf-muskulare-symptome/
https://gpcardio.org/de/2022-09-13_fruhe-rhythmuskontrolle-bei-patienten-mit-vorhofflimmern-und-hoher-komorbiditatslast/
https://gpcardio.org/de/2022-09-15_polypill-strategie-in-der-kardiovaskularen-sekundarpravention/
https://gpcardio.org/de/2022-09-15_rivaroxaban-bei-vorhofflimmern-im-zusammenhang-mit-rheumatischer-herzerkrankung/
https://gpcardio.org/de/2022-09-20_harmonisierung-der-blutdruck-hypertonie-leitlinien-des-american-college-of-cardiology-american-heart-association-und-der-european-society-of-cardiology-european-society-of-hypertension/
https://gpcardio.org/de/2022-09-22_dapagliflozin-bei-herzinsuffizienz-mit-leicht-reduzierter-oder-erhaltener-ejektionsfraktion/
https://gpcardio.org/de/2022-09-22_glykamiesenkung-bei-typ-2-diabetes-mikrovaskulare-und-kardiovaskulare-endpunkte/
https://gpcardio.org/de/2022-09-26_auswirkungen-von-salzersatzstoffen-auf-klinische-endpunkte/
https://gpcardio.org/de/2022-09-27_funfjahresergebnisse-bei-patienten-mit-vollstandig-magnetisch-levitierten-vs-axialen-linksventrikularen-unterstutzungssystemen-in-der-randomisierten-momentum-3-studie/
https://gpcardio.org/de/2022-09-27_randomisierte-studie-zu-stimulation-des-linken-tawara-schenkels-vs-biventrikularer-stimulation-fur-die-kardiale-resynchronisationstherapie/
https://gpcardio.org/de/2022-09-29_acetazolamid-bei-akut-dekompensierter-herzinsuffizienz-mit-volumenuberladung/
https://gpcardio.org/de/2022-10-04_2022-acc-expert-consensus-decision-pathway-zur-rolle-nicht-statinbasierter-therapien-zur-ldl-cholesterinsenkung-im-management-des-risikos-atherosklerotischer-kardiovaskularer-erkrankung/
https://gpcardio.org/de/2022-10-04_dapagliflozin-bei-patienten-mit-kurzlich-stattgehabter-hospitalisierung-wegen-herzinsuffizienz-und-leicht-reduzierter-oder-erhaltener-ejektionsfraktion/
https://gpcardio.org/de/2022-10-04_fruhe-versus-verzogerte-therapie-mit-nicht-vitamin-k-antagonisten-oralen-antikoagulanzien-nach-akutem-ischamischem-schlaganfall-bei-vorhofflimmern-timing/
https://gpcardio.org/de/2022-10-08_allopurinol-versus-ubliche-behandlung-bei-patienten-mit-ischamischer-herzerkrankung-im-vereinigten-konigreich-all-heart/
https://gpcardio.org/de/2022-10-13_perkutane-revaskularisierung-bei-ischamischer-linksventrikularer-dysfunktion/
https://gpcardio.org/de/2022-10-18_wirksamkeit-und-sicherheit-von-dapagliflozin-in-abhangigkeit-von-der-gebrechlichkeit-bei-patienten-mit-herzinsuffizienz/
https://gpcardio.org/de/2022-10-20_blutdruckziele-bei-komatosen-uberlebenden-eines-herzstillstands/
https://gpcardio.org/de/2022-10-22_kardiovaskulare-endpunkte-bei-erwachsenen-mit-hypertonie-bei-abendlicher-versus-morgendlicher-einnahme-ublicher-antihypertensiva-im-vereinigten-konigreich-time-studie/
https://gpcardio.org/de/2022-11-01_empagliflozin-bei-akutem-myokardinfarkt/
https://gpcardio.org/de/2022-11-01_patiromer-zur-behandlung-der-hyperkaliamie-bei-herzinsuffizienz-mit-reduzierter-ejektionsfraktion/
https://gpcardio.org/de/2022-11-05_intensive-blutdruckkontrolle-nach-endovaskularer-thrombektomie-bei-akutem-ischamischem-schlaganfall-enchanted2-mt/
https://gpcardio.org/de/2022-11-15_hospitalisierungen-und-mortalitat-bei-patienten-mit-sekundarer-mitralklappeninsuffizienz-und-herzinsuffizienz/
https://gpcardio.org/de/2022-11-17_small-interfering-rna-zur-senkung-von-lipoprotein-a-bei-kardiovaskularer-erkrankung/
https://gpcardio.org/de/2022-11-19_einfluss-von-diabetes-auf-die-effekte-von-natrium-glukose-cotransporter-2-inhibitoren-auf-renale-endpunkte/
https://gpcardio.org/de/2022-11-22_everolimus-freisetzende-stents-oder-bypass-operation-bei-koronarer-mehrgefaserkrankung/
https://gpcardio.org/de/2022-11-24_triglyceridsenkung-mit-pemafibrat-zur-reduktion-des-kardiovaskularen-risikos/
https://gpcardio.org/de/2022-11-26_ly3437943-ein-neuartiger-dreifacher-gip-glp-1-und-glukagon-rezeptoragonist-bei-menschen-mit-typ-2-diabetes/
https://gpcardio.org/de/2022-12-03_dualer-endothelin-antagonist-aprocitentan-bei-therapieresistenter-hypertonie-precision/
https://gpcardio.org/de/2022-12-03_sicherheit-vertraglichkeit-und-wirksamkeit-der-hochtitration-leitliniengerechter-medikamentoser-therapien-bei-akuter-herzinsuffizienz-strong-hf/
https://gpcardio.org/de/2022-12-06_apixaban-bei-patienten-mit-vorhofflimmern-unter-hamodialyse/
https://gpcardio.org/de/2022-12-17_intravenoses-eisen-iii-derisomaltose-bei-patienten-mit-herzinsuffizienz-und-eisenmangel-im-vereinigten-konigreich-ironman/
https://gpcardio.org/de/2022-12-21_blutdrucksenkung-und-demenzpravention/
https://gpcardio.org/de/2022-12-29_chlortalidon-vs-hydrochlorothiazid-bei-hypertonie-kardiovaskularen-ereignissen/
https://gpcardio.org/de/2023-01-01_einfluss-von-empagliflozin-auf-die-dekongestion-bei-akuter-herzinsuffizienz/
https://gpcardio.org/de/2023-01-03_phase-2-studie-zu-aficamten-bei-patienten-mit-obstruktiver-hypertropher-kardiomyopathie/
https://gpcardio.org/de/2023-01-03_uberleben-nach-invasivem-oder-konservativem-management-stabiler-koronarer-herzerkrankung/
https://gpcardio.org/de/2023-01-03_vergleichende-effekte-von-niedrig-dosiertem-rosuvastatin-placebo-und-nahrungserganzungsmitteln-auf-lipide-und-entzundliche-biomarker/
https://gpcardio.org/de/2023-01-10_aspirin-versus-clopidogrel-als-langzeit-erhaltungsmonotherapie-nach-perkutaner-koronarintervention/
https://gpcardio.org/de/2023-01-10_effekt-der-katheterablation-mittels-pulmonalvenenisolation-mit-vs-ohne-isolation-der-posterioren-linksatrialen-wand-auf-das-wiederauftreten-atrialer-arrhythmien-bei-patienten-mit-persistierendem-vorho/
https://gpcardio.org/de/2023-01-10_prospektiver-zusammenhang-zwischen-taglicher-schrittzahl-und-kardiovaskularer-erkrankung/
https://gpcardio.org/de/2023-01-12_empagliflozin-bei-patienten-mit-chronischer-nierenerkrankung/
https://gpcardio.org/de/2023-01-12_progression-von-vorhofflimmern-nach-kryoablation-oder-medikamentoser-therapie/
https://gpcardio.org/de/2023-01-14_kosteneffektivitat-des-bevolkerungsscreenings-auf-vorhofflimmern/
https://gpcardio.org/de/2023-01-17_effekt-von-torsemid-vs-furosemid-nach-entlassung-auf-die-gesamtmortalitat-bei-patienten-mit-krankenhausaufnahme-wegen-herzinsuffizienz/
https://gpcardio.org/de/2023-02-01_kombination-von-schleifen-mit-thiaziddiuretika-bei-dekompensierter-herzinsuffizienz/
https://gpcardio.org/de/2023-02-02_phase-2-studie-zu-baxdrostat-bei-therapieresistenter-hypertonie/
https://gpcardio.org/de/2023-02-07_extrakorporale-membranoxygenierung-in-der-therapie-des-kardiogenen-schocks/
https://gpcardio.org/de/2023-02-16_katheterablation-verbessert-kardiovaskulare-ergebnisse-bei-patienten-mit-vorhofflimmern-und-herzinsuffizienz/
https://gpcardio.org/de/2023-02-28_endovaskulare-ultraschall-nierendenervation-zur-behandlung-der-hypertonie/
https://gpcardio.org/de/2023-02-28_zufallig-entdecktes-koronares-kalzium/
https://gpcardio.org/de/2023-03-18_wirksamkeit-einer-von-nichtarztlichen-gemeindegesundheitshelfern-geleiteten-intensiven-blutdruckintervention-im-vergleich-zur-ublichen-versorgung-auf-kardiovaskulare-erkrankungen-crhcp/
https://gpcardio.org/de/2023-04-04_treat-to-target-strategie-oder-hochintensive-statintherapie-bei-patienten-mit-koronarer-herzkrankheit/
https://gpcardio.org/de/2023-04-08_sofortige-versus-gestaffelte-vollstandige-revaskularisation-bei-patienten-mit-akutem-koronarsyndrom-und-koronarer-mehrgefaserkrankung-biovasc/
https://gpcardio.org/de/2023-04-11_heterogenitat-des-blutdruckansprechens-auf-4-antihypertensiva/
https://gpcardio.org/de/2023-04-13_bempedoinsaure-und-kardiovaskulare-ergebnisse-bei-statinintoleranten-patienten/
https://gpcardio.org/de/2023-04-15_entzundung-und-cholesterin-als-pradiktoren-kardiovaskularer-ereignisse-bei-patienten-unter-statintherapie/
https://gpcardio.org/de/2023-04-17_deeskalation-der-dualen-antithrombozytaren-therapie-beim-akuten-koronarsyndrom/
https://gpcardio.org/de/2023-04-18_zusammenhang-zwischen-erreichten-ldl-cholesterinspiegeln-und-langfristigen-kardiovaskularen-und-sicherheitsergebnissen/
https://gpcardio.org/de/2023-04-20_phase-3-studie-zu-sotatercept-zur-behandlung-der-pulmonalarteriellen-hypertonie/
https://gpcardio.org/de/2023-04-25_randomisierte-phase-2b-studie-zum-oralen-pcsk9-hemmer-mk-0616/
https://gpcardio.org/de/2023-05-04_intravaskular-bildgesteuerte-oder-angiographiegesteuerte-komplexe-pci/
https://gpcardio.org/de/2023-05-09_acc-expert-consensus-decision-pathway-2023-zum-management-der-herzinsuffizienz-mit-erhaltener-ejektionsfraktion/
https://gpcardio.org/de/2023-05-18_transkatheter-reparatur-bei-patienten-mit-trikuspidalklappeninsuffizienz/
https://gpcardio.org/de/2023-05-27_zuerst-venenbypass-versus-zuerst-beste-endovaskulare-behandlung-als-revaskularisationsstrategie-bei-patienten-mit-chronisch-extremitatenbedrohender-ischamie-die-eine-infrapopliteale-mit-oder-ohne-zusa/
https://gpcardio.org/de/2023-06-01_funfjahres-follow-up-nach-transkatheter-reparatur-der-sekundaren-mitralklappeninsuffizienz/
https://gpcardio.org/de/2023-06-01_wirksamkeit-und-sicherheit-von-niedrig-dosierten-dreifach-und-vierfach-kombinationspraparaten-im-vergleich-zu-monotherapie-ublicher-versorgung-oder-placebo-fur-das-initiale-management-der-hypertonie/
https://gpcardio.org/de/2023-06-06_auftitration-der-behandlung-nach-herzinsuffizienz-hospitalisierung-uber-das-gesamte-spektrum-der-linksventrikularen-ejektionsfraktion/
https://gpcardio.org/de/2023-06-06_direkte-orale-antikoagulanzien-versus-warfarin-uber-das-gesamte-spektrum-der-nierenfunktion/
https://gpcardio.org/de/2023-06-08_behandlung-von-in-der-fruhschwangerschaft-diagnostiziertem-gestationsdiabetes-mellitus/
https://gpcardio.org/de/2023-06-24_fernuberwachung-der-hamodynamik-des-pulmonalarteriendrucks-bei-patienten-mit-chronischer-herzinsuffizienz-monitor-hf/
https://gpcardio.org/de/2023-06-27_wirkung-von-sglt2-hemmern-auf-kardiovaskulare-ergebnisse-in-verschiedenen-patientenpopulationen/
https://gpcardio.org/de/2023-06-29_fruhe-versus-spatere-antikoagulation-bei-schlaganfall-mit-vorhofflimmern/
https://gpcardio.org/de/2023-07-01_die-dritte-intensivpflege-bundel-studie-mit-blutdrucksenkung-bei-akuter-zerebraler-blutung-interact3/
https://gpcardio.org/de/2023-07-11_p2y12-hemmer-oder-aspirin-monotherapie-zur-sekundarpravention-koronarer-ereignisse/
https://gpcardio.org/de/2023-07-13_kardiovaskulare-sicherheit-der-testosteronersatztherapie/
https://gpcardio.org/de/2023-07-20_phase-1-studie-zum-antikorper-ni006-zur-elimination-des-kardialen-transthyretin-amyloids/
https://gpcardio.org/de/2023-07-20_zilebesiran-ein-rna-interferenz-therapeutikum-bei-hypertonie/
https://gpcardio.org/de/2023-08-08_atorvastatin-bei-anthrazyklinassoziierter-kardialer-dysfunktion/
https://gpcardio.org/de/2023-08-08_glp-1-rezeptoragonisten-therapie-mit-und-ohne-sglt2-hemmer-bei-patienten-mit-typ-2-diabetes/
https://gpcardio.org/de/2023-08-12_retatrutid-ein-gip-glp-1-und-glukagon-rezeptoragonist-bei-menschen-mit-typ-2-diabetes/
https://gpcardio.org/de/2023-08-14_sacubitril-valsartan-bei-herzinsuffizienz-mit-leicht-reduzierter-oder-erhaltener-ejektionsfraktion/
https://gpcardio.org/de/2023-08-24_fixdosiskombinationstherapien-in-der-primarpravention-kardiovaskularer-erkrankungen-in-verschiedenen-gruppen/
https://gpcardio.org/de/2023-08-24_pitavastatin-zur-pravention-kardiovaskularer-erkrankungen-bei-hiv-infektion/
https://gpcardio.org/de/2023-09-07_taglicher-oraler-glp-1-rezeptoragonist-orforglipron-bei-erwachsenen-mit-adipositas/
https://gpcardio.org/de/2023-09-07_vollstandige-oder-nur-die-kulprit-lasion-betreffende-pci-bei-alteren-patienten-mit-myokardinfarkt/
https://gpcardio.org/de/2023-09-14_ferricarboxymaltose-bei-herzinsuffizienz-mit-eisenmangel/
https://gpcardio.org/de/2023-09-19_fraktionelle-flussreserve-gesteuerte-pci-oder-koronare-bypass-operation-bei-koronarer-3-gefas-erkrankung/
https://gpcardio.org/de/2023-09-21_semaglutid-bei-patienten-mit-herzinsuffizienz-mit-erhaltener-ejektionsfraktion-und-adipositas/
https://gpcardio.org/de/2023-09-28_antikoagulation-mit-edoxaban-bei-patienten-mit-atrialen-hochfrequenzepisoden/
https://gpcardio.org/de/2023-10-01_mineralokortikoidrezeptor-antagonisten-in-kombination-mit-natrium-glukose-kotransporter-2-inhibitoren-bei-herzinsuffizienz/
https://gpcardio.org/de/2023-10-01_wirksamkeit-der-pulmonalarteriendruck-uberwachung-bei-patienten-mit-chronischer-herzinsuffizienz/
https://gpcardio.org/de/2023-10-03_geschatzte-glomerulare-filtrationsrate-albuminurie-und-unerwunschte-ereignisse/
https://gpcardio.org/de/2023-10-05_extrakorporale-lebenserhaltung-bei-infarktbedingtem-kardiogenem-schock/
https://gpcardio.org/de/2023-10-05_globale-auswirkung-modifizierbarer-risikofaktoren-auf-kardiovaskulare-erkrankungen-und-mortalitat/
https://gpcardio.org/de/2023-10-12_katheterablation-bei-terminaler-herzinsuffizienz-mit-vorhofflimmern/
https://gpcardio.org/de/2023-10-12_zeitpunkt-der-vollstandigen-revaskularisation-mittels-mehrgefas-pci-bei-myokardinfarkt/
https://gpcardio.org/de/2023-10-14_venoarterielle-extrakorporale-membranoxygenierung-bei-patienten-mit-infarktbedingtem-kardiogenem-schock/
https://gpcardio.org/de/2023-10-17_optische-koharenztomographie-gesteuerte-oder-intravaskularer-ultraschall-gesteuerte-perkutane-koronarintervention/
https://gpcardio.org/de/2023-10-17_orthostatische-hypotonie-hypertoniebehandlung-und-kardiovaskulare-erkrankung/
https://gpcardio.org/de/2023-10-19_oct-gesteuerte-versus-angiographisch-gesteuerte-pci/
https://gpcardio.org/de/2023-10-19_oct-oder-angiographie-gesteuerte-pci-bei-komplexen-bifurkationslasionen/
https://gpcardio.org/de/2023-10-24_traditionelle-chinesische-medizin-verbindung-tongxinluo-und-klinische-endpunkte-bei-patienten-mit-akutem-myokardinfarkt/
https://gpcardio.org/de/2023-11-02_pulsfeld-oder-konventionelle-thermische-ablation-bei-paroxysmalem-vorhofflimmern/
https://gpcardio.org/de/2023-11-23_transkatheter-aortenklappenersatz-bei-niedrigrisikopatienten-nach-funf-jahren/
https://gpcardio.org/de/2023-11-25_zibotentan-in-kombination-mit-dapagliflozin-im-vergleich-zu-dapagliflozin-bei-patienten-mit-chronischer-nierenerkrankung-zenith-ckd/
https://gpcardio.org/de/2023-12-14_semaglutid-und-kardiovaskulare-endpunkte-bei-adipositas-ohne-diabetes/
https://gpcardio.org/de/2023-12-21_eine-placebokontrollierte-studie-zur-perkutanen-koronarintervention-bei-stabiler-angina-pectoris/
https://gpcardio.org/de/2023-12-21_wirksamkeit-von-eisencarboxymaltose-bei-herzinsuffizienz-mit-eisenmangel/
https://gpcardio.org/de/2023-12-28_restriktive-oder-liberale-transfusionsstrategie-bei-myokardinfarkt-und-anamie/
https://gpcardio.org/de/2024-01-02_acc-aha-accp-hrs-leitlinie-2023-zur-diagnose-und-behandlung-von-vorhofflimmern/
https://gpcardio.org/de/2024-01-02_acc-aha-accp-hrs-leitlinie-2023-zur-diagnose-und-behandlung-von-vorhofflimmern/
https://gpcardio.org/de/2024-01-11_apixaban-zur-schlaganfallpravention-bei-subklinischem-vorhofflimmern/
https://gpcardio.org/de/2024-01-18_langzeitergebnisse-der-resynchronisations-defibrillation-bei-herzinsuffizienz/
https://gpcardio.org/de/2024-02-13_implantierbare-hamodynamische-monitore-verbessern-das-uberleben-bei-patienten-mit-herzinsuffizienz-und-reduzierter-ejektionsfraktion/
https://gpcardio.org/de/2024-02-20_absetzen-von-aspirin-innerhalb-von-1-monat-nach-stenting-zugunsten-einer-ticagrelor-monotherapie-beim-akuten-koronarsyndrom/
https://gpcardio.org/de/2024-02-20_eine-aspirinfreie-versus-duale-antithrombozytare-strategie-beim-koronaren-stenting/
https://gpcardio.org/de/2024-02-20_sicherheit-und-wirksamkeit-der-ticagrelor-monotherapie-bei-patienten-mit-akutem-koronarsyndrom-die-sich-einer-perkutanen-koronarintervention-unterziehen/
https://gpcardio.org/de/2024-03-01_einfluss-von-bempedosaure-auf-die-gesamtheit-kardiovaskularer-ereignisse/
https://gpcardio.org/de/2024-03-02_intravaskulare-bildgebungsgesteuerte-implantation-koronarer-medikamentenfreisetzender-stents/
https://gpcardio.org/de/2024-03-18_globaler-wandel-von-untergewicht-zur-adipositas-dominanz-uber-drei-jahrzehnte-und-generationen-hinweg/
https://gpcardio.org/de/2024-03-26_direkte-orale-antikoagulanzien-zur-schlaganfallpravention-bei-patienten-mit-geratedetektiertem-vorhofflimmern/
https://gpcardio.org/de/2024-04-01_transkatheter-oder-chirurgische-aortenklappenimplantation/
https://gpcardio.org/de/2024-04-02_stratify-hf-eine-europaische-kooperation-zur-entwicklung-eines-ki-basierten-unterstutzungssystems-fur-die-risikostratifizierung-und-fruherkennung-von-herzinsuffizienz/
https://gpcardio.org/de/2024-04-07_gamification-und-finanzielle-anreize-zur-steigerung-der-korperlichen-aktivitat-bei-patientinnen-und-patienten-mit-erhohtem-kardiovaskularem-risiko/
https://gpcardio.org/de/2024-04-08_verbessertes-fernbehandlungsprogramm-steigert-gdmt-verschreibungen-bei-hohem-kardiovaskularem-oder-renalem-risiko-bei-typ-2-diabetes-patientinnen-und-patienten/
https://gpcardio.org/de/2024-04-08_web-app-wirksam-bei-der-bestimmung-des-zugangs-zu-statinen-ohne-rezept/
https://gpcardio.org/de/2024-04-16_acc-expertenkonsens-entscheidungspfad-2024-zur-behandlung-der-herzinsuffizienz-mit-reduzierter-ejektionsfraktion/
https://gpcardio.org/de/2024-04-18_betablocker-nach-myokardinfarkt-und-erhaltener-ejektionsfraktion/
https://gpcardio.org/de/2024-04-18_mikroaxiale-flusspumpe-oder-standardversorgung-bei-infarktbedingtem-kardiogenem-schock/
https://gpcardio.org/de/2024-04-18_semaglutid-bei-patienten-mit-adipositasbedingter-herzinsuffizienz-und-typ-2-diabetes/
https://gpcardio.org/de/2024-04-25_empagliflozin-nach-akutem-myokardinfarkt/
https://gpcardio.org/de/2024-04-25_ffr-gesteuerte-vollstandige-oder-ausschlieslich-culprit-lasions-pci-bei-patienten-mit-myokardinfarkt/
https://gpcardio.org/de/2024-04-27_semaglutid-versus-placebo-bei-personen-mit-adipositasbedingter-herzinsuffizienz-mit-erhaltener-ejektionsfraktion/
https://gpcardio.org/de/2024-05-01_ticagrelor-oder-clopidogrel-monotherapie-versus-duale-thrombozytenaggregationshemmung-nach-perkutaner-koronarintervention/
https://gpcardio.org/de/2024-05-02_apolipoprotein-a1-infusionen-und-kardiovaskulare-endpunkte-nach-akutem-myokardinfarkt/
https://gpcardio.org/de/2024-05-04_praventive-perkutane-koronarintervention-versus-alleinige-optimale-medizinische-therapie-zur-behandlung-vulnerabler-atherosklerotischer-koronarplaques-prevent/
https://gpcardio.org/de/2024-05-04_stratifyhf-unterstutzung-der-hausarztlichen-versorgung-bei-der-fruhdiagnose-von-herzinsuffizienz/
https://gpcardio.org/de/2024-05-06_die-stratifyhf-forschungs-und-innovationsmasnahme/
https://gpcardio.org/de/2024-05-11_intravaskular-ultraschallgesteuerte-versus-angiographiegesteuerte-perkutane-koronarintervention-bei-akutem-koronarsyndrom-ivus-acs/
https://gpcardio.org/de/2024-05-11_ticagrelor-allein-versus-ticagrelor-plus-aspirin-von-monat-1-bis-monat-12-nach-perkutaner-koronarintervention-bei-patienten-mit-akutem-koronarsyndrom-ultimate-dapt/
https://gpcardio.org/de/2024-05-16_andexanet-bei-faktor-xa-inhibitor-assoziierter-akuter-intrazerebraler-blutung/
https://gpcardio.org/de/2024-05-16_olezarsen-akute-pankreatitis-und-familiares-chylomikronamie-syndrom/
https://gpcardio.org/de/2024-05-16_olezarsen-bei-hypertriglyceridamie-bei-patienten-mit-hohem-kardiovaskularem-risiko/
https://gpcardio.org/de/2024-05-30_intensive-im-rettungswagen-verabreichte-blutdrucksenkung-bei-hyperakutem-schlaganfall/
https://gpcardio.org/de/2024-06-01_behandlung-der-pulmonalarteriellen-hypertonie/
https://gpcardio.org/de/2024-06-04_natrium-glukose-cotransporter-2-inhibitoren-und-schwerwiegende-unerwunschte-kardiovaskulare-ereignisse/
https://gpcardio.org/de/2024-06-04_verbesserung-der-cvd-risikobewertung-integration-des-genetischen-risikos-fur-eine-bessere-vorhersage/
https://gpcardio.org/de/2024-06-06_selbstexpandierende-oder-ballonexpandierbare-tavr-bei-patienten-mit-kleinem-aortenanulus/
https://gpcardio.org/de/2024-06-14_invasives-vs-konservatives-management-alterer-patienten-mit-nicht-st-hebungs-akutem-koronarsyndrom/
https://gpcardio.org/de/2024-06-25_rasse-und-der-nutzen-der-ras-blockade-bei-herzinsuffizienz-erneut-betrachtet/
https://gpcardio.org/de/2024-07-01_plozasiran-aro-apoc3-bei-schwerer-hypertriglyceridamie/
https://gpcardio.org/de/2024-07-11_wirkungen-von-semaglutid-auf-chronische-nierenerkrankung-bei-patienten-mit-typ-2-diabetes/
https://gpcardio.org/de/2024-07-13_langzeit-colchicin-zur-pravention-rezidivierender-vaskularer-ereignisse-bei-nicht-kardioembolischem-schlaganfall-convince/
https://gpcardio.org/de/2024-07-20_senkung-des-systolischen-blutdrucks-auf-unter-120-mmhg-versus-unter-140-mmhg-bei-patienten-mit-hohem-kardiovaskularem-risiko-mit-und-ohne-diabetes-oder-vorherigen-schlaganfall/
https://gpcardio.org/de/2024-08-24_semaglutid-und-kardiovaskulare-endpunkte-bei-patienten-mit-adipositas-und-bestehender-herzinsuffizienz/
https://gpcardio.org/de/2024-09-01_ticagrelor-monotherapie-bei-akutem-koronarsyndrom/
https://gpcardio.org/de/2024-09-04_globale-erkenntnisse-aus-der-interaspire-studie-kartierung-der-lipoprotein-a-pravalenz-bei-koronarer-herzkrankheit-in-sechs-who-regionen/
https://gpcardio.org/de/2024-09-07_semaglutid-versus-placebo-bei-patienten-mit-herzinsuffizienz-und-leicht-reduzierter-oder-erhaltener-ejektionsfraktion/
https://gpcardio.org/de/2024-09-12_plozasiran-ein-rna-interferenz-wirkstoff-der-auf-apoc3-abzielt-bei-gemischter-hyperlipidamie/
https://gpcardio.org/de/2024-09-12_zodasiran-eine-rnai-therapie-gegen-angptl3-bei-gemischter-hyperlipidamie/
https://gpcardio.org/de/2024-09-14_temporare-mechanische-kreislaufunterstutzung-bei-infarktbedingtem-kardiogenem-schock/
https://gpcardio.org/de/2024-09-21_mineralokortikoidrezeptor-antagonisten-bei-herzinsuffizienz/
https://gpcardio.org/de/2024-09-24_fokussiertes-update-2024-des-acc-expertenkonsens-entscheidungspfads-zur-klinischen-beurteilung-behandlung-und-zum-verlauf-hospitalisierter-patienten-mit-herzinsuffizienz/
https://gpcardio.org/de/2024-09-29_esc-leitlinien-2024-fur-das-management-von-vorhofflimmern-entwickelt-in-zusammenarbeit-mit-der-european-association-for-cardio-thoracic-surgery-eacts/
https://gpcardio.org/de/2024-10-07_esc-leitlinien-2024-fur-das-management-von-erhohtem-blutdruck-und-hypertonie/
https://gpcardio.org/de/2024-10-07_semaglutid-und-blutdruck/
https://gpcardio.org/de/2024-10-10_unterbrechung-oder-fortsetzung-der-betablocker-therapie-nach-myokardinfarkt/
https://gpcardio.org/de/2024-10-22_wirkungen-von-semaglutid-auf-herzinsuffizienz-endpunkte-bei-diabetes-und-chronischer-nierenerkrankung-in-der-flow-studie/
https://gpcardio.org/de/2024-10-24_finerenon-bei-herzinsuffizienz-mit-leicht-reduzierter-oder-erhaltener-ejektionsfraktion/
https://gpcardio.org/de/2024-10-29_adjudikation-von-hospitalisierungen-und-todesfallen-in-der-ironman-studie-zu-intravenosem-eisen-bei-herzinsuffizienz/
https://gpcardio.org/de/2024-11-05_vollstandige-versus-nur-auf-die-culprit-lasion-beschrankte-revaskularisation-bei-alteren-patienten-mit-st-hebungsinfarkt/
https://gpcardio.org/de/2024-11-07_invasive-behandlungsstrategie-fur-altere-patienten-mit-myokardinfarkt/
https://gpcardio.org/de/2024-11-09_quantitatives-flussverhaltnis-versus-fraktionelle-flussreserve-zur-steuerung-der-koronaren-revaskularisation-favor-iii-europe/
https://gpcardio.org/de/2024-11-14_transkatheter-klappenreparatur-bei-herzinsuffizienz-mit-mittelschwerer-bis-schwerer-mitralinsuffizienz/
https://gpcardio.org/de/2024-11-14_transkatheter-reparatur-versus-mitralklappenchirurgie-bei-sekundarer-mitralinsuffizienz/
https://gpcardio.org/de/2024-11-19_wirkung-des-screenings-auf-nicht-diagnostiziertes-vorhofflimmern-auf-die-schlaganfallpravention/
https://gpcardio.org/de/2024-11-26_kardiovaskulare-renale-und-sicherheitsendpunkte-unter-glp-1-rezeptoragonisten-allein-und-in-kombination-mit-sglt2-inhibitoren-bei-typ-2-diabetes/
https://gpcardio.org/de/2024-12-12_pci-bei-patienten-mit-transkatheter-aortenklappenimplantation/
https://gpcardio.org/de/2024-12-14_die-zentrale-rolle-der-hausarztlichen-versorgung-bei-der-forderung-der-kardiovaskularen-gesundheit/
https://gpcardio.org/de/2025-01-02_asundexian-versus-apixaban-bei-patienten-mit-vorhofflimmern/
https://gpcardio.org/de/2025-01-07_wirksamkeit-und-sicherheit-von-finerenon-uber-das-gesamte-spektrum-der-ejektionsfraktion-bei-herzinsuffizienz-mit-leicht-reduzierter-oder-erhaltener-ejektionsfraktion/
https://gpcardio.org/de/2025-01-09_plozasiran-zur-behandlung-anhaltender-chylomikronamie-und-des-pankreatitisrisikos/
https://gpcardio.org/de/2025-01-09_transkatheter-klappenersatz-bei-schwerer-trikuspidalinsuffizienz/
https://gpcardio.org/de/2025-01-14_transkatheter-edge-to-edge-reparatur-bei-schwerer-isolierter-trikuspidalinsuffizienz/
https://gpcardio.org/de/2025-01-21_fruhzeitige-intervention-bei-patienten-mit-asymptomatischer-schwerer-aortenklappenstenose-und-myokardialer-fibrose/
https://gpcardio.org/de/2025-01-21_orales-muvalaplin-zur-senkung-von-lipoprotein-a/
https://gpcardio.org/de/2025-01-23_abelacimab-versus-rivaroxaban-bei-patienten-mit-vorhofflimmern/
https://gpcardio.org/de/2025-01-25_durch-koronar-ct-angiographie-gesteuertes-management-von-patienten-mit-stabilem-brustschmerz/
https://gpcardio.org/de/2025-01-30_fortsetzung-versus-unterbrechung-der-oralen-antikoagulation-wahrend-tavi/
https://gpcardio.org/de/2025-01-30_tirzepatid-bei-herzinsuffizienz-mit-erhaltener-ejektionsfraktion-und-adipositas/
https://gpcardio.org/de/2025-02-13_colchicin-bei-akutem-myokardinfarkt/
https://gpcardio.org/de/2025-02-13_routinemasige-gabe-von-spironolacton-bei-akutem-myokardinfarkt/
https://gpcardio.org/de/2025-02-20_katheterablation-oder-antiarrhythmika-bei-ventrikularer-tachykardie/
https://gpcardio.org/de/2025-03-11_transkatheter-aortenklappenersatz-bei-patienten-mit-systolischer-herzinsuffizienz-und-moderater-aortenklappenstenose/
https://gpcardio.org/de/2025-03-15_studie-zu-kardiovaskularen-risikofaktoren-und-der-inanspruchnahme-hausarztlicher-versorgung-in-spanien/
https://gpcardio.org/de/2025-03-16_primarpravention-der-atherosklerotischen-kardiovaskularen-erkrankung-ascvd-in-der-hausarztlichen-versorgung-ein-systematischer-review-von-leitlinien/
https://gpcardio.org/de/2025-03-17_geschlechtsunterschiede-und-trends-im-kardiovaskularen-risikomanagement-erkenntnisse-aus-einer-hausarztlichen-langzeitstudie/
https://gpcardio.org/de/2025-03-25_alters-und-geschlechtsunterschiede-in-der-wirksamkeit-von-behandlungen-bei-typ-2-diabetes/
https://gpcardio.org/de/2025-03-25_antikoagulation-und-thrombozytenaggregationshemmung-bei-vorhofflimmern-und-stabiler-koronarer-herzkrankheit/
https://gpcardio.org/de/2025-03-25_antithrombotische-therapie-zur-minimierung-der-gesamtzahl-von-ereignissen-nach-acs-oder-pci-bei-vorhofflimmern/
https://gpcardio.org/de/2025-03-27_intensive-blutdruckkontrolle-bei-patienten-mit-typ-2-diabetes/
https://gpcardio.org/de/2025-03-28_flecainidacetat-inhalationslosung-zur-kardioversion-von-akut-aufgetretenem-symptomatischem-vorhofflimmern/
https://gpcardio.org/de/2025-04-01_acc-aha-leitlinie-2025-fur-das-management-von-patienten-mit-akuten-koronarsyndromen/
https://gpcardio.org/de/2025-04-01_metaanalyse-zu-sotagliflozin-einem-dualen-natrium-glukose-cotransporter-1-2-inhibitor-bei-herzinsuffizienz-und-typ-2-diabetes/
https://gpcardio.org/de/2025-04-01_wirksamkeit-und-sicherheit-von-aldosteronsynthase-inhibitoren-bei-hypertonie/
https://gpcardio.org/de/2025-04-03_verschluss-des-linken-vorhofohrs-nach-ablation-bei-vorhofflimmern/
https://gpcardio.org/de/2025-04-07_empagliflozin-bei-resistenter-hypertonie-und-herzinsuffizienz-mit-erhaltener-ejektionsfraktion/
https://gpcardio.org/de/2025-04-07_natrium-glukose-cotransporter-2-inhibitoren-und-neu-aufgetretener-diabetes-bei-kardiovaskularer-oder-nierenerkrankung/
https://gpcardio.org/de/2025-04-10_dapagliflozin-bei-patienten-mit-transkatheter-aortenklappenimplantation/
https://gpcardio.org/de/2025-04-10_wir-stellen-vor-gpcardio-die-lucke-in-der-kardiovaskularen-versorgung-schliesen/
https://gpcardio.org/de/2025-04-17_pulsed-field-oder-kryoballon-ablation-bei-paroxysmalem-vorhofflimmern/
https://gpcardio.org/de/2025-05-03_semaglutid-und-gehfahigkeit-bei-menschen-mit-symptomatischer-peripherer-arterieller-verschlusskrankheit-und-typ-2-diabetes-stride/
https://gpcardio.org/de/2025-05-08_wirksamkeit-und-sicherheit-von-lorundrostat-bei-patienten-mit-unkontrollierter-hypertonie/
https://gpcardio.org/de/2025-05-13_wirkung-von-empagliflozin-auf-die-mechanismen-der-erythropoese-und-eisenmobilisierung-bei-patienten-mit-herzinsuffizienz/
https://gpcardio.org/de/2025-05-13_zusammenspiel-von-chronischer-nierenerkrankung-und-den-wirkungen-von-tirzepatid-bei-patienten-mit-herzinsuffizienz-erhaltener-ejektionsfraktion-und-adipositas/
https://gpcardio.org/de/2025-05-17_fixkombination-aus-obicetrapib-und-ezetimib-zur-senkung-des-ldl-cholesterins-tandem/
https://gpcardio.org/de/2025-05-29_orales-semaglutid-und-kardiovaskulare-endpunkte-bei-typ-2-diabetes-mit-hohem-risiko/
https://gpcardio.org/de/2025-06-01_ffr-gesteuerte-perkutane-koronarintervention-versus-koronare-bypass-operation-bei-patienten-mit-diabetes/
https://gpcardio.org/de/2025-06-01_neuartiger-kontrollierter-metabolischer-beschleuniger-bei-adipositasbedingter-hfpef/
https://gpcardio.org/de/2025-06-01_randomisierte-studie-zur-bewertung-einer-verschlechterung-der-nierenfunktion-durch-hinzufugen-von-dapagliflozin-bei-akut-dekompensierter-herzinsuffizienz/
https://gpcardio.org/de/2025-06-03_ein-oraler-pcsk9-inhibitor-zur-behandlung-der-hypercholesterinamie/
https://gpcardio.org/de/2025-06-10_acc-aha-leitlinie-2025-fur-das-management-von-patienten-mit-akuten-koronarsyndromen/
https://gpcardio.org/de/2025-06-10_intravenose-eisencarboxymaltose-bei-herzinsuffizienz-mit-eisenmangel/
https://gpcardio.org/de/2025-06-10_orales-semaglutid-und-kardiovaskulare-endpunkte-bei-menschen-mit-typ-2-diabetes-in-abhangigkeit-von-der-sglt2i-anwendung/
https://gpcardio.org/de/2025-06-13_die-auswirkung-von-gebrechlichkeit-auf-die-wirksamkeit-einer-intensiven-blutdruckkontrolle-bei-patienten-mit-typ-2-diabetes/
https://gpcardio.org/de/2025-06-17_langwirksame-faktor-xi-hemmung-und-periprozedurale-blutung/
https://gpcardio.org/de/2025-06-17_spironolacton-versus-amilorid-bei-resistenter-hypertonie/
https://gpcardio.org/de/2025-06-17_zeitpunkt-der-antihypertensiven-medikation-und-kardiovaskulare-ereignisse-sowie-tod/
https://gpcardio.org/de/2025-07-01_add-on-behandlung-mit-zilebesiran-bei-unzureichend-kontrollierter-hypertonie/
https://gpcardio.org/de/2025-07-01_gpcardio-epccs-tritt-der-each-der-european-alliance-for-cardiovascular-health-bei/
https://gpcardio.org/de/2025-07-01_nahezu-universelle-pravalenz-der-zentralen-adipositas-bei-herzinsuffizienz-mit-erhaltener-ejektionsfraktion/
https://gpcardio.org/de/2025-07-03_sicherheit-und-wirksamkeit-von-obicetrapib-bei-patienten-mit-hohem-kardiovaskularem-risiko/
https://gpcardio.org/de/2025-07-05_kollaboration-zum-optimalen-zeitpunkt-der-antikoagulation-nach-ischamischem-schlaganfall-und-vorhofflimmern/
https://gpcardio.org/de/2025-07-07_colchicin-zur-sekundarpravention-vaskularer-ereignisse/
https://gpcardio.org/de/2025-07-07_langzeitstudien-zu-colchicin-zur-sekundarpravention-vaskularer-ereignisse/
https://gpcardio.org/de/2025-07-08_katheterablation-versus-lebensstilmodifikation-mit-antiarrhythmika-zur-behandlung-von-vorhofflimmern/
https://gpcardio.org/de/2025-07-10_gpcardio-und-die-ncd-academy-des-acc-bundeln-ihre-krafte-um-die-hausarztliche-versorgung-bei-der-pravention-kardiovaskularer-erkrankungen-zu-starken/
https://gpcardio.org/de/2025-07-12_amycretin-ein-neuartiger-unimolekularer-glp-1-und-amylin-rezeptoragonist-zur-subkutanen-anwendung/
https://gpcardio.org/de/2025-07-12_sicherheit-vertraglichkeit-pharmakokinetik-und-pharmakodynamik-des-first-in-class-glp-1-und-amylin-rezeptoragonisten-amycretin/
https://gpcardio.org/de/2025-07-15_10-jahres-ergebnis-der-vollstandigen-versus-alleinigen-infarktarterien-revaskularisation-bei-stemi-mit-mehrgefaserkrankung/
https://gpcardio.org/de/2025-07-22_cooperative-pfa/
https://gpcardio.org/de/2025-07-28_langzeitnutzen-von-atorvastatin-auf-die-inzidenz-kardiovaskularer-ereignisse/
https://gpcardio.org/de/2025-07-29_cvd-hausarztliche-versorgung-der-bedarf-an-epccs-praxisanleitung/
https://gpcardio.org/de/2025-07-29_einfluss-von-body-mass-index-zentraler-adipositas-und-gewichtsverlust-auf-den-nutzen-von-tirzepatid-bei-hfpef/
https://gpcardio.org/de/2025-08-05_abelacimab-versus-rivaroxaban-bei-patienten-mit-vorhofflimmern-unter-thrombozytenaggregationshemmung/
https://gpcardio.org/de/2025-08-05_lorundrostat-bei-teilnehmern-mit-unkontrollierter-hypertonie-und-therapieresistenter-hypertonie/
https://gpcardio.org/de/2025-08-05_natrium-glukose-cotransporter-2-inhibitor-mit-und-ohne-aldosteronantagonist-bei-herzinsuffizienz-mit-erhaltener-ejektionsfraktion/
https://gpcardio.org/de/2025-08-12_ergebnisse-bei-alteren-patienten-nach-umstellung-auf-ein-neueres-antikoagulans-oder-verbleib-bei-warfarin/
https://gpcardio.org/de/2025-08-14_gemeinsam-verabreichtes-cagrilintid-und-semaglutid-bei-erwachsenen-mit-ubergewicht-oder-adipositas/
https://gpcardio.org/de/2025-08-21_praventive-perkutane-koronarintervention-bei-nicht-flusslimitierenden-vulnerablen-atherosklerotischen-koronarplaques-bei-diabetes/
https://gpcardio.org/de/2025-08-30_blutdrucksenkende-wirksamkeit-von-antihypertensiva-und-deren-kombinationen/
https://gpcardio.org/de/2025-09-01_diabetes-und-adipositas-sowie-der-behandlungseffekt-einer-fruhen-rhythmuskontrolle-versus-ublicher-versorgung-bei-patienten-mit-vorhofflimmern/
https://gpcardio.org/de/2025-09-01_kosteneffektivitat-von-apixaban-versus-aspirin-zur-reduktion-von-thromboembolien-bei-hochrisikopatienten-mit-geratedetektiertem-vorhofflimmern/
https://gpcardio.org/de/2025-09-01_reizleitungssystem-stimulation-versus-biventrikulare-stimulation-zur-kardialen-resynchronisation/
https://gpcardio.org/de/2025-09-02_fernuberwachtes-vorhofflimmern-screening-in-der-hausarztlichen-versorgung-mittels-ekg-patch-zeigt-bescheidene-vorteile/
https://gpcardio.org/de/2025-09-02_optimale-medizinische-versorgung-und-durch-die-koronare-flusskapazitat-gesteuerte-myokardiale-revaskularisation-versus-ubliche-versorgung-bei-chronischer-koronarer-herzkrankheit/
https://gpcardio.org/de/2025-09-05_blutdrucksenkungen-mit-baxdrostat-bei-patientinnen-und-patienten-mit-unkontrollierter-oder-resistenter-hypertonie/
https://gpcardio.org/de/2025-09-09_einfluss-von-typ-2-diabetes-auf-die-effekte-von-tirzepatid-bei-patienten-mit-herzinsuffizienz-mit-erhaltener-ejektionsfraktion-und-adipositas/
https://gpcardio.org/de/2025-09-11_multidomanen-rehabilitation-fur-altere-patienten-mit-myokardinfarkt/
https://gpcardio.org/de/2025-09-11_neue-leitlinie-empfiehlt-einen-neuen-ansatz-zur-bewertung-des-kardiovaskularen-risikos-und-zum-erreichen-von-behandlungszielen-fur-lipidwerte/
https://gpcardio.org/de/2025-09-13_betablocker-nach-myokardinfarkt-mit-gering-reduzierter-ejektionsfraktion/
https://gpcardio.org/de/2025-09-16_2025-aha-acc-guideline-for-the-prevention-detection-evaluation-and-management-of-high-blood-pressure-in-adults/
https://gpcardio.org/de/2025-09-16_bewaltigung-der-anhaltenden-kardiovaskularen-auswirkungen-von-covid-19-neue-leitlinien-fur-die-hausarztliche-versorgung/
https://gpcardio.org/de/2025-09-18_orforglipron-ein-oraler-niedermolekularer-glp-1-rezeptoragonist-bei-fruhem-typ-2-diabetes/
https://gpcardio.org/de/2025-09-20_effekt-von-evolocumab-auf-die-offenheitsrate-von-vena-saphena-bypassen-nach-koronarer-bypass-operation-newton-cabg-cardiolink-5/
https://gpcardio.org/de/2025-09-21_einfuhrung-und-die-auswirkungen-von-cmr-auf-patientinnen-patienten-und-gesundheitssysteme/
https://gpcardio.org/de/2025-09-24_wichtige-anderungen-in-der-klinischen-leitlinie-fur-blutdruck-und-lipidmanagement/
https://gpcardio.org/de/2025-09-25_digitoxin-bei-patienten-mit-herzinsuffizienz-und-reduzierter-ejektionsfraktion/
https://gpcardio.org/de/2025-09-28_warum-es-wichtig-ist-chronische-nierenerkrankung-ckd-zu-erkennen-und-zu-behandeln/
https://gpcardio.org/de/2025-10-01_2025-aha-acc-guideline-for-the-prevention-detection-evaluation-and-management-of-high-blood-pressure-in-adults/
https://gpcardio.org/de/2025-10-01_keine-evidenz-stutzt-vitamine-oder-nahrungserganzungsmittel-zur-senkung-des-ldl-cholesterins-und-zur-verringerung-des-kardiovaskularen-risikos/
https://gpcardio.org/de/2025-10-01_linderung-der-pulmonalen-stauung-durch-zugabe-von-dapagliflozin-zu-intravenosem-schleifendiuretikum-bei-patienten-mit-akuter-herzinsuffizienz/
https://gpcardio.org/de/2025-10-07_der-zusammenhang-zwischen-adipositas-und-chronischer-nierenerkrankung/
https://gpcardio.org/de/2025-10-07_einfluss-von-obicetrapib-auf-schwerwiegende-unerwunschte-kardiovaskulare-ereignisse-bei-hochrisikopatienten/
https://gpcardio.org/de/2025-10-07_verschluss-des-linken-vorhofohrs-bei-patienten-mit-terminaler-niereninsuffizienz/
https://gpcardio.org/de/2025-10-09_wirksamkeit-und-sicherheit-von-baxdrostat-bei-unkontrollierter-und-therapieresistenter-hypertonie/
https://gpcardio.org/de/2025-10-14_heparingabe-beim-ersten-medizinischen-kontakt-versus-unmittelbar-vor-primarer-perkutaner-koronarintervention/
https://gpcardio.org/de/2025-10-14_langfristiges-absetzen-der-antikoagulation-nach-katheterablation-bei-vorhofflimmern/
https://gpcardio.org/de/2025-10-23_aspirin-bei-patienten-mit-chronischem-koronarsyndrom-unter-oraler-antikoagulation/
https://gpcardio.org/de/2025-10-27_herz-und-schlaganfall-bewusstsein-verbinden-gemeinsam-starker/
https://gpcardio.org/de/2025-10-27_transkatheter-oder-chirurgischer-aortenklappenersatz-bei-patienten-mit-niedrigem-risiko-nach-7-jahren/
https://gpcardio.org/de/2025-10-28_effekt-einer-intensiven-blutdruckkontrolle-auf-schlaganfall/
https://gpcardio.org/de/2025-10-28_intensive-blutdruckkontrolle-bei-alteren-patienten-mit-hypertonie/
https://gpcardio.org/de/2025-10-28_sofortige-oder-verzogerte-pci-der-non-culprit-lasion-bei-myokardinfarkt/
https://gpcardio.org/de/2025-11-01_sicherheit-der-faktor-xi-hemmung-mit-abelacimab-bei-vorhofflimmern-nach-nierenfunktion/
https://gpcardio.org/de/2025-11-04_2025-aha-acc-guideline-for-the-prevention-detection-evaluation-and-management-of-high-blood-pressure-in-adults/
https://gpcardio.org/de/2025-11-06_orforglipron-ein-oraler-niedermolekularer-glp-1-rezeptoragonist-zur-behandlung-von-adipositas/
https://gpcardio.org/de/2025-11-09_pcsk9-hemmer-verhindert-den-ersten-herzinfarkt-oder-schlaganfall-bei-hochrisikopatientinnen-und-patienten/
https://gpcardio.org/de/2025-11-10_hochdosierter-versus-standarddosierter-grippeimpfstoff-und-kardiovaskulare-ergebnisse-bei-alteren-erwachsenen/
https://gpcardio.org/de/2025-11-11_decaf-eine-tasse-kaffee-am-tag-konnte-das-wiederauftreten-von-vorhofflimmern-verhindern/
https://gpcardio.org/de/2025-11-13_betablocker-nach-myokardinfarkt-bei-patienten-ohne-herzinsuffizienz/
https://gpcardio.org/de/2025-11-13_betablocker-nach-myokardinfarkt-ohne-reduzierte-ejektionsfraktion/
https://gpcardio.org/de/2025-11-18_dapagliflozin-bei-patienten-die-wegen-herzinsuffizienz-hospitalisiert-wurden/
https://gpcardio.org/de/2025-11-18_kardiovaskulare-wirkungen-und-vertraglichkeit-von-glp-1-rezeptoragonisten/
https://gpcardio.org/de/2025-11-18_wissenschaftliche-stellungnahme-des-acc-2025-zum-management-von-adipositas-bei-erwachsenen-mit-herzinsuffizienz/
https://gpcardio.org/de/2025-11-21_der-epccs-rat-lanciert-gpcardio-als-bekenntnis-zur-unterstutzung-der-hausarztlichen-versorgung/
https://gpcardio.org/de/2025-11-25_biomarkerbasierte-abc-af-risikoscores-fur-eine-personalisierte-behandlung-zur-reduktion-von-schlaganfall-oder-tod-bei-vorhofflimmern/
https://gpcardio.org/de/2025-12-01_schwerwiegende-blutungen-unter-apixaban-versus-aspirin/
https://gpcardio.org/de/2025-12-01_studie-zur-aggressiven-risikofaktorreduktion-bei-vorhofflimmern-auswirkungen-auf-die-ablationsergebnisse/
https://gpcardio.org/de/2025-12-13_vollstandige-versus-ausschlieslich-auf-die-culprit-lasion-beschrankte-revaskularisation-bei-akutem-myokardinfarkt-complete-revascularisation-trialists-collaboration/
https://gpcardio.org/de/2025-12-16_langzeiteffekt-von-icds-bei-nichtischamischer-herzinsuffizienz-mit-reduzierter-ejektionsfraktion/
https://gpcardio.org/de/2025-12-16_pharmakologische-behandlung-der-herzinsuffizienz-mit-reduzierter-ejektionsfraktion/
https://gpcardio.org/de/2025-12-18_acc-aha-leitlinie-2025-zum-management-von-erwachsenen-mit-angeborenem-herzfehler/
https://gpcardio.org/de/2025-12-18_improve-dice-eine-zweiteilige-offene-phase-2a-studie-zur-bewertung-der-sicherheit-und-wirksamkeit-von-ninerafaxstat-bei-patienten-mit-kardiometabolischen-syndromen/
https://gpcardio.org/de/2025-12-18_kardiovaskulare-ergebnisse-unter-tirzepatid-versus-dulaglutid-bei-typ-2-diabetes/
https://gpcardio.org/de/2025-12-19_die-eu-startet-den-ambitionierten-safe-hearts-plan-ein-neuer-fahrplan-fur-kardiovaskulare-gesundheit/
https://gpcardio.org/de/2025-12-20_orforglipron-ein-oraler-niedermolekularer-glp-1-rezeptoragonist-zur-behandlung-von-adipositas-bei-menschen-mit-typ-2-diabetes-attain-2/
https://gpcardio.org/de/2025-12-23_kurzzeitige-antikoagulation-versus-duale-thrombozytenaggregationshemmung-zur-pravention-der-device-thrombose-nach-verschluss-des-linken-vorhofohrs/
https://gpcardio.org/de/2026-01-06_dash-gemase-lebensmitteleinkaufe-und-ihre-auswirkungen-auf-den-blutdruck/
https://gpcardio.org/de/2026-01-06_who-veroffentlicht-globale-leitlinie-zum-einsatz-von-glp-1-medikamenten-bei-der-behandlung-von-adipositas/
https://gpcardio.org/de/2026-01-07_cxcr6-t-zellen-treiben-die-durch-immun-checkpoint-inhibitoren-verursachte-myokarditis-an/
https://gpcardio.org/de/2026-01-10_nikotin-und-das-kardiovaskulare-system-zentrale-erkenntnisse-fur-die-hausarztliche-versorgung/
https://gpcardio.org/de/2026-01-12_wirksamkeit-und-sicherheit-der-behandlung-mit-niedrig-dosiertem-spironolacton-bei-patienten-mit-primarem-hyperaldosteronismus/
https://gpcardio.org/de/2026-01-13_wirksamkeit-und-sicherheit-des-oralen-pcsk9-inhibitors-enlicitid-bei-erwachsenen-mit-heterozygoter-familiarer-hypercholesterinamie/
https://gpcardio.org/de/2026-01-14_glucagon-like-rezeptoragonisten-und-inkretin-basierte-medikamente-der-nachsten-generation/
https://gpcardio.org/de/2026-01-15_soziookonomische-und-strukturelle-barrieren-bei-der-bekampfung-von-adipositas-in-gemeinschaften/
https://gpcardio.org/de/2026-01-19_schlaganfall-als-zweithaufigste-todesursache-durch-kardiovaskulare-erkrankungen-und-wichtiger-faktor-fur-erworbene-langzeitbehinderung-identifiziert/
https://gpcardio.org/de/2026-01-20_dreifache-versus-duale-lipidsenkende-therapie-beim-akuten-koronarsyndrom/
https://gpcardio.org/de/2026-01-20_sglt2-hemmer-und-nierenendpunkte-nach-glomerularer-filtrationsrate-und-albuminurie/
https://gpcardio.org/de/2026-01-20_umweltbelastungen-und-kardiovaskulare-gesundheit/
https://gpcardio.org/de/2026-01-21_statistik-zu-herzerkrankungen-und-schlaganfall-2026/
https://gpcardio.org/de/2026-01-22_antithrombotische-therapie-nach-erfolgreicher-katheterablation-bei-vorhofflimmern/
https://gpcardio.org/de/2026-01-22_arzneimittel-stewardship-fur-ras-hemmer-und-sglt2-hemmer-bei-chronischer-nierenerkrankung/
https://gpcardio.org/de/2026-01-27_colchicin-bei-akuten-koronarsyndromen/
https://gpcardio.org/de/2026-01-27_monotherapie-mit-potentem-p2y12-hemmer-versus-dapt-nach-pci-bei-patienten-mit-und-ohne-stemi/
https://gpcardio.org/de/2026-01-28_kdigo-2026-leitlinie-fur-die-klinische-praxis-zur-anamie-bei-chronischer-nierenerkrankung-ckd/
https://gpcardio.org/de/2026-01-29_aus-wearables-abgeleitete-trainingsbelastung-und-koronare-atherosklerose-bei-athleten-mittleren-und-hoheren-alters-sowie-korperlich-aktiven-kontrollpersonen/
https://gpcardio.org/de/2026-01-29_durch-ein-multidisziplinares-team-geleitetes-management-der-schweren-aortenklappenstenose/
https://gpcardio.org/de/2026-01-29_olezarsen-zur-behandlung-schwerer-hypertriglyceridamie-und-des-pankreatitisrisikos/
https://gpcardio.org/de/2026-01-29_symptomlast-und-sekundarpravention-bei-patienten-mit-linksventrikularer-systolischer-dysfunktion-nach-akutem-myokardinfarkt/
https://gpcardio.org/de/2026-01-30_systemische-embolische-ereignisse-bei-vorhofflimmern/
https://gpcardio.org/de/2026-02-01_cagrisema-senkt-den-blutdruck-bei-erwachsenen-mit-ubergewicht-oder-adipositas/
https://gpcardio.org/de/2026-02-01_ergebnisse-nach-dem-wechsel-des-assays-fur-kardiales-troponin-bei-acs/
https://gpcardio.org/de/2026-02-01_kardiovaskular-renale-effekte-von-dapagliflozin-bei-patienten-mit-kardiovaskularem-risiko-mit-oder-ohne-typ-2-diabetes/
https://gpcardio.org/de/2026-02-01_semaglutid-und-hospitalisierungen-bei-patienten-mit-adipositas-und-bestehender-kardiovaskularer-erkrankung/
https://gpcardio.org/de/2026-02-01_β-blocker-nach-myokardinfarkt-bei-patienten-mit-erhaltener-ejektionsfraktion/
https://gpcardio.org/de/2026-02-02_sglt2-hemmer-anwendung-und-kardiorenale-ergebnisse-bei-typ-2-diabetes-mit-leberzirrhose/
https://gpcardio.org/de/2026-02-03_aktuelles-management-von-vorhofflimmern-bei-patienten-mit-krebs-die-umfrage-2025-der-european-heart-rhythm-association/
https://gpcardio.org/de/2026-02-03_dapagliflozin-zur-reduktion-der-fruhen-rezidivrate-nach-katheterablation-bei-vorhofflimmern/
https://gpcardio.org/de/2026-02-03_korperliche-aktivitat-und-risiko-unerwunschter-ereignisse-bei-vorhofflimmern/
https://gpcardio.org/de/2026-02-03_semaglutid-als-adjuvante-therapie-zur-katheterablation-bei-adipositasbedingtem-paroxysmalem-vorhofflimmern/
https://gpcardio.org/de/2026-02-03_semaglutid-versus-tirzepatid-bei-patienten-mit-adipositas-und-hfpef/
https://gpcardio.org/de/2026-02-04_ki-gestutzte-digitale-stethoskope-ubertreffen-herkommliches-screening-bei-signifikanter-vhd/
https://gpcardio.org/de/2026-02-05_die-erbliche-grundlage-der-koronaren-herzkrankheit/
https://gpcardio.org/de/2026-02-05_efimosfermin-alfa-bos-580-einmal-monatlich-bei-menschen-mit-metabolisch-dysfunktionsassoziierter-steatohepatitis-mit-f2-oder-f3-fibrose/
https://gpcardio.org/de/2026-02-05_eine-placebokontrollierte-studie-zum-oralen-pcsk9-inhibitor-enlicitid/
https://gpcardio.org/de/2026-02-05_intravenoses-tenecteplase-bei-akutem-ischamischem-schlaganfall-infolge-eines-basilararterienverschlusses-innerhalb-von-24-stunden/
https://gpcardio.org/de/2026-02-05_tenecteplase-versus-standardbehandlung-bei-basilararterienverschluss-innerhalb-von-24-stunden-trace-5/
https://gpcardio.org/de/2026-02-06_die-aldehyddehydrogenase-2-variante-rs671-verstarkt-die-thrombozytenaktivierung-und-die-arterielle-thrombose/
https://gpcardio.org/de/2026-02-06_gesprache-mit-patientinnen-und-patienten-uber-statine-warum-die-meisten-gemeldeten-symptome-nicht-ursachlich-sind/
https://gpcardio.org/de/2026-02-06_glucagon-like-peptid-rezeptoragonisten-und-renale-endpunkte-im-zeitalter-der-personalisierten-medizin/
https://gpcardio.org/de/2026-02-06_insulinresistenz-beeintrachtigt-den-pentosephosphatweg-und-die-durch-linksventrikulare-unterstutzungssysteme-lvad-vermittelte-myokardiale-erholung-bei-adiposen-patienten-mit-herzinsuffizienz/
https://gpcardio.org/de/2026-02-09_koronare-atherosklerose-bei-patienten-mit-krebs-und-krebsuberlebenden/
https://gpcardio.org/de/2026-02-10_beurteilung-und-management-der-transthyretin-amyloidose-des-herzens/
https://gpcardio.org/de/2026-02-10_klonale-hamatopoese-und-ihre-kardiovaskularen-implikationen/
https://gpcardio.org/de/2026-02-10_neue-medikamentose-therapien-bei-hypertonie/
https://gpcardio.org/de/2026-02-10_nieren-und-urothelkarzinomrisiken-unter-sglt2-inhibitoren-im-vergleich-zu-glp-1-rezeptoragonisten-bei-typ-2-diabetes/
https://gpcardio.org/de/2026-02-10_spontaner-myokardinfarkt-nach-hauptstamm-revaskularisation/
https://gpcardio.org/de/2026-02-11_aspirin-dosierung-nach-akutem-koronarsyndrom-bei-verdacht-auf-aspirinresistenz/
https://gpcardio.org/de/2026-02-11_kriterien-zur-bewertung-des-pradiktiven-und-klinischen-nutzens-neuer-modelle-biomarker-und-instrumente-fur-das-kardiovaskulare-risiko/
https://gpcardio.org/de/2026-02-11_verbesserung-der-ergebnisse-der-vorhofflimmern-ablation-durch-integrierte-personalisierte-lebensstilinterventionen/
https://gpcardio.org/de/2026-02-11_vericiguat-und-mortalitat-bei-herzinsuffizienz-mit-reduzierter-ejektionsfraktion/
https://gpcardio.org/de/2026-02-12_prognostischer-nutzen-der-stressperfusions-kardio-magnetresonanztomographie-bei-patienten-mit-bekannter-oder-vermuteter-koronarer-herzkrankheit-und-nicht-eindeutigem-belastungstest/
https://gpcardio.org/de/2026-02-12_prospektive-assoziationen-zwischen-adipositas-und-adipositasschweregrad-mit-9-kardiovaskularen-endpunkten/
https://gpcardio.org/de/2026-02-13_anwendung-nierenschutzender-medikamente-wahrend-der-stillzeit/
https://gpcardio.org/de/2026-02-16_fruhe-versus-spate-antikoagulationstherapie-nach-akutem-ischamischem-schlaganfall-bei-vorhofflimmern/
https://gpcardio.org/de/2026-02-16_neuartige-plasma-proteommarker-und-risiko-fur-venose-thromboembolie/
https://gpcardio.org/de/2026-02-17_albuminurie-oder-proteinurie-bei-glomerularen-erkrankungen-und-ckd-welche-sollte-verwendet-werden/
https://gpcardio.org/de/2026-02-18_betablocker-nach-myokardinfarkt/
https://gpcardio.org/de/2026-02-18_gentherapie-bei-nephropathischer-zystinose/
https://gpcardio.org/de/2026-02-19_erregungsleitungsstorungen-nach-transkatheter-aortenklappenimplantation/
https://gpcardio.org/de/2026-02-19_kardiovaskular-renal-metabolisches-zusammenspiel-bei-patienten-mit-vorhofflimmern-unter-direkten-oralen-antikoagulanzien/
https://gpcardio.org/de/2026-02-19_leitlinie-2026-der-aha-acc-zur-beurteilung-und-behandlung-der-akuten-lungenembolie-bei-erwachsenen/
https://gpcardio.org/de/2026-02-19_sekundarpravention-nach-ischamischem-schlaganfall/
https://gpcardio.org/de/2026-02-19_transkatheter-oder-chirurgischer-aortenklappenersatz-bei-niedrigrisikopatienten-nach-7-jahren/
https://gpcardio.org/de/2026-02-20_verbesserte-vorhersage-des-kardiovaskularen-erkrankungsrisikos-mittels-integrierter-machine-learning-modelle/
https://gpcardio.org/de/2026-02-21_pelacarsen-und-lipoprotein-a-apherese-in-der-sekundarpravention/
https://gpcardio.org/de/2026-02-22_kosteneffektivitat-von-natrium-glukose-cotransporter-2-hemmern-und-glucagon-like-peptid-1-rezeptoragonisten-bei-patienten-mit-hohem-kardiovaskularem-risiko-und-typ-2-diabetes-in-kanada/
https://gpcardio.org/de/2026-02-23_das-jahr-in-der-kardiovaskularen-medizin-2025/
https://gpcardio.org/de/2026-02-23_diabetes-erhoht-das-risiko-fur-herzinsuffizienz-bei-myokarditis/
https://gpcardio.org/de/2026-02-23_immunadsorption-bei-dilatativer-kardiomyopathie/
https://gpcardio.org/de/2026-02-23_mittels-akzelerometrie-erfasste-korperliche-aktivitat-und-lebensqualitat-bei-hypertropher-kardiomyopathie/
https://gpcardio.org/de/2026-02-23_primary-care-adherence-to-heart-failure-guidelines-in-post-discharge-evaluation-routine-management-pathfinder/
https://gpcardio.org/de/2026-02-23_risikominderung-der-nierenfunktionsstorung-nach-herztransplantation-und-therapeutische-ansatze/
https://gpcardio.org/de/2026-02-23_wirkung-von-semaglutid-auf-covid-19-und-andere-infektionen/
https://gpcardio.org/de/2026-02-24_mangelernahrung-und-kachexie-bei-stationaren-patienten-mit-akuten-kardialen-erkrankungen/
https://gpcardio.org/de/2026-02-24_risiko-der-hospitalisierung-wegen-herzinsuffizienz-unter-glp-1-rezeptoragonisten-im-vergleich-zu-dpp-4-inhibitoren-oder-sglt2-inhibitoren-bei-patienten-mit-typ-2-diabetes/
https://gpcardio.org/de/2026-02-24_systemische-embolische-ereignisse-bei-vorhofflimmern/
https://gpcardio.org/de/2026-02-25_ergebnisse-bei-herzinsuffizienz-mit-reduzierter-leicht-reduzierter-oder-erhaltener-ejektionsfraktion/
https://gpcardio.org/de/2026-02-25_kombinierte-assoziationen-von-glp-1-rezeptoragonisten-und-einem-gesunden-lebensstil-mit-kardiovaskularen-endpunkten-bei-personen-mit-typ-2-diabetes/
https://gpcardio.org/de/2026-02-25_niedrig-dosiertes-rivaroxaban-zur-pravention-linksventrikularer-thrombose-nach-anteriorem-myokardinfarkt/
https://gpcardio.org/de/2026-02-25_prognose-der-krankheitslast-von-kardiovaskularen-erkrankungen-und-schlaganfall-bei-frauen-in-den-vereinigten-staaten-bis-2050/
https://gpcardio.org/de/2026-02-26_intensive-blutdruckkontrolle-und-kognitive-funktion/
https://gpcardio.org/de/2026-02-27_additive-kardiorenale-vorteile-der-kombinationstherapie-aus-finerenon-und-sglt2-inhibitoren-bei-diabetischer-ckd/
https://gpcardio.org/de/2026-02-27_makrophagenlast-der-karotisplaque-und-entzundliche-lipid-assoziierte-makrophagenmarker-sagen-sekundare-schwerwiegende-unerwunschte-kardiovaskulare-ereignisse-nach-endarteriektomie-voraus/
https://gpcardio.org/de/2026-02-27_sglt2-hemmung-bei-patienten-mit-typ-2-diabetes-und-ckd-mit-verschlechterung-der-geschatzten-glomerularen-filtrationsrate-auf-20-ml-min-1-73-m/
https://gpcardio.org/de/2026-02-27_umstellung-von-warfarin-auf-direkte-orale-antikoagulanzien-bei-gebrechlichen-alteren-asiatischen-patienten-mit-vorhofflimmern/
https://gpcardio.org/de/2026-02-28_herzinsuffizienz-im-alter/
https://gpcardio.org/de/2026-03-01_abelacimab-versus-rivaroxaban-bei-alteren-personen-mit-vorhofflimmern/
https://gpcardio.org/de/2026-03-01_auswirkung-von-fruhem-verzogertem-oder-unterbrochenem-behandlungsbeginn-bei-kindern-mit-familiarer-hypercholesterinamie/
https://gpcardio.org/de/2026-03-01_dringend-benotigte-confidence-zur-bekampfung-des-risiko-behandlungs-paradoxons-bei-chronischer-nierenerkrankung/
https://gpcardio.org/de/2026-03-01_hochdosierte-influenza-impfung-bei-atherosklerotischer-kardiovaskularer-erkrankung/
https://gpcardio.org/de/2026-03-01_journal-club/
https://gpcardio.org/de/2026-03-01_kardiales-screening-auf-erkrankungen-im-zusammenhang-mit-plotzlichem-herztod/
https://gpcardio.org/de/2026-03-01_kardiales-screening-bei-jungen-menschen/
https://gpcardio.org/de/2026-03-01_leitlinie-2026-zur-akuten-lungenembolie-im-uberblick/
https://gpcardio.org/de/2026-03-01_sechsjahresergebnisse-nach-transkatheter-versus-chirurgischem-aortenklappenersatz-bei-niedrigrisikopatienten-mit-aortenstenose/
https://gpcardio.org/de/2026-03-01_vergleich-der-0-1-stunden-algorithmen-der-european-society-of-cardiology-und-hochsensitivem-troponin-bei-der-beurteilung-von-patienten-mit-verdacht-auf-akutes-koronarsyndrom-0-2-oder-0-3-stunden-algor/
https://gpcardio.org/de/2026-03-01_wirkung-von-baduanjin-auf-den-blutdruck-bei-personen-mit-hoch-normalem-blutdruck/
https://gpcardio.org/de/2026-03-01_zeitpunkt-kardiovaskularer-und-renaler-vorteile-von-finerenon-bei-herzinsuffizienz-und-chronischer-nierenerkrankung-mit-typ-2-diabetes/
https://gpcardio.org/de/2026-03-02_nachtlicher-strasenverkehrslarm-belastet-herz-und-blutgefase/
https://gpcardio.org/de/2026-03-02_schlechteres-risikoprofil-anzahl-der-bypasse-und-krankenhaussterblichkeit-jedoch-akzeptables-langzeituberleben-bei-frauen-die-sich-einer-koronaren-bypass-operation-unterziehen/
https://gpcardio.org/de/2026-03-03_in-vivo-base-editing-gentherapie-bei-heterozygoter-familiarer-hypercholesterinamie/
https://gpcardio.org/de/2026-03-03_invasive-hamodynamische-validierung-eines-echokardiographie-tools-mit-kunstlicher-intelligenz-zur-erkennung-von-herzinsuffizienz-mit-erhaltener-ejektionsfraktion/
https://gpcardio.org/de/2026-03-03_quantifizierung-des-energiestoffwechsels-der-skelettmuskulatur-wahrend-belastung-bei-herzinsuffizienz-mit-erhaltener-ejektionsfraktion-mittels-in-vivo-31p-magnetresonanzspektroskopie/
https://gpcardio.org/de/2026-03-04_aspirin-nach-pci-bei-akuten-koronarsyndromen/
https://gpcardio.org/de/2026-03-04_blutdruckzielwerte-im-hypertoniemanagement/
https://gpcardio.org/de/2026-03-04_finerenon-bei-diabetischer-nierenerkrankung-bei-typ-1-diabetes-eine-feine-antwort/
https://gpcardio.org/de/2026-03-04_wechselwirkung-von-alter-und-geschlecht-mit-klinischem-und-ambulantem-blutdruck-sowie-mortalitat/
https://gpcardio.org/de/2026-03-05_direkt-wirkendes-orales-antikoagulans-oder-vitamin-k-antagonist-fur-den-gebrechlichen-alteren-patienten-mit-vorhofflimmern/
https://gpcardio.org/de/2026-03-05_finerenon-bei-typ-1-diabetes-und-chronischer-nierenerkrankung/
https://gpcardio.org/de/2026-03-05_oraler-pcsk9-hemmer-enlicitide-senkt-ldl-cholesterinspiegel-in-phase-2-studie/
https://gpcardio.org/de/2026-03-05_semaglutid-bei-peripherer-arterieller-verschlusskrankheit-und-diabetes-nach-ausgangsschweregrad-der-erkrankung-und-alter/
https://gpcardio.org/de/2026-03-06_nierenerkrankung-und-herzinsuffizienz/
https://gpcardio.org/de/2026-03-07_auswirkungen-von-baxdrostat-auf-den-ambulanten-blutdruck-bei-patienten-mit-therapieresistenter-hypertonie-bax24/
https://gpcardio.org/de/2026-03-07_vorhofflimmern/
https://gpcardio.org/de/2026-03-07_wirkung-von-baxdrostat-auf-den-ambulanten-blutdruck-bei-patienten-mit-resistenter-hypertonie-bax24/
https://gpcardio.org/de/2026-03-09_semaglutid-fordert-den-fluss-knochenmarksstammzellabgeleiteter-vorlauferzellen-hin-zu-einem-antiinflammatorischen-und-proregenerativen-profil-bei-hochrisikopatienten/
https://gpcardio.org/de/2026-03-09_unterschiede-im-krankheitsverlauf-begleiterkrankungen-und-mortalitat-bei-sarcomerer-und-nicht-sarcomerer-hypertropher-kardiomyopathie/
https://gpcardio.org/de/2026-03-09_zielwerte-und-behandlungen-zur-kontrolle-von-ldl-c-in-der-hausarztlichen-versorgung/
https://gpcardio.org/de/2026-03-10_genetisches-screening-fur-fh-begrundung-und-erfahrungen/
https://gpcardio.org/de/2026-03-10_lp-a-zeit-mit-der-messung-in-der-hausarztlichen-versorgung-zu-beginnen/
https://gpcardio.org/de/2026-03-11_triglyzeride-ein-risikomarker-oder-ein-ziel-fur-das-kardiovaskulare-risiko/
https://gpcardio.org/de/2026-03-12_esc-leitlinien-zu-cvd-und-psychischer-gesundheit-in-der-hausarztlichen-versorgung/
https://gpcardio.org/de/2026-03-12_kardiovaskular-metabolisches-risiko-in-den-wechseljahren/
https://gpcardio.org/de/2026-03-12_off-label-unterdosierung-der-antithrombotischen-therapie-mit-edoxaban-bei-patienten-mit-vorhofflimmern-und-stabiler-koronarer-herzkrankheit/
https://gpcardio.org/de/2026-03-13_die-notwendigkeit-hausarztlichen-engagements-in-der-welt-der-interessenvertretung/
https://gpcardio.org/de/2026-03-13_herzinsuffizienz-in-der-hausarztlichen-versorgung-fruhzeitige-erkennung-und-einleitung-der-gdmt/
https://gpcardio.org/de/2026-03-13_leitlinie-der-acc-aha-2026-zur-behandlung-der-dyslipidamie/
https://gpcardio.org/de/2026-03-13_management-schwer-einstellbarer-hypertonie-und-was-gibt-es-neues/
https://gpcardio.org/de/2026-03-14_der-puls-der-hausarztlichen-versorgung-epccs-gipfel-2026/
https://gpcardio.org/de/2026-03-16_verwendung-der-koronararterien-kalzium-score-bestimmung-bei-personen-mit-erhohtem-lipoprotein-a/
https://gpcardio.org/de/2026-03-20_anamnese-lebenslanger-ungunstiger-schwangerschaftsausgange-und-kardiovaskulares-risiko/
https://gpcardio.org/de/2026-03-20_die-auswirkungen-der-epccs-leitlinien-auf-die-pharmakotherapie-in-der-ukraine/
https://gpcardio.org/de/2026-03-20_real-world-evidenz-zu-dapagliflozin-bei-herzinsuffizienz-mit-reduzierter-ejektionsfraktion-in-zentralosteuropa-und-der-ostseeregion-evolution-hf-cee-ba-studie/
https://gpcardio.org/de/2026-03-22_management-des-kardiovaskularen-risikos-in-polen/
https://gpcardio.org/de/2026-03-22_screening-auf-cvd-in-griechenland/
https://gpcardio.org/de/2026-03-22_update-der-hypertonie-leitlinien-in-der-turkei/
https://gpcardio.org/de/2026-03-23_leitliniengerechte-medikamentose-therapie-bei-ckd-die-entscheidende-rolle-der-hausarztlichen-versorgung/
https://gpcardio.org/de/2026-03-24_management-der-ckd-in-der-hausarztlichen-versorgung/
https://gpcardio.org/de/2026-03-24_screening-risikostratifizierung-bei-ckd-die-entscheidende-rolle-der-hausarztlichen-versorgung/
https://gpcardio.org/de/2026-03-24_systemische-entzundung-und-rezidiv-nach-einem-durch-vorhofflimmern-bedingten-schlaganfall/
https://gpcardio.org/de/2026-03-24_triglycerid-glucose-index-und-mortalitat-bei-kritisch-kranken-patienten-mit-kardiovaskular-nieren-metabolischem-syndrom-stadium-4/
https://gpcardio.org/de/2026-03-25_management-von-glucagon-like-peptid-1-rezeptor-agonisten-und-natrium-glukose-cotransporter-2-hemmern-in-der-klinischen-praxis/
https://gpcardio.org/de/2026-03-25_rolle-der-provokations-und-belastungs-bildgebung-zur-identifizierung-von-kandidaten-fur-kardiale-myosin-inhibitoren/
https://gpcardio.org/de/2026-03-25_vererblichkeit-und-kardiovaskulare-erkrankung-bei-erwachsenen-nachkommen-von-muttern-mit-schwangerschaftshypertonie/
https://gpcardio.org/de/2026-03-26_gen-editier-therapie-bei-kardiovaskularen-erkrankungen/
https://gpcardio.org/de/2026-03-26_neue-mechanismen-kardiovaskularer-metabolischer-risikofaktoren-und-therapeutische-moglichkeiten/
https://gpcardio.org/de/2026-03-26_seneszentes-adipositas-signatur-bei-brustkrebs/
https://gpcardio.org/de/2026-03-26_verschluss-des-linken-vorhofohrs-oder-medikamentose-therapie-bei-vorhofflimmern/
https://gpcardio.org/de/2026-03-27_nierenerkrankung/
https://gpcardio.org/de/2026-03-27_optimierung-der-einschluss-schwellenwerte-fur-nt-probnp-in-randomisierten-klinischen-studien-zur-herzinsuffizienz/
https://gpcardio.org/de/2026-03-27_tiefe-endotypisierung-der-nierenschadigung-bei-typ-2-diabetes/
https://gpcardio.org/de/2026-03-28_calciumfreisetzungskanal-defizit-syndrom-bei-patienten-mit-diagnostizierter-idiopathischer-ventrikularer-fibrillation-und-verstorbenen-die-als-plotzlicher-unerwarteter-kindstod-klassifiziert-wurden/
https://gpcardio.org/de/2026-03-29_evolocumab-reduziert-das-risiko-fur-erste-schwere-kardiovaskulare-ereignisse-um-31-bei-patienten-ohne-signifikante-atherosklerose/
https://gpcardio.org/de/2026-03-29_intensive-senkung-des-low-density-lipoprotein-cholesterins-bei-patienten-mit-atherosklerotischer-kardiovaskularer-erkrankung/
https://gpcardio.org/de/2026-03-29_ultraschall-unterstutzte-kathetergestutzte-fibrinolyse-bei-akuter-lungenembolie/
https://gpcardio.org/de/2026-03-29_verschluss-des-linken-vorhofohrs-oder-antikoagulation-bei-vorhofflimmern/
https://gpcardio.org/de/2026-03-30_die-liraglutid-effekte-bei-vorhofflimmern-leaf-studie/
https://gpcardio.org/de/2026-04-10_eu-projekt-nextgen-bringt-personalisierte-kardiologie-voran-indem-es-genomische-und-klinische-daten-in-ki-modelle-integriert/
https://gpcardio.org/de/2026-04-15_herzinsuffizienz-ist-bei-menschen-mit-im-screening-entdecktem-vorhofflimmern-haufig/
https://gpcardio.org/de/2026-04-17_akute-egfr-veranderungen-und-ihre-vermittlung-der-albuminurie-reduktion-durch-empagliflozin-und-finerenon/
https://gpcardio.org/de/2026-04-17_evolocumab-zur-reduktion-erster-schwerwiegender-kardiovaskularer-ereignisse-bei-patienten-ohne-bekannte-signifikante-atherosklerose-und-mit-diabetes/
https://gpcardio.org/de/2026-04-17_volumen-versus-intensitat-der-korperlichen-aktivitat-und-das-risiko-fur-kardiovaskulare-und-nicht-kardiovaskulare-chronische-erkrankungen/
https://gpcardio.org/de/2026-04-18_geschlechtsunterschiede-beim-kardiovaskularen-nieren-metabol-syndrom/
https://gpcardio.org/de/2026-04-18_glucagon-like-peptide-1-rezeptoragonisten-zur-pravention-von-herzinsuffizienz-ereignissen-bei-typ-2-diabetes-und-oder-adipositas/
https://gpcardio.org/de/2026-04-18_lipoprotein-a-und-das-auftreten-von-venosen-thromboembolien-bei-pra-und-postmenopausalen-frauen-sowie-bei-mannern/
https://gpcardio.org/de/2026-04-19_auswirkungen-genetischer-tests-bei-patienten-mit-familiarer-hypercholesterinamie-fh-auf-kardiovaskulare-ereignisse-die-hokuriku-plus-studie-zur-familiaren-hypercholesterinamie/
https://gpcardio.org/de/2026-04-20_lp-a-hat-spezifische-auswirkungen-auf-die-koronare-herzkrankheit-unabhangig-von-ldl-c/
https://gpcardio.org/de/2026-04-21_tragbare-gerate-und-kardiovaskulare-gesundheit/
https://gpcardio.org/de/2026-04-22_leitlinie-der-acc-aha-aacvpr-abc-acpm-ada-ags-apha-aspc-nla-pcna-zur-behandlung-der-dyslipidamie/
https://gpcardio.org/de/2026-04-22_memantin-bei-vorzeitigen-vorhofkontraktionen/
https://gpcardio.org/de/2026-04-22_vorhospitalische-heparin-gabe-bei-patienten-mit-stemi-im-rahmen-einer-primaren-pci/
https://gpcardio.org/de/2026-04-23_auswirkungen-der-apoc3-hemmung-durch-olezarsen-auf-die-koronare-atherosklerose/
https://gpcardio.org/de/2026-04-23_niedrigdosierte-rivaroxaban-therapie-zur-pravention-von-linksventrikularen-thrombosen-nach-anteriorem-myokardinfarkt/
https://gpcardio.org/de/2026-04-24_2026-ernahrungsleitlinien-zur-verbesserung-der-kardiovaskularen-gesundheit/
https://gpcardio.org/de/2026-04-24_stadien-des-kardiovaskular-nieren-metabolischen-syndroms-echokardiographische-merkmale-und-risiko-fur-herzinsuffizienz/
https://gpcardio.org/de/2026-04-24_zwei-studien-zum-vergleich-der-leitungsstystempacing-und-der-biventrikularen-stimulation/
https://gpcardio.org/de/2026-04-25_die-rolle-der-atrialen-taktunterstutzung-in-der-kardialen-resynchronisationstherapie/
https://gpcardio.org/de/2026-04-25_sotatercept-bei-kombinierter-post-und-precapillarer-pulmonaler-hypertonie-assoziiert-mit-herzinsuffizienz/
https://gpcardio.org/de/2026-04-26_bewertung-des-langfristigen-kardiovaskularen-erkrankungsrisikos-in-der-schwangerschaft/
https://gpcardio.org/de/2026-04-27_automatisierte-echokardiographische-erkennung-von-angeborenen-herzfehlern-unter-einsatz-kunstlicher-intelligenz/
https://gpcardio.org/de/2026-04-28_fruhe-pravention-von-atheromen/
https://gpcardio.org/de/2026-04-30_drei-niedrig-dosierte-antihypertensiva-in-einer-einzeltablette-nach-intrazerebraler-hamatomblutung/
https://gpcardio.org/de/2026-05-01_stereotaktische-radioablation-bei-refraktarer-ventrikularer-tachykardie/
https://gpcardio.org/de/2026-05-02_blockade-des-raas-in-der-niere-im-lebenszyklus-behandlungsstandard/
https://gpcardio.org/de/2026-05-03_nicht-invasives-kardiovaskulares-screening-mit-multimodalen-verfahren-und-geschlechtsspezifische-ergebnisse/
https://gpcardio.org/de/2026-05-04_fortsetzung-versus-umstellung-der-direkten-oralen-antikoagulationstherapie-nach-einem-schlaganfall-trotz-therapie/
https://gpcardio.org/de/2026-05-05_geschlechtsunterschiede-in-der-pharmakologischen-behandlung-der-herzinsuffizienz/
https://gpcardio.org/de/2026-05-05_umfassende-schwangerschaftsbedingte-absetzungszeit-bei-frauen-mit-familiarer-hypercholesterinamie/
https://gpcardio.org/de/2026-05-06_risikofaktoren-fur-kardiovaskulare-erkrankungen-durch-atherosklerose-bei-personen-mit-heterozygoter-familiarer-hypercholesterinamie-fh/
https://gpcardio.org/de/2026-05-07_kombinierte-kathetergestutzte-edge-to-edge-reparatur-der-mitralklappe-und-trikuspidalklappe-oder-alleinige-edge-to-edge-reparatur-der-trikuspidalklappe-bei-moderater-mitralinsuffizienz/
https://gpcardio.org/de/2026-05-08_nierenfunktion-und-risiko-einer-herzinsuffizienz-bei-alteren-erwachsenen/
https://gpcardio.org/de/2026-05-08_schlaganfall-und-blutungsrisiken-bei-nicht-valvularem-vorhofflimmern-unter-nicht-vitamin-k-abhangigen-oralen-antikoagulanzien/
https://gpcardio.org/de/2026-05-09_implantation-eines-subkutanen-defibrillators-mit-oder-ohne-defibrillationstest/
https://gpcardio.org/de/2026-05-10_angiotensin-rezeptor-neprilysin-inhibitor-bei-herzinsuffizienz-mit-erhaltener-ejektionsfraktion-und-sekundarer-mitralinsuffizienz/
https://gpcardio.org/de/2026-05-10_der-microrna-inhibitor-cdr132l-bei-patienten-mit-reduzierter-linksventrikularer-ejektionsfraktion-nach-myokardinfarkt/
https://gpcardio.org/de/2026-05-10_digoxin-bei-patienten-mit-symptomatischer-rheumatischer-herzerkrankung/
https://gpcardio.org/de/2026-05-10_niedrig-dosiertes-digoxin-bei-patienten-mit-herzinsuffizienz-mit-reduzierter-oder-leicht-reduzierter-ejektionsfraktion/
https://gpcardio.org/de/2026-05-10_verblindeter-entzug-der-randomisierten-behandlung-mit-niedrig-dosiertem-digoxin-oder-placebo-bei-patienten-mit-herzinsuffizienz/
https://gpcardio.org/de/2026-05-10_wirksamkeit-der-leitliniengerechten-medikamentosen-therapie-in-abhangigkeit-vom-einsatz-von-digoxin/
https://gpcardio.org/de/2026-05-11_anthropometrische-adipositasmase-und-natriuretische-peptide-beim-herzinsuffizienz-screening/
https://gpcardio.org/de/2026-05-11_kardiovaskulare-erkrankung-bei-sichelzellkrankheit/
https://gpcardio.org/de/2026-05-11_korperliche-aktivitat-bei-padiatrischen-kardiomyopathien/
https://gpcardio.org/de/2026-05-11_neu-auftretende-krebserkrankungen-bei-herzinsuffizienz-myokardinfarkt-oder-beidem/
https://gpcardio.org/de/2026-05-11_pravalenz-und-pradiktoren-eines-hohen-entzundlichen-risikos-bei-herzinsuffizienz-subtypen/
https://gpcardio.org/de/2026-05-11_subcut-hf-ii-hausliches-subkutanes-furosemid-reduziert-krankenhaustage-im-vergleich-zu-stationarem-intravenosem-furosemid-bei-patienten-die-mit-herzinsuffizienz-assoziiertem-odem-aufgenommen-wurden/
https://gpcardio.org/de/2026-05-12_pradiktoren-fur-langzeitendpunkte-bei-hypertropher-kardiomyopathie/
https://gpcardio.org/de/2026-05-12_sotatercept-bei-kombinierter-post-und-prakapillarer-pulmonaler-hypertonie-im-zusammenhang-mit-herzinsuffizienz/
https://gpcardio.org/de/2026-05-12_ubersteigt-die-globale-pravalenz-der-herzinsuffizienz-mittlerweile-600-millionen-menschen-von-mutmasung-zu-evidenz/
https://gpcardio.org/de/2026-05-15_einjahrige-multizentrische-prospektive-real-world-studie-zur-wirksamkeit-und-sicherheit-von-vericiguat-in-spanien/
https://gpcardio.org/de/2026-05-15_sekundarpravention-nach-koronarer-bypass-operation/
https://gpcardio.org/de/2026-05-18_auf-dem-weg-zu-umfassenden-kardiovaskularen-gesundheitschecks-in-ganz-europa/
https://gpcardio.org/de/2026-05-19_atlas-of-cardiology-vermeidbare-ungleichheiten-bei-der-krankheitslast-und-versorgung-kardiovaskularer-erkrankungen-bestehen-weiterhin/
https://gpcardio.org/de/2026-05-25_in-vivo-baseneditierung-von-pcsk9-mit-verve-102-bei-hypercholesterinamie/
https://gpcardio.org/de/2026-05-27_glucagon-like-peptid-1-rezeptor-agonisten-bei-patienten-mit-herzinsuffizienz-mit-reduzierter-ejektionsfraktion/
https://gpcardio.org/de/2026-05-27_pulsfeldablation-zur-interventionellen-behandlung-von-vorhofflimmern-eine-wissenschaftliche-stellungnahme-der-european-heart-rhythm-association-ehra-der-esc-der-heart-rhythm-society-hrs-der-asia-pacif/
https://gpcardio.org/de/2026-05-28_frauenherzzentren/
https://gpcardio.org/de/2026-05-28_sglt2-hemmer-sind-mit-einer-verringerung-des-volumens-und-der-dicke-des-epikardialen-fettgewebes-verbunden/
https://gpcardio.org/de/2026-05-29_pathophysiologie-pravention-und-management-der-koronaren-mikrovascularobstruktion/
https://gpcardio.org/de/2026-05-31_die-niere-in-der-mitte/
https://gpcardio.org/de/2026-06-01_gemeinsame-pathophysiologische-mechanismen-zwischen-diabetes-und-der-kalzifizierenden-aortenklappenerkrankung/
https://gpcardio.org/de/2026-06-01_nieren-diabetische-uberlappung-bei-pulmonaler-arterieller-hypertonie/
https://gpcardio.org/de/2026-06-02_epidemiologie-der-lungenembolie/
https://gpcardio.org/de/2026-06-02_ergebnisse-der-betami-danblock-studie-im-vergleich-zu-einer-landesweiten-norwegischen-population-mit-myokardinfarkt/
https://gpcardio.org/de/2026-06-02_obicetrapib-und-lipoprotein-a-spiegel-bei-patienten-mit-hohem-kardiovaskularem-risiko/
https://gpcardio.org/de/2026-06-03_familiare-hypercholesterinamie-bei-kindern-und-jugendlichen/
https://gpcardio.org/de/2026-06-03_lipoprotein-a-spiegel-kardiovaskulares-ereignisrisiko-und-nutzen-von-evolocumab/
https://gpcardio.org/de/2026-06-04_auswirkungen-von-semaglutid-auf-mortalitat-kardiovaskulare-und-nierenergebnisse-uber-das-kardiovaskular-nieren-metabolische-kontinuum-hinweg/
https://gpcardio.org/de/2026-06-04_lipidkliniken-weltweit/
https://gpcardio.org/de/2026-06-05_projizierte-reduktion-schwerwiegender-kardiovaskularer-ereignisse-bei-hochriskierten-us-erwachsenen-mit-typ-2-diabetes-die-fur-orale-semaglutid-inanspruchnahme-in-frage-kommen/
https://gpcardio.org/de/2026-06-07_autosomal-dominantes-alport-syndrom/
https://gpcardio.org/de/2026-06-09_veranderungen-der-korperzusammensetzung-bei-patienten-unter-glp-1-rezeptor-agonisten-die-ein-intensives-kardiologisches-rehabilitationsprogramm-durchlaufen/
https://gpcardio.org/de/2026-06-10_konservierungsstoffe-in-lebensmitteln-hypertonie-und-kardiovaskulare-erkrankungen/
https://gpcardio.org/de/2026-06-10_primare-ergebnisse-der-salamander-registry/
https://gpcardio.org/de/2026-06-11_mobile-health-unit-outreach-to-socially-disadvantaged-urban-communities-detects-uncontrolled-cardiometabolic-risk-factors/
https://gpcardio.org/de/2026-06-11_optimale-trainingsmodalitaten-und-dosierungen-zur-senkung-des-blutdrucks-bei-erwachsenen-mit-prahypertonie-und-etablierter-hypertonie/
https://gpcardio.org/de/2026-06-12_senkung-des-low-density-lipoprotein-cholesterins-mit-inclisiran-plus-standardversorgung-bei-kurzlich-aufgetretenem-akutes-koronarsyndrom/
https://gpcardio.org/de/2026-06-13_auswirkungen-verschiedener-arten-von-vollkorn-hulsenfruchten-auf-etablierte-therapeutische-lipidziele-zur-reduktion-des-kardiovaskularen-risikos/
https://gpcardio.org/de/2026-06-13_europaische-gesellschaft-fur-kardiologie/
https://gpcardio.org/de/2026-06-15_klinische-wirksamkeit-von-sglt2-hemmern-bei-alteren-patienten-die-aufgrund-einer-herzinsuffizienz-mit-reduzierter-ejektionsfraktion-hospitalisiert-wurden/
https://gpcardio.org/de/2026-06-15_kosteneffektivitats-und-budget-impact-analyse-von-tirzepatid-bei-herzinsuffizienz-mit-erhaltener-ejektionsfraktion-und-adipositas-im-deutschen-gesundheitssystem/
https://gpcardio.org/de/2026-06-15_vergleichende-wirksamkeit-einzelner-sglt2-hemmer-auf-kardiovaskulare-endpunkte-bei-typ-2-diabetes-mit-moderatem-kardiovaskularem-risiko/
https://gpcardio.org/de/2026-06-16_assoziation-von-ernahrungsmustern-und-genetischem-risiko-mit-kardiovaskularer-erkrankung-bei-krebsuberlebenden-in-der-uk-biobank/
https://gpcardio.org/de/2026-06-17_altersabhangige-assoziation-zwischen-herzinsuffizienz-und-schlaganfallrisiko-bei-vorhofflimmern/
https://gpcardio.org/de/2026-06-17_homozygote-familiare-hypercholesterinamie/
https://gpcardio.org/de/2026-06-19_intrakoronare-bildgebung-bei-perkutaner-koronarer-intervention-des-linken-hauptstamms/
https://gpcardio.org/de/2026-06-19_laroprovstat-der-erste-orale-kleine-molekul-pcsk9-inhibitor-zur-behandlung-der-hypercholesterinamie/
https://gpcardio.org/de/2026-06-20_arzneimittelziele-fur-die-lipidmodifikation-und-das-risiko-fur-typ-2-diabetes/
https://gpcardio.org/de/2026-06-20_lipidbezogenes-kardiovaskulares-risiko-jenseits-des-ldl-cholesterins/
https://gpcardio.org/de/2026-06-21_eine-einjahrige-multizentrische-prospektive-real-world-studie-zur-wirksamkeit-und-sicherheit-von-vericiguat-in-spanien/
https://gpcardio.org/de/2026-06-24_ergebnisse-nach-einem-ersten-akuten-myokardinfarkt-bei-patienten-mit-und-ohne-angeborene-herzfehler/
https://gpcardio.org/de/2026-06-25_ein-jahres-ergebnisse-aus-der-praxis-mit-dem-amulet-occluder-aus-der-emerge-laa-nachzulassungsstudie/
https://gpcardio.org/de/2026-06-25_verblindeter-abbruch-der-randomisierten-behandlung-mit-niedrig-dosiertem-digoxin-oder-placebo-bei-patienten-mit-herzinsuffizienz/
https://gpcardio.org/de/2026-06-27_hausarztliche-versorgung-von-patientinnen-und-patienten-mit-herzinsuffizienz-auserhalb-der-regularen-sprechstundenzeiten/
https://gpcardio.org/de/2026-06-29_koronare-embolie-bei-vorhofflimmern/
https://gpcardio.org/de/2026-06-30_index-fur-die-interaktion-zwischen-ernahrung-und-darmmikrobiota-sowie-das-risiko-fur-herzinsuffizienz-bei-diabetes-und-pradiabetes/
https://gpcardio.org/de/2026-07-01_direkte-orale-antikoagulanzien-cox-2-selektive-nsar-und-gastrointestinalen-blutungen-bei-vorhofflimmern/
https://gpcardio.org/de/2026-07-02_inzidenz-der-durch-die-krebstherapie-bedingten-kardialen-dysfunktion-in-einer-grosen-diversen-und-aktuellen-kohorte-im-real-world-setting/
https://gpcardio.org/de/2026-07-02_pulsfeld-ablation-versus-scheinbehandlung-zur-behandlung-von-vorhofflimmern/
https://gpcardio.org/de/2026-07-03_abschatzung-des-5-jahres-risikos-fur-eine-kardiovaskulare-erkrankung-unter-verwendung-routinemasig-erhobener-elektronischer-krankenakten-aus-australischen-hausarztpraxen/
https://gpcardio.org/de/2026-07-03_naturlicher-verlauf-der-asymptomatischen-moderaten-oder-schweren-aortenklappeninsuffizienz/
https://gpcardio.org/de/2026-07-05_kardiorespiratorische-fitness-bei-jugendlichen-und-die-abwagung-zwischen-dem-risiko-fur-vorhofflimmern-und-den-kardiovaskularen-vorteilen/
https://gpcardio.org/de/2026-07-05_korperliche-fitness-nach-myokardinfarkt-im-vergleich-zu-klinischen-referenzwerten/
https://gpcardio.org/de/2026-07-05_risikofaktoren-fur-die-multimorbiditat-kardiovaskularer-erkrankungen-in-der-prospektiven-million-women-study/
https://gpcardio.org/de/2026-07-06_kardiorespiratorische-fitness-bei-jugendlichen-und-die-abwagung-zwischen-dem-risiko-fur-vorhofflimmern-und-den-kardiovaskularen-vorteilen/
https://gpcardio.org/de/2026-07-07_hat-die-hausarztliche-versorgung-eine-rolle-im-adipositas-management-vom-gatekeeper-zur-fuhrungsrolle-in-der-bevolkerungsgesundheit/
https://gpcardio.org/de/2026-07-07_infektiose-endokarditis-nach-transkatheter-aortenklappenimplantation/
https://gpcardio.org/de/2026-07-07_nahrungsaufnahme-von-pflanzlichem-und-tierischem-nitrat-und-5-jahres-blutdruck-veranderungen/
https://gpcardio.org/de/2026-07-07_warum-ist-die-chronische-nierenerkrankung-ckd-fur-die-hausarztliche-versorgung-wichtiger-geworden/
https://gpcardio.org/de/2026-07-07_wichtige-anderungen-in-der-klinischen-leitlinie-fur-blutdruck-und-lipidmanagement/
https://gpcardio.org/de/2026-07-08_evolocumab-bei-patienten-mit-vorangegangener-perkutaner-koronarer-intervention-und-ohne-vorangegangenen-myokardinfarkt/
https://gpcardio.org/de/2026-07-08_kalziumkanalblockade-versus-β-blockade-bei-hypertonie-und-herzinsuffizienz-mit-erhaltener-ejektionsfraktion/
https://gpcardio.org/de/2026-07-08_nahrungsaufnahme-von-pflanzlichem-und-tierischem-nitrat-und-5-jahres-blutdruck-veranderungen/
https://gpcardio.org/de/2026-07-09_angiotensin-rezeptor-neprilysin-inhibitor-bei-herzinsuffizienz-mit-erhaltener-ejektionsfraktion-und-sekundarer-mitralklappeninsuffizienz/
https://gpcardio.org/de/2026-07-09_bestimmung-der-physiologischen-schwelle-fur-angina-orbita-fire/
https://gpcardio.org/de/2026-07-09_diastolische-dysfunktion-ist-bei-pradiabetes-und-diabetes-gleichermasen-haufig-und-mit-begleitenden-kardiometabolischen-risikofaktoren-assoziiert/
https://gpcardio.org/de/2026-07-09_nachts-gemessener-hauslicher-blutdruck-am-handgelenk-und-linksventrikulare-hypertrophie/
https://gpcardio.org/de/2026-07-10_evolocumab-bei-patienten-mit-vorheriger-perkutaner-koronarer-intervention-und-ohne-vorherigen-myokardinfarkt/
https://gpcardio.org/de/2026-07-11_kalziumkanalblockade-versus-betablockade-bei-hypertonie-und-herzinsuffizienz-mit-erhaltener-ejektionsfraktion/
https://gpcardio.org/de/2026-07-11_nachtlicher-blutdruck-zu-hause-am-handgelenk-gemessen-und-linksventrikulare-hypertrophie/
https://gpcardio.org/de/2026-07-12_angiotensin-rezeptor-neprilysin-inhibitor-bei-herzinsuffizienz-mit-erhaltener-ejektionsfraktion-und-sekundarer-mitralklappeninsuffizienz/
https://gpcardio.org/de/2026-07-12_bestimmung-der-physiologischen-schwelle-fur-angina-orbita-fire/
https://gpcardio.org/de/2026-07-14_linkskammerthrombus-bei-takotsubo-syndrom-und-st-strecken-hebungs-myokardinfarkt/
https://gpcardio.org/de/2026-07-15_der-naturliche-verlauf-der-massiven-linksventrikularen-hypertrophie-bei-padiatrischer-hypertropher-kardiomyopathie/
https://gpcardio.org/de/2026-07-16_multisystemische-physiologische-defizite-wahrend-der-belastung-identifizieren-die-klinische-und-molekulare-pradisposition-fur-eine-herzinsuffizienz-mit-erhaltener-ejektionsfraktion/
https://gpcardio.org/de/2026-07-18_klinische-ergebnisse-der-leitungsstystem-pacing-im-vergleich-zur-rechtsherzschrittmachertherapie-bei-patienten-mit-atrioventrikularer-blockade/
https://gpcardio.org/de/2026-07-18_sind-klinische-verbesserungen-bei-angst-oder-depression-mit-einer-verbesserung-der-gehfahigkeit-nach-einem-kardiologischen-rehabilitationsprogramm-assoziiert/
https://gpcardio.org/de/2026-07-18_zerebrale-amyloidangiopathie/
https://gpcardio.org/de/2026-07-19_behandlung-und-ergebnisse-unter-pcsk9-inhibitoren-bei-patienten-mit-atherosklerotischer-kardiovaskularer-erkrankung-ohne-vorangegangene-ischamische-ereignisse/
https://gpcardio.org/de/2026-07-19_pharmakologische-blutdrucksenkung-zur-pravention-kardiovaskularer-erkrankungen-und-des-todes-uber-das-gesamte-spektrum-der-schweregrade-chronischer-nierenerkrankungen/
https://gpcardio.org/de/2026-07-21_entwicklung-eines-integrierten-tools-zur-bewertung-des-monogenen-und-polygenen-risikos-fur-koronare-herzkrankheit-und-dessen-anwendung-in-einem-biobasierten-gemeindebasierten-gesundheitsversorgungssys/
https://gpcardio.org/de/2026-07-22_management-und-ergebnisse-bei-neu-aufgetretenem-postoperativem-vorhofflimmern/
https://gpcardio.org/de/2026-07-23_die-naturliche-entwicklung-der-massiven-linksventrikularen-hypertrophie-bei-padiatrischer-hypertropher-kardiomyopathie/
https://gpcardio.org/de/2026-07-23_physiologische-defizite-mehrerer-organe-wahrend-der-belastung-identifizieren-die-klinische-und-molekulare-pradisposition-fur-herzinsuffizienz-mit-erhaltener-ejektionsfraktion/
https://gpcardio.org/de/2026-07-24_blutdruckkontrolle-und-sterblichkeit-unter-us-veteranen/
https://gpcardio.org/de/2026-07-24_nierenfunktionsstorung-und-pulmonale-gefaserkrankung-bei-herzinsuffizienz-mit-erhaltener-ejektionsfraktion/
https://gpcardio.org/de/2026-07-25_lipoprotein-a-hochsensitives-c-reaktives-protein-und-das-risiko-fur-ein-erstes-ascvd-ereignis-bei-personen-ohne-standardmasige-modifizierbare-risikofaktoren/
https://gpcardio.org/de/2026-07-26_geschlechtsunterschiede-bei-den-ergebnissen-nach-einem-durchgebrochenen-ischamischen-schlaganfall-bei-oraler-antikoagulation-wegen-vorhofflimmerns/
https://gpcardio.org/de/2026-07-26_patientenversorgungspfade-und-ergebnisse-nach-neu-diagnostiziertem-vorhofflimmern/
https://gpcardio.org/de/2026-07-27_bewertung-und-management-des-kardiovaskularen-nieren-leber-metabolischen-syndroms-in-der-hausarztlichen-versorgung/
https://gpcardio.org/de/2026-07-27_phanotypisierung-von-patienten-mit-niedrigem-fluss-und-niedrigem-gradienten-bei-aortaler-stenose-und-erhaltener-ejektionsfraktion-die-sich-einer-tavi-unterziehen/
https://gpcardio.org/de/2026-07-28_epidemiologie-okonomische-belastung-und-mortalitat-von-vorhofflimmern-in-einer-region-mit-sehr-hoher-lebenserwartung/
https://gpcardio.org/de/2026-07-28_kombinierter-effekt-von-bildungsniveau-und-diabetes-auf-die-1-jahres-sterblichkeit-durch-alle-ursachen-bei-patientinnen-und-patienten-mit-herzinsuffizienz/
https://gpcardio.org/de/2026-07-28_neue-nieren-alte-risiken/
https://gpcardio.org/de/2026-07-29_lipidmanagement-bei-typ-2-diabetes-und-nicht-hdl-cholesterin/
https://gpcardio.org/de/2026-07-29_transseptale-punktion-bei-kardiovaskularen-interventionen/
https://gpcardio.org/de/2026-07-29_zeitlich-auf-den-chronotyp-abgestimmte-trainingszeiten-bei-mitteldurchschnittlichen-erwachsenen-mit-kardiovaskularem-und-metabolischem-risiko/
https://gpcardio.org/de/2026-07-31_fruhe-ergebnisse-und-pradiktoren-der-mortalitat-bei-einer-endokarditis-der-nativen-aortenklappe/
https://gpcardio.org/de/2026-07-31_geschlechtsunterschiede-bei-der-diagnose-dem-management-und-den-ergebnissen-von-patienten-mit-infektioser-endokarditis/
https://gpcardio.org/de/2026-08-02_entwicklungen-in-der-nephrologie/
https://gpcardio.org/de/2026-08-02_epccs-erneuert-ihre-identitat-um-die-integrierte-kardio-renal-metabolische-versorgung-in-der-hausarztlichen-versorgung-zu-starken/
https://gpcardio.org/de/2026-08-02_stellungnahme-kardiovaskularer-nutzen-bei-ublichem-kaffeekonsum-warnsignal-bei-energydrinks/
https://gpcardio.org/de/2026-08-02_zusammenhang-zwischen-c-reaktivem-protein-und-dem-risiko-fur-neu-auftretende-herzinsuffizienz-bei-krebsuberlebenden/
https://gpcardio.org/de/2026-08-03_antithrombotische-therapie-bei-patienten-mit-chronischem-koronarem-syndrom-unter-oraler-antikoagulation/
https://gpcardio.org/de/2026-08-03_expertenkonsensdokument-der-aha-acc-esc-whf/
https://gpcardio.org/de/2026-08-04_gebrechlichkeit-und-herzinsuffizienz/
https://gpcardio.org/de/2026-08-05_geschlechtsunterschiede-bei-der-risikofaktorkontrolle-und-der-medikamentenadharenz-nach-einem-akuten-koronarsyndrom/
https://gpcardio.org/de/2026-08-06_blutdruckkontrolle-und-sterblichkeit-unter-us-veteranen/
https://gpcardio.org/de/2026-08-06_die-senkung-des-systolischen-blutdrucks-und-der-albuminurie-vermitteln-die-kardiovaskularen-vorteile-von-finerenon-bei-typ-2-diabetes-und-chronischer-nierenerkrankung/
https://gpcardio.org/de/2026-08-06_peptidbasierte-kombinatorische-pharmakotherapien-bei-chronischen-stoffwechselerkrankungen/
https://gpcardio.org/de/2026-08-10_die-neue-esc-leitlinie-zur-herzinsuffizienz/
https://gpcardio.org/de/2026-08-10_hemmung-von-faktor-xi/
https://gpcardio.org/de/2026-08-10_herz-und-niere-in-einer-leitlinie/
https://gpcardio.org/de/2026-08-10_statine-uber-siebzig/
https://gpcardio.org/de/cvd-ckd-t2d/
https://gpcardio.org/de/each/
https://gpcardio.org/de/epccs-summit/
https://gpcardio.org/de/epccs-summit/der-eu-plan-fur-kardiovaskulare-gesundheit/
https://gpcardio.org/de/epccs-summit/herz-kreislauf-erkrankungen-in-besonderen-bevolkerungsgruppen/
https://gpcardio.org/de/epccs-summit/kardiorenales-update/
https://gpcardio.org/de/epccs-summit/kardiovaskulare-update-sitzung-fur-die-hausarztliche-versorgung/
https://gpcardio.org/de/epccs-summit/lipidmanagement-in-der-hausarztlichen-versorgung/
https://gpcardio.org/de/epccs-summit/management-des-kardiovaskularen-risikos-in-europa-lehren-aus-den-landern/
https://gpcardio.org/de/epccs-symposium-bei-wonca-europe-2026-zu-kardio-renal-metabolischen-erkrankungen/
https://gpcardio.org/de/epccs/
https://gpcardio.org/de/epccs/verbundene-gesellschaften/
https://gpcardio.org/de/esc-congress-2025/
https://gpcardio.org/de/gpcardio/
https://gpcardio.org/de/literatur/
https://gpcardio.org/de/literatur/
https://gpcardio.org/de/ncd-academy/
https://gpcardio.org/de/neuigkeiten-der-gesellschaft/
https://gpcardio.org/de/ressourcen/
https://gpcardio.org/de/ressourcen/aktuelle-nachrichten/
https://gpcardio.org/de/ressourcen/praxisorientierte-empfehlungen/
https://gpcardio.org/de/ressourcen/stratifyhf/
https://gpcardio.org/de/ressourcen/tagungsberichte/
https://gpcardio.org/de/ressourcen/video-updates/
https://gpcardio.org/de/uber-epccs/
https://gpcardio.org/de/uber-ipccs/
https://gpcardio.org/de/wissenschaftliche-updates/
https://gpcardio.org/de/wonca-world-2025/
https://gpcardio.org/el/
https://gpcardio.org/el/2014-05-28_πρακτική-καθοδήγηση-για-ιατρούς-πρωτοβάθμιας-φροντίδας-σχετικά-με-τη-χρήση-στατινών-σε-άτομα-με-κίνδυνο-εμφ/
https://gpcardio.org/el/2015-01-07_το-έγγραφο-καθοδήγησης-της-epccs-για-την-πρόληψη-εγκεφαλικού-επεισοδίου-στην-κολπική-μαρμαρυγή-1/
https://gpcardio.org/el/2015-09-29_ζωηρή-συζήτηση-στην-ετήσια-clinical-masterclass-της-epccs-οδηγεί-σε-πρακτική-καθοδήγηση/
https://gpcardio.org/el/2015-10-02_ποια-είναι-η-βάση-τεκμηρίωσης-για-την-τροποποίηση-της-αρτηριακής-πίεσης-στις-ενημερώσεις-των-κατευθυντήριων/
https://gpcardio.org/el/2015-10-02_ποια-είναι-η-βάση-τεκμηρίωσης-για-την-τροποποίηση-της-συμπεριφοράς-υγείας-στις-ενημερώσεις-των-κατευθυντήρι/
https://gpcardio.org/el/2015-10-12_ποια-είναι-η-βάση-τεκμηρίωσης-για-την-τροποποίηση-των-λιπιδίων-στις-ενημερώσεις-των-κατευθυντήριων-οδηγιών/
https://gpcardio.org/el/2015-10-14_ποια-είναι-η-βάση-τεκμηρίωσης-για-τη-διάγνωση-και-τη-διαχείριση-της-καρδιακής-ανεπάρκειας-στις-ενημερώσεις-τ/
https://gpcardio.org/el/2016-03-15_ποια-είναι-η-βάση-τεκμηρίωσης-για-την-τροποποίηση-των-λιπιδίων-στις-ενημερώσεις-των-κατευθυντήριων-οδηγιών/
https://gpcardio.org/el/2016-04-15_εντοπισμός-και-θεραπεία-ασθενών-με-αληθή-υπέρταση/
https://gpcardio.org/el/2016-05-26_η-βάση-τεκμηρίωσης-για-τις-αλλαγές-συμπεριφοράς-υγείας/
https://gpcardio.org/el/2016-09-06_οδηγός-συναίνεσης-της-epccs-για-την-πρόληψη-εγκεφαλικού-επεισοδίου-στην-κολπική-μαρμαρυγή-spaf-στην-πρωτοβάθμια/
https://gpcardio.org/el/2016-09-28_έγγραφα-καθοδήγησης-της-epccs/
https://gpcardio.org/el/2017-03-30_καθοδήγηση-για-την-αλλαγή-συμπεριφορών-υγείας-ποια-είναι-η-τεκμηρίωση-τι-συνιστάται-και-συμφωνώ/
https://gpcardio.org/el/2017-04-20_αντικρουόμενες-απόψεις-για-τα-λιπίδια-είναι-πλέον-σαφής-ο-ρόλος-των-στατινών-υπάρχουν-εναλλακτικές-και-τι-βρ/
https://gpcardio.org/el/2017-04-20_αντικρουόμενες-απόψεις-για-την-υπέρταση-ποιες-είναι-οι-επιπτώσεις-της-μελέτης-sprint-στο-πλαίσιο-των-πρόσφατων/
https://gpcardio.org/el/2017-04-20_διαχείριση-κολπικής-μαρμαρυγής-τι-λένε-οι-κατευθυντήριες-οδηγίες-και-ποιες-είναι-οι-επιπτώσεις-για-την-πρωτ/
https://gpcardio.org/el/2017-04-20_διαχείριση-λιπιδίων-τι-λένε-οι-κατευθυντήριες-οδηγίες-και-ποιες-είναι-οι-επιπτώσεις-για-την-πρωτοβάθμια-φρο/
https://gpcardio.org/el/2017-04-20_καθοδήγηση-για-την-αλλαγή-συμπεριφορών-υγείας-ποια-είναι-η-τεκμηρίωση-τι-συνιστάται-και-συμφωνώ/
https://gpcardio.org/el/2017-04-20_ποια-είναι-η-νέα-βάση-τεκμηρίωσης-για-τη-διάγνωση-και-τη-διαχείριση-της-καρδιακής-ανεπάρκειας/
https://gpcardio.org/el/2017-06-05_συστατικά-αποτελεσματικών-στρατηγικών-για-την-ενθάρρυνση-της-αλλαγής-συμπεριφοράς/
https://gpcardio.org/el/2017-06-22_πώς-επηρεάζουν-οι-πιο-πρόσφατες-αλλαγές-στις-κατευθυντήριες-οδηγίες-τη-διαχείριση-της-δυσλιπιδαιμίας-στην-π/
https://gpcardio.org/el/2017-07-01_η-καθοδήγηση-της-epccs-για-την-καρδιακή-ανεπάρκεια-δημοσιεύτηκε-ως-clinical-intelligence-στο-br-j-gen-prac/
https://gpcardio.org/el/2017-07-18_η-διάγνωση-και-η-διαχείριση-της-καρδιακής-ανεπάρκειας-διαφέρουν-σημαντικά-μεταξύ-των-ευρωπαϊκών-χωρών/
https://gpcardio.org/el/2017-09-13_τι-μπορούμε-να-μάθουμε-από-τις-πιο-πρόσφατες-μελέτες-για-την-υπέρταση/
https://gpcardio.org/el/2017-12-10_πρακτική-καθοδήγηση-της-epccs-για-τη-διάγνωση-και-τη-διαχείριση-της-καρδιακής-ανεπάρκειας-στην-πρωτοβάθμια-φρο/
https://gpcardio.org/el/2018-02-06_πώς-μπορεί-η-epccs-να-διευρύνει-τον-αριθμό-των-μελών-της/
https://gpcardio.org/el/2018-02-06_πώς-μπορεί-η-epccs-να-συνεργαστεί-καλύτερα-με-τους-ιατρούς-πρωτοβάθμιας-φροντίδας-σε-διάφορες-ευρωπαϊκές-χώρες/
https://gpcardio.org/el/2018-02-19_πρακτική-καθοδήγηση-για-τη-διάγνωση-και-τη-διαχείριση-της-καρδιακής-ανεπάρκειας-στην-πρωτοβάθμια-φροντίδα/
https://gpcardio.org/el/2018-02-19_πρόληψη-εγκεφαλικού-επεισοδίου-σε-ασθενείς-με-κολπική-μαρμαρυγή/
https://gpcardio.org/el/2018-02-19_χρόνια-καρδιακή-ανεπάρκεια/
https://gpcardio.org/el/2018-02-22_ενθάρρυνση-αλλαγών-συμπεριφοράς-υγείας-για-τη-μείωση-του-καρδιαγγειακού-κινδύνου-στην-πρωτοβάθμια-φροντίδα/
https://gpcardio.org/el/2018-02-25_διαφάνειες-οργάνωση-της-πρωτοβάθμιας-φροντίδας-στις-κάτω-χώρες/
https://gpcardio.org/el/2018-02-26_διαφάνειες-οργάνωση-της-πρωτοβάθμιας-φροντίδας-στη-σλοβακία/
https://gpcardio.org/el/2018-02-26_διαφάνειες-πρωτοβάθμια-φροντίδα-στη-βουλγαρία-nagpb/
https://gpcardio.org/el/2018-02-26_κάτω-χώρες-επισκόπηση-της-πρωτοβάθμιας-καρδιαγγειακής-φροντίδας/
https://gpcardio.org/el/2018-02-26_σλοβακία-επισκόπηση-της-πρωτοβάθμιας-καρδιαγγειακής-φροντίδας/
https://gpcardio.org/el/2018-02-27_διαφάνειες-οργάνωση-της-πρωτοβάθμιας-φροντίδας-στην-πορτογαλία/
https://gpcardio.org/el/2018-02-27_διαφάνειες-πρωτοβάθμια-καρδιαγγειακή-φροντίδα-στην-ισπανία/
https://gpcardio.org/el/2018-02-28_βουλγαρία-πρωτοβάθμια-καρδιαγγειακή-φροντίδα/
https://gpcardio.org/el/2018-02-28_διαφάνειες-πρωτοβάθμια-καρδιαγγειακή-φροντίδα-στη-γαλλία/
https://gpcardio.org/el/2018-02-28_ισπανία-επισκόπηση-της-πρωτοβάθμιας-καρδιαγγειακής-φροντίδας/
https://gpcardio.org/el/2018-02-28_πορτογαλία-επισκόπηση-της-πρωτοβάθμιας-καρδιαγγειακής-φροντίδας/
https://gpcardio.org/el/2018-03-01_γαλλία-επισκόπηση-της-πρωτοβάθμιας-καρδιαγγειακής-φροντίδας/
https://gpcardio.org/el/2018-03-01_διαφάνειες-πρωτοβάθμια-καρδιαγγειακή-φροντίδα-στη-ρουμανία/
https://gpcardio.org/el/2018-03-01_διαφάνειες-πρωτοβάθμια-καρδιαγγειακή-φροντίδα-στην-ελλάδα/
https://gpcardio.org/el/2018-03-01_ελλάδα-επισκόπηση-της-πρωτοβάθμιας-καρδιαγγειακής-φροντίδας/
https://gpcardio.org/el/2018-03-01_ρουμανία-επισκόπηση-της-πρωτοβάθμιας-καρδιαγγειακής-φροντίδας/
https://gpcardio.org/el/2018-03-02_γερμανία-επισκόπηση-της-πρωτοβάθμιας-καρδιαγγειακής-φροντίδας/
https://gpcardio.org/el/2018-03-02_διαφάνειες-πρωτοβάθμια-καρδιαγγειακή-φροντίδα-στη-γερμανία/
https://gpcardio.org/el/2018-03-13_συναινετική-κατευθυντήρια-οδηγία-της-epccs-για-την-πρόληψη-εγκεφαλικού-επεισοδίου-στην-κολπική-μαρμαρυγή-στην/
https://gpcardio.org/el/2018-03-27_νόσος-περιφερικών-αρτηριών-κάτω-άκρων-μια-παραμελημένη-σημαντική-καρδιαγγειακή-νόσος/
https://gpcardio.org/el/2018-03-27_προώθηση-αλλαγών-συμπεριφοράς-υγείας-για-τη-μείωση-του-καρδιαγγειακού-κινδύνου-στην-πρωτοβάθμια-ιατρική-φρ/
https://gpcardio.org/el/2018-03-28_διαβήτης-και-αγγειακή-νόσος-επιδημιολογία-και-επιλογές-διαχείρισης/
https://gpcardio.org/el/2018-04-04_διαφάνειες-αρτηριακή-νόσος-κάτω-άκρων-μια-παραμελημένη-σημαντική-καρδιαγγειακή-νόσος-διάγνωση-και-κλινική/
https://gpcardio.org/el/2018-04-04_διαφάνειες-διαχείριση-σύνθετης-καρδιακής-ανεπάρκειας-μια-εξειδικευμένη-άποψη-της-διεπαφής-πρωτοβάθμιας-δε/
https://gpcardio.org/el/2018-04-04_διαφάνειες-διαχείριση-της-καρδιακής-ανεπάρκειας-στην-πρωτοβάθμια-φροντίδα-η-άποψη-του-γενικού-ιατρού/
https://gpcardio.org/el/2018-04-04_διαφάνειες-ενημέρωση-για-τον-διαβήτη-τύπου-2-και-την-καρδιαγγειακή-νόσο/
https://gpcardio.org/el/2018-04-04_διαφάνειες-μείωση-λιπιδίων-η-τεκμηρίωση-οι-κατευθυντήριες-οδηγίες-η-κλινική-πραγματικότητα/
https://gpcardio.org/el/2018-04-04_διαφάνειες-πρακτικό-εργαστήριο-για-το-abpm/
https://gpcardio.org/el/2018-04-04_διαφάνειες-υπέρταση-μπορούμε-να-συμφωνήσουμε-σε-διαγνωστικά-και-θεραπευτικά-όρια/
https://gpcardio.org/el/2018-04-04_διαχείριση-αυξημένων-λιπιδίων-και-στατινών-το-καλό-το-κακό-και-το-άσχημο/
https://gpcardio.org/el/2018-04-10_πολυπλοκότητες-στη-διαχείριση-της-καρδιακής-ανεπάρκειας-στην-πρωτοβάθμια-φροντίδα/
https://gpcardio.org/el/2018-04-10_υπέρταση-μπορούμε-να-συμφωνήσουμε-σε-διαγνωστικά-και-θεραπευτικά-όρια/
https://gpcardio.org/el/2018-04-24_διαχείριση-του-καρδιαγγειακού-κινδύνου-που-συνοδεύει-τον-t2dm-υπό-το-πρίσμα-νέων-θεραπευτικών-επιλογών/
https://gpcardio.org/el/2018-05-16_διαφάνειες-πρωτοβάθμια-φροντίδα-στην-ιταλία/
https://gpcardio.org/el/2018-05-16_πρωτοβάθμια-καρδιαγγειακή-φροντίδα-στην-ιταλία/
https://gpcardio.org/el/2018-05-22_μείωση-λιπιδίων-η-τεκμηρίωση-οι-κατευθυντήριες-οδηγίες-η-κλινική-πραγματικότητα/
https://gpcardio.org/el/2018-06-15_semergen-η-πρεσβυτερη-εταιρεία-οικογενειακής-ιατρικής-στην-ισπανία/
https://gpcardio.org/el/2018-06-15_semergen-ισπανική-εταιρεία-ιατρών-πρωτοβάθμιας-φροντίδας/
https://gpcardio.org/el/2018-06-19_ισπανία-εισαγωγή-στην-epccs/
https://gpcardio.org/el/2018-07-18_πολυπλοκότητες-στη-διαχείριση-της-καρδιακής-ανεπάρκειας/
https://gpcardio.org/el/2018-08-16_υπέρταση-μπορούμε-να-συμφωνήσουμε-σε-διαγνωστικά-και-θεραπευτικά-όρια/
https://gpcardio.org/el/2018-08-22_διαχείριση-αυξημένων-λιπιδίων-στην-πρωτοβάθμια-φροντίδα/
https://gpcardio.org/el/2018-10-22_γενικός-ιατρός-στη-δανία/
https://gpcardio.org/el/2018-10-22_διαχείριση-της-δυσλιπιδαιμίας-στην-πρωτοβάθμια-ιατρική-φροντίδα/
https://gpcardio.org/el/2018-10-22_πρακτικός-οδηγός-για-τη-διάγνωση-και-θεραπεία-της-καρδιακής-ανεπάρκειας-στην-πρωτοβάθμια-φροντίδα-υγείας/
https://gpcardio.org/el/2018-10-22_προώθηση-αλλαγών-στον-τρόπο-ζωής-για-τη-μείωση-του-καρδιαγγειακού-κινδύνου-στην-πφυ/
https://gpcardio.org/el/2018-10-23_πρόληψη-μη-μεταδοτικής-καρδιαγγειακής-νόσου-στην-πρωτοβάθμια-φροντίδα-στη-ρωσία/
https://gpcardio.org/el/2018-10-25_διαχείριση-αυξημένων-λιπιδίων-στην-πρωτοβάθμια-φροντίδα-υγείας/
https://gpcardio.org/el/2018-10-30_τρόποι-ενθάρρυνσης-αλλαγών-συμπεριφοράς-για-τη-μείωση-του-καρδιαγγειακού-κινδύνου-στην-πρωτοβάθμια-φροντίδ/
https://gpcardio.org/el/2018-12-03_πρωτοβάθμια-καρδιαγγειακή-φροντίδα-στη-σερβία-αγγλικά/
https://gpcardio.org/el/2018-12-04_πρωτοβάθμια-καρδιαγγειακή-φροντίδα-στη-σερβία-σερβικά/
https://gpcardio.org/el/2018-12-04_πρωτοβάθμια-καρδιαγγειακή-φροντίδα-στην-ουκρανία-αγγλικά/
https://gpcardio.org/el/2018-12-04_πρωτοβάθμια-καρδιαγγειακή-φροντίδα-στην-ουκρανία-ουκρανικά/
https://gpcardio.org/el/2018-12-04_πρωτοβάθμια-καρδιαγγειακή-φροντίδα-στην-τσεχική-δημοκρατία-αγγλικά/
https://gpcardio.org/el/2018-12-04_πρωτοβάθμια-καρδιαγγειακή-φροντίδα-στην-τσεχική-δημοκρατία-τσεχικά/
https://gpcardio.org/el/2018-12-04_πρωτοβάθμια-καρδιαγγειακή-φροντίδα-στο-μαυροβούνιο-αγγλικά/
https://gpcardio.org/el/2018-12-05_πρωτοβάθμια-καρδιαγγειακή-φροντίδα-στη-σλοβακία-αγγλικά/
https://gpcardio.org/el/2018-12-05_πρωτοβάθμια-καρδιαγγειακή-φροντίδα-στη-σλοβακία-σλοβακικά/
https://gpcardio.org/el/2018-12-05_πρωτοβάθμια-καρδιαγγειακή-φροντίδα-στην-πολωνία-αγγλικά/
https://gpcardio.org/el/2018-12-05_πρωτοβάθμια-καρδιαγγειακή-φροντίδα-στην-πολωνία-πολωνικά/
https://gpcardio.org/el/2018-12-05_πρωτοβάθμια-καρδιαγγειακή-φροντίδα-στο-βέλγιο-αγγλικά/
https://gpcardio.org/el/2018-12-05_πρωτοβάθμια-καρδιαγγειακή-φροντίδα-στο-βέλγιο-φλαμανδικά/
https://gpcardio.org/el/2018-12-07_πρωτοβάθμια-καρδιαγγειακή-φροντίδα-στη-γερμανία-αγγλικά/
https://gpcardio.org/el/2018-12-07_πρωτοβάθμια-καρδιαγγειακή-φροντίδα-στη-γερμανία-γερμανικά/
https://gpcardio.org/el/2018-12-10_πρωτοβάθμια-καρδιαγγειακή-φροντίδα-στην-ιρλανδία-αγγλικά/
https://gpcardio.org/el/2018-12-10_πρωτοβάθμια-καρδιαγγειακή-φροντίδα-στην-τουρκία-τουρκικά/
https://gpcardio.org/el/2018-12-13_πρωτοβάθμια-καρδιαγγειακή-φροντίδα-στην-τουρκία-αγγλικά/
https://gpcardio.org/el/2018-12-17_πρωτοβάθμια-καρδιαγγειακή-φροντίδα-στη-δανία-αγγλικά/
https://gpcardio.org/el/2018-12-17_πρωτοβάθμια-καρδιαγγειακή-φροντίδα-στη-δανία-δανικά/
https://gpcardio.org/el/2018-12-17_πρωτοβάθμια-καρδιαγγειακή-φροντίδα-στη-ρουμανία-ρουμανικά/
https://gpcardio.org/el/2018-12-17_πρωτοβάθμια-καρδιαγγειακή-φροντίδα-στην-ισπανία-αγγλικά/
https://gpcardio.org/el/2018-12-17_πρωτοβάθμια-καρδιαγγειακή-φροντίδα-στην-ισπανία-ισπανικά/
https://gpcardio.org/el/2018-12-17_πρωτοβάθμια-καρδιαγγειακή-φροντίδα-στο-μαυροβούνιο-μαυροβουνιακά/
https://gpcardio.org/el/2018-12-18_διαφάνειες-βασικά-μηνύματα-της-κατευθυντήριας-οδηγίας-της-epccs-για-τη-διαχείριση-αυξημένων-λιπιδίων-στην-πρω/
https://gpcardio.org/el/2019-01-10_πρωτοβάθμια-καρδιαγγειακή-φροντίδα-στην-ισπανία-αγγλικά/
https://gpcardio.org/el/2019-01-10_πρωτοβάθμια-καρδιαγγειακή-φροντίδα-στην-ισπανία-ισπανικά/
https://gpcardio.org/el/2019-02-07_εταιρεία-epccs-τι-είναι-διαθέσιμο-για-τα-μέλη/
https://gpcardio.org/el/2019-02-25_τρέχουσα-διαχείριση-του-διαβήτη-και-του-καρδιαγγειακού-κινδύνου-στην-πρωτοβάθμια-φροντίδα/
https://gpcardio.org/el/2019-03-28_διαβήτης-και-καρδιαγγειακός-κίνδυνος/
https://gpcardio.org/el/2019-03-28_ενημέρωση-για-την-πρόληψη-εγκεφαλικού-επεισοδίου-στην-κολπική-μαρμαρυγή/
https://gpcardio.org/el/2019-03-28_πώς-να-αντιμετωπιστούν-οι-προκλήσεις-της-πολυνοσηρότητας-στη-γενική-ιατρική-πρακτική/
https://gpcardio.org/el/2019-04-02_διαφάνειες-cvd-και-ψυχική-υγεία/
https://gpcardio.org/el/2019-04-02_διαφάνειες-διαβήτης-και-καρδιαγγειακός-κίνδυνος/
https://gpcardio.org/el/2019-04-02_διαφάνειες-ενημέρωση-για-την-πρόληψη-εγκεφαλικού-επεισοδίου-στην-κολπική-μαρμαρυγή/
https://gpcardio.org/el/2019-04-02_διαφάνειες-ποια-είναι-η-τεκμηρίωση-ότι-ο-διαβήτης-συνδέεται-με-τον-κίνδυνο-cvd/
https://gpcardio.org/el/2019-04-02_διαφάνειες-πολυνοσηρότητα-καρδιαγγειακή-νόσος-και-πολυφαρμακία/
https://gpcardio.org/el/2019-04-02_διαφάνειες-πολυπλοκότητες-στη-διαχείριση-της-καρδιακής-ανεπάρκειας/
https://gpcardio.org/el/2019-04-02_διαφάνειες-πρόσφατες-ενημερώσεις-στις-διεθνείς-κατευθυντήριες-οδηγίες-για-την-υπέρταση-πού-διαφέρουν-και-σ/
https://gpcardio.org/el/2019-04-03_πολυπλοκότητες-στη-διαχείριση-της-καρδιακής-ανεπάρκειας/
https://gpcardio.org/el/2019-04-24_πρόσφατες-ενημερώσεις-στις-διεθνείς-κατευθυντήριες-οδηγίες-για-την-υπέρταση-πού-διαφέρουν-και-σε-τι-θα-πρέπ/
https://gpcardio.org/el/2019-04-25_εκπαίδευση-ανταλλαγή-καθοδήγηση-και-αλληλεπίδραση-κατά-τη-διάρκεια-του-epccs-summit-2019/
https://gpcardio.org/el/2019-05-02_διαφάνειες-διαβήτης-τύπου-2-και-καρδιαγγειακές-εκβάσεις-κάτι-περισσότερο-από-διαχείριση-γλυκόζης-διδάγματα/
https://gpcardio.org/el/2019-05-02_διαφάνειες-διαχείριση-του-διαβήτη-στην-καθημερινή-καρδιαγγειακή-πρακτική-μια-διεπιστημονική-προσέγγιση/
https://gpcardio.org/el/2019-05-02_διαφάνειες-στοχεύοντας-την-cvd-στον-διαβήτη-νέες-στρατηγικές-για-την-αντιμετώπιση-του-κινδύνου/
https://gpcardio.org/el/2019-05-07_πρόληψη-εγκεφαλικού-επεισοδίου-στην-κολπική-μαρμαρυγή/
https://gpcardio.org/el/2019-05-21_ενημέρωση-για-τη-διαχείριση-του-καρδιαγγειακού-κινδύνου-στον-διαβήτη-ποια-είναι-η-τεκμηρίωση/
https://gpcardio.org/el/2019-06-18_νέος-διαγνωστικός-αλγόριθμος-και-θεραπευτικές-επιλογές-στη-διαχείριση-της-hf/
https://gpcardio.org/el/2019-08-13_διαφάνειες-βασικά-μηνύματα-της-κατευθυντήριας-οδηγίας-της-epccs-για-την-τρέχουσα-διαχείριση-του-διαβήτη-και-το/
https://gpcardio.org/el/2019-08-29_διάγνωση-και-διαχείριση-της-υπέρτασης-στην-πρωτοβάθμια-φροντίδα/
https://gpcardio.org/el/2019-10-02_η-επέκταση-της-epccs-στις-ευρωπαϊκές-χώρες-τι-επιφυλάσσεται/
https://gpcardio.org/el/2019-10-03_epccs-και-πρωτοβάθμια-καρδιαγγειακή-φροντίδα-στη-σερβία/
https://gpcardio.org/el/2019-10-03_epccs-και-πρωτοβάθμια-καρδιαγγειακή-φροντίδα-στη-σλοβακία-αγγλικά/
https://gpcardio.org/el/2019-10-03_epccs-και-πρωτοβάθμια-καρδιαγγειακή-φροντίδα-στη-σλοβακία-σλοβακικά/
https://gpcardio.org/el/2019-10-03_epccs-και-πρωτοβάθμια-καρδιαγγειακή-φροντίδα-στην-ισπανία-αγγλικά/
https://gpcardio.org/el/2019-10-03_epccs-και-πρωτοβάθμια-καρδιαγγειακή-φροντίδα-στην-ισπανία-ισπανικά/
https://gpcardio.org/el/2019-10-03_πώς-στοχεύει-η-epccs-να-βοηθήσει-τους-ιατρούς-πρωτοβάθμιας-φροντίδας-σε-όλη-την-ευρώπη-στην-αναγνώριση-και-διαχ/
https://gpcardio.org/el/2019-10-09_πώς-στοχεύει-η-epccs-να-βοηθήσει-τους-ιατρούς-πρωτοβάθμιας-φροντίδας-σε-όλη-την-ευρώπη-στην-αναγνώριση-και-διαχ/
https://gpcardio.org/el/2019-10-29_societe-francaise-de-medecine-generale-sfmg/
https://gpcardio.org/el/2019-10-29_διάγνωση-και-διαχείριση-της-υπέρτασης-στην-πρωτοβάθμια-φροντίδα-γαλλική-περίληψη/
https://gpcardio.org/el/2019-10-29_διάγνωση-και-διαχείριση-της-υπέρτασης-στην-πρωτοβάθμια-φροντίδα-ελληνική-περίληψη/
https://gpcardio.org/el/2019-10-29_διάγνωση-και-διαχείριση-της-υπέρτασης-στην-πρωτοβάθμια-φροντίδα-ουκρανική-περίληψη/
https://gpcardio.org/el/2019-10-29_διαγνωση-και-θεραπεια-της-υπερτασης-στην-πρωτοβαθμια-φροντιδα-υγειας-σερβική-περίληψη-της-κατευθυντήριας-ο/
https://gpcardio.org/el/2019-10-29_ελληνικές-εταιρείες-που-εμπλέκονται-στην-πρωτοβάθμια-φροντίδα/
https://gpcardio.org/el/2019-11-04_epccs-και-πρωτοβάθμια-καρδιαγγειακή-φροντίδα-στη-γαλλία/
https://gpcardio.org/el/2019-11-04_epccs-και-πρωτοβάθμια-καρδιαγγειακή-φροντίδα-στην-ιρλανδία/
https://gpcardio.org/el/2019-11-04_epccs-και-πρωτοβάθμια-καρδιαγγειακή-φροντίδα-στην-ουκρανία/
https://gpcardio.org/el/2019-11-04_epccs-και-πρωτοβάθμια-καρδιαγγειακή-φροντίδα-στην-πολωνία-αγγλικά/
https://gpcardio.org/el/2019-11-04_epccs-και-πρωτοβάθμια-καρδιαγγειακή-φροντίδα-στην-πολωνία-πολωνικά/
https://gpcardio.org/el/2019-11-04_epccs-και-πρωτοβάθμια-καρδιαγγειακή-φροντίδα-στην-τουρκία/
https://gpcardio.org/el/2019-11-12_καρδιακή-ανεπάρκεια-και-συννοσηρότητες-νεφρική-νόσος-και-καρκίνος/
https://gpcardio.org/el/2020-04-09_αρχική-επεμβατική-ή-συντηρητική-στρατηγική-για-τη-σταθερή-στεφανιαία-νόσο/
https://gpcardio.org/el/2020-04-14_επίδραση-της-δαπαγλιφλοζίνης-στην-επιδείνωση-της-καρδιακής-ανεπάρκειας-και-τον-καρδιαγγειακό-θάνατο-σε-ασθ/
https://gpcardio.org/el/2020-04-16_δύο-μελέτες-φάσης-3-της-ινκλισιράνης-σε-ασθενείς-με-αυξημένη-χοληστερόλη-ldl/
https://gpcardio.org/el/2020-04-16_ινκλισιράνη-για-τη-θεραπεία-της-ετερόζυγης-οικογενούς-υπερχοληστερολαιμίας/
https://gpcardio.org/el/2020-04-23_διαχείριση-της-στεφανιαίας-νόσου-σε-ασθενείς-με-προχωρημένη-νεφρική-νόσο/
https://gpcardio.org/el/2020-04-25_κλοπιδογρέλη-έναντι-τικαγρελόρης-ή-πρασουγρέλης-σε-ασθενείς-ηλικίας-70-ετών-ή-άνω-με-οξύ-στεφανιαίο-σύνδρομο/
https://gpcardio.org/el/2020-05-01_βέλτιστα-αντιθρομβωτικά-σχήματα-για-ασθενείς-με-κολπική-μαρμαρυγή-που-υποβάλλονται-σε-διαδερμική-στεφανιαί/
https://gpcardio.org/el/2020-05-02_αποτελεσματικότητα-της-καθετηριακής-νεφρικής-απονεύρωσης-απουσία-αντιυπερτασικών-φαρμάκων-spyral-htn-off-med-pivotal/
https://gpcardio.org/el/2020-05-05_δεκαετή-αποτελέσματα-μετά-από-στεντ-επικαλυμμένα-με-φάρμακο-έναντι-στεφανιαίας-παράκαμψης-για-νόσο-του-αρισ/
https://gpcardio.org/el/2020-05-09_μονοθεραπεία-με-αναστολέα-p2y12-ή-ασπιρίνη-για-δευτερογενή-πρόληψη-σε-ασθενείς-με-εγκατεστημένη-αθηροσκλήρωση/
https://gpcardio.org/el/2020-05-12_κλινική-διαχείριση-της-σταθερής-στεφανιαίας-νόσου-σε-ασθενείς-με-σακχαρώδη-διαβήτη-τύπου-2/
https://gpcardio.org/el/2020-05-14_βερισιγκουάτη-σε-ασθενείς-με-καρδιακή-ανεπάρκεια-και-μειωμένο-κλάσμα-εξώθησης/
https://gpcardio.org/el/2020-05-19_συσχέτιση-της-μείωσης-της-αρτηριακής-πίεσης-με-επίπτωση-άνοιας-ή-γνωστικής-έκπτωσης/
https://gpcardio.org/el/2020-05-26_επίδραση-της-μείωσης-αντιυπερτασικής-φαρμακευτικής-αγωγής-έναντι-συνήθους-φροντίδας-στον-βραχυπρόθεσμο-έλ/
https://gpcardio.org/el/2020-05-26_παγκόσμιος-επιπολασμός-της-οικογενούς-υπερχοληστερολαιμίας/
https://gpcardio.org/el/2020-06-16_επίδραση-της-μονοθεραπείας-με-τικαγρελόρη-έναντι-τικαγρελόρης-με-ασπιρίνη-στη-σοβαρή-αιμορραγία-και-τα-καρδ/
https://gpcardio.org/el/2020-07-07_αναγνώριση-πρόγνωση-και-θεραπεία-της-συστηματικής-αμυλοείδωσης/
https://gpcardio.org/el/2020-07-11_εκτίμηση-των-οφελών-δια-βίου-των-ολοκληρωμένων-τροποποιητικών-της-νόσου-φαρμακολογικών-θεραπειών-σε-ασθενε/
https://gpcardio.org/el/2020-07-14_συγκριτική-αποτελεσματικότητα-και-ασφάλεια-των-από-του-στόματος-αναστολέων-p2y12-στο-οξύ-στεφανιαίο-σύνδρομο/
https://gpcardio.org/el/2020-07-14_συσχέτιση-του-μοσχεύματος-κερκιδικής-αρτηρίας-έναντι-μοσχεύματος-σαφηνούς-φλέβας-με-τα-μακροπρόθεσμα-καρδι/
https://gpcardio.org/el/2020-08-01_πλήρης-έναντι-περιοριζόμενης-στην-υπεύθυνη-βλάβη-επαναγγείωση-στο-έμφραγμα-του-μυοκαρδίου-με-ανάσπαση-του-δ/
https://gpcardio.org/el/2020-08-04_πορεία-λήψης-αποφάσεων-ομοφωνίας-εμπειρογνωμόνων-acc-2020-για-τη-διαχείριση-της-αιμορραγίας-σε-ασθενείς-υπό-από/
https://gpcardio.org/el/2020-08-07_ολοκληρωμένη-διαχείριση-της-κολπικής-μαρμαρυγής-στην-πρωτοβάθμια-φροντίδα/
https://gpcardio.org/el/2020-08-11_ασφάλεια-και-αποτελεσματικότητα-της-διακοπής-της-ασπιρίνης-υπό-συνεχιζόμενη-αγωγή-με-αναστολέα-p2y12-σε-ασθεν/
https://gpcardio.org/el/2020-08-20_εβινακουμάβη-για-την-ομόζυγη-οικογενή-υπερχοληστερολαιμία/
https://gpcardio.org/el/2020-08-25_επίδραση-της-καθοδηγούμενης-από-γονότυπο-επιλογής-από-του-στόματος-αναστολέα-p2y12-έναντι-της-συμβατικής-θερα/
https://gpcardio.org/el/2020-09-01_πορεία-λήψης-αποφάσεων-ομοφωνίας-εμπειρογνωμόνων-2020-για-νεότερες-θεραπείες-για-τη-μείωση-του-καρδιαγγειακο/
https://gpcardio.org/el/2020-09-07_θνησιμότητα-μετά-από-στεντ-έκλουσης-φαρμάκου-έναντι-στεφανιαίας-παράκαμψης-για-νόσο-του-κύριου-στελέχους-τη/
https://gpcardio.org/el/2020-09-14_επιδράσεις-των-αγωνιστών-υποδοχέα-πεπτιδίου-1-όμοιου-με-γλυκαγόνη-στα-σοβαρά-καρδιαγγειακά-συμβάντα-σε-ασθε/
https://gpcardio.org/el/2020-09-19_αναστολείς-sglt2-σε-ασθενείς-με-καρδιακή-ανεπάρκεια-με-μειωμένο-κλάσμα-εξώθησης/
https://gpcardio.org/el/2020-10-01_εβολοκουμάβη-στην-παιδιατρική-ετερόζυγη-οικογενή-υπερχοληστερολαιμία/
https://gpcardio.org/el/2020-10-01_πρώιμη-θεραπεία-ελέγχου-ρυθμού-σε-ασθενείς-με-κολπική-μαρμαρυγή/
https://gpcardio.org/el/2020-10-01_φυσική-πορεία-της-ασυμπτωματικής-σοβαρής-στένωσης-αορτής-και-συσχέτιση-της-πρώιμης-παρέμβασης-με-τα-αποτελέ/
https://gpcardio.org/el/2020-10-08_δαπαγλιφλοζίνη-σε-ασθενείς-με-χρόνια-νεφρική-νόσο/
https://gpcardio.org/el/2020-10-08_καρδιαγγειακά-αποτελέσματα-με-ερτουγλιφλοζίνη-στον-διαβήτη-τύπου-2/
https://gpcardio.org/el/2020-10-08_καρδιαγγειακά-και-νεφρικά-αποτελέσματα-με-εμπαγλιφλοζίνη-στην-καρδιακή-ανεπάρκεια/
https://gpcardio.org/el/2020-10-10_απο-κλιμάκωση-με-βάση-την-πρασουγρέλη-της-διπλής-αντιαιμοπεταλιακής-αγωγής-μετά-από-διαδερμική-στεφανιαία-π/
https://gpcardio.org/el/2020-10-13_διπλή-αντιαιμοπεταλιακή-αγωγή-μετά-από-διαδερμική-στεφανιαία-παρέμβαση-και-στεντ-έκλουσης-φαρμάκου/
https://gpcardio.org/el/2020-10-29_εδοξαμπάνη-χαμηλής-δόσης-σε-πολύ-ηλικιωμένους-ασθενείς-με-κολπική-μαρμαρυγή/
https://gpcardio.org/el/2020-10-31_επανασχεδιασμός-και-επικύρωση-της-βαθμολογίας-syntax-ii-για-την-εξατομίκευση-της-λήψης-αποφάσεων-μεταξύ-διαδερμ/
https://gpcardio.org/el/2020-11-07_η-πλήρης-επαναγγείωση-μειώνει-τον-καρδιαγγειακό-θάνατο-σε-ασθενείς-με-έμφραγμα-του-μυοκαρδίου-με-ανάσπαση-τ/
https://gpcardio.org/el/2020-11-10_έλεγχος-για-υψηλή-αρτηριακή-πίεση-σε-παιδιά-και-εφήβους/
https://gpcardio.org/el/2020-11-17_κολχικίνη-σε-ασθενείς-με-οξύ-στεφανιαίο-σύνδρομο/
https://gpcardio.org/el/2020-11-21_αποτελεσματικότητα-και-ασφάλεια-της-μείωσης-της-ldl-χοληστερόλης-σε-ηλικιωμένους-ασθενείς/
https://gpcardio.org/el/2020-11-21_η-μείωση-της-λιποπρωτεΐνης-a-από-την-αλιροκουμάβη-μειώνει-το-συνολικό-φορτίο-καρδιαγγειακών-συμβάντων-ανεξά/
https://gpcardio.org/el/2020-11-26_μελέτη-n-of-1-με-στατίνη-εικονικό-φάρμακο-ή-καμία-θεραπεία-για-την-αξιολόγηση-των-παρενεργειών/
https://gpcardio.org/el/2020-11-26_ριβαροξαμπάνη-σε-ασθενείς-με-κολπική-μαρμαρυγή-και-βιοπροσθετική-μιτροειδή-βαλβίδα/
https://gpcardio.org/el/2020-12-08_επίδραση-των-ωμέγα-3-λιπαρών-οξέων-υψηλής-δόσης-έναντι-του-καλαμποκέλαιου-στα-σοβαρά-ανεπιθύμητα-καρδιαγγει/
https://gpcardio.org/el/2020-12-10_εβινακουμάβη-σε-ασθενείς-με-ανθεκτική-στη-θεραπεία-υπερχοληστερολαιμία/
https://gpcardio.org/el/2020-12-12_καρβοξυμαλτόζη-σιδήρου-για-την-έλλειψη-σιδήρου-κατά-το-εξιτήριο-μετά-από-οξεία-καρδιακή-ανεπάρκεια/
https://gpcardio.org/el/2020-12-22_επίδραση-της-διγοξίνης-έναντι-της-βισοπρολόλης-για-τον-έλεγχο-του-καρδιακού-ρυθμού-στην-κολπική-μαρμαρυγή-σ/
https://gpcardio.org/el/2021-01-14_ενεργοποίηση-της-καρδιακής-μυοσίνης-με-ομεκαμτίβ-μεκαρβίλη-στη-συστολική-καρδιακή-ανεπάρκεια/
https://gpcardio.org/el/2021-01-14_σοταγλιφλοζίνη-σε-ασθενείς-με-διαβήτη-και-πρόσφατη-επιδείνωση-καρδιακής-ανεπάρκειας/
https://gpcardio.org/el/2021-01-14_σοταγλιφλοζίνη-σε-ασθενείς-με-διαβήτη-και-χρόνια-νεφρική-νόσο/
https://gpcardio.org/el/2021-01-21_βραχεία-διπλή-αντιαιμοπεταλιακή-αγωγή-ακολουθούμενη-από-μονοθεραπεία-αναστολέα-p2y12-έναντι-παρατεταμένης-δι/
https://gpcardio.org/el/2021-01-21_πολυχάπι-με-ή-χωρίς-ασπιρίνη-σε-άτομα-χωρίς-καρδιαγγειακή-νόσο/
https://gpcardio.org/el/2021-01-26_τυχαιοποιημένη-μελέτη-εμπαγλιφλοζίνης-σε-μη-διαβητικούς-ασθενείς-με-καρδιακή-ανεπάρκεια-και-μειωμένο-κλάσμ/
https://gpcardio.org/el/2021-01-28_εισπνεόμενη-τρεπροστινίλη-στην-πνευμονική-υπέρταση-λόγω-διάμεσης-πνευμονοπάθειας/
https://gpcardio.org/el/2021-01-28_κρυοαφαίρεση-ή-φαρμακευτική-θεραπεία-για-την-αρχική-θεραπεία-της-κολπικής-μαρμαρυγής/
https://gpcardio.org/el/2021-01-28_κρυοαφαίρεση-με-κρυομπαλόνι-ως-αρχική-θεραπεία-για-την-κολπική-μαρμαρυγή/
https://gpcardio.org/el/2021-02-01_συσχέτιση-των-αναστολέων-sglt2-με-τα-καρδιαγγειακά-και-νεφρικά-αποτελέσματα-σε-ασθενείς-με-διαβήτη-τύπου-2/
https://gpcardio.org/el/2021-02-09_επίδραση-της-προπόνησης-διαλειμματικής-υψηλής-έντασης-της-μέτριας-έντασης-συνεχούς-προπόνησης-ή-των-συμβου/
https://gpcardio.org/el/2021-02-09_πορεία-λήψης-αποφάσεων-ομοφωνίας-εμπειρογνωμόνων-acc-2020-για-την-αντιπηκτική-και-αντιαιμοπεταλιακή-θεραπεία-σ/
https://gpcardio.org/el/2021-02-09_φινερενόνη-και-καρδιαγγειακά-αποτελέσματα-σε-ασθενείς-με-χρόνια-νεφρική-νόσο-και-διαβήτη-τύπου-2/
https://gpcardio.org/el/2021-02-16_επικαιροποίηση-2021-της-πορείας-λήψης-αποφάσεων-ομοφωνίας-εμπειρογνωμόνων-acc-2017-για-τη-βελτιστοποίηση-της-θερ/
https://gpcardio.org/el/2021-03-02_αποτελέσματα-3-ετών-της-διακαθετηριακής-επιδιόρθωσης-μιτροειδούς-βαλβίδας-σε-ασθενείς-με-καρδιακή-ανεπάρκε/
https://gpcardio.org/el/2021-03-16_επίδραση-της-συμπληρωματικής-χορήγησης-θαλάσσιων-ωμέγα-3-λιπαρών-οξέων-και-βιταμίνης-d-στη-νέας-έναρξης-κολπ/
https://gpcardio.org/el/2021-03-31_επιδράσεις-της-δαπαγλιφλοζίνης-στη-θνησιμότητα-σε-ασθενείς-με-χρόνια-νεφρική-νόσο/
https://gpcardio.org/el/2021-04-07_κατευθυντήριες-οδηγίες-esc-2020-για-τη-διαχείριση-των-οξέων-στεφανιαίων-συνδρόμων-σε-ασθενείς-που-παρουσιάζοντ/
https://gpcardio.org/el/2021-04-17_καθοδηγούμενη-έναντι-τυπικής-αντιαιμοπεταλιακής-θεραπείας-σε-ασθενείς-που-υποβάλλονται-σε-διαδερμική-στεφ/
https://gpcardio.org/el/2021-05-01_φαρμακολογική-μείωση-της-αρτηριακής-πίεσης-για-την-πρωτογενή-και-δευτερογενή-πρόληψη-της-καρδιαγγειακής-νό/
https://gpcardio.org/el/2021-05-05_προκαλούν-οι-βήτα-αναστολείς-κατάθλιψη/
https://gpcardio.org/el/2021-05-20_τελική-αναφορά-μιας-μελέτης-εντατικού-έναντι-τυπικού-ελέγχου-αρτηριακής-πίεσης/
https://gpcardio.org/el/2021-05-27_συγκριτική-αποτελεσματικότητα-της-δοσολογίας-ασπιρίνης-στην-καρδιαγγειακή-νόσο/
https://gpcardio.org/el/2021-06-01_αξιολόγηση-της-κατάλυσης-με-καθετήρα-ή-αντιαρρυθμικών-φαρμάκων-ως-θεραπείας-πρώτης-γραμμής-της-κολπικής-μαρ/
https://gpcardio.org/el/2021-06-03_απόφραξη-του-ωτίου-του-αριστερού-κόλπου-κατά-τη-διάρκεια-καρδιοχειρουργικής-επέμβασης-για-την-πρόληψη-εγκεφ/
https://gpcardio.org/el/2021-06-26_ασπιρίνη-έναντι-κλοπιδογρέλης-για-χρόνια-μονοθεραπεία-συντήρησης-μετά-από-διαδερμική-στεφανιαία-παρέμβαση/
https://gpcardio.org/el/2021-06-26_νεφρική-απονεύρωση-με-υπερήχους-για-υπέρταση-ανθεκτική-σε-τριπλό-συνδυασμένο-δισκίο-φαρμάκων-radiance-htn-trio/
https://gpcardio.org/el/2021-07-10_αποτελεσματικότητα-και-ασφάλεια-ενός-νέου-διπλού-αγωνιστή-υποδοχέα-gip-και-glp-1-της-τιρζεπατίδης-σε-ασθενείς-μ/
https://gpcardio.org/el/2021-07-15_σωματική-αποκατάσταση-για-ηλικιωμένους-ασθενείς-που-νοσηλεύτηκαν-για-καρδιακή-ανεπάρκεια/
https://gpcardio.org/el/2021-07-21_αποτελεσματικότητα-και-ασφάλεια-χαμηλής-δόσης-κολχικίνης-σε-ασθενείς-με-στεφανιαία-νόσο/
https://gpcardio.org/el/2021-07-22_πολυαγγειακή-pci-καθοδηγούμενη-από-ffr-ή-αγγειογραφία-για-έμφραγμα-του-μυοκαρδίου/
https://gpcardio.org/el/2021-08-05_μιλρινόνη-σε-σύγκριση-με-ντοβουταμίνη-στη-θεραπεία-του-καρδιογενούς-shock/
https://gpcardio.org/el/2021-08-14_άπαξ-εβδομαδιαία-τιρζεπατίδη-έναντι-άπαξ-ημερησίως-ινσουλίνης-degludec-ως-προσθήκη-στη-μετφορμίνη-με-ή-χωρίς-αν/
https://gpcardio.org/el/2021-08-17_μείωση-χοληστερόλης-αρτηριακής-πίεσης-ή-αμφότερων-για-την-πρόληψη-καρδιαγγειακών-συμβάντων/
https://gpcardio.org/el/2021-08-31_πορεία-λήψης-αποφάσεων-ομοφωνίας-εμπειρογνωμόνων-acc-2021-για-τη-διαχείριση-της-μείωσης-κινδύνου-ascvd-σε-ασθενεί/
https://gpcardio.org/el/2021-09-02_καρδιαγγειακές-και-νεφρικές-εκβάσεις-με-εφπεγλενατίδη-στον-διαβήτη-τύπου-2/
https://gpcardio.org/el/2021-09-11_αιμοδυναμικά-καθοδηγούμενη-διαχείριση-της-καρδιακής-ανεπάρκειας-guide-hf/
https://gpcardio.org/el/2021-09-16_επίδραση-της-υποκατάστασης-αλατιού-στα-καρδιαγγειακά-συμβάντα-και-τον-θάνατο/
https://gpcardio.org/el/2021-09-18_αρχική-θεραπεία-με-ενιαίο-δισκίο-που-περιέχει-τετραπλό-συνδυασμό-δόσεων-ενός-τετάρτου-φαρμάκων-αρτηριακής-π/
https://gpcardio.org/el/2021-09-30_μελέτη-εντατικού-ελέγχου-αρτηριακής-πίεσης-σε-ηλικιωμένους-ασθενείς-με-υπέρταση/
https://gpcardio.org/el/2021-10-09_μη-καθοδηγούμενη-αποκλιμάκωση-από-τικαγρελόρη-σε-κλοπιδογρέλη-σε-σταθεροποιημένους-ασθενείς-με-οξύ-έμφραγμ/
https://gpcardio.org/el/2021-10-14_εμπαγλιφλοζίνη-και-σημαντικές-νεφρικές-εκβάσεις-στην-καρδιακή-ανεπάρκεια/
https://gpcardio.org/el/2021-10-14_εμπαγλιφλοζίνη-στην-καρδιακή-ανεπάρκεια-με-διατηρημένο-κλάσμα-εξώθησης/
https://gpcardio.org/el/2021-10-19_επίδραση-της-εμπαγλιφλοζίνης-στα-συμβάντα-επιδείνωσης-της-καρδιακής-ανεπάρκειας-σε-ασθενείς-με-καρδιακή-αν/
https://gpcardio.org/el/2021-10-23_κλινικές-εκβάσεις-στον-συστηματικό-έλεγχο-για-κολπική-μαρμαρυγή-strokestop/
https://gpcardio.org/el/2021-10-28_διπλή-αντιαιμοπεταλιακή-θεραπεία-μετά-από-pci-σε-ασθενείς-με-υψηλό-κίνδυνο-αιμορραγίας/
https://gpcardio.org/el/2021-11-02_εμβολιασμός-κατά-της-γρίπης-μετά-από-έμφραγμα-του-μυοκαρδίου/
https://gpcardio.org/el/2021-11-11_αναστολή-του-υποδοχέα-αγγειοτενσίνης-και-της-νεπριλυσίνης-σε-οξύ-έμφραγμα-του-μυοκαρδίου/
https://gpcardio.org/el/2021-11-13_μείωση-της-αρτηριακής-πίεσης-και-κίνδυνος-νεοεμφανιζόμενου-διαβήτη-τύπου-2/
https://gpcardio.org/el/2021-11-13_τιρζεπατίδη-έναντι-ινσουλίνης-glargine-στον-διαβήτη-τύπου-2-και-αυξημένο-καρδιαγγειακό-κίνδυνο-surpass-4/
https://gpcardio.org/el/2021-12-02_εδοξαμπάνη-έναντι-ανταγωνιστή-της-βιταμίνης-κ-για-κολπική-μαρμαρυγή-μετά-από-tavr/
https://gpcardio.org/el/2021-12-04_οπίσθια-αριστερή-περικαρδιοτομή-για-την-πρόληψη-της-κολπικής-μαρμαρυγής-μετά-από-καρδιοχειρουργική-επέμβασ/
https://gpcardio.org/el/2021-12-07_κατάλυση-κολποκοιλιακού-κόμβου-και-καρδιακή-επανασυγχρόνιση-σε-ασθενείς-με-μόνιμη-κολπική-μαρμαρυγή-και-στ/
https://gpcardio.org/el/2021-12-09_καρδιαγγειακά-συμβάντα-με-φινερενόνη-στη-νεφρική-νόσο-και-τον-διαβήτη-τύπου-2/
https://gpcardio.org/el/2021-12-11_στεφανιαία-παρέμβαση-καθοδηγούμενη-από-αγγειογραφικό-ποσοτικό-λόγο-ροής-favor-iii-china/
https://gpcardio.org/el/2021-12-18_διαδερμική-στεφανιαία-παρέμβαση-με-stent-έκλυσης-φαρμάκου-έναντι-αορτοστεφανιαίας-παράκαμψης-στη-νόσο-του-στε/
https://gpcardio.org/el/2021-12-21_επίδραση-της-μακροχρόνιας-συμπλήρωσης-με-θαλάσσια-λιπαρά-οξέα-ωμέγα-3-στον-κίνδυνο-κολπικής-μαρμαρυγής-σε-τυ/
https://gpcardio.org/el/2021-12-30_αγγειογραφία-μετά-από-εξωνοσοκομειακή-καρδιακή-ανακοπή-χωρίς-ανάσπαση-του-διαστήματος-st/
https://gpcardio.org/el/2021-12-30_χλωρθαλιδόνη-για-την-υπέρταση-σε-προχωρημένη-χρόνια-νεφρική-νόσο/
https://gpcardio.org/el/2022-01-13_pci-καθοδηγούμενη-από-κλασματική-εφεδρεία-ροής-σε-σύγκριση-με-αορτοστεφανιαία-παράκαμψη/
https://gpcardio.org/el/2022-01-18_κατευθυντήρια-οδηγία-2021-acc-aha-scai-για-τη-στεφανιαία-επαναγγείωση/
https://gpcardio.org/el/2022-01-25_άμεσα-από-του-στόματος-αντιπηκτικά-έναντι-βαρφαρίνης-σε-ασθενείς-με-κολπική-μαρμαρυγή/
https://gpcardio.org/el/2022-01-25_έλεγχος-για-κολπική-μαρμαρυγή/
https://gpcardio.org/el/2022-02-08_η-φινερενόνη-μειώνει-τον-κίνδυνο-επίπτωσης-καρδιακής-ανεπάρκειας-σε-ασθενείς-με-χρόνια-νεφρική-νόσο-και-δια/
https://gpcardio.org/el/2022-02-10_καρδιαγγειακές-και-νεφρικές-εκβάσεις-με-φινερενόνη-σε-ασθενείς-με-διαβήτη-τύπου-2-και-χρόνια-νεφρική-νόσο/
https://gpcardio.org/el/2022-03-07_συγκριτικές-επιδράσεις-καθοδηγούμενης-έναντι-ισχυρής-θεραπείας-με-αναστολέα-p2y12-στο-οξύ-στεφανιαίο-σύνδρομ/
https://gpcardio.org/el/2022-03-21_συστηματική-πρώιμη-στρατηγική-ελέγχου-ρυθμού-για-κολπική-μαρμαρυγή-σε-ασθενείς-με-ή-χωρίς-συμπτώματα/
https://gpcardio.org/el/2022-04-09_ασφάλεια-του-από-του-στόματος-αναστολέα-του-παράγοντα-xia-ασουνδεξιάνης-σε-σύγκριση-με-την-απιξαμπάνη-σε-ασθε/
https://gpcardio.org/el/2022-04-09_μείωση-του-διαιτητικού-νατρίου-σε-λιγότερο-από-100-mmol-στην-καρδιακή-ανεπάρκεια-sodium-hf/
https://gpcardio.org/el/2022-04-26_χρήση-ασπιρίνης-για-την-πρόληψη-της-καρδιαγγειακής-νόσου/
https://gpcardio.org/el/2022-05-03_κατευθυντήρια-οδηγία-2022-aha-acc-hfsa-για-τη-διαχείριση-της-καρδιακής-ανεπάρκειας/
https://gpcardio.org/el/2022-05-03_κατευθυντήρια-οδηγία-2022-aha-acc-hfsa-για-τη-διαχείριση-της-καρδιακής-ανεπάρκειας/
https://gpcardio.org/el/2022-05-03_κατευθυντήρια-οδηγία-2022-aha-acc-hfsa-για-τη-διαχείριση-της-καρδιακής-ανεπάρκειας/
https://gpcardio.org/el/2022-05-10_επίδραση-της-αλιροκουμάμπης-ως-προσθήκη-σε-θεραπεία-με-στατίνη-υψηλής-έντασης-στη-στεφανιαία-αθηροσκλήρωση/
https://gpcardio.org/el/2022-05-12_θεραπεία-της-ήπιας-χρόνιας-υπέρτασης-κατά-την-εγκυμοσύνη/
https://gpcardio.org/el/2022-05-21_βαριατρική-χειρουργική-και-καρδιαγγειακή-νόσος/
https://gpcardio.org/el/2022-05-31_επιδράσεις-μακροχρόνιων-παρεμβάσεων-μετφορμίνης-και-τρόπου-ζωής-στα-καρδιαγγειακά-συμβάντα-στο-diabetes-prevention-p/
https://gpcardio.org/el/2022-06-02_ανάγκη-επανεκκίνησης-και-κάλυψης-της-καθυστέρησης-στην-πρόληψη-της-cvd-εν-μέσω-covid-19/
https://gpcardio.org/el/2022-06-07_τυχαιοποιημένη-μελέτη-ελέγχου-ρυθμού-με-κατάλυση-έναντι-ελέγχου-συχνότητας-σε-ασθενείς-με-καρδιακή-ανεπάρκ/
https://gpcardio.org/el/2022-06-21_επίδραση-της-κατάλυσης-ίνωσης-καθοδηγούμενης-από-mri-έναντι-της-συμβατικής-κατάλυσης-καθετήρα-στην-υποτροπή/
https://gpcardio.org/el/2022-06-21_επηρεάζει-η-χρονική-στιγμή-της-κατάλυσης-κοιλιακής-ταχυκαρδίας-την-πρόγνωση-σε-ασθενείς-με-εμφυτεύσιμο-απιν/
https://gpcardio.org/el/2022-07-19_επίδραση-της-ομεκαμτίβ-μεκαρβίλης-στην-ικανότητα-άσκησης-στη-χρόνια-καρδιακή-ανεπάρκεια-με-μειωμένο-κλάσμα/
https://gpcardio.org/el/2022-07-26_επιδράσεις-της-εμπαγλιφλοζίνης-στα-συμπτώματα-τους-σωματικούς-περιορισμούς-και-την-ποιότητα-ζωής-σε-ασθενε/
https://gpcardio.org/el/2022-07-26_επιδράσεις-της-πρώιμης-έναρξης-εμπαγλιφλοζίνης-στη-διούρηση-και-τη-νεφρική-λειτουργία-σε-ασθενείς-με-οξεία/
https://gpcardio.org/el/2022-07-26_παρεμβάσεις-συμβουλευτικής-συμπεριφοράς-για-την-προαγωγή-υγιεινής-διατροφής-και-σωματικής-δραστηριότητας/
https://gpcardio.org/el/2022-07-30_μακροχρόνια-αποτελεσματικότητα-και-ασφάλεια-συνδυαστικής-θεραπείας-στατίνης-μέτριας-έντασης-με-εζετιμίμπη/
https://gpcardio.org/el/2022-08-09_αρχική-πτώση-dip-του-εκτιμώμενου-ρυθμού-σπειραματικής-διήθησης-μετά-την-έναρξη-δαπαγλιφλοζίνης-σε-ασθενείς-μ/
https://gpcardio.org/el/2022-08-23_χρήση-στατινών-για-την-πρωτογενή-πρόληψη-της-καρδιαγγειακής-νόσου-σε-ενήλικες/
https://gpcardio.org/el/2022-08-23_χρήση-στατινών-για-την-πρωτογενή-πρόληψη-της-καρδιαγγειακής-νόσου-σε-ενήλικες/
https://gpcardio.org/el/2022-08-30_εμπαγλιφλοζίνη-για-την-καρδιακή-ανεπάρκεια-με-διατηρημένο-κλάσμα-εξώθησης-αριστερής-κοιλίας-με-και-χωρίς-δι/
https://gpcardio.org/el/2022-09-01_κλασματική-εφεδρεία-ροής-ή-ενδαγγειακή-υπερηχογραφία-για-την-καθοδήγηση-της-pci/
https://gpcardio.org/el/2022-09-03_αναστολείς-sglt-2-σε-ασθενείς-με-καρδιακή-ανεπάρκεια/
https://gpcardio.org/el/2022-09-07_επιπολασμός-της-δυσανεξίας-στις-στατίνες/
https://gpcardio.org/el/2022-09-08_καθιερωμένος-λειτουργικός-έλεγχος-ή-τυπική-φροντίδα-σε-ασθενείς-υψηλού-κινδύνου-μετά-από-pci/
https://gpcardio.org/el/2022-09-10_επίδραση-της-θεραπείας-με-στατίνη-στα-μυϊκά-συμπτώματα/
https://gpcardio.org/el/2022-09-13_πρώιμος-έλεγχος-ρυθμού-σε-ασθενείς-με-κολπική-μαρμαρυγή-και-υψηλό-φορτίο-συννοσηροτήτων/
https://gpcardio.org/el/2022-09-15_ριβαροξαμπάνη-στην-κολπική-μαρμαρυγή-που-σχετίζεται-με-ρευματική-καρδιοπάθεια/
https://gpcardio.org/el/2022-09-15_στρατηγική-πολυχαπίου-στη-δευτερογενή-καρδιαγγειακή-πρόληψη/
https://gpcardio.org/el/2022-09-20_εναρμόνιση-των-κατευθυντήριων-οδηγιών-για-την-αρτηριακή-πίεση-υπέρταση-του-american-college-of-cardiology-american-heart-association-κ/
https://gpcardio.org/el/2022-09-22_δαπαγλιφλοζίνη-στην-καρδιακή-ανεπάρκεια-με-ήπια-μειωμένο-ή-διατηρημένο-κλάσμα-εξώθησης/
https://gpcardio.org/el/2022-09-22_μείωση-της-γλυκαιμίας-στον-σακχαρώδη-διαβήτη-τύπου-2-μικροαγγειακές-και-καρδιαγγειακές-εκβάσεις/
https://gpcardio.org/el/2022-09-26_επιδράσεις-των-υποκατάστατων-αλατιού-στις-κλινικές-εκβάσεις/
https://gpcardio.org/el/2022-09-27_πενταετή-αποτελέσματα-σε-ασθενείς-με-πλήρως-μαγνητικά-αιωρούμενες-έναντι-αξονικής-ροής-συσκευές-υποβοήθηση/
https://gpcardio.org/el/2022-09-27_τυχαιοποιημένη-μελέτη-βηματοδότησης-αριστερού-σκέλους-έναντι-αμφικοιλιακής-βηματοδότησης-για-καρδιακή-θερ/
https://gpcardio.org/el/2022-09-29_ακεταζολαμίδη-στην-οξεία-απορρυθμισμένη-καρδιακή-ανεπάρκεια-με-υπερφόρτωση-όγκου/
https://gpcardio.org/el/2022-10-04_2022-acc-expert-consensus-decision-pathway-σχετικά-με-τον-ρόλο-των-μη-στατινικών-θεραπειών-για-τη-μείωση-της-ldl-χοληστερόλης-στη/
https://gpcardio.org/el/2022-10-04_δαπαγλιφλοζίνη-σε-ασθενείς-που-νοσηλεύτηκαν-πρόσφατα-για-καρδιακή-ανεπάρκεια-με-ήπια-μειωμένο-ή-διατηρημέν/
https://gpcardio.org/el/2022-10-04_πρώιμη-έναντι-καθυστερημένης-θεραπείας-με-από-του-στόματος-αντιπηκτικά-μη-ανταγωνιστές-βιταμίνης-κ-μετά-από/
https://gpcardio.org/el/2022-10-08_αλλοπουρινόλη-έναντι-συνήθους-φροντίδας-σε-ασθενείς-του-ηνωμένου-βασιλείου-με-ισχαιμική-καρδιοπάθεια-all-heart/
https://gpcardio.org/el/2022-10-13_διαδερμική-επαναγγείωση-για-ισχαιμική-δυσλειτουργία-αριστερής-κοιλίας/
https://gpcardio.org/el/2022-10-18_αποτελεσματικότητα-και-ασφάλεια-της-δαπαγλιφλοζίνης-ανάλογα-με-την-ευθραυστότητα-σε-ασθενείς-με-καρδιακή-α/
https://gpcardio.org/el/2022-10-20_στόχοι-αρτηριακής-πίεσης-σε-κωματώδεις-επιζώντες-καρδιακής-ανακοπής/
https://gpcardio.org/el/2022-10-22_καρδιαγγειακές-εκβάσεις-σε-ενήλικες-με-υπέρταση-με-βραδινή-έναντι-πρωινή-χορήγηση-των-συνήθων-αντιυπερτασι/
https://gpcardio.org/el/2022-11-01_εμπαγλιφλοζίνη-στο-οξύ-έμφραγμα-του-μυοκαρδίου/
https://gpcardio.org/el/2022-11-01_πατιρομέρη-για-τη-διαχείριση-της-υπερκαλιαιμίας-στην-καρδιακή-ανεπάρκεια-με-μειωμένο-κλάσμα-εξώθησης/
https://gpcardio.org/el/2022-11-05_εντατικός-έλεγχος-αρτηριακής-πίεσης-μετά-από-ενδοαγγειακή-θρομβεκτομή-για-οξύ-ισχαιμικό-εγκεφαλικό-επεισόδ/
https://gpcardio.org/el/2022-11-15_νοσηλείες-και-θνησιμότητα-σε-ασθενείς-με-δευτεροπαθή-ανεπάρκεια-μιτροειδούς-και-καρδιακή-ανεπάρκεια/
https://gpcardio.org/el/2022-11-17_μικρό-παρεμβαλλόμενο-rna-για-τη-μείωση-της-λιποπρωτεΐνης-a-στην-καρδιαγγειακή-νόσο/
https://gpcardio.org/el/2022-11-19_επίδραση-του-διαβήτη-στις-επιδράσεις-των-αναστολέων-του-συμμεταφορέα-νατρίου-γλυκόζης-τύπου-2-στις-νεφρικές/
https://gpcardio.org/el/2022-11-22_ενδοπροθέσεις-εκλουόμενες-εβερόλιμους-ή-χειρουργική-παράκαμψη-για-πολυαγγειακή-στεφανιαία-νόσο/
https://gpcardio.org/el/2022-11-24_μείωση-τριγλυκεριδίων-με-πεμαφιμπράτη-για-τη-μείωση-του-καρδιαγγειακού-κινδύνου/
https://gpcardio.org/el/2022-11-26_ly3437943-ένας-νέος-τριπλός-αγωνιστής-υποδοχέων-gip-glp-1-και-γλυκαγόνης-σε-άτομα-με-σακχαρώδη-διαβήτη-τύπου-2/
https://gpcardio.org/el/2022-12-03_ασφάλεια-ανεκτικότητα-και-αποτελεσματικότητα-της-ανοδικής-τιτλοποίησης-θεραπειών-κατευθυνόμενων-από-κατευ/
https://gpcardio.org/el/2022-12-03_διπλός-ανταγωνιστής-ενδοθηλίνης-απροσιτεντάνη-για-ανθεκτική-υπέρταση-precision/
https://gpcardio.org/el/2022-12-06_απιξαμπάνη-σε-ασθενείς-με-κολπική-μαρμαρυγή-υπό-αιμοκάθαρση/
https://gpcardio.org/el/2022-12-17_ενδοφλέβια-σιδηρική-δερισομαλτόζη-σε-ασθενείς-με-καρδιακή-ανεπάρκεια-και-έλλειψη-σιδήρου-στο-ηνωμένο-βασίλ/
https://gpcardio.org/el/2022-12-21_μείωση-της-αρτηριακής-πίεσης-και-πρόληψη-της-άνοιας/
https://gpcardio.org/el/2022-12-29_χλωρθαλιδόνη-έναντι-υδροχλωροθειαζίδης-για-καρδιαγγειακά-συμβάντα-στην-υπέρταση/
https://gpcardio.org/el/2023-01-01_επίδραση-της-εμπαγλιφλοζίνης-στην-αποσυμφόρηση-στην-οξεία-καρδιακή-ανεπάρκεια/
https://gpcardio.org/el/2023-01-03_επιβίωση-μετά-από-επεμβατική-ή-συντηρητική-διαχείριση-σταθερής-στεφανιαίας-νόσου/
https://gpcardio.org/el/2023-01-03_μελέτη-φάσης-2-της-αφικαμτένης-σε-ασθενείς-με-αποφρακτική-υπερτροφική-μυοκαρδιοπάθεια/
https://gpcardio.org/el/2023-01-03_συγκριτικές-επιδράσεις-χαμηλής-δόσης-ροσουβαστατίνης-εικονικού-φαρμάκου-και-διατροφικών-συμπληρωμάτων-στα/
https://gpcardio.org/el/2023-01-10_ασπιρίνη-έναντι-κλοπιδογρέλης-ως-μακροχρόνια-μονοθεραπεία-συντήρησης-μετά-από-διαδερμική-στεφανιαία-παρέμ/
https://gpcardio.org/el/2023-01-10_επίδραση-της-κατευθυνόμενης-με-καθετήρα-κατάλυσης-με-απομόνωση-πνευμονικών-φλεβών-με-έναντι-χωρίς-απομόνωσ/
https://gpcardio.org/el/2023-01-10_προοπτική-συσχέτιση-των-ημερήσιων-βημάτων-με-την-καρδιαγγειακή-νόσο/
https://gpcardio.org/el/2023-01-12_εμπαγλιφλοζίνη-σε-ασθενείς-με-χρόνια-νεφρική-νόσο/
https://gpcardio.org/el/2023-01-12_εξέλιξη-της-κολπικής-μαρμαρυγής-μετά-από-κρυοκατάλυση-ή-φαρμακευτική-θεραπεία/
https://gpcardio.org/el/2023-01-14_κόστος-αποτελεσματικότητα-του-πληθυσμιακού-ελέγχου-για-κολπική-μαρμαρυγή/
https://gpcardio.org/el/2023-01-17_επίδραση-της-τορσεμίδης-έναντι-φουροσεμίδης-μετά-την-έξοδο-στη-θνησιμότητα-από-όλες-τις-αιτίες-σε-ασθενείς-π/
https://gpcardio.org/el/2023-02-01_συνδυασμός-διουρητικών-αγκύλης-με-θειαζιδικά-για-απορρυθμισμένη-καρδιακή-ανεπάρκεια/
https://gpcardio.org/el/2023-02-02_δοκιμή-φάσης-2-της-μπαξντροστάτης-για-την-ανθεκτική-στη-θεραπεία-υπέρταση/
https://gpcardio.org/el/2023-02-07_εξωσωματική-οξυγόνωση-μέσω-μεμβράνης-στη-θεραπεία-του-καρδιογενούς-shock/
https://gpcardio.org/el/2023-02-16_η-κατάλυση-με-καθετήρα-βελτιώνει-τα-καρδιαγγειακά-αποτελέσματα-σε-ασθενείς-με-κολπική-μαρμαρυγή-και-καρδιακ/
https://gpcardio.org/el/2023-02-28_ενδαγγειακή-απονεύρωση-των-νεφρών-με-υπερήχους-για-τη-θεραπεία-της-υπέρτασης/
https://gpcardio.org/el/2023-02-28_τυχαία-διαπιστούμενο-ασβέστιο-στεφανιαίων-αρτηριών/
https://gpcardio.org/el/2023-03-18_αποτελεσματικότητα-μιας-εντατικής-παρέμβασης-αρτηριακής-πίεσης-με-καθοδήγηση-από-μη-ιατρούς-παρόχους-κοινο/
https://gpcardio.org/el/2023-04-04_στρατηγική-στόχευσης-θεραπείας-treat-to-target-ή-στατίνη-υψηλής-έντασης-σε-ασθενείς-με-στεφανιαία-νόσο/
https://gpcardio.org/el/2023-04-08_άμεση-έναντι-σταδιακής-πλήρους-επαναγγείωσης-σε-ασθενείς-με-οξύ-στεφανιαίο-σύνδρομο-και-πολυαγγειακή-στεφα/
https://gpcardio.org/el/2023-04-11_ετερογένεια-στην-απόκριση-της-αρτηριακής-πίεσης-σε-4-αντιυπερτασικά-φάρμακα/
https://gpcardio.org/el/2023-04-13_βεμπεδοϊκό-οξύ-και-καρδιαγγειακά-αποτελέσματα-σε-ασθενείς-με-δυσανεξία-στις-στατίνες/
https://gpcardio.org/el/2023-04-15_η-φλεγμονή-και-η-χοληστερόλη-ως-προγνωστικοί-παράγοντες-καρδιαγγειακών-συμβάντων-σε-ασθενείς-υπό-θεραπεία-μ/
https://gpcardio.org/el/2023-04-17_απόκλιμάκωση-της-διπλής-αντιαιμοπεταλιακής-θεραπείας-στο-οξύ-στεφανιαίο-σύνδρομο/
https://gpcardio.org/el/2023-04-18_συσχέτιση-μεταξύ-των-επιτευχθέντων-επιπέδων-χοληστερόλης-λιποπρωτεϊνών-χαμηλής-πυκνότητας-και-των-μακροπρ/
https://gpcardio.org/el/2023-04-20_δοκιμή-φάσης-3-της-σοτατερσέπτης-για-τη-θεραπεία-της-πνευμονικής-αρτηριακής-υπέρτασης/
https://gpcardio.org/el/2023-04-25_τυχαιοποιημένη-δοκιμή-φάσης-2b-του-από-του-στόματος-αναστολέα-pcsk9-mk-0616/
https://gpcardio.org/el/2023-05-04_πολύπλοκη-pci-καθοδηγούμενη-από-ενδαγγειακή-απεικόνιση-ή-από-αγγειογραφία/
https://gpcardio.org/el/2023-05-09_οδός-λήψης-αποφάσεων-συναίνεσης-εμπειρογνωμόνων-acc-2023-για-τη-διαχείριση-της-καρδιακής-ανεπάρκειας-με-διατηρ/
https://gpcardio.org/el/2023-05-18_διακαθετηριακή-επιδιόρθωση-σε-ασθενείς-με-τριγλωχινική-ανεπάρκεια/
https://gpcardio.org/el/2023-05-27_στρατηγική-επαναγγείωσης-με-πρώτα-φλεβική-παράκαμψη-έναντι-πρώτα-βέλτιστη-ενδαγγειακή-θεραπεία-σε-ασθενείς/
https://gpcardio.org/el/2023-06-01_αποτελεσματικότητα-και-ασφάλεια-δισκίων-τριπλού-και-τετραπλού-συνδυασμού-χαμηλής-δόσης-έναντι-μονοθεραπεί/
https://gpcardio.org/el/2023-06-01_παρακολούθηση-πενταετίας-μετά-από-διακαθετηριακή-επιδιόρθωση-δευτεροπαθούς-μιτροειδικής-ανεπάρκειας/
https://gpcardio.org/el/2023-06-06_άμεσα-από-του-στόματος-αντιπηκτικά-έναντι-βαρφαρίνης-σε-όλο-το-φάσμα-της-νεφρικής-λειτουργίας/
https://gpcardio.org/el/2023-06-06_ανατιτλοποίηση-της-θεραπείας-μετά-από-νοσηλεία-λόγω-καρδιακής-ανεπάρκειας-σε-όλο-το-φάσμα-του-κλάσματος-εξώ/
https://gpcardio.org/el/2023-06-08_θεραπεία-του-διαβήτη-κύησης-που-διαγιγνώσκεται-νωρίς-στην-εγκυμοσύνη/
https://gpcardio.org/el/2023-06-24_απομακρυσμένη-αιμοδυναμική-παρακολούθηση-των-πιέσεων-της-πνευμονικής-αρτηρίας-σε-ασθενείς-με-χρόνια-καρδια/
https://gpcardio.org/el/2023-06-27_επίδραση-των-αναστολέων-sglt2-στα-καρδιαγγειακά-αποτελέσματα-σε-διάφορους-πληθυσμούς-ασθενών/
https://gpcardio.org/el/2023-06-29_πρώιμη-έναντι-μεταγενέστερης-αντιπηκτικής-αγωγής-για-αεε-με-κολπική-μαρμαρυγή/
https://gpcardio.org/el/2023-07-01_η-τρίτη-δοκιμή-δέσμης-εντατικής-φροντίδας-με-μείωση-της-αρτηριακής-πίεσης-στην-οξεία-εγκεφαλική-αιμορραγία-i/
https://gpcardio.org/el/2023-07-11_μονοθεραπεία-με-αναστολέα-p2y12-ή-ασπιρίνη-για-δευτερογενή-πρόληψη-στεφανιαίων-συμβάντων/
https://gpcardio.org/el/2023-07-13_καρδιαγγειακή-ασφάλεια-της-θεραπείας-υποκατάστασης-τεστοστερόνης/
https://gpcardio.org/el/2023-07-20_δοκιμή-φάσης-1-του-αντισώματος-ni006-για-την-απάλειψη-του-καρδιακού-αμυλοειδούς-τρανσθυρετίνης/
https://gpcardio.org/el/2023-07-20_ζιλεμπεσιράνη-ένας-θεραπευτικός-παράγοντας-παρεμβολής-rna-για-την-υπέρταση/
https://gpcardio.org/el/2023-08-08_ατορβαστατίνη-για-την-καρδιακή-δυσλειτουργία-που-σχετίζεται-με-ανθρακυκλίνες/
https://gpcardio.org/el/2023-08-08_θεραπεία-με-αγωνιστή-υποδοχέα-glp-1-με-και-χωρίς-αναστολείς-sglt2-σε-ασθενείς-με-διαβήτη-τύπου-2/
https://gpcardio.org/el/2023-08-12_ρετατρουτίδη-ένας-αγωνιστής-υποδοχέων-gip-glp-1-και-γλυκαγόνης-σε-άτομα-με-διαβήτη-τύπου-2/
https://gpcardio.org/el/2023-08-14_σακουβιτρίλη-βαλσαρτάνη-στην-καρδιακή-ανεπάρκεια-με-ήπια-μειωμένο-ή-διατηρημένο-κλάσμα-εξώθησης/
https://gpcardio.org/el/2023-08-24_θεραπείες-σταθερού-συνδυασμού-δόσης-στην-πρωτογενή-πρόληψη-καρδιαγγειακής-νόσου-σε-διαφορετικές-ομάδες/
https://gpcardio.org/el/2023-08-24_πιταβαστατίνη-για-την-πρόληψη-της-καρδιαγγειακής-νόσου-στη-λοίμωξη-hiv/
https://gpcardio.org/el/2023-09-07_ημερήσιος-από-του-στόματος-αγωνιστής-υποδοχέα-glp-1-ορφογλιπρόνη-για-ενήλικες-με-παχυσαρκία/
https://gpcardio.org/el/2023-09-07_πλήρης-ή-μόνο-υπεύθυνης-βλάβης-pci-σε-ηλικιωμένους-ασθενείς-με-έμφραγμα-του-μυοκαρδίου/
https://gpcardio.org/el/2023-09-14_καρβοξυμαλτόζη-σιδήρου-στην-καρδιακή-ανεπάρκεια-με-σιδηροπενία/
https://gpcardio.org/el/2023-09-19_pci-καθοδηγούμενη-από-κλασματική-εφεδρεία-ροής-ή-χειρουργική-επέμβαση-στεφανιαίας-παράκαμψης-για-στεφανιαία/
https://gpcardio.org/el/2023-09-21_σεμαγλουτίδη-σε-ασθενείς-με-καρδιακή-ανεπάρκεια-με-διατηρημένο-κλάσμα-εξώθησης-και-παχυσαρκία/
https://gpcardio.org/el/2023-09-28_αντιπηκτική-αγωγή-με-εδοξαβάνη-σε-ασθενείς-με-κολπικά-επεισόδια-υψηλής-συχνότητας/
https://gpcardio.org/el/2023-10-01_ανταγωνιστές-του-υποδοχέα-αλατοκορτικοειδών-με-αναστολείς-του-συμμεταφορέα-νατρίου-γλυκόζης-τύπου-2-στην-κα/
https://gpcardio.org/el/2023-10-01_αποτελεσματικότητα-της-παρακολούθησης-της-πίεσης-της-πνευμονικής-αρτηρίας-σε-ασθενείς-με-χρόνια-καρδιακή-α/
https://gpcardio.org/el/2023-10-03_εκτιμώμενος-ρυθμός-σπειραματικής-διήθησης-λευκωματινουρία-και-δυσμενή-αποτελέσματα/
https://gpcardio.org/el/2023-10-05_εξωσωματική-υποστήριξη-ζωής-στην-καρδιογενή-καταπληξία-σχετιζόμενη-με-έμφραγμα/
https://gpcardio.org/el/2023-10-05_παγκόσμια-επίδραση-των-τροποποιήσιμων-παραγόντων-κινδύνου-στην-καρδιαγγειακή-νόσο-και-τη-θνησιμότητα/
https://gpcardio.org/el/2023-10-12_κατάλυση-με-καθετήρα-σε-τελικού-σταδίου-καρδιακή-ανεπάρκεια-με-κολπική-μαρμαρυγή/
https://gpcardio.org/el/2023-10-12_χρονισμός-πλήρους-επαναγγείωσης-με-pci-πολλαπλών-αγγείων-για-έμφραγμα-του-μυοκαρδίου/
https://gpcardio.org/el/2023-10-14_φλεβοαρτηριακή-εξωσωματική-οξυγόνωση-μέσω-μεμβράνης-σε-ασθενείς-με-καρδιογενή-καταπληξία-σχετιζόμενη-με-έμ/
https://gpcardio.org/el/2023-10-17_διαδερμική-στεφανιαία-επέμβαση-καθοδηγούμενη-από-οπτική-τομογραφία-συνοχής-ή-από-ενδοαγγειακό-υπερηχογράφ/
https://gpcardio.org/el/2023-10-17_ορθοστατική-υπόταση-θεραπεία-της-υπέρτασης-και-καρδιαγγειακή-νόσος/
https://gpcardio.org/el/2023-10-19_pci-καθοδηγούμενη-από-οπτική-τομογραφία-συνοχής-έναντι-pci-καθοδηγούμενης-από-αγγειογραφία/
https://gpcardio.org/el/2023-10-19_καθοδήγηση-με-oct-ή-αγγειογραφία-για-pci-σε-πολύπλοκες-βλάβες-διχασμού/
https://gpcardio.org/el/2023-10-24_σύμπλοκο-παραδοσιακής-κινεζικής-ιατρικής-tongxinluo-και-κλινικά-αποτελέσματα-σε-ασθενείς-με-οξύ-έμφραγμα-του-μυο/
https://gpcardio.org/el/2023-11-02_κατάλυση-παλμικού-πεδίου-ή-συμβατική-θερμική-κατάλυση-για-παροξυσμική-κολπική-μαρμαρυγή/
https://gpcardio.org/el/2023-11-23_διακαθετηριακή-αντικατάσταση-αορτικής-βαλβίδας-σε-ασθενείς-χαμηλού-κινδύνου-στα-πέντε-έτη/
https://gpcardio.org/el/2023-11-25_ζιμποτεντάνη-σε-συνδυασμό-με-νταπαγλιφλοζίνη-σε-σύγκριση-με-νταπαγλιφλοζίνη-σε-ασθενείς-με-χρόνια-νεφρική-ν/
https://gpcardio.org/el/2023-12-14_σεμαγλουτίδη-και-καρδιαγγειακά-αποτελέσματα-στην-παχυσαρκία-χωρίς-διαβήτη/
https://gpcardio.org/el/2023-12-21_αποτελεσματικότητα-της-καρβοξυμαλτόζης-σιδήρου-στην-καρδιακή-ανεπάρκεια-με-σιδηροπενία/
https://gpcardio.org/el/2023-12-21_μια-ελεγχόμενη-με-εικονικό-φάρμακο-δοκιμή-διαδερμικής-στεφανιαίας-επέμβασης-για-σταθερή-στηθάγχη/
https://gpcardio.org/el/2023-12-28_περιοριστική-ή-ελεύθερη-στρατηγική-μετάγγισης-στο-έμφραγμα-του-μυοκαρδίου-και-την-αναιμία/
https://gpcardio.org/el/2024-01-02_κατευθυντήρια-οδηγία-acc-aha-accp-hrs-2023-για-τη-διάγνωση-και-τη-διαχείριση-της-κολπικής-μαρμαρυγής/
https://gpcardio.org/el/2024-01-02_κατευθυντήρια-οδηγία-acc-aha-accp-hrs-2023-για-τη-διάγνωση-και-τη-διαχείριση-της-κολπικής-μαρμαρυγής/
https://gpcardio.org/el/2024-01-11_απιξαμπάνη-για-την-πρόληψη-αεε-στην-υποκλινική-κολπική-μαρμαρυγή/
https://gpcardio.org/el/2024-01-18_μακροπρόθεσμα-αποτελέσματα-επανασυγχρονισμού-απινίδωσης-για-καρδιακή-ανεπάρκεια/
https://gpcardio.org/el/2024-02-13_οι-εμφυτεύσιμοι-αιμοδυναμικοί-μόνιτορ-βελτιώνουν-την-επιβίωση-σε-ασθενείς-με-καρδιακή-ανεπάρκεια-και-μειωμ/
https://gpcardio.org/el/2024-02-20_ασφάλεια-και-αποτελεσματικότητα-της-μονοθεραπείας-με-τικαγρελόρη-σε-ασθενείς-με-οξέα-στεφανιαία-σύνδρομα-π/
https://gpcardio.org/el/2024-02-20_διακοπή-της-ασπιρίνης-εντός-1-μηνός-μετά-την-τοποθέτηση-stent-για-μονοθεραπεία-τικαγρελόρης-στο-οξύ-στεφανιαίο/
https://gpcardio.org/el/2024-02-20_στρατηγική-χωρίς-ασπιρίνη-έναντι-διπλής-αντιαιμοπεταλιακής-στρατηγικής-για-στεφανιαία-τοποθέτηση-stent/
https://gpcardio.org/el/2024-03-01_επίδραση-του-βεμπεδοϊκού-οξέος-στο-σύνολο-των-καρδιαγγειακών-συμβάντων/
https://gpcardio.org/el/2024-03-02_εμφύτευση-στεφανιαίου-stent-εκλύσεως-φαρμάκου-καθοδηγούμενη-από-ενδοαγγειακή-απεικόνιση/
https://gpcardio.org/el/2024-03-18_παγκόσμια-μετατόπιση-από-την-ελλιποβαρότητα-στην-κυριαρχία-της-παχυσαρκίας-σε-τρεις-δεκαετίες-σε-όλες-τις-γ/
https://gpcardio.org/el/2024-03-26_άμεσα-από-του-στόματος-αντιπηκτικά-για-την-πρόληψη-αεε-σε-ασθενείς-με-κολπική-μαρμαρυγή-που-ανιχνεύεται-από/
https://gpcardio.org/el/2024-04-01_διακαθετηριακή-ή-χειρουργική-εμφύτευση-αορτικής-βαλβίδας/
https://gpcardio.org/el/2024-04-02_stratify-hf-μια-ευρωπαϊκή-συνεργασία-για-την-ανάπτυξη-ενός-συστήματος-υποστήριξης-βασισμένου-στην-τν-για-τη-διαστ/
https://gpcardio.org/el/2024-04-07_gamification-και-οικονομικά-κίνητρα-για-την-αύξηση-της-σωματικής-δραστηριότητας-σε-ασθενείς-με-αυξημένο-καρδιαγγε/
https://gpcardio.org/el/2024-04-08_διαδικτυακή-εφαρμογή-αποτελεσματική-στον-προσδιορισμό-της-πρόσβασης-σε-στατίνες-χωρίς-συνταγή/
https://gpcardio.org/el/2024-04-08_ενισχυμένο-πρόγραμμα-απομακρυσμένης-φαρμακευτικής-αγωγής-ενισχύει-τις-συνταγογραφήσεις-gdmt-σε-ασθενείς-με-t2/
https://gpcardio.org/el/2024-04-16_οδός-λήψης-αποφάσεων-συναίνεσης-ειδικών-acc-2024-για-τη-θεραπεία-της-καρδιακής-ανεπάρκειας-με-μειωμένο-κλάσμα-ε/
https://gpcardio.org/el/2024-04-18_β-αναστολείς-μετά-από-έμφραγμα-του-μυοκαρδίου-και-διατηρημένο-κλάσμα-εξώθησης/
https://gpcardio.org/el/2024-04-18_μικροαξονική-αντλία-ροής-ή-καθιερωμένη-φροντίδα-στην-καρδιογενή-καταπληξία-σχετιζόμενη-με-έμφραγμα/
https://gpcardio.org/el/2024-04-18_σεμαγλουτίδη-σε-ασθενείς-με-καρδιακή-ανεπάρκεια-σχετιζόμενη-με-παχυσαρκία-και-σακχαρώδη-διαβήτη-τύπου-2/
https://gpcardio.org/el/2024-04-25_pci-καθοδηγούμενη-από-ffr-πλήρης-ή-αποκλειστικά-της-υπεύθυνης-βλάβης-σε-ασθενείς-με-έμφραγμα-του-μυοκαρδίου/
https://gpcardio.org/el/2024-04-25_εμπαγλιφλοζίνη-μετά-από-οξύ-έμφραγμα-του-μυοκαρδίου/
https://gpcardio.org/el/2024-04-27_σεμαγλουτίδη-έναντι-εικονικού-φαρμάκου-σε-άτομα-με-καρδιακή-ανεπάρκεια-σχετιζόμενη-με-παχυσαρκία-με-διατηρ/
https://gpcardio.org/el/2024-05-01_μονοθεραπεία-με-τικαγρελόρη-ή-κλοπιδογρέλη-έναντι-διπλής-αντιαιμοπεταλιακής-θεραπείας-μετά-από-διαδερμική/
https://gpcardio.org/el/2024-05-02_εγχύσεις-απολιποπρωτεΐνης-a1-και-καρδιαγγειακά-αποτελέσματα-μετά-από-οξύ-έμφραγμα-του-μυοκαρδίου/
https://gpcardio.org/el/2024-05-04_stratifyhf-παροχή-υποστήριξης-στην-πρωτοβάθμια-φροντίδα-για-την-έγκαιρη-διάγνωση-της-καρδιακής-ανεπάρκειας/
https://gpcardio.org/el/2024-05-04_προληπτική-διαδερμική-στεφανιαία-επέμβαση-έναντι-αποκλειστικά-βέλτιστης-ιατρικής-θεραπείας-για-τη-θεραπεί/
https://gpcardio.org/el/2024-05-06_η-δράση-έρευνας-και-καινοτομίας-stratifyhf/
https://gpcardio.org/el/2024-05-11_διαδερμική-στεφανιαία-επέμβαση-καθοδηγούμενη-από-ενδοαγγειακό-υπερηχογράφημα-έναντι-καθοδηγούμενης-από-αγ/
https://gpcardio.org/el/2024-05-11_τικαγρελόρη-μόνη-έναντι-τικαγρελόρης-συν-ασπιρίνη-από-τον-μήνα-1-έως-τον-μήνα-12-μετά-από-διαδερμική-στεφανιαί/
https://gpcardio.org/el/2024-05-16_ανδεξανέτη-για-την-οξεία-ενδοεγκεφαλική-αιμορραγία-που-σχετίζεται-με-αναστολείς-του-παράγοντα-xa/
https://gpcardio.org/el/2024-05-16_ολεζαρσένη-για-την-υπερτριγλυκεριδαιμία-σε-ασθενείς-με-υψηλό-καρδιαγγειακό-κίνδυνο/
https://gpcardio.org/el/2024-05-16_ολεζαρσένη-οξεία-παγκρεατίτιδα-και-οικογενές-σύνδρομο-χυλομικροναιμίας/
https://gpcardio.org/el/2024-05-30_εντατική-μείωση-της-αρτηριακής-πίεσης-χορηγούμενη-στο-ασθενοφόρο-σε-υπεροξύ-αγγειακό-εγκεφαλικό-επεισόδιο/
https://gpcardio.org/el/2024-06-01_θεραπεία-της-πνευμονικής-αρτηριακής-υπέρτασης/
https://gpcardio.org/el/2024-06-04_αναστολείς-του-συμμεταφορέα-νατρίου-γλυκόζης-τύπου-2-και-σοβαρά-ανεπιθύμητα-καρδιαγγειακά-συμβάντα/
https://gpcardio.org/el/2024-06-04_βελτίωση-της-εκτίμησης-καρδιαγγειακού-κινδύνου-ενσωμάτωση-του-γενετικού-κινδύνου-για-καλύτερη-πρόβλεψη/
https://gpcardio.org/el/2024-06-06_αυτοεκπτυσσόμενη-ή-διατεινόμενη-με-μπαλόνι-tavr-σε-ασθενείς-με-μικρό-αορτικό-δακτύλιο/
https://gpcardio.org/el/2024-06-14_επεμβατική-έναντι-συντηρητικής-αντιμετώπισης-ηλικιωμένων-ασθενών-με-οξύ-στεφανιαίο-σύνδρομο-χωρίς-ανάσπασ/
https://gpcardio.org/el/2024-06-25_επανεξέταση-της-φυλής-και-του-οφέλους-της-αναστολής-του-ras-στην-καρδιακή-ανεπάρκεια/
https://gpcardio.org/el/2024-07-01_πλοζασιράνη-aro-apoc3-για-τη-σοβαρή-υπερτριγλυκεριδαιμία/
https://gpcardio.org/el/2024-07-11_επιδράσεις-της-σεμαγλουτίδης-στη-χρόνια-νεφρική-νόσο-σε-ασθενείς-με-σακχαρώδη-διαβήτη-τύπου-2/
https://gpcardio.org/el/2024-07-13_μακροχρόνια-κολχικίνη-για-την-πρόληψη-υποτροπιάζοντων-αγγειακών-συμβάντων-σε-μη-καρδιοεμβολικό-εγκεφαλικό/
https://gpcardio.org/el/2024-07-20_μείωση-της-συστολικής-αρτηριακής-πίεσης-σε-λιγότερο-από-120-mm-hg-έναντι-λιγότερο-από-140-mm-hg-σε-ασθενείς-με-υψηλό/
https://gpcardio.org/el/2024-08-24_σεμαγλουτίδη-και-καρδιαγγειακά-αποτελέσματα-σε-ασθενείς-με-παχυσαρκία-και-προϋπάρχουσα-καρδιακή-ανεπάρκει/
https://gpcardio.org/el/2024-09-01_μονοθεραπεία-με-τικαγρελόρη-για-οξύ-στεφανιαίο-σύνδρομο/
https://gpcardio.org/el/2024-09-04_παγκόσμια-στοιχεία-από-τη-μελέτη-interaspire-χαρτογράφηση-του-επιπολασμού-της-λιποπρωτεΐνης-a-στη-στεφανιαία-νόσο/
https://gpcardio.org/el/2024-09-07_σεμαγλουτίδη-έναντι-εικονικού-φαρμάκου-σε-ασθενείς-με-καρδιακή-ανεπάρκεια-και-ήπια-μειωμένο-ή-διατηρημένο-κ/
https://gpcardio.org/el/2024-09-12_ζοδασιράνη-μια-θεραπεία-rnai-που-στοχεύει-την-angptl3-για-μικτή-υπερλιπιδαιμία/
https://gpcardio.org/el/2024-09-12_πλοζασιράνη-ένας-παράγοντας-παρεμβολής-rna-που-στοχεύει-την-apoc3-για-μικτή-υπερλιπιδαιμία/
https://gpcardio.org/el/2024-09-14_προσωρινή-μηχανική-κυκλοφορική-υποστήριξη-σε-καρδιογενή-καταπληξία-σχετιζόμενη-με-έμφραγμα/
https://gpcardio.org/el/2024-09-21_ανταγωνιστές-του-υποδοχέα-αλατοκορτικοειδών-στην-καρδιακή-ανεπάρκεια/
https://gpcardio.org/el/2024-09-24_επικαιροποίηση-με-στόχευση-2024-της-οδού-απόφασης-ομοφωνίας-εμπειρογνωμόνων-του-acc-σχετικά-με-την-κλινική-αξιο/
https://gpcardio.org/el/2024-09-29_κατευθυντήριες-οδηγίες-esc-2024-για-την-αντιμετώπιση-της-κολπικής-μαρμαρυγής-που-αναπτύχθηκαν-σε-συνεργασία-με/
https://gpcardio.org/el/2024-10-07_κατευθυντήριες-οδηγίες-esc-2024-για-την-αντιμετώπιση-της-αυξημένης-αρτηριακής-πίεσης-και-της-υπέρτασης/
https://gpcardio.org/el/2024-10-07_σεμαγλουτίδη-και-αρτηριακή-πίεση/
https://gpcardio.org/el/2024-10-10_διακοπή-ή-συνέχιση-του-β-αναστολέα-μετά-από-έμφραγμα-του-μυοκαρδίου/
https://gpcardio.org/el/2024-10-22_επιδράσεις-της-σεμαγλουτίδης-στα-αποτελέσματα-καρδιακής-ανεπάρκειας-στον-διαβήτη-και-τη-χρόνια-νεφρική-νόσ/
https://gpcardio.org/el/2024-10-24_φινερενόνη-στην-καρδιακή-ανεπάρκεια-με-ήπια-μειωμένο-ή-διατηρημένο-κλάσμα-εξώθησης/
https://gpcardio.org/el/2024-10-29_κρίση-νοσηλειών-και-θανάτων-στη-δοκιμή-ironman-ενδοφλέβιου-σιδήρου-για-καρδιακή-ανεπάρκεια/
https://gpcardio.org/el/2024-11-05_πλήρης-έναντι-μόνο-της-υπεύθυνης-βλάβης-επαναγγείωση-σε-ηλικιωμένους-ασθενείς-με-έμφραγμα-του-μυοκαρδίου-με/
https://gpcardio.org/el/2024-11-07_επεμβατική-θεραπευτική-στρατηγική-για-ηλικιωμένους-ασθενείς-με-έμφραγμα-του-μυοκαρδίου/
https://gpcardio.org/el/2024-11-09_ποσοτικός-λόγος-ροής-έναντι-κλασματικής-εφεδρείας-ροής-για-καθοδήγηση-στεφανιαίας-επαναγγείωσης-favor-iii-europe/
https://gpcardio.org/el/2024-11-14_διαδερμική-επιδιόρθωση-έναντι-χειρουργικής-επέμβασης-μιτροειδούς-βαλβίδας-για-δευτεροπαθή-ανεπάρκεια-μιτρ/
https://gpcardio.org/el/2024-11-14_διαδερμική-επιδιόρθωση-βαλβίδας-στην-καρδιακή-ανεπάρκεια-με-μέτρια-έως-σοβαρή-ανεπάρκεια-μιτροειδούς/
https://gpcardio.org/el/2024-11-19_επίδραση-του-ελέγχου-για-μη-διαγνωσμένη-κολπική-μαρμαρυγή-στην-πρόληψη-εγκεφαλικού-επεισοδίου/
https://gpcardio.org/el/2024-11-26_καρδιαγγειακά-νεφρικά-και-αποτελέσματα-ασφάλειας-με-αγωνιστές-του-υποδοχέα-glp-1-μόνους-και-σε-συνδυασμό-με-αν/
https://gpcardio.org/el/2024-12-12_pci-σε-ασθενείς-που-υποβάλλονται-σε-διακαθετηριακή-εμφύτευση-αορτικής-βαλβίδας/
https://gpcardio.org/el/2024-12-14_ο-ζωτικός-ρόλος-της-πρωτοβάθμιας-φροντίδας-στην-προαγωγή-της-καρδιαγγειακής-υγείας/
https://gpcardio.org/el/2025-01-02_ασουνδεξιάνη-έναντι-απιξαμπάνης-σε-ασθενείς-με-κολπική-μαρμαρυγή/
https://gpcardio.org/el/2025-01-07_αποτελεσματικότητα-και-ασφάλεια-της-φινερενόνης-σε-όλο-το-φάσμα-του-κλάσματος-εξώθησης-στην-καρδιακή-ανεπάρ/
https://gpcardio.org/el/2025-01-09_διαδερμική-αντικατάσταση-βαλβίδας-σε-σοβαρή-ανεπάρκεια-τριγλώχινας/
https://gpcardio.org/el/2025-01-09_πλοζασιράνη-για-τη-διαχείριση-της-επίμονης-χυλομικροναιμίας-και-του-κινδύνου-παγκρεατίτιδας/
https://gpcardio.org/el/2025-01-14_διαδερμική-επιδιόρθωση-άκρο-προς-άκρο-για-σοβαρή-απομονωμένη-ανεπάρκεια-τριγλώχινας/
https://gpcardio.org/el/2025-01-21_από-του-στόματος-μουβαλαπλίνη-για-τη-μείωση-της-λιποπρωτεΐνης-a/
https://gpcardio.org/el/2025-01-21_πρώιμη-παρέμβαση-σε-ασθενείς-με-ασυμπτωματική-σοβαρή-αορτική-στένωση-και-μυοκαρδιακή-ίνωση/
https://gpcardio.org/el/2025-01-23_αμπελασιμάμπη-έναντι-ριβαροξαμπάνης-σε-ασθενείς-με-κολπική-μαρμαρυγή/
https://gpcardio.org/el/2025-01-25_διαχείριση-με-καθοδήγηση-στεφανιαίας-αγγειογραφίας-ct-σε-ασθενείς-με-σταθερό-θωρακικό-άλγος/
https://gpcardio.org/el/2025-01-30_συνέχιση-έναντι-διακοπής-της-από-του-στόματος-αντιπηκτικής-αγωγής-κατά-τη-διάρκεια-της-tavi/
https://gpcardio.org/el/2025-01-30_τιρζεπατίδη-για-καρδιακή-ανεπάρκεια-με-διατηρημένο-κλάσμα-εξώθησης-και-παχυσαρκία/
https://gpcardio.org/el/2025-02-13_κολχικίνη-σε-οξύ-έμφραγμα-του-μυοκαρδίου/
https://gpcardio.org/el/2025-02-13_συστηματική-χορήγηση-σπιρονολακτόνης-σε-οξύ-έμφραγμα-του-μυοκαρδίου/
https://gpcardio.org/el/2025-02-20_διαδερμική-κατάλυση-ή-αντιαρρυθμικά-φάρμακα-για-κοιλιακή-ταχυκαρδία/
https://gpcardio.org/el/2025-03-11_διαδερμική-αντικατάσταση-αορτικής-βαλβίδας-σε-ασθενείς-με-συστολική-καρδιακή-ανεπάρκεια-και-μέτρια-αορτική/
https://gpcardio.org/el/2025-03-15_μελέτη-σχετικά-με-τους-καρδιαγγειακούς-παράγοντες-κινδύνου-και-τη-χρήση-της-πρωτοβάθμιας-φροντίδας-στην-ισπ/
https://gpcardio.org/el/2025-03-16_πρωτογενής-πρόληψη-της-αθηροσκληρωτικής-καρδιαγγειακής-νόσου-ascvd-στην-πρωτοβάθμια-φροντίδα-μια-συστηματική/
https://gpcardio.org/el/2025-03-17_διαφορές-και-τάσεις-ανά-φύλο-στη-διαχείριση-του-καρδιαγγειακού-κινδύνου-στοιχεία-από-μακροχρόνια-μελέτη-πρω/
https://gpcardio.org/el/2025-03-25_αντιθρομβωτική-θεραπεία-για-την-ελαχιστοποίηση-των-συνολικών-συμβαμάτων-μετά-από-acs-ή-pci-σε-κολπική-μαρμαρυγ/
https://gpcardio.org/el/2025-03-25_αντιπηκτική-και-αντιαιμοπεταλιακή-θεραπεία-για-κολπική-μαρμαρυγή-και-σταθερή-στεφανιαία-νόσο/
https://gpcardio.org/el/2025-03-25_διαφορές-ηλικίας-και-φύλου-στην-αποτελεσματικότητα-των-θεραπειών-για-τον-σακχαρώδη-διαβήτη-τύπου-2/
https://gpcardio.org/el/2025-03-27_εντατικός-έλεγχος-της-αρτηριακής-πίεσης-σε-ασθενείς-με-σακχαρώδη-διαβήτη-τύπου-2/
https://gpcardio.org/el/2025-03-28_εισπνεόμενο-διάλυμα-οξικής-φλεκαϊνίδης-για-καρδιομετατροπή-πρόσφατης-έναρξης-συμπτωματικής-κολπικής-μαρμα/
https://gpcardio.org/el/2025-04-01_αποτελεσματικότητα-και-ασφάλεια-των-αναστολέων-της-συνθάσης-της-αλδοστερόνης-για-την-υπέρταση/
https://gpcardio.org/el/2025-04-01_κατευθυντήρια-οδηγία-acc-aha-2025-για-τη-διαχείριση-ασθενών-με-οξέα-στεφανιαία-σύνδρομα/
https://gpcardio.org/el/2025-04-01_μετα-ανάλυση-της-σοταγλιφλοζίνης-ενός-διπλού-αναστολέα-του-συμμεταφορέα-νατρίου-γλυκόζης-1-2-για-καρδιακή-αν/
https://gpcardio.org/el/2025-04-03_απόφραξη-του-αριστερού-κολπικού-ωτίου-μετά-από-κατάλυση-για-κολπική-μαρμαρυγή/
https://gpcardio.org/el/2025-04-07_αναστολείς-του-συμμεταφορέα-νατρίου-γλυκόζης-τύπου-2-και-νεοεμφανιζόμενος-διαβήτης-σε-καρδιαγγειακή-ή-νεφρι/
https://gpcardio.org/el/2025-04-07_εμπαγλιφλοζίνη-σε-ανθεκτική-υπέρταση-και-καρδιακή-ανεπάρκεια-με-διατηρημένο-κλάσμα-εξώθησης/
https://gpcardio.org/el/2025-04-10_δαπαγλιφλοζίνη-σε-ασθενείς-που-υποβάλλονται-σε-διαδερμική-εμφύτευση-αορτικής-βαλβίδας/
https://gpcardio.org/el/2025-04-10_παρουσιάζουμε-την-gpcardio-γεφυρώνοντας-το-χάσμα-στην-καρδιαγγειακή-φροντίδα/
https://gpcardio.org/el/2025-04-17_κατάλυση-με-παλμικό-πεδίο-ή-με-κρυοβαλόνι-για-παροξυσμική-κολπική-μαρμαρυγή/
https://gpcardio.org/el/2025-05-03_σεμαγλουτίδη-και-ικανότητα-βάδισης-σε-άτομα-με-συμπτωματική-περιφερική-αρτηριακή-νόσο-και-σακχαρώδη-διαβήτ/
https://gpcardio.org/el/2025-05-08_αποτελεσματικότητα-και-ασφάλεια-της-λορουνδροστάτης-σε-ασθενείς-με-ανεξέλεγκτη-υπέρταση/
https://gpcardio.org/el/2025-05-13_αλληλεπίδραση-χρόνιας-νεφρικής-νόσου-και-επιδράσεων-της-τιρζεπατίδης-σε-ασθενείς-με-καρδιακή-ανεπάρκεια-δι/
https://gpcardio.org/el/2025-05-13_επίδραση-της-εμπαγλιφλοζίνης-στους-μηχανισμούς-που-οδηγούν-την-ερυθροποίηση-και-την-κινητοποίηση-σιδήρου-σ/
https://gpcardio.org/el/2025-05-17_σταθερός-συνδυασμός-ομπισετραπίμπης-και-εζετιμίμπης-για-τη-μείωση-της-ldl-χοληστερόλης-tandem/
https://gpcardio.org/el/2025-05-29_από-του-στόματος-σεμαγλουτίδη-και-καρδιαγγειακά-αποτελέσματα-σε-σακχαρώδη-διαβήτη-τύπου-2-υψηλού-κινδύνου/
https://gpcardio.org/el/2025-06-01_διαδερμική-στεφανιαία-παρέμβαση-καθοδηγούμενη-από-ffr-έναντι-αορτοστεφανιαίας-παράκαμψης-σε-ασθενείς-με-δια/
https://gpcardio.org/el/2025-06-01_νέος-ελεγχόμενος-μεταβολικός-επιταχυντής-για-hfpef-σχετιζόμενη-με-την-παχυσαρκία/
https://gpcardio.org/el/2025-06-01_τυχαιοποιημένη-δοκιμή-για-την-αξιολόγηση-της-επιδείνωσης-της-νεφρικής-λειτουργίας-με-την-προσθήκη-δαπαγλιφ/
https://gpcardio.org/el/2025-06-03_ένας-από-του-στόματος-αναστολέας-pcsk9-για-τη-θεραπεία-της-υπερχοληστερολαιμίας/
https://gpcardio.org/el/2025-06-10_από-του-στόματος-σεμαγλουτίδη-και-καρδιαγγειακά-αποτελέσματα-σε-άτομα-με-σακχαρώδη-διαβήτη-τύπου-2-ανάλογα-μ/
https://gpcardio.org/el/2025-06-10_ενδοφλέβια-καρβοξυμαλτόζη-σιδήρου-σε-καρδιακή-ανεπάρκεια-με-έλλειψη-σιδήρου/
https://gpcardio.org/el/2025-06-10_κατευθυντήρια-οδηγία-acc-aha-2025-για-τη-διαχείριση-ασθενών-με-οξέα-στεφανιαία-σύνδρομα/
https://gpcardio.org/el/2025-06-13_η-επίδραση-της-ευθραυστότητας-στην-αποτελεσματικότητα-του-εντατικού-ελέγχου-της-αρτηριακής-πίεσης-σε-ασθεν/
https://gpcardio.org/el/2025-06-17_μακράς-δράσης-αναστολή-του-παράγοντα-xi-και-περιεπεμβατική-αιμορραγία/
https://gpcardio.org/el/2025-06-17_σπιρονολακτόνη-έναντι-αμιλορίδης-για-ανθεκτική-υπέρταση/
https://gpcardio.org/el/2025-06-17_χρονισμός-χορήγησης-αντιυπερτασικής-φαρμακευτικής-αγωγής-και-καρδιαγγειακά-συμβάματα-και-θάνατος/
https://gpcardio.org/el/2025-07-01_gpcardio-η-epccs-εντάσσεται-στην-each-την-european-alliance-for-cardiovascular-health/
https://gpcardio.org/el/2025-07-01_πρόσθετη-θεραπεία-με-ζιλεμπεσιράνη-για-ανεπαρκώς-ελεγχόμενη-υπέρταση/
https://gpcardio.org/el/2025-07-01_σχεδόν-καθολικός-επιπολασμός-της-κεντρικής-παχυσαρκίας-στην-καρδιακή-ανεπάρκεια-με-διατηρημένο-κλάσμα-εξώθ/
https://gpcardio.org/el/2025-07-03_ασφάλεια-και-αποτελεσματικότητα-της-ομπισετραπίμπης-σε-ασθενείς-με-υψηλό-καρδιαγγειακό-κίνδυνο/
https://gpcardio.org/el/2025-07-05_συνεργασία-σχετικά-με-τον-βέλτιστο-χρόνο-έναρξης-της-αντιπηκτικής-αγωγής-μετά-από-ισχαιμικό-εγκεφαλικό-επει/
https://gpcardio.org/el/2025-07-07_κολχικίνη-για-τη-δευτερογενή-πρόληψη-αγγειακών-επεισοδίων/
https://gpcardio.org/el/2025-07-07_μακροχρόνιες-μελέτες-κολχικίνης-για-τη-δευτερογενή-πρόληψη-αγγειακών-επεισοδίων/
https://gpcardio.org/el/2025-07-08_κατάλυση-με-καθετήρα-έναντι-τροποποίησης-του-τρόπου-ζωής-με-αντιαρρυθμικά-φάρμακα-για-τη-θεραπεία-της-κολπι/
https://gpcardio.org/el/2025-07-10_η-gpcardio-και-η-ncd-academy-της-acc-ενώνουν-δυνάμεις-για-την-ενίσχυση-της-πρωτοβάθμιας-φροντίδας-στην-πρόληψη-της-καρδι/
https://gpcardio.org/el/2025-07-12_αμυκρετίνη-ένας-νέος-μονομοριακός-αγωνιστής-υποδοχέων-glp-1-και-αμυλίνης-που-χορηγείται-υποδορίως/
https://gpcardio.org/el/2025-07-12_ασφάλεια-ανεκτικότητα-φαρμακοκινητική-και-φαρμακοδυναμική-του-πρώτου-στην-κατηγορία-του-αγωνιστή-υποδοχέω/
https://gpcardio.org/el/2025-07-15_10ετές-αποτέλεσμα-της-πλήρους-επαναγγείωσης-ή-της-επαναγγείωσης-μόνο-της-αρτηρίας-του-εμφράγματος-σε-stemi-με-π/
https://gpcardio.org/el/2025-07-22_cooperative-pfa/
https://gpcardio.org/el/2025-07-28_μακροπρόθεσμα-οφέλη-της-ατορβαστατίνης-στην-επίπτωση-καρδιαγγειακών-επεισοδίων/
https://gpcardio.org/el/2025-07-29_cvd-πρωτοβάθμια-φροντίδα-η-ανάγκη-για-πρακτική-καθοδήγηση-της-epccs/
https://gpcardio.org/el/2025-07-29_επίδραση-του-δείκτη-μάζας-σώματος-της-κεντρικής-παχυσαρκίας-και-της-απώλειας-βάρους-στα-οφέλη-της-τιρζεπατί/
https://gpcardio.org/el/2025-08-05_αμπελασιμάμπη-έναντι-ριβαροξαβάνης-σε-ασθενείς-με-κολπική-μαρμαρυγή-υπό-αντιαιμοπεταλιακή-θεραπεία/
https://gpcardio.org/el/2025-08-05_αναστολέας-του-συμμεταφορέα-νατρίου-γλυκόζης-τύπου-2-με-και-χωρίς-ανταγωνιστή-αλδοστερόνης-για-καρδιακή-ανε/
https://gpcardio.org/el/2025-08-05_λορουνδροστάτη-σε-συμμετέχοντες-με-ανεξέλεγκτη-υπέρταση-και-ανθεκτική-στη-θεραπεία-υπέρταση/
https://gpcardio.org/el/2025-08-12_αποτελέσματα-σε-ηλικιωμένους-ασθενείς-μετά-από-μετάβαση-σε-νεότερο-αντιπηκτικό-ή-παραμονή-σε-βαρφαρίνη/
https://gpcardio.org/el/2025-08-14_συγχορηγούμενη-καγκριλιντίδη-και-σεμαγλουτίδη-σε-ενήλικες-με-υπερβαρότητα-ή-παχυσαρκία/
https://gpcardio.org/el/2025-08-21_προληπτική-διαδερμική-στεφανιαία-επέμβαση-για-μη-περιοριστικές-της-ροής-ευάλωτες-αθηροσκληρωτικές-στεφανι/
https://gpcardio.org/el/2025-08-30_αποτελεσματικότητα-μείωσης-της-αρτηριακής-πίεσης-των-αντιυπερτασικών-φαρμάκων-και-των-συνδυασμών-τους/
https://gpcardio.org/el/2025-09-01_βηματοδότηση-του-συστήματος-αγωγιμότητας-έναντι-αμφικοιλιακής-βηματοδότησης-για-καρδιακό-επανασυγχρονισμ/
https://gpcardio.org/el/2025-09-01_διαβήτης-και-παχυσαρκία-και-η-επίδραση-της-θεραπείας-πρώιμου-ελέγχου-ρυθμού-έναντι-της-συνήθους-φροντίδας-σ/
https://gpcardio.org/el/2025-09-01_κόστος-αποτελεσματικότητα-της-απιξαμπάνης-έναντι-της-ασπιρίνης-για-τη-μείωση-της-θρομβοεμβολής-σε-ασθενείς/
https://gpcardio.org/el/2025-09-02_βέλτιστη-ιατρική-φροντίδα-και-επαναγγείωση-του-μυοκαρδίου-με-καθοδήγηση-της-στεφανιαίας-ροϊκής-ικανότητας/
https://gpcardio.org/el/2025-09-02_ο-απομακρυσμένος-έλεγχος-κολπικής-μαρμαρυγής-στην-πρωτοβάθμια-φροντίδα-με-τη-χρήση-επιθέματος-ηκγ-δείχνει-μ/
https://gpcardio.org/el/2025-09-05_μειώσεις-της-αρτηριακής-πίεσης-με-baxdrostat-σε-ασθενείς-με-ανεξέλεγκτη-ή-ανθεκτική-υπέρταση/
https://gpcardio.org/el/2025-09-09_επίδραση-του-σακχαρώδη-διαβήτη-τύπου-2-στις-επιδράσεις-της-τιρζεπατίδης-σε-ασθενείς-με-καρδιακή-ανεπάρκεια-μ/
https://gpcardio.org/el/2025-09-11_νέα-καθοδήγηση-συνιστά-μια-νέα-προσέγγιση-για-την-εκτίμηση-του-καρδιαγγειακού-κινδύνου-και-την-επίτευξη-θερ/
https://gpcardio.org/el/2025-09-11_πολυτομεακή-αποκατάσταση-για-ηλικιωμένους-ασθενείς-με-έμφραγμα-του-μυοκαρδίου/
https://gpcardio.org/el/2025-09-13_β-αναστολείς-μετά-από-έμφραγμα-του-μυοκαρδίου-με-ήπια-μειωμένο-κλάσμα-εξώθησης/
https://gpcardio.org/el/2025-09-16_2025-aha-acc-guideline-for-the-prevention-detection-evaluation-and-management-of-high-blood-pressure-in-adults/
https://gpcardio.org/el/2025-09-16_αντιμετώπιση-των-διαρκών-καρδιαγγειακών-επιπτώσεων-της-covid-19-νέα-καθοδήγηση-για-την-πρωτοβάθμια-φροντίδα/
https://gpcardio.org/el/2025-09-18_ορφογλιπρόνη-ένας-από-του-στόματος-αγωνιστής-υποδοχέων-glp-1-μικρού-μορίου-στον-πρώιμο-σακχαρώδη-διαβήτη-τύπο/
https://gpcardio.org/el/2025-09-20_επίδραση-της-εβολοκουμάμπης-στη-βατότητα-του-μοσχεύματος-φλέβας-σαφηνούς-μετά-από-χειρουργική-επέμβαση-στε/
https://gpcardio.org/el/2025-09-21_εισαγωγή-και-ο-αντίκτυπος-της-cmr-στους-ασθενείς-και-τα-συστήματα-υγείας/
https://gpcardio.org/el/2025-09-24_βασικές-αλλαγές-στην-κλινική-καθοδήγηση-για-τη-διαχείριση-της-αρτηριακής-πίεσης-και-των-λιπιδίων/
https://gpcardio.org/el/2025-09-25_διγιτοξίνη-σε-ασθενείς-με-καρδιακή-ανεπάρκεια-και-μειωμένο-κλάσμα-εξώθησης/
https://gpcardio.org/el/2025-09-28_γιατί-είναι-σημαντικό-να-αναγνωρίζεται-και-να-αντιμετωπίζεται-η-χρόνια-νεφρική-νόσος-ckd/
https://gpcardio.org/el/2025-10-01_2025-aha-acc-guideline-for-the-prevention-detection-evaluation-and-management-of-high-blood-pressure-in-adults/
https://gpcardio.org/el/2025-10-01_ανακούφιση-της-πνευμονικής-συμφόρησης-με-προσθήκη-δαπαγλιφλοζίνης-σε-ενδοφλέβιο-διουρητικό-αγκύλης-σε-ασθε/
https://gpcardio.org/el/2025-10-01_καμία-τεκμηρίωση-δεν-υποστηρίζει-τη-χρήση-βιταμινών-ή-συμπληρωμάτων-για-τη-μείωση-της-ldl-χοληστερόλης-και-το/
https://gpcardio.org/el/2025-10-07_απόφραξη-του-ωτίου-του-αριστερού-κόλπου-σε-ασθενείς-με-νεφρική-νόσο-τελικού-σταδίου/
https://gpcardio.org/el/2025-10-07_επίδραση-της-ομπισετραπίμπης-στα-σοβαρά-ανεπιθύμητα-καρδιαγγειακά-επεισόδια-σε-ασθενείς-υψηλού-κινδύνου/
https://gpcardio.org/el/2025-10-07_η-σχέση-μεταξύ-παχυσαρκίας-και-χρόνιας-νεφρικής-νόσου/
https://gpcardio.org/el/2025-10-09_αποτελεσματικότητα-και-ασφάλεια-της-μπαξδροστάτης-στην-ανεξέλεγκτη-και-ανθεκτική-στη-θεραπεία-υπέρταση/
https://gpcardio.org/el/2025-10-14_μακροχρόνια-διακοπή-της-αντιπηκτικής-αγωγής-μετά-από-κατάλυση-με-καθετήρα-για-κολπική-μαρμαρυγή/
https://gpcardio.org/el/2025-10-14_χορήγηση-ηπαρίνης-κατά-την-πρώτη-ιατρική-επαφή-έναντι-αμέσως-πριν-από-την-πρωτογενή-διαδερμική-στεφανιαία-ε/
https://gpcardio.org/el/2025-10-23_ασπιρίνη-σε-ασθενείς-με-χρόνιο-στεφανιαίο-σύνδρομο-που-λαμβάνουν-από-του-στόματος-αντιπηκτική-αγωγή/
https://gpcardio.org/el/2025-10-27_γεφυρώνοντας-την-ευαισθητοποίηση-για-την-καρδιά-και-το-εγκεφαλικό-επεισόδιο-πιο-δυνατοί-μαζί/
https://gpcardio.org/el/2025-10-27_διακαθετηριακή-ή-χειρουργική-αντικατάσταση-αορτικής-βαλβίδας-σε-ασθενείς-χαμηλού-κινδύνου-στα-7-έτη/
https://gpcardio.org/el/2025-10-28_άμεση-ή-καθυστερημένη-pci-της-μη-υπεύθυνης-βλάβης-σε-έμφραγμα-του-μυοκαρδίου/
https://gpcardio.org/el/2025-10-28_εντατικός-έλεγχος-της-αρτηριακής-πίεσης-σε-ηλικιωμένους-ασθενείς-με-υπέρταση/
https://gpcardio.org/el/2025-10-28_επίδραση-του-εντατικού-ελέγχου-της-αρτηριακής-πίεσης-στο-εγκεφαλικό-επεισόδιο/
https://gpcardio.org/el/2025-11-01_ασφάλεια-της-αναστολής-του-παράγοντα-xi-με-αμπελασιμάμπη-στην-κολπική-μαρμαρυγή-ανάλογα-με-τη-νεφρική-λειτου/
https://gpcardio.org/el/2025-11-04_2025-aha-acc-guideline-for-the-prevention-detection-evaluation-and-management-of-high-blood-pressure-in-adults/
https://gpcardio.org/el/2025-11-06_ορφογλιπρόνη-ένας-από-του-στόματος-αγωνιστής-υποδοχέων-glp-1-μικρού-μορίου-για-τη-θεραπεία-της-παχυσαρκίας/
https://gpcardio.org/el/2025-11-09_αναστολέας-pcsk9-προλαμβάνει-το-πρώτο-έμφραγμα-ή-εγκεφαλικό-επεισόδιο-σε-ασθενείς-υψηλού-κινδύνου/
https://gpcardio.org/el/2025-11-10_εμβόλιο-γρίπης-υψηλής-δόσης-έναντι-τυπικής-δόσης-και-καρδιαγγειακά-αποτελέσματα-σε-ηλικιωμένους-ενήλικες/
https://gpcardio.org/el/2025-11-11_decaf-ένα-φλιτζάνι-καφέ-την-ημέρα-θα-μπορούσε-να-εμποδίσει-την-υποτροπή-της-κολπικής-μαρμαρυγής/
https://gpcardio.org/el/2025-11-13_β-αναστολείς-μετά-από-έμφραγμα-του-μυοκαρδίου-σε-ασθενείς-χωρίς-καρδιακή-ανεπάρκεια/
https://gpcardio.org/el/2025-11-13_β-αναστολείς-μετά-από-έμφραγμα-του-μυοκαρδίου-χωρίς-μειωμένο-κλάσμα-εξώθησης/
https://gpcardio.org/el/2025-11-18_επιστημονική-δήλωση-του-acc-2025-σχετικά-με-τη-διαχείριση-της-παχυσαρκίας-σε-ενήλικες-με-καρδιακή-ανεπάρκεια/
https://gpcardio.org/el/2025-11-18_καρδιαγγειακές-επιδράσεις-και-ανεκτικότητα-των-αγωνιστών-του-υποδοχέα-glp-1/
https://gpcardio.org/el/2025-11-18_νταπαγλιφλοζίνη-σε-ασθενείς-νοσηλευόμενους-λόγω-καρδιακής-ανεπάρκειας/
https://gpcardio.org/el/2025-11-21_το-συμβούλιο-της-epccs-λανσάρει-την-gpcardio-ως-δέσμευση-για-την-υποστήριξη-της-πρωτοβάθμιας-φροντίδας/
https://gpcardio.org/el/2025-11-25_βαθμολογίες-κινδύνου-abc-af-βασισμένες-σε-βιοδείκτες-για-εξατομικευμένη-θεραπεία-με-στόχο-τη-μείωση-του-εγκεφα/
https://gpcardio.org/el/2025-12-01_μελέτη-επιθετικής-μείωσης-παραγόντων-κινδύνου-στην-κολπική-μαρμαρυγή-επιπτώσεις-στα-αποτελέσματα-της-κατάλ/
https://gpcardio.org/el/2025-12-01_σοβαρή-αιμορραγία-με-απιξαμπάνη-έναντι-ασπιρίνης/
https://gpcardio.org/el/2025-12-13_πλήρης-έναντι-περιοριζόμενης-στην-ένοχη-βλάβη-επαναγγείωσης-στο-οξύ-έμφραγμα-του-μυοκαρδίου-complete-revascularisation-t/
https://gpcardio.org/el/2025-12-16_μακροχρόνια-επίδραση-των-icd-στην-μη-ισχαιμική-καρδιακή-ανεπάρκεια-με-μειωμένο-κλάσμα-εξώθησης/
https://gpcardio.org/el/2025-12-16_φαρμακολογική-θεραπεία-της-καρδιακής-ανεπάρκειας-με-μειωμένο-κλάσμα-εξώθησης/
https://gpcardio.org/el/2025-12-18_improve-dice-μια-δίμερης-ανοιχτής-επισήμανσης-δοκιμή-φάσης-2a-που-αξιολογεί-την-ασφάλεια-και-την-αποτελεσματικότητ/
https://gpcardio.org/el/2025-12-18_καρδιαγγειακά-αποτελέσματα-με-τιρζεπατίδη-έναντι-δουλαγλουτίδης-στον-σακχαρώδη-διαβήτη-τύπου-2/
https://gpcardio.org/el/2025-12-18_κατευθυντήρια-οδηγία-acc-aha-2025-για-τη-διαχείριση-ενηλίκων-με-συγγενή-καρδιοπάθεια/
https://gpcardio.org/el/2025-12-19_η-εε-ξεκινά-το-φιλόδοξο-safe-hearts-plan-έναν-νέο-οδικό-χάρτη-για-την-καρδιαγγειακή-υγεία/
https://gpcardio.org/el/2025-12-20_ορφογλιπρόνη-ένας-από-του-στόματος-αγωνιστής-του-υποδοχέα-glp-1-μικρού-μορίου-για-τη-θεραπεία-της-παχυσαρκίας/
https://gpcardio.org/el/2025-12-23_βραχυπρόθεσμη-αντιπηκτική-αγωγή-έναντι-διπλής-αντιαιμοπεταλιακής-αγωγής-για-την-πρόληψη-της-θρόμβωσης-της/
https://gpcardio.org/el/2026-01-06_ο-που-εκδίδει-παγκόσμια-κατευθυντήρια-οδηγία-για-τη-χρήση-φαρμάκων-glp-1-στη-θεραπεία-της-παχυσαρκίας/
https://gpcardio.org/el/2026-01-06_ψώνια-τροφίμων-τύπου-dash-και-επιδράσεις-στην-αρτηριακή-πίεση/
https://gpcardio.org/el/2026-01-07_τα-cxcr6-τ-κύτταρα-οδηγούν-στη-μυοκαρδίτιδα-από-αναστολείς-ανοσολογικού-σημείου-ελέγχου/
https://gpcardio.org/el/2026-01-10_η-νικοτίνη-και-το-καρδιαγγειακό-σύστημα-βασικές-γνώσεις-για-την-πρωτοβάθμια-φροντίδα/
https://gpcardio.org/el/2026-01-12_αποτελεσματικότητα-και-ασφάλεια-της-θεραπείας-με-χαμηλές-δόσεις-σπιρονολακτόνης-σε-ασθενείς-με-πρωτοπαθή-υ/
https://gpcardio.org/el/2026-01-13_αποτελεσματικότητα-και-ασφάλεια-του-από-του-στόματος-αναστολέα-pcsk9-ενλισιτίδης-σε-ενήλικες-με-ετερόζυγη-οικ/
https://gpcardio.org/el/2026-01-14_αγωνιστές-υποδοχέα-τύπου-γλυκαγόνης-και-φάρμακα-νέας-γενιάς-βασισμένα-σε-ινκρετίνες/
https://gpcardio.org/el/2026-01-15_κοινωνικοοικονομικά-και-δομικά-εμπόδια-στην-αντιμετώπιση-της-παχυσαρκίας-στις-κοινότητες/
https://gpcardio.org/el/2026-01-19_το-εγκεφαλικό-επεισόδιο-αναγνωρίστηκε-ως-η-δεύτερη-κύρια-αιτία-θανάτου-από-καρδιαγγειακή-νόσο-και-σημαντικό/
https://gpcardio.org/el/2026-01-20_αναστολείς-sglt2-και-νεφρικά-αποτελέσματα-ανά-ρυθμό-σπειραματικής-διήθησης-και-λευκωματουρία/
https://gpcardio.org/el/2026-01-20_περιβαλλοντικοί-στρεσογόνοι-παράγοντες-και-καρδιαγγειακή-υγεία/
https://gpcardio.org/el/2026-01-20_τριπλή-έναντι-διπλής-υπολιπιδαιμικής-θεραπείας-στο-οξύ-στεφανιαίο-σύνδρομο/
https://gpcardio.org/el/2026-01-21_στατιστικά-στοιχεία-καρδιακών-παθήσεων-και-εγκεφαλικού-επεισοδίου-2026/
https://gpcardio.org/el/2026-01-22_αντιθρομβωτική-θεραπεία-μετά-από-επιτυχή-κατάλυση-με-καθετήρα-για-κολπική-μαρμαρυγή/
https://gpcardio.org/el/2026-01-22_υπεύθυνη-διαχείριση-φαρμάκων-για-αναστολείς-ras-και-αναστολείς-sglt2-στη-χρόνια-νεφρική-νόσο/
https://gpcardio.org/el/2026-01-27_κολχικίνη-στα-οξέα-στεφανιαία-σύνδρομα/
https://gpcardio.org/el/2026-01-27_μονοθεραπεία-με-ισχυρό-αναστολέα-p2y12-έναντι-dapt-μετά-από-pci-σε-ασθενείς-με-και-χωρίς-stemi/
https://gpcardio.org/el/2026-01-28_κατευθυντήρια-οδηγία-κλινικής-πρακτικής-kdigo-2026-για-την-αναιμία-στη-χρόνια-νεφρική-νόσο-ckd/
https://gpcardio.org/el/2026-01-29_διαχείριση-καθοδηγούμενη-από-πολυκλαδική-ομάδα-της-σοβαρής-στένωσης-της-αορτικής-βαλβίδας/
https://gpcardio.org/el/2026-01-29_επιβάρυνση-συμπτωμάτων-και-δευτερογενής-πρόληψη-σε-ασθενείς-με-συστολική-δυσλειτουργία-της-αριστερής-κοιλί/
https://gpcardio.org/el/2026-01-29_ολεζαρσένη-για-τη-διαχείριση-της-σοβαρής-υπερτριγλυκεριδαιμίας-και-του-κινδύνου-παγκρεατίτιδας/
https://gpcardio.org/el/2026-01-29_φορτίο-προπόνησης-προερχόμενο-από-φορητές-συσκευές-και-στεφανιαία-αθηροσκλήρωση-σε-αθλητές-μέσης-και-μεγαλ/
https://gpcardio.org/el/2026-01-30_συστηματικά-εμβολικά-συμβάντα-στην-κολπική-μαρμαρυγή/
https://gpcardio.org/el/2026-02-01_αποτελέσματα-μετά-την-αλλαγή-δοκιμασίας-καρδιακής-τροπονίνης-στο-acs/
https://gpcardio.org/el/2026-02-01_β-αναστολείς-μετά-από-έμφραγμα-του-μυοκαρδίου-σε-ασθενείς-με-διατηρημένο-κλάσμα-εξώθησης/
https://gpcardio.org/el/2026-02-01_η-cagrisema-μειώνει-την-αρτηριακή-πίεση-σε-ενήλικες-με-υπερβαρότητα-ή-παχυσαρκία/
https://gpcardio.org/el/2026-02-01_καρδιαγγειακές-νεφρικές-επιδράσεις-της-νταπαγλιφλοζίνης-σε-ασθενείς-με-καρδιαγγειακό-κίνδυνο-με-ή-χωρίς-σα/
https://gpcardio.org/el/2026-02-01_σεμαγλουτίδη-και-νοσηλείες-σε-ασθενείς-με-παχυσαρκία-και-εγκατεστημένη-καρδιαγγειακή-νόσο/
https://gpcardio.org/el/2026-02-02_χρήση-αναστολέων-sglt2-και-καρδιονεφρικά-αποτελέσματα-στον-σακχαρώδη-διαβήτη-τύπου-2-με-κίρρωση-του-ήπατος/
https://gpcardio.org/el/2026-02-03_η-σεμαγλουτίδη-ως-συμπληρωματική-θεραπεία-στην-κατάλυση-με-καθετήρα-στην-παχυσαρκία-σχετιζόμενη-παροξυσμικ/
https://gpcardio.org/el/2026-02-03_νταπαγλιφλοζίνη-για-τη-μείωση-της-πρώιμης-υποτροπής-μετά-από-κατάλυση-με-καθετήρα-για-κολπική-μαρμαρυγή/
https://gpcardio.org/el/2026-02-03_σεμαγλουτίδη-έναντι-τιρζεπατίδης-σε-ασθενείς-με-παχυσαρκία-και-hfpef/
https://gpcardio.org/el/2026-02-03_σωματική-δραστηριότητα-και-κίνδυνος-ανεπιθύμητων-συμβαμάτων-στην-κολπική-μαρμαρυγή/
https://gpcardio.org/el/2026-02-03_σύγχρονη-διαχείριση-της-κολπικής-μαρμαρυγής-σε-ασθενείς-με-καρκίνο-η-έρευνα-του-2025-της-european-heart-rhythm-association/
https://gpcardio.org/el/2026-02-04_τα-ψηφιακά-στηθοσκόπια-με-ai-υπερτερούν-του-παραδοσιακού-ελέγχου-για-σημαντική-vhd/
https://gpcardio.org/el/2026-02-05_ενδοφλέβια-τενεκτεπλάση-για-οξύ-ισχαιμικό-εγκεφαλικό-επεισόδιο-εντός-24-ωρών-λόγω-απόφραξης-της-βασικής-αρτη/
https://gpcardio.org/el/2026-02-05_εφιμοσφερμίνη-άλφα-bos-580-μία-φορά-τον-μήνα-σε-άτομα-με-στεατοηπατίτιδα-σχετιζόμενη-με-μεταβολική-δυσλειτουργ/
https://gpcardio.org/el/2026-02-05_η-κληρονομική-βάση-της-στεφανιαίας-νόσου/
https://gpcardio.org/el/2026-02-05_μια-ελεγχόμενη-με-εικονικό-φάρμακο-μελέτη-του-από-του-στόματος-αναστολέα-pcsk9-ενλισιτίδης/
https://gpcardio.org/el/2026-02-05_τενεκτεπλάση-έναντι-της-καθιερωμένης-ιατρικής-αγωγής-για-απόφραξη-της-βασικής-αρτηρίας-εντός-24-ωρών-trace-5/
https://gpcardio.org/el/2026-02-06_αγωνιστές-του-υποδοχέα-πεπτιδίου-τύπου-γλυκαγόνης-και-νεφρικά-αποτελέσματα-στην-εποχή-της-εξατομικευμένης/
https://gpcardio.org/el/2026-02-06_η-αντίσταση-στην-ινσουλίνη-διαταράσσει-την-οδό-των-πεντοζοφωσφορικών-και-επηρεάζει-τη-μυοκαρδιακή-ανάκαμψη/
https://gpcardio.org/el/2026-02-06_η-παραλλαγή-rs671-της-αλδεϋδικής-δεϋδρογονάσης-2-ενισχύει-την-ενεργοποίηση-των-αιμοπεταλίων-και-την-αρτηριακή/
https://gpcardio.org/el/2026-02-06_συζητώντας-με-τους-ασθενείς-για-τις-στατίνες-γιατί-τα-περισσότερα-αναφερόμενα-συμπτώματα-δεν-είναι-αιτιώδη/
https://gpcardio.org/el/2026-02-09_στεφανιαία-αθηροσκλήρωση-σε-ασθενείς-με-καρκίνο-και-επιζώντες/
https://gpcardio.org/el/2026-02-10_αξιολόγηση-και-διαχείριση-της-καρδιακής-αμυλοείδωσης-τρανσθυρετίνης/
https://gpcardio.org/el/2026-02-10_αυτόματο-έμφραγμα-του-μυοκαρδίου-μετά-από-επαναγγείωση-του-κύριου-στελέχους/
https://gpcardio.org/el/2026-02-10_κίνδυνοι-νεφρικού-και-ουροθηλιακού-καρκίνου-με-αναστολείς-sglt2-έναντι-αγωνιστών-του-υποδοχέα-glp-1-στον-σακχαρώ/
https://gpcardio.org/el/2026-02-10_κλωνική-αιμοποίηση-και-οι-καρδιαγγειακές-της-επιπτώσεις/
https://gpcardio.org/el/2026-02-10_νέες-φαρμακευτικές-θεραπείες-για-την-υπέρταση/
https://gpcardio.org/el/2026-02-11_βελτίωση-των-αποτελεσμάτων-της-κατάλυσης-κολπικής-μαρμαρυγής-μέσω-ολοκληρωμένων-εξατομικευμένων-παρεμβάσε/
https://gpcardio.org/el/2026-02-11_βερισιγκουάτη-και-θνησιμότητα-στην-καρδιακή-ανεπάρκεια-με-μειωμένο-κλάσμα-εξώθησης/
https://gpcardio.org/el/2026-02-11_δοσολογία-ασπιρίνης-μετά-από-οξύ-στεφανιαίο-σύνδρομο-με-υποψία-αντίστασης-στην-ασπιρίνη/
https://gpcardio.org/el/2026-02-11_κριτήρια-αξιολόγησης-της-προγνωστικής-και-κλινικής-χρησιμότητας-νέων-μοντέλων-βιοδεικτών-και-εργαλείων-για/
https://gpcardio.org/el/2026-02-12_προγνωστική-χρησιμότητα-της-καρδιακής-μαγνητικής-τομογραφίας-αιμάτωσης-υπό-stress-σε-ασθενείς-με-γνωστή-ή-πιθα/
https://gpcardio.org/el/2026-02-12_προοπτικές-συσχετίσεις-της-παχυσαρκίας-και-της-σοβαρότητας-της-παχυσαρκίας-με-9-καρδιαγγειακά-αποτελέσματα/
https://gpcardio.org/el/2026-02-13_χρήση-νεφροπροστατευτικών-φαρμάκων-κατά-τη-γαλουχία/
https://gpcardio.org/el/2026-02-16_νέοι-πλασματικοί-πρωτεωμικοί-δείκτες-και-κίνδυνος-φλεβικής-θρομβοεμβολής/
https://gpcardio.org/el/2026-02-16_πρώιμη-έναντι-όψιμης-αντιπηκτικής-θεραπείας-μετά-από-οξύ-ισχαιμικό-εγκεφαλικό-επεισόδιο-με-κολπική-μαρμαρυ/
https://gpcardio.org/el/2026-02-17_λευκωματουρία-ή-πρωτεϊνουρία-στη-σπειραματική-νόσο-και-τη-ckd-ποια-να-χρησιμοποιηθεί/
https://gpcardio.org/el/2026-02-18_β-αναστολείς-μετά-από-έμφραγμα-του-μυοκαρδίου/
https://gpcardio.org/el/2026-02-18_γονιδιακή-θεραπεία-για-τη-νεφροπαθητική-κυστίνωση/
https://gpcardio.org/el/2026-02-19_δευτερογενής-πρόληψη-μετά-από-ισχαιμικό-εγκεφαλικό-επεισόδιο/
https://gpcardio.org/el/2026-02-19_διακαθετηριακή-ή-χειρουργική-αντικατάσταση-αορτικής-βαλβίδας-σε-ασθενείς-χαμηλού-κινδύνου-στα-7-έτη/
https://gpcardio.org/el/2026-02-19_διαταραχές-αγωγιμότητας-μετά-από-διακαθετηριακή-εμφύτευση-αορτικής-βαλβίδας/
https://gpcardio.org/el/2026-02-19_καρδιαγγειακή-νεφρική-μεταβολική-αλληλεπίδραση-σε-ασθενείς-με-κολπική-μαρμαρυγή-που-λαμβάνουν-άμεσα-από-το/
https://gpcardio.org/el/2026-02-19_κατευθυντήρια-οδηγία-2026-της-aha-acc-για-την-αξιολόγηση-και-τη-διαχείριση-της-οξείας-πνευμονικής-εμβολής-σε-ενήλ/
https://gpcardio.org/el/2026-02-20_βελτιωμένη-πρόβλεψη-κινδύνου-καρδιαγγειακής-νόσου-με-χρήση-ολοκληρωμένων-μοντέλων-μηχανικής-μάθησης/
https://gpcardio.org/el/2026-02-21_πελακαρσένη-και-αφαίρεση-λιποπρωτεΐνης-a-στη-δευτερογενή-πρόληψη/
https://gpcardio.org/el/2026-02-22_κόστος-αποτελεσματικότητα-των-αναστολέων-του-συμμεταφορέα-νατρίου-γλυκόζης-τύπου-2-και-των-αγωνιστών-του-υπ/
https://gpcardio.org/el/2026-02-23_primary-care-adherence-to-heart-failure-guidelines-in-post-discharge-evaluation-routine-management-pathfinder/
https://gpcardio.org/el/2026-02-23_ανοσοπροσρόφηση-στη-διατατική-μυοκαρδιοπάθεια/
https://gpcardio.org/el/2026-02-23_επίδραση-της-σεμαγλουτίδης-στην-covid-19-και-σε-άλλες-λοιμώξεις/
https://gpcardio.org/el/2026-02-23_μείωση-του-κινδύνου-νεφρικής-δυσλειτουργίας-μετά-από-καρδιακή-μεταμόσχευση-και-θεραπευτικές-προσεγγίσεις/
https://gpcardio.org/el/2026-02-23_ο-διαβήτης-αυξάνει-τον-κίνδυνο-καρδιακής-ανεπάρκειας-στη-μυοκαρδίτιδα/
https://gpcardio.org/el/2026-02-23_σωματική-δραστηριότητα-προσδιοριζόμενη-με-επιταχυνσιομετρία-και-ποιότητα-ζωής-στην-υπερτροφική-μυοκαρδιοπ/
https://gpcardio.org/el/2026-02-23_το-έτος-στην-καρδιαγγειακή-ιατρική-2025/
https://gpcardio.org/el/2026-02-24_κίνδυνος-νοσηλείας-για-καρδιακή-ανεπάρκεια-με-αγωνιστές-του-υποδοχέα-glp-1-έναντι-αναστολέων-dpp-4-ή-αναστολέων-s/
https://gpcardio.org/el/2026-02-24_συστηματικά-εμβολικά-συμβάματα-στην-κολπική-μαρμαρυγή/
https://gpcardio.org/el/2026-02-24_υποσιτισμός-και-καχεξία-σε-νοσηλευόμενους-ασθενείς-με-οξείες-καρδιακές-παθήσεις/
https://gpcardio.org/el/2026-02-25_αποτελέσματα-καρδιακής-ανεπάρκειας-με-μειωμένο-ήπια-μειωμένο-ή-διατηρημένο-κλάσμα-εξώθησης/
https://gpcardio.org/el/2026-02-25_πρόβλεψη-του-φορτίου-καρδιαγγειακής-νόσου-και-εγκεφαλικού-επεισοδίου-σε-γυναίκες-στις-ηνωμένες-πολιτείες-έ/
https://gpcardio.org/el/2026-02-25_συνδυασμένες-συσχετίσεις-των-αγωνιστών-του-υποδοχέα-glp-1-και-ενός-υγιεινού-τρόπου-ζωής-με-τα-καρδιαγγειακά-απ/
https://gpcardio.org/el/2026-02-25_χαμηλή-δόση-ριβαροξαμπάνης-για-την-πρόληψη-της-θρόμβωσης-αριστερής-κοιλίας-μετά-από-πρόσθιο-έμφραγμα-του-μυ/
https://gpcardio.org/el/2026-02-26_εντατικός-έλεγχος-αρτηριακής-πίεσης-και-γνωστική-λειτουργία/
https://gpcardio.org/el/2026-02-27_αναστολή-sglt2-σε-ασθενείς-με-σακχαρώδη-διαβήτη-τύπου-2-και-ckd-που-εμφανίζουν-επιδείνωση-του-εκτιμώμενου-ρυθμού/
https://gpcardio.org/el/2026-02-27_μετάβαση-από-τη-βαρφαρίνη-σε-άμεσα-από-του-στόματος-αντιπηκτικά-σε-ευπαθείς-ηλικιωμένους-ασιάτες-ασθενείς-μ/
https://gpcardio.org/el/2026-02-27_προσθετικά-καρδιονεφρικά-οφέλη-της-συνδυαστικής-θεραπείας-φινερενόνης-και-αναστολέα-sglt2-στη-διαβητική-ckd/
https://gpcardio.org/el/2026-02-27_το-φορτίο-μακροφάγων-καρωτιδικής-πλάκας-και-οι-φλεγμονώδεις-δείκτες-μακροφάγων-που-σχετίζονται-με-λιπίδια-π/
https://gpcardio.org/el/2026-02-28_καρδιακή-ανεπάρκεια-στους-ηλικιωμένους/
https://gpcardio.org/el/2026-03-01_journal-club/
https://gpcardio.org/el/2026-03-01_αμπελασιμάμπη-έναντι-ριβαροξαμπάνης-σε-ηλικιωμένα-άτομα-με-κολπική-μαρμαρυγή/
https://gpcardio.org/el/2026-03-01_εμβολιασμός-υψηλής-δόσης-κατά-της-γρίπης-στην-αθηροσκληρωτική-καρδιαγγειακή-νόσο/
https://gpcardio.org/el/2026-03-01_εξαετή-αποτελέσματα-μετά-από-διακαθετηριακή-έναντι-χειρουργικής-αντικατάστασης-αορτικής-βαλβίδας-σε-ασθεν/
https://gpcardio.org/el/2026-03-01_επίδραση-της-πρώιμης-καθυστερημένης-ή-διακοπείσας-θεραπείας-σε-παιδιά-με-οικογενή-υπερχοληστερολαιμία/
https://gpcardio.org/el/2026-03-01_επίδραση-του-baduanjin-στην-αρτηριακή-πίεση-σε-άτομα-με-υψηλή-φυσιολογική-αρτηριακή-πίεση/
https://gpcardio.org/el/2026-03-01_κάποια-πολύ-αναγκαία-confidence-για-την-καταπολέμηση-του-παραδόξου-κινδύνου-θεραπείας-στη-χρόνια-νεφρική-νόσο/
https://gpcardio.org/el/2026-03-01_καρδιακός-έλεγχος-για-παθήσεις-που-σχετίζονται-με-τον-αιφνίδιο-καρδιακό-θάνατο/
https://gpcardio.org/el/2026-03-01_καρδιακός-έλεγχος-σε-νέους/
https://gpcardio.org/el/2026-03-01_κατευθυντήρια-οδηγία-2026-για-την-οξεία-πνευμονική-εμβολή-με-μια-ματιά/
https://gpcardio.org/el/2026-03-01_σύγκριση-των-αλγορίθμων-0-1-ώρας-της-european-society-of-cardiology-και-της-υψηλής-ευαισθησίας-τροπονίνης-στην-αξιολόγηση-α/
https://gpcardio.org/el/2026-03-01_χρονισμός-των-καρδιαγγειακών-και-νεφρικών-οφελών-της-φινερενόνης-στην-καρδιακή-ανεπάρκεια-και-τη-χρόνια-νεφ/
https://gpcardio.org/el/2026-03-02_ο-νυχτερινός-θόρυβος-της-οδικής-κυκλοφορίας-καταπονεί-την-καρδιά-και-τα-αιμοφόρα-αγγεία/
https://gpcardio.org/el/2026-03-02_χειρότερο-προφίλ-κινδύνου-αριθμός-μοσχευμάτων-και-ενδονοσοκομειακός-θάνατος-αλλά-αποδεκτή-όψιμη-επιβίωση-σ/
https://gpcardio.org/el/2026-03-03_γονιδιακή-θεραπεία-επεξεργασίας-βάσεων-in-vivo-για-ετερόζυγη-οικογενή-υπερχοληστερολαιμία/
https://gpcardio.org/el/2026-03-03_επεμβατική-αιμοδυναμική-επικύρωση-ενός-εργαλείου-ηχοκαρδιογραφίας-τεχνητής-νοημοσύνης-για-την-ανίχνευση-κ/
https://gpcardio.org/el/2026-03-03_ποσοτικοποίηση-του-ενεργειακού-μεταβολισμού-των-σκελετικών-μυών-κατά-τη-διάρκεια-άσκησης-σε-καρδιακή-ανεπά/
https://gpcardio.org/el/2026-03-04_αλληλεπίδραση-ηλικίας-και-φύλου-με-την-κλινική-και-περιπατητική-αρτηριακή-πίεση-και-τη-θνησιμότητα/
https://gpcardio.org/el/2026-03-04_ασπιρίνη-μετά-από-pci-σε-οξέα-στεφανιαία-σύνδρομα/
https://gpcardio.org/el/2026-03-04_στόχοι-αρτηριακής-πίεσης-στη-διαχείριση-της-υπέρτασης/
https://gpcardio.org/el/2026-03-04_φινερενόνη-για-τη-διαβητική-νεφρική-νόσο-στον-διαβήτη-τύπου-1-μια-επαρκής-απάντηση/
https://gpcardio.org/el/2026-03-05_άμεσης-δράσης-από-του-στόματος-αντιπηκτικό-ή-ανταγωνιστής-της-βιταμίνης-κ-για-τον-εύθραυστο-ηλικιωμένο-ασθε/
https://gpcardio.org/el/2026-03-05_ο-από-του-στόματος-αναστολέας-pcsk9-ενλισιτίδη-μειώνει-τα-επίπεδα-χοληστερόλης-ldl-σε-δοκιμή-φάσης-2/
https://gpcardio.org/el/2026-03-05_σεμαγλουτίδη-στην-περιφερική-αρτηριακή-νόσο-και-τον-διαβήτη-ανά-αρχική-βαρύτητα-νόσου-και-ηλικία/
https://gpcardio.org/el/2026-03-05_φινερενόνη-στον-διαβήτη-τύπου-1-και-τη-χρόνια-νεφρική-νόσο/
https://gpcardio.org/el/2026-03-06_νεφρική-νόσος-και-καρδιακή-ανεπάρκεια/
https://gpcardio.org/el/2026-03-07_επίδραση-της-βαξντροστάτης-στην-περιπατητική-αρτηριακή-πίεση-σε-ασθενείς-με-ανθεκτική-υπέρταση-bax24/
https://gpcardio.org/el/2026-03-07_επίδραση-του-baxdrostat-στην-αρτηριακή-πίεση-σε-ασθενείς-με-ανθεκτική-υπέρταση-bax24/
https://gpcardio.org/el/2026-03-07_κολπική-μαρμαρυγή/
https://gpcardio.org/el/2026-03-09_δ-differences-en-la-trayectoria-de-la-enfermedad-comorbilidades-y-mortalidad-en-la-miocardiopatia-hipertrofica-sarcomerica-y-no-sarcomerica/
https://gpcardio.org/el/2026-03-09_στόχοι-και-θεραπείες-για-τη-διαχείριση-της-ldl-c-στην-πρωτοβάθμια-φροντίδα/
https://gpcardio.org/el/2026-03-09_το-σεμαγλουτίδη-προάγει-τη-ροή-προγονικών-κυττάρων-που-προέρχονται-από-τον-μυελό-των-οστών-προς-ένα-αντιφλεγ/
https://gpcardio.org/el/2026-03-10_lp-a-ήρθε-η-ώρα-να-αρχίσουμε-τη-μέτρησή-του-στην-πρωτοβάθμια-φροντίδα/
https://gpcardio.org/el/2026-03-10_γενετικός-έλεγχος-για-fh-σκεπτικό-και-εμπειρία/
https://gpcardio.org/el/2026-03-11_τριγλυκερίδια-δείκτης-κινδύνου-ή-στόχος-για-τον-καρδιαγγειακό-κίνδυνο/
https://gpcardio.org/el/2026-03-12_καρδιαγγειακός-μεταβολικός-κίνδυνος-στην-εμμηνόπαυση/
https://gpcardio.org/el/2026-03-12_κατευθυντήριες-οδηγίες-της-esc-για-την-cvd-και-την-ψυχική-υγεία-στην-πρωτοβάθμια-φροντίδα/
https://gpcardio.org/el/2026-03-12_υπερδοσολογία-εκτός-ενδείξεων-αντιθρομβωτικής-θεραπείας-με-εδοξαβάνη-σε-ασθενείς-με-κολπική-μαρμαρυγή-και/
https://gpcardio.org/el/2026-03-13_διαχείριση-δυσχερώς-ελεγχόμενης-υπέρτασης-και-τι-νέο-υπάρχει/
https://gpcardio.org/el/2026-03-13_η-ανάγκη-συμμετοχής-των-γενικών-ιατρών-στον-κόσμο-της-υπεράσπισης-συμφερόντων/
https://gpcardio.org/el/2026-03-13_καρδιακή-ανεπάρκεια-στην-πρωτοβάθμια-φροντίδα-πρώιμη-αναγνώριση-και-έναρξη-gdmt/
https://gpcardio.org/el/2026-03-13_κατευθυντήρια-οδηγία-acc-aha-2026-για-τη-διαχείριση-της-δυσλιπιδαιμίας/
https://gpcardio.org/el/2026-03-14_ο-παλμός-της-πρωτοβάθμιας-φροντίδας-σύνοδος-κορυφής-epccs-2026/
https://gpcardio.org/el/2026-03-16_χρήση-της-βαθμολογίας-ασβεστίου-στεφανιαίων-αρτηριών-σε-άτομα-με-αυξημένη-λιποπρωτεΐνη-a/
https://gpcardio.org/el/2026-03-20_ιστορικό-μακροχρόνιων-δυσμενών-αποτελεσμάτων-εγκυμοσύνης-και-καρδιαγγειακός-κίνδυνος/
https://gpcardio.org/el/2026-03-20_ο-αντίκτυπος-των-κατευθυντήριων-οδηγιών-της-epccs-στη-φαρμακοθεραπεία-στην-ουκρανία/
https://gpcardio.org/el/2026-03-20_πραγματική-κλινική-εμπειρία-με-dapagliflozin-σε-καρδιακή-ανεπάρκεια-με-μειωμένο-κλάσμα-εκροής-στην-κεντρική-και-αν/
https://gpcardio.org/el/2026-03-22_έλεγχος-για-cvd-στην-ελλάδα/
https://gpcardio.org/el/2026-03-22_διαχείριση-του-καρδιαγγειακού-κινδύνου-στην-πολωνία/
https://gpcardio.org/el/2026-03-22_ενημέρωση-κατευθυντήριων-οδηγιών-υπέρτασης-στην-τουρκία/
https://gpcardio.org/el/2026-03-23_φαρμακευτική-θεραπεία-κατευθυνόμενη-από-κατευθυντήριες-οδηγίες-στην-ckd-ο-καθοριστικός-ρόλος-της-πρωτοβάθμι/
https://gpcardio.org/el/2026-03-24_έλεγχος-διαστρωμάτωση-κινδύνου-στην-ckd-ο-καθοριστικός-ρόλος-της-πρωτοβάθμιας-φροντίδας/
https://gpcardio.org/el/2026-03-24_δείκτης-τριγλυκεριδίων-γλυκόζης-και-θνητότητα-σε-κριτικά-ασθενείς-με-καρδιαγγειακό-νεφρικό-μεταβολικό-σύνδ/
https://gpcardio.org/el/2026-03-24_διαχείριση-της-ckd-στην-πρωτοβάθμια-φροντίδα/
https://gpcardio.org/el/2026-03-24_συστηματική-φλεγμονή-και-υποτροπή-μετά-από-αγγειακό-εγκεφαλικό-επεισόδιο-σχετιζόμενο-με-κολπική-μαρμαρυγή/
https://gpcardio.org/el/2026-03-25_διαχείριση-των-αγωνιστών-των-υποδοχέων-γλυκαγόνης-όπως-πεπτιδίου-1-και-των-αναστολέων-του-μεταφορέα-γλυκόζη/
https://gpcardio.org/el/2026-03-25_κληρονομικότητα-και-καρδιαγγειακή-νόσος-στην-ενήλικη-απόγονο-γυναικών-με-υπέρταση-της-κύησης/
https://gpcardio.org/el/2026-03-25_ο-ρόλος-της-απεικόνισης-με-δοκιμασία-πρόκλησης-και-άσκησης-για-την-ταυτοποίηση-υποψηφίων-για-αναστολείς-της/
https://gpcardio.org/el/2026-03-26_θεραπεία-επεξεργασίας-γονιδίων-σε-καρδιαγγειακή-νόσο/
https://gpcardio.org/el/2026-03-26_κλείσιμο-της-αριστερής-κολπικής-παραφυλάσιου-ή-ιατρική-θεραπεία-στην-κολπική-μαρμαρυγή/
https://gpcardio.org/el/2026-03-26_νέοι-μηχανισμοί-καρδιαγγειακών-μεταβολικών-παραγόντων-κινδύνου-και-θεραπευτικές-ευκαιρίες/
https://gpcardio.org/el/2026-03-26_υπογραφή-της-γηρασμένης-παχυσαρκίας-στον-καρκίνο-του-μαστού/
https://gpcardio.org/el/2026-03-27_βαθιά-ενδοτυποποίηση-της-νεφρικής-βλάβης-στον-διαβήτη-τύπου-2/
https://gpcardio.org/el/2026-03-27_βελτιστοποίηση-των-ορίων-ένταξης-nt-probnp-για-τυχαίες-κλινικές-μελέτες-στην-καρδιακή-ανεπάρκεια/
https://gpcardio.org/el/2026-03-27_νεφρική-νόσος/
https://gpcardio.org/el/2026-03-28_σύνδρομο-έλλειψης-καναλιού-απελευθέρωσης-ασβεστίου-σε-ασθενείς-με-διαγνωσμένη-ιδιοπαθή-κοιλιακή-μαρμαρυγή/
https://gpcardio.org/el/2026-03-29_έντονος-στοχευμένος-έλεγχος-της-χοληστερόλης-λιποπρωτεϊνών-χαμηλής-πυκνότητας-σε-ασθενείς-με-αθηροσκληρωτ/
https://gpcardio.org/el/2026-03-29_η-εβολοκουμάβη-μειώνει-κατά-31-τον-κίνδυνο-για-πρώτο-σοβαρό-καρδιαγγειακό-συμβάν-σε-ασθενείς-χωρίς-σημαντική/
https://gpcardio.org/el/2026-03-29_κλείσιμο-της-αριστερής-κολπικής-παραφυσης-ή-αντιπηξιαγωγή-για-κολπική-μαρμαρυγή/
https://gpcardio.org/el/2026-03-29_υπερηχογραφικά-διευκολυνόμενη-καθετηριακά-κατευθυνόμενη-ινολυτική-αγωγή-για-οξεία-πνευμονική-εμβολή/
https://gpcardio.org/el/2026-03-30_η-μελέτη-των-επιδράσεων-της-λιραγλουτίδης-στην-κολπική-μαρμαρυγή-leaf/
https://gpcardio.org/el/2026-04-10_το-ευρωπαϊκό-έργο-nextgen-προωθεί-την-εξατομικευμένη-καρδιολογία-ενσωματώνοντας-γονιδιωματικά-και-κλινικά-δεδ/
https://gpcardio.org/el/2026-04-15_η-καρδιακή-ανεπάρκεια-είναι-συχνή-σε-άτομα-με-κολπική-μαρμαρυγή-που-ανιχνεύεται-κατά-τον-έλεγχο/
https://gpcardio.org/el/2026-04-17_εβολοκουμάμπη-για-τη-μείωση-του-πρώτου-κύριου-καρδιαγγειακού-γεγονότος-σε-ασθενείς-χωρίς-γνωστή-σημαντική-α/
https://gpcardio.org/el/2026-04-17_οξείες-μεταβολές-της-εκροής-σφαιρινοειδούς-και-η-μεσολάβησή-τους-στη-μείωση-της-αλβουμινουρίας-με-εμπαραγλι/
https://gpcardio.org/el/2026-04-17_όγκος-έναντι-έντασης-της-σωματικής-δραστηριότητας-και-κίνδυνος-καρδιαγγειακών-και-μη-καρδιαγγειακών-χρόνιω/
https://gpcardio.org/el/2026-04-18_αγωνιστές-υποδοχέων-ομοίων-με-το-γλυκαγόνο-πεπτιδίου-1-για-την-πρόληψη-επεισοδίων-καρδιακής-ανεπάρκειας-σε-δ/
https://gpcardio.org/el/2026-04-18_λιποπρωτεΐνη-a-και-περιστατικά-φλεβοθρομβοεμβολισμού-σε-προ-και-μεταεμμηνοπαυσιακές-γυναίκες-καθώς-και-σε-ά/
https://gpcardio.org/el/2026-04-18_φύλο-σε-καρδιαγγειακό-νεφρομεταβολικό-σύνδρομο/
https://gpcardio.org/el/2026-04-19_επίδραση-των-γενετικών-εξετάσεων-σε-ασθενείς-με-οικογενή-υπερχοληστερολαιμία-στα-καρδιαγγειακά-συμβάντα-η/
https://gpcardio.org/el/2026-04-20_η-lp-a-έχει-συγκεκριμένες-επιπτώσεις-στη-στεφανιαία-νόσο-ανεξάρτητα-από-το-ldl-c/
https://gpcardio.org/el/2026-04-21_φορητές-συσκευές-και-καρδιαγγειακή-υγεία/
https://gpcardio.org/el/2026-04-22_κατευθυντήρια-οδηγία-acc-aha-aacvpr-abc-acpm-ada-ags-apha-aspc-nla-pcna-για-τη-διαχείριση-της-δυσλιπιδαιμίας/
https://gpcardio.org/el/2026-04-22_μεμαντίνη-για-πρόωρες-προκοιλιακές-συστολές/
https://gpcardio.org/el/2026-04-22_προνοσοκομειακή-χορήγηση-ηπαρίνης-σε-ασθενείς-με-μυεσς-που-υποβάλλονται-σε-πρωτογενή-pci/
https://gpcardio.org/el/2026-04-23_επίδραση-της-αναστολής-του-apoc3-με-ολεζάρσηνη-στη-στεφανιαία-αθηροσκλήρωση/
https://gpcardio.org/el/2026-04-23_χαμηλή-δόση-ριβαροξαμπάνης-για-την-πρόληψη-της-θρόμβωσης-της-αριστερής-κοιλίας-μετά-από-πρόσθιο-έμφραγμα-το/
https://gpcardio.org/el/2026-04-24_διατροφικές-κατευθυντήριες-οδηγίες-2026-για-τη-βελτίωση-της-καρδιαγγειακής-υγείας/
https://gpcardio.org/el/2026-04-24_δύο-δοκιμές-που-συγκρίνουν-την-πακycling-του-συστήματος-αγωγής-και-την-διενεργητική-πακycling/
https://gpcardio.org/el/2026-04-24_στάδια-καρδιαγγειακού-νεφρικού-μεταβολικού-συνδρόμου-ηχοκαρδιογραφικά-χαρακτηριστικά-και-κίνδυνος-καρδια/
https://gpcardio.org/el/2026-04-25_sotatercept-για-τη-συνδυασμένη-μετα-και-προτριχοειδή-πνευμονική-υπέρταση-που-σχετίζεται-με-καρδιακή-ανεπάρκεια/
https://gpcardio.org/el/2026-04-25_ο-ρόλος-της-υποστήριξης-κοιλιακού-βηματοδότη-στην-καρδιακή-αναχρονιστική-θεραπεία/
https://gpcardio.org/el/2026-04-26_αξιολόγηση-του-μακροπρόθεσμου-κινδύνου-καρδιαγγειακής-νόσου-κατά-την-εγκυμοσύνη/
https://gpcardio.org/el/2026-04-27_αυτόματη-ηχοκαρδιογραφική-ανίχνευση-συγγενών-καρδιοπαθειών-με-τη-χρήση-τεχνητής-νοημοσύνης/
https://gpcardio.org/el/2026-04-28_πρόληψη-πρώιμων-αθηρωμάτων/
https://gpcardio.org/el/2026-04-30_τρεις-αντιυπερτασικούς-παράγοντες-σε-χαμηλή-δόση-σε-ένα-μονό-χάπι-μετά-από-ενδοεγκεφαλική-αιμορραγία/
https://gpcardio.org/el/2026-05-01_στερεοτακτική-ραδιοαβλαστική-θεραπεία-για-την-ανθεκτική-κοιλιακή-ταχυκαρδία/
https://gpcardio.org/el/2026-05-02_αποκλεισμός-του-συστήματος-raas-στο-νεφρό-κατά-τη-διάρκεια-του-κύκλου-ζωής-πρότυπη-θεραπεία/
https://gpcardio.org/el/2026-05-03_μη-επεμβατικός-καρδιαγγειακός-έλεγχος-με-πολλαπλές-απεικονιστικές-μεθόδους-και-αποτελέσματα-ειδικά-για-το/
https://gpcardio.org/el/2026-05-04_συνέχιση-έναντι-διακοπής-της-θεραπείας-με-άμεσα-στοματικά-αντιπηκτικά-μετά-από-αγγειακό-εγκεφαλικό-επεισόδ/
https://gpcardio.org/el/2026-05-05_εκτεταμένος-χρόνος-διακοπής-της-θεραπείας-σχετικός-με-την-εγκυμοσύνη-σε-γυναίκες-με-οικογενή-υπερχοληστερο/
https://gpcardio.org/el/2026-05-05_φυλοδιαφορές-στη-φαρμακολογική-θεραπεία-της-καρδιακής-ανεπάρκειας/
https://gpcardio.org/el/2026-05-06_παράγοντες-κινδύνου-για-καρδιαγγειακή-νόσο-αθηροσκληρωτικής-αιτιολογίας-σε-άτομα-με-ετεροζυγωτική-οικογεν/
https://gpcardio.org/el/2026-05-07_συνδυασμένη-διακαθετηριακή-επιδιόρθωση-άκρου-προς-άκρο-της-μιτροειδούς-και-τριγλώχινας-βαλβίδας-ή-μοναδική/
https://gpcardio.org/el/2026-05-08_κίνδυνος-αγγειακού-εγκεφαλικού-επεισοδίου-και-αιμορραγίας-με-μη-βιταμίνης-κ-στοματικά-αντιπηκτικά-σε-μη-βαλ/
https://gpcardio.org/el/2026-05-08_νεφρική-λειτουργία-και-κίνδυνος-καρδιακής-ανεπάρκειας-σε-ηλικιωμένους-ενήλικες/
https://gpcardio.org/el/2026-05-09_εμφύτευση-υποδερμικού-απινιδωτή-με-ή-χωρίς-δοκιμή-απινίδωσης/
https://gpcardio.org/el/2026-05-10_αναστολέας-υποδοχέα-αγγειοτενσίνης-νεπριλυσίνης-στην-καρδιακή-ανεπάρκεια-με-διατηρημένο-κλάσμα-εξώθησης-κ/
https://gpcardio.org/el/2026-05-10_αποτελεσματικότητα-της-φαρμακευτικής-θεραπείας-σύμφωνα-με-τις-κατευθυντήριες-οδηγίες-ανάλογα-με-τη-χρήση-δ/
https://gpcardio.org/el/2026-05-10_διγοξίνη-σε-ασθενείς-με-συμπτωματική-ρευματική-καρδιοπάθεια/
https://gpcardio.org/el/2026-05-10_διγοξίνη-σε-χαμηλή-δόση-σε-ασθενείς-με-καρδιακή-ανεπάρκεια-με-μειωμένη-ή-ελαφρώς-μειωμένη-κλάση-εκροής/
https://gpcardio.org/el/2026-05-10_ο-αναστολέας-μικρο-rna-cdr132l-σε-ασθενείς-με-μειωμένη-κλάση-εκροής-της-αριστερής-κοιλίας-μετά-από-έμφραγμα-του-μυ/
https://gpcardio.org/el/2026-05-10_τυφλή-απόσυρση-της-τυχαιοποιημένης-θεραπείας-με-χαμηλή-δόση-διγοξίνης-ή-εικονικό-φάρμακο-σε-ασθενείς-με-καρ/
https://gpcardio.org/el/2026-05-11_subcut-hf-ii-η-κατ-οίκον-υποδόρια-φουροσεμίδη-μειώνει-τις-ημέρες-νοσηλείας-σε-σύγκριση-με-την-ενδοφλέβια-φουροσεμ/
https://gpcardio.org/el/2026-05-11_ανθρωπομετρικά-μέτρα-λιπώδους-ιστού-και-νατριουρητικά-πεπτίδια-στον-έλεγχο-καρδιακής-ανεπάρκειας/
https://gpcardio.org/el/2026-05-11_επίπτωση-καρκίνου-στην-καρδιακή-ανεπάρκεια-το-έμφραγμα-του-μυοκαρδίου-ή-και-τα-δύο/
https://gpcardio.org/el/2026-05-11_επιπολασμός-και-προγνωστικοί-παράγοντες-υψηλού-φλεγμονώδους-κινδύνου-στους-υποτύπους-καρδιακής-ανεπάρκεια/
https://gpcardio.org/el/2026-05-11_καρδιαγγειακή-νόσος-στη-δρεπανοκυτταρική-νόσο/
https://gpcardio.org/el/2026-05-11_σωματική-δραστηριότητα-στις-παιδιατρικές-μυοκαρδιοπάθειες/
https://gpcardio.org/el/2026-05-12_ξεπερνά-πλέον-ο-παγκόσμιος-επιπολασμός-της-καρδιακής-ανεπάρκειας-τα-600-εκατομμύρια-ανθρώπους-από-την-εικασί/
https://gpcardio.org/el/2026-05-12_προγνωστικοί-παράγοντες-μακροπρόθεσμων-εκβάσεων-στην-υπερτροφική-μυοκαρδιοπάθεια/
https://gpcardio.org/el/2026-05-12_σοτατερσέπτη-για-συνδυασμένη-μετα-και-προτριχοειδική-πνευμονική-υπέρταση-σχετιζόμενη-με-καρδιακή-ανεπάρκε/
https://gpcardio.org/el/2026-05-15_δευτερογενής-πρόληψη-μετά-από-χειρουργική-επέμβαση-παράκαμσης-στεφανιαίας-αρτηρίας/
https://gpcardio.org/el/2026-05-15_ετήσια-πολυκεντρική-προοπτική-μελέτη-πραγματικού-κόσμου-της-αποτελεσματικότητας-και-ασφάλειας-της-βερισιγ/
https://gpcardio.org/el/2026-05-18_προς-ολοκληρωμένους-καρδιαγγειακούς-ελέγχους-υγείας-σε-όλη-την-ευρώπη/
https://gpcardio.org/el/2026-05-19_atlas-of-cardiology-παραμένουν-αποφεύξιμες-ανισότητες-στο-βάρος-και-τη-φροντίδα-της-καρδιαγγειακής-νόσου/
https://gpcardio.org/el/2026-05-25_επεξεργασία-βάσεων-εν-ζώω-του-pcsk9-με-verve-102-για-υπερχοληστερολαιμία/
https://gpcardio.org/el/2026-05-27_αγωνιστές-των-υποδοχέων-του-ομοίου-του-γλυκαγόνου-πεπτιδίου-1-σε-ασθενείς-με-καρδιακή-ανεπάρκεια-με-μειωμένο/
https://gpcardio.org/el/2026-05-27_αφαίρεση-με-παλμικό-ηλεκτρικό-πεδίο-για-την-παρεμβατική-θεραπεία-της-κολπικής-μαρμαρυγής-μια-επιστημονική-δ/
https://gpcardio.org/el/2026-05-28_κέντρα-καρδιολογίας-για-γυναίκες/
https://gpcardio.org/el/2026-05-28_τα-αναστολικά-sglt2-συνδέονται-με-μείωση-του-όγκου-και-του-πάχους-του-επικαρδιακού-λιπώδους-ιστού/
https://gpcardio.org/el/2026-05-29_φυσιολογία-πρόληψη-και-διαχείριση-της-στεφανιαίας-μικροαγγειακής-απόφραξης/
https://gpcardio.org/el/2026-05-31_το-νεφρό-στο-κέντρο/
https://gpcardio.org/el/2026-06-01_επικάλυψη-νεφροδιαβητικού-συνδρόμου-στην-πνευμονική-αρτηριακή-υπέρταση/
https://gpcardio.org/el/2026-06-01_κοινά-παθοφυσιολογικά-μηχανισμούς-μεταξύ-διαβήτη-και-βαλβιδοπάθειας-αορτής-με-ασβεστώσεις/
https://gpcardio.org/el/2026-06-02_αποτελέσματα-της-δοκιμής-betami-danblock-σε-σύγκριση-με-έναν-εθνικό-πληθυσμό-της-νορβηγίας-με-έμφραγμα-του-μυοκαρδί/
https://gpcardio.org/el/2026-06-02_επιδημιολογία-της-πνευμονικής-εμβολής/
https://gpcardio.org/el/2026-06-02_ομπεκιτραπίμπ-και-επίπεδα-λιποπρωτεΐνης-a-σε-ασθενείς-με-υψηλό-καρδιαγγειακό-κίνδυνο/
https://gpcardio.org/el/2026-06-03_επίπεδα-λιποπρωτεΐνης-a-κίνδυνος-καρδιαγγειακών-γεγονότων-και-όφελος-από-την-evolocumab/
https://gpcardio.org/el/2026-06-03_οικογενής-υπερχοληστερολαιμία-σε-παιδιά-και-εφήβους/
https://gpcardio.org/el/2026-06-04_επιπτώσεις-του-σεμαγλουτίδης-στη-θνησιμότητα-τις-καρδιαγγειακές-και-νεφρικές-επιπλοκές-σε-όλο-το-καρδιο-νεφ/
https://gpcardio.org/el/2026-06-04_κλινικές-λιπιδίων-παγκοσμίως/
https://gpcardio.org/el/2026-06-05_προβλεπόμενη-μείωση-των-σοβαρών-καρδιαγγειακών-συμβάντων-σε-ενήλικες-υψηλού-κινδύνου-στις-ηπα-με-διαβήτη-τύ/
https://gpcardio.org/el/2026-06-07_αυτοσωματικό-επικρατές-σύνδρομο-alport/
https://gpcardio.org/el/2026-06-09_αλλαγές-στη-σύνθεση-του-σώματος-σε-ασθενείς-που-λαμβάνουν-αγωνιστές-υποδοχέα-glp-1-και-συμμετέχουν-σε-ένα-εντα/
https://gpcardio.org/el/2026-06-10_πρωτεύοντα-αποτελέσματα-του-μητρώου-salamander/
https://gpcardio.org/el/2026-06-10_συντηρητικά-τροφίμων-υπέρταση-και-καρδιαγγειακές-νόσοι/
https://gpcardio.org/el/2026-06-11_βέλτιστες-μορφές-και-δόσεις-άσκησης-για-τη-μείωση-της-αρτηριακής-πίεσης-σε-ενήλικες-με-προϋπέρταση-και-καθιε/
https://gpcardio.org/el/2026-06-11_η-κινητή-μονάδα-υγείας-που-παρέχει-υπηρεσίες-outreach-σε-κοινωνικά-μειονεκτούντες-αστικούς-πληθυσμούς-ανιχνεύε/
https://gpcardio.org/el/2026-06-12_μείωση-της-χοληστερόλης-των-λιποπρωτεϊνών-χαμηλής-πυκνότητας-με-inclisiran-σε-συνδυασμό-με-τη-συνηθισμένη-φροντί/
https://gpcardio.org/el/2026-06-13_επίδραση-διαφόρων-τύπων-ολικών-οσπρίων-σε-καθιερωμένους-θεραπευτικούς-στόχους-λιπιδίων-για-τη-μείωση-του-κα/
https://gpcardio.org/el/2026-06-13_ευρωπαϊκή-εταιρεία-καρδιολογίας/
https://gpcardio.org/el/2026-06-15_ανάλυση-κόστους-αποτελεσματικότητας-και-επιπτώσεων-στον-προϋπολογισμό-της-τιρζεπατίδης-στην-καρδιακή-ανεπ/
https://gpcardio.org/el/2026-06-15_κλινική-αποτελεσματικότητα-των-αναστολέων-του-μεταφορέα-νατρίου-γλυκόζης-2-σε-ηλικιωμένους-ασθενείς-που-νοσ/
https://gpcardio.org/el/2026-06-15_συγκριτική-αποτελεσματικότητα-των-ατομικών-αναστολέων-μεταφορέα-νατρίου-γλυκόζης-2-στις-καρδιαγγειακές-εκβ/
https://gpcardio.org/el/2026-06-16_σύμπραξη-διατροφικών-μοτίβων-και-γενετικού-κινδύνου-με-καρδιαγγειακή-νόσο-σε-επιζήσαντες-καρκίνου-στο-uk-bioban/
https://gpcardio.org/el/2026-06-17_ηλικιακά-εξαρτώμενη-συσχέτιση-μεταξύ-καρδιακής-ανεπάρκειας-και-κινδύνου-αγγειακού-εγκεφαλικού-επεισοδίου/
https://gpcardio.org/el/2026-06-17_ομόζυγη-οικογενής-υπερχοληστερολαιμία/
https://gpcardio.org/el/2026-06-19_laroprovstat-ο-πρώτος-στοματικός-αναστολέας-pcsk9-μικρού-μορίου-για-τη-θεραπεία-της-υπερχοληστερολαιμίας/
https://gpcardio.org/el/2026-06-19_ενδοστεφανιαία-απεικόνιση-για-την-διαδερμική-στεφανιαία-παρέμβαση-του-αριστερού-κύριου-κορμού/
https://gpcardio.org/el/2026-06-20_λιπιδικός-καρδιαγγειακός-κίνδυνος-πέραν-της-χοληστερόλης-ldl/
https://gpcardio.org/el/2026-06-20_φαρμακευτικοί-στόχοι-για-τη-τροποποίηση-των-λιπιδίων-και-ο-κίνδυνος-διαβήτη-τύπου-2/
https://gpcardio.org/el/2026-06-21_μιαετής-προοπτική-μελέτη-πραγματικής-κλινικής-πράξης-πολλαπλών-κέντρων-σχετικά-με-την-αποτελεσματικότητα-κ/
https://gpcardio.org/el/2026-06-24_αποτελέσματα-μετά-από-ένα-πρώτο-οξύ-έμφραγμα-του-μυοκαρδίου-σε-ασθενείς-με-ή-χωρίς-συγγενή-καρδιοπάθεια/
https://gpcardio.org/el/2026-06-25_αποτελέσματα-πραγματικής-ζωής-σε-1-έτος-με-τον-αποστραγγιστή-amulet-από-τη-μελέτη-emerge-laa-μετά-την-έγκριση/
https://gpcardio.org/el/2026-06-25_τυφλή-διακοπή-της-τυχαίας-θεραπείας-με-χαμηλή-δόση-διγοξίνης-ή-εικονικού-φαρμάκου-σε-ασθενείς-με-καρδιακή-αν/
https://gpcardio.org/el/2026-06-27_διαχείριση-καρδιακής-ανεπάρκειας-στην-πρωτοβάθμια-φροντίδα-εκτός-ωραρίου-λειτουργίας/
https://gpcardio.org/el/2026-06-29_στεφανιαία-εμβολή-σε-κολπική-μαρμαρυγή/
https://gpcardio.org/el/2026-06-30_δείκτης-αλληλεπίδρασης-διατροφής-μικροβιώματος-εντέρου-και-κίνδυνος-καρδιακής-ανεπάρκειας-σε-διαβήτη-και-π/
https://gpcardio.org/el/2026-07-01_άμεσα-στοματικά-αντιπηκτικά-εκλεκτικά-μσαε-cox-2-και-γαστρεντερική-αιμορραγία-στην-κολπική-μαρμαρυγή/
https://gpcardio.org/el/2026-07-02_αφαίρεση-με-παλμικό-ηλεκτρικό-πεδίο-έναντι-ψευδοθεραπείας-για-τη-θεραπεία-της-κολπικής-μαρμαρυγής/
https://gpcardio.org/el/2026-07-02_πραγματική-επίπτωση-της-καρδιακής-δυσλειτουργίας-που-σχετίζεται-με-την-αντινεοπλασματική-θεραπεία-σε-μια-μ/
https://gpcardio.org/el/2026-07-03_υπολογισμός-του-απόλυτου-5ετούς-κινδύνου-καρδιαγγειακής-νόσου-χρησιμοποιώντας-ηλεκτρονικά-ιατρικά-αρχεία-π/
https://gpcardio.org/el/2026-07-03_φυσική-πορεία-της-ασυμπτωματικής-μέτριας-ή-σοβαρής-αορτικής-ανεπάρκειας/
https://gpcardio.org/el/2026-07-05_αερόβια-ικανότητα-στην-εφηβεία-και-η-ισορροπία-μεταξύ-του-κινδύνου-κολπικής-μαρμαρυγής-και-των-καρδιαγγειακ/
https://gpcardio.org/el/2026-07-05_παράγοντες-κινδύνου-για-τη-συννοσηρότητα-καρδιαγγειακών-νόσων-στην-προοπτική-μελέτη-million-women-study/
https://gpcardio.org/el/2026-07-05_σωματική-κατάσταση-μετά-από-έμφραγμα-του-μυοκαρδίου-σε-σύγκριση-με-κλινικές-τιμές-αναφοράς/
https://gpcardio.org/el/2026-07-06_καρδιοαναπνευστική-φυσική-κατάσταση-στην-εφηβεία-και-η-ισορροπία-μεταξύ-του-κινδύνου-κολπικής-μαρμαρυγής-κ/
https://gpcardio.org/el/2026-07-07_βασικές-αλλαγές-στην-κλινική-καθοδήγηση-για-τη-διαχείριση-της-αρτηριακής-πίεσης-και-των-λιπιδίων/
https://gpcardio.org/el/2026-07-07_γιατί-η-χρόνια-νεφρική-νόσος-ckd-είναι-πιο-σημαντική-για-την-πρωτοβάθμια-φροντίδα/
https://gpcardio.org/el/2026-07-07_διατροφική-πρόσληψη-φυτικού-και-ζωικού-νιτρικού-και-αλλαγές-στην-αρτηριακή-πίεση-κατά-τη-διάρκεια-5-ετών/
https://gpcardio.org/el/2026-07-07_λοιμώδης-ενδοκαρδίτιδα-μετά-από-διακαθετηριακή-εμφύτευση-αορτικής-βαλβίδας/
https://gpcardio.org/el/2026-07-07_υπάρχει-ρόλος-για-την-πρωτοβάθμια-φροντίδα-στη-διαχείριση-της-παχυσαρκίας-από-θυρωρός-σε-ηγέτες-υγείας-του-π/
https://gpcardio.org/el/2026-07-08_αποκλεισμός-ασβεστίου-έναντι-β-αποκλεισμού-για-υπέρταση-σε-καρδιακή-ανεπάρκεια-με-διατηρημένη-κλάση-εκροής/
https://gpcardio.org/el/2026-07-08_διατροφική-πρόσληψη-φυτικού-και-ζωικού-νιτρικού-και-αλλαγές-στην-αρτηριακή-πίεση-κατά-5-έτη/
https://gpcardio.org/el/2026-07-08_εβολοκουμάμπη-σε-ασθενείς-με-προηγούμενη-διαδερμική-στεφανιαία-παρέμβαση-και-χωρίς-προηγούμενο-έμφραγμα-το/
https://gpcardio.org/el/2026-07-09_αναστολέας-υποδοχέα-αγγειοτενσίνης-και-νεπριλυσίνης-στην-καρδιακή-ανεπάρκεια-με-διατηρημένο-κλάσμα-εκροής/
https://gpcardio.org/el/2026-07-09_η-διαστολική-δυσλειτουργία-είναι-εξίσου-συχνή-στην-προδιαβήτη-και-τον-διαβήτη-και-συνδέεται-με-συνοδούς-καρ/
https://gpcardio.org/el/2026-07-09_νυχτερινή-μέτρηση-της-αρτηριακής-πίεσης-στο-σπίτι-με-συσκευή-καρπού-και-αριστερής-κοιλιακής-υπερτροφίας/
https://gpcardio.org/el/2026-07-09_προσδιορισμός-της-φυσιολογικής-κατωφλίου-για-την-αγγειοσπασμική-στηθάγχη-orbita-fire/
https://gpcardio.org/el/2026-07-10_εβολοκουμάμπη-σε-ασθενείς-με-προηγούμενη-διαδερμική-στεφανιαία-παρέμβαση-και-χωρίς-προηγούμενο-έμφραγμα-το/
https://gpcardio.org/el/2026-07-11_αποκλεισμός-ασβεστίου-έναντι-αποκλεισμού-βήτα-για-υπέρταση-και-καρδιακή-ανεπάρκεια-με-διατηρημένη-κλάση-εκ/
https://gpcardio.org/el/2026-07-11_νυχτερινή-αρτηριακή-πίεση-στο-σπίτι-με-μέτρηση-στον-καρπό-και-αριστερική-κοιλιακή-υπερτροφία/
https://gpcardio.org/el/2026-07-12_αναστολέας-των-υποδοχέων-της-αγγειοτενσίνης-και-της-νεπριλυσίνης-στην-καρδιακή-ανεπάρκεια-με-διατηρημένο-κ/
https://gpcardio.org/el/2026-07-12_προσδιορισμός-της-φυσιολογικής-κατωφλίου-για-την-αγγίνα-orbita-fire/
https://gpcardio.org/el/2026-07-14_θρόμβος-αριστερής-κοιλίας-στο-σύνδρομο-τακοτόμπο-και-έμφραγμα-του-μυοκαρδίου-με-ανύψωση-του-τμήματος-st/
https://gpcardio.org/el/2026-07-15_η-φυσική-ιστορία-της-μαζικής-αριστερής-κοιλιακής-υπερτροφίας-στην-παιδιατρική-υπερτροφική-καρδιομυοπάθεια/
https://gpcardio.org/el/2026-07-16_οι-πολυοργανικές-φυσιολογικές-ελλείψεις-κατά-την-άσκηση-εντοπίζουν-την-κλινική-και-μοριακή-προδιάθεση-για-κ/
https://gpcardio.org/el/2026-07-18_εγκεφαλική-αμυλοειδής-αγγειοπάθεια/
https://gpcardio.org/el/2026-07-18_κλινικά-αποτελέσματα-της-διέγερσης-του-συστήματος-αγωγής-σε-σύγκριση-με-τη-δεξιά-κοιλιακή-διέγερση-σε-ασθεν/
https://gpcardio.org/el/2026-07-18_συνδέονται-οι-κλινικές-βελτιώσεις-στο-άγχος-ή-την-κατάθλιψη-με-βελτίωση-στη-φυσική-κατάσταση-για-το-περπάτημ/
https://gpcardio.org/el/2026-07-19_θεραπεία-και-αποτελέσματα-με-αναστολείς-pcsk9-σε-ασθενείς-με-αθηροσκληρωτική-καρδιαγγειακή-νόσο-αλλά-χωρίς-πρ/
https://gpcardio.org/el/2026-07-19_φαρμακολογική-μείωση-της-αρτηριακής-πίεσης-για-την-πρόληψη-καρδιαγγειακής-νόσου-και-θανάτου-σε-όλο-το-φάσμα/
https://gpcardio.org/el/2026-07-21_ανάπτυξη-ενός-ολοκληρωμένου-εργαλείου-αξιολόγησης-μονογονιδιακού-και-πολυγονιδιακού-κινδύνου-για-στεφανια/
https://gpcardio.org/el/2026-07-22_διαχείριση-και-αποτελέσματα-της-νεοεμφανιζόμενης-μεταεγχειρητικής-κολπικής-μαρμαρυγής/
https://gpcardio.org/el/2026-07-23_η-φυσική-ιστορία-της-μαζικής-αριστερής-κοιλιακής-υπερτροφίας-στην-παιδιατρική-υπερτροφική-καρδιομυοπάθεια/
https://gpcardio.org/el/2026-07-23_οι-φυσιολογικές-ελλείψεις-πολλαπλών-οργάνων-κατά-την-άσκηση-εντοπίζουν-την-κλινική-και-μοριακή-προδιάθεση-γ/
https://gpcardio.org/el/2026-07-24_έλεγχος-αρτηριακής-πίεσης-και-θνησιμότητα-μεταξύ-των-βετεράνων-των-ηπα/
https://gpcardio.org/el/2026-07-24_νεφρική-δυσλειτουργία-και-πνευμονική-αγγειακή-νόσος-στην-καρδιακή-ανεπάρκεια-με-διατηρημένη-κλάση-εκροής/
https://gpcardio.org/el/2026-07-25_λιποπρωτεΐνη-a-πρωτεΐνη-c-αντιδρώντα-υψηλής-ευαισθησίας-και-κίνδυνος-πρώτου-επεισοδίου-ascvd-σε-άτομα-χωρίς-τυπ/
https://gpcardio.org/el/2026-07-26_διαδρομές-φροντίδας-ασθενών-και-αποτελέσματα-μετά-τη-νέα-διάγνωση-κολπικής-μαρμαρυγής/
https://gpcardio.org/el/2026-07-26_φύλο-σε-αποτελέσματα-μετά-από-αγγειακό-εγκεφαλικό-επεισόδιο-σε-ασθενείς-με-κολπική-μαρμαρυγή-που-λαμβάνουν/
https://gpcardio.org/el/2026-07-27_αξιολόγηση-και-διαχείριση-του-καρδιαγγειακού-νεφρικού-ηπατικού-μεταβολικού-συνδρόμου-στο-πλαίσιο-της-πρωτο/
https://gpcardio.org/el/2026-07-27_φαινοτυπική-ταξινόμηση-ασθενών-με-αορτική-στένωση-χαμηλής-ροής-και-χαμηλού-βαθμού-κλίσης-και-διατηρημένη-κλ/
https://gpcardio.org/el/2026-07-28_επιδημιολογία-οικονομικό-βάρος-και-θνητότητα-της-κολπικής-μαρμαρυγής-σε-περιοχή-με-πολύ-υψηλή-προσδόκιμη-δι/
https://gpcardio.org/el/2026-07-28_νεφρά-νέα-παλιοί-κίνδυνοι/
https://gpcardio.org/el/2026-07-28_συνδυαστική-επίδραση-της-εκπαιδευτικής-επίτευξης-και-του-διαβήτη-στη-θνησιμότητα-από-όλες-τις-αιτίες-σε-1-έτ/
https://gpcardio.org/el/2026-07-29_διαθωρακική-παρακέντηση-σε-καρδιαγγειακές-επεμβάσεις/
https://gpcardio.org/el/2026-07-29_διαχείριση-λιπιδίων-στον-διαβήτη-τύπου-2-και-χοληστερόλη-μη-hdl/
https://gpcardio.org/el/2026-07-29_χρονισμός-άσκησης-συμβατός-με-τον-χρονοτύπο-σε-ενήλικες-μέσης-ηλικίας-με-καρδιομεταβολικό-κίνδυνο/
https://gpcardio.org/el/2026-07-31_πρόωρα-αποτελέσματα-και-προγνωστικοί-παράγοντες-θνητότητας-στη-ενδοκαρδίτιδα-της-φυσιολογικής-αορτικής-βα/
https://gpcardio.org/el/2026-07-31_φύλο-σχετικές-διαφορές-στη-διάγνωση-τη-διαχείριση-και-τα-αποτελέσματα-ασθενών-με-μολυσματική-ενδοκαρδίτιδα/
https://gpcardio.org/el/2026-08-02_δήλωση-καρδιαγγειακό-όφελος-με-τυπική-κατανάλωση-καφέ-σήμα-βλάβης-με-τα-ενεργειακά-ποτά/
https://gpcardio.org/el/2026-08-02_η-epccs-ανανεώνει-την-ταυτότητά-της-για-να-προωθήσει-την-ολοκληρωμένη-καρδιο-νεφρο-μεταβολική-φροντίδα-στην-πρ/
https://gpcardio.org/el/2026-08-02_συσχέτιση-μεταξύ-της-c-αντιδρώσας-πρωτεΐνης-και-του-κινδύνου-εμφάνισης-καρδιακής-ανεπάρκειας-σε-επιζήσαντες/
https://gpcardio.org/el/2026-08-02_τάσεις-στη-νεφρολογία/
https://gpcardio.org/el/2026-08-03_έγγραφο-ειδικής-συναίνεσης-aha-acc-esc-whf/
https://gpcardio.org/el/2026-08-03_αντιθρομβωτική-διαχείριση-σε-ασθενείς-με-χρόνια-στεφανιαία-νόσο-που-λαμβάνουν-στοματική-αντιπηκτική-αγωγή/
https://gpcardio.org/el/2026-08-04_κακοποίηση-και-καρδιακή-ανεπάρκεια/
https://gpcardio.org/el/2026-08-05_φύλο-και-διαφορές-στον-έλεγχο-του-παράγοντα-κινδύνου-και-στην-συμμόρφωση-με-τη-φαρμακευτική-αγωγή-μετά-από-ο/
https://gpcardio.org/el/2026-08-06_έλεγχος-αρτηριακής-πίεσης-και-θνησιμότητα-μεταξύ-των-βετεράνων-των-ηπα/
https://gpcardio.org/el/2026-08-06_η-μείωση-της-αρτηριακής-πίεσης-και-της-αλβουμινουρίας-μεσολαβεί-στα-καρδιαγγειακά-οφέλη-της-φινερονόνης-στο/
https://gpcardio.org/el/2026-08-06_συνδυαστικές-φαρμακοθεραπείες-βασισμένες-σε-πεπτιδικές-ορμόνες-για-τις-χρόνιες-μεταβολικές-παθήσεις/
https://gpcardio.org/el/2026-08-10_αναστολή-του-παράγοντα-xi/
https://gpcardio.org/el/2026-08-10_καρδιά-και-νεφρό-σε-μία-κατευθυντήρια-οδηγία/
https://gpcardio.org/el/2026-08-10_οι-νέες-κατευθυντήριες-οδηγίες-της-esc-για-την-καρδιακή-ανεπάρκεια/
https://gpcardio.org/el/2026-08-10_οι-στατίνες-πέραν-των-εβδομήντα/
https://gpcardio.org/el/cvd-ckd-t2d/
https://gpcardio.org/el/each/
https://gpcardio.org/el/epccs-summit/
https://gpcardio.org/el/epccs-summit/διαχείριση-του-καρδιαγγειακού-κινδύνου-στην-ευρώπη-διδάγματα-από-τις-χώρες/
https://gpcardio.org/el/epccs-summit/διαχείριση-των-λιπιδίων-στην-πρωτοβάθμια-φροντίδα/
https://gpcardio.org/el/epccs-summit/καρδιαγγειακή-νόσος-σε-ειδικούς-πληθυσμούς/
https://gpcardio.org/el/epccs-summit/καρδιονεφρική-ενημέρωση/
https://gpcardio.org/el/epccs-summit/συνεδρία-καρδιαγγειακής-ενημέρωσης-για-την-πρωτοβάθμια-φροντίδα/
https://gpcardio.org/el/epccs-summit/το-σχέδιο-της-εε-για-την-καρδιαγγειακή-υγεία/
https://gpcardio.org/el/epccs/
https://gpcardio.org/el/epccs/συνδεδεμένες-εταιρείες/
https://gpcardio.org/el/esc-congress-2025/
https://gpcardio.org/el/gpcardio/
https://gpcardio.org/el/ncd-academy/
https://gpcardio.org/el/wonca-world-2025/
https://gpcardio.org/el/βιβλιογραφία/
https://gpcardio.org/el/βιβλιογραφία/
https://gpcardio.org/el/επιστημονική-ενημέρωση/
https://gpcardio.org/el/νέα-της-εταιρείας/
https://gpcardio.org/el/πόροι/
https://gpcardio.org/el/πόροι/stratifyhf/
https://gpcardio.org/el/πόροι/αναφορές-συνεδριάσεων/
https://gpcardio.org/el/πόροι/ενημερώσεις-σε-βίντεο/
https://gpcardio.org/el/πόροι/καθοδήγηση-για-την-κλινική-πρακτική/
https://gpcardio.org/el/πόροι/πρόσφατα-νέα/
https://gpcardio.org/el/συμπόσιο-της-epccs-στο-πλαίσιο-του-wonca-europe-2026-για-την-καρδιο-νεφρο-μεταβολική-νόσο/
https://gpcardio.org/el/σχετικά-με-την-epccs/
https://gpcardio.org/el/σχετικά-με-την-ipccs/
https://gpcardio.org/en/
https://gpcardio.org/en/2014-05-28_practical-guidance-for-primary-care-physicians-on-statin-use-in-people-at-risk-of-getting-diabetes/
https://gpcardio.org/en/2015-01-07_the-epccs-stroke-prevention-in-atrial-fibrillation-guidance-document-1/
https://gpcardio.org/en/2015-09-29_lively-debate-at-annual-epccs-clinical-masterclass-to-yield-practical-guidance/
https://gpcardio.org/en/2015-10-02_what-s-the-evidence-base-for-blood-pressure-modification-in-the-guideline-updates/
https://gpcardio.org/en/2015-10-02_what-s-the-evidence-base-for-health-behaviour-modification-in-the-guideline-updates/
https://gpcardio.org/en/2015-10-12_what-s-the-evidence-base-for-lipid-modification-in-the-guideline-updates/
https://gpcardio.org/en/2015-10-14_what-s-the-evidence-base-for-heart-failure-diagnosis-and-management-in-the-guideline-updates/
https://gpcardio.org/en/2016-03-15_what-is-the-evidence-base-for-lipid-modification-in-the-guidelines-updates/
https://gpcardio.org/en/2016-04-15_identifying-and-treating-patients-with-true-hypertension/
https://gpcardio.org/en/2016-05-26_the-evidence-base-for-health-behaviour-changes/
https://gpcardio.org/en/2016-09-06_epccs-consensus-guidance-on-stroke-prevention-in-atrial-fibrillation-spaf-in-primary-care/
https://gpcardio.org/en/2016-09-28_epccs-guidance-documents/
https://gpcardio.org/en/2017-03-30_guidance-on-changing-health-behaviours-what-is-the-evidence-what-s-recommended-and-do-i-agree/
https://gpcardio.org/en/2017-04-20_atrial-fibrillation-management-what-do-the-guidelines-say-and-what-are-the-implications-for-primary-care/
https://gpcardio.org/en/2017-04-20_controversies-in-hypertension-what-are-the-implication-of-sprint-in-the-context-of-recent-treatment-trials/
https://gpcardio.org/en/2017-04-20_controversies-in-lipids-is-the-role-of-statins-now-clear-are-there-alternatives-and-what-s-in-the-pipeline/
https://gpcardio.org/en/2017-04-20_guidance-on-changing-health-behaviours-what-is-the-evidence-what-s-recommended-and-do-i-agree/
https://gpcardio.org/en/2017-04-20_lipid-management-what-do-the-guidelines-say-and-what-are-the-implications-for-primary-care/
https://gpcardio.org/en/2017-04-20_what-s-the-new-evidence-base-for-heart-failure-diagnosis-management/
https://gpcardio.org/en/2017-06-05_ingredients-of-effective-strategies-to-stimulate-behaviour-change/
https://gpcardio.org/en/2017-06-22_how-do-the-latest-guideline-changes-affect-management-of-dyslipidaemia-in-primary-care/
https://gpcardio.org/en/2017-07-01_epccs-heart-failure-guidance-published-as-clinical-intelligence-in-br-j-gen-prac/
https://gpcardio.org/en/2017-07-18_heart-failure-diagnosis-and-management-varies-substantially-across-european-countries/
https://gpcardio.org/en/2017-09-13_what-can-be-learned-from-the-latest-hypertension-trials/
https://gpcardio.org/en/2017-12-10_epccs-practical-guidance-on-heart-failure-diagnosis-and-management-in-primary-care/
https://gpcardio.org/en/2018-02-06_how-can-epccs-expand-its-membership/
https://gpcardio.org/en/2018-02-06_how-can-the-epccs-better-engage-with-primary-care-physicians-in-various-european-countries-regarding-cardiovascular-disease-education/
https://gpcardio.org/en/2018-02-19_chronicke-srdcove-zlyhavanie/
https://gpcardio.org/en/2018-02-19_prevencia-cievnej-mozgovej-prihody-u-pacientov-s-fibrilaciou-predsieni/
https://gpcardio.org/en/2018-02-19_практична-настанова-по-діагностиці-та-менеджменту-серцевої-недостатності-в-системі-первинної-медичної-допо/
https://gpcardio.org/en/2018-02-22_stimulating-health-behaviour-changes-to-reduce-cardiovascular-risk-in-primary-care/
https://gpcardio.org/en/2018-02-25_slides-organisation-of-primary-care-in-the-netherlands/
https://gpcardio.org/en/2018-02-26_netherlands-cardiovascular-primary-care-overview/
https://gpcardio.org/en/2018-02-26_slides-organisation-of-primary-care-in-slovakia/
https://gpcardio.org/en/2018-02-26_slides-primary-care-in-bulgaria-nagpb/
https://gpcardio.org/en/2018-02-26_slovakia-cardiovascular-primary-care-overview/
https://gpcardio.org/en/2018-02-27_slides-cardiovascular-primary-care-in-spain/
https://gpcardio.org/en/2018-02-27_slides-organisation-of-primary-care-in-portugal/
https://gpcardio.org/en/2018-02-28_bulgaria-cardiovascular-primary-care/
https://gpcardio.org/en/2018-02-28_portugal-cardiovascular-primary-care-overview/
https://gpcardio.org/en/2018-02-28_slides-cardiovascular-primary-care-in-france/
https://gpcardio.org/en/2018-02-28_spain-cardiovascular-primary-care-overview/
https://gpcardio.org/en/2018-03-01_france-cardiovascular-primary-care-overview/
https://gpcardio.org/en/2018-03-01_greece-cardiovascular-primary-care-overview/
https://gpcardio.org/en/2018-03-01_romania-cardiovascular-primary-care-overview/
https://gpcardio.org/en/2018-03-01_slides-cardiovascular-primary-care-in-greece/
https://gpcardio.org/en/2018-03-01_slides-cardiovascular-primary-care-in-romania/
https://gpcardio.org/en/2018-03-02_germany-cardiovascular-primary-care-overview/
https://gpcardio.org/en/2018-03-02_slides-cardiovascular-primary-care-in-germany/
https://gpcardio.org/en/2018-03-13_погоджена-настанова-epccs-щодо-профілактики-інсульту-при-фібриляції-передсердь-в-системі-надання-первинної-ме/
https://gpcardio.org/en/2018-03-27_lower-extremity-artery-disease-a-neglected-major-cv-disease/
https://gpcardio.org/en/2018-03-27_stimularea-schimbarilor-de-comportament-in-domeniul-sanatatii-pentru-a-reduce-riscul-cardiovascular-in-asistenta-medicala-primara/
https://gpcardio.org/en/2018-03-28_diabetes-and-vascular-disease-epidemiology-and-management-options/
https://gpcardio.org/en/2018-04-04_managing-elevated-lipids-and-statins-the-good-the-bad-and-the-ugly/
https://gpcardio.org/en/2018-04-04_slides-hypertension-can-we-agree-on-diagnostic-and-therapeutic-thresholds/
https://gpcardio.org/en/2018-04-04_slides-lipid-lowering-the-evidence-the-guidelines-the-clinical-reality/
https://gpcardio.org/en/2018-04-04_slides-lower-extremity-artery-disease-a-neglected-major-cv-disease-diagnose-and-clinical-management-in-primary-care/
https://gpcardio.org/en/2018-04-04_slides-managing-complex-heart-failure-a-specialist-view-of-the-primary-secondary-interface/
https://gpcardio.org/en/2018-04-04_slides-managing-heart-failure-in-primary-care-the-gp-perspective/
https://gpcardio.org/en/2018-04-04_slides-practical-workshop-on-abpm/
https://gpcardio.org/en/2018-04-04_slides-type-2-diabetes-cardiovascular-disease-update/
https://gpcardio.org/en/2018-04-10_complexities-of-managing-heart-failure-in-primary-care/
https://gpcardio.org/en/2018-04-10_hypertension-can-we-agree-on-diagnostic-and-therapeutic-thresholds/
https://gpcardio.org/en/2018-04-24_management-of-cv-risk-that-comes-with-t2dm-in-light-of-novel-treatment-options/
https://gpcardio.org/en/2018-05-16_cardiovascular-primary-care-in-italy/
https://gpcardio.org/en/2018-05-16_slides-primary-care-in-italy/
https://gpcardio.org/en/2018-05-22_lipid-lowering-the-evidence-the-guidelines-the-clinical-reality/
https://gpcardio.org/en/2018-06-15_semergen-la-sociedad-decana-de-la-medicina-de-familia-en-espana/
https://gpcardio.org/en/2018-06-15_semergen-sociedad-espanola-de-medicos-de-atencion-primaria/
https://gpcardio.org/en/2018-06-19_spain-epccs-introduction/
https://gpcardio.org/en/2018-07-18_complexities-of-managing-heart-failure/
https://gpcardio.org/en/2018-08-16_hypertension-can-we-agree-on-diagnostic-and-therapeutic-thresholds/
https://gpcardio.org/en/2018-08-22_managing-elevated-lipids-in-primary-care/
https://gpcardio.org/en/2018-10-22_general-practitioner-in-denmark/
https://gpcardio.org/en/2018-10-22_managementul-dislipidemiei-in-asistenta-medicala-primara/
https://gpcardio.org/en/2018-10-22_praktican-vodic-za-dijagnostikovanje-i-lecenje-srcane-insuficijencije-u-primarnoj-zdravstvenoj-zastiti-pzz/
https://gpcardio.org/en/2018-10-22_stimulacija-promene-zivotnog-stila-u-cilju-smanjenja-kardiovaskularnog-rizika-u-pzz/
https://gpcardio.org/en/2018-10-23_prevention-of-cardiovascular-noncommunicable-disease-in-primary-care-in-russia/
https://gpcardio.org/en/2018-10-25_lecenje-povisenih-lipida-u-primarnoj-zdravstvenoj-zastiti-pzz/
https://gpcardio.org/en/2018-10-30_шляхи-стимулювання-модифікації-способу-життя-з-метою-зменшення-серцево-судинного-ризику-на-первинній-ланці/
https://gpcardio.org/en/2018-12-03_primary-cardiovascular-care-in-serbia-english/
https://gpcardio.org/en/2018-12-04_primary-cardiovascular-care-in-czech-republic-czech/
https://gpcardio.org/en/2018-12-04_primary-cardiovascular-care-in-czech-republic-english/
https://gpcardio.org/en/2018-12-04_primary-cardiovascular-care-in-montenegro-english/
https://gpcardio.org/en/2018-12-04_primary-cardiovascular-care-in-serbia-serbian/
https://gpcardio.org/en/2018-12-04_primary-cardiovascular-care-in-ukraine-english/
https://gpcardio.org/en/2018-12-04_primary-cardiovascular-care-in-ukraine-ukrainian/
https://gpcardio.org/en/2018-12-05_primary-cardiovascular-care-in-belgium-english/
https://gpcardio.org/en/2018-12-05_primary-cardiovascular-care-in-belgium-flemish/
https://gpcardio.org/en/2018-12-05_primary-cardiovascular-care-in-poland-english/
https://gpcardio.org/en/2018-12-05_primary-cardiovascular-care-in-poland-polish/
https://gpcardio.org/en/2018-12-05_primary-cardiovascular-care-in-slovakia-english/
https://gpcardio.org/en/2018-12-05_primary-cardiovascular-care-in-slovakia-slovak/
https://gpcardio.org/en/2018-12-07_primary-cardiovascular-care-in-germany-english/
https://gpcardio.org/en/2018-12-07_primary-cardiovascular-care-in-germany-german/
https://gpcardio.org/en/2018-12-10_primary-cardiovascular-care-in-ireland-english/
https://gpcardio.org/en/2018-12-10_primary-cardiovascular-care-in-turkey-turkish/
https://gpcardio.org/en/2018-12-13_primary-cardiovascular-care-in-turkey-english/
https://gpcardio.org/en/2018-12-17_primary-cardiovascular-care-in-denmark-danish/
https://gpcardio.org/en/2018-12-17_primary-cardiovascular-care-in-denmark-english/
https://gpcardio.org/en/2018-12-17_primary-cardiovascular-care-in-montenegro-montenegrin/
https://gpcardio.org/en/2018-12-17_primary-cardiovascular-care-in-romania-romanian/
https://gpcardio.org/en/2018-12-17_primary-cardiovascular-care-in-spain-english/
https://gpcardio.org/en/2018-12-17_primary-cardiovascular-care-in-spain-spanish/
https://gpcardio.org/en/2018-12-18_slides-take-home-messages-of-epccs-guidance-on-managing-elevated-lipids-in-primary-care/
https://gpcardio.org/en/2019-01-10_primary-cardiovascular-care-in-spain-english/
https://gpcardio.org/en/2019-01-10_primary-cardiovascular-care-in-spain-spanish/
https://gpcardio.org/en/2019-02-07_epccs-society-what-is-available-for-members/
https://gpcardio.org/en/2019-02-25_current-management-of-diabetes-and-cardiovascular-risk-in-primary-care/
https://gpcardio.org/en/2019-03-28_diabetes-and-cardiovascular-risk/
https://gpcardio.org/en/2019-03-28_how-to-deal-with-the-challenges-of-multimorbidity-in-general-practice/
https://gpcardio.org/en/2019-03-28_update-on-stroke-prevention-in-atrial-fibrillation/
https://gpcardio.org/en/2019-04-02_slides-complexities-of-managing-heart-failure/
https://gpcardio.org/en/2019-04-02_slides-cvd-and-mental-health/
https://gpcardio.org/en/2019-04-02_slides-diabetes-and-cardiovascular-risk/
https://gpcardio.org/en/2019-04-02_slides-multimorbidity-cv-disease-and-polypharmacy/
https://gpcardio.org/en/2019-04-02_slides-recent-updates-to-the-international-hypertension-guidelines-where-do-they-vary-and-what-should-we-agree-in-primary-care/
https://gpcardio.org/en/2019-04-02_slides-update-on-stroke-prevention-in-atrial-fibrillation/
https://gpcardio.org/en/2019-04-02_slides-what-s-the-evidence-that-diabetes-is-linked-to-cvd-risk/
https://gpcardio.org/en/2019-04-03_complexities-of-managing-heart-failure/
https://gpcardio.org/en/2019-04-24_recent-updates-to-the-international-hypertension-guidelines-where-do-they-vary-and-what-should-we-agree-in-primary-care/
https://gpcardio.org/en/2019-04-25_education-exchange-guidance-and-interaction-during-epccs-summit-2019/
https://gpcardio.org/en/2019-05-02_slides-managing-diabetes-in-daily-cardiovascular-practice-a-multidisciplinary-approach/
https://gpcardio.org/en/2019-05-02_slides-targeting-cvd-in-diabetes-novel-strategies-to-tackle-the-risk/
https://gpcardio.org/en/2019-05-02_slides-type-2-diabetes-cv-outcomes-more-than-glucose-management-lessons-from-glp1-ra-trials/
https://gpcardio.org/en/2019-05-07_stroke-prevention-in-atrial-fibrillation/
https://gpcardio.org/en/2019-05-21_update-on-managing-cv-risk-in-diabetes-what-s-the-evidence/
https://gpcardio.org/en/2019-06-18_new-diagnostic-algorithm-and-therapeutic-options-in-hf-management/
https://gpcardio.org/en/2019-08-13_slides-take-home-messages-of-epccs-guidance-on-current-management-of-diabetes-and-cv-risk-in-primary-care/
https://gpcardio.org/en/2019-08-29_diagnosis-and-management-of-hypertension-in-primary-care/
https://gpcardio.org/en/2019-10-02_outreach-of-epccs-into-european-countries-what-s-in-store/
https://gpcardio.org/en/2019-10-03_epccs-and-primary-cv-care-in-serbia/
https://gpcardio.org/en/2019-10-03_epccs-and-primary-cv-care-in-slovakia-english/
https://gpcardio.org/en/2019-10-03_epccs-and-primary-cv-care-in-slovakia-slovak/
https://gpcardio.org/en/2019-10-03_epccs-and-primary-cv-care-in-spain-english/
https://gpcardio.org/en/2019-10-03_epccs-and-primary-cv-care-in-spain-spanish/
https://gpcardio.org/en/2019-10-03_how-epccs-aims-to-help-primary-care-physicians-across-europe-in-recognizing-and-managing-cv-risk-greek/
https://gpcardio.org/en/2019-10-09_how-epccs-aims-to-help-primary-care-physicians-across-europe-in-recognizing-and-managing-cv-risk-english/
https://gpcardio.org/en/2019-10-29_diagnosis-and-management-of-hypertension-in-primary-care-french-abstract/
https://gpcardio.org/en/2019-10-29_diagnosis-and-management-of-hypertension-in-primary-care-greek-abstract/
https://gpcardio.org/en/2019-10-29_diagnosis-and-management-of-hypertension-in-primary-care-ukrainian-abstract/
https://gpcardio.org/en/2019-10-29_dijagnostikovanje-i-lecenje-hipertenzije-u-primarnoj-zdravstvenoj-zastiti-serbian-abstract-of-epccs-guidance-on-hypertension/
https://gpcardio.org/en/2019-10-29_french-society-of-general-medicine-sfmg/
https://gpcardio.org/en/2019-10-29_greek-societies-involved-in-primary-care/
https://gpcardio.org/en/2019-11-04_epccs-and-primary-cv-care-in-france/
https://gpcardio.org/en/2019-11-04_epccs-and-primary-cv-care-in-ireland/
https://gpcardio.org/en/2019-11-04_epccs-and-primary-cv-care-in-poland-english/
https://gpcardio.org/en/2019-11-04_epccs-and-primary-cv-care-in-poland-polish/
https://gpcardio.org/en/2019-11-04_epccs-and-primary-cv-care-in-turkey/
https://gpcardio.org/en/2019-11-04_epccs-and-primary-cv-care-in-ukraine/
https://gpcardio.org/en/2019-11-12_heart-failure-and-comorbidities-kidney-disease-and-cancer/
https://gpcardio.org/en/2020-04-09_initial-invasive-or-conservative-strategy-for-stable-coronary-disease/
https://gpcardio.org/en/2020-04-14_effect-of-dapagliflozin-on-worsening-heart-failure-and-cardiovascular-death-in-patients-with-heart-failure-with-and-without-diabetes/
https://gpcardio.org/en/2020-04-16_inclisiran-for-the-treatment-of-heterozygous-familial-hypercholesterolemia/
https://gpcardio.org/en/2020-04-16_two-phase-3-trials-of-inclisiran-in-patients-with-elevated-ldl-cholesterol/
https://gpcardio.org/en/2020-04-23_management-of-coronary-disease-in-patients-with-advanced-kidney-disease/
https://gpcardio.org/en/2020-04-25_clopidogrel-versus-ticagrelor-or-prasugrel-in-patients-aged-70-years-or-older-with-non-st-elevation-acute-coronary-syndrome-popular-age/
https://gpcardio.org/en/2020-05-01_optimal-antithrombotic-regimens-for-patients-with-atrial-fibrillation-undergoing-percutaneous-coronary-intervention/
https://gpcardio.org/en/2020-05-02_efficacy-of-catheter-based-renal-denervation-in-the-absence-of-antihypertensive-medications-spyral-htn-off-med-pivotal/
https://gpcardio.org/en/2020-05-05_ten-year-outcomes-after-drug-eluting-stents-versus-coronary-artery-bypass-grafting-for-left-main-coronary-disease/
https://gpcardio.org/en/2020-05-09_monotherapy-with-a-p2y12-inhibitor-or-aspirin-for-secondary-prevention-in-patients-with-established-atherosclerosis/
https://gpcardio.org/en/2020-05-12_clinical-management-of-stable-coronary-artery-disease-in-patients-with-type-2-diabetes-mellitus/
https://gpcardio.org/en/2020-05-14_vericiguat-in-patients-with-heart-failure-and-reduced-ejection-fraction/
https://gpcardio.org/en/2020-05-19_association-of-blood-pressure-lowering-with-incident-dementia-or-cognitive-impairment/
https://gpcardio.org/en/2020-05-26_effect-of-antihypertensive-medication-reduction-vs-usual-care-on-short-term-blood-pressure-control-in-patients-with-hypertension-aged-80-years-and-older/
https://gpcardio.org/en/2020-05-26_worldwide-prevalence-of-familial-hypercholesterolemia/
https://gpcardio.org/en/2020-06-16_effect-of-ticagrelor-monotherapy-vs-ticagrelor-with-aspirin-on-major-bleeding-and-cardiovascular-events-in-patients-with-acute-coronary-syndrome/
https://gpcardio.org/en/2020-07-07_systemic-amyloidosis-recognition-prognosis-and-therapy/
https://gpcardio.org/en/2020-07-11_estimating-lifetime-benefits-of-comprehensive-disease-modifying-pharmacological-therapies-in-patients-with-heart-failure-with-reduced-ejection-fraction/
https://gpcardio.org/en/2020-07-14_association-of-radial-artery-graft-vs-saphenous-vein-graft-with-long-term-cardiovascular-outcomes-among-patients-undergoing-coronary-artery-bypass-grafting/
https://gpcardio.org/en/2020-07-14_comparative-efficacy-and-safety-of-oral-p2y12-inhibitors-in-acute-coronary-syndrome/
https://gpcardio.org/en/2020-08-01_complete-vs-culprit-lesion-only-revascularization-for-st-segment-elevation-myocardial-infarction/
https://gpcardio.org/en/2020-08-04_2020-acc-expert-consensus-decision-pathway-on-management-of-bleeding-in-patients-on-oral-anticoagulants/
https://gpcardio.org/en/2020-08-07_integrated-management-of-atrial-fibrillation-in-primary-care/
https://gpcardio.org/en/2020-08-11_the-safety-and-efficacy-of-aspirin-discontinuation-on-a-background-of-a-p2y12-inhibitor-in-patients-after-percutaneous-coronary-intervention/
https://gpcardio.org/en/2020-08-20_evinacumab-for-homozygous-familial-hypercholesterolemia/
https://gpcardio.org/en/2020-08-25_effect-of-genotype-guided-oral-p2y12-inhibitor-selection-vs-conventional-clopidogrel-therapy-on-ischemic-outcomes-after-percutaneous-coronary-intervention/
https://gpcardio.org/en/2020-09-01_2020-expert-consensus-decision-pathway-on-novel-therapies-for-cardiovascular-risk-reduction-in-patients-with-type-2-diabetes/
https://gpcardio.org/en/2020-09-07_mortality-after-drug-eluting-stents-vs-coronary-artery-bypass-grafting-for-left-main-coronary-artery-disease/
https://gpcardio.org/en/2020-09-14_effects-of-glucagon-like-peptide-1-receptor-agonists-on-major-cardiovascular-events-in-patients-with-type-2-diabetes-mellitus-with-or-without-established-cardiovascular-disease/
https://gpcardio.org/en/2020-09-19_sglt2-inhibitors-in-patients-with-heart-failure-with-reduced-ejection-fraction/
https://gpcardio.org/en/2020-10-01_early-rhythm-control-therapy-in-patients-with-atrial-fibrillation/
https://gpcardio.org/en/2020-10-01_evolocumab-in-pediatric-heterozygous-familial-hypercholesterolemia/
https://gpcardio.org/en/2020-10-01_natural-history-of-asymptomatic-severe-aortic-stenosis-and-the-association-of-early-intervention-with-outcomes/
https://gpcardio.org/en/2020-10-08_cardiovascular-and-renal-outcomes-with-empagliflozin-in-heart-failure/
https://gpcardio.org/en/2020-10-08_cardiovascular-outcomes-with-ertugliflozin-in-type-2-diabetes/
https://gpcardio.org/en/2020-10-08_dapagliflozin-in-patients-with-chronic-kidney-disease/
https://gpcardio.org/en/2020-10-10_prasugrel-based-de-escalation-of-dual-antiplatelet-therapy-after-percutaneous-coronary-intervention-in-patients-with-acute-coronary-syndrome-host-reduce-polytech-acs/
https://gpcardio.org/en/2020-10-13_dual-antiplatelet-therapy-after-percutaneous-coronary-intervention-and-drug-eluting-stents/
https://gpcardio.org/en/2020-10-29_low-dose-edoxaban-in-very-elderly-patients-with-atrial-fibrillation/
https://gpcardio.org/en/2020-10-31_redevelopment-and-validation-of-the-syntax-score-ii-to-individualise-decision-making-between-percutaneous-and-surgical-revascularisation-in-patients-with-complex-coronary-artery-disease/
https://gpcardio.org/en/2020-11-07_complete-revascularization-reduces-cardiovascular-death-in-patients-with-st-segment-elevation-myocardial-infarction-and-multivessel-disease/
https://gpcardio.org/en/2020-11-10_screening-for-high-blood-pressure-in-children-and-adolescents/
https://gpcardio.org/en/2020-11-17_colchicine-in-patients-with-acute-coronary-syndrome/
https://gpcardio.org/en/2020-11-21_efficacy-and-safety-of-lowering-ldl-cholesterol-in-older-patients/
https://gpcardio.org/en/2020-11-21_lipoprotein-a-lowering-by-alirocumab-reduces-the-total-burden-of-cardiovascular-events-independent-of-low-density-lipoprotein-cholesterol-lowering/
https://gpcardio.org/en/2020-11-26_n-of-1-trial-of-a-statin-placebo-or-no-treatment-to-assess-side-effects/
https://gpcardio.org/en/2020-11-26_rivaroxaban-in-patients-with-atrial-fibrillation-and-a-bioprosthetic-mitral-valve/
https://gpcardio.org/en/2020-12-08_effect-of-high-dose-omega-3-fatty-acids-vs-corn-oil-on-major-adverse-cardiovascular-events-in-patients-at-high-cardiovascular-risk/
https://gpcardio.org/en/2020-12-10_evinacumab-in-patients-with-refractory-hypercholesterolemia/
https://gpcardio.org/en/2020-12-12_ferric-carboxymaltose-for-iron-deficiency-at-discharge-after-acute-heart-failure/
https://gpcardio.org/en/2020-12-22_effect-of-digoxin-vs-bisoprolol-for-heart-rate-control-in-atrial-fibrillation-on-patient-reported-quality-of-life/
https://gpcardio.org/en/2021-01-14_cardiac-myosin-activation-with-omecamtiv-mecarbil-in-systolic-heart-failure/
https://gpcardio.org/en/2021-01-14_sotagliflozin-in-patients-with-diabetes-and-chronic-kidney-disease/
https://gpcardio.org/en/2021-01-14_sotagliflozin-in-patients-with-diabetes-and-recent-worsening-heart-failure/
https://gpcardio.org/en/2021-01-21_polypill-with-or-without-aspirin-in-persons-without-cardiovascular-disease/
https://gpcardio.org/en/2021-01-21_short-dual-antiplatelet-therapy-followed-by-p2y12-inhibitor-monotherapy-vs-prolonged-dual-antiplatelet-therapy-after-percutaneous-coronary-intervention-with-second-generation-drug-eluting-stents/
https://gpcardio.org/en/2021-01-26_randomized-trial-of-empagliflozin-in-nondiabetic-patients-with-heart-failure-and-reduced-ejection-fraction/
https://gpcardio.org/en/2021-01-28_cryoablation-or-drug-therapy-for-initial-treatment-of-atrial-fibrillation/
https://gpcardio.org/en/2021-01-28_cryoballoon-ablation-as-initial-therapy-for-atrial-fibrillation/
https://gpcardio.org/en/2021-01-28_inhaled-treprostinil-in-pulmonary-hypertension-due-to-interstitial-lung-disease/
https://gpcardio.org/en/2021-02-01_association-of-sglt2-inhibitors-with-cardiovascular-and-kidney-outcomes-in-patients-with-type-2-diabetes/
https://gpcardio.org/en/2021-02-09_2020-acc-expert-consensus-decision-pathway-for-anticoagulant-and-antiplatelet-therapy-in-patients-with-atrial-fibrillation-or-venous-thromboembolism-undergoing-percutaneous-coronary-intervention-or-wi/
https://gpcardio.org/en/2021-02-09_effect-of-high-intensity-interval-training-moderate-continuous-training-or-guideline-based-physical-activity-advice-on-peak-oxygen-consumption-in-patients-with-heart-failure-with-preserved-ejection-fr/
https://gpcardio.org/en/2021-02-09_finerenone-and-cardiovascular-outcomes-in-patients-with-chronic-kidney-disease-and-type-2-diabetes/
https://gpcardio.org/en/2021-02-16_2021-update-to-the-2017-acc-expert-consensus-decision-pathway-for-optimization-of-heart-failure-treatment/
https://gpcardio.org/en/2021-03-02_3-year-outcomes-of-transcatheter-mitral-valve-repair-in-patients-with-heart-failure/
https://gpcardio.org/en/2021-03-16_effect-of-marine-omega-3-fatty-acid-and-vitamin-d-supplementation-on-incident-atrial-fibrillation/
https://gpcardio.org/en/2021-03-31_effects-of-dapagliflozin-on-mortality-in-patients-with-chronic-kidney-disease/
https://gpcardio.org/en/2021-04-07_2020-esc-guidelines-for-the-management-of-acute-coronary-syndromes-in-patients-presenting-without-persistent-st-segment-elevation/
https://gpcardio.org/en/2021-04-17_guided-versus-standard-antiplatelet-therapy-in-patients-undergoing-percutaneous-coronary-intervention/
https://gpcardio.org/en/2021-05-01_pharmacological-blood-pressure-lowering-for-primary-and-secondary-prevention-of-cardiovascular-disease-across-different-levels-of-blood-pressure/
https://gpcardio.org/en/2021-05-05_do-β-blockers-cause-depression/
https://gpcardio.org/en/2021-05-20_final-report-of-a-trial-of-intensive-versus-standard-blood-pressure-control/
https://gpcardio.org/en/2021-05-27_comparative-effectiveness-of-aspirin-dosing-in-cardiovascular-disease/
https://gpcardio.org/en/2021-06-01_assessment-of-catheter-ablation-or-antiarrhythmic-drugs-for-first-line-therapy-of-atrial-fibrillation/
https://gpcardio.org/en/2021-06-03_left-atrial-appendage-occlusion-during-cardiac-surgery-to-prevent-stroke/
https://gpcardio.org/en/2021-06-26_aspirin-versus-clopidogrel-for-chronic-maintenance-monotherapy-after-percutaneous-coronary-intervention-host-exam/
https://gpcardio.org/en/2021-06-26_ultrasound-renal-denervation-for-hypertension-resistant-to-a-triple-medication-pill-radiance-htn-trio/
https://gpcardio.org/en/2021-07-10_efficacy-and-safety-of-a-novel-dual-gip-and-glp-1-receptor-agonist-tirzepatide-in-patients-with-type-2-diabetes-surpass-1/
https://gpcardio.org/en/2021-07-15_physical-rehabilitation-for-older-patients-hospitalized-for-heart-failure/
https://gpcardio.org/en/2021-07-21_efficacy-and-safety-of-low-dose-colchicine-in-patients-with-coronary-disease/
https://gpcardio.org/en/2021-07-22_multivessel-pci-guided-by-ffr-or-angiography-for-myocardial-infarction/
https://gpcardio.org/en/2021-08-05_milrinone-as-compared-with-dobutamine-in-the-treatment-of-cardiogenic-shock/
https://gpcardio.org/en/2021-08-14_once-weekly-tirzepatide-versus-once-daily-insulin-degludec-as-add-on-to-metformin-with-or-without-sglt2-inhibitors-in-patients-with-type-2-diabetes-surpass-3/
https://gpcardio.org/en/2021-08-17_lowering-cholesterol-blood-pressure-or-both-to-prevent-cardiovascular-events/
https://gpcardio.org/en/2021-08-31_2021-acc-expert-consensus-decision-pathway-on-the-management-of-ascvd-risk-reduction-in-patients-with-persistent-hypertriglyceridemia/
https://gpcardio.org/en/2021-09-02_cardiovascular-and-renal-outcomes-with-efpeglenatide-in-type-2-diabetes/
https://gpcardio.org/en/2021-09-11_haemodynamic-guided-management-of-heart-failure-guide-hf/
https://gpcardio.org/en/2021-09-16_effect-of-salt-substitution-on-cardiovascular-events-and-death/
https://gpcardio.org/en/2021-09-18_initial-treatment-with-a-single-pill-containing-quadruple-combination-of-quarter-doses-of-blood-pressure-medicines-versus-standard-dose-monotherapy-in-patients-with-hypertension-quartet/
https://gpcardio.org/en/2021-09-30_trial-of-intensive-blood-pressure-control-in-older-patients-with-hypertension/
https://gpcardio.org/en/2021-10-09_unguided-de-escalation-from-ticagrelor-to-clopidogrel-in-stabilised-patients-with-acute-myocardial-infarction-undergoing-percutaneous-coronary-intervention-talos-ami/
https://gpcardio.org/en/2021-10-14_empagliflozin-and-major-renal-outcomes-in-heart-failure/
https://gpcardio.org/en/2021-10-14_empagliflozin-in-heart-failure-with-a-preserved-ejection-fraction/
https://gpcardio.org/en/2021-10-19_effect-of-empagliflozin-on-worsening-heart-failure-events-in-patients-with-heart-failure-and-preserved-ejection-fraction/
https://gpcardio.org/en/2021-10-23_clinical-outcomes-in-systematic-screening-for-atrial-fibrillation-strokestop/
https://gpcardio.org/en/2021-10-28_dual-antiplatelet-therapy-after-pci-in-patients-at-high-bleeding-risk/
https://gpcardio.org/en/2021-11-02_influenza-vaccination-after-myocardial-infarction/
https://gpcardio.org/en/2021-11-11_angiotensin-receptor-neprilysin-inhibition-in-acute-myocardial-infarction/
https://gpcardio.org/en/2021-11-13_blood-pressure-lowering-and-risk-of-new-onset-type-2-diabetes/
https://gpcardio.org/en/2021-11-13_tirzepatide-versus-insulin-glargine-in-type-2-diabetes-and-increased-cardiovascular-risk-surpass-4/
https://gpcardio.org/en/2021-12-02_edoxaban-versus-vitamin-k-antagonist-for-atrial-fibrillation-after-tavr/
https://gpcardio.org/en/2021-12-04_posterior-left-pericardiotomy-for-the-prevention-of-atrial-fibrillation-after-cardiac-surgery/
https://gpcardio.org/en/2021-12-07_av-junction-ablation-and-cardiac-resynchronization-for-patients-with-permanent-atrial-fibrillation-and-narrow-qrs/
https://gpcardio.org/en/2021-12-09_cardiovascular-events-with-finerenone-in-kidney-disease-and-type-2-diabetes/
https://gpcardio.org/en/2021-12-11_angiographic-quantitative-flow-ratio-guided-coronary-intervention-favor-iii-china/
https://gpcardio.org/en/2021-12-18_percutaneous-coronary-intervention-with-drug-eluting-stents-versus-coronary-artery-bypass-grafting-in-left-main-coronary-artery-disease/
https://gpcardio.org/en/2021-12-21_effect-of-long-term-marine-3-fatty-acids-supplementation-on-the-risk-of-atrial-fibrillation-in-randomized-controlled-trials-of-cardiovascular-outcomes/
https://gpcardio.org/en/2021-12-30_angiography-after-out-of-hospital-cardiac-arrest-without-st-segment-elevation/
https://gpcardio.org/en/2021-12-30_chlorthalidone-for-hypertension-in-advanced-chronic-kidney-disease/
https://gpcardio.org/en/2022-01-13_fractional-flow-reserve-guided-pci-as-compared-with-coronary-bypass-surgery/
https://gpcardio.org/en/2022-01-18_2021-acc-aha-scai-guideline-for-coronary-artery-revascularization/
https://gpcardio.org/en/2022-01-25_direct-oral-anticoagulants-versus-warfarin-in-patients-with-atrial-fibrillation/
https://gpcardio.org/en/2022-01-25_screening-for-atrial-fibrillation/
https://gpcardio.org/en/2022-02-08_finerenone-reduces-risk-of-incident-heart-failure-in-patients-with-chronic-kidney-disease-and-type-2-diabetes/
https://gpcardio.org/en/2022-02-10_cardiovascular-and-kidney-outcomes-with-finerenone-in-patients-with-type-2-diabetes-and-chronic-kidney-disease/
https://gpcardio.org/en/2022-03-07_comparative-effects-of-guided-vs-potent-p2y12-inhibitor-therapy-in-acute-coronary-syndrome/
https://gpcardio.org/en/2022-03-21_systematic-early-rhythm-control-strategy-for-atrial-fibrillation-in-patients-with-or-without-symptoms/
https://gpcardio.org/en/2022-04-09_reduction-of-dietary-sodium-to-less-than-100-mmol-in-heart-failure-sodium-hf/
https://gpcardio.org/en/2022-04-09_safety-of-the-oral-factor-xia-inhibitor-asundexian-compared-with-apixaban-in-patients-with-atrial-fibrillation-pacific-af/
https://gpcardio.org/en/2022-04-26_aspirin-use-to-prevent-cardiovascular-disease/
https://gpcardio.org/en/2022-05-03_2022-aha-acc-hfsa-guideline-for-the-management-of-heart-failure/
https://gpcardio.org/en/2022-05-03_2022-aha-acc-hfsa-guideline-for-the-management-of-heart-failure/
https://gpcardio.org/en/2022-05-03_2022-aha-acc-hfsa-guideline-for-the-management-of-heart-failure/
https://gpcardio.org/en/2022-05-10_effect-of-alirocumab-added-to-high-intensity-statin-therapy-on-coronary-atherosclerosis-in-patients-with-acute-myocardial-infarction/
https://gpcardio.org/en/2022-05-12_treatment-for-mild-chronic-hypertension-during-pregnancy/
https://gpcardio.org/en/2022-05-21_bariatric-surgery-and-cardiovascular-disease/
https://gpcardio.org/en/2022-05-31_effects-of-long-term-metformin-and-lifestyle-interventions-on-cardiovascular-events-in-the-diabetes-prevention-program-and-its-outcome-study/
https://gpcardio.org/en/2022-06-02_need-to-restart-and-catch-up-in-cvd-prevention-in-time-of-covid-19/
https://gpcardio.org/en/2022-06-07_randomized-ablation-based-rhythm-control-versus-rate-control-trial-in-patients-with-heart-failure-and-atrial-fibrillation/
https://gpcardio.org/en/2022-06-21_does-timing-of-ventricular-tachycardia-ablation-affect-prognosis-in-patients-with-an-implantable-cardioverter-defibrillator-results-from-the-multicenter-randomized-partita-trial/
https://gpcardio.org/en/2022-06-21_effect-of-mri-guided-fibrosis-ablation-vs-conventional-catheter-ablation-on-atrial-arrhythmia-recurrence-in-patients-with-persistent-atrial-fibrillation/
https://gpcardio.org/en/2022-07-19_effect-of-omecamtiv-mecarbil-on-exercise-capacity-in-chronic-heart-failure-with-reduced-ejection-fraction/
https://gpcardio.org/en/2022-07-26_behavioral-counseling-interventions-to-promote-a-healthy-diet-and-physical-activity-for-cardiovascular-disease-prevention-in-adults-without-cardiovascular-disease-risk-factors/
https://gpcardio.org/en/2022-07-26_effects-of-early-empagliflozin-initiation-on-diuresis-and-kidney-function-in-patients-with-acute-decompensated-heart-failure-empag-hf/
https://gpcardio.org/en/2022-07-26_effects-of-empagliflozin-on-symptoms-physical-limitations-and-quality-of-life-in-patients-hospitalized-for-acute-heart-failure/
https://gpcardio.org/en/2022-07-30_long-term-efficacy-and-safety-of-moderate-intensity-statin-with-ezetimibe-combination-therapy-versus-high-intensity-statin-monotherapy-in-patients-with-atherosclerotic-cardiovascular-disease-racing/
https://gpcardio.org/en/2022-08-09_initial-decline-dip-in-estimated-glomerular-filtration-rate-after-initiation-of-dapagliflozin-in-patients-with-heart-failure-and-reduced-ejection-fraction/
https://gpcardio.org/en/2022-08-23_statin-use-for-the-primary-prevention-of-cardiovascular-disease-in-adults/
https://gpcardio.org/en/2022-08-23_statin-use-for-the-primary-prevention-of-cardiovascular-disease-in-adults/
https://gpcardio.org/en/2022-08-30_empagliflozin-for-heart-failure-with-preserved-left-ventricular-ejection-fraction-with-and-without-diabetes/
https://gpcardio.org/en/2022-09-01_fractional-flow-reserve-or-intravascular-ultrasonography-to-guide-pci/
https://gpcardio.org/en/2022-09-03_sglt-2-inhibitors-in-patients-with-heart-failure/
https://gpcardio.org/en/2022-09-07_prevalence-of-statin-intolerance/
https://gpcardio.org/en/2022-09-08_routine-functional-testing-or-standard-care-in-high-risk-patients-after-pci/
https://gpcardio.org/en/2022-09-10_effect-of-statin-therapy-on-muscle-symptoms/
https://gpcardio.org/en/2022-09-13_early-rhythm-control-in-patients-with-atrial-fibrillation-and-high-comorbidity-burden/
https://gpcardio.org/en/2022-09-15_polypill-strategy-in-secondary-cardiovascular-prevention/
https://gpcardio.org/en/2022-09-15_rivaroxaban-in-rheumatic-heart-disease-associated-atrial-fibrillation/
https://gpcardio.org/en/2022-09-20_harmonization-of-the-american-college-of-cardiology-american-heart-association-and-european-society-of-cardiology-european-society-of-hypertension-blood-pressure-hypertension-guidelines/
https://gpcardio.org/en/2022-09-22_dapagliflozin-in-heart-failure-with-mildly-reduced-or-preserved-ejection-fraction/
https://gpcardio.org/en/2022-09-22_glycemia-reduction-in-type-2-diabetes-microvascular-and-cardiovascular-outcomes/
https://gpcardio.org/en/2022-09-26_effects-of-salt-substitutes-on-clinical-outcomes/
https://gpcardio.org/en/2022-09-27_five-year-outcomes-in-patients-with-fully-magnetically-levitated-vs-axial-flow-left-ventricular-assist-devices-in-the-momentum-3-randomized-trial/
https://gpcardio.org/en/2022-09-27_randomized-trial-of-left-bundle-branch-vs-biventricular-pacing-for-cardiac-resynchronization-therapy/
https://gpcardio.org/en/2022-09-29_acetazolamide-in-acute-decompensated-heart-failure-with-volume-overload/
https://gpcardio.org/en/2022-10-04_2022-acc-expert-consensus-decision-pathway-on-the-role-of-nonstatin-therapies-for-ldl-cholesterol-lowering-in-the-management-of-atherosclerotic-cardiovascular-disease-risk/
https://gpcardio.org/en/2022-10-04_dapagliflozin-in-patients-recently-hospitalized-with-heart-failure-and-mildly-reduced-or-preserved-ejection-fraction/
https://gpcardio.org/en/2022-10-04_early-versus-delayed-non-vitamin-k-antagonist-oral-anticoagulant-therapy-after-acute-ischemic-stroke-in-atrial-fibrillation-timing/
https://gpcardio.org/en/2022-10-08_allopurinol-versus-usual-care-in-uk-patients-with-ischaemic-heart-disease-all-heart/
https://gpcardio.org/en/2022-10-13_percutaneous-revascularization-for-ischemic-left-ventricular-dysfunction/
https://gpcardio.org/en/2022-10-18_efficacy-and-safety-of-dapagliflozin-according-to-frailty-in-patients-with-heart-failure/
https://gpcardio.org/en/2022-10-20_blood-pressure-targets-in-comatose-survivors-of-cardiac-arrest/
https://gpcardio.org/en/2022-10-22_cardiovascular-outcomes-in-adults-with-hypertension-with-evening-versus-morning-dosing-of-usual-antihypertensives-in-the-uk-time-study/
https://gpcardio.org/en/2022-11-01_empagliflozin-in-acute-myocardial-infarction/
https://gpcardio.org/en/2022-11-01_patiromer-for-the-management-of-hyperkalemia-in-heart-failure-with-reduced-ejection-fraction/
https://gpcardio.org/en/2022-11-05_intensive-blood-pressure-control-after-endovascular-thrombectomy-for-acute-ischaemic-stroke-enchanted2-mt/
https://gpcardio.org/en/2022-11-15_hospitalizations-and-mortality-in-patients-with-secondary-mitral-regurgitation-and-heart-failure/
https://gpcardio.org/en/2022-11-17_small-interfering-rna-to-reduce-lipoprotein-a-in-cardiovascular-disease/
https://gpcardio.org/en/2022-11-19_impact-of-diabetes-on-the-effects-of-sodium-glucose-co-transporter-2-inhibitors-on-kidney-outcomes/
https://gpcardio.org/en/2022-11-22_everolimus-eluting-stents-or-bypass-surgery-for-multivessel-coronary-artery-disease/
https://gpcardio.org/en/2022-11-24_triglyceride-lowering-with-pemafibrate-to-reduce-cardiovascular-risk/
https://gpcardio.org/en/2022-11-26_ly3437943-a-novel-triple-gip-glp-1-and-glucagon-receptor-agonist-in-people-with-type-2-diabetes/
https://gpcardio.org/en/2022-12-03_dual-endothelin-antagonist-aprocitentan-for-resistant-hypertension-precision/
https://gpcardio.org/en/2022-12-03_safety-tolerability-and-efficacy-of-up-titration-of-guideline-directed-medical-therapies-for-acute-heart-failure-strong-hf/
https://gpcardio.org/en/2022-12-06_apixaban-for-patients-with-atrial-fibrillation-on-hemodialysis/
https://gpcardio.org/en/2022-12-17_intravenous-ferric-derisomaltose-in-patients-with-heart-failure-and-iron-deficiency-in-the-uk-ironman/
https://gpcardio.org/en/2022-12-21_blood-pressure-lowering-and-prevention-of-dementia/
https://gpcardio.org/en/2022-12-29_chlorthalidone-vs-hydrochlorothiazide-for-hypertension-cardiovascular-events/
https://gpcardio.org/en/2023-01-01_impact-of-empagliflozin-on-decongestion-in-acute-heart-failure/
https://gpcardio.org/en/2023-01-03_comparative-effects-of-low-dose-rosuvastatin-placebo-and-dietary-supplements-on-lipids-and-inflammatory-biomarkers/
https://gpcardio.org/en/2023-01-03_phase-2-study-of-aficamten-in-patients-with-obstructive-hypertrophic-cardiomyopathy/
https://gpcardio.org/en/2023-01-03_survival-after-invasive-or-conservative-management-of-stable-coronary-disease/
https://gpcardio.org/en/2023-01-10_aspirin-versus-clopidogrel-for-long-term-maintenance-monotherapy-after-percutaneous-coronary-intervention/
https://gpcardio.org/en/2023-01-10_effect-of-catheter-ablation-using-pulmonary-vein-isolation-with-vs-without-posterior-left-atrial-wall-isolation-on-atrial-arrhythmia-recurrence-in-patients-with-persistent-atrial-fibrillation/
https://gpcardio.org/en/2023-01-10_prospective-association-of-daily-steps-with-cardiovascular-disease/
https://gpcardio.org/en/2023-01-12_empagliflozin-in-patients-with-chronic-kidney-disease/
https://gpcardio.org/en/2023-01-12_progression-of-atrial-fibrillation-after-cryoablation-or-drug-therapy/
https://gpcardio.org/en/2023-01-14_cost-effectiveness-of-population-screening-for-atrial-fibrillation/
https://gpcardio.org/en/2023-01-17_effect-of-torsemide-vs-furosemide-after-discharge-on-all-cause-mortality-in-patients-hospitalized-with-heart-failure/
https://gpcardio.org/en/2023-02-01_combining-loop-with-thiazide-diuretics-for-decompensated-heart-failure/
https://gpcardio.org/en/2023-02-02_phase-2-trial-of-baxdrostat-for-treatment-resistant-hypertension/
https://gpcardio.org/en/2023-02-07_extracorporeal-membrane-oxygenation-in-the-therapy-of-cardiogenic-shock/
https://gpcardio.org/en/2023-02-16_catheter-ablation-improves-cardiovascular-outcomes-in-patients-with-atrial-fibrillation-and-heart-failure/
https://gpcardio.org/en/2023-02-28_endovascular-ultrasound-renal-denervation-to-treat-hypertension/
https://gpcardio.org/en/2023-02-28_incidental-coronary-artery-calcium/
https://gpcardio.org/en/2023-03-18_effectiveness-of-a-non-physician-community-health-care-provider-led-intensive-blood-pressure-intervention-versus-usual-care-on-cardiovascular-disease-crhcp/
https://gpcardio.org/en/2023-04-04_treat-to-target-or-high-intensity-statin-in-patients-with-coronary-artery-disease/
https://gpcardio.org/en/2023-04-08_immediate-versus-staged-complete-revascularisation-in-patients-presenting-with-acute-coronary-syndrome-and-multivessel-coronary-disease-biovasc/
https://gpcardio.org/en/2023-04-11_heterogeneity-in-blood-pressure-response-to-4-antihypertensive-drugs/
https://gpcardio.org/en/2023-04-13_bempedoic-acid-and-cardiovascular-outcomes-in-statin-intolerant-patients/
https://gpcardio.org/en/2023-04-15_inflammation-and-cholesterol-as-predictors-of-cardiovascular-events-among-patients-receiving-statin-therapy/
https://gpcardio.org/en/2023-04-17_dual-antiplatelet-therapy-de-escalation-in-acute-coronary-syndrome/
https://gpcardio.org/en/2023-04-18_association-between-achieved-low-density-lipoprotein-cholesterol-levels-and-long-term-cardiovascular-and-safety-outcomes/
https://gpcardio.org/en/2023-04-20_phase-3-trial-of-sotatercept-for-treatment-of-pulmonary-arterial-hypertension/
https://gpcardio.org/en/2023-04-25_phase-2b-randomized-trial-of-the-oral-pcsk9-inhibitor-mk-0616/
https://gpcardio.org/en/2023-05-04_intravascular-imaging-guided-or-angiography-guided-complex-pci/
https://gpcardio.org/en/2023-05-09_2023-acc-expert-consensus-decision-pathway-on-management-of-heart-failure-with-preserved-ejection-fraction/
https://gpcardio.org/en/2023-05-18_transcatheter-repair-for-patients-with-tricuspid-regurgitation/
https://gpcardio.org/en/2023-05-27_a-vein-bypass-first-versus-a-best-endovascular-treatment-first-revascularisation-strategy-for-patients-with-chronic-limb-threatening-ischaemia-who-required-an-infra-popliteal-with-or-without-an-additi/
https://gpcardio.org/en/2023-06-01_efficacy-and-safety-of-low-dose-triple-and-quadruple-combination-pills-vs-monotherapy-usual-care-or-placebo-for-the-initial-management-of-hypertension/
https://gpcardio.org/en/2023-06-01_five-year-follow-up-after-transcatheter-repair-of-secondary-mitral-regurgitation/
https://gpcardio.org/en/2023-06-06_direct-oral-anticoagulants-versus-warfarin-across-the-spectrum-of-kidney-function/
https://gpcardio.org/en/2023-06-06_uptitrating-treatment-after-heart-failure-hospitalization-across-the-spectrum-of-left-ventricular-ejection-fraction/
https://gpcardio.org/en/2023-06-08_treatment-of-gestational-diabetes-mellitus-diagnosed-early-in-pregnancy/
https://gpcardio.org/en/2023-06-24_remote-haemodynamic-monitoring-of-pulmonary-artery-pressures-in-patients-with-chronic-heart-failure-monitor-hf/
https://gpcardio.org/en/2023-06-27_effect-of-sglt2-inhibitors-on-cardiovascular-outcomes-across-various-patient-populations/
https://gpcardio.org/en/2023-06-29_early-versus-later-anticoagulation-for-stroke-with-atrial-fibrillation/
https://gpcardio.org/en/2023-07-01_the-third-intensive-care-bundle-with-blood-pressure-reduction-in-acute-cerebral-haemorrhage-trial-interact3/
https://gpcardio.org/en/2023-07-11_p2y12-inhibitor-or-aspirin-monotherapy-for-secondary-prevention-of-coronary-events/
https://gpcardio.org/en/2023-07-13_cardiovascular-safety-of-testosterone-replacement-therapy/
https://gpcardio.org/en/2023-07-20_phase-1-trial-of-antibody-ni006-for-depletion-of-cardiac-transthyretin-amyloid/
https://gpcardio.org/en/2023-07-20_zilebesiran-an-rna-interference-therapeutic-agent-for-hypertension/
https://gpcardio.org/en/2023-08-08_atorvastatin-for-anthracycline-associated-cardiac-dysfunction/
https://gpcardio.org/en/2023-08-08_glp-1-receptor-agonist-therapy-with-and-without-sglt2-inhibitors-in-patients-with-type-2-diabetes/
https://gpcardio.org/en/2023-08-12_retatrutide-a-gip-glp-1-and-glucagon-receptor-agonist-for-people-with-type-2-diabetes/
https://gpcardio.org/en/2023-08-14_sacubitril-valsartan-in-heart-failure-with-mildly-reduced-or-preserved-ejection-fraction/
https://gpcardio.org/en/2023-08-24_fixed-dose-combination-therapies-in-primary-cardiovascular-disease-prevention-in-different-groups/
https://gpcardio.org/en/2023-08-24_pitavastatin-to-prevent-cardiovascular-disease-in-hiv-infection/
https://gpcardio.org/en/2023-09-07_complete-or-culprit-only-pci-in-older-patients-with-myocardial-infarction/
https://gpcardio.org/en/2023-09-07_daily-oral-glp-1-receptor-agonist-orforglipron-for-adults-with-obesity/
https://gpcardio.org/en/2023-09-14_ferric-carboxymaltose-in-heart-failure-with-iron-deficiency/
https://gpcardio.org/en/2023-09-19_fractional-flow-reserve-guided-pci-or-coronary-bypass-surgery-for-3-vessel-coronary-artery-disease/
https://gpcardio.org/en/2023-09-21_semaglutide-in-patients-with-heart-failure-with-preserved-ejection-fraction-and-obesity/
https://gpcardio.org/en/2023-09-28_anticoagulation-with-edoxaban-in-patients-with-atrial-high-rate-episodes/
https://gpcardio.org/en/2023-10-01_efficacy-of-pulmonary-artery-pressure-monitoring-in-patients-with-chronic-heart-failure/
https://gpcardio.org/en/2023-10-01_mineralocorticoid-receptor-antagonists-with-sodium-glucose-co-transporter-2-inhibitors-in-heart-failure/
https://gpcardio.org/en/2023-10-03_estimated-glomerular-filtration-rate-albuminuria-and-adverse-outcomes/
https://gpcardio.org/en/2023-10-05_extracorporeal-life-support-in-infarct-related-cardiogenic-shock/
https://gpcardio.org/en/2023-10-05_global-effect-of-modifiable-risk-factors-on-cardiovascular-disease-and-mortality/
https://gpcardio.org/en/2023-10-12_catheter-ablation-in-end-stage-heart-failure-with-atrial-fibrillation/
https://gpcardio.org/en/2023-10-12_timing-of-complete-revascularization-with-multivessel-pci-for-myocardial-infarction/
https://gpcardio.org/en/2023-10-14_venoarterial-extracorporeal-membrane-oxygenation-in-patients-with-infarct-related-cardiogenic-shock/
https://gpcardio.org/en/2023-10-17_optical-coherence-tomography-guided-or-intravascular-ultrasound-guided-percutaneous-coronary-intervention/
https://gpcardio.org/en/2023-10-17_orthostatic-hypotension-hypertension-treatment-and-cardiovascular-disease/
https://gpcardio.org/en/2023-10-19_oct-or-angiography-guidance-for-pci-in-complex-bifurcation-lesions/
https://gpcardio.org/en/2023-10-19_optical-coherence-tomography-guided-versus-angiography-guided-pci/
https://gpcardio.org/en/2023-10-24_traditional-chinese-medicine-compound-tongxinluo-and-clinical-outcomes-of-patients-with-acute-myocardial-infarction/
https://gpcardio.org/en/2023-11-02_pulsed-field-or-conventional-thermal-ablation-for-paroxysmal-atrial-fibrillation/
https://gpcardio.org/en/2023-11-23_transcatheter-aortic-valve-replacement-in-low-risk-patients-at-five-years/
https://gpcardio.org/en/2023-11-25_zibotentan-in-combination-with-dapagliflozin-compared-with-dapagliflozin-in-patients-with-chronic-kidney-disease-zenith-ckd/
https://gpcardio.org/en/2023-12-14_semaglutide-and-cardiovascular-outcomes-in-obesity-without-diabetes/
https://gpcardio.org/en/2023-12-21_a-placebo-controlled-trial-of-percutaneous-coronary-intervention-for-stable-angina/
https://gpcardio.org/en/2023-12-21_efficacy-of-ferric-carboxymaltose-in-heart-failure-with-iron-deficiency/
https://gpcardio.org/en/2023-12-28_restrictive-or-liberal-transfusion-strategy-in-myocardial-infarction-and-anemia/
https://gpcardio.org/en/2024-01-02_2023-acc-aha-accp-hrs-guideline-for-the-diagnosis-and-management-of-atrial-fibrillation/
https://gpcardio.org/en/2024-01-02_2023-acc-aha-accp-hrs-guideline-for-the-diagnosis-and-management-of-atrial-fibrillation/
https://gpcardio.org/en/2024-01-11_apixaban-for-stroke-prevention-in-subclinical-atrial-fibrillation/
https://gpcardio.org/en/2024-01-18_long-term-outcomes-of-resynchronization-defibrillation-for-heart-failure/
https://gpcardio.org/en/2024-02-13_implantable-hemodynamic-monitors-improve-survival-in-patients-with-heart-failure-and-reduced-ejection-fraction/
https://gpcardio.org/en/2024-02-20_an-aspirin-free-versus-dual-antiplatelet-strategy-for-coronary-stenting/
https://gpcardio.org/en/2024-02-20_safety-and-efficacy-of-ticagrelor-monotherapy-in-patients-with-acute-coronary-syndromes-undergoing-percutaneous-coronary-intervention/
https://gpcardio.org/en/2024-02-20_stopping-aspirin-within-1-month-after-stenting-for-ticagrelor-monotherapy-in-acute-coronary-syndrome/
https://gpcardio.org/en/2024-03-01_impact-of-bempedoic-acid-on-total-cardiovascular-events/
https://gpcardio.org/en/2024-03-02_intravascular-imaging-guided-coronary-drug-eluting-stent-implantation/
https://gpcardio.org/en/2024-03-18_global-shift-from-underweight-to-obesity-dominance-in-three-decades-across-generations/
https://gpcardio.org/en/2024-03-26_direct-oral-anticoagulants-for-stroke-prevention-in-patients-with-device-detected-atrial-fibrillation/
https://gpcardio.org/en/2024-04-01_transcatheter-or-surgical-aortic-valve-implantation/
https://gpcardio.org/en/2024-04-02_stratify-hf-a-european-collaboration-to-develop-an-ai-based-support-system-for-risk-stratification-and-early-detection-of-heart-failure/
https://gpcardio.org/en/2024-04-07_gamification-and-financial-incentives-to-increase-physical-activity-among-patients-at-elevated-cv-risk/
https://gpcardio.org/en/2024-04-08_enhanced-remote-medication-program-boosts-gdmt-prescriptions-for-high-cv-or-kidney-risk-in-t2d-patients/
https://gpcardio.org/en/2024-04-08_web-app-effective-in-determining-access-to-statins-without-a-prescription/
https://gpcardio.org/en/2024-04-16_2024-acc-expert-consensus-decision-pathway-for-treatment-of-heart-failure-with-reduced-ejection-fraction/
https://gpcardio.org/en/2024-04-18_beta-blockers-after-myocardial-infarction-and-preserved-ejection-fraction/
https://gpcardio.org/en/2024-04-18_microaxial-flow-pump-or-standard-care-in-infarct-related-cardiogenic-shock/
https://gpcardio.org/en/2024-04-18_semaglutide-in-patients-with-obesity-related-heart-failure-and-type-2-diabetes/
https://gpcardio.org/en/2024-04-25_empagliflozin-after-acute-myocardial-infarction/
https://gpcardio.org/en/2024-04-25_ffr-guided-complete-or-culprit-only-pci-in-patients-with-myocardial-infarction/
https://gpcardio.org/en/2024-04-27_semaglutide-versus-placebo-in-people-with-obesity-related-heart-failure-with-preserved-ejection-fraction/
https://gpcardio.org/en/2024-05-01_ticagrelor-or-clopidogrel-monotherapy-vs-dual-antiplatelet-therapy-after-percutaneous-coronary-intervention/
https://gpcardio.org/en/2024-05-02_apolipoprotein-a1-infusions-and-cardiovascular-outcomes-after-acute-myocardial-infarction/
https://gpcardio.org/en/2024-05-04_preventive-percutaneous-coronary-intervention-versus-optimal-medical-therapy-alone-for-the-treatment-of-vulnerable-atherosclerotic-coronary-plaques-prevent/
https://gpcardio.org/en/2024-05-04_stratifyhf-providing-support-to-primary-care-in-early-diagnosis-of-heart-failure/
https://gpcardio.org/en/2024-05-06_the-stratifyhf-research-and-innovation-action/
https://gpcardio.org/en/2024-05-11_intravascular-ultrasound-guided-versus-angiography-guided-percutaneous-coronary-intervention-in-acute-coronary-syndromes-ivus-acs/
https://gpcardio.org/en/2024-05-11_ticagrelor-alone-versus-ticagrelor-plus-aspirin-from-month-1-to-month-12-after-percutaneous-coronary-intervention-in-patients-with-acute-coronary-syndromes-ultimate-dapt/
https://gpcardio.org/en/2024-05-16_andexanet-for-factor-xa-inhibitor-associated-acute-intracerebral-hemorrhage/
https://gpcardio.org/en/2024-05-16_olezarsen-acute-pancreatitis-and-familial-chylomicronemia-syndrome/
https://gpcardio.org/en/2024-05-16_olezarsen-for-hypertriglyceridemia-in-patients-at-high-cardiovascular-risk/
https://gpcardio.org/en/2024-05-30_intensive-ambulance-delivered-blood-pressure-reduction-in-hyperacute-stroke/
https://gpcardio.org/en/2024-06-01_pulmonary-arterial-hypertension-treatment/
https://gpcardio.org/en/2024-06-04_enhancing-cvd-risk-assessment-integrating-genetic-risk-for-improved-prediction/
https://gpcardio.org/en/2024-06-04_sodium-glucose-cotransporter-2-inhibitors-and-major-adverse-cardiovascular-outcomes/
https://gpcardio.org/en/2024-06-06_self-expanding-or-balloon-expandable-tavr-in-patients-with-a-small-aortic-annulus/
https://gpcardio.org/en/2024-06-14_invasive-vs-conservative-management-of-older-patients-with-non-st-elevation-acute-coronary-syndrome/
https://gpcardio.org/en/2024-06-25_revisiting-race-and-the-benefit-of-ras-blockade-in-heart-failure/
https://gpcardio.org/en/2024-07-01_plozasiran-aro-apoc3-for-severe-hypertriglyceridemia/
https://gpcardio.org/en/2024-07-11_effects-of-semaglutide-on-chronic-kidney-disease-in-patients-with-type-2-diabetes/
https://gpcardio.org/en/2024-07-13_long-term-colchicine-for-the-prevention-of-vascular-recurrent-events-in-non-cardioembolic-stroke-convince/
https://gpcardio.org/en/2024-07-20_lowering-systolic-blood-pressure-to-less-than-120-mm-hg-versus-less-than-140-mm-hg-in-patients-with-high-cardiovascular-risk-with-and-without-diabetes-or-previous-stroke/
https://gpcardio.org/en/2024-08-24_semaglutide-and-cardiovascular-outcomes-in-patients-with-obesity-and-prevalent-heart-failure/
https://gpcardio.org/en/2024-09-01_ticagrelor-monotherapy-for-acute-coronary-syndrome/
https://gpcardio.org/en/2024-09-04_global-insights-from-the-interaspire-study-mapping-lipoprotein-a-prevalence-in-coronary-heart-disease-across-six-who-regions/
https://gpcardio.org/en/2024-09-07_semaglutide-versus-placebo-in-patients-with-heart-failure-and-mildly-reduced-or-preserved-ejection-fraction/
https://gpcardio.org/en/2024-09-12_plozasiran-an-rna-interference-agent-targeting-apoc3-for-mixed-hyperlipidemia/
https://gpcardio.org/en/2024-09-12_zodasiran-an-rnai-therapeutic-targeting-angptl3-for-mixed-hyperlipidemia/
https://gpcardio.org/en/2024-09-14_temporary-mechanical-circulatory-support-in-infarct-related-cardiogenic-shock/
https://gpcardio.org/en/2024-09-21_mineralocorticoid-receptor-antagonists-in-heart-failure/
https://gpcardio.org/en/2024-09-24_2024-acc-expert-consensus-decision-pathway-on-clinical-assessment-management-and-trajectory-of-patients-hospitalized-with-heart-failure-focused-update/
https://gpcardio.org/en/2024-09-29_2024-esc-guidelines-for-the-management-of-atrial-fibrillation-developed-in-collaboration-with-the-european-association-for-cardio-thoracic-surgery-eacts/
https://gpcardio.org/en/2024-10-07_2024-esc-guidelines-for-the-management-of-elevated-blood-pressure-and-hypertension/
https://gpcardio.org/en/2024-10-07_semaglutide-and-blood-pressure/
https://gpcardio.org/en/2024-10-10_beta-blocker-interruption-or-continuation-after-myocardial-infarction/
https://gpcardio.org/en/2024-10-22_effects-of-semaglutide-on-heart-failure-outcomes-in-diabetes-and-chronic-kidney-disease-in-the-flow-trial/
https://gpcardio.org/en/2024-10-24_finerenone-in-heart-failure-with-mildly-reduced-or-preserved-ejection-fraction/
https://gpcardio.org/en/2024-10-29_adjudication-of-hospitalizations-and-deaths-in-the-ironman-trial-of-intravenous-iron-for-heart-failure/
https://gpcardio.org/en/2024-11-05_complete-versus-culprit-only-revascularization-in-older-patients-with-st-segment-elevation-myocardial-infarction/
https://gpcardio.org/en/2024-11-07_invasive-treatment-strategy-for-older-patients-with-myocardial-infarction/
https://gpcardio.org/en/2024-11-09_quantitative-flow-ratio-versus-fractional-flow-reserve-for-coronary-revascularisation-guidance-favor-iii-europe/
https://gpcardio.org/en/2024-11-14_transcatheter-repair-versus-mitral-valve-surgery-for-secondary-mitral-regurgitation/
https://gpcardio.org/en/2024-11-14_transcatheter-valve-repair-in-heart-failure-with-moderate-to-severe-mitral-regurgitation/
https://gpcardio.org/en/2024-11-19_effect-of-screening-for-undiagnosed-atrial-fibrillation-on-stroke-prevention/
https://gpcardio.org/en/2024-11-26_cardiovascular-kidney-and-safety-outcomes-with-glp-1-receptor-agonists-alone-and-in-combination-with-sglt2-inhibitors-in-type-2-diabetes/
https://gpcardio.org/en/2024-12-12_pci-in-patients-undergoing-transcatheter-aortic-valve-implantation/
https://gpcardio.org/en/2024-12-14_the-vital-role-of-primary-care-in-advancing-cardiovascular-health/
https://gpcardio.org/en/2025-01-02_asundexian-versus-apixaban-in-patients-with-atrial-fibrillation/
https://gpcardio.org/en/2025-01-07_efficacy-and-safety-of-finerenone-across-the-ejection-fraction-spectrum-in-heart-failure-with-mildly-reduced-or-preserved-ejection-fraction/
https://gpcardio.org/en/2025-01-09_plozasiran-for-managing-persistent-chylomicronemia-and-pancreatitis-risk/
https://gpcardio.org/en/2025-01-09_transcatheter-valve-replacement-in-severe-tricuspid-regurgitation/
https://gpcardio.org/en/2025-01-14_transcatheter-edge-to-edge-repair-for-severe-isolated-tricuspid-regurgitation/
https://gpcardio.org/en/2025-01-21_early-intervention-in-patients-with-asymptomatic-severe-aortic-stenosis-and-myocardial-fibrosis/
https://gpcardio.org/en/2025-01-21_oral-muvalaplin-for-lowering-of-lipoprotein-a/
https://gpcardio.org/en/2025-01-23_abelacimab-versus-rivaroxaban-in-patients-with-atrial-fibrillation/
https://gpcardio.org/en/2025-01-25_coronary-ct-angiography-guided-management-of-patients-with-stable-chest-pain/
https://gpcardio.org/en/2025-01-30_continuation-versus-interruption-of-oral-anticoagulation-during-tavi/
https://gpcardio.org/en/2025-01-30_tirzepatide-for-heart-failure-with-preserved-ejection-fraction-and-obesity/
https://gpcardio.org/en/2025-02-13_colchicine-in-acute-myocardial-infarction/
https://gpcardio.org/en/2025-02-13_routine-spironolactone-in-acute-myocardial-infarction/
https://gpcardio.org/en/2025-02-20_catheter-ablation-or-antiarrhythmic-drugs-for-ventricular-tachycardia/
https://gpcardio.org/en/2025-03-11_transcatheter-aortic-valve-replacement-in-patients-with-systolic-heart-failure-and-moderate-aortic-stenosis/
https://gpcardio.org/en/2025-03-15_study-on-cardiovascular-risk-factors-and-primary-care-utilization-in-spain/
https://gpcardio.org/en/2025-03-16_primary-prevention-of-atherosclerotic-cardiovascular-disease-ascvd-in-primary-care-a-systematic-review-of-guidelines/
https://gpcardio.org/en/2025-03-17_sex-differences-and-trends-in-cardiovascular-risk-management-insights-from-a-long-term-primary-care-study/
https://gpcardio.org/en/2025-03-25_age-and-sex-differences-in-efficacy-of-treatments-for-type-2-diabetes/
https://gpcardio.org/en/2025-03-25_anticoagulation-and-antiplatelet-therapy-for-atrial-fibrillation-and-stable-coronary-disease/
https://gpcardio.org/en/2025-03-25_antithrombotic-therapy-to-minimize-total-events-after-acs-or-pci-in-atrial-fibrillation/
https://gpcardio.org/en/2025-03-27_intensive-blood-pressure-control-in-patients-with-type-2-diabetes/
https://gpcardio.org/en/2025-03-28_flecainide-acetate-inhalation-solution-for-cardioversion-of-recent-onset-symptomatic-atrial-fibrillation/
https://gpcardio.org/en/2025-04-01_2025-acc-aha-guideline-for-the-management-of-patients-with-acute-coronary-syndromes/
https://gpcardio.org/en/2025-04-01_efficacy-and-safety-of-aldosterone-synthase-inhibitors-for-hypertension/
https://gpcardio.org/en/2025-04-01_meta-analysis-of-sotagliflozin-a-dual-sodium-glucose-cotransporter-1-2-inhibitor-for-heart-failure-in-type-2-diabetes/
https://gpcardio.org/en/2025-04-03_left-atrial-appendage-closure-after-ablation-for-atrial-fibrillation/
https://gpcardio.org/en/2025-04-07_empagliflozin-in-resistant-hypertension-and-heart-failure-with-preserved-ejection-fraction/
https://gpcardio.org/en/2025-04-07_sodium-glucose-co-transporter-2-inhibitors-and-new-onset-diabetes-in-cardiovascular-or-kidney-disease/
https://gpcardio.org/en/2025-04-10_dapagliflozin-in-patients-undergoing-transcatheter-aortic-valve-implantation/
https://gpcardio.org/en/2025-04-10_introducing-gpcardio-bridging-the-gap-in-cardiovascular-care/
https://gpcardio.org/en/2025-04-17_pulsed-field-or-cryoballoon-ablation-for-paroxysmal-atrial-fibrillation/
https://gpcardio.org/en/2025-05-03_semaglutide-and-walking-capacity-in-people-with-symptomatic-peripheral-artery-disease-and-type-2-diabetes-stride/
https://gpcardio.org/en/2025-05-08_lorundrostat-efficacy-and-safety-in-patients-with-uncontrolled-hypertension/
https://gpcardio.org/en/2025-05-13_effect-of-empagliflozin-on-the-mechanisms-driving-erythropoiesis-and-iron-mobilization-in-patients-with-heart-failure/
https://gpcardio.org/en/2025-05-13_interplay-of-chronic-kidney-disease-and-the-effects-of-tirzepatide-in-patients-with-heart-failure-preserved-ejection-fraction-and-obesity/
https://gpcardio.org/en/2025-05-17_fixed-dose-combination-of-obicetrapib-and-ezetimibe-for-ldl-cholesterol-reduction-tandem/
https://gpcardio.org/en/2025-05-29_oral-semaglutide-and-cardiovascular-outcomes-in-high-risk-type-2-diabetes/
https://gpcardio.org/en/2025-06-01_ffr-guided-percutaneous-coronary-intervention-vs-coronary-artery-bypass-grafting-in-patients-with-diabetes/
https://gpcardio.org/en/2025-06-01_novel-controlled-metabolic-accelerator-for-obesity-related-hfpef/
https://gpcardio.org/en/2025-06-01_randomized-trial-to-assess-worsening-renal-function-by-adding-dapagliflozin-for-acute-decompensated-heart-failure/
https://gpcardio.org/en/2025-06-03_an-oral-pcsk9-inhibitor-for-treatment-of-hypercholesterolemia/
https://gpcardio.org/en/2025-06-10_2025-acc-aha-guideline-for-the-management-of-patients-with-acute-coronary-syndromes/
https://gpcardio.org/en/2025-06-10_intravenous-ferric-carboxymaltose-in-heart-failure-with-iron-deficiency/
https://gpcardio.org/en/2025-06-10_oral-semaglutide-and-cardiovascular-outcomes-in-people-with-type-2-diabetes-according-to-sglt2i-use/
https://gpcardio.org/en/2025-06-13_the-impact-of-frailty-on-the-effectiveness-of-intensive-blood-pressure-control-for-patients-with-type-2-diabetes/
https://gpcardio.org/en/2025-06-17_antihypertensive-medication-timing-and-cardiovascular-events-and-death/
https://gpcardio.org/en/2025-06-17_long-acting-factor-xi-inhibition-and-periprocedural-bleeding/
https://gpcardio.org/en/2025-06-17_spironolactone-vs-amiloride-for-resistant-hypertension/
https://gpcardio.org/en/2025-07-01_add-on-treatment-with-zilebesiran-for-inadequately-controlled-hypertension/
https://gpcardio.org/en/2025-07-01_gpcardio-epccs-joins-each-in-european-alliance-for-cardiovascular-health/
https://gpcardio.org/en/2025-07-01_near-universal-prevalence-of-central-adiposity-in-heart-failure-with-preserved-ejection-fraction/
https://gpcardio.org/en/2025-07-03_safety-and-efficacy-of-obicetrapib-in-patients-at-high-cardiovascular-risk/
https://gpcardio.org/en/2025-07-05_collaboration-on-the-optimal-timing-of-anticoagulation-after-ischaemic-stroke-and-atrial-fibrillation/
https://gpcardio.org/en/2025-07-07_colchicine-for-secondary-prevention-of-vascular-events/
https://gpcardio.org/en/2025-07-07_long-term-trials-of-colchicine-for-secondary-prevention-of-vascular-events/
https://gpcardio.org/en/2025-07-08_catheter-ablation-vs-lifestyle-modification-with-antiarrhythmic-drugs-to-treat-atrial-fibrillation/
https://gpcardio.org/en/2025-07-10_gpcardio-and-acc-s-ncd-academy-join-forces-to-strengthen-primary-care-in-cardiovascular-disease-prevention/
https://gpcardio.org/en/2025-07-12_amycretin-a-novel-unimolecular-glp-1-and-amylin-receptor-agonist-administered-subcutaneously/
https://gpcardio.org/en/2025-07-12_safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-the-first-in-class-glp-1-and-amylin-receptor-agonist-amycretin/
https://gpcardio.org/en/2025-07-15_10-year-outcome-of-complete-or-infarct-artery-only-revascularization-in-stemi-with-multivessel-disease/
https://gpcardio.org/en/2025-07-22_cooperative-pfa/
https://gpcardio.org/en/2025-07-28_long-term-benefits-of-atorvastatin-on-the-incidence-of-cardiovascular-events/
https://gpcardio.org/en/2025-07-29_cvd-primary-care-the-need-for-epccs-practice-guidance/
https://gpcardio.org/en/2025-07-29_impact-of-body-mass-index-central-adiposity-and-weight-loss-on-the-benefits-of-tirzepatide-in-hfpef/
https://gpcardio.org/en/2025-08-05_abelacimab-versus-rivaroxaban-in-patients-with-atrial-fibrillation-on-antiplatelet-therapy/
https://gpcardio.org/en/2025-08-05_lorundrostat-in-participants-with-uncontrolled-hypertension-and-treatment-resistant-hypertension/
https://gpcardio.org/en/2025-08-05_sodium-glucose-cotransporter-2-inhibitor-with-and-without-an-aldosterone-antagonist-for-heart-failure-with-preserved-ejection-fraction/
https://gpcardio.org/en/2025-08-12_outcomes-in-older-patients-after-switching-to-a-newer-anticoagulant-or-remaining-on-warfarin/
https://gpcardio.org/en/2025-08-14_coadministered-cagrilintide-and-semaglutide-in-adults-with-overweight-or-obesity/
https://gpcardio.org/en/2025-08-21_preventive-percutaneous-coronary-intervention-for-non-flow-limiting-vulnerable-atherosclerotic-coronary-plaques-in-diabetes/
https://gpcardio.org/en/2025-08-30_blood-pressure-lowering-efficacy-of-antihypertensive-drugs-and-their-combinations/
https://gpcardio.org/en/2025-09-01_conduction-system-pacing-vs-biventricular-pacing-for-cardiac-resynchronization/
https://gpcardio.org/en/2025-09-01_cost-effectiveness-of-apixaban-vs-aspirin-for-the-reduction-of-thrombo-embolism-in-high-risk-patients-with-device-detected-atrial-fibrillation/
https://gpcardio.org/en/2025-09-01_diabetes-and-obesity-and-treatment-effect-of-early-rhythm-control-vs-usual-care-in-patients-with-atrial-fibrillation/
https://gpcardio.org/en/2025-09-02_optimal-medical-care-and-coronary-flow-capacity-guided-myocardial-revascularization-vs-usual-care-for-chronic-coronary-artery-disease/
https://gpcardio.org/en/2025-09-02_remote-atrial-fibrillation-screening-in-primary-care-using-an-ecg-patch-demonstrates-modest-benefits/
https://gpcardio.org/en/2025-09-05_blood-pressure-reductions-with-baxdrostat-in-patients-with-uncontrolled-or-resistant-hypertension/
https://gpcardio.org/en/2025-09-09_influence-of-type-2-diabetes-on-the-effects-of-tirzepatide-in-patients-with-heart-failure-and-a-preserved-ejection-fraction-with-obesity/
https://gpcardio.org/en/2025-09-11_multidomain-rehabilitation-for-older-patients-with-myocardial-infarction/
https://gpcardio.org/en/2025-09-11_new-guidance-recommends-a-new-approach-to-assess-cardiovascular-risk-and-reach-treatment-goals-for-lipid-levels/
https://gpcardio.org/en/2025-09-13_β-blockers-after-myocardial-infarction-with-mildly-reduced-ejection-fraction/
https://gpcardio.org/en/2025-09-16_2025-aha-acc-guideline-for-the-prevention-detection-evaluation-and-management-of-high-blood-pressure-in-adults/
https://gpcardio.org/en/2025-09-16_tackling-the-enduring-cardiovascular-impact-of-covid-19-new-guidance-for-primary-care/
https://gpcardio.org/en/2025-09-18_orforglipron-an-oral-small-molecule-glp-1-receptor-agonist-in-early-type-2-diabetes/
https://gpcardio.org/en/2025-09-20_effect-of-evolocumab-on-saphenous-vein-graft-patency-after-coronary-artery-bypass-surgery-newton-cabg-cardiolink-5/
https://gpcardio.org/en/2025-09-21_introduction-and-the-impact-of-cmr-on-patients-and-health-systems/
https://gpcardio.org/en/2025-09-24_key-changes-in-clinical-guidance-for-blood-pressure-and-lipid-management/
https://gpcardio.org/en/2025-09-25_digitoxin-in-patients-with-heart-failure-and-reduced-ejection-fraction/
https://gpcardio.org/en/2025-09-28_why-it-s-important-to-recognise-manage-chronic-kidney-disease-ckd/
https://gpcardio.org/en/2025-10-01_2025-aha-acc-guideline-for-the-prevention-detection-evaluation-and-management-of-high-blood-pressure-in-adults/
https://gpcardio.org/en/2025-10-01_no-evidence-supports-vitamins-or-supplements-for-lowering-ldl-cholesterol-and-reducing-cardiovascular-risk/
https://gpcardio.org/en/2025-10-01_pulmonary-congestion-relief-by-adding-dapagliflozin-to-intravenous-loop-diuretic-in-acute-heart-failure-patients/
https://gpcardio.org/en/2025-10-07_impact-of-obicetrapib-on-major-adverse-cardiovascular-events-in-high-risk-patients/
https://gpcardio.org/en/2025-10-07_left-atrial-appendage-occlusion-in-patients-with-end-stage-renal-disease/
https://gpcardio.org/en/2025-10-07_the-relationship-between-obesity-and-chronic-kidney-disease/
https://gpcardio.org/en/2025-10-09_efficacy-and-safety-of-baxdrostat-in-uncontrolled-and-resistant-hypertension/
https://gpcardio.org/en/2025-10-14_heparin-administration-at-first-medical-contact-vs-immediately-before-primary-percutaneous-coronary-intervention/
https://gpcardio.org/en/2025-10-14_long-term-anticoagulation-discontinuation-after-catheter-ablation-for-atrial-fibrillation/
https://gpcardio.org/en/2025-10-23_aspirin-in-patients-with-chronic-coronary-syndrome-receiving-oral-anticoagulation/
https://gpcardio.org/en/2025-10-27_bridging-heart-and-stroke-awareness-stronger-together/
https://gpcardio.org/en/2025-10-27_transcatheter-or-surgical-aortic-valve-replacement-in-low-risk-patients-at-7-years/
https://gpcardio.org/en/2025-10-28_effect-of-intensive-blood-pressure-control-on-stroke/
https://gpcardio.org/en/2025-10-28_immediate-or-deferred-nonculprit-lesion-pci-in-myocardial-infarction/
https://gpcardio.org/en/2025-10-28_intensive-blood-pressure-control-in-older-patients-with-hypertension/
https://gpcardio.org/en/2025-11-01_safety-of-factor-xi-inhibition-with-abelacimab-in-atrial-fibrillation-by-kidney-function/
https://gpcardio.org/en/2025-11-04_2025-aha-acc-guideline-for-the-prevention-detection-evaluation-and-management-of-high-blood-pressure-in-adults/
https://gpcardio.org/en/2025-11-06_orforglipron-an-oral-small-molecule-glp-1-receptor-agonist-for-obesity-treatment/
https://gpcardio.org/en/2025-11-09_pcsk9-inhibitor-prevents-first-heart-attack-or-stroke-in-high-risk-patients/
https://gpcardio.org/en/2025-11-10_high-dose-vs-standard-dose-influenza-vaccine-and-cardiovascular-outcomes-in-older-adults/
https://gpcardio.org/en/2025-11-11_decaf-a-cup-of-coffee-a-day-could-keep-atrial-fibrillation-from-coming-back/
https://gpcardio.org/en/2025-11-13_beta-blockers-after-myocardial-infarction-in-patients-without-heart-failure/
https://gpcardio.org/en/2025-11-13_beta-blockers-after-myocardial-infarction-without-reduced-ejection-fraction/
https://gpcardio.org/en/2025-11-18_2025-acc-scientific-statement-on-the-management-of-obesity-in-adults-with-heart-failure/
https://gpcardio.org/en/2025-11-18_cardiovascular-effects-and-tolerability-of-glp-1-receptor-agonists/
https://gpcardio.org/en/2025-11-18_dapagliflozin-in-patients-hospitalized-for-heart-failure/
https://gpcardio.org/en/2025-11-21_epccs-council-launches-gpcardio-as-a-commitment-to-support-primary-care/
https://gpcardio.org/en/2025-11-25_biomarker-based-abc-af-risk-scores-for-personalized-treatment-to-reduce-stroke-or-death-in-atrial-fibrillation/
https://gpcardio.org/en/2025-12-01_aggressive-risk-factor-reduction-study-for-atrial-fibrillation-implications-for-ablation-outcomes/
https://gpcardio.org/en/2025-12-01_major-bleeding-with-apixaban-vs-aspirin/
https://gpcardio.org/en/2025-12-13_complete-versus-culprit-lesion-only-revascularisation-for-acute-myocardial-infarction-complete-revascularisation-trialists-collaboration/
https://gpcardio.org/en/2025-12-16_long-term-effect-of-icds-in-nonischemic-heart-failure-with-reduced-ejection-fraction/
https://gpcardio.org/en/2025-12-16_pharmacologic-treatment-of-heart-failure-with-reduced-ejection-fraction/
https://gpcardio.org/en/2025-12-18_2025-acc-aha-guideline-for-the-management-of-adults-with-congenital-heart-disease/
https://gpcardio.org/en/2025-12-18_cardiovascular-outcomes-with-tirzepatide-versus-dulaglutide-in-type-2-diabetes/
https://gpcardio.org/en/2025-12-18_improve-dice-a-2-part-open-label-phase-2a-trial-evaluating-the-safety-and-effectiveness-of-ninerafaxstat-in-patients-with-cardiometabolic-syndromes/
https://gpcardio.org/en/2025-12-19_eu-launches-ambitious-safe-hearts-plan-a-new-roadmap-in-cardiovascular-health/
https://gpcardio.org/en/2025-12-20_orforglipron-an-oral-small-molecule-glp-1-receptor-agonist-for-the-treatment-of-obesity-in-people-with-type-2-diabetes-attain-2/
https://gpcardio.org/en/2025-12-23_short-term-anticoagulation-versus-dual-antiplatelet-therapy-for-preventing-device-thrombosis-following-left-atrial-appendage-closure/
https://gpcardio.org/en/2026-01-06_dash-patterned-groceries-and-effects-on-blood-pressure/
https://gpcardio.org/en/2026-01-06_global-guideline-on-the-use-of-glp-1-medicines-in-treating-obesity-issued-by-who/
https://gpcardio.org/en/2026-01-07_cxcr6-t-cells-drive-immune-checkpoint-inhibitor-myocarditis/
https://gpcardio.org/en/2026-01-10_nicotine-and-the-cardiovascular-system-key-insights-for-primary-care/
https://gpcardio.org/en/2026-01-12_efficacy-and-safety-of-treatment-with-low-doses-of-spironolactone-in-patients-with-primary-aldosteronism/
https://gpcardio.org/en/2026-01-13_efficacy-and-safety-of-oral-pcsk9-inhibitor-enlicitide-in-adults-with-heterozygous-familial-hypercholesterolemia/
https://gpcardio.org/en/2026-01-14_glucagon-like-receptor-agonists-and-next-generation-incretin-based-medications/
https://gpcardio.org/en/2026-01-15_socioeconomic-and-structural-barriers-to-addressing-obesity-in-communities/
https://gpcardio.org/en/2026-01-19_stroke-identified-as-the-second-leading-cause-of-death-from-cardiovascular-disease-and-a-major-contributor-of-acquired-long-term-disability/
https://gpcardio.org/en/2026-01-20_environmental-stressors-and-cardiovascular-health/
https://gpcardio.org/en/2026-01-20_sglt2-inhibitors-and-kidney-outcomes-by-glomerular-filtration-rate-and-albuminuria/
https://gpcardio.org/en/2026-01-20_triple-versus-dual-lipid-lowering-therapy-in-acute-coronary-syndrome/
https://gpcardio.org/en/2026-01-21_2026-heart-disease-and-stroke-statistics/
https://gpcardio.org/en/2026-01-22_antithrombotic-therapy-after-successful-catheter-ablation-for-atrial-fibrillation/
https://gpcardio.org/en/2026-01-22_drug-stewardship-for-ras-inhibitors-and-sglt2-inhibitors-in-chronic-kidney-disease/
https://gpcardio.org/en/2026-01-27_colchicine-in-acute-coronary-syndromes/
https://gpcardio.org/en/2026-01-27_potent-p2y12-inhibitor-monotherapy-vs-dapt-after-pci-in-patients-with-and-without-stemi/
https://gpcardio.org/en/2026-01-28_kdigo-2026-clinical-practice-guideline-for-anemia-in-chronic-kidney-disease-ckd/
https://gpcardio.org/en/2026-01-29_multidisciplinary-team-guided-management-of-severe-aortic-stenosis/
https://gpcardio.org/en/2026-01-29_olezarsen-for-managing-severe-hypertriglyceridemia-and-pancreatitis-risk/
https://gpcardio.org/en/2026-01-29_symptom-burden-and-secondary-prevention-in-patients-with-left-ventricular-systolic-dysfunction-after-acute-myocardial-infarction/
https://gpcardio.org/en/2026-01-29_wearable-derived-training-load-and-coronary-atherosclerosis-in-middle-aged-and-older-athletes-and-physically-active-controls/
https://gpcardio.org/en/2026-01-30_systemic-embolic-events-in-atrial-fibrillation/
https://gpcardio.org/en/2026-02-01_cagrisema-reduces-blood-pressure-in-adults-with-overweight-or-obesity/
https://gpcardio.org/en/2026-02-01_cardiovascular-kidney-effects-of-dapagliflozin-in-patients-at-cardiovascular-risk-with-or-without-type-2-diabetes/
https://gpcardio.org/en/2026-02-01_outcomes-after-switching-cardiac-troponin-assays-in-acs/
https://gpcardio.org/en/2026-02-01_semaglutide-and-hospitalizations-in-patients-with-obesity-and-established-cardiovascular-disease/
https://gpcardio.org/en/2026-02-01_β-blockers-after-myocardial-infarction-in-patients-with-preserved-ejection-fraction/
https://gpcardio.org/en/2026-02-02_sglt2-inhibitor-use-and-cardiorenal-outcomes-in-type-2-diabetes-with-liver-cirrhosis/
https://gpcardio.org/en/2026-02-03_contemporary-management-of-atrial-fibrillation-in-patients-with-cancer-the-2025-european-heart-rhythm-association-survey/
https://gpcardio.org/en/2026-02-03_dapagliflozin-to-reduce-early-recurrence-after-catheter-ablation-for-atrial-fibrillation/
https://gpcardio.org/en/2026-02-03_physical-activity-and-risk-of-adverse-events-in-atrial-fibrillation/
https://gpcardio.org/en/2026-02-03_semaglutide-as-adjunctive-therapy-to-catheter-ablation-in-obesity-related-paroxysmal-atrial-fibrillation/
https://gpcardio.org/en/2026-02-03_semaglutide-vs-tirzepatide-in-patients-with-obesity-and-hfpef/
https://gpcardio.org/en/2026-02-04_ai-digital-stethoscopes-outperform-traditional-screening-for-significant-vhd/
https://gpcardio.org/en/2026-02-05_a-placebo-controlled-trial-of-the-oral-pcsk9-inhibitor-enlicitide/
https://gpcardio.org/en/2026-02-05_efimosfermin-alfa-bos-580-once-per-month-in-people-with-metabolic-dysfunction-associated-steatohepatitis-with-f2-or-f3-fibrosis/
https://gpcardio.org/en/2026-02-05_intravenous-tenecteplase-for-acute-ischaemic-stroke-within-24-h-due-to-basilar-artery-occlusion/
https://gpcardio.org/en/2026-02-05_tenecteplase-versus-standard-medical-treatment-for-basilar-artery-occlusion-within-24-h-trace-5/
https://gpcardio.org/en/2026-02-05_the-inherited-basis-of-coronary-artery-disease/
https://gpcardio.org/en/2026-02-06_glucagon-like-peptide-receptor-agonists-and-kidney-outcomes-in-the-era-of-personalized-medicine/
https://gpcardio.org/en/2026-02-06_insulin-resistance-compromises-the-pentose-phosphate-pathway-and-impairs-left-ventricular-assist-device-mediated-myocardial-recovery-in-obese-patients-with-heart-failure/
https://gpcardio.org/en/2026-02-06_talking-to-patients-about-statins-why-most-reported-symptoms-aren-t-causal/
https://gpcardio.org/en/2026-02-06_the-aldehyde-dehydrogenase-2-rs671-variant-enhances-platelet-activation-and-arterial-thrombosis/
https://gpcardio.org/en/2026-02-09_coronary-atherosclerosis-in-patients-with-cancer-and-survivors/
https://gpcardio.org/en/2026-02-10_clonal-hematopoiesis-and-its-cardiovascular-implications/
https://gpcardio.org/en/2026-02-10_new-drug-therapies-for-hypertension/
https://gpcardio.org/en/2026-02-10_renal-and-urothelial-cancer-risks-with-sglt2-inhibitors-vs-glp-1-receptor-agonists-in-type-2-diabetes/
https://gpcardio.org/en/2026-02-10_spontaneous-myocardial-infarction-after-left-main-revascularization/
https://gpcardio.org/en/2026-02-10_transthyretin-cardiac-amyloidosis-evaluation-and-management/
https://gpcardio.org/en/2026-02-11_aspirin-dosing-after-acute-coronary-syndrome-with-suspected-aspirin-resistance/
https://gpcardio.org/en/2026-02-11_criteria-to-assess-the-predictive-and-clinical-utility-of-novel-models-biomarkers-and-tools-for-risk-of-cardiovascular-disease/
https://gpcardio.org/en/2026-02-11_improving-outcomes-of-atrial-fibrillation-ablation-by-integrated-personalized-lifestyle-interventions/
https://gpcardio.org/en/2026-02-11_vericiguat-and-mortality-in-heart-failure-and-reduced-ejection-fraction/
https://gpcardio.org/en/2026-02-12_prognostic-utility-of-stress-perfusion-cardiac-magnetic-resonance-in-patients-with-known-or-suspected-coronary-artery-disease-and-inconclusive-exercise-stress-testing/
https://gpcardio.org/en/2026-02-12_prospective-associations-of-obesity-and-obesity-severity-with-9-cardiovascular-outcomes/
https://gpcardio.org/en/2026-02-13_use-of-kidney-preserving-medications-in-breastfeeding/
https://gpcardio.org/en/2026-02-16_early-versus-late-anticoagulation-treatment-after-acute-ischemic-stroke-with-atrial-fibrillation/
https://gpcardio.org/en/2026-02-16_novel-plasma-proteomic-markers-and-risk-of-venous-thromboembolism/
https://gpcardio.org/en/2026-02-17_albuminuria-or-proteinuria-in-glomerular-disease-and-ckd-which-one-to-use/
https://gpcardio.org/en/2026-02-18_beta-blockers-after-myocardial-infarction/
https://gpcardio.org/en/2026-02-18_gene-therapy-for-nephropathic-cystinosis/
https://gpcardio.org/en/2026-02-19_2026-aha-acc-guideline-for-the-evaluation-and-management-of-acute-pulmonary-embolism-in-adults/
https://gpcardio.org/en/2026-02-19_cardiovascular-kidney-metabolic-interplay-in-patients-with-atrial-fibrillation-receiving-direct-oral-anticoagulants/
https://gpcardio.org/en/2026-02-19_conduction-disturbances-after-transcatheter-aortic-valve-implantation/
https://gpcardio.org/en/2026-02-19_secondary-prevention-after-ischemic-stroke/
https://gpcardio.org/en/2026-02-19_transcatheter-or-surgical-aortic-valve-replacement-in-low-risk-patients-at-7-years/
https://gpcardio.org/en/2026-02-20_enhanced-cardiovascular-disease-risk-prediction-using-integrated-machine-learning-models/
https://gpcardio.org/en/2026-02-21_pelacarsen-and-lipoprotein-a-apheresis-in-secondary-prevention/
https://gpcardio.org/en/2026-02-22_cost-effectiveness-of-sodium-glucose-cotransporter-2-inhibitors-and-glucagon-like-peptide-1-receptor-agonists-for-patients-with-high-cardiovascular-risk-and-type-2-diabetes-in-canada/
https://gpcardio.org/en/2026-02-23_accelerometry-defined-physical-activity-and-quality-of-life-in-hypertrophic-cardiomyopathy/
https://gpcardio.org/en/2026-02-23_diabetes-increases-the-risk-of-heart-failure-in-myocarditis/
https://gpcardio.org/en/2026-02-23_effect-of-semaglutide-on-covid-19-and-other-infections/
https://gpcardio.org/en/2026-02-23_immunoadsorption-in-dilated-cardiomyopathy/
https://gpcardio.org/en/2026-02-23_mitigating-risk-of-kidney-dysfunction-after-heart-transplantation-and-therapeutic-approaches/
https://gpcardio.org/en/2026-02-23_primary-care-adherence-to-heart-failure-guidelines-in-post-discharge-evaluation-routine-management-pathfinder/
https://gpcardio.org/en/2026-02-23_the-year-in-cardiovascular-medicine-2025/
https://gpcardio.org/en/2026-02-24_malnutrition-and-cachexia-in-inpatients-with-acute-cardiac-conditions/
https://gpcardio.org/en/2026-02-24_risk-of-heart-failure-hospitalization-for-glp-1-receptor-agonists-versus-dpp-4-inhibitors-or-sglt-2-inhibitors-in-patients-with-type-2-diabetes/
https://gpcardio.org/en/2026-02-24_systemic-embolic-events-in-atrial-fibrillation/
https://gpcardio.org/en/2026-02-25_combined-associations-of-glp-1-receptor-agonists-and-a-healthy-lifestyle-with-cardiovascular-outcomes-among-individuals-with-type-2-diabetes/
https://gpcardio.org/en/2026-02-25_forecasting-the-burden-of-cardiovascular-disease-and-stroke-in-women-in-the-united-states-through-2050/
https://gpcardio.org/en/2026-02-25_low-dose-rivaroxaban-to-prevent-left-ventricular-thrombosis-after-anterior-myocardial-infarction/
https://gpcardio.org/en/2026-02-25_outcomes-of-heart-failure-with-reduced-mildly-reduced-or-preserved-ejection-fraction/
https://gpcardio.org/en/2026-02-26_intensive-bp-control-and-cognitive-function/
https://gpcardio.org/en/2026-02-27_additive-cardiorenal-benefits-of-finerenone-and-sglt2-inhibitor-combination-therapy-in-diabetic-ckd/
https://gpcardio.org/en/2026-02-27_carotid-plaque-macrophage-burden-and-inflammatory-lipid-associated-macrophage-markers-predict-secondary-major-adverse-cardiovascular-events-after-endarterectomy/
https://gpcardio.org/en/2026-02-27_sglt2-inhibition-in-patients-with-type-2-diabetes-and-ckd-experiencing-a-deterioration-in-estimated-glomerular-filtration-rate-to-20ml-min-1-73m/
https://gpcardio.org/en/2026-02-27_switching-from-warfarin-to-direct-oral-anticoagulants-in-frail-elderly-asian-patients-with-atrial-fibrillation/
https://gpcardio.org/en/2026-02-28_heart-failure-in-the-elderly/
https://gpcardio.org/en/2026-03-01_2026-acute-pulmonary-embolism-guideline-at-a-glance/
https://gpcardio.org/en/2026-03-01_abelacimab-vs-rivaroxaban-in-older-individuals-with-atrial-fibrillation/
https://gpcardio.org/en/2026-03-01_cardiac-screening-for-conditions-associated-with-sudden-cardiac-death/
https://gpcardio.org/en/2026-03-01_cardiac-screening-in-the-young/
https://gpcardio.org/en/2026-03-01_comparison-of-the-european-society-of-cardiology-0-1-hour-and-high-sensitivity-troponin-in-the-evaluation-of-patients-with-suspected-acute-coronary-syndrome-0-2-or-0-3-hour-algorithms-for-rapid-myocar/
https://gpcardio.org/en/2026-03-01_effect-of-baduanjin-on-blood-pressure-among-individuals-with-high-normal-blood-pressure/
https://gpcardio.org/en/2026-03-01_high-dose-influenza-vaccination-in-atherosclerotic-cardiovascular-disease/
https://gpcardio.org/en/2026-03-01_impact-of-early-delayed-or-interrupted-treatment-in-children-with-familial-hypercholesterolemia/
https://gpcardio.org/en/2026-03-01_journal-club/
https://gpcardio.org/en/2026-03-01_six-year-outcomes-after-transcatheter-vs-surgical-aortic-valve-replacement-in-low-risk-patients-with-aortic-stenosis/
https://gpcardio.org/en/2026-03-01_some-much-needed-confidence-to-combat-the-risk-treatment-paradox-in-chronic-kidney-disease/
https://gpcardio.org/en/2026-03-01_timing-of-cardiovascular-and-kidney-benefits-with-finerenone-in-heart-failure-and-chronic-kidney-disease-with-type-2-diabetes/
https://gpcardio.org/en/2026-03-02_nighttime-road-traffic-noise-stresses-the-heart-and-blood-vessels/
https://gpcardio.org/en/2026-03-02_worse-risk-profile-number-of-grafts-and-hospital-death-but-acceptable-late-survival-in-females-undergoing-coronary-surgery/
https://gpcardio.org/en/2026-03-03_in-vivo-base-editing-gene-therapy-for-heterozygous-familial-hypercholesterolemia/
https://gpcardio.org/en/2026-03-03_invasive-haemodynamic-validation-of-an-artificial-intelligence-echocardiographic-tool-for-detecting-heart-failure-with-preserved-ejection-fraction/
https://gpcardio.org/en/2026-03-03_quantifying-skeletal-muscle-energy-metabolism-during-exercise-in-heart-failure-with-preserved-ejection-fraction-using-in-vivo-31p-magnetic-resonance-spectroscopy/
https://gpcardio.org/en/2026-03-04_aspirin-after-pci-in-acute-coronary-syndromes/
https://gpcardio.org/en/2026-03-04_blood-pressure-targets-in-hypertension-management/
https://gpcardio.org/en/2026-03-04_finerenone-for-diabetic-kidney-disease-in-type-1-diabetes-a-fine-answer/
https://gpcardio.org/en/2026-03-04_interplay-of-age-and-sex-with-clinic-and-ambulatory-blood-pressure-and-mortality/
https://gpcardio.org/en/2026-03-05_direct-acting-oral-anticoagulant-or-vitamin-k-antagonist-for-the-frail-elderly-patient-with-atrial-fibrillation/
https://gpcardio.org/en/2026-03-05_finerenone-in-type-1-diabetes-and-chronic-kidney-disease/
https://gpcardio.org/en/2026-03-05_oral-pcsk9-inhibitor-enlicitide-lowers-ldl-cholesterol-levels-in-phase-2-trial/
https://gpcardio.org/en/2026-03-05_semaglutide-in-peripheral-artery-disease-and-diabetes-by-baseline-disease-severity-and-age/
https://gpcardio.org/en/2026-03-06_kidney-disease-and-heart-failure/
https://gpcardio.org/en/2026-03-07_atrial-fibrillation/
https://gpcardio.org/en/2026-03-07_effect-of-baxdrostat-on-ambulatory-blood-pressure-in-patients-with-resistant-hypertension-bax24/
https://gpcardio.org/en/2026-03-07_effect-of-baxdrostat-on-ambulatory-blood-pressure-in-patients-with-resistant-hypertension-bax24/
https://gpcardio.org/en/2026-03-09_differences-in-disease-trajectory-comorbidities-and-mortality-in-sarcomeric-and-nonsarcomeric-hypertrophic-cardiomyopathy/
https://gpcardio.org/en/2026-03-09_semaglutide-promotes-bone-marrow-derived-progenitor-cell-flux-towards-an-anti-inflammatory-and-pro-regenerative-profile-in-high-risk-patients/
https://gpcardio.org/en/2026-03-09_targets-and-treatments-to-manage-ldl-c-in-primary-care/
https://gpcardio.org/en/2026-03-10_genetic-screening-for-fh-rationale-and-experience/
https://gpcardio.org/en/2026-03-10_lp-a-time-to-start-measuring-in-primary-care/
https://gpcardio.org/en/2026-03-11_triglycerides-a-risk-marker-or-target-for-cv-risk/
https://gpcardio.org/en/2026-03-12_cardiovascular-metabolic-risk-in-menopause/
https://gpcardio.org/en/2026-03-12_esc-guidance-on-cvd-and-mental-health-in-primary-care/
https://gpcardio.org/en/2026-03-12_off-label-underdosing-of-edoxaban-antithrombotic-therapy-for-patients-with-atrial-fibrillation-and-stable-coronary-artery-disease/
https://gpcardio.org/en/2026-03-13_2026-acc-aha-guideline-on-the-management-of-dyslipidemia/
https://gpcardio.org/en/2026-03-13_heart-failure-in-primary-care-early-recognition-and-initiation-of-gdmt/
https://gpcardio.org/en/2026-03-13_managing-difficult-to-control-hypertension-and-what-s-new/
https://gpcardio.org/en/2026-03-13_the-need-for-gp-engagement-in-the-world-of-advocacy/
https://gpcardio.org/en/2026-03-14_the-pulse-of-primary-care-epccs-summit-2026/
https://gpcardio.org/en/2026-03-16_use-of-coronary-artery-calcium-scoring-in-individuals-with-elevated-lipoprotein-a/
https://gpcardio.org/en/2026-03-20_lifetime-adverse-pregnancy-outcome-history-and-cardiovascular-risk/
https://gpcardio.org/en/2026-03-20_real-world-evidence-with-dapagliflozin-in-heart-failure-with-reduced-ejection-fraction-in-central-eastern-europe-and-the-baltic-region-evolution-hf-cee-ba-study/
https://gpcardio.org/en/2026-03-20_the-impact-of-epccs-guidance-on-pharmacotherapy-in-ukraine/
https://gpcardio.org/en/2026-03-22_cardiovascular-risk-management-in-poland/
https://gpcardio.org/en/2026-03-22_hypertension-guidelines-update-in-turkey/
https://gpcardio.org/en/2026-03-22_screening-for-cvd-in-greece/
https://gpcardio.org/en/2026-03-23_guideline-directed-medical-therapy-in-ckd-the-crucial-role-for-primary-care/
https://gpcardio.org/en/2026-03-24_managing-ckd-in-primary-care/
https://gpcardio.org/en/2026-03-24_screening-risk-stratification-in-ckd-the-crucial-role-for-primary-care/
https://gpcardio.org/en/2026-03-24_systemic-inflammation-and-recurrence-after-atrial-fibrillation-related-stroke/
https://gpcardio.org/en/2026-03-24_triglyceride-glucose-index-and-mortality-in-critically-ill-patients-with-cardiovascular-kidney-metabolic-syndrome-stage-4/
https://gpcardio.org/en/2026-03-25_heritability-and-cardiovascular-disease-in-adult-offspring-of-hypertensive-disorder-of-pregnancy/
https://gpcardio.org/en/2026-03-25_managing-glucagon-like-peptide-1-receptor-agonists-and-sodium-glucose-cotransporter-2-inhibitors-in-clinical-practice/
https://gpcardio.org/en/2026-03-25_role-of-provocation-and-exercise-imaging-for-the-identification-of-candidates-for-cardiac-myosin-inhibitors/
https://gpcardio.org/en/2026-03-26_gene-editing-therapy-in-cardiovascular-disease/
https://gpcardio.org/en/2026-03-26_left-atrial-appendage-closure-or-medical-therapy-in-atrial-fibrillation/
https://gpcardio.org/en/2026-03-26_novel-cardiovascular-metabolic-risk-factor-mechanisms-and-therapeutic-opportunities/
https://gpcardio.org/en/2026-03-26_senescent-obesity-signature-in-breast-cancer/
https://gpcardio.org/en/2026-03-27_deep-endotyping-of-renal-damage-in-type-2-diabetes/
https://gpcardio.org/en/2026-03-27_kidney-disease/
https://gpcardio.org/en/2026-03-27_optimizing-nt-probnp-inclusion-cut-offs-for-randomized-clinical-trials-in-heart-failure/
https://gpcardio.org/en/2026-03-28_calcium-release-channel-deficiency-syndrome-in-patients-diagnosed-with-idiopathic-ventricular-fibrillation-and-decedents-classified-as-sudden-unexplained-death-in-the-young/
https://gpcardio.org/en/2026-03-29_evolocumab-reduces-risk-of-first-major-cardiovascular-events-by-31-in-patients-without-significant-atherosclerosis/
https://gpcardio.org/en/2026-03-29_intensive-low-density-lipoprotein-cholesterol-targeting-in-patients-with-atherosclerotic-cardiovascular-disease/
https://gpcardio.org/en/2026-03-29_left-atrial-appendage-closure-or-anticoagulation-for-atrial-fibrillation/
https://gpcardio.org/en/2026-03-29_ultrasound-facilitated-catheter-directed-fibrinolysis-for-acute-pulmonary-embolism/
https://gpcardio.org/en/2026-03-30_the-liraglutide-effects-in-atrial-fibrillation-leaf-study/
https://gpcardio.org/en/2026-04-10_eu-nextgen-project-advances-personalised-cardiology-by-integrating-genomic-and-clinical-data-into-ai-models/
https://gpcardio.org/en/2026-04-15_heart-failure-is-common-in-people-with-atrial-fibrillation-detected-during-screening/
https://gpcardio.org/en/2026-04-17_acute-egfr-changes-and-their-mediation-of-albuminuria-reduction-with-empagliflozin-and-finerenone/
https://gpcardio.org/en/2026-04-17_evolocumab-to-reduce-first-major-cardiovascular-events-in-patients-without-known-significant-atherosclerosis-and-with-diabetes/
https://gpcardio.org/en/2026-04-17_volume-vs-intensity-of-physical-activity-and-risk-of-cardiovascular-and-non-cardiovascular-chronic-diseases/
https://gpcardio.org/en/2026-04-18_glucagon-like-peptide-1-receptor-agonists-for-prevention-of-heart-failure-events-in-type-2-diabetes-and-or-obesity/
https://gpcardio.org/en/2026-04-18_lipoprotein-a-and-incident-venous-thromboembolism-in-pre-and-postmenopausal-women-and-in-men/
https://gpcardio.org/en/2026-04-18_sex-differences-in-cardiovascular-kidney-metabolic-syndrome/
https://gpcardio.org/en/2026-04-19_impact-of-genetic-testing-among-patients-with-familial-hypercholesterolemia-on-adverse-cardiovascular-events-the-hokuriku-plus-familial-hypercholesterolemia-registry-study/
https://gpcardio.org/en/2026-04-20_lp-a-has-specific-effects-on-coronary-artery-disease-independent-of-ldl-c/
https://gpcardio.org/en/2026-04-21_wearable-devices-and-cardiovascular-health/
https://gpcardio.org/en/2026-04-22_2026-acc-aha-aacvpr-abc-acpm-ada-ags-apha-aspc-nla-pcna-guideline-on-the-management-of-dyslipidemia/
https://gpcardio.org/en/2026-04-22_memantine-for-premature-atrial-contractions/
https://gpcardio.org/en/2026-04-22_prehospital-heparin-administration-in-patients-with-stemi-undergoing-primary-pci/
https://gpcardio.org/en/2026-04-23_effect-of-apoc3-inhibition-with-olezarsen-on-coronary-atherosclerosis/
https://gpcardio.org/en/2026-04-23_low-dose-rivaroxaban-to-prevent-left-ventricular-thrombosis-after-anterior-myocardial-infarction/
https://gpcardio.org/en/2026-04-24_2026-dietary-guidance-to-improve-cardiovascular-health/
https://gpcardio.org/en/2026-04-24_cardiovascular-kidney-metabolic-syndrome-stages-echocardiographic-characteristics-and-heart-failure-risk/
https://gpcardio.org/en/2026-04-24_two-trials-comparing-conduction-system-pacing-and-biventricular-pacing/
https://gpcardio.org/en/2026-04-25_sotatercept-for-combined-post-and-pre-capillary-pulmonary-hypertension-associated-with-heart-failure/
https://gpcardio.org/en/2026-04-25_the-role-of-atrial-pacing-support-in-cardiac-resynchronization-therapy/
https://gpcardio.org/en/2026-04-26_assessment-for-long-term-cardiovascular-disease-risk-in-pregnancy/
https://gpcardio.org/en/2026-04-27_automated-echocardiographic-detection-of-congenital-heart-disease-using-artificial-intelligence/
https://gpcardio.org/en/2026-04-28_early-atheroma-prevention/
https://gpcardio.org/en/2026-04-30_three-low-dose-antihypertensive-agents-in-a-single-pill-after-intracerebral-hemorrhage/
https://gpcardio.org/en/2026-05-01_stereotactic-arrhythmia-radioablation-for-refractory-ventricular-tachycardia/
https://gpcardio.org/en/2026-05-02_raas-blockade-in-the-kidney-life-cycle-treatment-standard/
https://gpcardio.org/en/2026-05-03_multi-modality-non-invasive-cardiovascular-screening-and-sex-specific-outcomes/
https://gpcardio.org/en/2026-05-04_continuation-vs-switching-direct-oral-anticoagulant-therapy-after-breakthrough-stroke/
https://gpcardio.org/en/2026-05-05_extensive-pregnancy-related-off-treatment-time-in-women-with-familial-hypercholesterolaemia/
https://gpcardio.org/en/2026-05-05_sex-differences-in-pharmacological-treatment-of-heart-failure/
https://gpcardio.org/en/2026-05-06_risk-factors-for-atherosclerotic-cardiovascular-disease-in-individuals-with-heterozygous-familial-hypercholesterolemia/
https://gpcardio.org/en/2026-05-07_combined-transcatheter-mitral-and-tricuspid-edge-to-edge-repair-or-tricuspid-edge-to-edge-repair-alone-in-moderate-mitral-regurgitation/
https://gpcardio.org/en/2026-05-08_kidney-function-and-risk-of-heart-failure-in-older-adults/
https://gpcardio.org/en/2026-05-08_stroke-and-bleeding-risks-with-non-vitamin-k-oral-anticoagulants-in-nonvalvular-atrial-fibrillation/
https://gpcardio.org/en/2026-05-09_subcutaneous-defibrillator-implantation-with-or-without-defibrillation-test/
https://gpcardio.org/en/2026-05-10_angiotensin-receptor-neprilysin-inhibitor-in-heart-failure-with-preserved-ejection-fraction-and-secondary-mitral-regurgitation/
https://gpcardio.org/en/2026-05-10_blinded-withdrawal-of-randomized-treatment-with-low-dose-digoxin-or-placebo-in-patients-with-heart-failure/
https://gpcardio.org/en/2026-05-10_digoxin-in-patients-with-symptomatic-rheumatic-heart-disease/
https://gpcardio.org/en/2026-05-10_guideline-recommended-medical-therapy-efficacy-according-to-use-of-digoxin/
https://gpcardio.org/en/2026-05-10_low-dose-digoxin-in-patients-with-heart-failure-with-reduced-or-mildly-reduced-ejection-fraction/
https://gpcardio.org/en/2026-05-10_the-microrna-inhibitor-cdr132l-in-patients-with-reduced-left-ventricular-ejection-fraction-after-myocardial-infarction/
https://gpcardio.org/en/2026-05-11_anthropometric-adiposity-measures-and-natriuretic-peptides-in-heart-failure-screening/
https://gpcardio.org/en/2026-05-11_cardiovascular-disease-in-sickle-cell/
https://gpcardio.org/en/2026-05-11_incident-cancer-in-heart-failure-myocardial-infarction-or-both/
https://gpcardio.org/en/2026-05-11_physical-activity-in-pediatric-cardiomyopathies/
https://gpcardio.org/en/2026-05-11_prevalence-and-predictors-of-high-inflammatory-risk-in-heart-failure-subtypes/
https://gpcardio.org/en/2026-05-11_subcut-hf-ii-at-home-subcutaneous-furosemide-reduces-hospital-days-versus-inpatient-intravenous-furosemide-in-patients-admitted-with-heart-failure-associated-edema/
https://gpcardio.org/en/2026-05-12_does-the-global-prevalence-of-heart-failure-now-exceed-600-million-people-from-guesswork-to-evidence/
https://gpcardio.org/en/2026-05-12_predictors-of-long-term-outcomes-in-hypertrophic-cardiomyopathy/
https://gpcardio.org/en/2026-05-12_sotatercept-for-combined-post-and-pre-capillary-pulmonary-hypertension-associated-with-heart-failure/
https://gpcardio.org/en/2026-05-15_one-year-multicenter-prospective-real-world-study-of-vericiguat-effectiveness-and-safety-in-spain/
https://gpcardio.org/en/2026-05-15_secondary-prevention-after-coronary-artery-bypass-graft-surgery/
https://gpcardio.org/en/2026-05-18_towards-comprehensive-cardiovascular-health-checks-accross-europe/
https://gpcardio.org/en/2026-05-19_atlas-of-cardiology-avoidable-inequalities-remain-in-cardiovascular-disease-burden-and-care/
https://gpcardio.org/en/2026-05-25_in-vivo-base-editing-of-pcsk9-with-verve-102-for-hypercholesterolemia/
https://gpcardio.org/en/2026-05-27_glucagon-like-peptide-1-receptor-agonists-in-patients-with-heart-failure-with-reduced-ejection-fraction/
https://gpcardio.org/en/2026-05-27_pulsed-field-ablation-for-the-interventional-treatment-of-atrial-fibrillation-a-scientific-statement-of-the-european-heart-rhythm-association-ehra-of-the-esc-the-heart-rhythm-society-hrs-the-asia-paci/
https://gpcardio.org/en/2026-05-28_sglt2-inhibitors-are-associated-with-reductions-in-epicardial-adipose-tissue-volume-and-thickness/
https://gpcardio.org/en/2026-05-28_women-s-heart-centres/
https://gpcardio.org/en/2026-05-29_pathophysiology-prevention-and-management-of-coronary-microvascular-obstruction/
https://gpcardio.org/en/2026-05-31_the-kidney-in-the-middle/
https://gpcardio.org/en/2026-06-01_renal-diabetic-overlap-in-pulmonary-arterial-hypertension/
https://gpcardio.org/en/2026-06-01_shared-pathophysiological-mechanisms-between-diabetes-and-calcific-aortic-valve-disease/
https://gpcardio.org/en/2026-06-02_obicetrapib-and-lipoprotein-a-levels-in-patients-at-high-cardiovascular-risk/
https://gpcardio.org/en/2026-06-02_outcomes-in-the-betami-danblock-trial-compared-with-a-norwegian-nationwide-myocardial-infarction-population/
https://gpcardio.org/en/2026-06-02_pulmonary-embolism-epidemiology/
https://gpcardio.org/en/2026-06-03_familial-hypercholesterolaemia-in-children-and-adolescents/
https://gpcardio.org/en/2026-06-03_lipoprotein-a-levels-risk-of-cardiovascular-events-and-benefit-of-evolocumab/
https://gpcardio.org/en/2026-06-04_effects-of-semaglutide-on-mortality-cardiovascular-and-kidney-outcomes-across-the-cardio-kidney-metabolic-continuum/
https://gpcardio.org/en/2026-06-04_lipid-clinics-worldwide/
https://gpcardio.org/en/2026-06-05_projected-reduction-in-major-adverse-cardiovascular-events-among-high-risk-u-s-adults-with-type-2-diabetes-eligible-for-oral-semaglutide/
https://gpcardio.org/en/2026-06-07_autosomal-dominant-alport-syndrome/
https://gpcardio.org/en/2026-06-09_body-composition-changes-in-patients-on-glp-1-receptor-agonists-undergoing-an-intensive-cardiac-rehabilitation-program/
https://gpcardio.org/en/2026-06-10_preservative-food-additives-hypertension-and-cardiovascular-diseases/
https://gpcardio.org/en/2026-06-10_primary-results-of-the-salamander-registry/
https://gpcardio.org/en/2026-06-11_mobile-health-unit-outreach-to-socially-disadvantaged-urban-communities-detects-uncontrolled-cardiometabolic-risk-factors/
https://gpcardio.org/en/2026-06-11_optimal-exercise-modalities-and-dosages-for-blood-pressure-reduction-in-adults-with-prehypertension-and-established-hypertension/
https://gpcardio.org/en/2026-06-12_low-density-lipoprotein-cholesterol-lowering-with-inclisiran-plus-usual-care-in-recent-acute-coronary-syndrome/
https://gpcardio.org/en/2026-06-13_effect-of-different-types-of-whole-dietary-pulses-on-established-therapeutic-lipid-targets-for-cardiovascular-risk-reduction/
https://gpcardio.org/en/2026-06-13_european-society-of-cardiology/
https://gpcardio.org/en/2026-06-15_clinical-effectiveness-of-sodium-glucose-cotransporter-2-inhibitors-among-older-patients-hospitalized-for-heart-failure-with-reduced-ejection-fraction/
https://gpcardio.org/en/2026-06-15_comparative-effectiveness-of-individual-sodium-glucose-transporter-2-inhibitors-on-cardiovascular-outcomes-in-type-2-diabetes-with-moderate-cardiovascular-risk/
https://gpcardio.org/en/2026-06-15_cost-effectiveness-and-budget-impact-analysis-of-tirzepatide-in-heart-failure-with-preserved-ejection-fraction-and-obesity-in-the-german-health-care-system/
https://gpcardio.org/en/2026-06-16_association-of-dietary-patterns-and-genetic-risk-with-cardiovascular-disease-in-uk-biobank-cancer-survivors/
https://gpcardio.org/en/2026-06-17_age-dependent-association-between-heart-failure-and-stroke-risk-in-atrial-fibrillation/
https://gpcardio.org/en/2026-06-17_homozygous-familial-hypercholesterolaemia/
https://gpcardio.org/en/2026-06-19_intracoronary-imaging-for-left-main-percutaneous-coronary-intervention/
https://gpcardio.org/en/2026-06-19_laroprovstat-the-first-oral-small-molecule-pcsk9-inhibitor-for-the-treatment-of-hypercholesterolemia/
https://gpcardio.org/en/2026-06-20_drug-targets-for-lipid-modification-and-risk-of-type-2-diabetes/
https://gpcardio.org/en/2026-06-20_lipid-related-cardiovascular-risk-beyond-low-density-lipoprotein-cholesterol/
https://gpcardio.org/en/2026-06-21_one-year-multicenter-prospective-real-world-study-of-vericiguat-effectiveness-and-safety-in-spain/
https://gpcardio.org/en/2026-06-24_outcomes-after-a-first-acute-myocardial-infarction-in-patients-with-or-without-congenital-heart-disease/
https://gpcardio.org/en/2026-06-25_1-year-real-world-outcomes-with-the-amulet-occluder-from-the-emerge-laa-postapproval-study/
https://gpcardio.org/en/2026-06-25_blinded-withdrawal-of-randomized-treatment-with-low-dose-digoxin-or-placebo-in-patients-with-heart-failure/
https://gpcardio.org/en/2026-06-27_out-of-hours-primary-care-management-for-patients-with-heart-failure/
https://gpcardio.org/en/2026-06-29_coronary-embolism-in-atrial-fibrillation/
https://gpcardio.org/en/2026-06-30_diet-gut-microbiota-interaction-index-and-heart-failure-risk-in-diabetes-and-prediabetes/
https://gpcardio.org/en/2026-07-01_direct-oral-anticoagulants-cox-2-selective-nsaids-and-gastrointestinal-bleeding-in-atrial-fibrillation/
https://gpcardio.org/en/2026-07-02_pulsed-field-ablation-versus-sham-to-treat-atrial-fibrillation/
https://gpcardio.org/en/2026-07-02_real-world-incidence-of-cancer-therapy-related-cardiac-dysfunction-in-a-large-diverse-and-contemporary-cohort/
https://gpcardio.org/en/2026-07-03_estimating-5-year-absolute-risk-of-cardiovascular-disease-using-routinely-collected-electronic-medical-records-from-australian-general-practices/
https://gpcardio.org/en/2026-07-03_natural-history-of-asymptomatic-moderate-or-severe-aortic-regurgitation/
https://gpcardio.org/en/2026-07-05_adolescent-cardiorespiratory-fitness-and-the-trade-off-between-atrial-fibrillation-risk-and-cardiovascular-benefits/
https://gpcardio.org/en/2026-07-05_physical-fitness-after-myocardial-infarction-compared-with-clinical-reference-values/
https://gpcardio.org/en/2026-07-05_risk-factors-for-multimorbidity-of-cardiovascular-diseases-in-the-prospective-million-women-study/
https://gpcardio.org/en/2026-07-06_adolescent-cardiorespiratory-fitness-and-the-trade-off-between-atrial-fibrillation-risk-and-cardiovascular-benefits/
https://gpcardio.org/en/2026-07-07_dietary-intakes-of-plant-and-animal-nitrate-and-5-year-blood-pressure-changes/
https://gpcardio.org/en/2026-07-07_infective-endocarditis-after-transcatheter-aortic-valve-implantation/
https://gpcardio.org/en/2026-07-07_is-there-a-role-for-primary-care-in-obesity-management-from-gatekeeper-to-population-health-leaders/
https://gpcardio.org/en/2026-07-07_key-changes-in-clinical-guidance-for-blood-pressure-and-lipid-management/
https://gpcardio.org/en/2026-07-07_why-is-chronic-kidney-disease-ckd-more-important-for-primary-care/
https://gpcardio.org/en/2026-07-08_calcium-channel-blockade-versus-β-blockade-for-hypertension-in-heart-failure-with-preserved-ejection-fraction/
https://gpcardio.org/en/2026-07-08_dietary-intakes-of-plant-and-animal-nitrate-and-5-year-blood-pressure-changes/
https://gpcardio.org/en/2026-07-08_evolocumab-in-patients-with-prior-percutaneous-coronary-intervention-and-no-prior-mi/
https://gpcardio.org/en/2026-07-09_angiotensin-receptor-neprilysin-inhibitor-in-heart-failure-with-preserved-ejection-fraction-and-secondary-mitral-regurgitation/
https://gpcardio.org/en/2026-07-09_determining-the-physiological-threshold-for-angina-orbita-fire/
https://gpcardio.org/en/2026-07-09_diastolic-dysfunction-is-equally-common-in-pre-diabetes-and-diabetes-and-associated-with-concomitant-cardiometabolic-risk-factors/
https://gpcardio.org/en/2026-07-09_wrist-measured-nighttime-home-bp-and-left-ventricular-hypertrophy/
https://gpcardio.org/en/2026-07-10_evolocumab-in-patients-with-prior-percutaneous-coronary-intervention-and-no-prior-mi/
https://gpcardio.org/en/2026-07-11_calcium-channel-blockade-versus-beta-blockade-for-hypertension-in-heart-failure-with-preserved-ejection-fraction/
https://gpcardio.org/en/2026-07-11_wrist-measured-nighttime-home-bp-and-left-ventricular-hypertrophy/
https://gpcardio.org/en/2026-07-12_angiotensin-receptor-neprilysin-inhibitor-in-heart-failure-with-preserved-ejection-fraction-and-secondary-mitral-regurgitation/
https://gpcardio.org/en/2026-07-12_determining-the-physiological-threshold-for-angina-orbita-fire/
https://gpcardio.org/en/2026-07-14_left-ventricular-thrombus-in-takotsubo-syndrome-and-st-elevation-myocardial-infarction/
https://gpcardio.org/en/2026-07-15_the-natural-history-of-massive-left-ventricular-hypertrophy-in-pediatric-hypertrophic-cardiomyopathy/
https://gpcardio.org/en/2026-07-16_multiorgan-physiological-deficits-during-exercise-identify-clinical-and-molecular-predisposition-to-heart-failure-with-preserved-ejection-fraction/
https://gpcardio.org/en/2026-07-18_are-clinical-improvements-in-anxiety-or-depression-associated-with-improvement-in-walking-fitness-following-a-cardiac-rehabilitation-programme/
https://gpcardio.org/en/2026-07-18_cerebral-amyloid-angiopathy/
https://gpcardio.org/en/2026-07-18_clinical-outcomes-of-conduction-system-pacing-versus-right-ventricular-pacing-in-patients-with-atrioventricular-block/
https://gpcardio.org/en/2026-07-19_pcsk9-inhibitor-treatment-and-outcomes-in-patients-with-atherosclerotic-cardiovascular-disease-but-without-prior-ischaemic-events/
https://gpcardio.org/en/2026-07-19_pharmacological-blood-pressure-lowering-for-the-prevention-of-cardiovascular-disease-and-death-across-the-full-spectrum-of-chronic-kidney-disease-severity/
https://gpcardio.org/en/2026-07-21_development-of-an-integrated-monogenic-and-polygenic-risk-assessment-tool-for-coronary-artery-disease-and-its-application-in-a-community-based-health-care-biobank/
https://gpcardio.org/en/2026-07-22_new-onset-postoperative-atrial-fibrillation-management-and-outcomes/
https://gpcardio.org/en/2026-07-23_multi-organ-physiologic-deficits-during-exercise-identify-clinical-and-molecular-predisposition-to-heart-failure-with-preserved-ejection-fraction/
https://gpcardio.org/en/2026-07-23_the-natural-history-of-massive-left-ventricular-hypertrophy-in-pediatric-hypertrophic-cardiomyopathy/
https://gpcardio.org/en/2026-07-24_blood-pressure-control-and-mortality-among-us-veterans/
https://gpcardio.org/en/2026-07-24_kidney-dysfunction-and-pulmonary-vascular-disease-in-heart-failure-with-preserved-ejection-fraction/
https://gpcardio.org/en/2026-07-25_lipoprotein-a-high-sensitivity-c-reactive-protein-and-incident-ascvd-risk-in-individuals-without-standard-modifiable-risk-factors/
https://gpcardio.org/en/2026-07-26_patient-care-pathways-and-outcomes-following-newly-diagnosed-atrial-fibrillation/
https://gpcardio.org/en/2026-07-26_sex-differences-in-outcomes-after-breakthrough-ischemic-stroke-on-oral-anticoagulants-for-atrial-fibrillation/
https://gpcardio.org/en/2026-07-27_assessment-and-management-of-cardiovascular-kidney-liver-metabolic-syndrome-in-the-primary-care-setting/
https://gpcardio.org/en/2026-07-27_phenotyping-patients-with-a-low-flow-low-gradient-aortic-stenosis-and-a-preserved-ejection-fraction-undergoing-tavi/
https://gpcardio.org/en/2026-07-28_combined-effect-of-educational-attainment-and-diabetes-on-1-year-all-cause-mortality-in-heart-failure-patients/
https://gpcardio.org/en/2026-07-28_epidemiology-economic-burden-and-mortality-of-atrial-fibrillation-in-a-region-with-very-high-life-expectancy/
https://gpcardio.org/en/2026-07-28_new-kidneys-old-risks/
https://gpcardio.org/en/2026-07-29_chronotype-aligned-exercise-timing-in-middle-aged-adults-at-cardiometabolic-risk/
https://gpcardio.org/en/2026-07-29_lipid-management-in-type-2-diabetes-and-non-hdl-cholesterol/
https://gpcardio.org/en/2026-07-29_transseptal-puncture-in-cardiovascular-interventions/
https://gpcardio.org/en/2026-07-31_early-outcomes-and-predictors-of-mortality-in-native-aortic-valve-endocarditis/
https://gpcardio.org/en/2026-07-31_sex-differences-in-the-diagnosis-management-and-outcomes-of-patients-with-infective-endocarditis/
https://gpcardio.org/en/2026-08-02_association-between-c-reactive-protein-and-risk-of-incident-heart-failure-in-cancer-survivors/
https://gpcardio.org/en/2026-08-02_epccs-refreshes-identity-to-champion-integrated-cardiorenalmetabolic-care-in-primary-care/
https://gpcardio.org/en/2026-08-02_statement-finds-cardiovascular-benefit-with-typical-coffee-intake-harm-signal-with-energy-drinks/
https://gpcardio.org/en/2026-08-02_trends-in-nephrology/
https://gpcardio.org/en/2026-08-03_aha-acc-esc-whf-expert-consensus-document/
https://gpcardio.org/en/2026-08-03_antithrombotic-management-in-patients-with-chronic-coronary-syndrome-receiving-oral-anticoagulation/
https://gpcardio.org/en/2026-08-04_frailty-and-heart-failure/
https://gpcardio.org/en/2026-08-05_sex-differences-in-risk-factor-control-and-medication-adherence-post-acs/
https://gpcardio.org/en/2026-08-06_blood-pressure-control-and-mortality-among-us-veterans/
https://gpcardio.org/en/2026-08-06_peptide-hormone-based-combinational-pharmacotherapies-for-chronic-metabolic-diseases/
https://gpcardio.org/en/2026-08-06_systolic-blood-pressure-and-albuminuria-reduction-mediate-cardiovascular-benefits-of-finerenone-in-t2-diabetes-and-ckd/
https://gpcardio.org/en/2026-08-10_factor-xi-inhibition/
https://gpcardio.org/en/2026-08-10_heart-and-kidney-in-one-guideline/
https://gpcardio.org/en/2026-08-10_statins-beyond-seventy/
https://gpcardio.org/en/2026-08-10_the-new-esc-heart-failure-guideline/
https://gpcardio.org/en/about-epccs/
https://gpcardio.org/en/about-ipccs/
https://gpcardio.org/en/cvd-ckd-t2d/
https://gpcardio.org/en/each/
https://gpcardio.org/en/epccs-summit/
https://gpcardio.org/en/epccs-summit/cardio-renal-update/
https://gpcardio.org/en/epccs-summit/cardiovascular-disease-in-special-populations/
https://gpcardio.org/en/epccs-summit/cardiovascular-update-session-for-primary-care/
https://gpcardio.org/en/epccs-summit/lipid-management-in-primary-care/
https://gpcardio.org/en/epccs-summit/managing-cv-risk-in-europe-lessons-from-countries/
https://gpcardio.org/en/epccs-summit/the-eu-cardiovascular-health-plan/
https://gpcardio.org/en/epccs-symposium-held-at-wonca-europe-2026-on-cardio-renal-metabolic-disease/
https://gpcardio.org/en/epccs/
https://gpcardio.org/en/epccs/connected-societies/
https://gpcardio.org/en/esc-congress-2025/
https://gpcardio.org/en/gpcardio/
https://gpcardio.org/en/literature/
https://gpcardio.org/en/literature/
https://gpcardio.org/en/ncd-academy/
https://gpcardio.org/en/resources/
https://gpcardio.org/en/resources/meeting-reports/
https://gpcardio.org/en/resources/practice-guidance/
https://gpcardio.org/en/resources/recent-news/
https://gpcardio.org/en/resources/stratifyhf/
https://gpcardio.org/en/resources/video-updates/
https://gpcardio.org/en/science-updates/
https://gpcardio.org/en/society-updates/
https://gpcardio.org/en/wonca-world-2025/
https://gpcardio.org/es/
https://gpcardio.org/es/2014-05-28_guia-practica-para-los-medicos-de-atencion-primaria-sobre-el-uso-de-estatinas-en-personas-con-riesgo-de-desarrollar-diabetes/
https://gpcardio.org/es/2015-01-07_el-documento-de-orientacion-de-la-epccs-sobre-la-prevencion-del-ictus-en-la-fibrilacion-auricular-1/
https://gpcardio.org/es/2015-09-29_animado-debate-en-la-clinical-masterclass-anual-de-la-epccs-da-lugar-a-orientacion-practica/
https://gpcardio.org/es/2015-10-02_cual-es-la-base-de-evidencia-para-la-modificacion-de-la-presion-arterial-en-las-actualizaciones-de-las-guias/
https://gpcardio.org/es/2015-10-02_cual-es-la-base-de-evidencia-para-la-modificacion-del-comportamiento-de-salud-en-las-actualizaciones-de-las-guias/
https://gpcardio.org/es/2015-10-12_cual-es-la-base-de-evidencia-para-la-modificacion-de-los-lipidos-en-las-actualizaciones-de-las-guias/
https://gpcardio.org/es/2015-10-14_cual-es-la-base-de-evidencia-para-el-diagnostico-y-el-manejo-de-la-insuficiencia-cardiaca-en-las-actualizaciones-de-las-guias/
https://gpcardio.org/es/2016-03-15_cual-es-la-base-de-evidencia-para-la-modificacion-de-los-lipidos-en-las-actualizaciones-de-las-guias/
https://gpcardio.org/es/2016-04-15_identificacion-y-tratamiento-de-pacientes-con-hipertension-verdadera/
https://gpcardio.org/es/2016-05-26_la-base-de-evidencia-para-los-cambios-en-el-comportamiento-de-salud/
https://gpcardio.org/es/2016-09-06_guia-de-consenso-de-la-epccs-sobre-la-prevencion-del-ictus-en-la-fibrilacion-auricular-spaf-en-atencion-primaria/
https://gpcardio.org/es/2016-09-28_documentos-de-orientacion-de-la-epccs/
https://gpcardio.org/es/2017-03-30_orientacion-sobre-el-cambio-de-comportamientos-de-salud-que-dice-la-evidencia-que-se-recomienda-y-estoy-de-acuerdo/
https://gpcardio.org/es/2017-04-20_controversias-en-hipertension-cuales-son-las-implicaciones-de-sprint-en-el-contexto-de-los-ensayos-de-tratamiento-recientes/
https://gpcardio.org/es/2017-04-20_controversias-en-lipidos-esta-ya-clara-la-funcion-de-las-estatinas-hay-alternativas-y-que-hay-en-desarrollo/
https://gpcardio.org/es/2017-04-20_cual-es-la-nueva-base-de-evidencia-para-el-diagnostico-y-el-manejo-de-la-insuficiencia-cardiaca/
https://gpcardio.org/es/2017-04-20_manejo-de-la-fibrilacion-auricular-que-dicen-las-guias-y-cuales-son-las-implicaciones-para-la-atencion-primaria/
https://gpcardio.org/es/2017-04-20_manejo-de-los-lipidos-que-dicen-las-guias-y-cuales-son-las-implicaciones-para-la-atencion-primaria/
https://gpcardio.org/es/2017-04-20_orientacion-sobre-el-cambio-de-comportamientos-de-salud-que-dice-la-evidencia-que-se-recomienda-y-estoy-de-acuerdo/
https://gpcardio.org/es/2017-06-05_componentes-de-estrategias-eficaces-para-fomentar-el-cambio-de-comportamiento/
https://gpcardio.org/es/2017-06-22_como-afectan-los-ultimos-cambios-en-las-guias-al-manejo-de-la-dislipidemia-en-atencion-primaria/
https://gpcardio.org/es/2017-07-01_la-guia-epccs-sobre-insuficiencia-cardiaca-publicada-como-clinical-intelligence-en-el-br-j-gen-prac/
https://gpcardio.org/es/2017-07-18_el-diagnostico-y-el-manejo-de-la-insuficiencia-cardiaca-varian-sustancialmente-entre-los-paises-europeos/
https://gpcardio.org/es/2017-09-13_que-se-puede-aprender-de-los-ultimos-ensayos-sobre-hipertension/
https://gpcardio.org/es/2017-12-10_guia-practica-de-la-epccs-para-el-diagnostico-y-manejo-de-la-insuficiencia-cardiaca-en-atencion-primaria/
https://gpcardio.org/es/2018-02-06_como-puede-la-epccs-ampliar-su-numero-de-socios/
https://gpcardio.org/es/2018-02-06_como-puede-la-epccs-interactuar-mejor-con-los-medicos-de-atencion-primaria-de-diversos-paises-europeos-en-relacion-con-la-educacion-sobre-enfermedad-cardiovascular/
https://gpcardio.org/es/2018-02-19_guia-practica-para-el-diagnostico-y-manejo-de-la-insuficiencia-cardiaca-en-atencion-primaria/
https://gpcardio.org/es/2018-02-19_insuficiencia-cardiaca-cronica/
https://gpcardio.org/es/2018-02-19_prevencion-del-ictus-en-pacientes-con-fibrilacion-auricular/
https://gpcardio.org/es/2018-02-22_fomentar-cambios-en-el-comportamiento-de-salud-para-reducir-el-riesgo-cardiovascular-en-atencion-primaria/
https://gpcardio.org/es/2018-02-25_diapositivas-organizacion-de-la-atencion-primaria-en-los-paises-bajos/
https://gpcardio.org/es/2018-02-26_diapositivas-atencion-primaria-en-bulgaria-nagpb/
https://gpcardio.org/es/2018-02-26_diapositivas-organizacion-de-la-atencion-primaria-en-eslovaquia/
https://gpcardio.org/es/2018-02-26_eslovaquia-panorama-de-la-atencion-primaria-cardiovascular/
https://gpcardio.org/es/2018-02-26_paises-bajos-panorama-de-la-atencion-primaria-cardiovascular/
https://gpcardio.org/es/2018-02-27_diapositivas-atencion-primaria-cardiovascular-en-espana/
https://gpcardio.org/es/2018-02-27_diapositivas-organizacion-de-la-atencion-primaria-en-portugal/
https://gpcardio.org/es/2018-02-28_bulgaria-atencion-primaria-cardiovascular/
https://gpcardio.org/es/2018-02-28_diapositivas-atencion-primaria-cardiovascular-en-francia/
https://gpcardio.org/es/2018-02-28_espana-panorama-de-la-atencion-primaria-cardiovascular/
https://gpcardio.org/es/2018-02-28_portugal-panorama-de-la-atencion-primaria-cardiovascular/
https://gpcardio.org/es/2018-03-01_diapositivas-atencion-primaria-cardiovascular-en-grecia/
https://gpcardio.org/es/2018-03-01_diapositivas-atencion-primaria-cardiovascular-en-rumania/
https://gpcardio.org/es/2018-03-01_francia-panorama-de-la-atencion-primaria-cardiovascular/
https://gpcardio.org/es/2018-03-01_grecia-panorama-de-la-atencion-primaria-cardiovascular/
https://gpcardio.org/es/2018-03-01_rumania-panorama-de-la-atencion-primaria-cardiovascular/
https://gpcardio.org/es/2018-03-02_alemania-panorama-de-la-atencion-primaria-cardiovascular/
https://gpcardio.org/es/2018-03-02_diapositivas-atencion-primaria-cardiovascular-en-alemania/
https://gpcardio.org/es/2018-03-13_guia-consensuada-de-la-epccs-sobre-la-prevencion-del-ictus-en-la-fibrilacion-auricular-en-la-atencion-medica-primaria/
https://gpcardio.org/es/2018-03-27_enfermedad-arterial-de-miembros-inferiores-una-enfermedad-cv-mayor-descuidada/
https://gpcardio.org/es/2018-03-27_fomento-de-cambios-en-el-comportamiento-de-salud-para-reducir-el-riesgo-cardiovascular-en-la-atencion-medica-primaria/
https://gpcardio.org/es/2018-03-28_diabetes-y-enfermedad-vascular-epidemiologia-y-opciones-de-manejo/
https://gpcardio.org/es/2018-04-04_diapositivas-actualizacion-sobre-diabetes-tipo-2-y-enfermedad-cardiovascular/
https://gpcardio.org/es/2018-04-04_diapositivas-enfermedad-arterial-de-las-extremidades-inferiores-una-enfermedad-cardiovascular-importante-y-desatendida-diagnostico-y-manejo-clinico-en-atencion-primaria/
https://gpcardio.org/es/2018-04-04_diapositivas-hipertension-podemos-ponernos-de-acuerdo-sobre-los-umbrales-diagnosticos-y-terapeuticos/
https://gpcardio.org/es/2018-04-04_diapositivas-manejo-de-la-insuficiencia-cardiaca-compleja-una-perspectiva-especializada-de-la-interfaz-primaria-secundaria/
https://gpcardio.org/es/2018-04-04_diapositivas-manejo-de-la-insuficiencia-cardiaca-en-atencion-primaria-la-perspectiva-del-medico-de-familia/
https://gpcardio.org/es/2018-04-04_diapositivas-reduccion-de-lipidos-la-evidencia-las-guias-la-realidad-clinica/
https://gpcardio.org/es/2018-04-04_diapositivas-taller-practico-sobre-la-mapa/
https://gpcardio.org/es/2018-04-04_manejo-de-lipidos-elevados-y-estatinas-lo-bueno-lo-malo-y-lo-feo/
https://gpcardio.org/es/2018-04-10_complejidades-del-manejo-de-la-insuficiencia-cardiaca-en-atencion-primaria/
https://gpcardio.org/es/2018-04-10_hipertension-podemos-ponernos-de-acuerdo-sobre-los-umbrales-diagnosticos-y-terapeuticos/
https://gpcardio.org/es/2018-04-24_manejo-del-riesgo-cardiovascular-asociado-a-la-dmt2-a-la-luz-de-las-nuevas-opciones-de-tratamiento/
https://gpcardio.org/es/2018-05-16_atencion-cardiovascular-primaria-en-italia/
https://gpcardio.org/es/2018-05-16_diapositivas-atencion-primaria-en-italia/
https://gpcardio.org/es/2018-05-22_reduccion-de-lipidos-la-evidencia-las-guias-la-realidad-clinica/
https://gpcardio.org/es/2018-06-15_semergen-la-sociedad-decana-de-la-medicina-de-familia-en-espana/
https://gpcardio.org/es/2018-06-15_semergen-sociedad-espanola-de-medicos-de-atencion-primaria/
https://gpcardio.org/es/2018-06-19_espana-introduccion-a-la-epccs/
https://gpcardio.org/es/2018-07-18_complejidades-del-manejo-de-la-insuficiencia-cardiaca/
https://gpcardio.org/es/2018-08-16_hipertension-podemos-ponernos-de-acuerdo-sobre-los-umbrales-diagnosticos-y-terapeuticos/
https://gpcardio.org/es/2018-08-22_manejo-de-lipidos-elevados-en-atencion-primaria/
https://gpcardio.org/es/2018-10-22_fomento-de-cambios-en-el-estilo-de-vida-para-reducir-el-riesgo-cardiovascular-en-la-aps/
https://gpcardio.org/es/2018-10-22_guia-practica-para-el-diagnostico-y-tratamiento-de-la-insuficiencia-cardiaca-en-la-atencion-primaria-de-salud/
https://gpcardio.org/es/2018-10-22_manejo-de-la-dislipidemia-en-la-atencion-medica-primaria/
https://gpcardio.org/es/2018-10-22_medico-de-familia-en-dinamarca/
https://gpcardio.org/es/2018-10-23_prevencion-de-la-enfermedad-cardiovascular-no-transmisible-en-atencion-primaria-en-rusia/
https://gpcardio.org/es/2018-10-25_manejo-de-lipidos-elevados-en-la-atencion-primaria-de-salud/
https://gpcardio.org/es/2018-10-30_formas-de-fomentar-cambios-de-comportamiento-para-reducir-el-riesgo-cardiovascular-en-atencion-primaria/
https://gpcardio.org/es/2018-12-03_atencion-cardiovascular-primaria-en-serbia-ingles/
https://gpcardio.org/es/2018-12-04_atencion-cardiovascular-primaria-en-la-republica-checa-checo/
https://gpcardio.org/es/2018-12-04_atencion-cardiovascular-primaria-en-la-republica-checa-ingles/
https://gpcardio.org/es/2018-12-04_atencion-cardiovascular-primaria-en-montenegro-ingles/
https://gpcardio.org/es/2018-12-04_atencion-cardiovascular-primaria-en-serbia-serbio/
https://gpcardio.org/es/2018-12-04_atencion-cardiovascular-primaria-en-ucrania-ingles/
https://gpcardio.org/es/2018-12-04_atencion-cardiovascular-primaria-en-ucrania-ucraniano/
https://gpcardio.org/es/2018-12-05_atencion-cardiovascular-primaria-en-belgica-flamenco/
https://gpcardio.org/es/2018-12-05_atencion-cardiovascular-primaria-en-belgica-ingles/
https://gpcardio.org/es/2018-12-05_atencion-cardiovascular-primaria-en-eslovaquia-eslovaco/
https://gpcardio.org/es/2018-12-05_atencion-cardiovascular-primaria-en-eslovaquia-ingles/
https://gpcardio.org/es/2018-12-05_atencion-cardiovascular-primaria-en-polonia-ingles/
https://gpcardio.org/es/2018-12-05_atencion-cardiovascular-primaria-en-polonia-polaco/
https://gpcardio.org/es/2018-12-07_atencion-cardiovascular-primaria-en-alemania-aleman/
https://gpcardio.org/es/2018-12-07_atencion-cardiovascular-primaria-en-alemania-ingles/
https://gpcardio.org/es/2018-12-10_atencion-cardiovascular-primaria-en-irlanda-ingles/
https://gpcardio.org/es/2018-12-10_atencion-cardiovascular-primaria-en-turquia-turco/
https://gpcardio.org/es/2018-12-13_atencion-cardiovascular-primaria-en-turquia-ingles/
https://gpcardio.org/es/2018-12-17_atencion-cardiovascular-primaria-en-dinamarca-danes/
https://gpcardio.org/es/2018-12-17_atencion-cardiovascular-primaria-en-dinamarca-ingles/
https://gpcardio.org/es/2018-12-17_atencion-cardiovascular-primaria-en-espana-espanol/
https://gpcardio.org/es/2018-12-17_atencion-cardiovascular-primaria-en-espana-ingles/
https://gpcardio.org/es/2018-12-17_atencion-cardiovascular-primaria-en-montenegro-montenegrino/
https://gpcardio.org/es/2018-12-17_atencion-cardiovascular-primaria-en-rumania-rumano/
https://gpcardio.org/es/2018-12-18_diapositivas-mensajes-clave-de-la-guia-de-la-epccs-sobre-el-manejo-de-lipidos-elevados-en-atencion-primaria/
https://gpcardio.org/es/2019-01-10_atencion-cardiovascular-primaria-en-espana-espanol/
https://gpcardio.org/es/2019-01-10_atencion-cardiovascular-primaria-en-espana-ingles/
https://gpcardio.org/es/2019-02-07_sociedad-epccs-que-esta-disponible-para-los-miembros/
https://gpcardio.org/es/2019-02-25_manejo-actual-de-la-diabetes-y-el-riesgo-cardiovascular-en-atencion-primaria/
https://gpcardio.org/es/2019-03-28_actualizacion-sobre-la-prevencion-del-ictus-en-la-fibrilacion-auricular/
https://gpcardio.org/es/2019-03-28_como-abordar-los-desafios-de-la-multimorbilidad-en-la-practica-de-la-medicina-general/
https://gpcardio.org/es/2019-03-28_diabetes-y-riesgo-cardiovascular/
https://gpcardio.org/es/2019-04-02_diapositivas-actualizacion-sobre-la-prevencion-del-ictus-en-la-fibrilacion-auricular/
https://gpcardio.org/es/2019-04-02_diapositivas-actualizaciones-recientes-de-las-guias-internacionales-sobre-hipertension-donde-difieren-y-en-que-deberiamos-ponernos-de-acuerdo-en-atencion-primaria/
https://gpcardio.org/es/2019-04-02_diapositivas-complejidades-del-manejo-de-la-insuficiencia-cardiaca/
https://gpcardio.org/es/2019-04-02_diapositivas-cvd-y-salud-mental/
https://gpcardio.org/es/2019-04-02_diapositivas-diabetes-y-riesgo-cardiovascular/
https://gpcardio.org/es/2019-04-02_diapositivas-multimorbilidad-enfermedad-cardiovascular-y-polifarmacia/
https://gpcardio.org/es/2019-04-02_diapositivas-que-evidencia-existe-de-que-la-diabetes-esta-vinculada-al-riesgo-de-cvd/
https://gpcardio.org/es/2019-04-03_complejidades-del-manejo-de-la-insuficiencia-cardiaca/
https://gpcardio.org/es/2019-04-24_actualizaciones-recientes-de-las-guias-internacionales-sobre-hipertension-donde-difieren-y-en-que-deberiamos-ponernos-de-acuerdo-en-atencion-primaria/
https://gpcardio.org/es/2019-04-25_educacion-intercambio-orientacion-e-interaccion-durante-la-cumbre-epccs-2019/
https://gpcardio.org/es/2019-05-02_diapositivas-abordar-la-cvd-en-la-diabetes-nuevas-estrategias-para-afrontar-el-riesgo/
https://gpcardio.org/es/2019-05-02_diapositivas-diabetes-tipo-2-y-resultados-cardiovasculares-algo-mas-que-el-manejo-de-la-glucosa-lecciones-de-los-ensayos-con-ar-glp1/
https://gpcardio.org/es/2019-05-02_diapositivas-manejo-de-la-diabetes-en-la-practica-cardiovascular-diaria-un-enfoque-multidisciplinario/
https://gpcardio.org/es/2019-05-07_prevencion-del-ictus-en-la-fibrilacion-auricular/
https://gpcardio.org/es/2019-05-21_actualizacion-sobre-el-manejo-del-riesgo-cardiovascular-en-la-diabetes-cual-es-la-evidencia/
https://gpcardio.org/es/2019-06-18_nuevo-algoritmo-diagnostico-y-opciones-terapeuticas-en-el-manejo-de-la-hf/
https://gpcardio.org/es/2019-08-13_diapositivas-mensajes-clave-de-la-guia-de-la-epccs-sobre-el-manejo-actual-de-la-diabetes-y-el-riesgo-cardiovascular-en-atencion-primaria/
https://gpcardio.org/es/2019-08-29_diagnostico-y-manejo-de-la-hipertension-en-atencion-primaria/
https://gpcardio.org/es/2019-10-02_el-alcance-de-la-epccs-hacia-los-paises-europeos-lo-que-esta-por-venir/
https://gpcardio.org/es/2019-10-03_como-la-epccs-pretende-ayudar-a-los-medicos-de-atencion-primaria-en-toda-europa-a-reconocer-y-gestionar-el-riesgo-cardiovascular-griego/
https://gpcardio.org/es/2019-10-03_epccs-y-la-atencion-cardiovascular-primaria-en-eslovaquia-eslovaco/
https://gpcardio.org/es/2019-10-03_epccs-y-la-atencion-cardiovascular-primaria-en-eslovaquia-ingles/
https://gpcardio.org/es/2019-10-03_epccs-y-la-atencion-cardiovascular-primaria-en-espana-espanol/
https://gpcardio.org/es/2019-10-03_epccs-y-la-atencion-cardiovascular-primaria-en-espana-ingles/
https://gpcardio.org/es/2019-10-03_epccs-y-la-atencion-cardiovascular-primaria-en-serbia/
https://gpcardio.org/es/2019-10-09_como-la-epccs-pretende-ayudar-a-los-medicos-de-atencion-primaria-en-toda-europa-a-reconocer-y-gestionar-el-riesgo-cardiovascular-ingles/
https://gpcardio.org/es/2019-10-29_diagnostico-y-manejo-de-la-hipertension-en-atencion-primaria-resumen-en-frances/
https://gpcardio.org/es/2019-10-29_diagnostico-y-manejo-de-la-hipertension-en-atencion-primaria-resumen-en-griego/
https://gpcardio.org/es/2019-10-29_diagnostico-y-manejo-de-la-hipertension-en-atencion-primaria-resumen-en-ucraniano/
https://gpcardio.org/es/2019-10-29_diagnostico-y-tratamiento-de-la-hipertension-en-la-atencion-primaria-de-salud-resumen-en-serbio-de-la-guia-de-la-epccs-sobre-hipertension/
https://gpcardio.org/es/2019-10-29_sociedades-griegas-involucradas-en-la-atencion-primaria/
https://gpcardio.org/es/2019-10-29_societe-francaise-de-medecine-generale-sfmg/
https://gpcardio.org/es/2019-11-04_epccs-y-la-atencion-cardiovascular-primaria-en-francia/
https://gpcardio.org/es/2019-11-04_epccs-y-la-atencion-cardiovascular-primaria-en-irlanda/
https://gpcardio.org/es/2019-11-04_epccs-y-la-atencion-cardiovascular-primaria-en-polonia-ingles/
https://gpcardio.org/es/2019-11-04_epccs-y-la-atencion-cardiovascular-primaria-en-polonia-polaco/
https://gpcardio.org/es/2019-11-04_epccs-y-la-atencion-cardiovascular-primaria-en-turquia/
https://gpcardio.org/es/2019-11-04_epccs-y-la-atencion-cardiovascular-primaria-en-ucrania/
https://gpcardio.org/es/2019-11-12_insuficiencia-cardiaca-y-comorbilidades-enfermedad-renal-y-cancer/
https://gpcardio.org/es/2020-04-09_estrategia-invasiva-o-conservadora-inicial-para-la-enfermedad-coronaria-estable/
https://gpcardio.org/es/2020-04-14_efecto-de-la-dapagliflozina-sobre-el-empeoramiento-de-la-insuficiencia-cardiaca-y-la-muerte-cardiovascular-en-pacientes-con-insuficiencia-cardiaca-con-y-sin-diabetes/
https://gpcardio.org/es/2020-04-16_dos-ensayos-de-fase-3-de-inclisiran-en-pacientes-con-colesterol-ldl-elevado/
https://gpcardio.org/es/2020-04-16_inclisiran-para-el-tratamiento-de-la-hipercolesterolemia-familiar-heterocigota/
https://gpcardio.org/es/2020-04-23_manejo-de-la-enfermedad-coronaria-en-pacientes-con-enfermedad-renal-avanzada/
https://gpcardio.org/es/2020-04-25_clopidogrel-frente-a-ticagrelor-o-prasugrel-en-pacientes-de-70-anos-o-mas-con-sindrome-coronario-agudo-sin-elevacion-del-segmento-st-popular-age/
https://gpcardio.org/es/2020-05-01_regimenes-antitromboticos-optimos-para-pacientes-con-fibrilacion-auricular-sometidos-a-intervencion-coronaria-percutanea/
https://gpcardio.org/es/2020-05-02_eficacia-de-la-denervacion-renal-basada-en-cateter-en-ausencia-de-medicacion-antihipertensiva-spyral-htn-off-med-pivotal/
https://gpcardio.org/es/2020-05-05_resultados-a-diez-anos-tras-stents-liberadores-de-farmaco-frente-a-cirugia-de-revascularizacion-coronaria-por-enfermedad-del-tronco-comun-izquierdo/
https://gpcardio.org/es/2020-05-09_monoterapia-con-un-inhibidor-de-p2y12-o-aspirina-para-la-prevencion-secundaria-en-pacientes-con-aterosclerosis-establecida/
https://gpcardio.org/es/2020-05-12_manejo-clinico-de-la-enfermedad-coronaria-estable-en-pacientes-con-diabetes-mellitus-tipo-2/
https://gpcardio.org/es/2020-05-14_vericiguat-en-pacientes-con-insuficiencia-cardiaca-y-fraccion-de-eyeccion-reducida/
https://gpcardio.org/es/2020-05-19_asociacion-de-la-reduccion-de-la-presion-arterial-con-la-demencia-incidente-o-el-deterioro-cognitivo/
https://gpcardio.org/es/2020-05-26_efecto-de-la-reduccion-de-la-medicacion-antihipertensiva-frente-a-la-atencion-habitual-sobre-el-control-a-corto-plazo-de-la-presion-arterial-en-pacientes-con-hipertension-de-80-anos-o-mas/
https://gpcardio.org/es/2020-05-26_prevalencia-mundial-de-la-hipercolesterolemia-familiar/
https://gpcardio.org/es/2020-06-16_efecto-de-la-monoterapia-con-ticagrelor-frente-a-ticagrelor-con-aspirina-sobre-la-hemorragia-mayor-y-los-eventos-cardiovasculares-en-pacientes-con-sindrome-coronario-agudo/
https://gpcardio.org/es/2020-07-07_reconocimiento-pronostico-y-tratamiento-de-la-amiloidosis-sistemica/
https://gpcardio.org/es/2020-07-11_estimacion-de-los-beneficios-a-lo-largo-de-la-vida-de-las-terapias-farmacologicas-modificadoras-de-la-enfermedad-integrales-en-pacientes-con-insuficiencia-cardiaca-con-fraccion-de-eyeccion-reducida/
https://gpcardio.org/es/2020-07-14_asociacion-del-injerto-de-arteria-radial-frente-al-injerto-de-vena-safena-con-los-resultados-cardiovasculares-a-largo-plazo-en-pacientes-sometidos-a-cirugia-de-revascularizacion-coronaria/
https://gpcardio.org/es/2020-07-14_eficacia-y-seguridad-comparativas-de-los-inhibidores-orales-de-p2y12-en-el-sindrome-coronario-agudo/
https://gpcardio.org/es/2020-08-01_revascularizacion-completa-frente-a-revascularizacion-limitada-a-la-lesion-culpable-en-el-infarto-de-miocardio-con-elevacion-del-segmento-st/
https://gpcardio.org/es/2020-08-04_via-de-decision-del-consenso-de-expertos-de-la-acc-de-2020-sobre-el-manejo-de-la-hemorragia-en-pacientes-con-anticoagulantes-orales/
https://gpcardio.org/es/2020-08-07_manejo-integrado-de-la-fibrilacion-auricular-en-atencion-primaria/
https://gpcardio.org/es/2020-08-11_seguridad-y-eficacia-de-la-interrupcion-de-la-aspirina-sobre-la-base-de-un-inhibidor-de-p2y12-en-pacientes-tras-una-intervencion-coronaria-percutanea/
https://gpcardio.org/es/2020-08-20_evinacumab-para-la-hipercolesterolemia-familiar-homocigota/
https://gpcardio.org/es/2020-08-25_efecto-de-la-seleccion-de-inhibidores-orales-de-p2y12-guiada-por-genotipo-frente-a-la-terapia-convencional-con-clopidogrel-sobre-los-resultados-isquemicos-tras-una-intervencion-coronaria-percutanea/
https://gpcardio.org/es/2020-09-01_via-de-decision-del-consenso-de-expertos-de-2020-sobre-nuevas-terapias-para-la-reduccion-del-riesgo-cardiovascular-en-pacientes-con-diabetes-tipo-2/
https://gpcardio.org/es/2020-09-07_mortalidad-tras-stents-liberadores-de-farmacos-frente-a-cirugia-de-revascularizacion-coronaria-en-la-enfermedad-del-tronco-comun-izquierdo/
https://gpcardio.org/es/2020-09-14_efectos-de-los-agonistas-del-receptor-del-peptido-similar-al-glucagon-tipo-1-sobre-los-eventos-cardiovasculares-mayores-en-pacientes-con-diabetes-mellitus-tipo-2-con-o-sin-enfermedad-cardiovascular-es/
https://gpcardio.org/es/2020-09-19_inhibidores-de-sglt2-en-pacientes-con-insuficiencia-cardiaca-con-fraccion-de-eyeccion-reducida/
https://gpcardio.org/es/2020-10-01_evolocumab-en-la-hipercolesterolemia-familiar-heterocigota-pediatrica/
https://gpcardio.org/es/2020-10-01_historia-natural-de-la-estenosis-aortica-grave-asintomatica-y-la-asociacion-de-la-intervencion-temprana-con-los-resultados/
https://gpcardio.org/es/2020-10-01_terapia-de-control-temprano-del-ritmo-en-pacientes-con-fibrilacion-auricular/
https://gpcardio.org/es/2020-10-08_dapagliflozina-en-pacientes-con-enfermedad-renal-cronica/
https://gpcardio.org/es/2020-10-08_resultados-cardiovasculares-con-ertugliflozina-en-la-diabetes-tipo-2/
https://gpcardio.org/es/2020-10-08_resultados-cardiovasculares-y-renales-con-empagliflozina-en-la-insuficiencia-cardiaca/
https://gpcardio.org/es/2020-10-10_desescalada-basada-en-prasugrel-de-la-doble-terapia-antiplaquetaria-tras-la-intervencion-coronaria-percutanea-en-pacientes-con-sindrome-coronario-agudo-host-reduce-polytech-acs/
https://gpcardio.org/es/2020-10-13_doble-terapia-antiplaquetaria-tras-la-intervencion-coronaria-percutanea-y-stents-liberadores-de-farmacos/
https://gpcardio.org/es/2020-10-29_edoxaban-en-dosis-baja-en-pacientes-muy-ancianos-con-fibrilacion-auricular/
https://gpcardio.org/es/2020-10-31_rediseno-y-validacion-de-la-puntuacion-syntax-ii-para-individualizar-la-toma-de-decisiones-entre-revascularizacion-percutanea-y-quirurgica-en-pacientes-con-enfermedad-coronaria-compleja/
https://gpcardio.org/es/2020-11-07_la-revascularizacion-completa-reduce-la-muerte-cardiovascular-en-pacientes-con-infarto-de-miocardio-con-elevacion-del-segmento-st-y-enfermedad-multivaso/
https://gpcardio.org/es/2020-11-10_cribado-de-la-hipertension-arterial-en-ninos-y-adolescentes/
https://gpcardio.org/es/2020-11-17_colchicina-en-pacientes-con-sindrome-coronario-agudo/
https://gpcardio.org/es/2020-11-21_eficacia-y-seguridad-de-la-reduccion-del-colesterol-ldl-en-pacientes-de-edad-avanzada/
https://gpcardio.org/es/2020-11-21_la-reduccion-de-la-lipoproteina-a-por-alirocumab-disminuye-la-carga-total-de-eventos-cardiovasculares-independientemente-de-la-reduccion-del-colesterol-de-lipoproteinas-de-baja-densidad/
https://gpcardio.org/es/2020-11-26_ensayo-n-of-1-con-estatina-placebo-o-ningun-tratamiento-para-evaluar-los-efectos-secundarios/
https://gpcardio.org/es/2020-11-26_rivaroxaban-en-pacientes-con-fibrilacion-auricular-y-valvula-mitral-bioprotesica/
https://gpcardio.org/es/2020-12-08_efecto-de-los-acidos-grasos-omega-3-en-dosis-altas-frente-al-aceite-de-maiz-sobre-los-eventos-cardiovasculares-adversos-mayores-en-pacientes-con-alto-riesgo-cardiovascular/
https://gpcardio.org/es/2020-12-10_evinacumab-en-pacientes-con-hipercolesterolemia-refractaria/
https://gpcardio.org/es/2020-12-12_carboximaltosa-ferrica-para-la-deficiencia-de-hierro-al-alta-tras-insuficiencia-cardiaca-aguda/
https://gpcardio.org/es/2020-12-22_efecto-de-digoxina-frente-a-bisoprolol-para-el-control-de-la-frecuencia-cardiaca-en-la-fibrilacion-auricular-sobre-la-calidad-de-vida-referida-por-el-paciente/
https://gpcardio.org/es/2021-01-14_activacion-de-la-miosina-cardiaca-con-omecamtiv-mecarbil-en-la-insuficiencia-cardiaca-sistolica/
https://gpcardio.org/es/2021-01-14_sotagliflozina-en-pacientes-con-diabetes-y-empeoramiento-reciente-de-la-insuficiencia-cardiaca/
https://gpcardio.org/es/2021-01-14_sotagliflozina-en-pacientes-con-diabetes-y-enfermedad-renal-cronica/
https://gpcardio.org/es/2021-01-21_doble-terapia-antiplaquetaria-corta-seguida-de-monoterapia-con-inhibidor-de-p2y12-frente-a-doble-terapia-antiplaquetaria-prolongada-tras-la-intervencion-coronaria-percutanea-con-stents-liberadores-de/
https://gpcardio.org/es/2021-01-21_polipildora-con-o-sin-aspirina-en-personas-sin-enfermedad-cardiovascular/
https://gpcardio.org/es/2021-01-26_ensayo-aleatorizado-de-empagliflozina-en-pacientes-no-diabeticos-con-insuficiencia-cardiaca-y-fraccion-de-eyeccion-reducida/
https://gpcardio.org/es/2021-01-28_ablacion-con-criobalon-como-terapia-inicial-para-la-fibrilacion-auricular/
https://gpcardio.org/es/2021-01-28_crioablacion-o-terapia-farmacologica-para-el-tratamiento-inicial-de-la-fibrilacion-auricular/
https://gpcardio.org/es/2021-01-28_treprostinil-inhalado-en-la-hipertension-pulmonar-debida-a-enfermedad-pulmonar-intersticial/
https://gpcardio.org/es/2021-02-01_asociacion-de-los-inhibidores-de-sglt2-con-los-resultados-cardiovasculares-y-renales-en-pacientes-con-diabetes-tipo-2/
https://gpcardio.org/es/2021-02-09_efecto-del-entrenamiento-intervalico-de-alta-intensidad-el-entrenamiento-continuo-moderado-o-el-asesoramiento-sobre-actividad-fisica-basado-en-guias-clinicas-sobre-el-consumo-maximo-de-oxigeno-en-paci/
https://gpcardio.org/es/2021-02-09_finerenona-y-resultados-cardiovasculares-en-pacientes-con-enfermedad-renal-cronica-y-diabetes-tipo-2/
https://gpcardio.org/es/2021-02-09_via-de-decision-del-consenso-de-expertos-de-la-acc-de-2020-para-la-terapia-anticoagulante-y-antiplaquetaria-en-pacientes-con-fibrilacion-auricular-o-tromboembolismo-venoso-sometidos-a-intervencion-cor/
https://gpcardio.org/es/2021-02-16_actualizacion-de-2021-de-la-via-de-decision-del-consenso-de-expertos-de-la-acc-de-2017-para-la-optimizacion-del-tratamiento-de-la-insuficiencia-cardiaca/
https://gpcardio.org/es/2021-03-02_resultados-a-3-anos-de-la-reparacion-transcateter-de-la-valvula-mitral-en-pacientes-con-insuficiencia-cardiaca/
https://gpcardio.org/es/2021-03-16_efecto-de-la-suplementacion-con-acidos-grasos-omega-3-marinos-y-vitamina-d-sobre-la-fibrilacion-auricular-incidente/
https://gpcardio.org/es/2021-03-31_efectos-de-la-dapagliflozina-sobre-la-mortalidad-en-pacientes-con-enfermedad-renal-cronica/
https://gpcardio.org/es/2021-04-07_guias-de-la-esc-de-2020-para-el-manejo-de-los-sindromes-coronarios-agudos-en-pacientes-que-se-presentan-sin-elevacion-persistente-del-segmento-st/
https://gpcardio.org/es/2021-04-17_terapia-antiplaquetaria-guiada-frente-a-estandar-en-pacientes-sometidos-a-intervencion-coronaria-percutanea/
https://gpcardio.org/es/2021-05-01_reduccion-farmacologica-de-la-presion-arterial-para-la-prevencion-primaria-y-secundaria-de-la-enfermedad-cardiovascular-en-diferentes-niveles-de-presion-arterial/
https://gpcardio.org/es/2021-05-05_los-betabloqueantes-causan-depresion/
https://gpcardio.org/es/2021-05-20_informe-final-de-un-ensayo-de-control-intensivo-frente-a-estandar-de-la-presion-arterial/
https://gpcardio.org/es/2021-05-27_eficacia-comparativa-de-la-dosificacion-de-aspirina-en-la-enfermedad-cardiovascular/
https://gpcardio.org/es/2021-06-01_evaluacion-de-la-ablacion-con-cateter-o-los-farmacos-antiarritmicos-como-tratamiento-de-primera-linea-de-la-fibrilacion-auricular/
https://gpcardio.org/es/2021-06-03_oclusion-de-la-orejuela-auricular-izquierda-durante-la-cirugia-cardiaca-para-prevenir-el-ictus/
https://gpcardio.org/es/2021-06-26_aspirina-frente-a-clopidogrel-para-la-monoterapia-cronica-de-mantenimiento-tras-la-intervencion-coronaria-percutanea-host-exam/
https://gpcardio.org/es/2021-06-26_denervacion-renal-por-ultrasonido-para-la-hipertension-resistente-a-una-combinacion-de-tres-medicamentos-en-un-solo-comprimido-radiance-htn-trio/
https://gpcardio.org/es/2021-07-10_eficacia-y-seguridad-del-nuevo-agonista-dual-del-receptor-de-gip-y-glp-1-tirzepatida-en-pacientes-con-diabetes-tipo-2-surpass-1/
https://gpcardio.org/es/2021-07-15_rehabilitacion-fisica-para-pacientes-de-edad-avanzada-hospitalizados-por-insuficiencia-cardiaca/
https://gpcardio.org/es/2021-07-21_eficacia-y-seguridad-de-la-colchicina-en-dosis-bajas-en-pacientes-con-enfermedad-coronaria/
https://gpcardio.org/es/2021-07-22_icp-multivaso-guiada-por-ffr-o-angiografia-para-el-infarto-de-miocardio/
https://gpcardio.org/es/2021-08-05_milrinona-en-comparacion-con-dobutamina-en-el-tratamiento-del-shock-cardiogenico/
https://gpcardio.org/es/2021-08-14_tirzepatida-una-vez-a-la-semana-frente-a-insulina-degludec-una-vez-al-dia-como-tratamiento-anadido-a-metformina-con-o-sin-inhibidores-de-sglt2-en-pacientes-con-diabetes-tipo-2-surpass-3/
https://gpcardio.org/es/2021-08-17_reduccion-del-colesterol-la-presion-arterial-o-ambos-para-prevenir-eventos-cardiovasculares/
https://gpcardio.org/es/2021-08-31_via-de-decision-del-consenso-de-expertos-de-la-acc-de-2021-para-el-manejo-de-la-reduccion-del-riesgo-de-ascvd-en-pacientes-con-hipertrigliceridemia-persistente/
https://gpcardio.org/es/2021-09-02_resultados-cardiovasculares-y-renales-con-efpeglenatida-en-la-diabetes-tipo-2/
https://gpcardio.org/es/2021-09-11_manejo-guiado-por-hemodinamica-de-la-insuficiencia-cardiaca-guide-hf/
https://gpcardio.org/es/2021-09-16_efecto-de-la-sustitucion-de-la-sal-sobre-los-eventos-cardiovasculares-y-la-muerte/
https://gpcardio.org/es/2021-09-18_tratamiento-inicial-con-un-solo-comprimido-que-contiene-una-combinacion-cuadruple-de-dosis-a-un-cuarto-de-los-medicamentos-para-la-presion-arterial-frente-a-la-monoterapia-con-dosis-estandar-en-pacien/
https://gpcardio.org/es/2021-09-30_ensayo-de-control-intensivo-de-la-presion-arterial-en-pacientes-de-edad-avanzada-con-hipertension/
https://gpcardio.org/es/2021-10-09_desescalado-no-guiado-de-ticagrelor-a-clopidogrel-en-pacientes-estabilizados-con-infarto-agudo-de-miocardio-sometidos-a-intervencion-coronaria-percutanea-talos-ami/
https://gpcardio.org/es/2021-10-14_empagliflozina-en-la-insuficiencia-cardiaca-con-fraccion-de-eyeccion-preservada/
https://gpcardio.org/es/2021-10-14_empagliflozina-y-resultados-renales-mayores-en-la-insuficiencia-cardiaca/
https://gpcardio.org/es/2021-10-19_efecto-de-la-empagliflozina-sobre-los-eventos-de-empeoramiento-de-la-insuficiencia-cardiaca-en-pacientes-con-insuficiencia-cardiaca-y-fraccion-de-eyeccion-preservada/
https://gpcardio.org/es/2021-10-23_resultados-clinicos-del-cribado-sistematico-de-la-fibrilacion-auricular-strokestop/
https://gpcardio.org/es/2021-10-28_doble-terapia-antiplaquetaria-tras-la-icp-en-pacientes-con-alto-riesgo-de-sangrado/
https://gpcardio.org/es/2021-11-02_vacunacion-contra-la-influenza-tras-el-infarto-de-miocardio/
https://gpcardio.org/es/2021-11-11_inhibicion-del-receptor-de-angiotensina-y-de-la-neprilisina-en-el-infarto-agudo-de-miocardio/
https://gpcardio.org/es/2021-11-13_reduccion-de-la-presion-arterial-y-riesgo-de-diabetes-tipo-2-de-nueva-aparicion/
https://gpcardio.org/es/2021-11-13_tirzepatida-frente-a-insulina-glargina-en-la-diabetes-tipo-2-y-riesgo-cardiovascular-aumentado-surpass-4/
https://gpcardio.org/es/2021-12-02_edoxaban-frente-a-antagonista-de-la-vitamina-k-para-la-fibrilacion-auricular-tras-el-tavr/
https://gpcardio.org/es/2021-12-04_pericardiotomia-posterior-izquierda-para-la-prevencion-de-la-fibrilacion-auricular-tras-la-cirugia-cardiaca/
https://gpcardio.org/es/2021-12-07_ablacion-de-la-union-av-y-resincronizacion-cardiaca-en-pacientes-con-fibrilacion-auricular-permanente-y-qrs-estrecho/
https://gpcardio.org/es/2021-12-09_eventos-cardiovasculares-con-finerenona-en-la-enfermedad-renal-y-la-diabetes-tipo-2/
https://gpcardio.org/es/2021-12-11_intervencion-coronaria-guiada-por-indice-de-flujo-cuantitativo-angiografico-favor-iii-china/
https://gpcardio.org/es/2021-12-18_intervencion-coronaria-percutanea-con-stents-liberadores-de-farmaco-frente-a-cirugia-de-revascularizacion-coronaria-en-la-enfermedad-del-tronco-coronario-izquierdo/
https://gpcardio.org/es/2021-12-21_efecto-de-la-suplementacion-a-largo-plazo-con-acidos-grasos-omega-3-marinos-sobre-el-riesgo-de-fibrilacion-auricular-en-ensayos-controlados-aleatorizados-de-resultados-cardiovasculares/
https://gpcardio.org/es/2021-12-30_angiografia-despues-de-una-parada-cardiaca-extrahospitalaria-sin-elevacion-del-segmento-st/
https://gpcardio.org/es/2021-12-30_clortalidona-para-la-hipertension-en-la-enfermedad-renal-cronica-avanzada/
https://gpcardio.org/es/2022-01-13_icp-guiada-por-reserva-fraccional-de-flujo-en-comparacion-con-la-cirugia-de-revascularizacion-coronaria/
https://gpcardio.org/es/2022-01-18_guia-2021-del-acc-aha-scai-para-la-revascularizacion-de-arterias-coronarias/
https://gpcardio.org/es/2022-01-25_anticoagulantes-orales-directos-frente-a-warfarina-en-pacientes-con-fibrilacion-auricular/
https://gpcardio.org/es/2022-01-25_cribado-de-la-fibrilacion-auricular/
https://gpcardio.org/es/2022-02-08_la-finerenona-reduce-el-riesgo-de-insuficiencia-cardiaca-incidente-en-pacientes-con-enfermedad-renal-cronica-y-diabetes-tipo-2/
https://gpcardio.org/es/2022-02-10_resultados-cardiovasculares-y-renales-con-finerenona-en-pacientes-con-diabetes-tipo-2-y-enfermedad-renal-cronica/
https://gpcardio.org/es/2022-03-07_efectos-comparativos-de-la-terapia-guiada-frente-a-la-terapia-potente-con-inhibidores-del-p2y12-en-el-sindrome-coronario-agudo/
https://gpcardio.org/es/2022-03-21_estrategia-sistematica-y-precoz-de-control-del-ritmo-para-la-fibrilacion-auricular-en-pacientes-con-o-sin-sintomas/
https://gpcardio.org/es/2022-04-09_reduccion-del-sodio-dietetico-a-menos-de-100-mmol-en-la-insuficiencia-cardiaca-sodium-hf/
https://gpcardio.org/es/2022-04-09_seguridad-del-inhibidor-oral-del-factor-xia-asundexian-en-comparacion-con-apixaban-en-pacientes-con-fibrilacion-auricular-pacific-af/
https://gpcardio.org/es/2022-04-26_uso-de-aspirina-para-prevenir-la-enfermedad-cardiovascular/
https://gpcardio.org/es/2022-05-03_guia-2022-de-la-aha-acc-hfsa-para-el-manejo-de-la-insuficiencia-cardiaca/
https://gpcardio.org/es/2022-05-03_guia-2022-de-la-aha-acc-hfsa-para-el-manejo-de-la-insuficiencia-cardiaca/
https://gpcardio.org/es/2022-05-03_guia-2022-de-la-aha-acc-hfsa-para-el-manejo-de-la-insuficiencia-cardiaca/
https://gpcardio.org/es/2022-05-10_efecto-de-alirocumab-anadido-a-la-terapia-con-estatinas-de-alta-intensidad-sobre-la-aterosclerosis-coronaria-en-pacientes-con-infarto-de-miocardio-agudo/
https://gpcardio.org/es/2022-05-12_tratamiento-de-la-hipertension-cronica-leve-durante-el-embarazo/
https://gpcardio.org/es/2022-05-21_cirugia-bariatrica-y-enfermedad-cardiovascular/
https://gpcardio.org/es/2022-05-31_efectos-de-las-intervenciones-a-largo-plazo-con-metformina-y-estilo-de-vida-sobre-los-eventos-cardiovasculares-en-el-diabetes-prevention-program-y-su-estudio-de-resultados/
https://gpcardio.org/es/2022-06-02_necesidad-de-reiniciar-y-ponerse-al-dia-en-la-prevencion-de-la-cvd-en-tiempos-de-covid-19/
https://gpcardio.org/es/2022-06-07_ensayo-aleatorizado-de-control-del-ritmo-mediante-ablacion-frente-a-control-de-la-frecuencia-en-pacientes-con-insuficiencia-cardiaca-y-fibrilacion-auricular/
https://gpcardio.org/es/2022-06-21_afecta-el-momento-de-la-ablacion-de-la-taquicardia-ventricular-al-pronostico-en-pacientes-con-desfibrilador-automatico-implantable-resultados-del-ensayo-multicentrico-aleatorizado-partita/
https://gpcardio.org/es/2022-06-21_efecto-de-la-ablacion-de-fibrosis-guiada-por-rm-frente-a-la-ablacion-con-cateter-convencional-sobre-la-recurrencia-de-arritmia-auricular-en-pacientes-con-fibrilacion-auricular-persistente/
https://gpcardio.org/es/2022-07-19_efecto-del-omecamtiv-mecarbil-sobre-la-capacidad-de-ejercicio-en-la-insuficiencia-cardiaca-cronica-con-fraccion-de-eyeccion-reducida/
https://gpcardio.org/es/2022-07-26_efectos-de-la-empagliflozina-sobre-los-sintomas-las-limitaciones-fisicas-y-la-calidad-de-vida-en-pacientes-hospitalizados-por-insuficiencia-cardiaca-aguda/
https://gpcardio.org/es/2022-07-26_efectos-del-inicio-precoz-de-empagliflozina-sobre-la-diuresis-y-la-funcion-renal-en-pacientes-con-insuficiencia-cardiaca-aguda-descompensada-empag-hf/
https://gpcardio.org/es/2022-07-26_intervenciones-de-asesoramiento-conductual-para-promover-una-dieta-saludable-y-la-actividad-fisica-para-la-prevencion-de-la-enfermedad-cardiovascular-en-adultos-sin-factores-de-riesgo-cardiovascular/
https://gpcardio.org/es/2022-07-30_eficacia-y-seguridad-a-largo-plazo-de-la-terapia-combinada-de-estatina-de-intensidad-moderada-con-ezetimiba-frente-a-la-monoterapia-con-estatina-de-alta-intensidad-en-pacientes-con-enfermedad-cardiova/
https://gpcardio.org/es/2022-08-09_descenso-inicial-dip-de-la-tasa-de-filtracion-glomerular-estimada-tras-el-inicio-de-dapagliflozina-en-pacientes-con-insuficiencia-cardiaca-y-fraccion-de-eyeccion-reducida/
https://gpcardio.org/es/2022-08-23_uso-de-estatinas-para-la-prevencion-primaria-de-la-enfermedad-cardiovascular-en-adultos/
https://gpcardio.org/es/2022-08-23_uso-de-estatinas-para-la-prevencion-primaria-de-la-enfermedad-cardiovascular-en-adultos/
https://gpcardio.org/es/2022-08-30_empagliflozina-para-la-insuficiencia-cardiaca-con-fraccion-de-eyeccion-ventricular-izquierda-conservada-con-y-sin-diabetes/
https://gpcardio.org/es/2022-09-01_reserva-fraccional-de-flujo-o-ecografia-intravascular-para-guiar-la-icp/
https://gpcardio.org/es/2022-09-03_inhibidores-del-sglt-2-en-pacientes-con-insuficiencia-cardiaca/
https://gpcardio.org/es/2022-09-07_prevalencia-de-la-intolerancia-a-las-estatinas/
https://gpcardio.org/es/2022-09-08_pruebas-funcionales-rutinarias-o-atencion-estandar-en-pacientes-de-alto-riesgo-tras-la-icp/
https://gpcardio.org/es/2022-09-10_efecto-de-la-terapia-con-estatinas-sobre-los-sintomas-musculares/
https://gpcardio.org/es/2022-09-13_control-precoz-del-ritmo-en-pacientes-con-fibrilacion-auricular-y-alta-carga-de-comorbilidad/
https://gpcardio.org/es/2022-09-15_estrategia-de-polipildora-en-la-prevencion-cardiovascular-secundaria/
https://gpcardio.org/es/2022-09-15_rivaroxaban-en-la-fibrilacion-auricular-asociada-a-cardiopatia-reumatica/
https://gpcardio.org/es/2022-09-20_armonizacion-de-las-guias-de-presion-arterial-hipertension-del-american-college-of-cardiology-american-heart-association-y-de-la-european-society-of-cardiology-european-society-of-hypertension/
https://gpcardio.org/es/2022-09-22_dapagliflozina-en-la-insuficiencia-cardiaca-con-fraccion-de-eyeccion-levemente-reducida-o-preservada/
https://gpcardio.org/es/2022-09-22_reduccion-de-la-glucemia-en-la-diabetes-tipo-2-resultados-microvasculares-y-cardiovasculares/
https://gpcardio.org/es/2022-09-26_efectos-de-los-sustitutos-de-la-sal-sobre-los-resultados-clinicos/
https://gpcardio.org/es/2022-09-27_ensayo-aleatorizado-de-estimulacion-de-la-rama-izquierda-del-haz-frente-a-estimulacion-biventricular-para-la-terapia-de-resincronizacion-cardiaca/
https://gpcardio.org/es/2022-09-27_resultados-a-cinco-anos-en-pacientes-con-dispositivos-de-asistencia-ventricular-izquierda-totalmente-levitados-magneticamente-frente-a-flujo-axial-en-el-ensayo-aleatorizado-momentum-3/
https://gpcardio.org/es/2022-09-29_acetazolamida-en-la-insuficiencia-cardiaca-aguda-descompensada-con-sobrecarga-de-volumen/
https://gpcardio.org/es/2022-10-04_2022-acc-expert-consensus-decision-pathway-sobre-el-papel-de-las-terapias-no-estatinicas-para-la-reduccion-del-colesterol-ldl-en-el-manejo-del-riesgo-de-enfermedad-cardiovascular-aterosclerotica/
https://gpcardio.org/es/2022-10-04_dapagliflozina-en-pacientes-hospitalizados-recientemente-por-insuficiencia-cardiaca-con-fraccion-de-eyeccion-levemente-reducida-o-preservada/
https://gpcardio.org/es/2022-10-04_terapia-temprana-frente-a-tardia-con-anticoagulantes-orales-no-antagonistas-de-la-vitamina-k-tras-un-ictus-isquemico-agudo-en-la-fibrilacion-auricular-timing/
https://gpcardio.org/es/2022-10-08_alopurinol-frente-a-atencion-habitual-en-pacientes-del-reino-unido-con-cardiopatia-isquemica-all-heart/
https://gpcardio.org/es/2022-10-13_revascularizacion-percutanea-en-la-disfuncion-ventricular-izquierda-isquemica/
https://gpcardio.org/es/2022-10-18_eficacia-y-seguridad-de-la-dapagliflozina-segun-la-fragilidad-en-pacientes-con-insuficiencia-cardiaca/
https://gpcardio.org/es/2022-10-20_objetivos-de-presion-arterial-en-supervivientes-comatosos-de-una-parada-cardiaca/
https://gpcardio.org/es/2022-10-22_resultados-cardiovasculares-en-adultos-con-hipertension-con-administracion-vespertina-frente-a-matutina-de-los-antihipertensivos-habituales-en-el-reino-unido-estudio-time/
https://gpcardio.org/es/2022-11-01_empagliflozina-en-el-infarto-agudo-de-miocardio/
https://gpcardio.org/es/2022-11-01_patiromero-para-el-manejo-de-la-hiperpotasemia-en-la-insuficiencia-cardiaca-con-fraccion-de-eyeccion-reducida/
https://gpcardio.org/es/2022-11-05_control-intensivo-de-la-presion-arterial-tras-trombectomia-endovascular-por-ictus-isquemico-agudo-enchanted2-mt/
https://gpcardio.org/es/2022-11-15_hospitalizaciones-y-mortalidad-en-pacientes-con-insuficiencia-mitral-secundaria-e-insuficiencia-cardiaca/
https://gpcardio.org/es/2022-11-17_arn-de-interferencia-pequeno-para-reducir-la-lipoproteina-a-en-la-enfermedad-cardiovascular/
https://gpcardio.org/es/2022-11-19_impacto-de-la-diabetes-sobre-los-efectos-de-los-inhibidores-del-cotransportador-de-sodio-glucosa-tipo-2-en-los-resultados-renales/
https://gpcardio.org/es/2022-11-22_stents-liberadores-de-everolimus-o-cirugia-de-derivacion-para-la-enfermedad-coronaria-multivaso/
https://gpcardio.org/es/2022-11-24_reduccion-de-trigliceridos-con-pemafibrato-para-disminuir-el-riesgo-cardiovascular/
https://gpcardio.org/es/2022-11-26_ly3437943-un-nuevo-agonista-triple-de-los-receptores-de-gip-glp-1-y-glucagon-en-personas-con-diabetes-tipo-2/
https://gpcardio.org/es/2022-12-03_antagonista-dual-de-la-endotelina-aprocitentan-para-la-hipertension-resistente-precision/
https://gpcardio.org/es/2022-12-03_seguridad-tolerabilidad-y-eficacia-de-la-optimizacion-de-las-terapias-medicas-dirigidas-por-guias-en-la-insuficiencia-cardiaca-aguda-strong-hf/
https://gpcardio.org/es/2022-12-06_apixaban-en-pacientes-con-fibrilacion-auricular-en-hemodialisis/
https://gpcardio.org/es/2022-12-17_derisomaltosa-ferrica-intravenosa-en-pacientes-con-insuficiencia-cardiaca-y-deficiencia-de-hierro-en-el-reino-unido-ironman/
https://gpcardio.org/es/2022-12-21_reduccion-de-la-presion-arterial-y-prevencion-de-la-demencia/
https://gpcardio.org/es/2022-12-29_clortalidona-frente-a-hidroclorotiazida-para-eventos-cardiovasculares-en-la-hipertension/
https://gpcardio.org/es/2023-01-01_impacto-de-la-empagliflozina-en-la-descongestion-en-la-insuficiencia-cardiaca-aguda/
https://gpcardio.org/es/2023-01-03_efectos-comparativos-de-rosuvastatina-en-dosis-baja-placebo-y-suplementos-dieteticos-sobre-los-lipidos-y-los-biomarcadores-inflamatorios/
https://gpcardio.org/es/2023-01-03_estudio-de-fase-2-de-aficamten-en-pacientes-con-miocardiopatia-hipertrofica-obstructiva/
https://gpcardio.org/es/2023-01-03_supervivencia-tras-el-manejo-invasivo-o-conservador-de-la-enfermedad-coronaria-estable/
https://gpcardio.org/es/2023-01-10_acido-acetilsalicilico-frente-a-clopidogrel-como-monoterapia-de-mantenimiento-a-largo-plazo-tras-la-intervencion-coronaria-percutanea/
https://gpcardio.org/es/2023-01-10_asociacion-prospectiva-de-los-pasos-diarios-con-la-enfermedad-cardiovascular/
https://gpcardio.org/es/2023-01-10_efecto-de-la-ablacion-con-cateter-mediante-aislamiento-de-venas-pulmonares-con-vs-sin-aislamiento-de-la-pared-posterior-de-la-auricula-izquierda-sobre-la-recurrencia-de-arritmia-auricular-en-pacientes/
https://gpcardio.org/es/2023-01-12_empagliflozina-en-pacientes-con-enfermedad-renal-cronica/
https://gpcardio.org/es/2023-01-12_progresion-de-la-fibrilacion-auricular-tras-crioablacion-o-tratamiento-farmacologico/
https://gpcardio.org/es/2023-01-14_coste-efectividad-del-cribado-poblacional-de-la-fibrilacion-auricular/
https://gpcardio.org/es/2023-01-17_efecto-de-torasemida-frente-a-furosemida-tras-el-alta-sobre-la-mortalidad-por-todas-las-causas-en-pacientes-hospitalizados-por-insuficiencia-cardiaca/
https://gpcardio.org/es/2023-02-01_combinacion-de-diureticos-de-asa-con-tiazidicos-en-la-insuficiencia-cardiaca-descompensada/
https://gpcardio.org/es/2023-02-02_ensayo-de-fase-2-de-baxdrostat-para-la-hipertension-resistente-al-tratamiento/
https://gpcardio.org/es/2023-02-07_oxigenacion-por-membrana-extracorporea-en-el-tratamiento-del-shock-cardiogenico/
https://gpcardio.org/es/2023-02-16_la-ablacion-por-cateter-mejora-los-resultados-cardiovasculares-en-pacientes-con-fibrilacion-auricular-e-insuficiencia-cardiaca/
https://gpcardio.org/es/2023-02-28_calcio-coronario-incidental/
https://gpcardio.org/es/2023-02-28_denervacion-renal-endovascular-por-ultrasonido-para-tratar-la-hipertension/
https://gpcardio.org/es/2023-03-18_eficacia-de-una-intervencion-intensiva-sobre-la-presion-arterial-dirigida-por-profesionales-sanitarios-comunitarios-no-medicos-frente-a-la-atencion-habitual-sobre-la-enfermedad-cardiovascular-crhcp/
https://gpcardio.org/es/2023-04-04_estrategia-de-tratamiento-hasta-el-objetivo-o-estatina-de-alta-intensidad-en-pacientes-con-enfermedad-coronaria/
https://gpcardio.org/es/2023-04-08_revascularizacion-completa-inmediata-frente-a-escalonada-en-pacientes-con-sindrome-coronario-agudo-y-enfermedad-coronaria-multivaso-biovasc/
https://gpcardio.org/es/2023-04-11_heterogeneidad-en-la-respuesta-de-la-presion-arterial-a-4-farmacos-antihipertensivos/
https://gpcardio.org/es/2023-04-13_acido-bempedoico-y-resultados-cardiovasculares-en-pacientes-intolerantes-a-las-estatinas/
https://gpcardio.org/es/2023-04-15_la-inflamacion-y-el-colesterol-como-predictores-de-eventos-cardiovasculares-en-pacientes-que-reciben-tratamiento-con-estatinas/
https://gpcardio.org/es/2023-04-17_desescalada-del-tratamiento-antiagregante-plaquetario-doble-en-el-sindrome-coronario-agudo/
https://gpcardio.org/es/2023-04-18_asociacion-entre-los-niveles-alcanzados-de-colesterol-de-lipoproteinas-de-baja-densidad-y-los-resultados-cardiovasculares-y-de-seguridad-a-largo-plazo/
https://gpcardio.org/es/2023-04-20_ensayo-de-fase-3-de-sotatercept-para-el-tratamiento-de-la-hipertension-arterial-pulmonar/
https://gpcardio.org/es/2023-04-25_ensayo-aleatorizado-de-fase-2b-del-inhibidor-oral-del-pcsk9-mk-0616/
https://gpcardio.org/es/2023-05-04_icp-compleja-guiada-por-imagen-intravascular-o-guiada-por-angiografia/
https://gpcardio.org/es/2023-05-09_via-de-decision-de-consenso-de-expertos-del-acc-2023-sobre-el-manejo-de-la-insuficiencia-cardiaca-con-fraccion-de-eyeccion-preservada/
https://gpcardio.org/es/2023-05-18_reparacion-transcateter-en-pacientes-con-regurgitacion-tricuspidea/
https://gpcardio.org/es/2023-05-27_estrategia-de-revascularizacion-con-bypass-venoso-primero-frente-a-mejor-tratamiento-endovascular-primero-en-pacientes-con-isquemia-cronica-que-amenaza-la-extremidad-que-requerian-un-procedimiento-de/
https://gpcardio.org/es/2023-06-01_eficacia-y-seguridad-de-los-comprimidos-combinados-triples-y-cuadruples-de-dosis-baja-frente-a-la-monoterapia-la-atencion-habitual-o-el-placebo-para-el-manejo-inicial-de-la-hipertension/
https://gpcardio.org/es/2023-06-01_seguimiento-a-cinco-anos-tras-la-reparacion-transcateter-de-la-regurgitacion-mitral-secundaria/
https://gpcardio.org/es/2023-06-06_anticoagulantes-orales-directos-frente-a-warfarina-en-todo-el-espectro-de-la-funcion-renal/
https://gpcardio.org/es/2023-06-06_optimizacion-del-tratamiento-tras-la-hospitalizacion-por-insuficiencia-cardiaca-en-todo-el-espectro-de-la-fraccion-de-eyeccion-del-ventriculo-izquierdo/
https://gpcardio.org/es/2023-06-08_tratamiento-de-la-diabetes-mellitus-gestacional-diagnosticada-precozmente-en-el-embarazo/
https://gpcardio.org/es/2023-06-24_monitorizacion-hemodinamica-remota-de-las-presiones-de-la-arteria-pulmonar-en-pacientes-con-insuficiencia-cardiaca-cronica-monitor-hf/
https://gpcardio.org/es/2023-06-27_efecto-de-los-inhibidores-del-sglt2-sobre-los-resultados-cardiovasculares-en-diversas-poblaciones-de-pacientes/
https://gpcardio.org/es/2023-06-29_anticoagulacion-precoz-frente-a-tardia-en-el-ictus-con-fibrilacion-auricular/
https://gpcardio.org/es/2023-07-01_el-tercer-ensayo-de-paquete-de-cuidados-intensivos-con-reduccion-de-la-presion-arterial-en-la-hemorragia-cerebral-aguda-interact3/
https://gpcardio.org/es/2023-07-11_monoterapia-con-inhibidor-del-p2y12-o-aspirina-para-la-prevencion-secundaria-de-eventos-coronarios/
https://gpcardio.org/es/2023-07-13_seguridad-cardiovascular-de-la-terapia-de-reemplazo-de-testosterona/
https://gpcardio.org/es/2023-07-20_ensayo-de-fase-1-del-anticuerpo-ni006-para-la-deplecion-del-amiloide-de-transtiretina-cardiaco/
https://gpcardio.org/es/2023-07-20_zilebesiran-un-agente-terapeutico-de-interferencia-por-arn-para-la-hipertension/
https://gpcardio.org/es/2023-08-08_atorvastatina-para-la-disfuncion-cardiaca-asociada-a-antraciclinas/
https://gpcardio.org/es/2023-08-08_terapia-con-agonistas-del-receptor-de-glp-1-con-y-sin-inhibidores-del-sglt2-en-pacientes-con-diabetes-tipo-2/
https://gpcardio.org/es/2023-08-12_retatrutida-un-agonista-de-los-receptores-de-gip-glp-1-y-glucagon-en-personas-con-diabetes-tipo-2/
https://gpcardio.org/es/2023-08-14_sacubitril-valsartan-en-la-insuficiencia-cardiaca-con-fraccion-de-eyeccion-levemente-reducida-o-preservada/
https://gpcardio.org/es/2023-08-24_pitavastatina-para-prevenir-la-enfermedad-cardiovascular-en-la-infeccion-por-vih/
https://gpcardio.org/es/2023-08-24_terapias-de-combinacion-a-dosis-fija-en-la-prevencion-primaria-de-la-enfermedad-cardiovascular-en-diferentes-grupos/
https://gpcardio.org/es/2023-09-07_icp-completa-o-solo-de-la-lesion-culpable-en-pacientes-de-edad-avanzada-con-infarto-de-miocardio/
https://gpcardio.org/es/2023-09-07_orforglipron-un-agonista-oral-diario-del-receptor-de-glp-1-para-adultos-con-obesidad/
https://gpcardio.org/es/2023-09-14_carboximaltosa-ferrica-en-la-insuficiencia-cardiaca-con-deficit-de-hierro/
https://gpcardio.org/es/2023-09-19_icp-guiada-por-la-reserva-de-flujo-fraccional-o-cirugia-de-bypass-coronario-para-la-enfermedad-coronaria-de-3-vasos/
https://gpcardio.org/es/2023-09-21_semaglutida-en-pacientes-con-insuficiencia-cardiaca-con-fraccion-de-eyeccion-preservada-y-obesidad/
https://gpcardio.org/es/2023-09-28_anticoagulacion-con-edoxaban-en-pacientes-con-episodios-auriculares-de-alta-frecuencia/
https://gpcardio.org/es/2023-10-01_antagonistas-del-receptor-de-mineralocorticoides-con-inhibidores-del-cotransportador-de-sodio-glucosa-tipo-2-en-la-insuficiencia-cardiaca/
https://gpcardio.org/es/2023-10-01_eficacia-de-la-monitorizacion-de-la-presion-arterial-pulmonar-en-pacientes-con-insuficiencia-cardiaca-cronica/
https://gpcardio.org/es/2023-10-03_tasa-de-filtracion-glomerular-estimada-albuminuria-y-resultados-adversos/
https://gpcardio.org/es/2023-10-05_efecto-global-de-los-factores-de-riesgo-modificables-sobre-la-enfermedad-cardiovascular-y-la-mortalidad/
https://gpcardio.org/es/2023-10-05_soporte-vital-extracorporeo-en-el-shock-cardiogenico-relacionado-con-infarto/
https://gpcardio.org/es/2023-10-12_ablacion-con-cateter-en-la-insuficiencia-cardiaca-terminal-con-fibrilacion-auricular/
https://gpcardio.org/es/2023-10-12_momento-de-la-revascularizacion-completa-con-icp-multivaso-para-el-infarto-de-miocardio/
https://gpcardio.org/es/2023-10-14_oxigenacion-por-membrana-extracorporea-venoarterial-en-pacientes-con-shock-cardiogenico-relacionado-con-infarto/
https://gpcardio.org/es/2023-10-17_hipotension-ortostatica-tratamiento-de-la-hipertension-y-enfermedad-cardiovascular/
https://gpcardio.org/es/2023-10-17_intervencion-coronaria-percutanea-guiada-por-tomografia-de-coherencia-optica-o-por-ecografia-intravascular/
https://gpcardio.org/es/2023-10-19_guia-por-oct-o-angiografia-para-la-icp-en-lesiones-complejas-de-bifurcacion/
https://gpcardio.org/es/2023-10-19_icp-guiada-por-tomografia-de-coherencia-optica-frente-a-icp-guiada-por-angiografia/
https://gpcardio.org/es/2023-10-24_compuesto-de-medicina-tradicional-china-tongxinluo-y-resultados-clinicos-en-pacientes-con-infarto-agudo-de-miocardio/
https://gpcardio.org/es/2023-11-02_ablacion-por-campo-pulsado-o-ablacion-termica-convencional-para-la-fibrilacion-auricular-paroxistica/
https://gpcardio.org/es/2023-11-23_reemplazo-valvular-aortico-transcateter-en-pacientes-de-bajo-riesgo-a-los-cinco-anos/
https://gpcardio.org/es/2023-11-25_zibotentan-en-combinacion-con-dapagliflozina-comparado-con-dapagliflozina-en-pacientes-con-enfermedad-renal-cronica-zenith-ckd/
https://gpcardio.org/es/2023-12-14_semaglutida-y-resultados-cardiovasculares-en-la-obesidad-sin-diabetes/
https://gpcardio.org/es/2023-12-21_eficacia-de-la-carboxymaltosa-ferrica-en-la-insuficiencia-cardiaca-con-deficit-de-hierro/
https://gpcardio.org/es/2023-12-21_un-ensayo-controlado-con-placebo-de-intervencion-coronaria-percutanea-para-la-angina-estable/
https://gpcardio.org/es/2023-12-28_estrategia-transfusional-restrictiva-o-liberal-en-el-infarto-de-miocardio-y-la-anemia/
https://gpcardio.org/es/2024-01-02_guia-acc-aha-accp-hrs-de-2023-para-el-diagnostico-y-el-tratamiento-de-la-fibrilacion-auricular/
https://gpcardio.org/es/2024-01-02_guia-acc-aha-accp-hrs-de-2023-para-el-diagnostico-y-el-tratamiento-de-la-fibrilacion-auricular/
https://gpcardio.org/es/2024-01-11_apixaban-para-la-prevencion-del-ictus-en-la-fibrilacion-auricular-subclinica/
https://gpcardio.org/es/2024-01-18_resultados-a-largo-plazo-de-la-resincronizacion-desfibrilacion-en-la-insuficiencia-cardiaca/
https://gpcardio.org/es/2024-02-13_los-monitores-hemodinamicos-implantables-mejoran-la-supervivencia-en-pacientes-con-insuficiencia-cardiaca-y-fraccion-de-eyeccion-reducida/
https://gpcardio.org/es/2024-02-20_seguridad-y-eficacia-de-la-monoterapia-con-ticagrelor-en-pacientes-con-sindromes-coronarios-agudos-sometidos-a-intervencion-coronaria-percutanea/
https://gpcardio.org/es/2024-02-20_suspension-de-la-aspirina-dentro-del-primer-mes-tras-la-colocacion-de-stent-para-monoterapia-con-ticagrelor-en-el-sindrome-coronario-agudo/
https://gpcardio.org/es/2024-02-20_una-estrategia-sin-aspirina-frente-a-una-estrategia-antiplaquetaria-doble-para-la-colocacion-de-stent-coronario/
https://gpcardio.org/es/2024-03-01_impacto-del-acido-bempedoico-en-el-total-de-eventos-cardiovasculares/
https://gpcardio.org/es/2024-03-02_implantacion-de-stent-coronario-liberador-de-farmaco-guiada-por-imagen-intravascular/
https://gpcardio.org/es/2024-03-18_cambio-global-del-bajo-peso-al-predominio-de-la-obesidad-en-tres-decadas-a-traves-de-generaciones/
https://gpcardio.org/es/2024-03-26_anticoagulantes-orales-directos-para-la-prevencion-del-ictus-en-pacientes-con-fibrilacion-auricular-detectada-por-dispositivo/
https://gpcardio.org/es/2024-04-01_implantacion-de-valvula-aortica-transcateter-o-quirurgica/
https://gpcardio.org/es/2024-04-02_stratify-hf-una-colaboracion-europea-para-desarrollar-un-sistema-de-apoyo-basado-en-ia-para-la-estratificacion-del-riesgo-y-la-deteccion-precoz-de-la-insuficiencia-cardiaca/
https://gpcardio.org/es/2024-04-07_gamificacion-e-incentivos-economicos-para-aumentar-la-actividad-fisica-en-pacientes-con-riesgo-cardiovascular-elevado/
https://gpcardio.org/es/2024-04-08_aplicacion-web-eficaz-para-determinar-el-acceso-a-estatinas-sin-receta/
https://gpcardio.org/es/2024-04-08_un-programa-mejorado-de-medicacion-remota-impulsa-las-prescripciones-de-gdmt-en-pacientes-con-t2d-de-alto-riesgo-cardiovascular-o-renal/
https://gpcardio.org/es/2024-04-16_via-de-decision-de-consenso-de-expertos-del-acc-de-2024-para-el-tratamiento-de-la-insuficiencia-cardiaca-con-fraccion-de-eyeccion-reducida/
https://gpcardio.org/es/2024-04-18_betabloqueantes-tras-el-infarto-de-miocardio-y-fraccion-de-eyeccion-preservada/
https://gpcardio.org/es/2024-04-18_bomba-de-flujo-microaxial-o-tratamiento-estandar-en-el-shock-cardiogenico-relacionado-con-infarto/
https://gpcardio.org/es/2024-04-18_semaglutida-en-pacientes-con-insuficiencia-cardiaca-relacionada-con-la-obesidad-y-diabetes-de-tipo-2/
https://gpcardio.org/es/2024-04-25_empagliflozina-tras-el-infarto-agudo-de-miocardio/
https://gpcardio.org/es/2024-04-25_icp-completa-guiada-por-ffr-o-icp-exclusiva-de-la-lesion-culpable-en-pacientes-con-infarto-de-miocardio/
https://gpcardio.org/es/2024-04-27_semaglutida-frente-a-placebo-en-personas-con-insuficiencia-cardiaca-relacionada-con-la-obesidad-y-fraccion-de-eyeccion-preservada/
https://gpcardio.org/es/2024-05-01_monoterapia-con-ticagrelor-o-clopidogrel-frente-a-tratamiento-antiplaquetario-doble-tras-la-intervencion-coronaria-percutanea/
https://gpcardio.org/es/2024-05-02_infusiones-de-apolipoproteina-a1-y-resultados-cardiovasculares-tras-el-infarto-agudo-de-miocardio/
https://gpcardio.org/es/2024-05-04_intervencion-coronaria-percutanea-preventiva-frente-al-tratamiento-medico-optimo-exclusivo-para-el-tratamiento-de-placas-coronarias-ateroscleroticas-vulnerables-prevent/
https://gpcardio.org/es/2024-05-04_stratifyhf-apoyo-a-la-atencion-primaria-en-el-diagnostico-precoz-de-la-insuficiencia-cardiaca/
https://gpcardio.org/es/2024-05-06_la-accion-de-investigacion-e-innovacion-stratifyhf/
https://gpcardio.org/es/2024-05-11_intervencion-coronaria-percutanea-guiada-por-ecografia-intravascular-frente-a-guiada-por-angiografia-en-sindromes-coronarios-agudos-ivus-acs/
https://gpcardio.org/es/2024-05-11_ticagrelor-solo-frente-a-ticagrelor-mas-aspirina-desde-el-mes-1-hasta-el-mes-12-tras-la-intervencion-coronaria-percutanea-en-pacientes-con-sindromes-coronarios-agudos-ultimate-dapt/
https://gpcardio.org/es/2024-05-16_andexanet-para-la-hemorragia-intracerebral-aguda-asociada-a-inhibidores-del-factor-xa/
https://gpcardio.org/es/2024-05-16_olezarsen-pancreatitis-aguda-y-sindrome-de-quilomicronemia-familiar/
https://gpcardio.org/es/2024-05-16_olezarsen-para-la-hipertrigliceridemia-en-pacientes-con-alto-riesgo-cardiovascular/
https://gpcardio.org/es/2024-05-30_reduccion-intensiva-de-la-presion-arterial-administrada-en-ambulancia-en-el-ictus-hiperagudo/
https://gpcardio.org/es/2024-06-01_tratamiento-de-la-hipertension-arterial-pulmonar/
https://gpcardio.org/es/2024-06-04_inhibidores-del-cotransportador-de-sodio-glucosa-tipo-2-y-eventos-cardiovasculares-adversos-mayores/
https://gpcardio.org/es/2024-06-04_mejorando-la-evaluacion-del-riesgo-de-cvd-integracion-del-riesgo-genetico-para-una-mejor-prediccion/
https://gpcardio.org/es/2024-06-06_tavr-autoexpandible-o-expandible-con-balon-en-pacientes-con-anillo-aortico-pequeno/
https://gpcardio.org/es/2024-06-14_manejo-invasivo-frente-a-conservador-de-pacientes-mayores-con-sindrome-coronario-agudo-sin-elevacion-del-st/
https://gpcardio.org/es/2024-06-25_revisitando-la-raza-y-el-beneficio-del-bloqueo-del-sra-en-la-insuficiencia-cardiaca/
https://gpcardio.org/es/2024-07-01_plozasiran-aro-apoc3-para-la-hipertrigliceridemia-grave/
https://gpcardio.org/es/2024-07-11_efectos-de-la-semaglutida-sobre-la-enfermedad-renal-cronica-en-pacientes-con-diabetes-tipo-2/
https://gpcardio.org/es/2024-07-13_colchicina-a-largo-plazo-para-la-prevencion-de-eventos-vasculares-recurrentes-en-el-ictus-no-cardioembolico-convince/
https://gpcardio.org/es/2024-07-20_reduccion-de-la-presion-arterial-sistolica-por-debajo-de-120-mm-hg-frente-a-por-debajo-de-140-mm-hg-en-pacientes-con-alto-riesgo-cardiovascular-con-y-sin-diabetes-o-ictus-previo/
https://gpcardio.org/es/2024-08-24_semaglutida-y-resultados-cardiovasculares-en-pacientes-con-obesidad-e-insuficiencia-cardiaca-prevalente/
https://gpcardio.org/es/2024-09-01_monoterapia-con-ticagrelor-en-el-sindrome-coronario-agudo/
https://gpcardio.org/es/2024-09-04_perspectivas-globales-del-estudio-interaspire-mapeo-de-la-prevalencia-de-lipoproteina-a-en-la-enfermedad-coronaria-en-seis-regiones-de-la-oms/
https://gpcardio.org/es/2024-09-07_semaglutida-frente-a-placebo-en-pacientes-con-insuficiencia-cardiaca-y-fraccion-de-eyeccion-levemente-reducida-o-conservada/
https://gpcardio.org/es/2024-09-12_plozasiran-un-agente-de-interferencia-por-arn-dirigido-contra-apoc3-para-la-hiperlipidemia-mixta/
https://gpcardio.org/es/2024-09-12_zodasiran-un-tratamiento-de-arni-dirigido-contra-angptl3-para-la-hiperlipidemia-mixta/
https://gpcardio.org/es/2024-09-14_soporte-circulatorio-mecanico-temporal-en-el-shock-cardiogenico-relacionado-con-infarto/
https://gpcardio.org/es/2024-09-21_antagonistas-del-receptor-de-mineralocorticoides-en-la-insuficiencia-cardiaca/
https://gpcardio.org/es/2024-09-24_actualizacion-focalizada-2024-de-la-via-de-decision-de-consenso-de-expertos-del-acc-sobre-la-evaluacion-clinica-el-manejo-y-la-trayectoria-de-los-pacientes-hospitalizados-con-insuficiencia-cardiaca/
https://gpcardio.org/es/2024-09-29_guias-esc-2024-para-el-manejo-de-la-fibrilacion-auricular-desarrolladas-en-colaboracion-con-la-european-association-for-cardio-thoracic-surgery-eacts/
https://gpcardio.org/es/2024-10-07_guias-esc-2024-para-el-manejo-de-la-presion-arterial-elevada-y-la-hipertension/
https://gpcardio.org/es/2024-10-07_semaglutida-y-presion-arterial/
https://gpcardio.org/es/2024-10-10_interrupcion-o-continuacion-de-los-betabloqueantes-tras-el-infarto-de-miocardio/
https://gpcardio.org/es/2024-10-22_efectos-de-la-semaglutida-sobre-los-resultados-de-insuficiencia-cardiaca-en-la-diabetes-y-la-enfermedad-renal-cronica-en-el-ensayo-flow/
https://gpcardio.org/es/2024-10-24_finerenona-en-la-insuficiencia-cardiaca-con-fraccion-de-eyeccion-levemente-reducida-o-conservada/
https://gpcardio.org/es/2024-10-29_adjudicacion-de-hospitalizaciones-y-muertes-en-el-ensayo-ironman-de-hierro-intravenoso-para-la-insuficiencia-cardiaca/
https://gpcardio.org/es/2024-11-05_revascularizacion-completa-frente-a-revascularizacion-limitada-a-la-lesion-culpable-en-pacientes-mayores-con-infarto-de-miocardio-con-elevacion-del-segmento-st/
https://gpcardio.org/es/2024-11-07_estrategia-de-tratamiento-invasivo-para-pacientes-mayores-con-infarto-de-miocardio/
https://gpcardio.org/es/2024-11-09_razon-de-flujo-cuantitativa-frente-a-reserva-de-flujo-fraccional-para-guiar-la-revascularizacion-coronaria-favor-iii-europe/
https://gpcardio.org/es/2024-11-14_reparacion-transcateter-frente-a-cirugia-de-la-valvula-mitral-para-la-insuficiencia-mitral-secundaria/
https://gpcardio.org/es/2024-11-14_reparacion-valvular-transcateter-en-la-insuficiencia-cardiaca-con-insuficiencia-mitral-moderada-a-grave/
https://gpcardio.org/es/2024-11-19_efecto-del-cribado-de-fibrilacion-auricular-no-diagnosticada-sobre-la-prevencion-del-ictus/
https://gpcardio.org/es/2024-11-26_resultados-cardiovasculares-renales-y-de-seguridad-con-agonistas-del-receptor-de-glp-1-solos-y-en-combinacion-con-inhibidores-de-sglt2-en-la-diabetes-tipo-2/
https://gpcardio.org/es/2024-12-12_icp-en-pacientes-sometidos-a-implantacion-de-valvula-aortica-transcateter/
https://gpcardio.org/es/2024-12-14_el-papel-vital-de-la-atencion-primaria-en-el-avance-de-la-salud-cardiovascular/
https://gpcardio.org/es/2025-01-02_asundexian-frente-a-apixaban-en-pacientes-con-fibrilacion-auricular/
https://gpcardio.org/es/2025-01-07_eficacia-y-seguridad-de-finerenona-en-todo-el-espectro-de-la-fraccion-de-eyeccion-en-la-insuficiencia-cardiaca-con-fraccion-de-eyeccion-levemente-reducida-o-conservada/
https://gpcardio.org/es/2025-01-09_plozasiran-para-el-manejo-de-la-quilomicronemia-persistente-y-el-riesgo-de-pancreatitis/
https://gpcardio.org/es/2025-01-09_sustitucion-valvular-transcateter-en-la-insuficiencia-tricuspidea-grave/
https://gpcardio.org/es/2025-01-14_reparacion-transcateter-borde-a-borde-para-la-insuficiencia-tricuspidea-aislada-grave/
https://gpcardio.org/es/2025-01-21_intervencion-temprana-en-pacientes-con-estenosis-aortica-grave-asintomatica-y-fibrosis-miocardica/
https://gpcardio.org/es/2025-01-21_muvalaplina-oral-para-la-reduccion-de-la-lipoproteina-a/
https://gpcardio.org/es/2025-01-23_abelacimab-frente-a-rivaroxaban-en-pacientes-con-fibrilacion-auricular/
https://gpcardio.org/es/2025-01-25_manejo-guiado-por-angiografia-coronaria-por-tc-en-pacientes-con-dolor-toracico-estable/
https://gpcardio.org/es/2025-01-30_continuacion-frente-a-interrupcion-de-la-anticoagulacion-oral-durante-el-tavi/
https://gpcardio.org/es/2025-01-30_tirzepatida-en-la-insuficiencia-cardiaca-con-fraccion-de-eyeccion-preservada-y-obesidad/
https://gpcardio.org/es/2025-02-13_colchicina-en-el-infarto-agudo-de-miocardio/
https://gpcardio.org/es/2025-02-13_espironolactona-sistematica-en-el-infarto-agudo-de-miocardio/
https://gpcardio.org/es/2025-02-20_ablacion-con-cateter-o-farmacos-antiarritmicos-para-la-taquicardia-ventricular/
https://gpcardio.org/es/2025-03-11_sustitucion-valvular-aortica-transcateter-en-pacientes-con-insuficiencia-cardiaca-sistolica-y-estenosis-aortica-moderada/
https://gpcardio.org/es/2025-03-15_estudio-sobre-factores-de-riesgo-cardiovascular-y-utilizacion-de-la-atencion-primaria-en-espana/
https://gpcardio.org/es/2025-03-16_prevencion-primaria-de-la-enfermedad-cardiovascular-aterosclerotica-ascvd-en-atencion-primaria-una-revision-sistematica-de-guias/
https://gpcardio.org/es/2025-03-17_diferencias-y-tendencias-por-sexo-en-el-manejo-del-riesgo-cardiovascular-hallazgos-de-un-estudio-de-atencion-primaria-a-largo-plazo/
https://gpcardio.org/es/2025-03-25_anticoagulacion-y-tratamiento-antiagregante-plaquetario-para-la-fibrilacion-auricular-y-la-enfermedad-coronaria-estable/
https://gpcardio.org/es/2025-03-25_diferencias-de-edad-y-sexo-en-la-eficacia-de-los-tratamientos-para-la-diabetes-tipo-2/
https://gpcardio.org/es/2025-03-25_tratamiento-antitrombotico-para-minimizar-los-eventos-totales-tras-un-sca-o-una-icp-en-la-fibrilacion-auricular/
https://gpcardio.org/es/2025-03-27_control-intensivo-de-la-presion-arterial-en-pacientes-con-diabetes-tipo-2/
https://gpcardio.org/es/2025-03-28_solucion-para-inhalacion-de-acetato-de-flecainida-para-la-cardioversion-de-la-fibrilacion-auricular-sintomatica-de-inicio-reciente/
https://gpcardio.org/es/2025-04-01_eficacia-y-seguridad-de-los-inhibidores-de-la-aldosterona-sintasa-para-la-hipertension/
https://gpcardio.org/es/2025-04-01_guia-acc-aha-2025-para-el-manejo-de-pacientes-con-sindromes-coronarios-agudos/
https://gpcardio.org/es/2025-04-01_metaanalisis-de-sotagliflozina-un-inhibidor-dual-del-cotransportador-de-sodio-glucosa-1-2-para-la-insuficiencia-cardiaca-en-la-diabetes-tipo-2/
https://gpcardio.org/es/2025-04-03_cierre-de-la-orejuela-auricular-izquierda-tras-ablacion-por-fibrilacion-auricular/
https://gpcardio.org/es/2025-04-07_empagliflozina-en-la-hipertension-resistente-y-la-insuficiencia-cardiaca-con-fraccion-de-eyeccion-preservada/
https://gpcardio.org/es/2025-04-07_inhibidores-del-cotransportador-de-sodio-glucosa-tipo-2-y-diabetes-de-nueva-aparicion-en-la-enfermedad-cardiovascular-o-renal/
https://gpcardio.org/es/2025-04-10_dapagliflozina-en-pacientes-sometidos-a-implantacion-percutanea-de-valvula-aortica/
https://gpcardio.org/es/2025-04-10_presentamos-gpcardio-cerrando-la-brecha-en-la-atencion-cardiovascular/
https://gpcardio.org/es/2025-04-17_ablacion-con-campo-pulsado-o-crioballon-para-la-fibrilacion-auricular-paroxistica/
https://gpcardio.org/es/2025-05-03_semaglutida-y-capacidad-de-marcha-en-personas-con-enfermedad-arterial-periferica-sintomatica-y-diabetes-tipo-2-stride/
https://gpcardio.org/es/2025-05-08_eficacia-y-seguridad-de-lorundrostat-en-pacientes-con-hipertension-no-controlada/
https://gpcardio.org/es/2025-05-13_efecto-de-la-empagliflozina-sobre-los-mecanismos-que-impulsan-la-eritropoyesis-y-la-movilizacion-de-hierro-en-pacientes-con-insuficiencia-cardiaca/
https://gpcardio.org/es/2025-05-13_interaccion-de-la-enfermedad-renal-cronica-y-los-efectos-de-la-tirzepatida-en-pacientes-con-insuficiencia-cardiaca-fraccion-de-eyeccion-preservada-y-obesidad/
https://gpcardio.org/es/2025-05-17_combinacion-de-dosis-fija-de-obicetrapib-y-ezetimiba-para-la-reduccion-del-colesterol-ldl-tandem/
https://gpcardio.org/es/2025-05-29_semaglutida-oral-y-resultados-cardiovasculares-en-la-diabetes-tipo-2-de-alto-riesgo/
https://gpcardio.org/es/2025-06-01_ensayo-aleatorizado-para-evaluar-el-empeoramiento-de-la-funcion-renal-al-anadir-dapagliflozina-para-la-insuficiencia-cardiaca-aguda-descompensada/
https://gpcardio.org/es/2025-06-01_intervencion-coronaria-percutanea-guiada-por-ffr-frente-a-cirugia-de-revascularizacion-coronaria-en-pacientes-con-diabetes/
https://gpcardio.org/es/2025-06-01_nuevo-acelerador-metabolico-controlado-para-la-hfpef-relacionada-con-la-obesidad/
https://gpcardio.org/es/2025-06-03_un-inhibidor-oral-de-pcsk9-para-el-tratamiento-de-la-hipercolesterolemia/
https://gpcardio.org/es/2025-06-10_carboximaltosa-ferrica-intravenosa-en-la-insuficiencia-cardiaca-con-deficiencia-de-hierro/
https://gpcardio.org/es/2025-06-10_guia-acc-aha-2025-para-el-manejo-de-pacientes-con-sindromes-coronarios-agudos/
https://gpcardio.org/es/2025-06-10_semaglutida-oral-y-resultados-cardiovasculares-en-personas-con-diabetes-tipo-2-segun-el-uso-de-sglt2i/
https://gpcardio.org/es/2025-06-13_el-impacto-de-la-fragilidad-en-la-eficacia-del-control-intensivo-de-la-presion-arterial-en-pacientes-con-diabetes-tipo-2/
https://gpcardio.org/es/2025-06-17_espironolactona-frente-a-amilorida-para-la-hipertension-resistente/
https://gpcardio.org/es/2025-06-17_inhibicion-del-factor-xi-de-accion-prolongada-y-sangrado-periprocedimiento/
https://gpcardio.org/es/2025-06-17_momento-de-administracion-de-la-medicacion-antihipertensiva-y-eventos-cardiovasculares-y-muerte/
https://gpcardio.org/es/2025-07-01_gpcardio-la-epccs-se-une-a-each-la-european-alliance-for-cardiovascular-health/
https://gpcardio.org/es/2025-07-01_prevalencia-casi-universal-de-la-adiposidad-central-en-la-insuficiencia-cardiaca-con-fraccion-de-eyeccion-preservada/
https://gpcardio.org/es/2025-07-01_tratamiento-adicional-con-zilebesiran-para-la-hipertension-insuficientemente-controlada/
https://gpcardio.org/es/2025-07-03_seguridad-y-eficacia-de-obicetrapib-en-pacientes-con-alto-riesgo-cardiovascular/
https://gpcardio.org/es/2025-07-05_colaboracion-sobre-el-momento-optimo-de-la-anticoagulacion-tras-un-ictus-isquemico-y-fibrilacion-auricular/
https://gpcardio.org/es/2025-07-07_colchicina-para-la-prevencion-secundaria-de-eventos-vasculares/
https://gpcardio.org/es/2025-07-07_ensayos-a-largo-plazo-de-colchicina-para-la-prevencion-secundaria-de-eventos-vasculares/
https://gpcardio.org/es/2025-07-08_ablacion-con-cateter-frente-a-modificacion-del-estilo-de-vida-con-farmacos-antiarritmicos-para-tratar-la-fibrilacion-auricular/
https://gpcardio.org/es/2025-07-10_gpcardio-y-la-ncd-academy-del-acc-unen-fuerzas-para-fortalecer-la-atencion-primaria-en-la-prevencion-de-la-enfermedad-cardiovascular/
https://gpcardio.org/es/2025-07-12_amycretin-un-novedoso-agonista-unimolecular-de-los-receptores-de-glp-1-y-amilina-administrado-por-via-subcutanea/
https://gpcardio.org/es/2025-07-12_seguridad-tolerabilidad-farmacocinetica-y-farmacodinamica-del-agonista-first-in-class-de-los-receptores-de-glp-1-y-amilina-amycretin/
https://gpcardio.org/es/2025-07-15_resultado-a-10-anos-de-la-revascularizacion-completa-o-solo-de-la-arteria-del-infarto-en-el-stemi-con-enfermedad-multivaso/
https://gpcardio.org/es/2025-07-22_cooperative-pfa/
https://gpcardio.org/es/2025-07-28_beneficios-a-largo-plazo-de-la-atorvastatina-sobre-la-incidencia-de-eventos-cardiovasculares/
https://gpcardio.org/es/2025-07-29_cvd-y-atencion-primaria-la-necesidad-de-la-orientacion-practica-de-la-epccs/
https://gpcardio.org/es/2025-07-29_impacto-del-indice-de-masa-corporal-la-adiposidad-central-y-la-perdida-de-peso-en-los-beneficios-de-tirzepatida-en-la-hfpef/
https://gpcardio.org/es/2025-08-05_abelacimab-frente-a-rivaroxaban-en-pacientes-con-fibrilacion-auricular-en-tratamiento-antiagregante-plaquetario/
https://gpcardio.org/es/2025-08-05_inhibidor-del-cotransportador-de-sodio-glucosa-tipo-2-con-y-sin-un-antagonista-de-la-aldosterona-para-la-insuficiencia-cardiaca-con-fraccion-de-eyeccion-preservada/
https://gpcardio.org/es/2025-08-05_lorundrostat-en-participantes-con-hipertension-no-controlada-e-hipertension-resistente-al-tratamiento/
https://gpcardio.org/es/2025-08-12_resultados-en-pacientes-de-edad-avanzada-tras-el-cambio-a-un-anticoagulante-mas-reciente-o-al-continuar-con-warfarina/
https://gpcardio.org/es/2025-08-14_cagrilintida-y-semaglutida-coadministradas-en-adultos-con-sobrepeso-u-obesidad/
https://gpcardio.org/es/2025-08-21_intervencion-coronaria-percutanea-preventiva-para-placas-coronarias-ateroscleroticas-vulnerables-sin-limitacion-del-flujo-en-la-diabetes/
https://gpcardio.org/es/2025-08-30_eficacia-para-reducir-la-presion-arterial-de-los-farmacos-antihipertensivos-y-sus-combinaciones/
https://gpcardio.org/es/2025-09-01_coste-efectividad-de-apixaban-frente-a-aspirina-para-la-reduccion-de-la-tromboembolia-en-pacientes-de-alto-riesgo-con-fibrilacion-auricular-detectada-por-dispositivo/
https://gpcardio.org/es/2025-09-01_diabetes-y-obesidad-y-efecto-del-tratamiento-del-control-precoz-del-ritmo-frente-a-la-atencion-habitual-en-pacientes-con-fibrilacion-auricular/
https://gpcardio.org/es/2025-09-01_estimulacion-del-sistema-de-conduccion-frente-a-estimulacion-biventricular-para-la-resincronizacion-cardiaca/
https://gpcardio.org/es/2025-09-02_atencion-medica-optima-y-revascularizacion-miocardica-guiada-por-la-capacidad-de-flujo-coronario-frente-a-la-atencion-habitual-para-la-enfermedad-coronaria-cronica/
https://gpcardio.org/es/2025-09-02_el-cribado-remoto-de-la-fibrilacion-auricular-en-atencion-primaria-mediante-un-parche-de-ecg-muestra-beneficios-modestos/
https://gpcardio.org/es/2025-09-05_reducciones-de-la-presion-arterial-con-baxdrostat-en-pacientes-con-hipertension-no-controlada-o-resistente/
https://gpcardio.org/es/2025-09-09_influencia-de-la-diabetes-tipo-2-en-los-efectos-de-tirzepatida-en-pacientes-con-insuficiencia-cardiaca-y-fraccion-de-eyeccion-preservada-con-obesidad/
https://gpcardio.org/es/2025-09-11_rehabilitacion-multidominio-para-pacientes-de-edad-avanzada-con-infarto-de-miocardio/
https://gpcardio.org/es/2025-09-11_una-nueva-guia-recomienda-un-nuevo-enfoque-para-evaluar-el-riesgo-cardiovascular-y-alcanzar-los-objetivos-de-tratamiento-de-los-niveles-de-lipidos/
https://gpcardio.org/es/2025-09-13_betabloqueantes-tras-infarto-de-miocardio-con-fraccion-de-eyeccion-levemente-reducida/
https://gpcardio.org/es/2025-09-16_2025-aha-acc-guideline-for-the-prevention-detection-evaluation-and-management-of-high-blood-pressure-in-adults/
https://gpcardio.org/es/2025-09-16_abordar-el-impacto-cardiovascular-persistente-de-la-covid-19-nueva-guia-para-la-atencion-primaria/
https://gpcardio.org/es/2025-09-18_orforglipron-un-agonista-oral-del-receptor-de-glp-1-de-molecula-pequena-en-la-diabetes-tipo-2-temprana/
https://gpcardio.org/es/2025-09-20_efecto-de-evolocumab-sobre-la-permeabilidad-del-injerto-de-vena-safena-tras-la-cirugia-de-revascularizacion-coronaria-newton-cabg-cardiolink-5/
https://gpcardio.org/es/2025-09-21_introduccion-y-el-impacto-de-la-cmr-en-los-pacientes-y-los-sistemas-de-salud/
https://gpcardio.org/es/2025-09-24_cambios-clave-en-la-guia-clinica-para-el-manejo-de-la-presion-arterial-y-los-lipidos/
https://gpcardio.org/es/2025-09-25_digitoxina-en-pacientes-con-insuficiencia-cardiaca-y-fraccion-de-eyeccion-reducida/
https://gpcardio.org/es/2025-09-28_por-que-es-importante-reconocer-y-tratar-la-enfermedad-renal-cronica-ckd/
https://gpcardio.org/es/2025-10-01_2025-aha-acc-guideline-for-the-prevention-detection-evaluation-and-management-of-high-blood-pressure-in-adults/
https://gpcardio.org/es/2025-10-01_alivio-de-la-congestion-pulmonar-mediante-la-adicion-de-dapagliflozina-al-diuretico-de-asa-intravenoso-en-pacientes-con-insuficiencia-cardiaca-aguda/
https://gpcardio.org/es/2025-10-01_no-hay-evidencia-que-respalde-el-uso-de-vitaminas-o-suplementos-para-reducir-el-colesterol-ldl-y-el-riesgo-cardiovascular/
https://gpcardio.org/es/2025-10-07_impacto-de-obicetrapib-en-los-eventos-cardiovasculares-adversos-mayores-en-pacientes-de-alto-riesgo/
https://gpcardio.org/es/2025-10-07_la-relacion-entre-la-obesidad-y-la-enfermedad-renal-cronica/
https://gpcardio.org/es/2025-10-07_oclusion-de-la-orejuela-auricular-izquierda-en-pacientes-con-enfermedad-renal-terminal/
https://gpcardio.org/es/2025-10-09_eficacia-y-seguridad-de-baxdrostat-en-la-hipertension-no-controlada-y-resistente/
https://gpcardio.org/es/2025-10-14_administracion-de-heparina-en-el-primer-contacto-medico-frente-a-inmediatamente-antes-de-la-intervencion-coronaria-percutanea-primaria/
https://gpcardio.org/es/2025-10-14_interrupcion-a-largo-plazo-de-la-anticoagulacion-tras-la-ablacion-con-cateter-para-la-fibrilacion-auricular/
https://gpcardio.org/es/2025-10-23_aspirina-en-pacientes-con-sindrome-coronario-cronico-que-reciben-anticoagulacion-oral/
https://gpcardio.org/es/2025-10-27_reemplazo-valvular-aortico-transcateter-o-quirurgico-en-pacientes-de-bajo-riesgo-a-los-7-anos/
https://gpcardio.org/es/2025-10-27_uniendo-la-concienciacion-sobre-el-corazon-y-el-ictus-mas-fuertes-juntos/
https://gpcardio.org/es/2025-10-28_control-intensivo-de-la-presion-arterial-en-pacientes-de-edad-avanzada-con-hipertension/
https://gpcardio.org/es/2025-10-28_efecto-del-control-intensivo-de-la-presion-arterial-sobre-el-ictus/
https://gpcardio.org/es/2025-10-28_icp-inmediata-o-diferida-de-la-lesion-no-culpable-en-el-infarto-de-miocardio/
https://gpcardio.org/es/2025-11-01_seguridad-de-la-inhibicion-del-factor-xi-con-abelacimab-en-la-fibrilacion-auricular-segun-la-funcion-renal/
https://gpcardio.org/es/2025-11-04_2025-aha-acc-guideline-for-the-prevention-detection-evaluation-and-management-of-high-blood-pressure-in-adults/
https://gpcardio.org/es/2025-11-06_orforglipron-un-agonista-oral-del-receptor-de-glp-1-de-molecula-pequena-para-el-tratamiento-de-la-obesidad/
https://gpcardio.org/es/2025-11-09_un-inhibidor-de-pcsk9-previene-el-primer-infarto-o-ictus-en-pacientes-de-alto-riesgo/
https://gpcardio.org/es/2025-11-10_vacuna-antigripal-de-dosis-alta-frente-a-dosis-estandar-y-resultados-cardiovasculares-en-adultos-de-edad-avanzada/
https://gpcardio.org/es/2025-11-11_decaf-una-taza-de-cafe-al-dia-podria-evitar-la-reaparicion-de-la-fibrilacion-auricular/
https://gpcardio.org/es/2025-11-13_betabloqueantes-despues-de-un-infarto-de-miocardio-en-pacientes-sin-insuficiencia-cardiaca/
https://gpcardio.org/es/2025-11-13_betabloqueantes-despues-de-un-infarto-de-miocardio-sin-fraccion-de-eyeccion-reducida/
https://gpcardio.org/es/2025-11-18_dapagliflozina-en-pacientes-hospitalizados-por-insuficiencia-cardiaca/
https://gpcardio.org/es/2025-11-18_declaracion-cientifica-de-2025-del-acc-sobre-el-manejo-de-la-obesidad-en-adultos-con-insuficiencia-cardiaca/
https://gpcardio.org/es/2025-11-18_efectos-cardiovasculares-y-tolerabilidad-de-los-agonistas-del-receptor-de-glp-1/
https://gpcardio.org/es/2025-11-21_el-consejo-de-la-epccs-lanza-gpcardio-como-compromiso-de-apoyo-a-la-atencion-primaria/
https://gpcardio.org/es/2025-11-25_puntuaciones-de-riesgo-abc-af-basadas-en-biomarcadores-para-un-tratamiento-personalizado-que-reduzca-el-ictus-o-la-muerte-en-la-fibrilacion-auricular/
https://gpcardio.org/es/2025-12-01_estudio-de-reduccion-agresiva-de-factores-de-riesgo-en-la-fibrilacion-auricular-implicaciones-para-los-resultados-de-la-ablacion/
https://gpcardio.org/es/2025-12-01_hemorragia-mayor-con-apixaban-frente-a-aspirina/
https://gpcardio.org/es/2025-12-13_revascularizacion-completa-frente-a-revascularizacion-limitada-a-la-lesion-responsable-en-el-infarto-de-miocardio-agudo-complete-revascularisation-trialists-collaboration/
https://gpcardio.org/es/2025-12-16_efecto-a-largo-plazo-de-los-dai-en-la-insuficiencia-cardiaca-no-isquemica-con-fraccion-de-eyeccion-reducida/
https://gpcardio.org/es/2025-12-16_tratamiento-farmacologico-de-la-insuficiencia-cardiaca-con-fraccion-de-eyeccion-reducida/
https://gpcardio.org/es/2025-12-18_guia-acc-aha-de-2025-para-el-manejo-de-adultos-con-cardiopatia-congenita/
https://gpcardio.org/es/2025-12-18_improve-dice-un-ensayo-abierto-de-fase-2a-en-dos-partes-para-evaluar-la-seguridad-y-la-eficacia-de-ninerafaxstat-en-pacientes-con-sindromes-cardiometabolicos/
https://gpcardio.org/es/2025-12-18_resultados-cardiovasculares-con-tirzepatida-frente-a-dulaglutida-en-la-diabetes-tipo-2/
https://gpcardio.org/es/2025-12-19_la-ue-lanza-el-ambicioso-safe-hearts-plan-una-nueva-hoja-de-ruta-para-la-salud-cardiovascular/
https://gpcardio.org/es/2025-12-20_orforglipron-un-agonista-oral-del-receptor-de-glp-1-de-molecula-pequena-para-el-tratamiento-de-la-obesidad-en-personas-con-diabetes-tipo-2-attain-2/
https://gpcardio.org/es/2025-12-23_anticoagulacion-a-corto-plazo-frente-a-doble-terapia-antiplaquetaria-para-la-prevencion-de-la-trombosis-del-dispositivo-tras-el-cierre-de-la-orejuela-auricular-izquierda/
https://gpcardio.org/es/2026-01-06_compras-de-alimentos-con-patron-dash-y-sus-efectos-sobre-la-presion-arterial/
https://gpcardio.org/es/2026-01-06_la-oms-publica-una-guia-mundial-sobre-el-uso-de-medicamentos-glp-1-para-el-tratamiento-de-la-obesidad/
https://gpcardio.org/es/2026-01-07_los-linfocitos-t-cxcr6-impulsan-la-miocarditis-por-inhibidores-del-punto-de-control-inmunitario/
https://gpcardio.org/es/2026-01-10_la-nicotina-y-el-sistema-cardiovascular-puntos-clave-para-la-atencion-primaria/
https://gpcardio.org/es/2026-01-12_eficacia-y-seguridad-del-tratamiento-con-dosis-bajas-de-espironolactona-en-pacientes-con-hiperaldosteronismo-primario/
https://gpcardio.org/es/2026-01-13_eficacia-y-seguridad-de-enlicitida-un-inhibidor-oral-de-pcsk9-en-adultos-con-hipercolesterolemia-familiar-heterocigota/
https://gpcardio.org/es/2026-01-14_agonistas-del-receptor-de-tipo-glucagon-y-medicamentos-de-nueva-generacion-basados-en-incretinas/
https://gpcardio.org/es/2026-01-15_barreras-socioeconomicas-y-estructurales-para-abordar-la-obesidad-en-las-comunidades/
https://gpcardio.org/es/2026-01-19_el-ictus-identificado-como-la-segunda-causa-principal-de-muerte-por-enfermedad-cardiovascular-y-un-importante-factor-de-discapacidad-adquirida-a-largo-plazo/
https://gpcardio.org/es/2026-01-20_factores-de-estres-ambiental-y-salud-cardiovascular/
https://gpcardio.org/es/2026-01-20_inhibidores-de-sglt2-y-resultados-renales-segun-la-tasa-de-filtracion-glomerular-y-la-albuminuria/
https://gpcardio.org/es/2026-01-20_triple-frente-a-doble-terapia-hipolipemiante-en-el-sindrome-coronario-agudo/
https://gpcardio.org/es/2026-01-21_estadisticas-de-enfermedades-cardiacas-y-accidentes-cerebrovasculares-de-2026/
https://gpcardio.org/es/2026-01-22_gestion-responsable-de-farmacos-para-inhibidores-del-sra-e-inhibidores-de-sglt2-en-la-enfermedad-renal-cronica/
https://gpcardio.org/es/2026-01-22_tratamiento-antitrombotico-tras-una-ablacion-con-cateter-exitosa-por-fibrilacion-auricular/
https://gpcardio.org/es/2026-01-27_colchicina-en-los-sindromes-coronarios-agudos/
https://gpcardio.org/es/2026-01-27_monoterapia-con-inhibidor-potente-de-p2y12-frente-a-dapt-tras-pci-en-pacientes-con-y-sin-stemi/
https://gpcardio.org/es/2026-01-28_guia-de-practica-clinica-kdigo-2026-sobre-la-anemia-en-la-enfermedad-renal-cronica-erc/
https://gpcardio.org/es/2026-01-29_carga-de-entrenamiento-derivada-de-dispositivos-portatiles-y-aterosclerosis-coronaria-en-atletas-de-mediana-edad-y-mayores-y-controles-fisicamente-activos/
https://gpcardio.org/es/2026-01-29_carga-sintomatica-y-prevencion-secundaria-en-pacientes-con-disfuncion-sistolica-del-ventriculo-izquierdo-tras-un-infarto-de-miocardio-agudo/
https://gpcardio.org/es/2026-01-29_manejo-guiado-por-un-equipo-multidisciplinario-de-la-estenosis-aortica-grave/
https://gpcardio.org/es/2026-01-29_olezarsen-para-el-manejo-de-la-hipertrigliceridemia-grave-y-el-riesgo-de-pancreatitis/
https://gpcardio.org/es/2026-01-30_eventos-embolicos-sistemicos-en-la-fibrilacion-auricular/
https://gpcardio.org/es/2026-02-01_cagrisema-reduce-la-presion-arterial-en-adultos-con-sobrepeso-u-obesidad/
https://gpcardio.org/es/2026-02-01_efectos-cardiovasculares-renales-de-dapagliflozina-en-pacientes-con-riesgo-cardiovascular-con-o-sin-diabetes-tipo-2/
https://gpcardio.org/es/2026-02-01_resultados-tras-el-cambio-de-ensayo-de-troponina-cardiaca-en-el-sca/
https://gpcardio.org/es/2026-02-01_semaglutida-y-hospitalizaciones-en-pacientes-con-obesidad-y-enfermedad-cardiovascular-establecida/
https://gpcardio.org/es/2026-02-01_β-bloqueantes-despues-de-un-infarto-de-miocardio-en-pacientes-con-fraccion-de-eyeccion-preservada/
https://gpcardio.org/es/2026-02-02_uso-de-inhibidores-de-sglt2-y-resultados-cardiorrenales-en-la-diabetes-tipo-2-con-cirrosis-hepatica/
https://gpcardio.org/es/2026-02-03_actividad-fisica-y-riesgo-de-eventos-adversos-en-la-fibrilacion-auricular/
https://gpcardio.org/es/2026-02-03_dapagliflozina-para-reducir-la-recurrencia-temprana-tras-la-ablacion-con-cateter-por-fibrilacion-auricular/
https://gpcardio.org/es/2026-02-03_manejo-actual-de-la-fibrilacion-auricular-en-pacientes-con-cancer-la-encuesta-de-2025-de-la-european-heart-rhythm-association/
https://gpcardio.org/es/2026-02-03_semaglutida-como-terapia-adyuvante-a-la-ablacion-con-cateter-en-la-fibrilacion-auricular-paroxistica-relacionada-con-la-obesidad/
https://gpcardio.org/es/2026-02-03_semaglutida-frente-a-tirzepatida-en-pacientes-con-obesidad-y-hfpef/
https://gpcardio.org/es/2026-02-04_los-estetoscopios-digitales-con-ia-superan-al-cribado-tradicional-para-la-vhd-significativa/
https://gpcardio.org/es/2026-02-05_efimosfermina-alfa-bos-580-una-vez-al-mes-en-personas-con-esteatohepatitis-asociada-a-disfuncion-metabolica-con-fibrosis-f2-o-f3/
https://gpcardio.org/es/2026-02-05_la-base-hereditaria-de-la-enfermedad-coronaria/
https://gpcardio.org/es/2026-02-05_tenecteplasa-frente-al-tratamiento-medico-estandar-para-la-oclusion-de-la-arteria-basilar-dentro-de-las-24-horas-trace-5/
https://gpcardio.org/es/2026-02-05_tenecteplasa-intravenosa-para-el-ictus-isquemico-agudo-dentro-de-las-24-horas-debido-a-oclusion-de-la-arteria-basilar/
https://gpcardio.org/es/2026-02-05_un-ensayo-controlado-con-placebo-del-inhibidor-oral-de-pcsk9-enlicitida/
https://gpcardio.org/es/2026-02-06_agonistas-del-receptor-del-peptido-similar-al-glucagon-y-resultados-renales-en-la-era-de-la-medicina-personalizada/
https://gpcardio.org/es/2026-02-06_hablar-con-los-pacientes-sobre-las-estatinas-por-que-la-mayoria-de-los-sintomas-notificados-no-son-causales/
https://gpcardio.org/es/2026-02-06_la-resistencia-a-la-insulina-compromete-la-via-de-las-pentosas-fosfato-y-deteriora-la-recuperacion-miocardica-mediada-por-dispositivos-de-asistencia-ventricular-izquierda-lvad-en-pacientes-obesos-con/
https://gpcardio.org/es/2026-02-06_la-variante-rs671-de-la-aldehido-deshidrogenasa-2-potencia-la-activacion-plaquetaria-y-la-trombosis-arterial/
https://gpcardio.org/es/2026-02-09_aterosclerosis-coronaria-en-pacientes-con-cancer-y-supervivientes/
https://gpcardio.org/es/2026-02-10_evaluacion-y-manejo-de-la-amiloidosis-cardiaca-por-transtiretina/
https://gpcardio.org/es/2026-02-10_hematopoyesis-clonal-y-sus-implicaciones-cardiovasculares/
https://gpcardio.org/es/2026-02-10_infarto-de-miocardio-espontaneo-tras-la-revascularizacion-del-tronco-comun-izquierdo/
https://gpcardio.org/es/2026-02-10_nuevas-terapias-farmacologicas-para-la-hipertension/
https://gpcardio.org/es/2026-02-10_riesgos-de-cancer-renal-y-urotelial-con-inhibidores-de-sglt2-frente-a-agonistas-del-receptor-de-glp-1-en-la-diabetes-tipo-2/
https://gpcardio.org/es/2026-02-11_criterios-para-evaluar-la-utilidad-predictiva-y-clinica-de-nuevos-modelos-biomarcadores-e-instrumentos-para-el-riesgo-de-enfermedad-cardiovascular/
https://gpcardio.org/es/2026-02-11_dosificacion-de-aspirina-tras-el-sindrome-coronario-agudo-con-sospecha-de-resistencia-a-la-aspirina/
https://gpcardio.org/es/2026-02-11_mejora-de-los-resultados-de-la-ablacion-de-la-fibrilacion-auricular-mediante-intervenciones-integradas-y-personalizadas-del-estilo-de-vida/
https://gpcardio.org/es/2026-02-11_vericiguat-y-mortalidad-en-la-insuficiencia-cardiaca-con-fraccion-de-eyeccion-reducida/
https://gpcardio.org/es/2026-02-12_asociaciones-prospectivas-de-la-obesidad-y-su-gravedad-con-9-resultados-cardiovasculares/
https://gpcardio.org/es/2026-02-12_utilidad-pronostica-de-la-resonancia-magnetica-cardiaca-de-perfusion-en-estres-en-pacientes-con-enfermedad-arterial-coronaria-conocida-o-sospechada-y-prueba-de-esfuerzo-no-concluyente/
https://gpcardio.org/es/2026-02-13_uso-de-medicamentos-nefroprotectores-durante-la-lactancia/
https://gpcardio.org/es/2026-02-16_nuevos-marcadores-proteomicos-plasmaticos-y-riesgo-de-tromboembolismo-venoso/
https://gpcardio.org/es/2026-02-16_tratamiento-anticoagulante-precoz-frente-a-tardio-tras-el-ictus-isquemico-agudo-con-fibrilacion-auricular/
https://gpcardio.org/es/2026-02-17_albuminuria-o-proteinuria-en-la-enfermedad-glomerular-y-la-ckd-cual-utilizar/
https://gpcardio.org/es/2026-02-18_betabloqueantes-tras-el-infarto-de-miocardio/
https://gpcardio.org/es/2026-02-18_terapia-genica-para-la-cistinosis-nefropatica/
https://gpcardio.org/es/2026-02-19_alteraciones-de-la-conduccion-tras-la-implantacion-percutanea-de-valvula-aortica/
https://gpcardio.org/es/2026-02-19_guia-2026-de-la-aha-acc-para-la-evaluacion-y-el-manejo-de-la-embolia-pulmonar-aguda-en-adultos/
https://gpcardio.org/es/2026-02-19_interaccion-cardiovascular-renal-metabolica-en-pacientes-con-fibrilacion-auricular-en-tratamiento-con-anticoagulantes-orales-directos/
https://gpcardio.org/es/2026-02-19_prevencion-secundaria-tras-el-ictus-isquemico/
https://gpcardio.org/es/2026-02-19_reemplazo-valvular-aortico-transcateter-o-quirurgico-en-pacientes-de-bajo-riesgo-a-los-7-anos/
https://gpcardio.org/es/2026-02-20_prediccion-mejorada-del-riesgo-de-enfermedad-cardiovascular-mediante-modelos-integrados-de-aprendizaje-automatico/
https://gpcardio.org/es/2026-02-21_pelacarsen-y-aferesis-de-lipoproteina-a-en-prevencion-secundaria/
https://gpcardio.org/es/2026-02-22_coste-efectividad-de-los-inhibidores-del-cotransportador-de-sodio-glucosa-tipo-2-y-los-agonistas-del-receptor-del-peptido-similar-al-glucagon-tipo-1-en-pacientes-con-alto-riesgo-cardiovascular-y-diabe/
https://gpcardio.org/es/2026-02-23_actividad-fisica-definida-por-acelerometria-y-calidad-de-vida-en-la-miocardiopatia-hipertrofica/
https://gpcardio.org/es/2026-02-23_efecto-de-la-semaglutida-sobre-la-covid-19-y-otras-infecciones/
https://gpcardio.org/es/2026-02-23_el-ano-en-medicina-cardiovascular-2025/
https://gpcardio.org/es/2026-02-23_inmunoadsorcion-en-la-miocardiopatia-dilatada/
https://gpcardio.org/es/2026-02-23_la-diabetes-aumenta-el-riesgo-de-insuficiencia-cardiaca-en-la-miocarditis/
https://gpcardio.org/es/2026-02-23_mitigacion-del-riesgo-de-disfuncion-renal-tras-el-trasplante-cardiaco-y-enfoques-terapeuticos/
https://gpcardio.org/es/2026-02-23_primary-care-adherence-to-heart-failure-guidelines-in-post-discharge-evaluation-routine-management-pathfinder/
https://gpcardio.org/es/2026-02-24_desnutricion-y-caquexia-en-pacientes-hospitalizados-con-afecciones-cardiacas-agudas/
https://gpcardio.org/es/2026-02-24_eventos-embolicos-sistemicos-en-la-fibrilacion-auricular/
https://gpcardio.org/es/2026-02-24_riesgo-de-hospitalizacion-por-insuficiencia-cardiaca-con-agonistas-del-receptor-de-glp-1-frente-a-inhibidores-de-dpp-4-o-inhibidores-de-sglt2-en-pacientes-con-diabetes-tipo-2/
https://gpcardio.org/es/2026-02-25_asociaciones-combinadas-de-los-agonistas-del-receptor-de-glp-1-y-un-estilo-de-vida-saludable-con-los-resultados-cardiovasculares-en-personas-con-diabetes-tipo-2/
https://gpcardio.org/es/2026-02-25_prevision-de-la-carga-de-la-enfermedad-cardiovascular-y-el-ictus-en-mujeres-en-los-estados-unidos-hasta-2050/
https://gpcardio.org/es/2026-02-25_resultados-de-la-insuficiencia-cardiaca-con-fraccion-de-eyeccion-reducida-levemente-reducida-o-preservada/
https://gpcardio.org/es/2026-02-25_rivaroxaban-a-dosis-bajas-para-prevenir-la-trombosis-ventricular-izquierda-tras-el-infarto-de-miocardio-anterior/
https://gpcardio.org/es/2026-02-26_control-intensivo-de-la-presion-arterial-y-funcion-cognitiva/
https://gpcardio.org/es/2026-02-27_beneficios-cardiorrenales-aditivos-de-la-terapia-combinada-de-finerenona-e-inhibidores-de-sglt2-en-la-ckd-diabetica/
https://gpcardio.org/es/2026-02-27_cambio-de-warfarina-a-anticoagulantes-orales-directos-en-pacientes-asiaticos-ancianos-fragiles-con-fibrilacion-auricular/
https://gpcardio.org/es/2026-02-27_inhibicion-de-sglt2-en-pacientes-con-diabetes-tipo-2-y-ckd-que-experimentan-un-deterioro-de-la-tasa-de-filtracion-glomerular-estimada-a-20-ml-min-1-73-m/
https://gpcardio.org/es/2026-02-27_la-carga-de-macrofagos-de-la-placa-carotidea-y-los-marcadores-de-macrofagos-inflamatorios-asociados-a-lipidos-predicen-eventos-cardiovasculares-adversos-mayores-secundarios-tras-la-endarterectomia/
https://gpcardio.org/es/2026-02-28_insuficiencia-cardiaca-en-los-ancianos/
https://gpcardio.org/es/2026-03-01_abelacimab-frente-a-rivaroxaban-en-personas-mayores-con-fibrilacion-auricular/
https://gpcardio.org/es/2026-03-01_algo-de-confidence-muy-necesaria-para-combatir-la-paradoja-riesgo-tratamiento-en-la-enfermedad-renal-cronica/
https://gpcardio.org/es/2026-03-01_comparacion-de-los-algoritmos-de-0-1-horas-de-la-european-society-of-cardiology-y-troponina-de-alta-sensibilidad-en-la-evaluacion-de-pacientes-con-sospecha-de-sindrome-coronario-agudo-algoritmos-de-0/
https://gpcardio.org/es/2026-03-01_cribado-cardiaco-en-jovenes/
https://gpcardio.org/es/2026-03-01_cribado-cardiaco-para-afecciones-asociadas-con-la-muerte-subita-cardiaca/
https://gpcardio.org/es/2026-03-01_efecto-del-baduanjin-sobre-la-presion-arterial-en-personas-con-presion-arterial-normal-alta/
https://gpcardio.org/es/2026-03-01_guia-2026-de-la-embolia-pulmonar-aguda-de-un-vistazo/
https://gpcardio.org/es/2026-03-01_impacto-del-tratamiento-precoz-tardio-o-interrumpido-en-ninos-con-hipercolesterolemia-familiar/
https://gpcardio.org/es/2026-03-01_journal-club/
https://gpcardio.org/es/2026-03-01_momento-de-aparicion-de-los-beneficios-cardiovasculares-y-renales-de-finerenona-en-la-insuficiencia-cardiaca-y-la-enfermedad-renal-cronica-con-diabetes-tipo-2/
https://gpcardio.org/es/2026-03-01_resultados-a-seis-anos-tras-el-reemplazo-valvular-aortico-transcateter-frente-al-quirurgico-en-pacientes-de-bajo-riesgo-con-estenosis-aortica/
https://gpcardio.org/es/2026-03-01_vacunacion-antigripal-en-dosis-alta-en-la-enfermedad-cardiovascular-aterosclerotica/
https://gpcardio.org/es/2026-03-02_el-ruido-nocturno-del-trafico-rodado-estresa-el-corazon-y-los-vasos-sanguineos/
https://gpcardio.org/es/2026-03-02_peor-perfil-de-riesgo-numero-de-injertos-y-mortalidad-hospitalaria-pero-supervivencia-tardia-aceptable-en-mujeres-sometidas-a-cirugia-coronaria/
https://gpcardio.org/es/2026-03-03_cuantificacion-del-metabolismo-energetico-del-musculo-esqueletico-durante-el-ejercicio-en-la-insuficiencia-cardiaca-con-fraccion-de-eyeccion-preservada-mediante-espectroscopia-de-resonancia-magnetica/
https://gpcardio.org/es/2026-03-03_terapia-genica-de-edicion-de-bases-in-vivo-para-la-hipercolesterolemia-familiar-heterocigota/
https://gpcardio.org/es/2026-03-03_validacion-hemodinamica-invasiva-de-una-herramienta-ecocardiografica-de-inteligencia-artificial-para-la-deteccion-de-la-insuficiencia-cardiaca-con-fraccion-de-eyeccion-preservada/
https://gpcardio.org/es/2026-03-04_aspirina-tras-la-pci-en-los-sindromes-coronarios-agudos/
https://gpcardio.org/es/2026-03-04_finerenona-para-la-enfermedad-renal-diabetica-en-la-diabetes-tipo-1-una-respuesta-fina/
https://gpcardio.org/es/2026-03-04_interaccion-de-la-edad-y-el-sexo-con-la-presion-arterial-clinica-y-ambulatoria-y-la-mortalidad/
https://gpcardio.org/es/2026-03-04_objetivos-de-presion-arterial-en-el-manejo-de-la-hipertension/
https://gpcardio.org/es/2026-03-05_anticoagulante-oral-de-accion-directa-o-antagonista-de-la-vitamina-k-para-el-paciente-anciano-fragil-con-fibrilacion-auricular/
https://gpcardio.org/es/2026-03-05_el-inhibidor-oral-de-pcsk9-enlicitide-reduce-los-niveles-de-colesterol-ldl-en-un-ensayo-de-fase-2/
https://gpcardio.org/es/2026-03-05_finerenona-en-la-diabetes-tipo-1-y-la-enfermedad-renal-cronica/
https://gpcardio.org/es/2026-03-05_semaglutida-en-la-enfermedad-arterial-periferica-y-la-diabetes-segun-la-gravedad-basal-de-la-enfermedad-y-la-edad/
https://gpcardio.org/es/2026-03-06_enfermedad-renal-e-insuficiencia-cardiaca/
https://gpcardio.org/es/2026-03-07_efecto-de-baxdrostat-sobre-la-presion-arterial-ambulatoria-en-pacientes-con-hipertension-resistente-bax24/
https://gpcardio.org/es/2026-03-07_efecto-de-baxdrostat-sobre-la-presion-arterial-ambulatoria-en-pacientes-con-hipertension-resistente-bax24/
https://gpcardio.org/es/2026-03-07_fibrilacion-auricular/
https://gpcardio.org/es/2026-03-09_diferencias-en-la-trayectoria-de-la-enfermedad-comorbilidades-y-mortalidad-en-la-miocardiopatia-hipertrofica-sarcomerica-y-no-sarcomerica/
https://gpcardio.org/es/2026-03-09_el-semaglutido-promueve-el-flujo-de-celulas-progenitoras-derivadas-de-la-medula-osea-hacia-un-perfil-antiinflamatorio-y-proregenerador-en-pacientes-de-alto-riesgo/
https://gpcardio.org/es/2026-03-09_objetivos-y-tratamientos-para-el-manejo-del-ldl-c-en-atencion-primaria/
https://gpcardio.org/es/2026-03-10_cribado-genetico-de-la-hf-fundamento-y-experiencia/
https://gpcardio.org/es/2026-03-10_lp-a-es-hora-de-empezar-a-medirlo-en-atencion-primaria/
https://gpcardio.org/es/2026-03-11_trigliceridos-un-marcador-de-riesgo-o-un-objetivo-para-el-riesgo-cv/
https://gpcardio.org/es/2026-03-12_dosificacion-insuficiente-fuera-de-indicacion-de-la-terapia-antitrombotica-con-edoxaban-en-pacientes-con-fibrilacion-auricular-y-enfermedad-arterial-coronaria-estable/
https://gpcardio.org/es/2026-03-12_orientacion-de-la-esc-sobre-cvd-y-salud-mental-en-atencion-primaria/
https://gpcardio.org/es/2026-03-12_riesgo-cardiovascular-metabolico-en-la-menopausia/
https://gpcardio.org/es/2026-03-13_guia-clinica-de-la-acc-aha-2026-sobre-el-manejo-de-la-dislipidemia/
https://gpcardio.org/es/2026-03-13_insuficiencia-cardiaca-en-atencion-primaria-reconocimiento-temprano-e-inicio-del-gdmt/
https://gpcardio.org/es/2026-03-13_la-necesidad-de-la-implicacion-de-los-medicos-de-familia-en-el-mundo-de-la-incidencia-politica/
https://gpcardio.org/es/2026-03-13_manejo-de-la-hipertension-de-dificil-control-que-hay-de-nuevo/
https://gpcardio.org/es/2026-03-14_el-pulso-de-la-atencion-primaria-cumbre-epccs-2026/
https://gpcardio.org/es/2026-03-16_uso-de-la-puntuacion-de-calcio-coronario-en-individuos-con-lipoproteina-a-elevada/
https://gpcardio.org/es/2026-03-20_antecedentes-de-resultados-adversos-del-embarazo-a-lo-largo-de-la-vida-y-riesgo-cardiovascular/
https://gpcardio.org/es/2026-03-20_el-impacto-de-las-guias-de-la-epccs-sobre-la-farmacoterapia-en-ucrania/
https://gpcardio.org/es/2026-03-20_evidencia-del-mundo-real-con-dapagliflozina-en-insuficiencia-cardiaca-con-fraccion-de-eyeccion-reducida-en-europa-central-y-oriental-y-la-region-baltica-estudio-evolution-hf-cee-ba/
https://gpcardio.org/es/2026-03-22_actualizacion-de-las-guias-de-hipertension-en-turquia/
https://gpcardio.org/es/2026-03-22_cribado-de-cvd-en-grecia/
https://gpcardio.org/es/2026-03-22_manejo-del-riesgo-cardiovascular-en-polonia/
https://gpcardio.org/es/2026-03-23_tratamiento-medico-dirigido-por-guias-en-la-erc-el-papel-crucial-de-la-atencion-primaria/
https://gpcardio.org/es/2026-03-24_cribado-y-estratificacion-del-riesgo-en-la-erc-el-papel-crucial-de-la-atencion-primaria/
https://gpcardio.org/es/2026-03-24_indice-trigliceridos-glucosa-y-mortalidad-en-pacientes-criticamente-enfermos-con-sindrome-cardiorenal-metabolico-etapa-4/
https://gpcardio.org/es/2026-03-24_inflamacion-sistemica-y-recurrencia-tras-ictus-relacionado-con-fibrilacion-auricular/
https://gpcardio.org/es/2026-03-24_manejo-de-la-erc-en-atencion-primaria/
https://gpcardio.org/es/2026-03-25_herencia-y-enfermedad-cardiovascular-en-la-descendencia-adulta-de-mujeres-con-trastorno-hipertensivo-del-embarazo/
https://gpcardio.org/es/2026-03-25_manejo-de-los-agonistas-de-los-receptores-del-peptido-similar-al-glucagon-1-y-de-los-inhibidores-del-cotransportador-de-sodio-glucosa-2-en-la-practica-clinica/
https://gpcardio.org/es/2026-03-25_papel-de-la-imagen-de-provocacion-y-de-esfuerzo-para-la-identificacion-de-candidatos-a-inhibidores-de-la-miosina-cardiaca/
https://gpcardio.org/es/2026-03-26_cierre-del-apendice-auricular-izquierdo-o-terapia-medica-en-fibrilacion-auricular/
https://gpcardio.org/es/2026-03-26_firma-de-obesidad-senescente-en-el-cancer-de-mama/
https://gpcardio.org/es/2026-03-26_nuevos-mecanismos-de-los-factores-de-riesgo-cardiovascular-metabolico-y-oportunidades-terapeuticas/
https://gpcardio.org/es/2026-03-26_terapia-de-edicion-genetica-en-enfermedades-cardiovasculares/
https://gpcardio.org/es/2026-03-27_endotipificacion-profunda-del-dano-renal-en-la-diabetes-tipo-2/
https://gpcardio.org/es/2026-03-27_enfermedad-renal/
https://gpcardio.org/es/2026-03-27_optimizacion-de-los-puntos-de-corte-de-inclusion-de-nt-probnp-para-ensayos-clinicos-aleatorizados-en-insuficiencia-cardiaca/
https://gpcardio.org/es/2026-03-28_sindrome-de-deficiencia-del-canal-de-liberacion-de-calcio-en-pacientes-diagnosticados-con-fibrilacion-ventricular-idiopatica-y-en-fallecidos-clasificados-como-muerte-subita-inexplicable-en-jovenes/
https://gpcardio.org/es/2026-03-29_cierre-del-apendice-auricular-izquierdo-o-anticoagulacion-para-la-fibrilacion-auricular/
https://gpcardio.org/es/2026-03-29_evolocumab-reduce-el-riesgo-de-primeros-eventos-cardiovasculares-mayores-en-un-31-en-pacientes-sin-aterosclerosis-significativa/
https://gpcardio.org/es/2026-03-29_fibrinolisis-cateter-dirigida-facilitada-por-ultrasonido-para-la-embolia-pulmonar-aguda/
https://gpcardio.org/es/2026-03-29_intensificacion-del-objetivo-de-colesterol-de-lipoproteinas-de-baja-densidad-en-pacientes-con-enfermedad-cardiovascular-aterosclerotica/
https://gpcardio.org/es/2026-03-30_el-estudio-de-efectos-de-la-liraglutida-en-la-fibrilacion-auricular-leaf/
https://gpcardio.org/es/2026-04-10_el-proyecto-nextgen-de-la-ue-impulsa-la-cardiologia-personalizada-integrando-datos-genomicos-y-clinicos-en-modelos-de-ia/
https://gpcardio.org/es/2026-04-15_la-insuficiencia-cardiaca-es-frecuente-en-personas-con-fibrilacion-auricular-detectada-durante-el-cribado/
https://gpcardio.org/es/2026-04-17_cambios-agudos-en-la-tfge-y-su-mediacion-en-la-reduccion-de-la-albuminuria-con-empagliflozina-y-finerenona/
https://gpcardio.org/es/2026-04-17_evolocumab-para-reducir-el-primer-evento-cardiovascular-mayor-en-pacientes-sin-aterosclerosis-significativa-conocida-y-con-diabetes/
https://gpcardio.org/es/2026-04-17_volumen-frente-a-intensidad-de-la-actividad-fisica-y-riesgo-de-enfermedades-cronicas-cardiovasculares-y-no-cardiovasculares/
https://gpcardio.org/es/2026-04-18_agonistas-del-receptor-del-peptido-1-similar-al-glucagon-para-la-prevencion-de-eventos-de-insuficiencia-cardiaca-en-diabetes-tipo-2-y-o-obesidad/
https://gpcardio.org/es/2026-04-18_diferencias-sexuales-en-el-sindrome-cardiovascular-renal-metabolico/
https://gpcardio.org/es/2026-04-18_lipoproteina-a-y-trombosis-venosa-embolica-incidente-en-mujeres-pre-y-postmenopausicas-y-en-hombres/
https://gpcardio.org/es/2026-04-19_impacto-de-las-pruebas-geneticas-en-pacientes-con-hipercolesterolemia-familiar-hf-sobre-los-eventos-cardiovasculares-adversos-el-estudio-del-registro-hokuriku-plus-de-hipercolesterolemia-familiar/
https://gpcardio.org/es/2026-04-20_lp-a-tiene-efectos-especificos-sobre-la-enfermedad-arterial-coronaria-independientes-de-ldl-c/
https://gpcardio.org/es/2026-04-21_dispositivos-portatiles-y-salud-cardiovascular/
https://gpcardio.org/es/2026-04-22_administracion-prehospitalaria-de-heparina-en-pacientes-con-iamcest-sometidos-a-pci-primaria/
https://gpcardio.org/es/2026-04-22_guia-clinica-de-la-acc-aha-aacvpr-abc-acpm-ada-ags-apha-aspc-nla-pcna-sobre-el-manejo-de-la-dislipidemia/
https://gpcardio.org/es/2026-04-22_memantina-para-las-contracciones-prematuras-de-origen-auricular/
https://gpcardio.org/es/2026-04-23_efecto-de-la-inhibicion-de-apoc3-con-olezarsen-en-la-aterosclerosis-coronaria/
https://gpcardio.org/es/2026-04-23_rivaroxaban-en-dosis-baja-para-prevenir-la-trombosis-ventricular-izquierda-tras-infarto-de-miocardio-anterior/
https://gpcardio.org/es/2026-04-24_dos-ensayos-que-comparan-el-estimulacion-del-sistema-de-conduccion-y-la-estimulacion-biventricular/
https://gpcardio.org/es/2026-04-24_etapas-del-sindrome-cardiovascular-renal-metabolico-caracteristicas-ecocardiograficas-y-riesgo-de-insuficiencia-cardiaca/
https://gpcardio.org/es/2026-04-24_guias-dieteticas-de-2026-para-mejorar-la-salud-cardiovascular/
https://gpcardio.org/es/2026-04-25_el-papel-del-soporte-de-estimulacion-auricular-en-la-terapia-de-resincronizacion-cardiaca/
https://gpcardio.org/es/2026-04-25_sotatercept-para-la-hipertension-pulmonar-combinada-post-y-precapilar-asociada-con-insuficiencia-cardiaca/
https://gpcardio.org/es/2026-04-26_evaluacion-del-riesgo-cardiovascular-a-largo-plazo-durante-el-embarazo/
https://gpcardio.org/es/2026-04-27_deteccion-ecocardiografica-automatizada-de-cardiopatias-congenitas-mediante-inteligencia-artificial/
https://gpcardio.org/es/2026-04-28_prevencion-temprana-de-ateromas/
https://gpcardio.org/es/2026-04-30_tres-agentes-antihipertensivos-de-baja-dosis-en-una-sola-pastilla-despues-de-la-hemorragia-intracerebral/
https://gpcardio.org/es/2026-05-01_radioablacion-estereotactica-para-la-taquicardia-ventricular-refractaria/
https://gpcardio.org/es/2026-05-02_bloqueo-del-sara-en-el-rinon-durante-el-ciclo-de-vida-estandar-de-tratamiento/
https://gpcardio.org/es/2026-05-03_cribado-cardiovascular-no-invasivo-multimodal-y-resultados-especificos-por-sexo/
https://gpcardio.org/es/2026-05-04_continuacion-frente-al-cambio-de-la-terapia-anticoagulante-oral-directa-tras-un-ictus-a-pesar-del-tratamiento/
https://gpcardio.org/es/2026-05-05_amplio-tiempo-de-interrupcion-del-tratamiento-relacionado-con-el-embarazo-en-mujeres-con-hipercolesterolemia-familiar/
https://gpcardio.org/es/2026-05-05_diferencias-sexuales-en-el-tratamiento-farmacologico-de-la-insuficiencia-cardiaca/
https://gpcardio.org/es/2026-05-06_factores-de-riesgo-de-enfermedad-cardiovascular-aterosclerotica-en-individuos-con-hipercolesterolemia-familiar-heterocigota/
https://gpcardio.org/es/2026-05-07_reparacion-de-borde-a-borde-percutanea-combinada-de-las-valvulas-mitral-y-tricuspide-o-reparacion-de-borde-a-borde-de-la-tricuspide-sola-en-insuficiencia-mitral-moderada/
https://gpcardio.org/es/2026-05-08_funcion-renal-y-riesgo-de-insuficiencia-cardiaca-en-adultos-mayores/
https://gpcardio.org/es/2026-05-08_riesgos-de-ictus-y-hemorragia-con-anticoagulantes-orales-no-vitaminicos-k-en-fibrilacion-auricular-no-valvular/
https://gpcardio.org/es/2026-05-09_implantacion-de-desfibrilador-subcutaneo-con-o-sin-prueba-de-desfibrilacion/
https://gpcardio.org/es/2026-05-10_digoxina-en-dosis-bajas-en-pacientes-con-insuficiencia-cardiaca-con-fraccion-de-eyeccion-reducida-o-ligeramente-reducida/
https://gpcardio.org/es/2026-05-10_digoxina-en-pacientes-con-cardiopatia-reumatica-sintomatica/
https://gpcardio.org/es/2026-05-10_eficacia-del-tratamiento-medico-recomendado-por-las-guias-segun-el-uso-de-digoxina/
https://gpcardio.org/es/2026-05-10_el-inhibidor-de-microarn-cdr132l-en-pacientes-con-fraccion-de-eyeccion-ventricular-izquierda-reducida-tras-infarto-de-miocardio/
https://gpcardio.org/es/2026-05-10_inhibidor-de-la-neprilisina-y-del-receptor-de-angiotensina-en-la-insuficiencia-cardiaca-con-fraccion-de-eyeccion-preservada-e-insuficiencia-mitral-secundaria/
https://gpcardio.org/es/2026-05-10_retirada-cegada-del-tratamiento-aleatorizado-con-digoxina-en-dosis-baja-o-placebo-en-pacientes-con-insuficiencia-cardiaca/
https://gpcardio.org/es/2026-05-11_actividad-fisica-en-las-cardiomiopatias-pediatricas/
https://gpcardio.org/es/2026-05-11_cancer-incidente-en-la-insuficiencia-cardiaca-el-infarto-de-miocardio-o-ambos/
https://gpcardio.org/es/2026-05-11_enfermedad-cardiovascular-en-la-enfermedad-de-celulas-falciformes/
https://gpcardio.org/es/2026-05-11_medidas-antropometricas-de-adiposidad-y-peptidos-natriureticos-en-el-cribado-de-la-insuficiencia-cardiaca/
https://gpcardio.org/es/2026-05-11_prevalencia-y-predictores-del-alto-riesgo-inflamatorio-en-los-subtipos-de-insuficiencia-cardiaca/
https://gpcardio.org/es/2026-05-11_subcut-hf-ii-la-furosemida-subcutanea-domiciliaria-reduce-los-dias-de-hospitalizacion-en-comparacion-con-la-furosemida-intravenosa-hospitalaria-en-pacientes-ingresados-con-edema-asociado-a-la-insufici/
https://gpcardio.org/es/2026-05-12_predictores-de-los-resultados-a-largo-plazo-en-la-miocardiopatia-hipertrofica/
https://gpcardio.org/es/2026-05-12_sotatercept-para-la-hipertension-pulmonar-poscapilar-y-precapilar-combinada-asociada-a-la-insuficiencia-cardiaca/
https://gpcardio.org/es/2026-05-12_supera-ya-la-prevalencia-global-de-la-insuficiencia-cardiaca-los-600-millones-de-personas-de-la-conjetura-a-la-evidencia/
https://gpcardio.org/es/2026-05-15_estudio-prospectivo-multicentrico-de-un-ano-en-el-mundo-real-sobre-la-eficacia-y-seguridad-del-vericiguat-en-espana/
https://gpcardio.org/es/2026-05-15_prevencion-secundaria-despues-de-la-cirugia-de-revascularizacion-coronaria/
https://gpcardio.org/es/2026-05-18_hacia-controles-cardiovasculares-integrales-en-toda-europa/
https://gpcardio.org/es/2026-05-19_atlas-of-cardiology-persisten-desigualdades-evitables-en-la-carga-y-la-atencion-de-la-enfermedad-cardiovascular/
https://gpcardio.org/es/2026-05-25_edicion-de-bases-in-vivo-de-pcsk9-con-verve-102-para-hipercolesterolemia/
https://gpcardio.org/es/2026-05-27_ablacion-por-campo-pulsado-para-el-tratamiento-intervencionista-de-la-fibrilacion-auricular-una-declaracion-cientifica-de-la-european-heart-rhythm-association-ehra-de-la-esc-la-heart-rhythm-society-hr/
https://gpcardio.org/es/2026-05-27_agonistas-del-receptor-del-peptido-similar-al-glucagon-1-en-pacientes-con-insuficiencia-cardiaca-con-fraccion-de-eyeccion-reducida/
https://gpcardio.org/es/2026-05-28_centros-de-salud-cardiovascular-femenina/
https://gpcardio.org/es/2026-05-28_los-inhibidores-de-sglt2-se-asocian-con-una-reduccion-del-volumen-y-del-grosor-del-tejido-adiposo-epicardico/
https://gpcardio.org/es/2026-05-29_fisiopatologia-prevencion-y-manejo-de-la-obstruccion-microvascular-coronaria/
https://gpcardio.org/es/2026-05-31_el-rinon-en-el-centro/
https://gpcardio.org/es/2026-06-01_mecanismos-fisiopatologicos-compartidos-entre-la-diabetes-y-la-enfermedad-de-la-valvula-aortica-calcificada/
https://gpcardio.org/es/2026-06-01_solapso-renal-diabetico-en-hipertension-pulmonar-arterial/
https://gpcardio.org/es/2026-06-02_epidemiologia-de-la-embolia-pulmonar/
https://gpcardio.org/es/2026-06-02_obicetrapib-y-los-niveles-de-lipoproteina-a-en-pacientes-con-alto-riesgo-cardiovascular/
https://gpcardio.org/es/2026-06-02_resultados-del-ensayo-betami-danblock-en-comparacion-con-una-poblacion-nacional-noruega-con-infarto-de-miocardio/
https://gpcardio.org/es/2026-06-03_hipercolesterolemia-familiar-en-ninos-y-adolescentes/
https://gpcardio.org/es/2026-06-03_niveles-de-lipoproteina-a-riesgo-de-eventos-cardiovasculares-y-beneficio-de-evolocumab/
https://gpcardio.org/es/2026-06-04_clinicas-de-lipidos-en-todo-el-mundo/
https://gpcardio.org/es/2026-06-04_efectos-del-semaglutida-en-la-mortalidad-los-resultados-cardiovasculares-y-renales-a-lo-largo-del-continuo-cardiorenal-metabolico/
https://gpcardio.org/es/2026-06-05_reduccion-proyectada-de-eventos-cardiovasculares-adversos-mayores-en-adultos-estadounidenses-de-alto-riesgo-con-diabetes-tipo-2-elegibles-para-semaglutida-oral/
https://gpcardio.org/es/2026-06-07_sindrome-de-alport-autosomico-dominante/
https://gpcardio.org/es/2026-06-09_cambios-en-la-composicion-corporal-en-pacientes-con-agonistas-del-receptor-de-glp-1-que-participan-en-un-programa-intensivo-de-rehabilitacion-cardiaca/
https://gpcardio.org/es/2026-06-10_aditivos-alimentarios-conservantes-hipertension-y-enfermedades-cardiovasculares/
https://gpcardio.org/es/2026-06-10_resultados-primarios-del-registro-salamander/
https://gpcardio.org/es/2026-06-11_la-unidad-de-salud-movil-que-realiza-actividades-de-extension-en-comunidades-urbanas-socialmente-desfavorecidas-detecta-factores-de-riesgo-cardiometabolicos-no-controlados/
https://gpcardio.org/es/2026-06-11_modalidades-y-dosis-optimas-de-ejercicio-para-la-reduccion-de-la-presion-arterial-en-adultos-con-prehipertension-e-hipertension-establecida/
https://gpcardio.org/es/2026-06-12_reduccion-del-colesterol-de-lipoproteinas-de-baja-densidad-con-inclisiran-mas-el-cuidado-habitual-en-sindrome-coronario-agudo-reciente/
https://gpcardio.org/es/2026-06-13_efecto-de-diferentes-tipos-de-legumbres-integrales-sobre-los-objetivos-terapeuticos-lipidicos-establecidos-para-la-reduccion-del-riesgo-cardiovascular/
https://gpcardio.org/es/2026-06-13_sociedad-europea-de-cardiologia/
https://gpcardio.org/es/2026-06-15_analisis-de-rentabilidad-e-impacto-presupuestario-de-la-tirzepatida-en-insuficiencia-cardiaca-con-fraccion-de-eyeccion-preservada-y-obesidad-en-el-sistema-sanitario-aleman/
https://gpcardio.org/es/2026-06-15_efectividad-clinica-de-los-inhibidores-del-cotransportador-de-sodio-glucosa-2-en-pacientes-mayores-hospitalizados-por-insuficiencia-cardiaca-con-fraccion-de-eyeccion-reducida/
https://gpcardio.org/es/2026-06-15_efectividad-comparativa-de-los-inhibidores-individuales-del-cotransportador-de-sodio-glucosa-2-sobre-los-resultados-cardiovasculares-en-la-diabetes-tipo-2-con-riesgo-cardiovascular-moderado/
https://gpcardio.org/es/2026-06-16_asociacion-de-patrones-dieteticos-y-riesgo-genetico-con-enfermedad-cardiovascular-en-supervivientes-de-cancer-del-uk-biobank/
https://gpcardio.org/es/2026-06-17_asociacion-dependiente-de-la-edad-entre-insuficiencia-cardiaca-y-riesgo-de-ictus-en-fibrilacion-auricular/
https://gpcardio.org/es/2026-06-17_hipercolesterolemia-familiar-homocigota/
https://gpcardio.org/es/2026-06-19_imagen-intracoronaria-para-la-intervencion-coronaria-percutanea-del-tronco-izquierdo/
https://gpcardio.org/es/2026-06-19_laroprovstat-el-primer-inhibidor-de-pcsk9-de-pequena-molecula-oral-para-el-tratamiento-de-la-hipercolesterolemia/
https://gpcardio.org/es/2026-06-20_dianas-farmacologicas-para-la-modificacion-lipidica-y-el-riesgo-de-diabetes-tipo-2/
https://gpcardio.org/es/2026-06-20_riesgo-cardiovascular-lipidico-mas-alla-del-colesterol-ldl/
https://gpcardio.org/es/2026-06-21_estudio-prospectivo-multicentrico-de-mundo-real-de-un-ano-de-duracion-sobre-la-eficacia-y-la-seguridad-del-vericiguat-en-espana/
https://gpcardio.org/es/2026-06-24_resultados-tras-un-primer-infarto-de-miocardio-agudo-en-pacientes-con-o-sin-cardiopatia-congenita/
https://gpcardio.org/es/2026-06-25_resultados-a-1-ano-en-la-practica-real-con-el-oclusor-amulet-del-estudio-emerge-laa-postaprobacion/
https://gpcardio.org/es/2026-06-25_retirada-enmascarada-del-tratamiento-aleatorizado-con-digoxina-en-dosis-bajas-o-placebo-en-pacientes-con-insuficiencia-cardiaca/
https://gpcardio.org/es/2026-06-27_manejo-de-insuficiencia-cardiaca-en-atencion-primaria-fuera-del-horario-habitual/
https://gpcardio.org/es/2026-06-29_embolia-coronaria-en-fibrilacion-auricular/
https://gpcardio.org/es/2026-06-30_indice-de-interaccion-dieta-microbiota-intestinal-y-riesgo-de-insuficiencia-cardiaca-en-diabetes-y-prediabetes/
https://gpcardio.org/es/2026-07-01_anticoagulantes-orales-directos-aines-selectivos-de-cox-2-y-sangrado-gastrointestinal-en-fibrilacion-auricular/
https://gpcardio.org/es/2026-07-02_ablacion-por-campo-pulsado-versus-simulado-para-tratar-la-fibrilacion-auricular/
https://gpcardio.org/es/2026-07-02_incidencia-de-la-disfuncion-cardiaca-relacionada-con-la-terapia-contra-el-cancer-en-una-cohorte-grande-diversa-y-contemporanea-en-la-practica-clinica-habitual/
https://gpcardio.org/es/2026-07-03_curso-natural-de-la-insuficiencia-aortica-moderada-o-grave-asintomatica/
https://gpcardio.org/es/2026-07-03_estimacion-del-riesgo-absoluto-de-enfermedad-cardiovascular-a-5-anos-utilizando-registros-medicos-electronicos-recopilados-de-forma-rutinaria-en-consultorios-de-atencion-primaria-de-australia/
https://gpcardio.org/es/2026-07-05_aptitud-cardiorespiratoria-en-adolescentes-y-el-equilibrio-entre-el-riesgo-de-fibrilacion-auricular-y-los-beneficios-cardiovasculares/
https://gpcardio.org/es/2026-07-05_condicion-fisica-tras-infarto-de-miocardio-en-comparacion-con-valores-de-referencia-clinicos/
https://gpcardio.org/es/2026-07-05_factores-de-riesgo-de-la-multimorbilidad-de-enfermedades-cardiovasculares-en-el-estudio-prospectivo-million-women-study/
https://gpcardio.org/es/2026-07-06_aptitud-cardiorespiratoria-en-adolescentes-y-el-equilibrio-entre-el-riesgo-de-fibrilacion-auricular-y-los-beneficios-cardiovasculares/
https://gpcardio.org/es/2026-07-07_cambios-clave-en-la-orientacion-clinica-para-el-manejo-de-la-presion-arterial-y-los-lipidos/
https://gpcardio.org/es/2026-07-07_endocarditis-infecciosa-tras-el-implante-de-valvula-aortica-transcateter/
https://gpcardio.org/es/2026-07-07_ingesta-dieteticas-de-nitrato-vegetal-y-animal-y-cambios-en-la-presion-arterial-a-5-anos/
https://gpcardio.org/es/2026-07-07_por-que-la-enfermedad-renal-cronica-erc-es-mas-importante-para-la-atencion-primaria/
https://gpcardio.org/es/2026-07-07_tiene-la-atencion-primaria-un-papel-en-el-manejo-de-la-obesidad-de-guardianes-del-sistema-a-lideres-en-salud-poblacional/
https://gpcardio.org/es/2026-07-08_bloqueo-de-los-canales-de-calcio-frente-a-bloqueo-beta-para-la-hipertension-en-la-insuficiencia-cardiaca-con-fraccion-de-eyeccion-preservada/
https://gpcardio.org/es/2026-07-08_consumo-dietetico-de-nitrato-vegetal-y-animal-y-cambios-en-la-presion-arterial-a-5-anos/
https://gpcardio.org/es/2026-07-08_evolocumab-en-pacientes-con-intervencion-coronaria-percutanea-previa-y-sin-infarto-de-miocardio-previo/
https://gpcardio.org/es/2026-07-09_determinacion-del-umbral-fisiologico-para-la-angina-orbita-fire/
https://gpcardio.org/es/2026-07-09_inhibidor-de-los-receptores-de-la-angiotensina-y-de-la-neprilisina-en-la-insuficiencia-cardiaca-con-fraccion-de-eyeccion-preservada-y-regurgitacion-mitral-secundaria/
https://gpcardio.org/es/2026-07-09_la-disfuncion-diastolica-es-igualmente-frecuente-en-la-prediabetes-y-la-diabetes-y-esta-asociada-a-factores-de-riesgo-cardiometabolicos-concomitantes/
https://gpcardio.org/es/2026-07-09_tension-arterial-domiciliaria-nocturna-medida-con-dispositivo-de-muneca-e-hipertrofia-ventricular-izquierda/
https://gpcardio.org/es/2026-07-10_evolocumab-en-pacientes-con-intervencion-coronaria-percutanea-previa-y-sin-infarto-de-miocardio-previo/
https://gpcardio.org/es/2026-07-11_bloqueo-de-los-canales-del-calcio-frente-al-bloqueo-beta-en-la-hipertension-e-insuficiencia-cardiaca-con-fraccion-de-eyeccion-preservada/
https://gpcardio.org/es/2026-07-11_tension-arterial-nocturna-medida-en-casa-con-dispositivo-de-muneca-e-hipertrofia-ventricular-izquierda/
https://gpcardio.org/es/2026-07-12_determinacion-del-umbral-fisiologico-para-la-angina-orbita-fire/
https://gpcardio.org/es/2026-07-12_inhibidor-de-los-receptores-de-la-angiotensina-y-la-neprilisina-en-la-insuficiencia-cardiaca-con-fraccion-de-eyeccion-preservada-y-regurgitacion-mitral-secundaria/
https://gpcardio.org/es/2026-07-14_tromboventricular-izquierdo-en-el-sindrome-de-takotsubo-e-infarto-de-miocardio-con-elevacion-del-segmento-st/
https://gpcardio.org/es/2026-07-15_la-historia-natural-de-la-hipertrofia-ventricular-izquierda-masiva-en-la-cardiomiopatia-hipertrofica-pediatrica/
https://gpcardio.org/es/2026-07-16_los-deficits-fisiologicos-multiorganicos-durante-el-ejercicio-identifican-la-predisposicion-clinica-y-molecular-a-la-insuficiencia-cardiaca-con-fraccion-de-eyeccion-preservada/
https://gpcardio.org/es/2026-07-18_angiopatia-amiloide-cerebral/
https://gpcardio.org/es/2026-07-18_mejoras-clinicas-en-la-ansiedad-o-la-depresion-se-asocian-con-una-mejora-en-la-aptitud-para-caminar-tras-un-programa-de-rehabilitacion-cardiaca/
https://gpcardio.org/es/2026-07-18_resultados-clinicos-del-marcapasos-del-sistema-de-conduccion-frente-al-marcapasos-ventricular-derecho-en-pacientes-con-bloqueo-auriculoventricular/
https://gpcardio.org/es/2026-07-19_reduccion-farmacologica-de-la-presion-arterial-para-la-prevencion-de-enfermedades-cardiovasculares-y-muerte-en-todo-el-espectro-de-gravedad-de-la-enfermedad-renal-cronica/
https://gpcardio.org/es/2026-07-19_tratamiento-y-resultados-con-inhibidores-de-pcsk9-en-pacientes-con-enfermedad-cardiovascular-aterosclerotica-pero-sin-eventos-isquemicos-previos/
https://gpcardio.org/es/2026-07-21_desarrollo-de-una-herramienta-integrada-de-evaluacion-del-riesgo-monogenico-y-poligenico-para-la-enfermedad-arterial-coronaria-y-su-aplicacion-en-una-biobanca-de-atencion-sanitaria-basada-en-la-comuni/
https://gpcardio.org/es/2026-07-22_manejo-y-resultados-de-la-fibrilacion-auricular-postoperatoria-de-nuevo-inicio/
https://gpcardio.org/es/2026-07-23_la-historia-natural-de-la-hipertrofia-ventricular-izquierda-masiva-en-la-cardiomiopatia-hipertrofica-pediatrica/
https://gpcardio.org/es/2026-07-23_los-deficits-fisiologicos-multiorganicos-durante-el-ejercicio-identifican-la-predisposicion-clinica-y-molecular-a-insuficiencia-cardiaca-con-fraccion-de-eyeccion-preservada/
https://gpcardio.org/es/2026-07-24_control-de-la-presion-arterial-y-mortalidad-entre-veteranos-de-ee-uu/
https://gpcardio.org/es/2026-07-24_disfuncion-renal-y-enfermedad-vascular-pulmonar-en-insuficiencia-cardiaca-con-fraccion-de-eyeccion-preservada/
https://gpcardio.org/es/2026-07-25_lipoproteina-a-proteina-c-reactiva-de-alta-sensibilidad-y-riesgo-de-ascvd-incidente-en-individuos-sin-factores-de-riesgo-modificables-estandar/
https://gpcardio.org/es/2026-07-26_diferencias-por-sexo-en-los-resultados-tras-un-ictus-isquemico-a-pesar-del-uso-de-anticoagulantes-orales-en-la-fibrilacion-auricular/
https://gpcardio.org/es/2026-07-26_vias-de-atencion-al-paciente-y-resultados-tras-el-diagnostico-reciente-de-fibrilacion-auricular/
https://gpcardio.org/es/2026-07-27_evaluacion-y-manejo-del-sindrome-metabolico-cardiovascular-renal-hepatico-en-el-ambito-de-la-atencion-primaria/
https://gpcardio.org/es/2026-07-27_fenotipado-de-pacientes-con-estenosis-aortica-de-bajo-flujo-y-bajo-gradiente-y-fraccion-de-eyeccion-preservada-que-se-someten-a-tavi/
https://gpcardio.org/es/2026-07-28_efecto-combinado-del-nivel-educativo-y-la-diabetes-sobre-la-mortalidad-por-todas-las-causas-a-1-ano-en-pacientes-con-insuficiencia-cardiaca/
https://gpcardio.org/es/2026-07-28_epidemiologia-carga-economica-y-mortalidad-por-fibrilacion-auricular-en-una-region-con-una-esperanza-de-vida-muy-elevada/
https://gpcardio.org/es/2026-07-28_rinones-nuevos-riesgos-antiguos/
https://gpcardio.org/es/2026-07-29_manejo-de-lipidos-en-diabetes-tipo-2-y-colesterol-no-hdl/
https://gpcardio.org/es/2026-07-29_momento-del-ejercicio-alineado-con-el-cronotipo-en-adultos-de-mediana-edad-con-riesgo-cardiometabolico/
https://gpcardio.org/es/2026-07-29_puncion-transseptal-en-intervenciones-cardiovasculares/
https://gpcardio.org/es/2026-07-31_diferencias-por-sexo-en-el-diagnostico-el-manejo-y-los-resultados-de-los-pacientes-con-endocarditis-infecciosa/
https://gpcardio.org/es/2026-07-31_resultados-tempranos-y-predictores-de-mortalidad-en-endocarditis-de-la-valvula-aortica-nativa/
https://gpcardio.org/es/2026-08-02_asociacion-entre-la-proteina-c-reactiva-y-el-riesgo-de-insuficiencia-cardiaca-incidente-en-supervivientes-de-cancer/
https://gpcardio.org/es/2026-08-02_declaracion-beneficio-cardiovascular-con-el-consumo-tipico-de-cafe-senal-de-dano-con-las-bebidas-energeticas/
https://gpcardio.org/es/2026-08-02_epccs-renueva-su-identidad-para-impulsar-la-atencion-cardio-renal-metabolica-integrada-en-atencion-primaria/
https://gpcardio.org/es/2026-08-02_tendencias-en-nefrologia/
https://gpcardio.org/es/2026-08-03_documento-de-consenso-experto-de-la-aha-acc-esc-whf/
https://gpcardio.org/es/2026-08-03_manejo-antitrombotico-en-pacientes-con-sindrome-coronario-cronico-que-reciben-anticoagulacion-oral/
https://gpcardio.org/es/2026-08-04_fragilidad-e-insuficiencia-cardiaca/
https://gpcardio.org/es/2026-08-05_diferencias-de-sexo-en-el-control-del-factor-de-riesgo-y-la-adherencia-a-la-medicacion-tras-un-sindrome-coronario-agudo/
https://gpcardio.org/es/2026-08-06_control-de-la-presion-arterial-y-mortalidad-entre-veteranos-de-ee-uu/
https://gpcardio.org/es/2026-08-06_la-reduccion-de-la-presion-arterial-sistolica-y-la-albuminuria-media-los-beneficios-cardiovasculares-de-la-finerenona-en-la-diabetes-tipo-2-y-la-enfermedad-renal-cronica/
https://gpcardio.org/es/2026-08-06_terapias-farmacologicas-combinadas-basadas-en-hormonas-peptidicas-para-enfermedades-metabolicas-cronicas/
https://gpcardio.org/es/2026-08-10_corazon-y-rinon-en-una-unica-guia-clinica/
https://gpcardio.org/es/2026-08-10_estatinas-mas-alla-de-los-setenta/
https://gpcardio.org/es/2026-08-10_inhibicion-del-factor-xi/
https://gpcardio.org/es/2026-08-10_la-nueva-guia-clinica-de-la-esc-sobre-insuficiencia-cardiaca/
https://gpcardio.org/es/acerca-de-epccs/
https://gpcardio.org/es/cvd-ckd-t2d/
https://gpcardio.org/es/each/
https://gpcardio.org/es/epccs-summit/
https://gpcardio.org/es/epccs-summit/actualizacion-cardiorrenal/
https://gpcardio.org/es/epccs-summit/el-plan-de-salud-cardiovascular-de-la-ue/
https://gpcardio.org/es/epccs-summit/enfermedad-cardiovascular-en-poblaciones-especiales/
https://gpcardio.org/es/epccs-summit/manejo-de-los-lipidos-en-atencion-primaria/
https://gpcardio.org/es/epccs-summit/manejo-del-riesgo-cardiovascular-en-europa-lecciones-de-los-paises/
https://gpcardio.org/es/epccs-summit/sesion-de-actualizacion-cardiovascular-para-atencion-primaria/
https://gpcardio.org/es/epccs/
https://gpcardio.org/es/epccs/sociedades-asociadas/
https://gpcardio.org/es/esc-congress-2025/
https://gpcardio.org/es/gpcardio/
https://gpcardio.org/es/literatura/
https://gpcardio.org/es/literatura/
https://gpcardio.org/es/ncd-academy/
https://gpcardio.org/es/novedades-cientificas/
https://gpcardio.org/es/novedades-de-la-sociedad/
https://gpcardio.org/es/recursos/
https://gpcardio.org/es/recursos/informes-de-reuniones/
https://gpcardio.org/es/recursos/noticias-recientes/
https://gpcardio.org/es/recursos/novedades-en-video/
https://gpcardio.org/es/recursos/orientacion-para-la-practica-clinica/
https://gpcardio.org/es/recursos/stratifyhf/
https://gpcardio.org/es/simposio-de-la-epccs-celebrado-en-wonca-europe-2026-sobre-la-enfermedad-cardio-renal-metabolica/
https://gpcardio.org/es/sobre-ipccs/
https://gpcardio.org/es/wonca-world-2025/
https://gpcardio.org/fr/
https://gpcardio.org/fr/2014-05-28_guide-pratique-pour-les-medecins-de-premier-recours-sur-l-utilisation-des-statines-chez-les-personnes-a-risque-de-diabete/
https://gpcardio.org/fr/2015-01-07_le-document-d-orientation-de-l-epccs-sur-la-prevention-de-l-avc-dans-la-fibrillation-auriculaire-1/
https://gpcardio.org/fr/2015-09-29_un-debat-anime-lors-de-la-clinical-masterclass-annuelle-de-l-epccs-donne-lieu-a-des-recommandations-pratiques/
https://gpcardio.org/fr/2015-10-02_quelle-est-la-base-de-donnees-probantes-pour-la-modification-de-la-pression-arterielle-dans-les-mises-a-jour-des-recommandations/
https://gpcardio.org/fr/2015-10-02_quelle-est-la-base-de-donnees-probantes-pour-la-modification-du-comportement-de-sante-dans-les-mises-a-jour-des-recommandations/
https://gpcardio.org/fr/2015-10-12_quelle-est-la-base-de-donnees-probantes-pour-la-modification-des-lipides-dans-les-mises-a-jour-des-recommandations/
https://gpcardio.org/fr/2015-10-14_quelle-est-la-base-de-donnees-probantes-pour-le-diagnostic-et-la-prise-en-charge-de-l-insuffisance-cardiaque-dans-les-mises-a-jour-des-recommandations/
https://gpcardio.org/fr/2016-03-15_quelle-est-la-base-de-donnees-probantes-pour-la-modification-des-lipides-dans-les-mises-a-jour-des-recommandations/
https://gpcardio.org/fr/2016-04-15_identifier-et-traiter-les-patients-atteints-d-une-veritable-hypertension/
https://gpcardio.org/fr/2016-05-26_la-base-de-donnees-probantes-pour-les-changements-de-comportement-de-sante/
https://gpcardio.org/fr/2016-09-06_guide-de-consensus-de-l-epccs-sur-la-prevention-de-l-avc-dans-la-fibrillation-auriculaire-spaf-en-medecine-de-premier-recours/
https://gpcardio.org/fr/2016-09-28_documents-d-orientation-de-l-epccs/
https://gpcardio.org/fr/2017-03-30_recommandations-sur-le-changement-des-comportements-de-sante-que-disent-les-donnees-probantes-que-recommande-t-on-et-suis-je-d-accord/
https://gpcardio.org/fr/2017-04-20_controverses-sur-l-hypertension-quelles-sont-les-implications-de-sprint-dans-le-contexte-des-essais-therapeutiques-recents/
https://gpcardio.org/fr/2017-04-20_controverses-sur-les-lipides-le-role-des-statines-est-il-desormais-clair-existe-t-il-des-alternatives-et-qu-y-a-t-il-en-developpement/
https://gpcardio.org/fr/2017-04-20_prise-en-charge-de-la-fibrillation-auriculaire-que-disent-les-recommandations-et-quelles-en-sont-les-implications-pour-les-soins-primaires/
https://gpcardio.org/fr/2017-04-20_prise-en-charge-des-lipides-que-disent-les-recommandations-et-quelles-en-sont-les-implications-pour-les-soins-primaires/
https://gpcardio.org/fr/2017-04-20_quelle-est-la-nouvelle-base-de-donnees-probantes-pour-le-diagnostic-et-la-prise-en-charge-de-l-insuffisance-cardiaque/
https://gpcardio.org/fr/2017-04-20_recommandations-sur-le-changement-des-comportements-de-sante-que-disent-les-donnees-probantes-que-recommande-t-on-et-suis-je-d-accord/
https://gpcardio.org/fr/2017-06-05_composantes-des-strategies-efficaces-pour-favoriser-le-changement-de-comportement/
https://gpcardio.org/fr/2017-06-22_comment-les-derniers-changements-de-recommandations-affectent-ils-la-prise-en-charge-de-la-dyslipidemie-en-soins-primaires/
https://gpcardio.org/fr/2017-07-01_le-guide-epccs-sur-l-insuffisance-cardiaque-publie-en-tant-que-clinical-intelligence-dans-le-br-j-gen-prac/
https://gpcardio.org/fr/2017-07-18_le-diagnostic-et-la-prise-en-charge-de-l-insuffisance-cardiaque-varient-considerablement-selon-les-pays-europeens/
https://gpcardio.org/fr/2017-09-13_que-peut-on-apprendre-des-derniers-essais-sur-l-hypertension/
https://gpcardio.org/fr/2017-12-10_guide-pratique-de-l-epccs-pour-le-diagnostic-et-la-prise-en-charge-de-l-insuffisance-cardiaque-en-soins-primaires/
https://gpcardio.org/fr/2018-02-06_comment-l-epccs-peut-elle-elargir-son-nombre-d-adherents/
https://gpcardio.org/fr/2018-02-06_comment-l-epccs-peut-elle-mieux-s-engager-aupres-des-medecins-de-premier-recours-de-differents-pays-europeens-en-matiere-d-education-sur-les-maladies-cardiovasculaires/
https://gpcardio.org/fr/2018-02-19_guide-pratique-pour-le-diagnostic-et-la-prise-en-charge-de-l-insuffisance-cardiaque-en-soins-primaires/
https://gpcardio.org/fr/2018-02-19_insuffisance-cardiaque-chronique/
https://gpcardio.org/fr/2018-02-19_prevention-de-l-accident-vasculaire-cerebral-chez-les-patients-atteints-de-fibrillation-auriculaire/
https://gpcardio.org/fr/2018-02-22_favoriser-les-changements-de-comportement-de-sante-pour-reduire-le-risque-cardiovasculaire-en-soins-primaires/
https://gpcardio.org/fr/2018-02-25_diapositives-organisation-des-soins-primaires-aux-pays-bas/
https://gpcardio.org/fr/2018-02-26_diapositives-organisation-des-soins-primaires-en-slovaquie/
https://gpcardio.org/fr/2018-02-26_diapositives-soins-primaires-en-bulgarie-nagpb/
https://gpcardio.org/fr/2018-02-26_pays-bas-apercu-des-soins-primaires-cardiovasculaires/
https://gpcardio.org/fr/2018-02-26_slovaquie-apercu-des-soins-primaires-cardiovasculaires/
https://gpcardio.org/fr/2018-02-27_diapositives-organisation-des-soins-primaires-au-portugal/
https://gpcardio.org/fr/2018-02-27_diapositives-soins-primaires-cardiovasculaires-en-espagne/
https://gpcardio.org/fr/2018-02-28_bulgarie-soins-primaires-cardiovasculaires/
https://gpcardio.org/fr/2018-02-28_diapositives-soins-primaires-cardiovasculaires-en-france/
https://gpcardio.org/fr/2018-02-28_espagne-apercu-des-soins-primaires-cardiovasculaires/
https://gpcardio.org/fr/2018-02-28_portugal-apercu-des-soins-primaires-cardiovasculaires/
https://gpcardio.org/fr/2018-03-01_diapositives-soins-primaires-cardiovasculaires-en-grece/
https://gpcardio.org/fr/2018-03-01_diapositives-soins-primaires-cardiovasculaires-en-roumanie/
https://gpcardio.org/fr/2018-03-01_france-apercu-des-soins-primaires-cardiovasculaires/
https://gpcardio.org/fr/2018-03-01_grece-apercu-des-soins-primaires-cardiovasculaires/
https://gpcardio.org/fr/2018-03-01_roumanie-apercu-des-soins-primaires-cardiovasculaires/
https://gpcardio.org/fr/2018-03-02_allemagne-apercu-des-soins-primaires-cardiovasculaires/
https://gpcardio.org/fr/2018-03-02_diapositives-soins-primaires-cardiovasculaires-en-allemagne/
https://gpcardio.org/fr/2018-03-13_recommandation-consensuelle-de-l-epccs-sur-la-prevention-de-l-avc-dans-la-fibrillation-auriculaire-dans-les-soins-medicaux-primaires/
https://gpcardio.org/fr/2018-03-27_arteriopathie-des-membres-inferieurs-une-maladie-cv-majeure-negligee/
https://gpcardio.org/fr/2018-03-27_promotion-des-changements-de-comportement-de-sante-pour-reduire-le-risque-cardiovasculaire-dans-les-soins-medicaux-primaires/
https://gpcardio.org/fr/2018-03-28_diabete-et-maladie-vasculaire-epidemiologie-et-options-de-prise-en-charge/
https://gpcardio.org/fr/2018-04-04_diapositives-actualisation-sur-le-diabete-de-type-2-et-la-maladie-cardiovasculaire/
https://gpcardio.org/fr/2018-04-04_diapositives-atelier-pratique-sur-la-mapa/
https://gpcardio.org/fr/2018-04-04_diapositives-hypertension-pouvons-nous-nous-accorder-sur-des-seuils-diagnostiques-et-therapeutiques/
https://gpcardio.org/fr/2018-04-04_diapositives-maladie-arterielle-des-membres-inferieurs-une-maladie-cardiovasculaire-majeure-negligee-diagnostic-et-prise-en-charge-clinique-en-medecine-de-premier-recours/
https://gpcardio.org/fr/2018-04-04_diapositives-prise-en-charge-de-l-insuffisance-cardiaque-complexe-une-perspective-specialisee-de-l-interface-premier-recours-secondaire/
https://gpcardio.org/fr/2018-04-04_diapositives-prise-en-charge-de-l-insuffisance-cardiaque-en-medecine-de-premier-recours-le-point-de-vue-du-medecin-generaliste/
https://gpcardio.org/fr/2018-04-04_diapositives-reduction-des-lipides-les-donnees-probantes-les-recommandations-la-realite-clinique/
https://gpcardio.org/fr/2018-04-04_prise-en-charge-des-lipides-eleves-et-des-statines-le-bon-la-brute-et-le-truand/
https://gpcardio.org/fr/2018-04-10_complexites-de-la-prise-en-charge-de-l-insuffisance-cardiaque-en-medecine-de-premier-recours/
https://gpcardio.org/fr/2018-04-10_hypertension-pouvons-nous-nous-accorder-sur-des-seuils-diagnostiques-et-therapeutiques/
https://gpcardio.org/fr/2018-04-24_prise-en-charge-du-risque-cardiovasculaire-associe-au-dt2-a-la-lumiere-des-nouvelles-options-therapeutiques/
https://gpcardio.org/fr/2018-05-16_diapositives-medecine-de-premier-recours-en-italie/
https://gpcardio.org/fr/2018-05-16_soins-cardiovasculaires-de-premier-recours-en-italie/
https://gpcardio.org/fr/2018-05-22_reduction-des-lipides-les-donnees-probantes-les-recommandations-la-realite-clinique/
https://gpcardio.org/fr/2018-06-15_semergen-la-societe-doyenne-de-la-medecine-de-famille-en-espagne/
https://gpcardio.org/fr/2018-06-15_semergen-societe-espagnole-des-medecins-de-soins-primaires/
https://gpcardio.org/fr/2018-06-19_espagne-introduction-a-l-epccs/
https://gpcardio.org/fr/2018-07-18_complexites-de-la-prise-en-charge-de-l-insuffisance-cardiaque/
https://gpcardio.org/fr/2018-08-16_hypertension-pouvons-nous-nous-accorder-sur-des-seuils-diagnostiques-et-therapeutiques/
https://gpcardio.org/fr/2018-08-22_prise-en-charge-des-lipides-eleves-en-medecine-de-premier-recours/
https://gpcardio.org/fr/2018-10-22_guide-pratique-pour-le-diagnostic-et-le-traitement-de-l-insuffisance-cardiaque-dans-les-soins-de-sante-primaires/
https://gpcardio.org/fr/2018-10-22_medecin-generaliste-au-danemark/
https://gpcardio.org/fr/2018-10-22_prise-en-charge-de-la-dyslipidemie-dans-les-soins-medicaux-primaires/
https://gpcardio.org/fr/2018-10-22_promotion-des-changements-de-mode-de-vie-pour-reduire-le-risque-cardiovasculaire-en-ssp/
https://gpcardio.org/fr/2018-10-23_prevention-des-maladies-cardiovasculaires-non-transmissibles-en-medecine-de-premier-recours-en-russie/
https://gpcardio.org/fr/2018-10-25_prise-en-charge-des-lipides-eleves-dans-les-soins-de-sante-primaires/
https://gpcardio.org/fr/2018-10-30_moyens-de-favoriser-les-changements-de-comportement-pour-reduire-le-risque-cardiovasculaire-en-medecine-de-premier-recours/
https://gpcardio.org/fr/2018-12-03_soins-cardiovasculaires-de-premier-recours-en-serbie-anglais/
https://gpcardio.org/fr/2018-12-04_soins-cardiovasculaires-de-premier-recours-au-montenegro-anglais/
https://gpcardio.org/fr/2018-12-04_soins-cardiovasculaires-de-premier-recours-en-republique-tcheque-anglais/
https://gpcardio.org/fr/2018-12-04_soins-cardiovasculaires-de-premier-recours-en-republique-tcheque-tcheque/
https://gpcardio.org/fr/2018-12-04_soins-cardiovasculaires-de-premier-recours-en-serbie-serbe/
https://gpcardio.org/fr/2018-12-04_soins-cardiovasculaires-de-premier-recours-en-ukraine-anglais/
https://gpcardio.org/fr/2018-12-04_soins-cardiovasculaires-de-premier-recours-en-ukraine-ukrainien/
https://gpcardio.org/fr/2018-12-05_soins-cardiovasculaires-de-premier-recours-en-belgique-anglais/
https://gpcardio.org/fr/2018-12-05_soins-cardiovasculaires-de-premier-recours-en-belgique-flamand/
https://gpcardio.org/fr/2018-12-05_soins-cardiovasculaires-de-premier-recours-en-pologne-anglais/
https://gpcardio.org/fr/2018-12-05_soins-cardiovasculaires-de-premier-recours-en-pologne-polonais/
https://gpcardio.org/fr/2018-12-05_soins-cardiovasculaires-de-premier-recours-en-slovaquie-anglais/
https://gpcardio.org/fr/2018-12-05_soins-cardiovasculaires-de-premier-recours-en-slovaquie-slovaque/
https://gpcardio.org/fr/2018-12-07_soins-cardiovasculaires-de-premier-recours-en-allemagne-allemand/
https://gpcardio.org/fr/2018-12-07_soins-cardiovasculaires-de-premier-recours-en-allemagne-anglais/
https://gpcardio.org/fr/2018-12-10_soins-cardiovasculaires-de-premier-recours-en-irlande-anglais/
https://gpcardio.org/fr/2018-12-10_soins-cardiovasculaires-de-premier-recours-en-turquie-turc/
https://gpcardio.org/fr/2018-12-13_soins-cardiovasculaires-de-premier-recours-en-turquie-anglais/
https://gpcardio.org/fr/2018-12-17_soins-cardiovasculaires-de-premier-recours-au-danemark-anglais/
https://gpcardio.org/fr/2018-12-17_soins-cardiovasculaires-de-premier-recours-au-danemark-danois/
https://gpcardio.org/fr/2018-12-17_soins-cardiovasculaires-de-premier-recours-au-montenegro-montenegrin/
https://gpcardio.org/fr/2018-12-17_soins-cardiovasculaires-de-premier-recours-en-espagne-anglais/
https://gpcardio.org/fr/2018-12-17_soins-cardiovasculaires-de-premier-recours-en-espagne-espagnol/
https://gpcardio.org/fr/2018-12-17_soins-cardiovasculaires-de-premier-recours-en-roumanie-roumain/
https://gpcardio.org/fr/2018-12-18_diapositives-messages-cles-de-la-recommandation-de-l-epccs-sur-la-prise-en-charge-des-lipides-eleves-en-medecine-de-premier-recours/
https://gpcardio.org/fr/2019-01-10_soins-cardiovasculaires-de-premier-recours-en-espagne-anglais/
https://gpcardio.org/fr/2019-01-10_soins-cardiovasculaires-de-premier-recours-en-espagne-espagnol/
https://gpcardio.org/fr/2019-02-07_societe-epccs-que-propose-t-elle-a-ses-membres/
https://gpcardio.org/fr/2019-02-25_prise-en-charge-actuelle-du-diabete-et-du-risque-cardiovasculaire-en-medecine-de-premier-recours/
https://gpcardio.org/fr/2019-03-28_actualisation-sur-la-prevention-de-l-avc-dans-la-fibrillation-auriculaire/
https://gpcardio.org/fr/2019-03-28_comment-relever-les-defis-de-la-multimorbidite-en-medecine-generale/
https://gpcardio.org/fr/2019-03-28_diabete-et-risque-cardiovasculaire/
https://gpcardio.org/fr/2019-04-02_diapositives-actualisation-sur-la-prevention-de-l-avc-dans-la-fibrillation-auriculaire/
https://gpcardio.org/fr/2019-04-02_diapositives-actualisations-recentes-des-recommandations-internationales-sur-l-hypertension-ou-different-elles-et-sur-quoi-devrions-nous-nous-accorder-en-medecine-de-premier-recours/
https://gpcardio.org/fr/2019-04-02_diapositives-complexites-de-la-prise-en-charge-de-l-insuffisance-cardiaque/
https://gpcardio.org/fr/2019-04-02_diapositives-cvd-et-sante-mentale/
https://gpcardio.org/fr/2019-04-02_diapositives-diabete-et-risque-cardiovasculaire/
https://gpcardio.org/fr/2019-04-02_diapositives-multimorbidite-maladie-cardiovasculaire-et-polymedication/
https://gpcardio.org/fr/2019-04-02_diapositives-quelles-sont-les-donnees-probantes-que-le-diabete-est-lie-au-risque-de-cvd/
https://gpcardio.org/fr/2019-04-03_complexites-de-la-prise-en-charge-de-l-insuffisance-cardiaque/
https://gpcardio.org/fr/2019-04-24_actualisations-recentes-des-recommandations-internationales-sur-l-hypertension-ou-different-elles-et-sur-quoi-devrions-nous-nous-accorder-en-medecine-de-premier-recours/
https://gpcardio.org/fr/2019-04-25_education-echange-orientation-et-interaction-lors-du-sommet-epccs-2019/
https://gpcardio.org/fr/2019-05-02_diapositives-cibler-la-cvd-dans-le-diabete-nouvelles-strategies-pour-lutter-contre-le-risque/
https://gpcardio.org/fr/2019-05-02_diapositives-diabete-de-type-2-et-resultats-cardiovasculaires-plus-qu-une-simple-gestion-de-la-glycemie-enseignements-des-essais-sur-les-ar-glp1/
https://gpcardio.org/fr/2019-05-02_diapositives-prise-en-charge-du-diabete-dans-la-pratique-cardiovasculaire-quotidienne-une-approche-multidisciplinaire/
https://gpcardio.org/fr/2019-05-07_prevention-de-l-avc-dans-la-fibrillation-auriculaire/
https://gpcardio.org/fr/2019-05-21_actualisation-sur-la-gestion-du-risque-cardiovasculaire-dans-le-diabete-quelles-sont-les-donnees-probantes/
https://gpcardio.org/fr/2019-06-18_nouvel-algorithme-diagnostique-et-options-therapeutiques-dans-la-prise-en-charge-de-l-hf/
https://gpcardio.org/fr/2019-08-13_diapositives-messages-cles-de-la-recommandation-de-l-epccs-sur-la-prise-en-charge-actuelle-du-diabete-et-du-risque-cardiovasculaire-en-medecine-de-premier-recours/
https://gpcardio.org/fr/2019-08-29_diagnostic-et-prise-en-charge-de-l-hypertension-en-medecine-de-premier-recours/
https://gpcardio.org/fr/2019-10-02_l-expansion-de-l-epccs-vers-les-pays-europeens-ce-qui-est-prevu/
https://gpcardio.org/fr/2019-10-03_comment-l-epccs-vise-a-aider-les-medecins-de-premier-recours-a-travers-l-europe-a-reconnaitre-et-gerer-le-risque-cardiovasculaire-grec/
https://gpcardio.org/fr/2019-10-03_epccs-et-les-soins-cardiovasculaires-de-premier-recours-en-espagne-anglais/
https://gpcardio.org/fr/2019-10-03_epccs-et-les-soins-cardiovasculaires-de-premier-recours-en-espagne-espagnol/
https://gpcardio.org/fr/2019-10-03_epccs-et-les-soins-cardiovasculaires-de-premier-recours-en-serbie/
https://gpcardio.org/fr/2019-10-03_epccs-et-les-soins-cardiovasculaires-de-premier-recours-en-slovaquie-anglais/
https://gpcardio.org/fr/2019-10-03_epccs-et-les-soins-cardiovasculaires-de-premier-recours-en-slovaquie-slovaque/
https://gpcardio.org/fr/2019-10-09_comment-l-epccs-vise-a-aider-les-medecins-de-premier-recours-a-travers-l-europe-a-reconnaitre-et-gerer-le-risque-cardiovasculaire-anglais/
https://gpcardio.org/fr/2019-10-29_diagnostic-et-prise-en-charge-de-l-hypertension-en-medecine-de-premier-recours-resume-en-francais/
https://gpcardio.org/fr/2019-10-29_diagnostic-et-prise-en-charge-de-l-hypertension-en-medecine-de-premier-recours-resume-en-grec/
https://gpcardio.org/fr/2019-10-29_diagnostic-et-prise-en-charge-de-l-hypertension-en-medecine-de-premier-recours-resume-en-ukrainien/
https://gpcardio.org/fr/2019-10-29_diagnostic-et-traitement-de-l-hypertension-dans-les-soins-de-sante-primaires-resume-en-serbe-de-la-recommandation-de-l-epccs-sur-l-hypertension/
https://gpcardio.org/fr/2019-10-29_societe-francaise-de-medecine-generale-sfmg/
https://gpcardio.org/fr/2019-10-29_societes-grecques-impliquees-dans-la-medecine-de-premier-recours/
https://gpcardio.org/fr/2019-11-04_epccs-et-les-soins-cardiovasculaires-de-premier-recours-en-france/
https://gpcardio.org/fr/2019-11-04_epccs-et-les-soins-cardiovasculaires-de-premier-recours-en-irlande/
https://gpcardio.org/fr/2019-11-04_epccs-et-les-soins-cardiovasculaires-de-premier-recours-en-pologne-anglais/
https://gpcardio.org/fr/2019-11-04_epccs-et-les-soins-cardiovasculaires-de-premier-recours-en-pologne-polonais/
https://gpcardio.org/fr/2019-11-04_epccs-et-les-soins-cardiovasculaires-de-premier-recours-en-turquie/
https://gpcardio.org/fr/2019-11-04_epccs-et-les-soins-cardiovasculaires-de-premier-recours-en-ukraine/
https://gpcardio.org/fr/2019-11-12_insuffisance-cardiaque-et-comorbidites-maladie-renale-et-cancer/
https://gpcardio.org/fr/2020-04-09_strategie-invasive-ou-conservatrice-initiale-pour-la-maladie-coronarienne-stable/
https://gpcardio.org/fr/2020-04-14_effet-de-la-dapagliflozine-sur-l-aggravation-de-l-insuffisance-cardiaque-et-le-deces-cardiovasculaire-chez-des-patients-atteints-d-insuffisance-cardiaque-avec-et-sans-diabete/
https://gpcardio.org/fr/2020-04-16_deux-essais-de-phase-3-sur-l-inclisiran-chez-des-patients-presentant-un-cholesterol-ldl-eleve/
https://gpcardio.org/fr/2020-04-16_inclisiran-pour-le-traitement-de-l-hypercholesterolemie-familiale-heterozygote/
https://gpcardio.org/fr/2020-04-23_prise-en-charge-de-la-maladie-coronarienne-chez-des-patients-atteints-de-maladie-renale-avancee/
https://gpcardio.org/fr/2020-04-25_clopidogrel-versus-ticagrelor-ou-prasugrel-chez-des-patients-ages-de-70-ans-ou-plus-atteints-de-syndrome-coronarien-aigu-sans-sus-decalage-du-segment-st-popular-age/
https://gpcardio.org/fr/2020-05-01_schemas-antithrombotiques-optimaux-pour-des-patients-atteints-de-fibrillation-auriculaire-beneficiant-d-une-intervention-coronarienne-percutanee/
https://gpcardio.org/fr/2020-05-02_efficacite-de-la-denervation-renale-par-catheter-en-l-absence-de-medicaments-antihypertenseurs-spyral-htn-off-med-pivotal/
https://gpcardio.org/fr/2020-05-05_resultats-a-dix-ans-apres-stents-a-elution-de-medicament-versus-pontage-aorto-coronarien-pour-maladie-du-tronc-commun-gauche/
https://gpcardio.org/fr/2020-05-09_monotherapie-par-inhibiteur-de-p2y12-ou-aspirine-pour-la-prevention-secondaire-chez-des-patients-atteints-d-atherosclerose-etablie/
https://gpcardio.org/fr/2020-05-12_prise-en-charge-clinique-de-la-maladie-coronarienne-stable-chez-des-patients-atteints-de-diabete-sucre-de-type-2/
https://gpcardio.org/fr/2020-05-14_vericiguat-chez-des-patients-atteints-d-insuffisance-cardiaque-et-de-fraction-d-ejection-reduite/
https://gpcardio.org/fr/2020-05-19_association-entre-la-reduction-de-la-pression-arterielle-et-la-demence-incidente-ou-l-alteration-cognitive/
https://gpcardio.org/fr/2020-05-26_effet-de-la-reduction-des-medicaments-antihypertenseurs-versus-les-soins-habituels-sur-le-controle-a-court-terme-de-la-pression-arterielle-chez-des-patients-atteints-d-hypertension-ages-de-80-ans-et-p/
https://gpcardio.org/fr/2020-05-26_prevalence-mondiale-de-l-hypercholesterolemie-familiale/
https://gpcardio.org/fr/2020-06-16_effet-de-la-monotherapie-par-ticagrelor-versus-ticagrelor-avec-aspirine-sur-le-saignement-majeur-et-les-evenements-cardiovasculaires-chez-des-patients-atteints-de-syndrome-coronarien-aigu/
https://gpcardio.org/fr/2020-07-07_reconnaissance-pronostic-et-traitement-de-l-amylose-systemique/
https://gpcardio.org/fr/2020-07-11_estimation-des-benefices-a-vie-des-traitements-pharmacologiques-modificateurs-de-la-maladie-complets-chez-des-patients-atteints-d-insuffisance-cardiaque-a-fraction-d-ejection-reduite/
https://gpcardio.org/fr/2020-07-14_association-entre-le-greffon-d-artere-radiale-et-le-greffon-de-veine-saphene-et-les-criteres-cardiovasculaires-a-long-terme-chez-des-patients-beneficiant-d-un-pontage-aorto-coronarien/
https://gpcardio.org/fr/2020-07-14_efficacite-et-securite-comparatives-des-inhibiteurs-oraux-de-p2y12-dans-le-syndrome-coronarien-aigu/
https://gpcardio.org/fr/2020-08-01_revascularisation-complete-versus-revascularisation-limitee-a-la-lesion-coupable-dans-l-infarctus-du-myocarde-avec-elevation-du-segment-st/
https://gpcardio.org/fr/2020-08-04_parcours-decisionnel-du-consensus-d-experts-de-l-acc-2020-sur-la-prise-en-charge-des-hemorragies-chez-des-patients-sous-anticoagulants-oraux/
https://gpcardio.org/fr/2020-08-07_prise-en-charge-integree-de-la-fibrillation-auriculaire-en-medecine-de-premier-recours/
https://gpcardio.org/fr/2020-08-11_securite-et-efficacite-de-l-arret-de-l-aspirine-sur-fond-d-un-inhibiteur-de-p2y12-chez-des-patients-apres-une-intervention-coronarienne-percutanee/
https://gpcardio.org/fr/2020-08-20_evinacumab-dans-l-hypercholesterolemie-familiale-homozygote/
https://gpcardio.org/fr/2020-08-25_effet-de-la-selection-d-un-inhibiteur-oral-de-p2y12-guidee-par-le-genotype-par-rapport-au-traitement-conventionnel-par-clopidogrel-sur-les-criteres-ischemiques-apres-une-intervention-coronarienne-perc/
https://gpcardio.org/fr/2020-09-01_parcours-decisionnel-du-consensus-d-experts-2020-sur-les-nouvelles-therapies-pour-la-reduction-du-risque-cardiovasculaire-chez-des-patients-atteints-de-diabete-de-type-2/
https://gpcardio.org/fr/2020-09-07_mortalite-apres-stents-actifs-versus-pontage-aorto-coronarien-pour-la-maladie-du-tronc-commun-gauche/
https://gpcardio.org/fr/2020-09-14_effets-des-agonistes-des-recepteurs-du-peptide-1-de-type-glucagon-sur-les-evenements-cardiovasculaires-majeurs-chez-des-patients-atteints-de-diabete-sucre-de-type-2-avec-ou-sans-maladie-cardiovasculai/
https://gpcardio.org/fr/2020-09-19_inhibiteurs-du-sglt2-chez-des-patients-atteints-d-insuffisance-cardiaque-a-fraction-d-ejection-reduite/
https://gpcardio.org/fr/2020-10-01_evolocumab-dans-l-hypercholesterolemie-familiale-heterozygote-pediatrique/
https://gpcardio.org/fr/2020-10-01_histoire-naturelle-de-la-stenose-aortique-severe-asymptomatique-et-association-d-une-intervention-precoce-avec-les-resultats/
https://gpcardio.org/fr/2020-10-01_traitement-precoce-de-controle-du-rythme-chez-des-patients-atteints-de-fibrillation-auriculaire/
https://gpcardio.org/fr/2020-10-08_dapagliflozine-chez-des-patients-atteints-de-maladie-renale-chronique/
https://gpcardio.org/fr/2020-10-08_resultats-cardiovasculaires-avec-l-ertugliflozine-dans-le-diabete-de-type-2/
https://gpcardio.org/fr/2020-10-08_resultats-cardiovasculaires-et-renaux-avec-l-empagliflozine-dans-l-insuffisance-cardiaque/
https://gpcardio.org/fr/2020-10-10_desescalade-a-base-de-prasugrel-de-la-bitherapie-antiplaquettaire-apres-une-intervention-coronarienne-percutanee-chez-des-patients-atteints-de-syndrome-coronarien-aigu-host-reduce-polytech-acs/
https://gpcardio.org/fr/2020-10-13_bitherapie-antiplaquettaire-apres-intervention-coronarienne-percutanee-et-stents-actifs/
https://gpcardio.org/fr/2020-10-29_edoxaban-a-faible-dose-chez-des-patients-tres-ages-atteints-de-fibrillation-auriculaire/
https://gpcardio.org/fr/2020-10-31_redeveloppement-et-validation-du-score-syntax-ii-pour-individualiser-la-prise-de-decision-entre-revascularisation-percutanee-et-chirurgicale-chez-des-patients-atteints-de-maladie-coronarienne-complexe/
https://gpcardio.org/fr/2020-11-07_la-revascularisation-complete-reduit-le-deces-cardiovasculaire-chez-des-patients-atteints-d-infarctus-du-myocarde-avec-elevation-du-segment-st-et-d-une-maladie-multitronculaire/
https://gpcardio.org/fr/2020-11-10_depistage-de-l-hypertension-arterielle-chez-les-enfants-et-les-adolescents/
https://gpcardio.org/fr/2020-11-17_colchicine-chez-des-patients-atteints-de-syndrome-coronarien-aigu/
https://gpcardio.org/fr/2020-11-21_efficacite-et-securite-de-la-reduction-du-cholesterol-ldl-chez-des-patients-ages/
https://gpcardio.org/fr/2020-11-21_la-reduction-de-la-lipoproteine-a-par-l-alirocumab-diminue-la-charge-totale-d-evenements-cardiovasculaires-independamment-de-la-reduction-du-cholesterol-des-lipoproteines-de-basse-densite/
https://gpcardio.org/fr/2020-11-26_essai-n-of-1-avec-statine-placebo-ou-absence-de-traitement-pour-evaluer-les-effets-secondaires/
https://gpcardio.org/fr/2020-11-26_rivaroxaban-chez-des-patients-atteints-de-fibrillation-auriculaire-et-porteurs-d-une-valve-mitrale-bioprothetique/
https://gpcardio.org/fr/2020-12-08_effet-des-acides-gras-omega-3-a-forte-dose-versus-l-huile-de-mais-sur-les-evenements-cardiovasculaires-indesirables-majeurs-chez-des-patients-a-haut-risque-cardiovasculaire/
https://gpcardio.org/fr/2020-12-10_evinacumab-chez-des-patients-atteints-d-hypercholesterolemie-refractaire/
https://gpcardio.org/fr/2020-12-12_carboxymaltose-ferrique-pour-la-carence-en-fer-a-la-sortie-apres-une-insuffisance-cardiaque-aigue/
https://gpcardio.org/fr/2020-12-22_effet-de-la-digoxine-versus-le-bisoprolol-pour-le-controle-de-la-frequence-cardiaque-dans-la-fibrillation-auriculaire-sur-la-qualite-de-vie-rapportee-par-le-patient/
https://gpcardio.org/fr/2021-01-14_activation-de-la-myosine-cardiaque-par-l-omecamtiv-mecarbil-dans-l-insuffisance-cardiaque-systolique/
https://gpcardio.org/fr/2021-01-14_sotagliflozine-chez-des-patients-atteints-de-diabete-et-d-une-aggravation-recente-de-l-insuffisance-cardiaque/
https://gpcardio.org/fr/2021-01-14_sotagliflozine-chez-des-patients-atteints-de-diabete-et-de-maladie-renale-chronique/
https://gpcardio.org/fr/2021-01-21_bitherapie-antiplaquettaire-courte-suivie-d-une-monotherapie-par-inhibiteur-de-p2y12-versus-bitherapie-antiplaquettaire-prolongee-apres-intervention-coronarienne-percutanee-avec-stents-actifs-de-deuxi/
https://gpcardio.org/fr/2021-01-21_polypilule-avec-ou-sans-aspirine-chez-des-personnes-sans-maladie-cardiovasculaire/
https://gpcardio.org/fr/2021-01-26_essai-randomise-de-l-empagliflozine-chez-des-patients-non-diabetiques-atteints-d-insuffisance-cardiaque-a-fraction-d-ejection-reduite/
https://gpcardio.org/fr/2021-01-28_ablation-par-cryoballon-comme-traitement-initial-de-la-fibrillation-auriculaire/
https://gpcardio.org/fr/2021-01-28_cryoablation-ou-traitement-medicamenteux-pour-le-traitement-initial-de-la-fibrillation-auriculaire/
https://gpcardio.org/fr/2021-01-28_treprostinil-inhale-dans-l-hypertension-pulmonaire-due-a-une-maladie-pulmonaire-interstitielle/
https://gpcardio.org/fr/2021-02-01_association-des-inhibiteurs-du-sglt2-avec-les-resultats-cardiovasculaires-et-renaux-chez-des-patients-atteints-de-diabete-de-type-2/
https://gpcardio.org/fr/2021-02-09_effet-de-l-entrainement-fractionne-de-haute-intensite-de-l-entrainement-continu-modere-ou-des-conseils-sur-l-activite-physique-fondes-sur-les-recommandations-sur-la-consommation-maximale-d-oxygene-che/
https://gpcardio.org/fr/2021-02-09_finerenone-et-resultats-cardiovasculaires-chez-des-patients-atteints-de-maladie-renale-chronique-et-de-diabete-de-type-2/
https://gpcardio.org/fr/2021-02-09_parcours-decisionnel-du-consensus-d-experts-de-l-acc-2020-pour-le-traitement-anticoagulant-et-antiplaquettaire-chez-des-patients-atteints-de-fibrillation-auriculaire-ou-de-thromboembolie-veineuse-bene/
https://gpcardio.org/fr/2021-02-16_mise-a-jour-2021-du-parcours-decisionnel-du-consensus-d-experts-de-l-acc-2017-pour-l-optimisation-du-traitement-de-l-insuffisance-cardiaque/
https://gpcardio.org/fr/2021-03-02_resultats-a-3-ans-de-la-reparation-transcatheter-de-la-valve-mitrale-chez-des-patients-atteints-d-insuffisance-cardiaque/
https://gpcardio.org/fr/2021-03-16_effet-de-la-supplementation-en-acides-gras-omega-3-marins-et-en-vitamine-d-sur-la-fibrillation-auriculaire-incidente/
https://gpcardio.org/fr/2021-03-31_effets-de-la-dapagliflozine-sur-la-mortalite-chez-des-patients-atteints-de-maladie-renale-chronique/
https://gpcardio.org/fr/2021-04-07_recommandations-de-l-esc-2020-pour-la-prise-en-charge-des-syndromes-coronariens-aigus-chez-des-patients-se-presentant-sans-sus-decalage-persistant-du-segment-st/
https://gpcardio.org/fr/2021-04-17_traitement-antiplaquettaire-guide-versus-standard-chez-des-patients-beneficiant-d-une-intervention-coronarienne-percutanee/
https://gpcardio.org/fr/2021-05-01_reduction-pharmacologique-de-la-pression-arterielle-pour-la-prevention-primaire-et-secondaire-de-la-maladie-cardiovasculaire-a-differents-niveaux-de-pression-arterielle/
https://gpcardio.org/fr/2021-05-05_les-betabloquants-causent-ils-une-depression/
https://gpcardio.org/fr/2021-05-20_rapport-final-d-un-essai-de-controle-intensif-versus-standard-de-la-pression-arterielle/
https://gpcardio.org/fr/2021-05-27_efficacite-comparative-du-dosage-de-l-aspirine-dans-la-maladie-cardiovasculaire/
https://gpcardio.org/fr/2021-06-01_evaluation-de-l-ablation-par-catheter-ou-des-medicaments-antiarythmiques-en-traitement-de-premiere-intention-de-la-fibrillation-auriculaire/
https://gpcardio.org/fr/2021-06-03_occlusion-de-l-appendice-auriculaire-gauche-pendant-la-chirurgie-cardiaque-pour-prevenir-l-avc/
https://gpcardio.org/fr/2021-06-26_aspirine-versus-clopidogrel-en-monotherapie-d-entretien-chronique-apres-intervention-coronarienne-percutanee-host-exam/
https://gpcardio.org/fr/2021-06-26_denervation-renale-par-ultrasons-pour-l-hypertension-resistante-a-un-comprime-associant-trois-medicaments-radiance-htn-trio/
https://gpcardio.org/fr/2021-07-10_efficacite-et-securite-d-un-nouvel-agoniste-double-des-recepteurs-du-gip-et-du-glp-1-le-tirzepatide-chez-des-patients-atteints-de-diabete-de-type-2-surpass-1/
https://gpcardio.org/fr/2021-07-15_readaptation-physique-pour-des-patients-ages-hospitalises-pour-insuffisance-cardiaque/
https://gpcardio.org/fr/2021-07-21_efficacite-et-securite-de-la-colchicine-a-faible-dose-chez-des-patients-atteints-de-maladie-coronarienne/
https://gpcardio.org/fr/2021-07-22_icp-multivaisseaux-guidee-par-ffr-ou-angiographie-pour-l-infarctus-du-myocarde/
https://gpcardio.org/fr/2021-08-05_milrinone-comparee-a-la-dobutamine-dans-le-traitement-du-choc-cardiogenique/
https://gpcardio.org/fr/2021-08-14_le-tirzepatide-une-fois-par-semaine-versus-l-insuline-degludec-une-fois-par-jour-en-ajout-a-la-metformine-avec-ou-sans-inhibiteurs-du-sglt2-chez-des-patients-atteints-de-diabete-de-type-2-surpass-3/
https://gpcardio.org/fr/2021-08-17_reduction-du-cholesterol-de-la-pression-arterielle-ou-des-deux-pour-prevenir-les-evenements-cardiovasculaires/
https://gpcardio.org/fr/2021-08-31_parcours-decisionnel-du-consensus-d-experts-de-l-acc-2021-pour-la-prise-en-charge-de-la-reduction-du-risque-d-ascvd-chez-des-patients-atteints-d-hypertriglyceridemie-persistante/
https://gpcardio.org/fr/2021-09-02_resultats-cardiovasculaires-et-renaux-avec-l-efpeglenatide-dans-le-diabete-de-type-2/
https://gpcardio.org/fr/2021-09-11_prise-en-charge-guidee-par-l-hemodynamique-de-l-insuffisance-cardiaque-guide-hf/
https://gpcardio.org/fr/2021-09-16_effet-de-la-substitution-du-sel-sur-les-evenements-cardiovasculaires-et-le-deces/
https://gpcardio.org/fr/2021-09-18_traitement-initial-par-un-comprime-unique-contenant-une-association-quadruple-de-doses-au-quart-des-medicaments-antihypertenseurs-versus-monotherapie-a-dose-standard-chez-des-patients-atteints-d-hyper/
https://gpcardio.org/fr/2021-09-30_essai-de-controle-intensif-de-la-pression-arterielle-chez-des-patients-ages-atteints-d-hypertension/
https://gpcardio.org/fr/2021-10-09_desescalade-non-guidee-du-ticagrelor-au-clopidogrel-chez-des-patients-stabilises-atteints-d-un-infarctus-aigu-du-myocarde-beneficiant-d-une-intervention-coronarienne-percutanee-talos-ami/
https://gpcardio.org/fr/2021-10-14_empagliflozine-dans-l-insuffisance-cardiaque-a-fraction-d-ejection-preservee/
https://gpcardio.org/fr/2021-10-14_empagliflozine-et-principaux-resultats-renaux-dans-l-insuffisance-cardiaque/
https://gpcardio.org/fr/2021-10-19_effet-de-l-empagliflozine-sur-les-evenements-d-aggravation-de-l-insuffisance-cardiaque-chez-des-patients-atteints-d-insuffisance-cardiaque-a-fraction-d-ejection-preservee/
https://gpcardio.org/fr/2021-10-23_resultats-cliniques-du-depistage-systematique-de-la-fibrillation-auriculaire-strokestop/
https://gpcardio.org/fr/2021-10-28_double-therapie-antiplaquettaire-apres-icp-chez-des-patients-a-haut-risque-hemorragique/
https://gpcardio.org/fr/2021-11-02_vaccination-antigrippale-apres-un-infarctus-du-myocarde/
https://gpcardio.org/fr/2021-11-11_inhibition-du-recepteur-de-l-angiotensine-et-de-la-neprilysine-dans-l-infarctus-aigu-du-myocarde/
https://gpcardio.org/fr/2021-11-13_le-tirzepatide-versus-l-insuline-glargine-dans-le-diabete-de-type-2-et-un-risque-cardiovasculaire-accru-surpass-4/
https://gpcardio.org/fr/2021-11-13_reduction-de-la-pression-arterielle-et-risque-de-diabete-de-type-2-de-novo/
https://gpcardio.org/fr/2021-12-02_edoxaban-versus-antagoniste-de-la-vitamine-k-pour-la-fibrillation-auriculaire-apres-tavr/
https://gpcardio.org/fr/2021-12-04_pericardiotomie-posterieure-gauche-pour-la-prevention-de-la-fibrillation-auriculaire-apres-chirurgie-cardiaque/
https://gpcardio.org/fr/2021-12-07_ablation-de-la-jonction-av-et-resynchronisation-cardiaque-chez-des-patients-atteints-de-fibrillation-auriculaire-permanente-et-de-qrs-etroit/
https://gpcardio.org/fr/2021-12-09_evenements-cardiovasculaires-avec-la-finerenone-dans-la-maladie-renale-et-le-diabete-de-type-2/
https://gpcardio.org/fr/2021-12-11_intervention-coronarienne-guidee-par-le-rapport-de-flux-quantitatif-angiographique-favor-iii-china/
https://gpcardio.org/fr/2021-12-18_intervention-coronarienne-percutanee-avec-stents-a-elution-medicamenteuse-versus-pontage-aortocoronarien-dans-la-maladie-du-tronc-commun-coronaire-gauche/
https://gpcardio.org/fr/2021-12-21_effet-de-la-supplementation-a-long-terme-en-acides-gras-omega-3-marins-sur-le-risque-de-fibrillation-auriculaire-dans-les-essais-controles-randomises-portant-sur-des-criteres-cardiovasculaires/
https://gpcardio.org/fr/2021-12-30_angiographie-apres-un-arret-cardiaque-extrahospitalier-sans-sus-decalage-du-segment-st/
https://gpcardio.org/fr/2021-12-30_chlortalidone-pour-l-hypertension-dans-la-maladie-renale-chronique-avancee/
https://gpcardio.org/fr/2022-01-13_icp-guidee-par-la-reserve-de-flux-fractionnaire-par-rapport-au-pontage-aortocoronarien/
https://gpcardio.org/fr/2022-01-18_recommandations-2021-de-l-acc-aha-scai-pour-la-revascularisation-coronarienne/
https://gpcardio.org/fr/2022-01-25_anticoagulants-oraux-directs-versus-warfarine-chez-des-patients-atteints-de-fibrillation-auriculaire/
https://gpcardio.org/fr/2022-01-25_depistage-de-la-fibrillation-auriculaire/
https://gpcardio.org/fr/2022-02-08_la-finerenone-reduit-le-risque-d-insuffisance-cardiaque-incidente-chez-des-patients-atteints-de-maladie-renale-chronique-et-de-diabete-de-type-2/
https://gpcardio.org/fr/2022-02-10_resultats-cardiovasculaires-et-renaux-sous-finerenone-chez-des-patients-atteints-de-diabete-de-type-2-et-de-maladie-renale-chronique/
https://gpcardio.org/fr/2022-03-07_effets-comparatifs-d-un-traitement-guide-versus-un-traitement-puissant-par-inhibiteur-du-p2y12-dans-le-syndrome-coronarien-aigu/
https://gpcardio.org/fr/2022-03-21_strategie-systematique-de-controle-precoce-du-rythme-pour-la-fibrillation-auriculaire-chez-des-patients-symptomatiques-ou-non/
https://gpcardio.org/fr/2022-04-09_reduction-du-sodium-alimentaire-a-moins-de-100-mmol-dans-l-insuffisance-cardiaque-sodium-hf/
https://gpcardio.org/fr/2022-04-09_securite-de-l-inhibiteur-oral-du-facteur-xia-l-asundexian-compare-a-l-apixaban-chez-des-patients-atteints-de-fibrillation-auriculaire-pacific-af/
https://gpcardio.org/fr/2022-04-26_utilisation-de-l-aspirine-pour-prevenir-les-maladies-cardiovasculaires/
https://gpcardio.org/fr/2022-05-03_recommandations-2022-de-l-aha-acc-hfsa-pour-la-prise-en-charge-de-l-insuffisance-cardiaque/
https://gpcardio.org/fr/2022-05-03_recommandations-2022-de-l-aha-acc-hfsa-pour-la-prise-en-charge-de-l-insuffisance-cardiaque/
https://gpcardio.org/fr/2022-05-03_recommandations-2022-de-l-aha-acc-hfsa-pour-la-prise-en-charge-de-l-insuffisance-cardiaque/
https://gpcardio.org/fr/2022-05-10_effet-de-l-alirocumab-ajoute-a-un-traitement-par-statine-de-forte-intensite-sur-l-atherosclerose-coronaire-chez-des-patients-victimes-d-un-infarctus-du-myocarde-aigu/
https://gpcardio.org/fr/2022-05-12_traitement-de-l-hypertension-chronique-legere-pendant-la-grossesse/
https://gpcardio.org/fr/2022-05-21_chirurgie-bariatrique-et-maladie-cardiovasculaire/
https://gpcardio.org/fr/2022-05-31_effets-a-long-terme-des-interventions-par-metformine-et-par-mode-de-vie-sur-les-evenements-cardiovasculaires-dans-le-diabetes-prevention-program-et-son-etude-de-suivi/
https://gpcardio.org/fr/2022-06-02_necessite-de-relancer-et-de-rattraper-le-retard-en-matiere-de-prevention-des-cvd-en-periode-de-covid-19/
https://gpcardio.org/fr/2022-06-07_essai-randomise-de-controle-du-rythme-par-ablation-versus-controle-de-la-frequence-chez-des-patients-atteints-d-insuffisance-cardiaque-et-de-fibrillation-auriculaire/
https://gpcardio.org/fr/2022-06-21_effet-de-l-ablation-de-la-fibrose-guidee-par-irm-par-rapport-a-l-ablation-par-catheter-conventionnelle-sur-la-recidive-d-arythmie-auriculaire-chez-des-patients-atteints-de-fibrillation-auriculaire-per/
https://gpcardio.org/fr/2022-06-21_le-moment-de-l-ablation-de-la-tachycardie-ventriculaire-influence-t-il-le-pronostic-chez-des-patients-porteurs-d-un-defibrillateur-automatique-implantable-resultats-de-l-essai-multicentrique-randomise/
https://gpcardio.org/fr/2022-07-19_effet-de-l-omecamtiv-mecarbil-sur-la-capacite-a-l-effort-dans-l-insuffisance-cardiaque-chronique-a-fraction-d-ejection-reduite/
https://gpcardio.org/fr/2022-07-26_effets-de-l-empagliflozine-sur-les-symptomes-les-limitations-physiques-et-la-qualite-de-vie-chez-des-patients-hospitalises-pour-insuffisance-cardiaque-aigue/
https://gpcardio.org/fr/2022-07-26_effets-de-l-instauration-precoce-de-l-empagliflozine-sur-la-diurese-et-la-fonction-renale-chez-des-patients-atteints-d-insuffisance-cardiaque-aigue-decompensee-empag-hf/
https://gpcardio.org/fr/2022-07-26_interventions-de-conseil-comportemental-visant-a-promouvoir-une-alimentation-saine-et-l-activite-physique-pour-la-prevention-des-maladies-cardiovasculaires-chez-des-adultes-sans-facteurs-de-risque-car/
https://gpcardio.org/fr/2022-07-30_efficacite-et-securite-a-long-terme-d-une-bitherapie-statine-d-intensite-moderee-plus-ezetimibe-versus-monotherapie-par-statine-de-forte-intensite-chez-des-patients-atteints-de-maladie-cardiovasculair/
https://gpcardio.org/fr/2022-08-09_baisse-initiale-dip-du-debit-de-filtration-glomerulaire-estime-apres-l-instauration-de-la-dapagliflozine-chez-des-patients-atteints-d-insuffisance-cardiaque-a-fraction-d-ejection-reduite/
https://gpcardio.org/fr/2022-08-23_utilisation-des-statines-pour-la-prevention-primaire-des-maladies-cardiovasculaires-chez-les-adultes/
https://gpcardio.org/fr/2022-08-23_utilisation-des-statines-pour-la-prevention-primaire-des-maladies-cardiovasculaires-chez-les-adultes/
https://gpcardio.org/fr/2022-08-30_empagliflozine-dans-l-insuffisance-cardiaque-a-fraction-d-ejection-ventriculaire-gauche-preservee-avec-et-sans-diabete/
https://gpcardio.org/fr/2022-09-01_reserve-de-flux-fractionnaire-ou-echographie-intravasculaire-pour-guider-l-icp/
https://gpcardio.org/fr/2022-09-03_inhibiteurs-du-sglt-2-chez-des-patients-atteints-d-insuffisance-cardiaque/
https://gpcardio.org/fr/2022-09-07_prevalence-de-l-intolerance-aux-statines/
https://gpcardio.org/fr/2022-09-08_tests-fonctionnels-systematiques-ou-soins-standard-chez-des-patients-a-haut-risque-apres-icp/
https://gpcardio.org/fr/2022-09-10_effet-du-traitement-par-statine-sur-les-symptomes-musculaires/
https://gpcardio.org/fr/2022-09-13_controle-precoce-du-rythme-chez-des-patients-atteints-de-fibrillation-auriculaire-et-presentant-une-charge-elevee-de-comorbidites/
https://gpcardio.org/fr/2022-09-15_rivaroxaban-dans-la-fibrillation-auriculaire-associee-a-une-cardiopathie-rhumatismale/
https://gpcardio.org/fr/2022-09-15_strategie-de-polypilule-dans-la-prevention-cardiovasculaire-secondaire/
https://gpcardio.org/fr/2022-09-20_harmonisation-des-recommandations-sur-la-pression-arterielle-l-hypertension-de-l-american-college-of-cardiology-american-heart-association-et-de-l-european-society-of-cardiology-european-society-of-hy/
https://gpcardio.org/fr/2022-09-22_dapagliflozine-dans-l-insuffisance-cardiaque-a-fraction-d-ejection-legerement-reduite-ou-preservee/
https://gpcardio.org/fr/2022-09-22_reduction-de-la-glycemie-dans-le-diabete-de-type-2-resultats-microvasculaires-et-cardiovasculaires/
https://gpcardio.org/fr/2022-09-26_effets-des-substituts-de-sel-sur-les-resultats-cliniques/
https://gpcardio.org/fr/2022-09-27_essai-randomise-de-stimulation-de-la-branche-gauche-du-faisceau-de-his-versus-stimulation-biventriculaire-pour-la-therapie-de-resynchronisation-cardiaque/
https://gpcardio.org/fr/2022-09-27_resultats-a-cinq-ans-chez-des-patients-porteurs-de-dispositifs-d-assistance-ventriculaire-gauche-a-sustentation-magnetique-integrale-versus-a-flux-axial-dans-l-essai-randomise-momentum-3/
https://gpcardio.org/fr/2022-09-29_acetazolamide-dans-l-insuffisance-cardiaque-aigue-decompensee-avec-surcharge-volemique/
https://gpcardio.org/fr/2022-10-04_2022-acc-expert-consensus-decision-pathway-sur-le-role-des-therapies-non-statiniques-pour-la-reduction-du-cholesterol-ldl-dans-la-prise-en-charge-du-risque-de-maladie-cardiovasculaire-atherosclereuse/
https://gpcardio.org/fr/2022-10-04_dapagliflozine-chez-des-patients-recemment-hospitalises-pour-insuffisance-cardiaque-a-fraction-d-ejection-legerement-reduite-ou-preservee/
https://gpcardio.org/fr/2022-10-04_traitement-precoce-versus-differe-par-anticoagulant-oral-non-antagoniste-de-la-vitamine-k-apres-un-avc-ischemique-aigu-dans-la-fibrillation-auriculaire-timing/
https://gpcardio.org/fr/2022-10-08_allopurinol-versus-prise-en-charge-habituelle-chez-des-patients-du-royaume-uni-atteints-de-cardiopathie-ischemique-all-heart/
https://gpcardio.org/fr/2022-10-13_revascularisation-percutanee-pour-dysfonction-ventriculaire-gauche-ischemique/
https://gpcardio.org/fr/2022-10-18_efficacite-et-securite-de-la-dapagliflozine-selon-la-fragilite-chez-des-patients-atteints-d-insuffisance-cardiaque/
https://gpcardio.org/fr/2022-10-20_cibles-de-pression-arterielle-chez-des-survivants-comateux-d-un-arret-cardiaque/
https://gpcardio.org/fr/2022-10-22_resultats-cardiovasculaires-chez-des-adultes-hypertendus-avec-prise-vesperale-versus-matinale-des-antihypertenseurs-habituels-au-royaume-uni-etude-time/
https://gpcardio.org/fr/2022-11-01_empagliflozine-dans-l-infarctus-aigu-du-myocarde/
https://gpcardio.org/fr/2022-11-01_patiromer-pour-la-prise-en-charge-de-l-hyperkaliemie-dans-l-insuffisance-cardiaque-a-fraction-d-ejection-reduite/
https://gpcardio.org/fr/2022-11-05_controle-intensif-de-la-pression-arterielle-apres-thrombectomie-endovasculaire-pour-un-avc-ischemique-aigu-enchanted2-mt/
https://gpcardio.org/fr/2022-11-15_hospitalisations-et-mortalite-chez-des-patients-atteints-d-insuffisance-mitrale-secondaire-et-d-insuffisance-cardiaque/
https://gpcardio.org/fr/2022-11-17_arn-interferent-court-pour-reduire-la-lipoproteine-a-dans-la-maladie-cardiovasculaire/
https://gpcardio.org/fr/2022-11-19_impact-du-diabete-sur-les-effets-des-inhibiteurs-du-cotransporteur-sodium-glucose-de-type-2-sur-les-resultats-renaux/
https://gpcardio.org/fr/2022-11-22_stents-a-elution-d-everolimus-ou-chirurgie-de-pontage-pour-la-maladie-coronarienne-pluritronculaire/
https://gpcardio.org/fr/2022-11-24_reduction-des-triglycerides-par-le-pemafibrate-pour-diminuer-le-risque-cardiovasculaire/
https://gpcardio.org/fr/2022-11-26_ly3437943-un-nouvel-agoniste-triple-des-recepteurs-du-gip-du-glp-1-et-du-glucagon-chez-des-personnes-atteintes-de-diabete-de-type-2/
https://gpcardio.org/fr/2022-12-03_antagoniste-double-de-l-endotheline-aprocitentan-pour-l-hypertension-resistante-precision/
https://gpcardio.org/fr/2022-12-03_securite-tolerabilite-et-efficacite-de-la-titration-ascendante-des-traitements-medicaux-guides-par-les-recommandations-dans-l-insuffisance-cardiaque-aigue-strong-hf/
https://gpcardio.org/fr/2022-12-06_apixaban-chez-des-patients-atteints-de-fibrillation-auriculaire-sous-hemodialyse/
https://gpcardio.org/fr/2022-12-17_derisomaltose-ferrique-intraveineux-chez-des-patients-atteints-d-insuffisance-cardiaque-et-de-carence-en-fer-au-royaume-uni-ironman/
https://gpcardio.org/fr/2022-12-21_reduction-de-la-pression-arterielle-et-prevention-de-la-demence/
https://gpcardio.org/fr/2022-12-29_chlortalidone-versus-hydrochlorothiazide-pour-les-evenements-cardiovasculaires-lies-a-l-hypertension/
https://gpcardio.org/fr/2023-01-01_impact-de-l-empagliflozine-sur-la-decongestion-dans-l-insuffisance-cardiaque-aigue/
https://gpcardio.org/fr/2023-01-03_effets-comparatifs-de-la-rosuvastatine-a-faible-dose-du-placebo-et-des-complements-alimentaires-sur-les-lipides-et-les-biomarqueurs-inflammatoires/
https://gpcardio.org/fr/2023-01-03_etude-de-phase-2-de-l-aficamten-chez-des-patients-atteints-de-cardiomyopathie-hypertrophique-obstructive/
https://gpcardio.org/fr/2023-01-03_survie-apres-prise-en-charge-invasive-ou-conservatrice-de-la-maladie-coronarienne-stable/
https://gpcardio.org/fr/2023-01-10_aspirine-versus-clopidogrel-en-monotherapie-d-entretien-a-long-terme-apres-une-intervention-coronarienne-percutanee/
https://gpcardio.org/fr/2023-01-10_association-prospective-entre-le-nombre-de-pas-quotidiens-et-la-maladie-cardiovasculaire/
https://gpcardio.org/fr/2023-01-10_effet-de-l-ablation-par-catheter-par-isolation-des-veines-pulmonaires-avec-vs-sans-isolation-de-la-paroi-posterieure-de-l-oreillette-gauche-sur-la-recidive-d-arythmie-auriculaire-chez-des-patients-att/
https://gpcardio.org/fr/2023-01-12_empagliflozine-chez-des-patients-atteints-de-maladie-renale-chronique/
https://gpcardio.org/fr/2023-01-12_progression-de-la-fibrillation-auriculaire-apres-cryoablation-ou-traitement-medicamenteux/
https://gpcardio.org/fr/2023-01-14_rapport-cout-efficacite-du-depistage-populationnel-de-la-fibrillation-auriculaire/
https://gpcardio.org/fr/2023-01-17_effet-du-torasemide-versus-furosemide-apres-la-sortie-sur-la-mortalite-toutes-causes-confondues-chez-des-patients-hospitalises-pour-insuffisance-cardiaque/
https://gpcardio.org/fr/2023-02-01_association-de-diuretiques-de-l-anse-et-thiazidiques-pour-l-insuffisance-cardiaque-decompensee/
https://gpcardio.org/fr/2023-02-02_essai-de-phase-2-du-baxdrostat-pour-l-hypertension-resistante-au-traitement/
https://gpcardio.org/fr/2023-02-07_oxygenation-par-membrane-extracorporelle-dans-le-traitement-du-choc-cardiogenique/
https://gpcardio.org/fr/2023-02-16_l-ablation-par-catheter-ameliore-les-resultats-cardiovasculaires-chez-les-patients-atteints-de-fibrillation-auriculaire-et-d-insuffisance-cardiaque/
https://gpcardio.org/fr/2023-02-28_calcium-coronarien-de-decouverte-fortuite/
https://gpcardio.org/fr/2023-02-28_denervation-renale-endovasculaire-par-ultrasons-pour-traiter-l-hypertension/
https://gpcardio.org/fr/2023-03-18_efficacite-d-une-intervention-intensive-sur-la-pression-arterielle-dirigee-par-des-agents-de-sante-communautaires-non-medecins-par-rapport-aux-soins-habituels-sur-la-maladie-cardiovasculaire-crhcp/
https://gpcardio.org/fr/2023-04-04_strategie-de-traitement-a-la-cible-ou-statine-a-haute-intensite-chez-des-patients-atteints-de-coronaropathie/
https://gpcardio.org/fr/2023-04-08_revascularisation-complete-immediate-versus-echelonnee-chez-des-patients-presentant-un-syndrome-coronarien-aigu-et-une-maladie-coronarienne-multitronculaire-biovasc/
https://gpcardio.org/fr/2023-04-11_heterogeneite-de-la-reponse-de-la-pression-arterielle-a-4-medicaments-antihypertenseurs/
https://gpcardio.org/fr/2023-04-13_acide-bempedoique-et-resultats-cardiovasculaires-chez-des-patients-intolerants-aux-statines/
https://gpcardio.org/fr/2023-04-15_l-inflammation-et-le-cholesterol-comme-predicteurs-d-evenements-cardiovasculaires-chez-des-patients-sous-traitement-par-statine/
https://gpcardio.org/fr/2023-04-17_desescalade-de-la-bitherapie-antiplaquettaire-dans-le-syndrome-coronarien-aigu/
https://gpcardio.org/fr/2023-04-18_association-entre-les-taux-de-cholesterol-des-lipoproteines-de-basse-densite-atteints-et-les-resultats-cardiovasculaires-et-de-securite-a-long-terme/
https://gpcardio.org/fr/2023-04-20_essai-de-phase-3-du-sotatercept-pour-le-traitement-de-l-hypertension-arterielle-pulmonaire/
https://gpcardio.org/fr/2023-04-25_essai-randomise-de-phase-2b-de-l-inhibiteur-oral-du-pcsk9-mk-0616/
https://gpcardio.org/fr/2023-05-04_icp-complexe-guidee-par-imagerie-intravasculaire-ou-par-angiographie/
https://gpcardio.org/fr/2023-05-09_voie-decisionnelle-de-consensus-d-experts-de-l-acc-2023-sur-la-prise-en-charge-de-l-insuffisance-cardiaque-a-fraction-d-ejection-preservee/
https://gpcardio.org/fr/2023-05-18_reparation-par-voie-transcatheter-chez-des-patients-presentant-une-regurgitation-tricuspide/
https://gpcardio.org/fr/2023-05-27_strategie-de-revascularisation-par-pontage-veineux-en-premier-versus-meilleur-traitement-endovasculaire-en-premier-chez-des-patients-presentant-une-ischemie-chronique-menacant-le-membre-necessitant-un/
https://gpcardio.org/fr/2023-06-01_efficacite-et-securite-des-comprimes-combines-triples-et-quadruples-a-faible-dose-par-rapport-a-la-monotherapie-aux-soins-habituels-ou-au-placebo-pour-la-prise-en-charge-initiale-de-l-hypertension/
https://gpcardio.org/fr/2023-06-01_suivi-a-cinq-ans-apres-reparation-par-voie-transcatheter-de-la-regurgitation-mitrale-secondaire/
https://gpcardio.org/fr/2023-06-06_anticoagulants-oraux-directs-versus-warfarine-a-travers-l-ensemble-du-spectre-de-la-fonction-renale/
https://gpcardio.org/fr/2023-06-06_optimisation-du-traitement-apres-hospitalisation-pour-insuffisance-cardiaque-a-travers-le-spectre-de-la-fraction-d-ejection-ventriculaire-gauche/
https://gpcardio.org/fr/2023-06-08_traitement-du-diabete-sucre-gestationnel-diagnostique-precocement-pendant-la-grossesse/
https://gpcardio.org/fr/2023-06-24_surveillance-hemodynamique-a-distance-des-pressions-de-l-artere-pulmonaire-chez-des-patients-atteints-d-insuffisance-cardiaque-chronique-monitor-hf/
https://gpcardio.org/fr/2023-06-27_effet-des-inhibiteurs-du-sglt2-sur-les-resultats-cardiovasculaires-dans-diverses-populations-de-patients/
https://gpcardio.org/fr/2023-06-29_anticoagulation-precoce-versus-tardive-dans-l-avc-avec-fibrillation-auriculaire/
https://gpcardio.org/fr/2023-07-01_le-troisieme-essai-de-bouquet-de-soins-intensifs-avec-reduction-de-la-pression-arterielle-dans-l-hemorragie-cerebrale-aigue-interact3/
https://gpcardio.org/fr/2023-07-11_monotherapie-par-inhibiteur-du-p2y12-ou-par-aspirine-pour-la-prevention-secondaire-des-evenements-coronariens/
https://gpcardio.org/fr/2023-07-13_securite-cardiovasculaire-du-traitement-substitutif-par-testosterone/
https://gpcardio.org/fr/2023-07-20_essai-de-phase-1-de-l-anticorps-ni006-pour-l-elimination-de-l-amylose-a-transthyretine-cardiaque/
https://gpcardio.org/fr/2023-07-20_le-zilebesiran-un-agent-therapeutique-d-interference-par-arn-pour-l-hypertension/
https://gpcardio.org/fr/2023-08-08_l-atorvastatine-pour-la-dysfonction-cardiaque-associee-aux-anthracyclines/
https://gpcardio.org/fr/2023-08-08_traitement-par-agoniste-des-recepteurs-du-glp-1-avec-et-sans-inhibiteurs-du-sglt2-chez-des-patients-atteints-de-diabete-de-type-2/
https://gpcardio.org/fr/2023-08-12_le-retatrutide-un-agoniste-des-recepteurs-du-gip-du-glp-1-et-du-glucagon-chez-des-personnes-atteintes-de-diabete-de-type-2/
https://gpcardio.org/fr/2023-08-14_le-sacubitril-valsartan-dans-l-insuffisance-cardiaque-a-fraction-d-ejection-legerement-reduite-ou-preservee/
https://gpcardio.org/fr/2023-08-24_la-pitavastatine-pour-prevenir-la-maladie-cardiovasculaire-dans-l-infection-par-le-vih/
https://gpcardio.org/fr/2023-08-24_therapies-combinees-a-dose-fixe-dans-la-prevention-primaire-de-la-maladie-cardiovasculaire-selon-differents-groupes/
https://gpcardio.org/fr/2023-09-07_icp-complete-ou-de-la-seule-lesion-coupable-chez-des-patients-ages-atteints-d-infarctus-du-myocarde/
https://gpcardio.org/fr/2023-09-07_l-orforglipron-agoniste-oral-quotidien-des-recepteurs-du-glp-1-chez-des-adultes-obeses/
https://gpcardio.org/fr/2023-09-14_le-carboxymaltose-ferrique-dans-l-insuffisance-cardiaque-avec-carence-en-fer/
https://gpcardio.org/fr/2023-09-19_icp-guidee-par-la-reserve-de-flux-fractionnaire-ou-pontage-coronarien-pour-la-maladie-coronarienne-tritronculaire/
https://gpcardio.org/fr/2023-09-21_semaglutide-chez-les-patients-atteints-d-insuffisance-cardiaque-a-fraction-d-ejection-preservee-et-d-obesite/
https://gpcardio.org/fr/2023-09-28_anticoagulation-par-l-edoxaban-chez-les-patients-presentant-des-episodes-auriculaires-a-haute-frequence/
https://gpcardio.org/fr/2023-10-01_antagonistes-des-recepteurs-des-mineralocorticoides-associes-aux-inhibiteurs-du-cotransporteur-sodium-glucose-de-type-2-dans-l-insuffisance-cardiaque/
https://gpcardio.org/fr/2023-10-01_efficacite-de-la-surveillance-de-la-pression-arterielle-pulmonaire-chez-les-patients-atteints-d-insuffisance-cardiaque-chronique/
https://gpcardio.org/fr/2023-10-03_debit-de-filtration-glomerulaire-estime-albuminurie-et-resultats-indesirables/
https://gpcardio.org/fr/2023-10-05_assistance-circulatoire-extracorporelle-dans-le-choc-cardiogenique-lie-a-l-infarctus/
https://gpcardio.org/fr/2023-10-05_effet-mondial-des-facteurs-de-risque-modifiables-sur-la-maladie-cardiovasculaire-et-la-mortalite/
https://gpcardio.org/fr/2023-10-12_ablation-par-catheter-dans-l-insuffisance-cardiaque-terminale-avec-fibrillation-auriculaire/
https://gpcardio.org/fr/2023-10-12_moment-de-la-revascularisation-complete-par-icp-multitronculaire-pour-l-infarctus-du-myocarde/
https://gpcardio.org/fr/2023-10-14_oxygenation-par-membrane-extracorporelle-veino-arterielle-chez-les-patients-presentant-un-choc-cardiogenique-lie-a-l-infarctus/
https://gpcardio.org/fr/2023-10-17_hypotension-orthostatique-traitement-de-l-hypertension-et-maladie-cardiovasculaire/
https://gpcardio.org/fr/2023-10-17_intervention-coronarienne-percutanee-guidee-par-tomographie-par-coherence-optique-ou-par-echographie-intravasculaire/
https://gpcardio.org/fr/2023-10-19_guidage-par-oct-ou-par-angiographie-pour-l-icp-dans-les-lesions-complexes-de-bifurcation/
https://gpcardio.org/fr/2023-10-19_icp-guidee-par-tomographie-par-coherence-optique-versus-icp-guidee-par-angiographie/
https://gpcardio.org/fr/2023-10-24_compose-de-medecine-traditionnelle-chinoise-tongxinluo-et-resultats-cliniques-chez-les-patients-atteints-d-infarctus-aigu-du-myocarde/
https://gpcardio.org/fr/2023-11-02_ablation-par-champ-pulse-ou-ablation-thermique-conventionnelle-pour-la-fibrillation-auriculaire-paroxystique/
https://gpcardio.org/fr/2023-11-23_remplacement-valvulaire-aortique-par-catheter-chez-les-patients-a-faible-risque-a-cinq-ans/
https://gpcardio.org/fr/2023-11-25_zibotentan-en-association-avec-la-dapagliflozine-compare-a-la-dapagliflozine-chez-les-patients-atteints-de-maladie-renale-chronique-zenith-ckd/
https://gpcardio.org/fr/2023-12-14_semaglutide-et-resultats-cardiovasculaires-dans-l-obesite-sans-diabete/
https://gpcardio.org/fr/2023-12-21_efficacite-du-carboxymaltose-ferrique-dans-l-insuffisance-cardiaque-avec-carence-en-fer/
https://gpcardio.org/fr/2023-12-21_un-essai-controle-par-placebo-de-l-intervention-coronarienne-percutanee-pour-l-angine-stable/
https://gpcardio.org/fr/2023-12-28_strategie-transfusionnelle-restrictive-ou-liberale-dans-l-infarctus-du-myocarde-et-l-anemie/
https://gpcardio.org/fr/2024-01-02_recommandations-acc-aha-accp-hrs-2023-pour-le-diagnostic-et-la-prise-en-charge-de-la-fibrillation-auriculaire/
https://gpcardio.org/fr/2024-01-02_recommandations-acc-aha-accp-hrs-2023-pour-le-diagnostic-et-la-prise-en-charge-de-la-fibrillation-auriculaire/
https://gpcardio.org/fr/2024-01-11_apixaban-pour-la-prevention-de-l-avc-dans-la-fibrillation-auriculaire-infraclinique/
https://gpcardio.org/fr/2024-01-18_resultats-a-long-terme-de-la-resynchronisation-defibrillation-dans-l-insuffisance-cardiaque/
https://gpcardio.org/fr/2024-02-13_les-moniteurs-hemodynamiques-implantables-ameliorent-la-survie-chez-les-patients-atteints-d-insuffisance-cardiaque-a-fraction-d-ejection-reduite/
https://gpcardio.org/fr/2024-02-20_arret-de-l-aspirine-dans-le-mois-suivant-la-pose-d-un-stent-pour-une-monotherapie-par-ticagrelor-dans-le-syndrome-coronarien-aigu/
https://gpcardio.org/fr/2024-02-20_securite-et-efficacite-de-la-monotherapie-par-ticagrelor-chez-les-patients-presentant-des-syndromes-coronariens-aigus-subissant-une-intervention-coronarienne-percutanee/
https://gpcardio.org/fr/2024-02-20_une-strategie-sans-aspirine-versus-une-strategie-antiplaquettaire-double-pour-la-pose-de-stent-coronarien/
https://gpcardio.org/fr/2024-03-01_impact-de-l-acide-bempedoique-sur-le-total-des-evenements-cardiovasculaires/
https://gpcardio.org/fr/2024-03-02_implantation-de-stent-coronaire-a-elution-medicamenteuse-guidee-par-imagerie-intravasculaire/
https://gpcardio.org/fr/2024-03-18_changement-mondial-de-l-insuffisance-ponderale-a-la-predominance-de-l-obesite-en-trois-decennies-a-travers-les-generations/
https://gpcardio.org/fr/2024-03-26_anticoagulants-oraux-directs-pour-la-prevention-de-l-avc-chez-les-patients-presentant-une-fibrillation-auriculaire-detectee-par-dispositif/
https://gpcardio.org/fr/2024-04-01_implantation-de-valve-aortique-par-catheter-ou-chirurgicale/
https://gpcardio.org/fr/2024-04-02_stratify-hf-une-collaboration-europeenne-pour-developper-un-systeme-de-soutien-base-sur-l-ia-pour-la-stratification-du-risque-et-la-detection-precoce-de-l-insuffisance-cardiaque/
https://gpcardio.org/fr/2024-04-07_gamification-et-incitations-financieres-pour-augmenter-l-activite-physique-chez-les-patients-a-risque-cardiovasculaire-eleve/
https://gpcardio.org/fr/2024-04-08_un-programme-ameliore-de-gestion-des-medicaments-a-distance-stimule-les-prescriptions-de-gdmt-chez-les-patients-atteints-de-t2d-a-risque-cv-ou-renal-eleve/
https://gpcardio.org/fr/2024-04-08_une-application-web-efficace-pour-determiner-l-acces-aux-statines-sans-ordonnance/
https://gpcardio.org/fr/2024-04-16_voie-decisionnelle-de-consensus-d-experts-de-l-acc-2024-pour-le-traitement-de-l-insuffisance-cardiaque-a-fraction-d-ejection-reduite/
https://gpcardio.org/fr/2024-04-18_betabloquants-apres-infarctus-du-myocarde-et-fraction-d-ejection-preservee/
https://gpcardio.org/fr/2024-04-18_pompe-a-flux-micro-axial-ou-soins-standard-dans-le-choc-cardiogenique-lie-a-l-infarctus/
https://gpcardio.org/fr/2024-04-18_semaglutide-chez-les-patients-atteints-d-insuffisance-cardiaque-liee-a-l-obesite-et-de-diabete-de-type-2/
https://gpcardio.org/fr/2024-04-25_empagliflozine-apres-un-infarctus-aigu-du-myocarde/
https://gpcardio.org/fr/2024-04-25_icp-complete-guidee-par-ffr-ou-icp-limitee-a-la-lesion-coupable-chez-les-patients-atteints-d-infarctus-du-myocarde/
https://gpcardio.org/fr/2024-04-27_semaglutide-versus-placebo-chez-les-personnes-atteintes-d-insuffisance-cardiaque-liee-a-l-obesite-a-fraction-d-ejection-preservee/
https://gpcardio.org/fr/2024-05-01_monotherapie-par-ticagrelor-ou-clopidogrel-versus-bitherapie-antiplaquettaire-apres-intervention-coronarienne-percutanee/
https://gpcardio.org/fr/2024-05-02_perfusions-d-apolipoproteine-a1-et-resultats-cardiovasculaires-apres-un-infarctus-aigu-du-myocarde/
https://gpcardio.org/fr/2024-05-04_intervention-coronarienne-percutanee-preventive-versus-traitement-medical-optimal-seul-pour-le-traitement-des-plaques-coronariennes-atherosclereuses-vulnerables-prevent/
https://gpcardio.org/fr/2024-05-04_stratifyhf-soutenir-la-medecine-de-premier-recours-dans-le-diagnostic-precoce-de-l-insuffisance-cardiaque/
https://gpcardio.org/fr/2024-05-06_l-action-de-recherche-et-d-innovation-stratifyhf/
https://gpcardio.org/fr/2024-05-11_intervention-coronarienne-percutanee-guidee-par-echographie-intravasculaire-versus-guidee-par-angiographie-dans-les-syndromes-coronariens-aigus-ivus-acs/
https://gpcardio.org/fr/2024-05-11_ticagrelor-seul-versus-ticagrelor-plus-aspirine-du-mois-1-au-mois-12-apres-intervention-coronarienne-percutanee-chez-des-patients-presentant-un-syndrome-coronarien-aigu-ultimate-dapt/
https://gpcardio.org/fr/2024-05-16_andexanet-dans-l-hemorragie-intracerebrale-aigue-associee-aux-inhibiteurs-du-facteur-xa/
https://gpcardio.org/fr/2024-05-16_olezarsen-dans-l-hypertriglyceridemie-chez-des-patients-a-haut-risque-cardiovasculaire/
https://gpcardio.org/fr/2024-05-16_olezarsen-pancreatite-aigue-et-syndrome-de-chylomicronemie-familiale/
https://gpcardio.org/fr/2024-05-30_reduction-intensive-de-la-pression-arterielle-administree-en-ambulance-dans-l-avc-hyperaigu/
https://gpcardio.org/fr/2024-06-01_traitement-de-l-hypertension-arterielle-pulmonaire/
https://gpcardio.org/fr/2024-06-04_ameliorer-l-evaluation-du-risque-de-cvd-integrer-le-risque-genetique-pour-une-meilleure-prediction/
https://gpcardio.org/fr/2024-06-04_inhibiteurs-du-cotransporteur-sodium-glucose-de-type-2-et-evenements-cardiovasculaires-indesirables-majeurs/
https://gpcardio.org/fr/2024-06-06_tavi-autoextensible-ou-expansible-par-ballonnet-chez-des-patients-presentant-un-petit-anneau-aortique/
https://gpcardio.org/fr/2024-06-14_prise-en-charge-invasive-versus-conservatrice-des-patients-ages-presentant-un-syndrome-coronarien-aigu-sans-sus-decalage-du-segment-st/
https://gpcardio.org/fr/2024-06-25_reexamen-de-la-race-et-du-benefice-du-blocage-du-sra-dans-l-insuffisance-cardiaque/
https://gpcardio.org/fr/2024-07-01_plozasiran-aro-apoc3-dans-l-hypertriglyceridemie-severe/
https://gpcardio.org/fr/2024-07-11_effets-du-semaglutide-sur-la-maladie-renale-chronique-chez-des-patients-atteints-de-diabete-de-type-2/
https://gpcardio.org/fr/2024-07-13_colchicine-au-long-cours-pour-la-prevention-des-evenements-vasculaires-recurrents-dans-l-avc-non-cardioembolique-convince/
https://gpcardio.org/fr/2024-07-20_reduction-de-la-pression-arterielle-systolique-en-dessous-de-120-mm-hg-versus-en-dessous-de-140-mm-hg-chez-des-patients-a-haut-risque-cardiovasculaire-avec-ou-sans-diabete-ou-antecedent-d-avc/
https://gpcardio.org/fr/2024-08-24_semaglutide-et-resultats-cardiovasculaires-chez-des-patients-obeses-presentant-une-insuffisance-cardiaque-preexistante/
https://gpcardio.org/fr/2024-09-01_monotherapie-par-ticagrelor-dans-le-syndrome-coronarien-aigu/
https://gpcardio.org/fr/2024-09-04_perspectives-mondiales-de-l-etude-interaspire-cartographie-de-la-prevalence-de-la-lipoproteine-a-dans-la-coronaropathie-a-travers-six-regions-de-l-oms/
https://gpcardio.org/fr/2024-09-07_semaglutide-versus-placebo-chez-des-patients-presentant-une-insuffisance-cardiaque-a-fraction-d-ejection-legerement-reduite-ou-preservee/
https://gpcardio.org/fr/2024-09-12_plozasiran-un-agent-d-interference-par-arn-ciblant-l-apoc3-dans-l-hyperlipidemie-mixte/
https://gpcardio.org/fr/2024-09-12_zodasiran-un-traitement-par-arni-ciblant-l-angptl3-dans-l-hyperlipidemie-mixte/
https://gpcardio.org/fr/2024-09-14_assistance-circulatoire-mecanique-temporaire-dans-le-choc-cardiogenique-lie-a-un-infarctus/
https://gpcardio.org/fr/2024-09-21_antagonistes-des-recepteurs-des-mineralocorticoides-dans-l-insuffisance-cardiaque/
https://gpcardio.org/fr/2024-09-24_mise-a-jour-ciblee-2024-du-parcours-decisionnel-de-consensus-d-experts-de-l-acc-sur-l-evaluation-clinique-la-prise-en-charge-et-la-trajectoire-des-patients-hospitalises-pour-insuffisance-cardiaque/
https://gpcardio.org/fr/2024-09-29_recommandations-esc-2024-pour-la-prise-en-charge-de-la-fibrillation-auriculaire-elaborees-en-collaboration-avec-l-european-association-for-cardio-thoracic-surgery-eacts/
https://gpcardio.org/fr/2024-10-07_recommandations-esc-2024-pour-la-prise-en-charge-de-la-pression-arterielle-elevee-et-de-l-hypertension/
https://gpcardio.org/fr/2024-10-07_semaglutide-et-pression-arterielle/
https://gpcardio.org/fr/2024-10-10_interruption-ou-poursuite-des-betabloquants-apres-un-infarctus-du-myocarde/
https://gpcardio.org/fr/2024-10-22_effets-du-semaglutide-sur-les-resultats-d-insuffisance-cardiaque-dans-le-diabete-et-la-maladie-renale-chronique-dans-l-essai-flow/
https://gpcardio.org/fr/2024-10-24_finerenone-dans-l-insuffisance-cardiaque-a-fraction-d-ejection-legerement-reduite-ou-preservee/
https://gpcardio.org/fr/2024-10-29_adjudication-des-hospitalisations-et-des-deces-dans-l-essai-ironman-sur-le-fer-intraveineux-dans-l-insuffisance-cardiaque/
https://gpcardio.org/fr/2024-11-05_revascularisation-complete-versus-revascularisation-limitee-a-la-lesion-coupable-chez-les-patients-ages-presentant-un-infarctus-du-myocarde-avec-sus-decalage-du-segment-st/
https://gpcardio.org/fr/2024-11-07_strategie-de-traitement-invasive-pour-les-patients-ages-presentant-un-infarctus-du-myocarde/
https://gpcardio.org/fr/2024-11-09_rapport-de-flux-quantitatif-versus-reserve-de-flux-fractionnaire-pour-guider-la-revascularisation-coronarienne-favor-iii-europe/
https://gpcardio.org/fr/2024-11-14_reparation-par-catheter-versus-chirurgie-de-la-valve-mitrale-pour-l-insuffisance-mitrale-secondaire/
https://gpcardio.org/fr/2024-11-14_reparation-valvulaire-par-catheter-dans-l-insuffisance-cardiaque-avec-insuffisance-mitrale-moderee-a-severe/
https://gpcardio.org/fr/2024-11-19_effet-du-depistage-de-la-fibrillation-auriculaire-non-diagnostiquee-sur-la-prevention-de-l-avc/
https://gpcardio.org/fr/2024-11-26_resultats-cardiovasculaires-renaux-et-de-securite-avec-les-agonistes-des-recepteurs-du-glp-1-seuls-et-en-association-avec-les-inhibiteurs-du-sglt2-dans-le-diabete-de-type-2/
https://gpcardio.org/fr/2024-12-12_icp-chez-les-patients-beneficiant-d-une-implantation-valvulaire-aortique-par-catheter/
https://gpcardio.org/fr/2024-12-14_le-role-essentiel-de-la-medecine-de-premier-recours-dans-la-promotion-de-la-sante-cardiovasculaire/
https://gpcardio.org/fr/2025-01-02_asundexian-versus-apixaban-chez-des-patients-atteints-de-fibrillation-auriculaire/
https://gpcardio.org/fr/2025-01-07_efficacite-et-securite-de-la-finerenone-sur-l-ensemble-du-spectre-de-fraction-d-ejection-dans-l-insuffisance-cardiaque-a-fraction-d-ejection-legerement-reduite-ou-preservee/
https://gpcardio.org/fr/2025-01-09_plozasiran-pour-la-prise-en-charge-de-la-chylomicronemie-persistante-et-du-risque-de-pancreatite/
https://gpcardio.org/fr/2025-01-09_remplacement-valvulaire-par-catheter-dans-l-insuffisance-tricuspide-severe/
https://gpcardio.org/fr/2025-01-14_reparation-transcatheter-bord-a-bord-pour-l-insuffisance-tricuspide-isolee-severe/
https://gpcardio.org/fr/2025-01-21_intervention-precoce-chez-des-patients-presentant-une-stenose-aortique-severe-asymptomatique-et-une-fibrose-myocardique/
https://gpcardio.org/fr/2025-01-21_muvalaplin-par-voie-orale-pour-la-reduction-de-la-lipoproteine-a/
https://gpcardio.org/fr/2025-01-23_abelacimab-versus-rivaroxaban-chez-des-patients-atteints-de-fibrillation-auriculaire/
https://gpcardio.org/fr/2025-01-25_prise-en-charge-guidee-par-angiographie-coronaire-par-tdm-chez-des-patients-presentant-une-douleur-thoracique-stable/
https://gpcardio.org/fr/2025-01-30_poursuite-versus-interruption-de-l-anticoagulation-orale-pendant-le-tavi/
https://gpcardio.org/fr/2025-01-30_tirzepatide-dans-l-insuffisance-cardiaque-a-fraction-d-ejection-preservee-et-l-obesite/
https://gpcardio.org/fr/2025-02-13_colchicine-dans-l-infarctus-aigu-du-myocarde/
https://gpcardio.org/fr/2025-02-13_spironolactone-systematique-dans-l-infarctus-aigu-du-myocarde/
https://gpcardio.org/fr/2025-02-20_ablation-par-catheter-ou-medicaments-antiarythmiques-pour-la-tachycardie-ventriculaire/
https://gpcardio.org/fr/2025-03-11_remplacement-valvulaire-aortique-par-catheter-chez-des-patients-presentant-une-insuffisance-cardiaque-systolique-et-une-stenose-aortique-moderee/
https://gpcardio.org/fr/2025-03-15_etude-sur-les-facteurs-de-risque-cardiovasculaire-et-le-recours-a-la-medecine-de-premier-recours-en-espagne/
https://gpcardio.org/fr/2025-03-16_prevention-primaire-de-la-maladie-cardiovasculaire-atherosclereuse-ascvd-en-medecine-de-premier-recours-une-revue-systematique-des-recommandations/
https://gpcardio.org/fr/2025-03-17_differences-et-tendances-liees-au-sexe-dans-la-gestion-du-risque-cardiovasculaire-enseignements-d-une-etude-de-medecine-de-premier-recours-a-long-terme/
https://gpcardio.org/fr/2025-03-25_anticoagulation-et-traitement-antiplaquettaire-pour-la-fibrillation-auriculaire-et-la-maladie-coronarienne-stable/
https://gpcardio.org/fr/2025-03-25_differences-liees-a-l-age-et-au-sexe-dans-l-efficacite-des-traitements-du-diabete-de-type-2/
https://gpcardio.org/fr/2025-03-25_traitement-antithrombotique-pour-minimiser-les-evenements-totaux-apres-un-sca-ou-une-icp-dans-la-fibrillation-auriculaire/
https://gpcardio.org/fr/2025-03-27_controle-intensif-de-la-pression-arterielle-chez-des-patients-atteints-de-diabete-de-type-2/
https://gpcardio.org/fr/2025-03-28_solution-pour-inhalation-d-acetate-de-flecainide-pour-la-cardioversion-de-la-fibrillation-auriculaire-symptomatique-d-apparition-recente/
https://gpcardio.org/fr/2025-04-01_efficacite-et-securite-des-inhibiteurs-de-l-aldosterone-synthase-dans-l-hypertension/
https://gpcardio.org/fr/2025-04-01_meta-analyse-de-la-sotagliflozine-un-inhibiteur-double-du-cotransporteur-sodium-glucose-1-2-pour-l-insuffisance-cardiaque-dans-le-diabete-de-type-2/
https://gpcardio.org/fr/2025-04-01_recommandations-acc-aha-2025-pour-la-prise-en-charge-des-patients-presentant-des-syndromes-coronariens-aigus/
https://gpcardio.org/fr/2025-04-03_fermeture-de-l-auricule-gauche-apres-ablation-pour-fibrillation-auriculaire/
https://gpcardio.org/fr/2025-04-07_empagliflozine-dans-l-hypertension-resistante-et-l-insuffisance-cardiaque-a-fraction-d-ejection-preservee/
https://gpcardio.org/fr/2025-04-07_inhibiteurs-du-cotransporteur-sodium-glucose-de-type-2-et-diabete-de-novo-dans-la-maladie-cardiovasculaire-ou-renale/
https://gpcardio.org/fr/2025-04-10_dapagliflozine-chez-des-patients-subissant-une-implantation-valvulaire-aortique-par-catheter/
https://gpcardio.org/fr/2025-04-10_presentation-de-gpcardio-combler-l-ecart-dans-les-soins-cardiovasculaires/
https://gpcardio.org/fr/2025-04-17_ablation-par-champ-pulse-ou-par-cryoballon-pour-la-fibrillation-auriculaire-paroxystique/
https://gpcardio.org/fr/2025-05-03_semaglutide-et-capacite-de-marche-chez-les-personnes-atteintes-d-arteriopathie-peripherique-symptomatique-et-de-diabete-de-type-2-stride/
https://gpcardio.org/fr/2025-05-08_efficacite-et-securite-du-lorundrostat-chez-des-patients-atteints-d-hypertension-non-controlee/
https://gpcardio.org/fr/2025-05-13_effet-de-l-empagliflozine-sur-les-mecanismes-de-l-erythropoiese-et-de-la-mobilisation-du-fer-chez-des-patients-atteints-d-insuffisance-cardiaque/
https://gpcardio.org/fr/2025-05-13_interaction-entre-la-maladie-renale-chronique-et-les-effets-du-tirzepatide-chez-des-patients-atteints-d-insuffisance-cardiaque-de-fraction-d-ejection-preservee-et-d-obesite/
https://gpcardio.org/fr/2025-05-17_association-a-dose-fixe-d-obicetrapib-et-d-ezetimibe-pour-la-reduction-du-cholesterol-ldl-tandem/
https://gpcardio.org/fr/2025-05-29_semaglutide-oral-et-resultats-cardiovasculaires-dans-le-diabete-de-type-2-a-haut-risque/
https://gpcardio.org/fr/2025-06-01_essai-randomise-visant-a-evaluer-l-aggravation-de-la-fonction-renale-par-l-ajout-de-dapagliflozine-pour-l-insuffisance-cardiaque-aigue-decompensee/
https://gpcardio.org/fr/2025-06-01_intervention-coronaire-percutanee-guidee-par-la-ffr-versus-pontage-aortocoronarien-chez-des-patients-diabetiques/
https://gpcardio.org/fr/2025-06-01_nouvel-accelerateur-metabolique-controle-pour-l-hfpef-liee-a-l-obesite/
https://gpcardio.org/fr/2025-06-03_un-inhibiteur-oral-de-pcsk9-pour-le-traitement-de-l-hypercholesterolemie/
https://gpcardio.org/fr/2025-06-10_carboxymaltose-ferrique-intraveineux-dans-l-insuffisance-cardiaque-avec-carence-en-fer/
https://gpcardio.org/fr/2025-06-10_recommandations-acc-aha-2025-pour-la-prise-en-charge-des-patients-presentant-des-syndromes-coronariens-aigus/
https://gpcardio.org/fr/2025-06-10_semaglutide-oral-et-resultats-cardiovasculaires-chez-des-personnes-atteintes-de-diabete-de-type-2-selon-l-utilisation-d-isglt2/
https://gpcardio.org/fr/2025-06-13_l-impact-de-la-fragilite-sur-l-efficacite-du-controle-intensif-de-la-pression-arterielle-chez-des-patients-atteints-de-diabete-de-type-2/
https://gpcardio.org/fr/2025-06-17_inhibition-du-facteur-xi-a-action-prolongee-et-hemorragie-periprocedurale/
https://gpcardio.org/fr/2025-06-17_moment-d-administration-du-traitement-antihypertenseur-et-evenements-cardiovasculaires-et-deces/
https://gpcardio.org/fr/2025-06-17_spironolactone-versus-amiloride-pour-l-hypertension-resistante/
https://gpcardio.org/fr/2025-07-01_gpcardio-l-epccs-rejoint-l-each-l-european-alliance-for-cardiovascular-health/
https://gpcardio.org/fr/2025-07-01_prevalence-quasi-universelle-de-l-adiposite-centrale-dans-l-insuffisance-cardiaque-a-fraction-d-ejection-preservee/
https://gpcardio.org/fr/2025-07-01_traitement-d-appoint-par-zilebesiran-pour-l-hypertension-insuffisamment-controlee/
https://gpcardio.org/fr/2025-07-03_securite-et-efficacite-de-l-obicetrapib-chez-des-patients-a-haut-risque-cardiovasculaire/
https://gpcardio.org/fr/2025-07-05_collaboration-sur-le-moment-optimal-de-l-anticoagulation-apres-un-avc-ischemique-et-une-fibrillation-auriculaire/
https://gpcardio.org/fr/2025-07-07_essais-a-long-terme-de-la-colchicine-pour-la-prevention-secondaire-des-evenements-vasculaires/
https://gpcardio.org/fr/2025-07-07_la-colchicine-pour-la-prevention-secondaire-des-evenements-vasculaires/
https://gpcardio.org/fr/2025-07-08_ablation-par-catheter-versus-modification-du-mode-de-vie-associee-a-des-antiarythmiques-pour-traiter-la-fibrillation-auriculaire/
https://gpcardio.org/fr/2025-07-10_gpcardio-et-la-ncd-academy-de-l-acc-unissent-leurs-forces-pour-renforcer-la-medecine-de-premier-recours-dans-la-prevention-de-la-maladie-cardiovasculaire/
https://gpcardio.org/fr/2025-07-12_l-amycretin-un-nouvel-agoniste-unimoleculaire-des-recepteurs-du-glp-1-et-de-l-amyline-administre-par-voie-sous-cutanee/
https://gpcardio.org/fr/2025-07-12_securite-tolerabilite-pharmacocinetique-et-pharmacodynamique-de-l-agoniste-first-in-class-des-recepteurs-du-glp-1-et-de-l-amyline-l-amycretin/
https://gpcardio.org/fr/2025-07-15_resultat-a-10-ans-de-la-revascularisation-complete-ou-de-l-artere-de-l-infarctus-seule-dans-le-stemi-avec-atteinte-pluritronculaire/
https://gpcardio.org/fr/2025-07-22_cooperative-pfa/
https://gpcardio.org/fr/2025-07-28_benefices-a-long-terme-de-l-atorvastatine-sur-l-incidence-des-evenements-cardiovasculaires/
https://gpcardio.org/fr/2025-07-29_cvd-et-medecine-de-premier-recours-la-necessite-des-recommandations-pratiques-de-l-epccs/
https://gpcardio.org/fr/2025-07-29_impact-de-l-indice-de-masse-corporelle-de-l-adiposite-centrale-et-de-la-perte-de-poids-sur-les-benefices-du-tirzepatide-dans-l-hfpef/
https://gpcardio.org/fr/2025-08-05_abelacimab-versus-rivaroxaban-chez-des-patients-atteints-de-fibrillation-auriculaire-sous-traitement-antiplaquettaire/
https://gpcardio.org/fr/2025-08-05_inhibiteur-du-cotransporteur-sodium-glucose-de-type-2-avec-et-sans-antagoniste-de-l-aldosterone-pour-l-insuffisance-cardiaque-a-fraction-d-ejection-preservee/
https://gpcardio.org/fr/2025-08-05_le-lorundrostat-chez-des-participants-presentant-une-hypertension-non-controlee-et-une-hypertension-resistante-au-traitement/
https://gpcardio.org/fr/2025-08-12_resultats-chez-les-patients-ages-apres-passage-a-un-anticoagulant-plus-recent-ou-maintien-sous-warfarine/
https://gpcardio.org/fr/2025-08-14_cagrilintide-et-semaglutide-coadministres-chez-des-adultes-en-surpoids-ou-obeses/
https://gpcardio.org/fr/2025-08-21_intervention-coronaire-percutanee-preventive-pour-les-plaques-coronaires-atherosclerotiques-vulnerables-sans-limitation-du-flux-dans-le-diabete/
https://gpcardio.org/fr/2025-08-30_efficacite-de-reduction-de-la-pression-arterielle-des-medicaments-antihypertenseurs-et-de-leurs-associations/
https://gpcardio.org/fr/2025-09-01_diabete-et-obesite-et-effet-du-traitement-du-controle-precoce-du-rythme-versus-soins-habituels-chez-des-patients-atteints-de-fibrillation-auriculaire/
https://gpcardio.org/fr/2025-09-01_rapport-cout-efficacite-de-l-apixaban-versus-l-aspirine-pour-la-reduction-de-la-thromboembolie-chez-des-patients-a-haut-risque-presentant-une-fibrillation-auriculaire-detectee-par-dispositif/
https://gpcardio.org/fr/2025-09-01_stimulation-du-systeme-de-conduction-versus-stimulation-biventriculaire-pour-la-resynchronisation-cardiaque/
https://gpcardio.org/fr/2025-09-02_le-depistage-a-distance-de-la-fibrillation-auriculaire-en-medecine-de-premier-recours-au-moyen-d-un-patch-ecg-montre-des-benefices-modestes/
https://gpcardio.org/fr/2025-09-02_prise-en-charge-medicale-optimale-et-revascularisation-myocardique-guidee-par-la-capacite-de-flux-coronaire-versus-soins-habituels-pour-la-coronaropathie-chronique/
https://gpcardio.org/fr/2025-09-05_reductions-de-la-pression-arterielle-avec-le-baxdrostat-chez-les-patients-atteints-d-hypertension-non-controlee-ou-resistante/
https://gpcardio.org/fr/2025-09-09_influence-du-diabete-de-type-2-sur-les-effets-du-tirzepatide-chez-des-patients-atteints-d-insuffisance-cardiaque-a-fraction-d-ejection-preservee-et-d-obesite/
https://gpcardio.org/fr/2025-09-11_readaptation-multidomaine-pour-les-patients-ages-victimes-d-un-infarctus-du-myocarde/
https://gpcardio.org/fr/2025-09-11_une-nouvelle-recommandation-propose-une-nouvelle-approche-pour-evaluer-le-risque-cardiovasculaire-et-atteindre-les-objectifs-therapeutiques-concernant-les-taux-de-lipides/
https://gpcardio.org/fr/2025-09-13_betabloquants-apres-infarctus-du-myocarde-avec-fraction-d-ejection-legerement-reduite/
https://gpcardio.org/fr/2025-09-16_2025-aha-acc-guideline-for-the-prevention-detection-evaluation-and-management-of-high-blood-pressure-in-adults/
https://gpcardio.org/fr/2025-09-16_faire-face-a-l-impact-cardiovasculaire-durable-de-la-covid-19-nouvelles-recommandations-pour-la-medecine-de-premier-recours/
https://gpcardio.org/fr/2025-09-18_l-orforglipron-un-agoniste-oral-des-recepteurs-du-glp-1-a-petite-molecule-dans-le-diabete-de-type-2-precoce/
https://gpcardio.org/fr/2025-09-20_effet-de-l-evolocumab-sur-la-permeabilite-du-greffon-veineux-saphene-apres-pontage-aortocoronarien-newton-cabg-cardiolink-5/
https://gpcardio.org/fr/2025-09-21_introduction-et-impact-de-la-cmr-sur-les-patients-et-les-systemes-de-sante/
https://gpcardio.org/fr/2025-09-24_principaux-changements-dans-les-recommandations-cliniques-pour-la-prise-en-charge-de-la-pression-arterielle-et-des-lipides/
https://gpcardio.org/fr/2025-09-25_la-digitoxine-chez-des-patients-atteints-d-insuffisance-cardiaque-a-fraction-d-ejection-reduite/
https://gpcardio.org/fr/2025-09-28_pourquoi-il-est-important-de-reconnaitre-et-de-prendre-en-charge-la-maladie-renale-chronique-ckd/
https://gpcardio.org/fr/2025-10-01_2025-aha-acc-guideline-for-the-prevention-detection-evaluation-and-management-of-high-blood-pressure-in-adults/
https://gpcardio.org/fr/2025-10-01_aucune-preuve-ne-soutient-l-utilisation-de-vitamines-ou-de-complements-pour-reduire-le-cholesterol-ldl-et-le-risque-cardiovasculaire/
https://gpcardio.org/fr/2025-10-01_soulagement-de-la-congestion-pulmonaire-par-l-ajout-de-dapagliflozine-au-diuretique-de-l-anse-intraveineux-chez-des-patients-atteints-d-insuffisance-cardiaque-aigue/
https://gpcardio.org/fr/2025-10-07_impact-de-l-obicetrapib-sur-les-evenements-cardiovasculaires-indesirables-majeurs-chez-des-patients-a-haut-risque/
https://gpcardio.org/fr/2025-10-07_la-relation-entre-l-obesite-et-la-maladie-renale-chronique/
https://gpcardio.org/fr/2025-10-07_occlusion-de-l-auricule-gauche-chez-des-patients-atteints-d-insuffisance-renale-terminale/
https://gpcardio.org/fr/2025-10-09_efficacite-et-securite-du-baxdrostat-dans-l-hypertension-non-controlee-et-resistante/
https://gpcardio.org/fr/2025-10-14_administration-d-heparine-au-premier-contact-medical-versus-immediatement-avant-l-intervention-coronaire-percutanee-primaire/
https://gpcardio.org/fr/2025-10-14_arret-a-long-terme-de-l-anticoagulation-apres-ablation-par-catheter-pour-fibrillation-auriculaire/
https://gpcardio.org/fr/2025-10-23_l-aspirine-chez-des-patients-atteints-de-syndrome-coronarien-chronique-sous-anticoagulation-orale/
https://gpcardio.org/fr/2025-10-27_relier-la-sensibilisation-au-coeur-et-a-l-avc-plus-forts-ensemble/
https://gpcardio.org/fr/2025-10-27_remplacement-valvulaire-aortique-par-voie-transcatheter-ou-chirurgicale-chez-des-patients-a-faible-risque-a-7-ans/
https://gpcardio.org/fr/2025-10-28_controle-intensif-de-la-pression-arterielle-chez-des-patients-ages-atteints-d-hypertension/
https://gpcardio.org/fr/2025-10-28_effet-du-controle-intensif-de-la-pression-arterielle-sur-l-avc/
https://gpcardio.org/fr/2025-10-28_icp-immediate-ou-differee-de-la-lesion-non-coupable-dans-l-infarctus-du-myocarde/
https://gpcardio.org/fr/2025-11-01_securite-de-l-inhibition-du-facteur-xi-par-l-abelacimab-dans-la-fibrillation-auriculaire-selon-la-fonction-renale/
https://gpcardio.org/fr/2025-11-04_2025-aha-acc-guideline-for-the-prevention-detection-evaluation-and-management-of-high-blood-pressure-in-adults/
https://gpcardio.org/fr/2025-11-06_l-orforglipron-un-agoniste-oral-des-recepteurs-du-glp-1-a-petite-molecule-pour-le-traitement-de-l-obesite/
https://gpcardio.org/fr/2025-11-09_un-inhibiteur-de-pcsk9-previent-un-premier-infarctus-ou-avc-chez-les-patients-a-haut-risque/
https://gpcardio.org/fr/2025-11-10_vaccin-antigrippal-a-haute-dose-versus-dose-standard-et-resultats-cardiovasculaires-chez-des-adultes-ages/
https://gpcardio.org/fr/2025-11-11_decaf-une-tasse-de-cafe-par-jour-pourrait-empecher-la-recidive-de-la-fibrillation-auriculaire/
https://gpcardio.org/fr/2025-11-13_betabloquants-apres-un-infarctus-du-myocarde-chez-des-patients-sans-insuffisance-cardiaque/
https://gpcardio.org/fr/2025-11-13_betabloquants-apres-un-infarctus-du-myocarde-sans-fraction-d-ejection-reduite/
https://gpcardio.org/fr/2025-11-18_dapagliflozine-chez-des-patients-hospitalises-pour-insuffisance-cardiaque/
https://gpcardio.org/fr/2025-11-18_declaration-scientifique-2025-de-l-acc-sur-la-prise-en-charge-de-l-obesite-chez-les-adultes-atteints-d-insuffisance-cardiaque/
https://gpcardio.org/fr/2025-11-18_effets-cardiovasculaires-et-tolerance-des-agonistes-du-recepteur-du-glp-1/
https://gpcardio.org/fr/2025-11-21_le-conseil-de-l-epccs-lance-gpcardio-un-engagement-en-faveur-de-la-medecine-de-premier-recours/
https://gpcardio.org/fr/2025-11-25_scores-de-risque-abc-af-fondes-sur-des-biomarqueurs-pour-un-traitement-personnalise-visant-a-reduire-l-accident-vasculaire-cerebral-ou-le-deces-dans-la-fibrillation-auriculaire/
https://gpcardio.org/fr/2025-12-01_etude-de-reduction-agressive-des-facteurs-de-risque-dans-la-fibrillation-auriculaire-implications-pour-les-resultats-de-l-ablation/
https://gpcardio.org/fr/2025-12-01_hemorragie-majeure-sous-apixaban-versus-aspirine/
https://gpcardio.org/fr/2025-12-13_revascularisation-complete-versus-revascularisation-limitee-a-la-lesion-coupable-dans-l-infarctus-du-myocarde-aigu-complete-revascularisation-trialists-collaboration/
https://gpcardio.org/fr/2025-12-16_effet-a-long-terme-des-dai-dans-l-insuffisance-cardiaque-non-ischemique-a-fraction-d-ejection-reduite/
https://gpcardio.org/fr/2025-12-16_traitement-pharmacologique-de-l-insuffisance-cardiaque-a-fraction-d-ejection-reduite/
https://gpcardio.org/fr/2025-12-18_improve-dice-un-essai-ouvert-de-phase-2a-en-deux-parties-evaluant-la-securite-et-l-efficacite-du-ninerafaxstat-chez-des-patients-presentant-des-syndromes-cardiometaboliques/
https://gpcardio.org/fr/2025-12-18_recommandations-acc-aha-2025-pour-la-prise-en-charge-des-adultes-atteints-de-cardiopathie-congenitale/
https://gpcardio.org/fr/2025-12-18_resultats-cardiovasculaires-sous-tirzepatide-versus-dulaglutide-dans-le-diabete-de-type-2/
https://gpcardio.org/fr/2025-12-19_l-ue-lance-l-ambitieux-safe-hearts-plan-une-nouvelle-feuille-de-route-pour-la-sante-cardiovasculaire/
https://gpcardio.org/fr/2025-12-20_l-orforglipron-un-agoniste-oral-du-recepteur-du-glp-1-a-petite-molecule-pour-le-traitement-de-l-obesite-chez-les-personnes-atteintes-de-diabete-de-type-2-attain-2/
https://gpcardio.org/fr/2025-12-23_anticoagulation-a-court-terme-versus-double-antiagregation-plaquettaire-pour-la-prevention-de-la-thrombose-du-dispositif-apres-fermeture-de-l-auricule-gauche/
https://gpcardio.org/fr/2026-01-06_courses-alimentaires-selon-le-modele-dash-et-effets-sur-la-pression-arterielle/
https://gpcardio.org/fr/2026-01-06_l-oms-publie-une-recommandation-mondiale-sur-l-utilisation-des-medicaments-glp-1-dans-le-traitement-de-l-obesite/
https://gpcardio.org/fr/2026-01-07_les-lymphocytes-t-cxcr6-favorisent-la-myocardite-liee-aux-inhibiteurs-de-point-de-controle-immunitaire/
https://gpcardio.org/fr/2026-01-10_la-nicotine-et-le-systeme-cardiovasculaire-points-cles-pour-la-medecine-de-premier-recours/
https://gpcardio.org/fr/2026-01-12_efficacite-et-securite-du-traitement-par-de-faibles-doses-de-spironolactone-chez-des-patients-atteints-d-hyperaldosteronisme-primaire/
https://gpcardio.org/fr/2026-01-13_efficacite-et-securite-de-l-enlicitide-un-inhibiteur-oral-de-pcsk9-chez-des-adultes-atteints-d-hypercholesterolemie-familiale-heterozygote/
https://gpcardio.org/fr/2026-01-14_agonistes-du-recepteur-de-type-glucagon-et-medicaments-de-nouvelle-generation-bases-sur-les-incretines/
https://gpcardio.org/fr/2026-01-15_obstacles-socio-economiques-et-structurels-a-la-lutte-contre-l-obesite-dans-les-communautes/
https://gpcardio.org/fr/2026-01-19_l-avc-identifie-comme-la-deuxieme-cause-de-deces-due-a-la-maladie-cardiovasculaire-et-un-facteur-majeur-de-handicap-acquis-de-longue-duree/
https://gpcardio.org/fr/2026-01-20_facteurs-de-stress-environnementaux-et-sante-cardiovasculaire/
https://gpcardio.org/fr/2026-01-20_inhibiteurs-du-sglt2-et-resultats-renaux-selon-le-debit-de-filtration-glomerulaire-et-l-albuminurie/
https://gpcardio.org/fr/2026-01-20_triple-versus-double-traitement-hypolipemiant-dans-le-syndrome-coronarien-aigu/
https://gpcardio.org/fr/2026-01-21_statistiques-2026-sur-les-maladies-cardiaques-et-les-accidents-vasculaires-cerebraux/
https://gpcardio.org/fr/2026-01-22_bon-usage-des-medicaments-pour-les-inhibiteurs-du-sra-et-les-inhibiteurs-du-sglt2-dans-la-maladie-renale-chronique/
https://gpcardio.org/fr/2026-01-22_traitement-antithrombotique-apres-ablation-par-catheter-reussie-pour-fibrillation-auriculaire/
https://gpcardio.org/fr/2026-01-27_la-colchicine-dans-les-syndromes-coronariens-aigus/
https://gpcardio.org/fr/2026-01-27_monotherapie-par-inhibiteur-puissant-du-p2y12-versus-dapt-apres-pci-chez-des-patients-avec-et-sans-stemi/
https://gpcardio.org/fr/2026-01-28_recommandations-de-pratique-clinique-kdigo-2026-sur-l-anemie-dans-la-maladie-renale-chronique-mrc/
https://gpcardio.org/fr/2026-01-29_charge-d-entrainement-derivee-d-objets-connectes-et-atherosclerose-coronaire-chez-des-athletes-d-age-moyen-et-plus-ages-et-des-temoins-physiquement-actifs/
https://gpcardio.org/fr/2026-01-29_charge-symptomatique-et-prevention-secondaire-chez-des-patients-presentant-une-dysfonction-systolique-ventriculaire-gauche-apres-un-infarctus-du-myocarde-aigu/
https://gpcardio.org/fr/2026-01-29_l-olezarsen-pour-la-prise-en-charge-de-l-hypertriglyceridemie-severe-et-du-risque-de-pancreatite/
https://gpcardio.org/fr/2026-01-29_prise-en-charge-guidee-par-une-equipe-multidisciplinaire-de-la-stenose-aortique-severe/
https://gpcardio.org/fr/2026-01-30_evenements-emboliques-systemiques-dans-la-fibrillation-auriculaire/
https://gpcardio.org/fr/2026-02-01_betabloquants-apres-un-infarctus-du-myocarde-chez-des-patients-a-fraction-d-ejection-preservee/
https://gpcardio.org/fr/2026-02-01_cagrisema-reduit-la-pression-arterielle-chez-des-adultes-en-surpoids-ou-obeses/
https://gpcardio.org/fr/2026-02-01_effets-cardiovasculaires-renaux-de-la-dapagliflozine-chez-des-patients-a-risque-cardiovasculaire-avec-ou-sans-diabete-de-type-2/
https://gpcardio.org/fr/2026-02-01_resultats-apres-changement-de-dosage-de-la-troponine-cardiaque-dans-le-sca/
https://gpcardio.org/fr/2026-02-01_semaglutide-et-hospitalisations-chez-des-patients-atteints-d-obesite-et-de-maladie-cardiovasculaire-etablie/
https://gpcardio.org/fr/2026-02-02_utilisation-des-inhibiteurs-du-sglt2-et-resultats-cardiorenaux-dans-le-diabete-de-type-2-avec-cirrhose-hepatique/
https://gpcardio.org/fr/2026-02-03_activite-physique-et-risque-d-evenements-indesirables-dans-la-fibrillation-auriculaire/
https://gpcardio.org/fr/2026-02-03_la-dapagliflozine-pour-reduire-la-recidive-precoce-apres-ablation-par-catheter-pour-fibrillation-auriculaire/
https://gpcardio.org/fr/2026-02-03_le-semaglutide-en-traitement-adjuvant-a-l-ablation-par-catheter-dans-la-fibrillation-auriculaire-paroxystique-liee-a-l-obesite/
https://gpcardio.org/fr/2026-02-03_prise-en-charge-actuelle-de-la-fibrillation-auriculaire-chez-des-patients-atteints-de-cancer-l-enquete-2025-de-l-european-heart-rhythm-association/
https://gpcardio.org/fr/2026-02-03_semaglutide-versus-tirzepatide-chez-des-patients-atteints-d-obesite-et-d-hfpef/
https://gpcardio.org/fr/2026-02-04_les-stethoscopes-numeriques-dotes-d-ia-surpassent-le-depistage-traditionnel-pour-la-vhd-significative/
https://gpcardio.org/fr/2026-02-05_efimosfermine-alfa-bos-580-une-fois-par-mois-chez-des-personnes-atteintes-de-steatohepatite-associee-a-un-dysfonctionnement-metabolique-avec-fibrose-f2-ou-f3/
https://gpcardio.org/fr/2026-02-05_les-bases-hereditaires-de-la-maladie-coronarienne/
https://gpcardio.org/fr/2026-02-05_tenecteplase-par-voie-intraveineuse-pour-l-avc-ischemique-aigu-dans-les-24-heures-du-a-une-occlusion-de-l-artere-basilaire/
https://gpcardio.org/fr/2026-02-05_tenecteplase-versus-traitement-medical-standard-pour-l-occlusion-de-l-artere-basilaire-dans-les-24-heures-trace-5/
https://gpcardio.org/fr/2026-02-05_un-essai-controle-par-placebo-de-l-inhibiteur-oral-de-pcsk9-l-enlicitide/
https://gpcardio.org/fr/2026-02-06_agonistes-du-recepteur-du-peptide-1-de-type-glucagon-et-resultats-renaux-a-l-ere-de-la-medecine-personnalisee/
https://gpcardio.org/fr/2026-02-06_la-resistance-a-l-insuline-compromet-la-voie-des-pentoses-phosphates-et-altere-la-recuperation-myocardique-mediee-par-les-dispositifs-d-assistance-ventriculaire-gauche-lvad-chez-des-patients-obeses-at/
https://gpcardio.org/fr/2026-02-06_le-variant-rs671-de-l-aldehyde-deshydrogenase-2-renforce-l-activation-plaquettaire-et-la-thrombose-arterielle/
https://gpcardio.org/fr/2026-02-06_parler-aux-patients-des-statines-pourquoi-la-plupart-des-symptomes-rapportes-ne-sont-pas-causaux/
https://gpcardio.org/fr/2026-02-09_atherosclerose-coronarienne-chez-les-patients-atteints-de-cancer-et-les-survivants/
https://gpcardio.org/fr/2026-02-10_evaluation-et-prise-en-charge-de-l-amylose-cardiaque-a-transthyretine/
https://gpcardio.org/fr/2026-02-10_hematopoiese-clonale-et-ses-implications-cardiovasculaires/
https://gpcardio.org/fr/2026-02-10_infarctus-du-myocarde-spontane-apres-revascularisation-du-tronc-commun/
https://gpcardio.org/fr/2026-02-10_nouveaux-traitements-medicamenteux-de-l-hypertension/
https://gpcardio.org/fr/2026-02-10_risques-de-cancer-renal-et-urothelial-avec-les-inhibiteurs-du-sglt2-versus-les-agonistes-du-recepteur-du-glp-1-dans-le-diabete-de-type-2/
https://gpcardio.org/fr/2026-02-11_amelioration-des-resultats-de-l-ablation-de-la-fibrillation-auriculaire-par-des-interventions-personnalisees-et-integrees-sur-le-mode-de-vie/
https://gpcardio.org/fr/2026-02-11_criteres-pour-evaluer-l-utilite-predictive-et-clinique-de-nouveaux-modeles-biomarqueurs-et-outils-pour-le-risque-de-maladie-cardiovasculaire/
https://gpcardio.org/fr/2026-02-11_le-vericiguat-et-la-mortalite-dans-l-insuffisance-cardiaque-a-fraction-d-ejection-reduite/
https://gpcardio.org/fr/2026-02-11_posologie-de-l-aspirine-apres-un-syndrome-coronarien-aigu-avec-suspicion-de-resistance-a-l-aspirine/
https://gpcardio.org/fr/2026-02-12_associations-prospectives-de-l-obesite-et-de-sa-severite-avec-9-resultats-cardiovasculaires/
https://gpcardio.org/fr/2026-02-12_utilite-pronostique-de-l-irm-cardiaque-de-perfusion-de-stress-chez-des-patients-atteints-de-maladie-coronarienne-connue-ou-suspectee-et-presentant-une-epreuve-d-effort-non-concluante/
https://gpcardio.org/fr/2026-02-13_utilisation-de-medicaments-nephroprotecteurs-pendant-l-allaitement/
https://gpcardio.org/fr/2026-02-16_nouveaux-marqueurs-proteomiques-plasmatiques-et-risque-de-thromboembolie-veineuse/
https://gpcardio.org/fr/2026-02-16_traitement-anticoagulant-precoce-versus-tardif-apres-un-avc-ischemique-aigu-avec-fibrillation-auriculaire/
https://gpcardio.org/fr/2026-02-17_albuminurie-ou-proteinurie-dans-la-maladie-glomerulaire-et-la-ckd-laquelle-utiliser/
https://gpcardio.org/fr/2026-02-18_beta-bloquants-apres-un-infarctus-du-myocarde/
https://gpcardio.org/fr/2026-02-18_therapie-genique-pour-la-cystinose-nephropathique/
https://gpcardio.org/fr/2026-02-19_interaction-cardiovasculaire-renale-metabolique-chez-des-patients-atteints-de-fibrillation-auriculaire-recevant-des-anticoagulants-oraux-directs/
https://gpcardio.org/fr/2026-02-19_prevention-secondaire-apres-un-avc-ischemique/
https://gpcardio.org/fr/2026-02-19_recommandation-2026-de-l-aha-acc-pour-l-evaluation-et-la-prise-en-charge-de-l-embolie-pulmonaire-aigue-chez-l-adulte/
https://gpcardio.org/fr/2026-02-19_remplacement-valvulaire-aortique-par-catheter-ou-chirurgical-chez-des-patients-a-faible-risque-a-7-ans/
https://gpcardio.org/fr/2026-02-19_troubles-de-la-conduction-apres-implantation-valvulaire-aortique-par-catheter/
https://gpcardio.org/fr/2026-02-20_prediction-amelioree-du-risque-de-maladie-cardiovasculaire-a-l-aide-de-modeles-integres-d-apprentissage-automatique/
https://gpcardio.org/fr/2026-02-21_pelacarsen-et-apherese-de-la-lipoproteine-a-en-prevention-secondaire/
https://gpcardio.org/fr/2026-02-22_rapport-cout-efficacite-des-inhibiteurs-du-cotransporteur-sodium-glucose-de-type-2-et-des-agonistes-du-recepteur-du-peptide-1-de-type-glucagon-chez-des-patients-a-haut-risque-cardiovasculaire-et-diabe/
https://gpcardio.org/fr/2026-02-23_activite-physique-definie-par-accelerometrie-et-qualite-de-vie-dans-la-cardiomyopathie-hypertrophique/
https://gpcardio.org/fr/2026-02-23_attenuation-du-risque-de-dysfonction-renale-apres-transplantation-cardiaque-et-approches-therapeutiques/
https://gpcardio.org/fr/2026-02-23_effet-du-semaglutide-sur-la-covid-19-et-d-autres-infections/
https://gpcardio.org/fr/2026-02-23_immunoadsorption-dans-la-cardiomyopathie-dilatee/
https://gpcardio.org/fr/2026-02-23_l-annee-en-medecine-cardiovasculaire-2025/
https://gpcardio.org/fr/2026-02-23_le-diabete-augmente-le-risque-d-insuffisance-cardiaque-dans-la-myocardite/
https://gpcardio.org/fr/2026-02-23_primary-care-adherence-to-heart-failure-guidelines-in-post-discharge-evaluation-routine-management-pathfinder/
https://gpcardio.org/fr/2026-02-24_denutrition-et-cachexie-chez-des-patients-hospitalises-atteints-d-affections-cardiaques-aigues/
https://gpcardio.org/fr/2026-02-24_evenements-emboliques-systemiques-dans-la-fibrillation-auriculaire/
https://gpcardio.org/fr/2026-02-24_risque-d-hospitalisation-pour-insuffisance-cardiaque-avec-les-agonistes-du-recepteur-du-glp-1-versus-les-inhibiteurs-de-la-dpp-4-ou-les-inhibiteurs-du-sglt2-chez-des-patients-atteints-de-diabete-de-ty/
https://gpcardio.org/fr/2026-02-25_associations-combinees-des-agonistes-du-recepteur-du-glp-1-et-d-un-mode-de-vie-sain-avec-les-resultats-cardiovasculaires-chez-des-personnes-atteintes-de-diabete-de-type-2/
https://gpcardio.org/fr/2026-02-25_prevision-du-fardeau-de-la-maladie-cardiovasculaire-et-de-l-avc-chez-les-femmes-aux-etats-unis-jusqu-en-2050/
https://gpcardio.org/fr/2026-02-25_resultats-de-l-insuffisance-cardiaque-a-fraction-d-ejection-reduite-legerement-reduite-ou-preservee/
https://gpcardio.org/fr/2026-02-25_rivaroxaban-a-faible-dose-pour-prevenir-la-thrombose-ventriculaire-gauche-apres-un-infarctus-du-myocarde-anterieur/
https://gpcardio.org/fr/2026-02-26_controle-intensif-de-la-pression-arterielle-et-fonction-cognitive/
https://gpcardio.org/fr/2026-02-27_benefices-cardiorenaux-additifs-de-l-association-finerenone-et-inhibiteur-du-sglt2-dans-la-ckd-diabetique/
https://gpcardio.org/fr/2026-02-27_inhibition-du-sglt2-chez-des-patients-atteints-de-diabete-de-type-2-et-de-ckd-presentant-une-deterioration-du-debit-de-filtration-glomerulaire-estime-a-20-ml-min-1-73-m/
https://gpcardio.org/fr/2026-02-27_la-charge-en-macrophages-de-la-plaque-carotidienne-et-les-marqueurs-de-macrophages-inflammatoires-associes-aux-lipides-predisent-des-evenements-cardiovasculaires-indesirables-majeurs-secondaires-apres/
https://gpcardio.org/fr/2026-02-27_passage-de-la-warfarine-aux-anticoagulants-oraux-directs-chez-des-patients-asiatiques-ages-fragiles-atteints-de-fibrillation-auriculaire/
https://gpcardio.org/fr/2026-02-28_insuffisance-cardiaque-chez-les-personnes-agees/
https://gpcardio.org/fr/2026-03-01_abelacimab-versus-rivaroxaban-chez-des-personnes-agees-atteintes-de-fibrillation-auriculaire/
https://gpcardio.org/fr/2026-03-01_chronologie-des-benefices-cardiovasculaires-et-renaux-de-la-finerenone-dans-l-insuffisance-cardiaque-et-la-maladie-renale-chronique-avec-diabete-de-type-2/
https://gpcardio.org/fr/2026-03-01_comparaison-des-algorithmes-a-0-1-heure-de-l-european-society-of-cardiology-et-de-la-troponine-a-haute-sensibilite-dans-l-evaluation-des-patients-suspects-de-syndrome-coronarien-aigu-algorithmes-a-0-2/
https://gpcardio.org/fr/2026-03-01_depistage-cardiaque-chez-les-jeunes/
https://gpcardio.org/fr/2026-03-01_depistage-cardiaque-des-affections-associees-a-la-mort-subite-cardiaque/
https://gpcardio.org/fr/2026-03-01_effet-du-baduanjin-sur-la-pression-arterielle-chez-des-personnes-presentant-une-pression-arterielle-normale-haute/
https://gpcardio.org/fr/2026-03-01_impact-d-un-traitement-precoce-tardif-ou-interrompu-chez-des-enfants-atteints-d-hypercholesterolemie-familiale/
https://gpcardio.org/fr/2026-03-01_journal-club/
https://gpcardio.org/fr/2026-03-01_recommandation-2026-sur-l-embolie-pulmonaire-aigue-en-un-coup-d-oeil/
https://gpcardio.org/fr/2026-03-01_resultats-a-six-ans-apres-remplacement-valvulaire-aortique-par-catheter-versus-chirurgical-chez-des-patients-a-faible-risque-atteints-de-stenose-aortique/
https://gpcardio.org/fr/2026-03-01_un-peu-de-confidence-bien-necessaire-pour-combattre-le-paradoxe-risque-traitement-dans-la-maladie-renale-chronique/
https://gpcardio.org/fr/2026-03-01_vaccination-antigrippale-a-haute-dose-dans-la-maladie-cardiovasculaire-atherosclereuse/
https://gpcardio.org/fr/2026-03-02_le-bruit-nocturne-de-la-circulation-routiere-stresse-le-coeur-et-les-vaisseaux-sanguins/
https://gpcardio.org/fr/2026-03-02_profil-de-risque-nombre-de-greffons-et-mortalite-hospitaliere-plus-defavorables-mais-survie-tardive-acceptable-chez-des-femmes-subissant-une-chirurgie-coronarienne/
https://gpcardio.org/fr/2026-03-03_quantification-du-metabolisme-energetique-du-muscle-squelettique-pendant-l-exercice-dans-l-insuffisance-cardiaque-a-fraction-d-ejection-preservee-par-spectroscopie-par-resonance-magnetique-du-31p-in-v/
https://gpcardio.org/fr/2026-03-03_therapie-genique-d-edition-de-bases-in-vivo-pour-l-hypercholesterolemie-familiale-heterozygote/
https://gpcardio.org/fr/2026-03-03_validation-hemodynamique-invasive-d-un-outil-echocardiographique-d-intelligence-artificielle-pour-la-detection-de-l-insuffisance-cardiaque-a-fraction-d-ejection-preservee/
https://gpcardio.org/fr/2026-03-04_aspirine-apres-une-pci-dans-les-syndromes-coronariens-aigus/
https://gpcardio.org/fr/2026-03-04_finerenone-dans-la-maladie-renale-diabetique-associee-au-diabete-de-type-1-une-fine-reponse/
https://gpcardio.org/fr/2026-03-04_interaction-entre-l-age-le-sexe-la-pression-arterielle-en-cabinet-et-ambulatoire-et-la-mortalite/
https://gpcardio.org/fr/2026-03-04_objectifs-de-pression-arterielle-dans-la-prise-en-charge-de-l-hypertension/
https://gpcardio.org/fr/2026-03-05_anticoagulant-oral-d-action-directe-ou-antagoniste-de-la-vitamine-k-pour-le-patient-age-fragile-atteint-de-fibrillation-auriculaire/
https://gpcardio.org/fr/2026-03-05_finerenone-dans-le-diabete-de-type-1-et-la-maladie-renale-chronique/
https://gpcardio.org/fr/2026-03-05_l-inhibiteur-oral-de-pcsk9-enlicitide-reduit-les-taux-de-cholesterol-ldl-dans-un-essai-de-phase-2/
https://gpcardio.org/fr/2026-03-05_semaglutide-dans-l-arteriopathie-peripherique-et-le-diabete-selon-la-severite-initiale-de-la-maladie-et-l-age/
https://gpcardio.org/fr/2026-03-06_maladie-renale-et-insuffisance-cardiaque/
https://gpcardio.org/fr/2026-03-07_effet-du-baxdrostat-sur-la-pression-arterielle-ambulatoire-chez-des-patients-atteints-d-hypertension-resistante-bax24/
https://gpcardio.org/fr/2026-03-07_effet-du-baxdrostat-sur-la-pression-arterielle-ambulatoire-chez-les-patients-atteints-d-hypertension-resistante-bax24/
https://gpcardio.org/fr/2026-03-07_fibrillation-auriculaire/
https://gpcardio.org/fr/2026-03-09_differences-de-trajectoire-de-la-maladie-comorbidites-et-mortalite-dans-la-cardiomyopathie-hypertrophique-sarcomerique-et-non-sarcomerique/
https://gpcardio.org/fr/2026-03-09_le-semaglutide-favorise-le-flux-de-cellules-progenitrices-derivees-de-la-moelle-osseuse-vers-un-profil-anti-inflammatoire-et-pro-regeneratif-chez-les-patients-a-haut-risque/
https://gpcardio.org/fr/2026-03-09_objectifs-et-traitements-pour-la-gestion-du-ldl-c-en-medecine-de-premier-recours/
https://gpcardio.org/fr/2026-03-10_depistage-genetique-de-l-hf-justification-et-retour-d-experience/
https://gpcardio.org/fr/2026-03-10_lp-a-est-il-temps-de-commencer-a-le-mesurer-en-medecine-de-premier-recours/
https://gpcardio.org/fr/2026-03-11_triglycerides-un-marqueur-de-risque-ou-une-cible-pour-le-risque-cv/
https://gpcardio.org/fr/2026-03-12_recommandations-de-l-esc-sur-la-cvd-et-la-sante-mentale-en-medecine-de-premier-recours/
https://gpcardio.org/fr/2026-03-12_risque-cardiovasculaire-metabolique-a-la-menopause/
https://gpcardio.org/fr/2026-03-12_surdosage-hors-indication-du-traitement-antithrombotique-par-edoxaban-chez-les-patients-atteints-de-fibrillation-auriculaire-et-de-maladie-coronarienne-stable/
https://gpcardio.org/fr/2026-03-13_insuffisance-cardiaque-en-medecine-de-premier-recours-reconnaissance-precoce-et-instauration-du-gdmt/
https://gpcardio.org/fr/2026-03-13_la-necessite-d-un-engagement-des-generalistes-dans-le-monde-du-plaidoyer/
https://gpcardio.org/fr/2026-03-13_prise-en-charge-de-l-hypertension-difficile-a-controler-et-les-nouveautes/
https://gpcardio.org/fr/2026-03-13_recommandation-acc-aha-2026-sur-la-prise-en-charge-de-la-dyslipidemie/
https://gpcardio.org/fr/2026-03-14_le-pouls-de-la-medecine-de-premier-recours-sommet-epccs-2026/
https://gpcardio.org/fr/2026-03-16_utilisation-du-score-calcique-coronaire-chez-les-individus-presentant-une-lipoproteine-a-elevee/
https://gpcardio.org/fr/2026-03-20_antecedents-d-issues-de-grossesse-defavorables-tout-au-long-de-la-vie-et-risque-cardiovasculaire/
https://gpcardio.org/fr/2026-03-20_l-impact-des-recommandations-de-l-epccs-sur-la-pharmacotherapie-en-ukraine/
https://gpcardio.org/fr/2026-03-20_preuves-issues-de-la-vie-reelle-avec-la-dapagliflozine-dans-l-insuffisance-cardiaque-a-fraction-d-ejection-reduite-en-europe-centrale-et-orientale-et-dans-la-region-balte-etude-evolution-hf-cee-ba/
https://gpcardio.org/fr/2026-03-22_depistage-de-la-cvd-en-grece/
https://gpcardio.org/fr/2026-03-22_gestion-du-risque-cardiovasculaire-en-pologne/
https://gpcardio.org/fr/2026-03-22_mise-a-jour-des-recommandations-sur-l-hypertension-en-turquie/
https://gpcardio.org/fr/2026-03-23_traitement-medical-guide-par-les-recommandations-dans-la-ckd-le-role-crucial-de-la-medecine-de-premier-recours/
https://gpcardio.org/fr/2026-03-24_depistage-et-stratification-du-risque-dans-la-ckd-le-role-crucial-de-la-medecine-de-premier-recours/
https://gpcardio.org/fr/2026-03-24_indice-triglycerides-glucose-et-mortalite-chez-les-patients-critiques-atteints-de-syndrome-cardio-reno-metabolique-stade-4/
https://gpcardio.org/fr/2026-03-24_inflammation-systemique-et-recidive-apres-un-accident-vasculaire-cerebral-lie-a-la-fibrillation-auriculaire/
https://gpcardio.org/fr/2026-03-24_prise-en-charge-de-la-ckd-en-medecine-de-premier-recours/
https://gpcardio.org/fr/2026-03-25_gestion-des-agonistes-des-recepteurs-du-peptide-intestinal-glucagon-like-1-et-des-inhibiteurs-du-cotransporteur-sodium-glucose-2-dans-la-pratique-clinique/
https://gpcardio.org/fr/2026-03-25_heritabilite-et-maladie-cardiovasculaire-chez-la-descendance-adulte-des-femmes-ayant-presente-un-trouble-hypertensif-de-la-grossesse/
https://gpcardio.org/fr/2026-03-25_role-de-l-imagerie-de-provocation-et-d-exercice-pour-l-identification-des-candidats-aux-inhibiteurs-de-la-myosine-cardiaque/
https://gpcardio.org/fr/2026-03-26_fermeture-de-l-appendice-auriculaire-gauche-ou-traitement-medical-dans-la-fibrillation-auriculaire/
https://gpcardio.org/fr/2026-03-26_nouveaux-mecanismes-des-facteurs-de-risque-cardiovasculaire-metabolique-et-opportunites-therapeutiques/
https://gpcardio.org/fr/2026-03-26_signature-de-l-obesite-senescence-dans-le-cancer-du-sein/
https://gpcardio.org/fr/2026-03-26_therapie-par-edition-genique-dans-les-maladies-cardiovasculaires/
https://gpcardio.org/fr/2026-03-27_endotypage-approfondi-des-lesions-renales-dans-le-diabete-de-type-2/
https://gpcardio.org/fr/2026-03-27_maladie-renale/
https://gpcardio.org/fr/2026-03-27_optimisation-des-seuils-d-inclusion-du-nt-probnp-pour-les-essais-cliniques-randomises-sur-l-insuffisance-cardiaque/
https://gpcardio.org/fr/2026-03-28_syndrome-de-deficit-du-canal-de-liberation-du-calcium-chez-les-patients-diagnostiques-avec-une-fibrillation-ventriculaire-idiopathique-et-chez-les-decedes-classes-comme-mort-subite-inexpliquee-chez-le/
https://gpcardio.org/fr/2026-03-29_ciblage-intensif-du-cholesterol-lipoproteique-de-basse-densite-chez-les-patients-atteints-de-maladie-cardiovasculaire-atherosclereuse/
https://gpcardio.org/fr/2026-03-29_fermeture-de-l-appendice-auriculaire-gauche-ou-anticoagulation-pour-la-fibrillation-auriculaire/
https://gpcardio.org/fr/2026-03-29_fibrinolyse-facilitee-par-ultrasons-et-dirigee-par-catheter-pour-l-embolie-pulmonaire-aigue/
https://gpcardio.org/fr/2026-03-29_l-evolocumab-reduit-de-31-le-risque-de-premier-evenement-cardiovasculaire-majeur-chez-les-patients-sans-atherosclerose-significative/
https://gpcardio.org/fr/2026-03-30_l-etude-sur-les-effets-du-liraglutide-dans-la-fibrillation-auriculaire-leaf/
https://gpcardio.org/fr/2026-04-10_le-projet-europeen-nextgen-fait-progresser-la-cardiologie-personnalisee-en-integrant-des-donnees-genomiques-et-cliniques-dans-des-modeles-d-ia/
https://gpcardio.org/fr/2026-04-15_l-insuffisance-cardiaque-est-frequente-chez-les-personnes-dont-la-fibrillation-auriculaire-est-detectee-lors-du-depistage/
https://gpcardio.org/fr/2026-04-17_evolocumab-pour-reduire-le-premier-evenement-cardiovasculaire-majeur-chez-les-patients-sans-atherosclerose-significative-connue-et-atteints-de-diabete/
https://gpcardio.org/fr/2026-04-17_modifications-aigues-de-la-dfge-et-leur-mediation-dans-la-reduction-de-l-albuminurie-avec-l-empagliflozine-et-la-finerenone/
https://gpcardio.org/fr/2026-04-17_volume-versus-intensite-de-l-activite-physique-et-risque-de-maladies-chroniques-cardiovasculaires-et-non-cardiovasculaires/
https://gpcardio.org/fr/2026-04-18_agonistes-des-recepteurs-du-peptide-1-semblable-au-glucagon-pour-la-prevention-des-evenements-d-insuffisance-cardiaque-dans-le-diabete-de-type-2-et-ou-l-obesite/
https://gpcardio.org/fr/2026-04-18_differences-sexuelles-dans-le-syndrome-cardio-reno-metabolique/
https://gpcardio.org/fr/2026-04-18_lipoproteine-a-et-thromboembolie-veineuse-incidente-chez-les-femmes-pre-et-post-menopausees-et-chez-les-hommes/
https://gpcardio.org/fr/2026-04-19_impact-des-tests-genetiques-chez-les-patients-atteints-d-hypercholesterolemie-familiale-hf-sur-les-evenements-cardiovasculaires-indesirables-l-etude-du-registre-hokuriku-plus-sur-l-hypercholesterolemi/
https://gpcardio.org/fr/2026-04-20_lp-a-a-des-effets-specifiques-sur-la-maladie-coronarienne-independamment-du-ldl-c/
https://gpcardio.org/fr/2026-04-21_appareils-portables-et-sante-cardiovasculaire/
https://gpcardio.org/fr/2026-04-22_administration-prehospitaliere-d-heparine-chez-les-patients-avec-infarctus-du-myocarde-a-sus-decalage-du-segment-st-subissant-une-angioplastie-coronaire-primaire/
https://gpcardio.org/fr/2026-04-22_memantine-pour-les-contractions-prematurees-auriculaires/
https://gpcardio.org/fr/2026-04-22_recommandation-de-l-acc-aha-aacvpr-abc-acpm-ada-ags-apha-aspc-nla-pcna-sur-la-prise-en-charge-de-la-dyslipidemie/
https://gpcardio.org/fr/2026-04-23_effet-de-l-inhibition-de-l-apoc3-par-l-olezarsen-sur-l-atherosclerose-coronaire/
https://gpcardio.org/fr/2026-04-23_rivaroxaban-a-faible-dose-pour-prevenir-la-thrombose-ventriculaire-gauche-apres-infarctus-du-myocarde-anterieur/
https://gpcardio.org/fr/2026-04-24_deux-essais-comparant-la-stimulation-du-systeme-de-conduction-et-la-stimulation-biventriculaire/
https://gpcardio.org/fr/2026-04-24_recommandations-alimentaires-2026-pour-ameliorer-la-sante-cardiovasculaire/
https://gpcardio.org/fr/2026-04-24_stades-du-syndrome-cardio-reno-metabolique-caracteristiques-echocardiographiques-et-risque-d-insuffisance-cardiaque/
https://gpcardio.org/fr/2026-04-25_le-role-du-soutien-de-la-stimulation-atriale-dans-la-therapie-de-resynchronisation-cardiaque/
https://gpcardio.org/fr/2026-04-25_sotatercept-pour-l-hypertension-pulmonaire-combinee-post-et-precapillaire-associee-a-une-insuffisance-cardiaque/
https://gpcardio.org/fr/2026-04-26_evaluation-du-risque-de-maladie-cardiovasculaire-a-long-terme-pendant-la-grossesse/
https://gpcardio.org/fr/2026-04-27_detection-echocardiographique-automatisee-des-cardiopathies-congenitales-a-l-aide-de-l-intelligence-artificielle/
https://gpcardio.org/fr/2026-04-28_prevention-precoce-des-atheromes/
https://gpcardio.org/fr/2026-04-30_trois-agents-antihypertenseurs-a-faible-dose-dans-un-comprime-unique-apres-une-hemorragie-intracerebrale/
https://gpcardio.org/fr/2026-05-01_radioablation-stereotaxique-pour-la-tachycardie-ventriculaire-refractaire/
https://gpcardio.org/fr/2026-05-02_blocage-du-sraa-dans-le-rein-au-cours-du-cycle-de-vie-norme-de-traitement/
https://gpcardio.org/fr/2026-05-03_depistage-cardiovasculaire-non-invasif-multimodal-et-resultats-specifiques-selon-le-sexe/
https://gpcardio.org/fr/2026-05-04_poursuite-versus-interruption-de-l-anticoagulation-orale-directe-apres-un-accident-vasculaire-cerebral-survenant-sous-traitement/
https://gpcardio.org/fr/2026-05-05_differences-sexuelles-dans-le-traitement-pharmacologique-de-l-insuffisance-cardiaque/
https://gpcardio.org/fr/2026-05-05_periode-prolongee-d-interruption-du-traitement-liee-a-la-grossesse-chez-les-femmes-atteintes-d-hypercholesterolemie-familiale/
https://gpcardio.org/fr/2026-05-06_facteurs-de-risque-de-maladie-cardiovasculaire-atherosclerotique-chez-les-individus-atteints-d-hypercholesterolemie-familiale-heterozygote/
https://gpcardio.org/fr/2026-05-07_reparation-combinee-par-voie-transcatethere-en-bord-a-bord-des-valves-mitrale-et-tricuspide-ou-reparation-en-bord-a-bord-de-la-valve-tricuspide-seule-en-cas-d-insuffisance-mitrale-moderee/
https://gpcardio.org/fr/2026-05-08_fonction-renale-et-risque-d-insuffisance-cardiaque-chez-les-personnes-agees/
https://gpcardio.org/fr/2026-05-08_risques-d-accident-vasculaire-cerebral-et-d-hemorragie-avec-les-anticoagulants-oraux-directs-dans-la-fibrillation-auriculaire-non-valvulaire/
https://gpcardio.org/fr/2026-05-09_implantation-d-un-defibrillateur-sous-cutane-avec-ou-sans-test-de-defibrillation/
https://gpcardio.org/fr/2026-05-10_digoxine-a-faible-dose-chez-les-patients-atteints-d-insuffisance-cardiaque-avec-fraction-d-ejection-reduite-ou-legerement-reduite/
https://gpcardio.org/fr/2026-05-10_digoxine-chez-des-patients-atteints-de-cardiopathie-rhumatismale-symptomatique/
https://gpcardio.org/fr/2026-05-10_efficacite-du-traitement-medical-recommande-par-les-recommandations-selon-l-utilisation-de-la-digoxine/
https://gpcardio.org/fr/2026-05-10_inhibiteur-du-recepteur-de-l-angiotensine-et-de-la-neprilysine-dans-l-insuffisance-cardiaque-a-fraction-d-ejection-preservee-et-l-insuffisance-mitrale-secondaire/
https://gpcardio.org/fr/2026-05-10_l-inhibiteur-de-microarn-cdr132l-chez-les-patients-presentant-une-fraction-d-ejection-du-ventricule-gauche-reduite-apres-un-infarctus-du-myocarde/
https://gpcardio.org/fr/2026-05-10_retrait-en-aveugle-du-traitement-randomise-par-digoxine-a-faible-dose-ou-placebo-chez-des-patients-atteints-d-insuffisance-cardiaque/
https://gpcardio.org/fr/2026-05-11_activite-physique-dans-les-cardiomyopathies-pediatriques/
https://gpcardio.org/fr/2026-05-11_cancer-incident-dans-l-insuffisance-cardiaque-l-infarctus-du-myocarde-ou-les-deux/
https://gpcardio.org/fr/2026-05-11_maladie-cardiovasculaire-dans-la-drepanocytose/
https://gpcardio.org/fr/2026-05-11_mesures-anthropometriques-de-l-adiposite-et-peptides-natriuretiques-dans-le-depistage-de-l-insuffisance-cardiaque/
https://gpcardio.org/fr/2026-05-11_prevalence-et-predicteurs-d-un-risque-inflammatoire-eleve-selon-les-sous-types-d-insuffisance-cardiaque/
https://gpcardio.org/fr/2026-05-11_subcut-hf-ii-le-furosemide-sous-cutane-a-domicile-reduit-les-jours-d-hospitalisation-par-rapport-au-furosemide-intraveineux-hospitalier-chez-des-patients-admis-pour-un-oedeme-associe-a-l-insuffisance/
https://gpcardio.org/fr/2026-05-12_la-prevalence-mondiale-de-l-insuffisance-cardiaque-depasse-t-elle-desormais-600-millions-de-personnes-de-la-conjecture-aux-donnees-probantes/
https://gpcardio.org/fr/2026-05-12_predicteurs-des-resultats-a-long-terme-dans-la-cardiomyopathie-hypertrophique/
https://gpcardio.org/fr/2026-05-12_sotatercept-dans-l-hypertension-pulmonaire-post-et-precapillaire-combinee-associee-a-l-insuffisance-cardiaque/
https://gpcardio.org/fr/2026-05-15_etude-prospective-multicentrique-en-vie-reelle-d-un-an-sur-l-efficacite-et-la-securite-du-vericiguat-en-espagne/
https://gpcardio.org/fr/2026-05-15_prevention-secondaire-apres-chirurgie-de-pontage-coronaire/
https://gpcardio.org/fr/2026-05-18_vers-des-bilans-de-sante-cardiovasculaire-complets-dans-toute-l-europe/
https://gpcardio.org/fr/2026-05-19_atlas-of-cardiology-des-inegalites-evitables-persistent-dans-le-fardeau-et-la-prise-en-charge-de-la-maladie-cardiovasculaire/
https://gpcardio.org/fr/2026-05-25_edition-de-bases-in-vivo-de-pcsk9-avec-verve-102-pour-l-hypercholesterolemie/
https://gpcardio.org/fr/2026-05-27_ablation-par-champ-pulse-pour-le-traitement-interventionnel-de-la-fibrillation-auriculaire-une-declaration-scientifique-de-l-european-heart-rhythm-association-ehra-de-la-esc-de-la-heart-rhythm-society/
https://gpcardio.org/fr/2026-05-27_agonistes-des-recepteurs-du-peptide-intestinal-glucagon-like-1-chez-les-patients-atteints-d-insuffisance-cardiaque-avec-fraction-d-ejection-reduite/
https://gpcardio.org/fr/2026-05-28_centres-cardiaques-feminins/
https://gpcardio.org/fr/2026-05-28_les-inhibiteurs-du-sglt2-sont-associes-a-une-reduction-du-volume-et-de-l-epaisseur-du-tissu-adipeux-epicardique/
https://gpcardio.org/fr/2026-05-29_physiopathologie-prevention-et-prise-en-charge-de-l-obstruction-microvasculaire-coronaire/
https://gpcardio.org/fr/2026-05-31_le-rein-au-centre/
https://gpcardio.org/fr/2026-06-01_chevauchement-reno-diabetique-dans-l-hypertension-arterielle-pulmonaire/
https://gpcardio.org/fr/2026-06-01_mecanismes-physiopathologiques-communs-entre-le-diabete-et-la-maladie-valvulaire-aortique-calcifiee/
https://gpcardio.org/fr/2026-06-02_epidemiologie-de-l-embolie-pulmonaire/
https://gpcardio.org/fr/2026-06-02_obicetrapib-et-les-niveaux-de-lipoproteine-a-chez-les-patients-a-risque-cardiovasculaire-eleve/
https://gpcardio.org/fr/2026-06-02_resultats-de-l-essai-betami-danblock-compares-a-une-population-nationale-norvegienne-atteinte-d-infarctus-du-myocarde/
https://gpcardio.org/fr/2026-06-03_hypercholesterolemie-familiale-chez-l-enfant-et-l-adolescent/
https://gpcardio.org/fr/2026-06-03_niveaux-de-lipoproteine-a-risque-d-evenements-cardiovasculaires-et-benefice-de-l-evolocumab/
https://gpcardio.org/fr/2026-06-04_cliniques-lipidologiques-dans-le-monde-entier/
https://gpcardio.org/fr/2026-06-04_effets-du-semaglutide-sur-la-mortalite-les-resultats-cardiovasculaires-et-renaux-tout-au-long-du-continuum-cardio-reno-metabolique/
https://gpcardio.org/fr/2026-06-05_reduction-projetee-des-evenements-cardiovasculaires-indesirables-majeurs-chez-les-adultes-americains-a-haut-risque-atteints-de-diabete-de-type-2-eligibles-au-semaglutide-oral/
https://gpcardio.org/fr/2026-06-07_syndrome-d-alport-autosomique-dominant/
https://gpcardio.org/fr/2026-06-09_modifications-de-la-composition-corporelle-chez-les-patients-sous-agonistes-des-recepteurs-du-glp-1-suivant-un-programme-intensif-de-readaptation-cardiaque/
https://gpcardio.org/fr/2026-06-10_additifs-alimentaires-conservateurs-hypertension-et-maladies-cardiovasculaires/
https://gpcardio.org/fr/2026-06-10_resultats-primaires-du-registre-salamander/
https://gpcardio.org/fr/2026-06-11_l-unite-de-sante-mobile-en-outreach-aupres-des-communautes-urbaines-socialement-defavorisees-detecte-des-facteurs-de-risque-cardiometaboliques-non-controles/
https://gpcardio.org/fr/2026-06-11_modalites-et-dosages-optimaux-d-exercice-pour-la-reduction-de-la-pression-arterielle-chez-les-adultes-presentant-une-prehypertension-et-une-hypertension-etablie/
https://gpcardio.org/fr/2026-06-12_abaissement-du-cholesterol-lipoproteique-de-basse-densite-par-l-inclisiran-en-plus-des-soins-habituels-dans-le-syndrome-coronarien-aigu-recent/
https://gpcardio.org/fr/2026-06-13_effet-de-differents-types-de-legumineuses-completes-sur-les-cibles-lipidiques-therapeutiques-etablies-pour-la-reduction-du-risque-cardiovasculaire/
https://gpcardio.org/fr/2026-06-13_societe-europeenne-de-cardiologie/
https://gpcardio.org/fr/2026-06-15_analyse-de-l-efficacite-economique-et-de-l-impact-budgetaire-de-la-tirzepatide-dans-l-insuffisance-cardiaque-a-fraction-d-ejection-preservee-et-l-obesite-dans-le-systeme-de-sante-allemand/
https://gpcardio.org/fr/2026-06-15_efficacite-clinique-des-inhibiteurs-du-cotransporteur-sodium-glucose-2-chez-les-patients-ages-hospitalises-pour-une-insuffisance-cardiaque-avec-fraction-d-ejection-reduite/
https://gpcardio.org/fr/2026-06-15_efficacite-comparative-des-inhibiteurs-individuels-du-transporteur-de-sodium-glucose-2-sur-les-resultats-cardiovasculaires-dans-le-diabete-de-type-2-avec-un-risque-cardiovasculaire-modere/
https://gpcardio.org/fr/2026-06-16_association-des-regimes-alimentaires-et-du-risque-genetique-avec-la-maladie-cardiovasculaire-chez-les-survivants-du-cancer-de-l-uk-biobank/
https://gpcardio.org/fr/2026-06-17_association-dependante-de-l-age-entre-l-insuffisance-cardiaque-et-le-risque-d-accident-vasculaire-cerebral-dans-la-fibrillation-auriculaire/
https://gpcardio.org/fr/2026-06-17_hypercholesterolemie-familiale-homozygote/
https://gpcardio.org/fr/2026-06-19_imagerie-intracoronaire-pour-l-intervention-coronarienne-percutanee-du-tronc-gauche/
https://gpcardio.org/fr/2026-06-19_laroprovstat-le-premier-inhibiteur-de-pcsk9-de-petite-molecule-orale-pour-le-traitement-de-l-hypercholesterolemie/
https://gpcardio.org/fr/2026-06-20_cibles-medicamenteuses-pour-la-modification-lipidique-et-le-risque-de-diabete-de-type-2/
https://gpcardio.org/fr/2026-06-20_risque-cardiovasculaire-lipidique-au-dela-du-cholesterol-ldl/
https://gpcardio.org/fr/2026-06-21_etude-prospective-multicentrique-en-conditions-reelles-d-utilisation-sur-un-an-de-l-efficacite-et-de-la-securite-du-vereciguat-en-espagne/
https://gpcardio.org/fr/2026-06-24_resultats-apres-un-premier-infarctus-du-myocarde-aigu-chez-les-patients-avec-ou-sans-cardiopathie-congenitale/
https://gpcardio.org/fr/2026-06-25_arret-en-aveugle-du-traitement-randomise-par-digoxine-a-faible-dose-ou-placebo-chez-les-patients-insuffisants-cardiaques/
https://gpcardio.org/fr/2026-06-25_resultats-a-1-an-en-vie-reelle-avec-l-obturateur-amulet-issus-de-l-etude-emerge-laa-post-approbation/
https://gpcardio.org/fr/2026-06-27_prise-en-charge-de-l-insuffisance-cardiaque-en-medecine-de-premier-recours-en-dehors-des-heures-d-ouverture/
https://gpcardio.org/fr/2026-06-29_embolie-coronaire-en-fibrillation-auriculaire/
https://gpcardio.org/fr/2026-06-30_indice-d-interaction-alimentation-microbiote-intestinal-et-risque-d-insuffisance-cardiaque-dans-le-diabete-et-la-prediabete/
https://gpcardio.org/fr/2026-07-01_anticoagulants-oraux-directs-ains-selectifs-du-cox-2-et-saignements-gastro-intestinaux-dans-la-fibrillation-auriculaire/
https://gpcardio.org/fr/2026-07-02_ablation-par-champ-pulse-versus-placebo-pour-traiter-la-fibrillation-auriculaire/
https://gpcardio.org/fr/2026-07-02_incidence-reelle-de-la-dysfonction-cardiaque-liee-a-la-therapie-anticancereuse-dans-une-cohorte-large-diversifiee-et-contemporaine/
https://gpcardio.org/fr/2026-07-03_estimation-du-risque-absolu-de-maladie-cardiovasculaire-a-5-ans-a-partir-des-dossiers-medicaux-electroniques-recueillis-de-routine-dans-les-cabinets-de-medecine-generale-australiens/
https://gpcardio.org/fr/2026-07-03_histoire-naturelle-de-la-regurgitation-aortique-moderee-ou-severe-asymptomatique/
https://gpcardio.org/fr/2026-07-05_condition-cardiorespiratoire-a-l-adolescence-et-compromis-entre-le-risque-de-fibrillation-auriculaire-et-les-benefices-cardiovasculaires/
https://gpcardio.org/fr/2026-07-05_condition-physique-apres-infarctus-du-myocarde-par-rapport-aux-valeurs-de-reference-cliniques/
https://gpcardio.org/fr/2026-07-05_facteurs-de-risque-de-multimorbidite-des-maladies-cardiovasculaires-dans-l-etude-prospective-million-women-study/
https://gpcardio.org/fr/2026-07-06_condition-cardiorespiratoire-a-l-adolescence-et-compromis-entre-le-risque-de-fibrillation-auriculaire-et-les-benefices-cardiovasculaires/
https://gpcardio.org/fr/2026-07-07_apports-alimentaires-en-nitrate-vegetal-et-animal-et-variations-de-la-pression-arterielle-sur-5-ans/
https://gpcardio.org/fr/2026-07-07_changements-cles-dans-les-recommandations-cliniques-pour-la-prise-en-charge-de-la-pression-arterielle-et-des-lipides/
https://gpcardio.org/fr/2026-07-07_endocardite-infectieuse-apres-implantation-de-valve-aortique-par-catheter/
https://gpcardio.org/fr/2026-07-07_la-medecine-de-premier-recours-a-t-elle-un-role-a-jouer-dans-la-prise-en-charge-de-l-obesite-du-role-de-gatekeeper-a-celui-de-leader-de-la-sante-des-populations/
https://gpcardio.org/fr/2026-07-07_pourquoi-la-maladie-renale-chronique-ckd-est-elle-plus-importante-pour-la-medecine-de-premier-recours/
https://gpcardio.org/fr/2026-07-08_apports-alimentaires-en-nitrate-vegetal-et-animal-et-modifications-de-la-pression-arterielle-sur-5-ans/
https://gpcardio.org/fr/2026-07-08_blocage-des-canaux-calciques-versus-blocage-beta-pour-l-hypertension-dans-l-insuffisance-cardiaque-a-fraction-d-ejection-preservee/
https://gpcardio.org/fr/2026-07-08_evolocumab-chez-les-patients-ayant-beneficie-d-une-intervention-coronaire-percutanee-anterieure-et-sans-antecedent-d-infarctus-du-myocarde/
https://gpcardio.org/fr/2026-07-09_determination-du-seuil-physiologique-de-l-angine-de-poitrine-orbita-fire/
https://gpcardio.org/fr/2026-07-09_inhibiteur-des-recepteurs-de-l-angiotensine-et-de-la-neprilysine-dans-l-insuffisance-cardiaque-a-fraction-d-ejection-preservee-et-regurgitation-mitrale-secondaire/
https://gpcardio.org/fr/2026-07-09_la-dysfonction-diastolique-est-tout-aussi-frequente-dans-le-prediabete-et-le-diabete-et-est-associee-a-des-facteurs-de-risque-cardiometaboliques-concomitants/
https://gpcardio.org/fr/2026-07-09_tension-arterielle-nocturne-mesuree-a-domicile-au-poignet-et-hypertrophie-ventriculaire-gauche/
https://gpcardio.org/fr/2026-07-10_evolocumab-chez-les-patients-ayant-antecedent-d-intervention-coronarienne-percutanee-et-sans-antecedent-d-infarctus-du-myocarde/
https://gpcardio.org/fr/2026-07-11_blocage-des-canaux-calciques-versus-blocage-beta-dans-l-hypertension-et-l-insuffisance-cardiaque-a-fraction-d-ejection-preservee/
https://gpcardio.org/fr/2026-07-11_tension-arterielle-nocturne-mesuree-a-domicile-au-poignet-et-hypertrophie-ventriculaire-gauche/
https://gpcardio.org/fr/2026-07-12_determination-du-seuil-physiologique-de-l-angine-orbita-fire/
https://gpcardio.org/fr/2026-07-12_inhibiteur-des-recepteurs-de-l-angiotensine-et-de-la-neprilysine-dans-l-insuffisance-cardiaque-a-fraction-d-ejection-preservee-et-regurgitation-mitrale-secondaire/
https://gpcardio.org/fr/2026-07-14_thrombus-ventriculaire-gauche-dans-le-syndrome-de-takotsubo-et-l-infarctus-du-myocarde-avec-sus-decalage-du-segment-st/
https://gpcardio.org/fr/2026-07-15_l-histoire-naturelle-de-l-hypertrophie-ventriculaire-gauche-massive-dans-la-cardiomyopathie-hypertrophique-pediatrique/
https://gpcardio.org/fr/2026-07-16_les-deficits-physiologiques-multiorganiques-lors-de-l-exercice-identifient-la-predisposition-clinique-et-moleculaire-a-l-insuffisance-cardiaque-a-fraction-d-ejection-preservee/
https://gpcardio.org/fr/2026-07-18_angiopathie-amyloide-cerebrale/
https://gpcardio.org/fr/2026-07-18_les-ameliorations-cliniques-de-l-anxiete-ou-de-la-depression-sont-elles-associees-a-une-amelioration-de-la-capacite-a-la-marche-apres-un-programme-de-readaptation-cardiaque/
https://gpcardio.org/fr/2026-07-18_resultats-cliniques-de-la-pacification-du-systeme-de-conduction-par-rapport-a-la-pacification-ventriculaire-droite-chez-les-patients-atteints-de-bloc-auriculoventriculaire/
https://gpcardio.org/fr/2026-07-19_abaissement-pharmacologique-de-la-pression-arterielle-pour-la-prevention-des-maladies-cardiovasculaires-et-du-deces-dans-tout-le-spectre-de-severite-de-la-maladie-renale-chronique/
https://gpcardio.org/fr/2026-07-19_traitement-et-resultats-des-inhibiteurs-de-pcsk9-chez-les-patients-atteints-de-maladie-cardiovasculaire-atherosclereuse-mais-sans-antecedent-d-evenements-ischemiques/
https://gpcardio.org/fr/2026-07-21_developpement-d-un-outil-integre-d-evaluation-du-risque-monogenique-et-polygenique-pour-la-maladie-coronarienne-et-son-application-dans-une-biobanque-de-sante-communautaire/
https://gpcardio.org/fr/2026-07-22_prise-en-charge-et-resultats-de-la-fibrillation-auriculaire-postoperatoire-de-novo/
https://gpcardio.org/fr/2026-07-23_l-evolution-naturelle-de-l-hypertrophie-ventriculaire-gauche-massive-dans-la-cardiomyopathie-hypertrophique-pediatrique/
https://gpcardio.org/fr/2026-07-23_les-deficits-physiologiques-multi-organes-pendant-l-exercice-identifient-la-predisposition-clinique-et-moleculaire-a-l-insuffisance-cardiaque-a-fraction-d-ejection-preservee/
https://gpcardio.org/fr/2026-07-24_controle-de-la-pression-arterielle-et-mortalite-parmi-les-anciens-combattants-americains/
https://gpcardio.org/fr/2026-07-24_dysfonction-renale-et-maladie-vasculaire-pulmonaire-dans-l-insuffisance-cardiaque-a-fraction-d-ejection-preservee/
https://gpcardio.org/fr/2026-07-25_lipoproteine-a-proteine-c-reactive-de-haute-sensibilite-et-risque-d-ascvd-incident-chez-les-individus-sans-facteurs-de-risque-modifiables-standard/
https://gpcardio.org/fr/2026-07-26_differences-entre-les-sexes-en-matiere-de-resultats-apres-un-accident-vasculaire-cerebral-ischemique-survenant-malgre-un-traitement-anticoagulant-oral-pour-fibrillation-auriculaire/
https://gpcardio.org/fr/2026-07-26_parcours-de-soins-et-resultats-des-patients-apres-un-diagnostic-recent-de-fibrillation-auriculaire/
https://gpcardio.org/fr/2026-07-27_evaluation-et-prise-en-charge-du-syndrome-metabolique-cardio-reno-hepatique-dans-le-cadre-de-la-medecine-de-premier-recours/
https://gpcardio.org/fr/2026-07-27_phenotypage-des-patients-presentant-une-stenose-aortique-a-bas-debit-et-a-bas-gradient-avec-une-fraction-d-ejection-preservee-subissant-une-tavi/
https://gpcardio.org/fr/2026-07-28_effet-combine-du-niveau-d-education-et-du-diabete-sur-la-mortalite-toutes-causes-confondues-a-1-an-chez-les-patients-insuffisants-cardiaques/
https://gpcardio.org/fr/2026-07-28_epidemiologie-fardeau-economique-et-mortalite-de-la-fibrillation-auriculaire-dans-une-region-a-tres-haute-esperance-de-vie/
https://gpcardio.org/fr/2026-07-28_nouveaux-reins-anciens-risques/
https://gpcardio.org/fr/2026-07-29_gestion-lipidique-dans-le-diabete-de-type-2-et-le-cholesterol-non-hdl/
https://gpcardio.org/fr/2026-07-29_moment-d-exercice-aligne-sur-le-chronotype-chez-les-adultes-d-age-moyen-a-risque-cardiometabolique/
https://gpcardio.org/fr/2026-07-29_ponction-transseptale-dans-les-interventions-cardiovasculaires/
https://gpcardio.org/fr/2026-07-31_differences-entre-les-sexes-dans-le-diagnostic-la-prise-en-charge-et-les-resultats-des-patients-atteints-d-endocardite-infectieuse/
https://gpcardio.org/fr/2026-07-31_resultats-precoces-et-predicteurs-de-mortalite-dans-l-endocardite-de-la-valve-aortique-native/
https://gpcardio.org/fr/2026-08-02_association-entre-la-proteine-c-reactive-et-le-risque-d-insuffisance-cardiaque-incidente-chez-les-survivants-du-cancer/
https://gpcardio.org/fr/2026-08-02_declaration-benefice-cardiovasculaire-avec-une-consommation-habituelle-de-cafe-signal-de-risque-avec-les-boissons-energisantes/
https://gpcardio.org/fr/2026-08-02_l-epccs-renouvelle-son-identite-pour-promouvoir-une-prise-en-charge-cardio-renale-metabolique-integree-en-medecine-de-premier-recours/
https://gpcardio.org/fr/2026-08-02_tendances-en-nephrologie/
https://gpcardio.org/fr/2026-08-03_document-de-consensus-d-experts-de-l-aha-acc-esc-whf/
https://gpcardio.org/fr/2026-08-03_gestion-antithrombotique-des-patients-atteints-de-syndrome-coronarien-chronique-sous-anticoagulation-orale/
https://gpcardio.org/fr/2026-08-04_fragilite-et-insuffisance-cardiaque/
https://gpcardio.org/fr/2026-08-05_differences-entre-les-sexes-dans-le-controle-des-facteurs-de-risque-et-l-observance-medicamenteuse-post-sca/
https://gpcardio.org/fr/2026-08-06_controle-de-la-pression-arterielle-et-mortalite-parmi-les-veterans-americains/
https://gpcardio.org/fr/2026-08-06_la-reduction-de-la-pression-arterielle-systolique-et-de-l-albuminurie-medie-les-benefices-cardiovasculaires-de-la-finerenone-dans-le-diabete-de-type-2-et-la-maladie-renale-chronique/
https://gpcardio.org/fr/2026-08-06_therapies-pharmacologiques-combinees-a-base-de-peptides-hormonaux-pour-les-maladies-metaboliques-chroniques/
https://gpcardio.org/fr/2026-08-10_coeur-et-reins-dans-une-seule-recommandation/
https://gpcardio.org/fr/2026-08-10_inhibition-du-facteur-xi/
https://gpcardio.org/fr/2026-08-10_la-nouvelle-recommandation-de-l-esc-sur-l-insuffisance-cardiaque/
https://gpcardio.org/fr/2026-08-10_les-statines-au-dela-de-soixante-dix-ans/
https://gpcardio.org/fr/a-propos-d-ipccs/
https://gpcardio.org/fr/a-propos-de-l-epccs/
https://gpcardio.org/fr/actualites-de-la-societe/
https://gpcardio.org/fr/actualites-scientifiques/
https://gpcardio.org/fr/cvd-ckd-t2d/
https://gpcardio.org/fr/each/
https://gpcardio.org/fr/epccs-summit/
https://gpcardio.org/fr/epccs-summit/actualite-cardiorenale/
https://gpcardio.org/fr/epccs-summit/gestion-du-risque-cardiovasculaire-en-europe-les-enseignements-des-pays/
https://gpcardio.org/fr/epccs-summit/le-plan-de-l-ue-pour-la-sante-cardiovasculaire/
https://gpcardio.org/fr/epccs-summit/maladies-cardiovasculaires-dans-les-populations-particulieres/
https://gpcardio.org/fr/epccs-summit/prise-en-charge-des-lipides-en-medecine-de-premier-recours/
https://gpcardio.org/fr/epccs-summit/session-d-actualisation-cardiovasculaire-pour-la-medecine-de-premier-recours/
https://gpcardio.org/fr/epccs/
https://gpcardio.org/fr/epccs/societes-partenaires/
https://gpcardio.org/fr/esc-congress-2025/
https://gpcardio.org/fr/gpcardio/
https://gpcardio.org/fr/litterature/
https://gpcardio.org/fr/litterature/
https://gpcardio.org/fr/ncd-academy/
https://gpcardio.org/fr/ressources/
https://gpcardio.org/fr/ressources/actualites-recentes/
https://gpcardio.org/fr/ressources/actualites-video/
https://gpcardio.org/fr/ressources/comptes-rendus-de-reunions/
https://gpcardio.org/fr/ressources/recommandations-pour-la-pratique/
https://gpcardio.org/fr/ressources/stratifyhf/
https://gpcardio.org/fr/symposium-de-l-epccs-tenu-lors-de-wonca-europe-2026-sur-la-maladie-cardio-renale-metabolique/
https://gpcardio.org/fr/wonca-world-2025/
https://gpcardio.org/it/
https://gpcardio.org/it/2014-05-28_guida-pratica-per-i-medici-di-medicina-generale-sull-uso-delle-statine-nelle-persone-a-rischio-di-sviluppare-il-diabete/
https://gpcardio.org/it/2015-01-07_il-documento-guida-dell-epccs-sulla-prevenzione-dell-ictus-nella-fibrillazione-atriale-1/
https://gpcardio.org/it/2015-09-29_un-vivace-dibattito-alla-clinical-masterclass-annuale-dell-epccs-produce-indicazioni-pratiche/
https://gpcardio.org/it/2015-10-02_qual-e-la-base-di-evidenze-per-la-modifica-del-comportamento-di-salute-negli-aggiornamenti-delle-linee-guida/
https://gpcardio.org/it/2015-10-02_qual-e-la-base-di-evidenze-per-la-modifica-della-pressione-arteriosa-negli-aggiornamenti-delle-linee-guida/
https://gpcardio.org/it/2015-10-12_qual-e-la-base-di-evidenze-per-la-modifica-dei-lipidi-negli-aggiornamenti-delle-linee-guida/
https://gpcardio.org/it/2015-10-14_qual-e-la-base-di-evidenze-per-la-diagnosi-e-la-gestione-dell-insufficienza-cardiaca-negli-aggiornamenti-delle-linee-guida/
https://gpcardio.org/it/2016-03-15_qual-e-la-base-di-evidenze-per-la-modifica-dei-lipidi-negli-aggiornamenti-delle-linee-guida/
https://gpcardio.org/it/2016-04-15_identificazione-e-trattamento-dei-pazienti-con-ipertensione-vera/
https://gpcardio.org/it/2016-05-26_la-base-di-evidenze-per-i-cambiamenti-del-comportamento-di-salute/
https://gpcardio.org/it/2016-09-06_linee-guida-di-consenso-epccs-sulla-prevenzione-dell-ictus-nella-fibrillazione-atriale-spaf-nella-medicina-generale/
https://gpcardio.org/it/2016-09-28_documenti-guida-dell-epccs/
https://gpcardio.org/it/2017-03-30_indicazioni-sul-cambiamento-dei-comportamenti-di-salute-qual-e-l-evidenza-cosa-si-raccomanda-e-sono-d-accordo/
https://gpcardio.org/it/2017-04-20_controversie-sui-lipidi-il-ruolo-delle-statine-e-ormai-chiaro-esistono-alternative-e-cosa-c-e-in-sviluppo/
https://gpcardio.org/it/2017-04-20_controversie-sull-ipertensione-quali-sono-le-implicazioni-di-sprint-nel-contesto-dei-recenti-studi-terapeutici/
https://gpcardio.org/it/2017-04-20_gestione-dei-lipidi-cosa-dicono-le-linee-guida-e-quali-sono-le-implicazioni-per-la-medicina-generale/
https://gpcardio.org/it/2017-04-20_gestione-della-fibrillazione-atriale-cosa-dicono-le-linee-guida-e-quali-sono-le-implicazioni-per-la-medicina-generale/
https://gpcardio.org/it/2017-04-20_indicazioni-sul-cambiamento-dei-comportamenti-di-salute-qual-e-l-evidenza-cosa-si-raccomanda-e-sono-d-accordo/
https://gpcardio.org/it/2017-04-20_qual-e-la-nuova-base-di-evidenze-per-la-diagnosi-e-la-gestione-dell-insufficienza-cardiaca/
https://gpcardio.org/it/2017-06-05_elementi-delle-strategie-efficaci-per-promuovere-il-cambiamento-comportamentale/
https://gpcardio.org/it/2017-06-22_in-che-modo-le-ultime-modifiche-alle-linee-guida-influenzano-la-gestione-della-dislipidemia-in-medicina-generale/
https://gpcardio.org/it/2017-07-01_la-guida-epccs-sull-insufficienza-cardiaca-pubblicata-come-clinical-intelligence-sul-br-j-gen-prac/
https://gpcardio.org/it/2017-07-18_la-diagnosi-e-la-gestione-dell-insufficienza-cardiaca-variano-notevolmente-tra-i-paesi-europei/
https://gpcardio.org/it/2017-09-13_cosa-si-puo-imparare-dagli-ultimi-studi-sull-ipertensione/
https://gpcardio.org/it/2017-12-10_guida-pratica-epccs-per-la-diagnosi-e-la-gestione-dell-insufficienza-cardiaca-in-medicina-generale/
https://gpcardio.org/it/2018-02-06_in-che-modo-l-epccs-puo-ampliare-il-numero-dei-propri-iscritti/
https://gpcardio.org/it/2018-02-06_in-che-modo-l-epccs-puo-coinvolgere-meglio-i-medici-di-medicina-generale-nei-diversi-paesi-europei-riguardo-all-educazione-sulle-malattie-cardiovascolari/
https://gpcardio.org/it/2018-02-19_guida-pratica-per-la-diagnosi-e-la-gestione-dell-insufficienza-cardiaca-in-medicina-generale/
https://gpcardio.org/it/2018-02-19_insufficienza-cardiaca-cronica/
https://gpcardio.org/it/2018-02-19_prevenzione-dell-ictus-nei-pazienti-con-fibrillazione-atriale/
https://gpcardio.org/it/2018-02-22_promuovere-cambiamenti-nel-comportamento-di-salute-per-ridurre-il-rischio-cardiovascolare-in-medicina-generale/
https://gpcardio.org/it/2018-02-25_slide-organizzazione-dell-assistenza-primaria-nei-paesi-bassi/
https://gpcardio.org/it/2018-02-26_paesi-bassi-panoramica-dell-assistenza-primaria-cardiovascolare/
https://gpcardio.org/it/2018-02-26_slide-assistenza-primaria-in-bulgaria-nagpb/
https://gpcardio.org/it/2018-02-26_slide-organizzazione-dell-assistenza-primaria-in-slovacchia/
https://gpcardio.org/it/2018-02-26_slovacchia-panoramica-dell-assistenza-primaria-cardiovascolare/
https://gpcardio.org/it/2018-02-27_slide-assistenza-primaria-cardiovascolare-in-spagna/
https://gpcardio.org/it/2018-02-27_slide-organizzazione-dell-assistenza-primaria-in-portogallo/
https://gpcardio.org/it/2018-02-28_bulgaria-assistenza-primaria-cardiovascolare/
https://gpcardio.org/it/2018-02-28_portogallo-panoramica-dell-assistenza-primaria-cardiovascolare/
https://gpcardio.org/it/2018-02-28_slide-assistenza-primaria-cardiovascolare-in-francia/
https://gpcardio.org/it/2018-02-28_spagna-panoramica-dell-assistenza-primaria-cardiovascolare/
https://gpcardio.org/it/2018-03-01_francia-panoramica-dell-assistenza-primaria-cardiovascolare/
https://gpcardio.org/it/2018-03-01_grecia-panoramica-dell-assistenza-primaria-cardiovascolare/
https://gpcardio.org/it/2018-03-01_romania-panoramica-dell-assistenza-primaria-cardiovascolare/
https://gpcardio.org/it/2018-03-01_slide-assistenza-primaria-cardiovascolare-in-grecia/
https://gpcardio.org/it/2018-03-01_slide-assistenza-primaria-cardiovascolare-in-romania/
https://gpcardio.org/it/2018-03-02_germania-panoramica-dell-assistenza-primaria-cardiovascolare/
https://gpcardio.org/it/2018-03-02_slide-assistenza-primaria-cardiovascolare-in-germania/
https://gpcardio.org/it/2018-03-13_linea-guida-concordata-dell-epccs-sulla-prevenzione-dell-ictus-nella-fibrillazione-atriale-nell-assistenza-medica-primaria/
https://gpcardio.org/it/2018-03-27_arteriopatia-degli-arti-inferiori-una-malattia-cv-maggiore-trascurata/
https://gpcardio.org/it/2018-03-27_promozione-dei-cambiamenti-comportamentali-per-la-salute-al-fine-di-ridurre-il-rischio-cardiovascolare-nell-assistenza-medica-primaria/
https://gpcardio.org/it/2018-03-28_diabete-e-malattia-vascolare-epidemiologia-e-opzioni-di-gestione/
https://gpcardio.org/it/2018-04-04_gestione-dei-lipidi-elevati-e-delle-statine-il-buono-il-brutto-e-il-cattivo/
https://gpcardio.org/it/2018-04-04_slide-aggiornamento-su-diabete-di-tipo-2-e-malattia-cardiovascolare/
https://gpcardio.org/it/2018-04-04_slide-gestione-dell-insufficienza-cardiaca-complessa-una-prospettiva-specialistica-dell-interfaccia-primaria-secondaria/
https://gpcardio.org/it/2018-04-04_slide-gestione-dell-insufficienza-cardiaca-nella-medicina-generale-la-prospettiva-del-medico-di-medicina-generale/
https://gpcardio.org/it/2018-04-04_slide-ipertensione-possiamo-concordare-sulle-soglie-diagnostiche-e-terapeutiche/
https://gpcardio.org/it/2018-04-04_slide-malattia-arteriosa-degli-arti-inferiori-una-malattia-cardiovascolare-maggiore-trascurata-diagnosi-e-gestione-clinica-nella-medicina-generale/
https://gpcardio.org/it/2018-04-04_slide-riduzione-dei-lipidi-l-evidenza-le-linee-guida-la-realta-clinica/
https://gpcardio.org/it/2018-04-04_slide-workshop-pratico-sull-abpm/
https://gpcardio.org/it/2018-04-10_complessita-nella-gestione-dell-insufficienza-cardiaca-nella-medicina-generale/
https://gpcardio.org/it/2018-04-10_ipertensione-possiamo-concordare-sulle-soglie-diagnostiche-e-terapeutiche/
https://gpcardio.org/it/2018-04-24_gestione-del-rischio-cardiovascolare-associato-al-t2dm-alla-luce-delle-nuove-opzioni-terapeutiche/
https://gpcardio.org/it/2018-05-16_assistenza-cardiovascolare-di-base-in-italia/
https://gpcardio.org/it/2018-05-16_slide-medicina-generale-in-italia/
https://gpcardio.org/it/2018-05-22_riduzione-dei-lipidi-l-evidenza-le-linee-guida-la-realta-clinica/
https://gpcardio.org/it/2018-06-15_semergen-la-societa-decana-della-medicina-di-famiglia-in-spagna/
https://gpcardio.org/it/2018-06-15_semergen-societa-spagnola-dei-medici-di-assistenza-primaria/
https://gpcardio.org/it/2018-06-19_spagna-introduzione-all-epccs/
https://gpcardio.org/it/2018-07-18_complessita-nella-gestione-dell-insufficienza-cardiaca/
https://gpcardio.org/it/2018-08-16_ipertensione-possiamo-concordare-sulle-soglie-diagnostiche-e-terapeutiche/
https://gpcardio.org/it/2018-08-22_gestione-dei-lipidi-elevati-nella-medicina-generale/
https://gpcardio.org/it/2018-10-22_gestione-della-dislipidemia-nell-assistenza-medica-primaria/
https://gpcardio.org/it/2018-10-22_guida-pratica-per-la-diagnosi-e-il-trattamento-dell-insufficienza-cardiaca-nell-assistenza-sanitaria-primaria/
https://gpcardio.org/it/2018-10-22_medico-di-medicina-generale-in-danimarca/
https://gpcardio.org/it/2018-10-22_promozione-dei-cambiamenti-dello-stile-di-vita-per-ridurre-il-rischio-cardiovascolare-nell-asp/
https://gpcardio.org/it/2018-10-23_prevenzione-delle-malattie-cardiovascolari-non-trasmissibili-nella-medicina-generale-in-russia/
https://gpcardio.org/it/2018-10-25_gestione-dei-lipidi-elevati-nell-assistenza-sanitaria-primaria/
https://gpcardio.org/it/2018-10-30_modi-per-incoraggiare-i-cambiamenti-comportamentali-per-ridurre-il-rischio-cardiovascolare-nella-medicina-generale/
https://gpcardio.org/it/2018-12-03_assistenza-cardiovascolare-di-base-in-serbia-inglese/
https://gpcardio.org/it/2018-12-04_assistenza-cardiovascolare-di-base-in-montenegro-inglese/
https://gpcardio.org/it/2018-12-04_assistenza-cardiovascolare-di-base-in-serbia-serbo/
https://gpcardio.org/it/2018-12-04_assistenza-cardiovascolare-di-base-in-ucraina-inglese/
https://gpcardio.org/it/2018-12-04_assistenza-cardiovascolare-di-base-in-ucraina-ucraino/
https://gpcardio.org/it/2018-12-04_assistenza-cardiovascolare-di-base-nella-repubblica-ceca-ceco/
https://gpcardio.org/it/2018-12-04_assistenza-cardiovascolare-di-base-nella-repubblica-ceca-inglese/
https://gpcardio.org/it/2018-12-05_assistenza-cardiovascolare-di-base-in-belgio-fiammingo/
https://gpcardio.org/it/2018-12-05_assistenza-cardiovascolare-di-base-in-belgio-inglese/
https://gpcardio.org/it/2018-12-05_assistenza-cardiovascolare-di-base-in-polonia-inglese/
https://gpcardio.org/it/2018-12-05_assistenza-cardiovascolare-di-base-in-polonia-polacco/
https://gpcardio.org/it/2018-12-05_assistenza-cardiovascolare-di-base-in-slovacchia-inglese/
https://gpcardio.org/it/2018-12-05_assistenza-cardiovascolare-di-base-in-slovacchia-slovacco/
https://gpcardio.org/it/2018-12-07_assistenza-cardiovascolare-di-base-in-germania-inglese/
https://gpcardio.org/it/2018-12-07_assistenza-cardiovascolare-di-base-in-germania-tedesco/
https://gpcardio.org/it/2018-12-10_assistenza-cardiovascolare-di-base-in-irlanda-inglese/
https://gpcardio.org/it/2018-12-10_assistenza-cardiovascolare-di-base-in-turchia-turco/
https://gpcardio.org/it/2018-12-13_assistenza-cardiovascolare-di-base-in-turchia-inglese/
https://gpcardio.org/it/2018-12-17_assistenza-cardiovascolare-di-base-in-danimarca-danese/
https://gpcardio.org/it/2018-12-17_assistenza-cardiovascolare-di-base-in-danimarca-inglese/
https://gpcardio.org/it/2018-12-17_assistenza-cardiovascolare-di-base-in-montenegro-montenegrino/
https://gpcardio.org/it/2018-12-17_assistenza-cardiovascolare-di-base-in-romania-rumeno/
https://gpcardio.org/it/2018-12-17_assistenza-cardiovascolare-di-base-in-spagna-inglese/
https://gpcardio.org/it/2018-12-17_assistenza-cardiovascolare-di-base-in-spagna-spagnolo/
https://gpcardio.org/it/2018-12-18_slide-messaggi-chiave-della-linea-guida-epccs-su-gestione-dei-lipidi-elevati-nella-medicina-generale/
https://gpcardio.org/it/2019-01-10_assistenza-cardiovascolare-di-base-in-spagna-inglese/
https://gpcardio.org/it/2019-01-10_assistenza-cardiovascolare-di-base-in-spagna-spagnolo/
https://gpcardio.org/it/2019-02-07_societa-epccs-cosa-e-disponibile-per-i-membri/
https://gpcardio.org/it/2019-02-25_gestione-attuale-del-diabete-e-del-rischio-cardiovascolare-nella-medicina-generale/
https://gpcardio.org/it/2019-03-28_aggiornamento-sulla-prevenzione-dell-ictus-nella-fibrillazione-atriale/
https://gpcardio.org/it/2019-03-28_come-affrontare-le-sfide-della-multimorbilita-nella-pratica-di-medicina-generale/
https://gpcardio.org/it/2019-03-28_diabete-e-rischio-cardiovascolare/
https://gpcardio.org/it/2019-04-02_slide-aggiornamenti-recenti-alle-linee-guida-internazionali-sull-ipertensione-dove-differiscono-e-su-cosa-dovremmo-concordare-nella-medicina-generale/
https://gpcardio.org/it/2019-04-02_slide-aggiornamento-sulla-prevenzione-dell-ictus-nella-fibrillazione-atriale/
https://gpcardio.org/it/2019-04-02_slide-complessita-nella-gestione-dell-insufficienza-cardiaca/
https://gpcardio.org/it/2019-04-02_slide-cvd-e-salute-mentale/
https://gpcardio.org/it/2019-04-02_slide-diabete-e-rischio-cardiovascolare/
https://gpcardio.org/it/2019-04-02_slide-multimorbilita-malattia-cardiovascolare-e-politerapia/
https://gpcardio.org/it/2019-04-02_slide-quali-evidenze-dimostrano-che-il-diabete-e-collegato-al-rischio-di-cvd/
https://gpcardio.org/it/2019-04-03_complessita-nella-gestione-dell-insufficienza-cardiaca/
https://gpcardio.org/it/2019-04-24_aggiornamenti-recenti-alle-linee-guida-internazionali-sull-ipertensione-dove-differiscono-e-su-cosa-dovremmo-concordare-nella-medicina-generale/
https://gpcardio.org/it/2019-04-25_formazione-scambio-orientamento-e-interazione-durante-il-summit-epccs-2019/
https://gpcardio.org/it/2019-05-02_slide-affrontare-le-cvd-nel-diabete-nuove-strategie-per-contrastare-il-rischio/
https://gpcardio.org/it/2019-05-02_slide-diabete-di-tipo-2-ed-esiti-cardiovascolari-piu-della-semplice-gestione-della-glicemia-lezioni-dagli-studi-sugli-ar-glp1/
https://gpcardio.org/it/2019-05-02_slide-gestione-del-diabete-nella-pratica-cardiovascolare-quotidiana-un-approccio-multidisciplinare/
https://gpcardio.org/it/2019-05-07_prevenzione-dell-ictus-nella-fibrillazione-atriale/
https://gpcardio.org/it/2019-05-21_aggiornamento-sulla-gestione-del-rischio-cardiovascolare-nel-diabete-qual-e-l-evidenza/
https://gpcardio.org/it/2019-06-18_nuovo-algoritmo-diagnostico-e-opzioni-terapeutiche-nella-gestione-dell-hf/
https://gpcardio.org/it/2019-08-13_slide-messaggi-chiave-della-linea-guida-epccs-sulla-gestione-attuale-del-diabete-e-del-rischio-cardiovascolare-nella-medicina-generale/
https://gpcardio.org/it/2019-08-29_diagnosi-e-gestione-dell-ipertensione-nella-medicina-generale/
https://gpcardio.org/it/2019-10-02_l-espansione-dell-epccs-nei-paesi-europei-cosa-ci-riserva-il-futuro/
https://gpcardio.org/it/2019-10-03_come-l-epccs-mira-ad-aiutare-i-medici-di-medicina-generale-in-tutta-europa-a-riconoscere-e-gestire-il-rischio-cardiovascolare-greco/
https://gpcardio.org/it/2019-10-03_epccs-e-l-assistenza-cardiovascolare-di-base-in-serbia/
https://gpcardio.org/it/2019-10-03_epccs-e-l-assistenza-cardiovascolare-di-base-in-slovacchia-inglese/
https://gpcardio.org/it/2019-10-03_epccs-e-l-assistenza-cardiovascolare-di-base-in-slovacchia-slovacco/
https://gpcardio.org/it/2019-10-03_epccs-e-l-assistenza-cardiovascolare-di-base-in-spagna-inglese/
https://gpcardio.org/it/2019-10-03_epccs-e-l-assistenza-cardiovascolare-di-base-in-spagna-spagnolo/
https://gpcardio.org/it/2019-10-09_come-l-epccs-mira-ad-aiutare-i-medici-di-medicina-generale-in-tutta-europa-a-riconoscere-e-gestire-il-rischio-cardiovascolare-inglese/
https://gpcardio.org/it/2019-10-29_diagnosi-e-gestione-dell-ipertensione-nella-medicina-generale-riassunto-in-francese/
https://gpcardio.org/it/2019-10-29_diagnosi-e-gestione-dell-ipertensione-nella-medicina-generale-riassunto-in-greco/
https://gpcardio.org/it/2019-10-29_diagnosi-e-gestione-dell-ipertensione-nella-medicina-generale-riassunto-in-ucraino/
https://gpcardio.org/it/2019-10-29_diagnosi-e-trattamento-dell-ipertensione-nell-assistenza-sanitaria-primaria-riassunto-in-serbo-della-linea-guida-epccs-sull-ipertensione/
https://gpcardio.org/it/2019-10-29_societa-greche-coinvolte-nella-medicina-generale/
https://gpcardio.org/it/2019-10-29_societe-francaise-de-medecine-generale-sfmg/
https://gpcardio.org/it/2019-11-04_epccs-e-l-assistenza-cardiovascolare-di-base-in-francia/
https://gpcardio.org/it/2019-11-04_epccs-e-l-assistenza-cardiovascolare-di-base-in-irlanda/
https://gpcardio.org/it/2019-11-04_epccs-e-l-assistenza-cardiovascolare-di-base-in-polonia-inglese/
https://gpcardio.org/it/2019-11-04_epccs-e-l-assistenza-cardiovascolare-di-base-in-polonia-polacco/
https://gpcardio.org/it/2019-11-04_epccs-e-l-assistenza-cardiovascolare-di-base-in-turchia/
https://gpcardio.org/it/2019-11-04_epccs-e-l-assistenza-cardiovascolare-di-base-in-ucraina/
https://gpcardio.org/it/2019-11-12_insufficienza-cardiaca-e-comorbilita-malattia-renale-e-cancro/
https://gpcardio.org/it/2020-04-09_strategia-invasiva-o-conservativa-iniziale-per-la-malattia-coronarica-stabile/
https://gpcardio.org/it/2020-04-14_effetto-di-dapagliflozin-sul-peggioramento-dell-insufficienza-cardiaca-e-sulla-morte-cardiovascolare-in-pazienti-con-insufficienza-cardiaca-con-e-senza-diabete/
https://gpcardio.org/it/2020-04-16_due-studi-di-fase-3-su-inclisiran-in-pazienti-con-colesterolo-ldl-elevato/
https://gpcardio.org/it/2020-04-16_inclisiran-per-il-trattamento-dell-ipercolesterolemia-familiare-eterozigote/
https://gpcardio.org/it/2020-04-23_gestione-della-malattia-coronarica-in-pazienti-con-malattia-renale-avanzata/
https://gpcardio.org/it/2020-04-25_clopidogrel-rispetto-a-ticagrelor-o-prasugrel-in-pazienti-di-eta-pari-o-superiore-a-70-anni-con-sindrome-coronarica-acuta-senza-sopraslivellamento-del-tratto-st-popular-age/
https://gpcardio.org/it/2020-05-01_regimi-antitrombotici-ottimali-per-pazienti-con-fibrillazione-atriale-sottoposti-a-intervento-coronarico-percutaneo/
https://gpcardio.org/it/2020-05-02_efficacia-della-denervazione-renale-basata-su-catetere-in-assenza-di-farmaci-antipertensivi-spyral-htn-off-med-pivotal/
https://gpcardio.org/it/2020-05-05_esiti-a-dieci-anni-dopo-stent-a-rilascio-di-farmaco-rispetto-a-bypass-aortocoronarico-per-malattia-del-tronco-comune-sinistro/
https://gpcardio.org/it/2020-05-09_monoterapia-con-un-inibitore-di-p2y12-o-aspirina-per-la-prevenzione-secondaria-in-pazienti-con-aterosclerosi-accertata/
https://gpcardio.org/it/2020-05-12_gestione-clinica-della-malattia-coronarica-stabile-in-pazienti-con-diabete-mellito-di-tipo-2/
https://gpcardio.org/it/2020-05-14_vericiguat-in-pazienti-con-insufficienza-cardiaca-e-frazione-di-eiezione-ridotta/
https://gpcardio.org/it/2020-05-19_associazione-tra-riduzione-della-pressione-arteriosa-e-demenza-incidente-o-compromissione-cognitiva/
https://gpcardio.org/it/2020-05-26_effetto-della-riduzione-dei-farmaci-antipertensivi-rispetto-alle-cure-abituali-sul-controllo-a-breve-termine-della-pressione-arteriosa-in-pazienti-con-ipertensione-di-eta-pari-o-superiore-a-80-anni/
https://gpcardio.org/it/2020-05-26_prevalenza-mondiale-dell-ipercolesterolemia-familiare/
https://gpcardio.org/it/2020-06-16_effetto-della-monoterapia-con-ticagrelor-rispetto-a-ticagrelor-con-aspirina-sul-sanguinamento-maggiore-e-sugli-eventi-cardiovascolari-in-pazienti-con-sindrome-coronarica-acuta/
https://gpcardio.org/it/2020-07-07_riconoscimento-prognosi-e-terapia-dell-amiloidosi-sistemica/
https://gpcardio.org/it/2020-07-11_stima-dei-benefici-a-vita-delle-terapie-farmacologiche-modificanti-la-malattia-complete-in-pazienti-con-insufficienza-cardiaca-con-frazione-di-eiezione-ridotta/
https://gpcardio.org/it/2020-07-14_associazione-tra-graft-di-arteria-radiale-e-graft-di-vena-safena-con-gli-esiti-cardiovascolari-a-lungo-termine-in-pazienti-sottoposti-a-bypass-aortocoronarico/
https://gpcardio.org/it/2020-07-14_efficacia-e-sicurezza-comparative-degli-inibitori-orali-di-p2y12-nella-sindrome-coronarica-acuta/
https://gpcardio.org/it/2020-08-01_rivascolarizzazione-completa-rispetto-alla-rivascolarizzazione-limitata-alla-lesione-colpevole-nell-infarto-miocardico-con-sopraslivellamento-del-tratto-st/
https://gpcardio.org/it/2020-08-04_percorso-decisionale-del-consenso-di-esperti-acc-2020-sulla-gestione-del-sanguinamento-in-pazienti-in-trattamento-con-anticoagulanti-orali/
https://gpcardio.org/it/2020-08-07_gestione-integrata-della-fibrillazione-atriale-nella-medicina-generale/
https://gpcardio.org/it/2020-08-11_sicurezza-ed-efficacia-della-sospensione-dell-aspirina-in-presenza-di-un-inibitore-di-p2y12-in-pazienti-dopo-intervento-coronarico-percutaneo/
https://gpcardio.org/it/2020-08-20_evinacumab-per-l-ipercolesterolemia-familiare-omozigote/
https://gpcardio.org/it/2020-08-25_effetto-della-selezione-di-inibitori-orali-di-p2y12-guidata-dal-genotipo-rispetto-alla-terapia-convenzionale-con-clopidogrel-sugli-esiti-ischemici-dopo-intervento-coronarico-percutaneo/
https://gpcardio.org/it/2020-09-01_percorso-decisionale-del-consenso-di-esperti-2020-sulle-nuove-terapie-per-la-riduzione-del-rischio-cardiovascolare-in-pazienti-con-diabete-di-tipo-2/
https://gpcardio.org/it/2020-09-07_mortalita-dopo-stent-a-rilascio-di-farmaco-rispetto-al-bypass-aortocoronarico-per-la-malattia-del-tronco-comune-sinistro/
https://gpcardio.org/it/2020-09-14_effetti-degli-agonisti-del-recettore-del-peptide-1-glucagone-simile-sugli-eventi-cardiovascolari-maggiori-in-pazienti-con-diabete-mellito-di-tipo-2-con-o-senza-malattia-cardiovascolare-accertata/
https://gpcardio.org/it/2020-09-19_inibitori-di-sglt2-in-pazienti-con-insufficienza-cardiaca-con-frazione-di-eiezione-ridotta/
https://gpcardio.org/it/2020-10-01_evolocumab-nell-ipercolesterolemia-familiare-eterozigote-pediatrica/
https://gpcardio.org/it/2020-10-01_storia-naturale-della-stenosi-aortica-severa-asintomatica-e-associazione-dell-intervento-precoce-con-gli-esiti/
https://gpcardio.org/it/2020-10-01_terapia-precoce-di-controllo-del-ritmo-in-pazienti-con-fibrillazione-atriale/
https://gpcardio.org/it/2020-10-08_dapagliflozin-in-pazienti-con-malattia-renale-cronica/
https://gpcardio.org/it/2020-10-08_esiti-cardiovascolari-con-ertugliflozin-nel-diabete-di-tipo-2/
https://gpcardio.org/it/2020-10-08_esiti-cardiovascolari-e-renali-con-empagliflozin-nell-insufficienza-cardiaca/
https://gpcardio.org/it/2020-10-10_de-escalation-basata-su-prasugrel-della-doppia-terapia-antiaggregante-dopo-intervento-coronarico-percutaneo-in-pazienti-con-sindrome-coronarica-acuta-host-reduce-polytech-acs/
https://gpcardio.org/it/2020-10-13_doppia-terapia-antiaggregante-dopo-intervento-coronarico-percutaneo-e-stent-a-rilascio-di-farmaco/
https://gpcardio.org/it/2020-10-29_edoxaban-a-basso-dosaggio-in-pazienti-molto-anziani-con-fibrillazione-atriale/
https://gpcardio.org/it/2020-10-31_rielaborazione-e-validazione-del-punteggio-syntax-ii-per-individualizzare-il-processo-decisionale-tra-rivascolarizzazione-percutanea-e-chirurgica-in-pazienti-con-malattia-coronarica-complessa/
https://gpcardio.org/it/2020-11-07_la-rivascolarizzazione-completa-riduce-la-morte-cardiovascolare-in-pazienti-con-infarto-miocardico-con-sopraslivellamento-del-tratto-st-e-malattia-multivasale/
https://gpcardio.org/it/2020-11-10_screening-per-l-ipertensione-arteriosa-nei-bambini-e-negli-adolescenti/
https://gpcardio.org/it/2020-11-17_colchicina-in-pazienti-con-sindrome-coronarica-acuta/
https://gpcardio.org/it/2020-11-21_efficacia-e-sicurezza-della-riduzione-del-colesterolo-ldl-nei-pazienti-anziani/
https://gpcardio.org/it/2020-11-21_la-riduzione-della-lipoproteina-a-mediante-alirocumab-riduce-il-carico-totale-di-eventi-cardiovascolari-indipendentemente-dalla-riduzione-del-colesterolo-delle-lipoproteine-a-bassa-densita/
https://gpcardio.org/it/2020-11-26_rivaroxaban-in-pazienti-con-fibrillazione-atriale-e-valvola-mitrale-bioprotesica/
https://gpcardio.org/it/2020-11-26_studio-n-of-1-con-statina-placebo-o-nessun-trattamento-per-valutare-gli-effetti-collaterali/
https://gpcardio.org/it/2020-12-08_effetto-degli-acidi-grassi-omega-3-ad-alto-dosaggio-rispetto-all-olio-di-mais-sugli-eventi-cardiovascolari-avversi-maggiori-in-pazienti-ad-alto-rischio-cardiovascolare/
https://gpcardio.org/it/2020-12-10_evinacumab-in-pazienti-con-ipercolesterolemia-refrattaria/
https://gpcardio.org/it/2020-12-12_carbossimaltosio-ferrico-per-la-carenza-di-ferro-alla-dimissione-dopo-insufficienza-cardiaca-acuta/
https://gpcardio.org/it/2020-12-22_effetto-della-digossina-rispetto-al-bisoprololo-per-il-controllo-della-frequenza-cardiaca-nella-fibrillazione-atriale-sulla-qualita-della-vita-riferita-dal-paziente/
https://gpcardio.org/it/2021-01-14_attivazione-della-miosina-cardiaca-con-omecamtiv-mecarbil-nell-insufficienza-cardiaca-sistolica/
https://gpcardio.org/it/2021-01-14_sotagliflozin-in-pazienti-con-diabete-e-malattia-renale-cronica/
https://gpcardio.org/it/2021-01-14_sotagliflozin-in-pazienti-con-diabete-e-recente-peggioramento-dell-insufficienza-cardiaca/
https://gpcardio.org/it/2021-01-21_doppia-terapia-antiaggregante-breve-seguita-da-monoterapia-con-inibitore-di-p2y12-rispetto-a-doppia-terapia-antiaggregante-prolungata-dopo-intervento-coronarico-percutaneo-con-stent-a-rilascio-di-farm/
https://gpcardio.org/it/2021-01-21_polipillola-con-o-senza-aspirina-in-persone-senza-malattia-cardiovascolare/
https://gpcardio.org/it/2021-01-26_studio-randomizzato-di-empagliflozin-in-pazienti-non-diabetici-con-insufficienza-cardiaca-e-frazione-di-eiezione-ridotta/
https://gpcardio.org/it/2021-01-28_ablazione-con-criopallone-come-terapia-iniziale-per-la-fibrillazione-atriale/
https://gpcardio.org/it/2021-01-28_crioablazione-o-terapia-farmacologica-per-il-trattamento-iniziale-della-fibrillazione-atriale/
https://gpcardio.org/it/2021-01-28_treprostinil-inalato-nell-ipertensione-polmonare-dovuta-a-malattia-polmonare-interstiziale/
https://gpcardio.org/it/2021-02-01_associazione-degli-inibitori-di-sglt2-con-gli-esiti-cardiovascolari-e-renali-in-pazienti-con-diabete-di-tipo-2/
https://gpcardio.org/it/2021-02-09_effetto-dell-allenamento-a-intervalli-ad-alta-intensita-dell-allenamento-continuo-moderato-o-della-consulenza-sull-attivita-fisica-basata-sulle-linee-guida-sul-consumo-di-ossigeno-di-picco-in-pazienti/
https://gpcardio.org/it/2021-02-09_finerenone-ed-esiti-cardiovascolari-in-pazienti-con-malattia-renale-cronica-e-diabete-di-tipo-2/
https://gpcardio.org/it/2021-02-09_percorso-decisionale-del-consenso-di-esperti-acc-2020-per-la-terapia-anticoagulante-e-antiaggregante-in-pazienti-con-fibrillazione-atriale-o-tromboembolismo-venoso-sottoposti-a-intervento-coronarico-p/
https://gpcardio.org/it/2021-02-16_aggiornamento-2021-al-percorso-decisionale-del-consenso-di-esperti-acc-2017-per-l-ottimizzazione-del-trattamento-dell-insufficienza-cardiaca/
https://gpcardio.org/it/2021-03-02_risultati-a-3-anni-della-riparazione-transcatetere-della-valvola-mitrale-in-pazienti-con-insufficienza-cardiaca/
https://gpcardio.org/it/2021-03-16_effetto-della-supplementazione-con-acidi-grassi-omega-3-marini-e-vitamina-d-sulla-fibrillazione-atriale-incidente/
https://gpcardio.org/it/2021-03-31_effetti-di-dapagliflozin-sulla-mortalita-in-pazienti-con-malattia-renale-cronica/
https://gpcardio.org/it/2021-04-07_linee-guida-esc-2020-per-la-gestione-delle-sindromi-coronariche-acute-in-pazienti-che-si-presentano-senza-sopraslivellamento-persistente-del-tratto-st/
https://gpcardio.org/it/2021-04-17_terapia-antiaggregante-guidata-rispetto-a-standard-in-pazienti-sottoposti-a-intervento-coronarico-percutaneo/
https://gpcardio.org/it/2021-05-01_riduzione-farmacologica-della-pressione-arteriosa-per-la-prevenzione-primaria-e-secondaria-della-malattia-cardiovascolare-a-diversi-livelli-di-pressione-arteriosa/
https://gpcardio.org/it/2021-05-05_i-beta-bloccanti-causano-depressione/
https://gpcardio.org/it/2021-05-20_rapporto-finale-di-uno-studio-sul-controllo-intensivo-rispetto-a-standard-della-pressione-arteriosa/
https://gpcardio.org/it/2021-05-27_efficacia-comparativa-del-dosaggio-di-aspirina-nella-malattia-cardiovascolare/
https://gpcardio.org/it/2021-06-01_valutazione-dell-ablazione-con-catetere-o-dei-farmaci-antiaritmici-come-terapia-di-prima-linea-della-fibrillazione-atriale/
https://gpcardio.org/it/2021-06-03_occlusione-dell-auricola-sinistra-durante-la-chirurgia-cardiaca-per-prevenire-l-ictus/
https://gpcardio.org/it/2021-06-26_aspirina-rispetto-a-clopidogrel-per-la-monoterapia-cronica-di-mantenimento-dopo-intervento-coronarico-percutaneo-host-exam/
https://gpcardio.org/it/2021-06-26_denervazione-renale-a-ultrasuoni-per-l-ipertensione-resistente-a-una-pillola-con-tripla-combinazione-di-farmaci-radiance-htn-trio/
https://gpcardio.org/it/2021-07-10_efficacia-e-sicurezza-di-un-nuovo-agonista-duale-del-recettore-gip-e-glp-1-tirzepatide-in-pazienti-con-diabete-di-tipo-2-surpass-1/
https://gpcardio.org/it/2021-07-15_riabilitazione-fisica-per-pazienti-anziani-ospedalizzati-per-insufficienza-cardiaca/
https://gpcardio.org/it/2021-07-21_efficacia-e-sicurezza-della-colchicina-a-basso-dosaggio-in-pazienti-con-malattia-coronarica/
https://gpcardio.org/it/2021-07-22_pci-multivaso-guidata-da-ffr-o-angiografia-per-l-infarto-miocardico/
https://gpcardio.org/it/2021-08-05_milrinone-a-confronto-con-dobutamina-nel-trattamento-dello-shock-cardiogeno/
https://gpcardio.org/it/2021-08-14_tirzepatide-una-volta-alla-settimana-rispetto-a-insulina-degludec-una-volta-al-giorno-come-terapia-aggiuntiva-alla-metformina-con-o-senza-inibitori-di-sglt2-in-pazienti-con-diabete-di-tipo-2-surpass-3/
https://gpcardio.org/it/2021-08-17_riduzione-del-colesterolo-della-pressione-arteriosa-o-di-entrambi-per-prevenire-gli-eventi-cardiovascolari/
https://gpcardio.org/it/2021-08-31_percorso-decisionale-del-consenso-di-esperti-acc-2021-per-la-gestione-della-riduzione-del-rischio-ascvd-in-pazienti-con-ipertrigliceridemia-persistente/
https://gpcardio.org/it/2021-09-02_esiti-cardiovascolari-e-renali-con-efpeglenatide-nel-diabete-di-tipo-2/
https://gpcardio.org/it/2021-09-11_gestione-guidata-dall-emodinamica-dell-insufficienza-cardiaca-guide-hf/
https://gpcardio.org/it/2021-09-16_effetto-della-sostituzione-del-sale-sugli-eventi-cardiovascolari-e-sulla-morte/
https://gpcardio.org/it/2021-09-18_trattamento-iniziale-con-una-singola-pillola-contenente-una-combinazione-quadrupla-di-un-quarto-della-dose-di-farmaci-per-la-pressione-arteriosa-rispetto-alla-monoterapia-a-dose-standard-in-pazienti-c/
https://gpcardio.org/it/2021-09-30_studio-sul-controllo-intensivo-della-pressione-arteriosa-in-pazienti-anziani-con-ipertensione/
https://gpcardio.org/it/2021-10-09_de-escalation-non-guidata-da-ticagrelor-a-clopidogrel-in-pazienti-stabilizzati-con-infarto-miocardico-acuto-sottoposti-a-intervento-coronarico-percutaneo-talos-ami/
https://gpcardio.org/it/2021-10-14_empagliflozin-ed-esiti-renali-maggiori-nell-insufficienza-cardiaca/
https://gpcardio.org/it/2021-10-14_empagliflozin-nell-insufficienza-cardiaca-con-frazione-di-eiezione-preservata/
https://gpcardio.org/it/2021-10-19_effetto-di-empagliflozin-sugli-eventi-di-peggioramento-dell-insufficienza-cardiaca-in-pazienti-con-insufficienza-cardiaca-e-frazione-di-eiezione-preservata/
https://gpcardio.org/it/2021-10-23_esiti-clinici-dello-screening-sistematico-per-la-fibrillazione-atriale-strokestop/
https://gpcardio.org/it/2021-10-28_doppia-terapia-antiaggregante-dopo-pci-in-pazienti-ad-alto-rischio-emorragico/
https://gpcardio.org/it/2021-11-02_vaccinazione-antinfluenzale-dopo-l-infarto-miocardico/
https://gpcardio.org/it/2021-11-11_inibizione-del-recettore-dell-angiotensina-e-della-neprilisina-nell-infarto-miocardico-acuto/
https://gpcardio.org/it/2021-11-13_riduzione-della-pressione-arteriosa-e-rischio-di-diabete-di-tipo-2-di-nuova-insorgenza/
https://gpcardio.org/it/2021-11-13_tirzepatide-rispetto-a-insulina-glargine-nel-diabete-di-tipo-2-e-aumentato-rischio-cardiovascolare-surpass-4/
https://gpcardio.org/it/2021-12-02_edoxaban-rispetto-ad-antagonista-della-vitamina-k-per-la-fibrillazione-atriale-dopo-tavr/
https://gpcardio.org/it/2021-12-04_pericardiotomia-posteriore-sinistra-per-la-prevenzione-della-fibrillazione-atriale-dopo-chirurgia-cardiaca/
https://gpcardio.org/it/2021-12-07_ablazione-della-giunzione-av-e-resincronizzazione-cardiaca-in-pazienti-con-fibrillazione-atriale-permanente-e-qrs-stretto/
https://gpcardio.org/it/2021-12-09_eventi-cardiovascolari-con-finerenone-nella-malattia-renale-e-nel-diabete-di-tipo-2/
https://gpcardio.org/it/2021-12-11_intervento-coronarico-guidato-dal-rapporto-di-flusso-quantitativo-angiografico-favor-iii-china/
https://gpcardio.org/it/2021-12-18_intervento-coronarico-percutaneo-con-stent-a-rilascio-di-farmaco-rispetto-al-bypass-aortocoronarico-nella-malattia-del-tronco-comune-sinistro/
https://gpcardio.org/it/2021-12-21_effetto-della-supplementazione-a-lungo-termine-con-acidi-grassi-omega-3-marini-sul-rischio-di-fibrillazione-atriale-negli-studi-randomizzati-controllati-sugli-esiti-cardiovascolari/
https://gpcardio.org/it/2021-12-30_angiografia-dopo-arresto-cardiaco-extraospedaliero-senza-sopraslivellamento-del-tratto-st/
https://gpcardio.org/it/2021-12-30_clortalidone-per-l-ipertensione-nella-malattia-renale-cronica-avanzata/
https://gpcardio.org/it/2022-01-13_pci-guidata-dalla-riserva-di-flusso-frazionaria-rispetto-al-bypass-aortocoronarico/
https://gpcardio.org/it/2022-01-18_linea-guida-2021-acc-aha-scai-per-la-rivascolarizzazione-coronarica/
https://gpcardio.org/it/2022-01-25_anticoagulanti-orali-diretti-rispetto-al-warfarin-in-pazienti-con-fibrillazione-atriale/
https://gpcardio.org/it/2022-01-25_screening-per-la-fibrillazione-atriale/
https://gpcardio.org/it/2022-02-08_il-finerenone-riduce-il-rischio-di-insufficienza-cardiaca-incidente-in-pazienti-con-malattia-renale-cronica-e-diabete-di-tipo-2/
https://gpcardio.org/it/2022-02-10_esiti-cardiovascolari-e-renali-con-finerenone-in-pazienti-con-diabete-di-tipo-2-e-malattia-renale-cronica/
https://gpcardio.org/it/2022-03-07_effetti-comparativi-della-terapia-guidata-rispetto-alla-terapia-potente-con-inibitori-del-p2y12-nella-sindrome-coronarica-acuta/
https://gpcardio.org/it/2022-03-21_strategia-sistematica-e-precoce-di-controllo-del-ritmo-per-la-fibrillazione-atriale-in-pazienti-con-o-senza-sintomi/
https://gpcardio.org/it/2022-04-09_riduzione-del-sodio-alimentare-a-meno-di-100-mmol-nell-insufficienza-cardiaca-sodium-hf/
https://gpcardio.org/it/2022-04-09_sicurezza-dell-inibitore-orale-del-fattore-xia-asundexian-rispetto-ad-apixaban-in-pazienti-con-fibrillazione-atriale-pacific-af/
https://gpcardio.org/it/2022-04-26_uso-dell-aspirina-per-prevenire-la-malattia-cardiovascolare/
https://gpcardio.org/it/2022-05-03_linea-guida-2022-aha-acc-hfsa-per-la-gestione-dell-insufficienza-cardiaca/
https://gpcardio.org/it/2022-05-03_linea-guida-2022-aha-acc-hfsa-per-la-gestione-dell-insufficienza-cardiaca/
https://gpcardio.org/it/2022-05-03_linea-guida-2022-aha-acc-hfsa-per-la-gestione-dell-insufficienza-cardiaca/
https://gpcardio.org/it/2022-05-10_effetto-dell-alirocumab-aggiunto-alla-terapia-con-statine-ad-alta-intensita-sull-aterosclerosi-coronarica-in-pazienti-con-infarto-miocardico-acuto/
https://gpcardio.org/it/2022-05-12_trattamento-dell-ipertensione-cronica-lieve-in-gravidanza/
https://gpcardio.org/it/2022-05-21_chirurgia-bariatrica-e-malattia-cardiovascolare/
https://gpcardio.org/it/2022-05-31_effetti-a-lungo-termine-della-metformina-e-degli-interventi-sullo-stile-di-vita-sugli-eventi-cardiovascolari-nel-diabetes-prevention-program-e-nel-suo-studio-di-esito/
https://gpcardio.org/it/2022-06-02_necessita-di-ripartire-e-recuperare-il-ritardo-nella-prevenzione-delle-cvd-in-epoca-di-covid-19/
https://gpcardio.org/it/2022-06-07_studio-randomizzato-di-controllo-del-ritmo-mediante-ablazione-rispetto-al-controllo-della-frequenza-in-pazienti-con-insufficienza-cardiaca-e-fibrillazione-atriale/
https://gpcardio.org/it/2022-06-21_effetto-dell-ablazione-della-fibrosi-guidata-da-rm-rispetto-all-ablazione-transcatetere-convenzionale-sulla-recidiva-di-aritmia-atriale-in-pazienti-con-fibrillazione-atriale-persistente/
https://gpcardio.org/it/2022-06-21_il-timing-dell-ablazione-della-tachicardia-ventricolare-influisce-sulla-prognosi-nei-pazienti-con-defibrillatore-cardioverter-impiantabile-risultati-dello-studio-multicentrico-randomizzato-partita/
https://gpcardio.org/it/2022-07-19_effetto-dell-omecamtiv-mecarbil-sulla-capacita-di-esercizio-nell-insufficienza-cardiaca-cronica-con-frazione-di-eiezione-ridotta/
https://gpcardio.org/it/2022-07-26_effetti-dell-empagliflozin-su-sintomi-limitazioni-fisiche-e-qualita-della-vita-in-pazienti-ospedalizzati-per-insufficienza-cardiaca-acuta/
https://gpcardio.org/it/2022-07-26_effetti-dell-inizio-precoce-dell-empagliflozin-sulla-diuresi-e-sulla-funzione-renale-in-pazienti-con-insufficienza-cardiaca-acuta-scompensata-empag-hf/
https://gpcardio.org/it/2022-07-26_interventi-di-counseling-comportamentale-per-promuovere-una-dieta-sana-e-l-attivita-fisica-per-la-prevenzione-della-malattia-cardiovascolare-in-adulti-senza-fattori-di-rischio-cardiovascolare/
https://gpcardio.org/it/2022-07-30_efficacia-e-sicurezza-a-lungo-termine-della-terapia-di-combinazione-con-statina-a-intensita-moderata-piu-ezetimibe-rispetto-alla-monoterapia-con-statina-ad-alta-intensita-in-pazienti-con-malattia-card/
https://gpcardio.org/it/2022-08-09_declino-iniziale-dip-della-velocita-di-filtrazione-glomerulare-stimata-dopo-l-inizio-del-dapagliflozin-in-pazienti-con-insufficienza-cardiaca-e-frazione-di-eiezione-ridotta/
https://gpcardio.org/it/2022-08-23_uso-di-statine-per-la-prevenzione-primaria-della-malattia-cardiovascolare-negli-adulti/
https://gpcardio.org/it/2022-08-23_uso-di-statine-per-la-prevenzione-primaria-della-malattia-cardiovascolare-negli-adulti/
https://gpcardio.org/it/2022-08-30_empagliflozin-per-l-insufficienza-cardiaca-con-frazione-di-eiezione-ventricolare-sinistra-preservata-con-e-senza-diabete/
https://gpcardio.org/it/2022-09-01_riserva-di-flusso-frazionaria-o-ecografia-intravascolare-per-guidare-la-pci/
https://gpcardio.org/it/2022-09-03_inibitori-dell-sglt-2-in-pazienti-con-insufficienza-cardiaca/
https://gpcardio.org/it/2022-09-07_prevalenza-dell-intolleranza-alle-statine/
https://gpcardio.org/it/2022-09-08_test-funzionali-di-routine-o-cura-standard-in-pazienti-ad-alto-rischio-dopo-pci/
https://gpcardio.org/it/2022-09-10_effetto-della-terapia-con-statine-sui-sintomi-muscolari/
https://gpcardio.org/it/2022-09-13_controllo-precoce-del-ritmo-in-pazienti-con-fibrillazione-atriale-e-elevato-carico-di-comorbidita/
https://gpcardio.org/it/2022-09-15_rivaroxaban-nella-fibrillazione-atriale-associata-a-cardiopatia-reumatica/
https://gpcardio.org/it/2022-09-15_strategia-della-polipillola-nella-prevenzione-cardiovascolare-secondaria/
https://gpcardio.org/it/2022-09-20_armonizzazione-delle-linee-guida-su-pressione-arteriosa-ipertensione-dell-american-college-of-cardiology-american-heart-association-e-della-european-society-of-cardiology-european-society-of-hypertens/
https://gpcardio.org/it/2022-09-22_dapagliflozin-nell-insufficienza-cardiaca-con-frazione-di-eiezione-lievemente-ridotta-o-preservata/
https://gpcardio.org/it/2022-09-22_riduzione-della-glicemia-nel-diabete-di-tipo-2-esiti-microvascolari-e-cardiovascolari/
https://gpcardio.org/it/2022-09-26_effetti-dei-sostituti-del-sale-sugli-esiti-clinici/
https://gpcardio.org/it/2022-09-27_esiti-a-cinque-anni-in-pazienti-con-dispositivi-di-assistenza-ventricolare-sinistra-completamente-a-levitazione-magnetica-rispetto-a-flusso-assiale-nello-studio-randomizzato-momentum-3/
https://gpcardio.org/it/2022-09-27_studio-randomizzato-di-stimolazione-della-branca-sinistra-rispetto-alla-stimolazione-biventricolare-per-la-terapia-di-resincronizzazione-cardiaca/
https://gpcardio.org/it/2022-09-29_acetazolamide-nell-insufficienza-cardiaca-acuta-scompensata-con-sovraccarico-di-volume/
https://gpcardio.org/it/2022-10-04_2022-acc-expert-consensus-decision-pathway-sul-ruolo-delle-terapie-non-statiniche-per-la-riduzione-del-colesterolo-ldl-nella-gestione-del-rischio-di-malattia-cardiovascolare-aterosclerotica/
https://gpcardio.org/it/2022-10-04_dapagliflozin-in-pazienti-recentemente-ospedalizzati-per-insufficienza-cardiaca-con-frazione-di-eiezione-lievemente-ridotta-o-preservata/
https://gpcardio.org/it/2022-10-04_terapia-precoce-rispetto-a-ritardata-con-anticoagulanti-orali-non-antagonisti-della-vitamina-k-dopo-ictus-ischemico-acuto-nella-fibrillazione-atriale-timing/
https://gpcardio.org/it/2022-10-08_allopurinolo-rispetto-alla-cura-abituale-in-pazienti-del-regno-unito-con-cardiopatia-ischemica-all-heart/
https://gpcardio.org/it/2022-10-13_rivascolarizzazione-percutanea-per-la-disfunzione-ventricolare-sinistra-ischemica/
https://gpcardio.org/it/2022-10-18_efficacia-e-sicurezza-del-dapagliflozin-in-base-alla-fragilita-in-pazienti-con-insufficienza-cardiaca/
https://gpcardio.org/it/2022-10-20_obiettivi-di-pressione-arteriosa-nei-sopravvissuti-in-coma-dopo-arresto-cardiaco/
https://gpcardio.org/it/2022-10-22_esiti-cardiovascolari-in-adulti-con-ipertensione-con-somministrazione-serale-rispetto-a-mattutina-degli-antipertensivi-abituali-nel-regno-unito-studio-time/
https://gpcardio.org/it/2022-11-01_empagliflozin-nell-infarto-miocardico-acuto/
https://gpcardio.org/it/2022-11-01_patiromer-per-la-gestione-dell-iperkaliemia-nell-insufficienza-cardiaca-con-frazione-di-eiezione-ridotta/
https://gpcardio.org/it/2022-11-05_controllo-intensivo-della-pressione-arteriosa-dopo-trombectomia-endovascolare-per-ictus-ischemico-acuto-enchanted2-mt/
https://gpcardio.org/it/2022-11-15_ospedalizzazioni-e-mortalita-in-pazienti-con-insufficienza-mitralica-secondaria-e-insufficienza-cardiaca/
https://gpcardio.org/it/2022-11-17_rna-a-piccola-interferenza-per-ridurre-la-lipoproteina-a-nella-malattia-cardiovascolare/
https://gpcardio.org/it/2022-11-19_impatto-del-diabete-sugli-effetti-degli-inibitori-del-cotrasportatore-sodio-glucosio-di-tipo-2-sugli-esiti-renali/
https://gpcardio.org/it/2022-11-22_stent-a-rilascio-di-everolimus-o-bypass-chirurgico-per-la-malattia-coronarica-multivasale/
https://gpcardio.org/it/2022-11-24_riduzione-dei-trigliceridi-con-pemafibrato-per-ridurre-il-rischio-cardiovascolare/
https://gpcardio.org/it/2022-11-26_ly3437943-un-nuovo-agonista-triplo-dei-recettori-di-gip-glp-1-e-glucagone-in-persone-con-diabete-di-tipo-2/
https://gpcardio.org/it/2022-12-03_antagonista-duale-dell-endotelina-aprocitentan-per-l-ipertensione-resistente-precision/
https://gpcardio.org/it/2022-12-03_sicurezza-tollerabilita-ed-efficacia-della-titolazione-verso-l-alto-delle-terapie-mediche-guidate-dalle-linee-guida-nell-insufficienza-cardiaca-acuta-strong-hf/
https://gpcardio.org/it/2022-12-06_apixaban-in-pazienti-con-fibrillazione-atriale-in-emodialisi/
https://gpcardio.org/it/2022-12-17_derisomaltosio-ferrico-endovenoso-in-pazienti-con-insufficienza-cardiaca-e-carenza-di-ferro-nel-regno-unito-ironman/
https://gpcardio.org/it/2022-12-21_riduzione-della-pressione-arteriosa-e-prevenzione-della-demenza/
https://gpcardio.org/it/2022-12-29_clortalidone-rispetto-a-idroclorotiazide-per-gli-eventi-cardiovascolari-nell-ipertensione/
https://gpcardio.org/it/2023-01-01_impatto-dell-empagliflozin-sulla-decongestione-nell-insufficienza-cardiaca-acuta/
https://gpcardio.org/it/2023-01-03_effetti-comparativi-di-rosuvastatina-a-basso-dosaggio-placebo-e-integratori-alimentari-sui-lipidi-e-sui-biomarcatori-infiammatori/
https://gpcardio.org/it/2023-01-03_sopravvivenza-dopo-gestione-invasiva-o-conservativa-della-malattia-coronarica-stabile/
https://gpcardio.org/it/2023-01-03_studio-di-fase-2-su-aficamten-in-pazienti-con-cardiomiopatia-ipertrofica-ostruttiva/
https://gpcardio.org/it/2023-01-10_aspirina-rispetto-a-clopidogrel-come-monoterapia-di-mantenimento-a-lungo-termine-dopo-intervento-coronarico-percutaneo/
https://gpcardio.org/it/2023-01-10_associazione-prospettica-tra-passi-giornalieri-e-malattia-cardiovascolare/
https://gpcardio.org/it/2023-01-10_effetto-dell-ablazione-transcatetere-mediante-isolamento-delle-vene-polmonari-con-vs-senza-isolamento-della-parete-posteriore-dell-atrio-sinistro-sulla-recidiva-di-aritmia-atriale-in-pazienti-con-fibr/
https://gpcardio.org/it/2023-01-12_empagliflozin-in-pazienti-con-malattia-renale-cronica/
https://gpcardio.org/it/2023-01-12_progressione-della-fibrillazione-atriale-dopo-crioablazione-o-terapia-farmacologica/
https://gpcardio.org/it/2023-01-14_costo-efficacia-dello-screening-di-popolazione-per-la-fibrillazione-atriale/
https://gpcardio.org/it/2023-01-17_effetto-di-torasemide-rispetto-a-furosemide-dopo-la-dimissione-sulla-mortalita-per-tutte-le-cause-in-pazienti-ospedalizzati-per-insufficienza-cardiaca/
https://gpcardio.org/it/2023-02-01_combinazione-di-diuretici-dell-ansa-con-tiazidici-per-l-insufficienza-cardiaca-scompensata/
https://gpcardio.org/it/2023-02-02_studio-di-fase-2-su-baxdrostat-per-l-ipertensione-resistente-al-trattamento/
https://gpcardio.org/it/2023-02-07_ossigenazione-extracorporea-a-membrana-nella-terapia-dello-shock-cardiogeno/
https://gpcardio.org/it/2023-02-16_l-ablazione-con-catetere-migliora-gli-esiti-cardiovascolari-nei-pazienti-con-fibrillazione-atriale-e-insufficienza-cardiaca/
https://gpcardio.org/it/2023-02-28_calcio-coronarico-incidentale/
https://gpcardio.org/it/2023-02-28_denervazione-renale-endovascolare-con-ultrasuoni-per-il-trattamento-dell-ipertensione/
https://gpcardio.org/it/2023-03-18_efficacia-di-un-intervento-intensivo-sulla-pressione-arteriosa-guidato-da-operatori-sanitari-di-comunita-non-medici-rispetto-alla-cura-abituale-sulla-malattia-cardiovascolare-crhcp/
https://gpcardio.org/it/2023-04-04_strategia-treat-to-target-o-statina-ad-alta-intensita-in-pazienti-con-coronaropatia/
https://gpcardio.org/it/2023-04-08_rivascolarizzazione-completa-immediata-rispetto-a-quella-scaglionata-in-pazienti-con-sindrome-coronarica-acuta-e-malattia-coronarica-multivasale-biovasc/
https://gpcardio.org/it/2023-04-11_eterogeneita-della-risposta-pressoria-a-4-farmaci-antipertensivi/
https://gpcardio.org/it/2023-04-13_acido-bempedoico-ed-esiti-cardiovascolari-in-pazienti-intolleranti-alle-statine/
https://gpcardio.org/it/2023-04-15_infiammazione-e-colesterolo-come-predittori-di-eventi-cardiovascolari-in-pazienti-in-terapia-con-statine/
https://gpcardio.org/it/2023-04-17_de-escalation-della-doppia-terapia-antiaggregante-nella-sindrome-coronarica-acuta/
https://gpcardio.org/it/2023-04-18_associazione-tra-i-livelli-raggiunti-di-colesterolo-delle-lipoproteine-a-bassa-densita-e-gli-esiti-cardiovascolari-e-di-sicurezza-a-lungo-termine/
https://gpcardio.org/it/2023-04-20_studio-di-fase-3-su-sotatercept-per-il-trattamento-dell-ipertensione-arteriosa-polmonare/
https://gpcardio.org/it/2023-04-25_studio-randomizzato-di-fase-2b-sull-inibitore-orale-del-pcsk9-mk-0616/
https://gpcardio.org/it/2023-05-04_pci-complessa-guidata-da-imaging-intravascolare-o-da-angiografia/
https://gpcardio.org/it/2023-05-09_percorso-decisionale-di-consenso-di-esperti-acc-2023-sulla-gestione-dell-insufficienza-cardiaca-con-frazione-di-eiezione-preservata/
https://gpcardio.org/it/2023-05-18_riparazione-transcatetere-in-pazienti-con-rigurgito-tricuspidale/
https://gpcardio.org/it/2023-05-27_strategia-di-rivascolarizzazione-con-bypass-venoso-per-primo-rispetto-al-miglior-trattamento-endovascolare-per-primo-in-pazienti-con-ischemia-cronica-minacciante-l-arto-che-richiedevano-una-procedura/
https://gpcardio.org/it/2023-06-01_efficacia-e-sicurezza-delle-compresse-combinate-triple-e-quadruple-a-basso-dosaggio-rispetto-alla-monoterapia-alla-cura-abituale-o-al-placebo-per-la-gestione-iniziale-dell-ipertensione/
https://gpcardio.org/it/2023-06-01_follow-up-a-cinque-anni-dopo-la-riparazione-transcatetere-del-rigurgito-mitralico-secondario/
https://gpcardio.org/it/2023-06-06_anticoagulanti-orali-diretti-rispetto-a-warfarin-nell-intero-spettro-della-funzione-renale/
https://gpcardio.org/it/2023-06-06_ottimizzazione-del-trattamento-dopo-ospedalizzazione-per-insufficienza-cardiaca-nell-intero-spettro-della-frazione-di-eiezione-ventricolare-sinistra/
https://gpcardio.org/it/2023-06-08_trattamento-del-diabete-mellito-gestazionale-diagnosticato-precocemente-in-gravidanza/
https://gpcardio.org/it/2023-06-24_monitoraggio-emodinamico-remoto-delle-pressioni-dell-arteria-polmonare-in-pazienti-con-insufficienza-cardiaca-cronica-monitor-hf/
https://gpcardio.org/it/2023-06-27_effetto-degli-inibitori-dell-sglt2-sugli-esiti-cardiovascolari-in-varie-popolazioni-di-pazienti/
https://gpcardio.org/it/2023-06-29_anticoagulazione-precoce-rispetto-a-tardiva-per-l-ictus-con-fibrillazione-atriale/
https://gpcardio.org/it/2023-07-01_il-terzo-studio-del-bundle-di-terapia-intensiva-con-riduzione-della-pressione-arteriosa-nell-emorragia-cerebrale-acuta-interact3/
https://gpcardio.org/it/2023-07-11_monoterapia-con-inibitore-del-p2y12-o-aspirina-per-la-prevenzione-secondaria-degli-eventi-coronarici/
https://gpcardio.org/it/2023-07-13_sicurezza-cardiovascolare-della-terapia-sostitutiva-con-testosterone/
https://gpcardio.org/it/2023-07-20_studio-di-fase-1-sull-anticorpo-ni006-per-la-deplezione-dell-amiloide-da-transtiretina-cardiaca/
https://gpcardio.org/it/2023-07-20_zilebesiran-un-agente-terapeutico-a-interferenza-dell-rna-per-l-ipertensione/
https://gpcardio.org/it/2023-08-08_atorvastatina-per-la-disfunzione-cardiaca-associata-alle-antracicline/
https://gpcardio.org/it/2023-08-08_terapia-con-agonisti-del-recettore-del-glp-1-con-e-senza-inibitori-dell-sglt2-in-pazienti-con-diabete-di-tipo-2/
https://gpcardio.org/it/2023-08-12_retatrutide-un-agonista-dei-recettori-di-gip-glp-1-e-glucagone-in-persone-con-diabete-di-tipo-2/
https://gpcardio.org/it/2023-08-14_sacubitril-valsartan-nell-insufficienza-cardiaca-con-frazione-di-eiezione-lievemente-ridotta-o-preservata/
https://gpcardio.org/it/2023-08-24_pitavastatina-per-prevenire-la-malattia-cardiovascolare-nell-infezione-da-hiv/
https://gpcardio.org/it/2023-08-24_terapie-combinate-a-dose-fissa-nella-prevenzione-primaria-della-malattia-cardiovascolare-in-diversi-gruppi/
https://gpcardio.org/it/2023-09-07_orforglipron-agonista-orale-quotidiano-del-recettore-del-glp-1-per-adulti-con-obesita/
https://gpcardio.org/it/2023-09-07_pci-completa-o-solo-della-lesione-colpevole-in-pazienti-anziani-con-infarto-miocardico/
https://gpcardio.org/it/2023-09-14_carbossimaltosio-ferrico-nell-insufficienza-cardiaca-con-carenza-di-ferro/
https://gpcardio.org/it/2023-09-19_pci-guidata-dalla-riserva-di-flusso-frazionale-o-bypass-coronarico-per-la-malattia-coronarica-a-3-vasi/
https://gpcardio.org/it/2023-09-21_semaglutide-in-pazienti-con-insufficienza-cardiaca-a-frazione-di-eiezione-preservata-e-obesita/
https://gpcardio.org/it/2023-09-28_anticoagulazione-con-edoxaban-in-pazienti-con-episodi-atriali-ad-alta-frequenza/
https://gpcardio.org/it/2023-10-01_antagonisti-del-recettore-mineralocorticoide-con-inibitori-del-cotrasportatore-sodio-glucosio-di-tipo-2-nell-insufficienza-cardiaca/
https://gpcardio.org/it/2023-10-01_efficacia-del-monitoraggio-della-pressione-arteriosa-polmonare-in-pazienti-con-insufficienza-cardiaca-cronica/
https://gpcardio.org/it/2023-10-03_velocita-di-filtrazione-glomerulare-stimata-albuminuria-ed-esiti-avversi/
https://gpcardio.org/it/2023-10-05_effetto-globale-dei-fattori-di-rischio-modificabili-sulla-malattia-cardiovascolare-e-la-mortalita/
https://gpcardio.org/it/2023-10-05_supporto-vitale-extracorporeo-nello-shock-cardiogeno-correlato-a-infarto/
https://gpcardio.org/it/2023-10-12_ablazione-con-catetere-nell-insufficienza-cardiaca-terminale-con-fibrillazione-atriale/
https://gpcardio.org/it/2023-10-12_tempistica-della-rivascolarizzazione-completa-con-pci-multivasale-per-l-infarto-miocardico/
https://gpcardio.org/it/2023-10-14_ossigenazione-a-membrana-extracorporea-veno-arteriosa-in-pazienti-con-shock-cardiogeno-correlato-a-infarto/
https://gpcardio.org/it/2023-10-17_intervento-coronarico-percutaneo-guidato-da-tomografia-a-coerenza-ottica-o-da-ecografia-intravascolare/
https://gpcardio.org/it/2023-10-17_ipotensione-ortostatica-trattamento-dell-ipertensione-e-malattia-cardiovascolare/
https://gpcardio.org/it/2023-10-19_guida-oct-o-angiografica-per-la-pci-in-lesioni-complesse-di-biforcazione/
https://gpcardio.org/it/2023-10-19_pci-guidata-da-tomografia-a-coerenza-ottica-rispetto-a-pci-guidata-da-angiografia/
https://gpcardio.org/it/2023-10-24_composto-della-medicina-tradizionale-cinese-tongxinluo-ed-esiti-clinici-in-pazienti-con-infarto-miocardico-acuto/
https://gpcardio.org/it/2023-11-02_ablazione-a-campo-pulsato-o-ablazione-termica-convenzionale-per-la-fibrillazione-atriale-parossistica/
https://gpcardio.org/it/2023-11-23_sostituzione-della-valvola-aortica-transcatetere-in-pazienti-a-basso-rischio-a-cinque-anni/
https://gpcardio.org/it/2023-11-25_zibotentan-in-combinazione-con-dapagliflozin-rispetto-a-dapagliflozin-in-pazienti-con-malattia-renale-cronica-zenith-ckd/
https://gpcardio.org/it/2023-12-14_semaglutide-ed-esiti-cardiovascolari-nell-obesita-senza-diabete/
https://gpcardio.org/it/2023-12-21_efficacia-del-ferro-carbossimaltosato-nell-insufficienza-cardiaca-con-carenza-di-ferro/
https://gpcardio.org/it/2023-12-21_uno-studio-controllato-con-placebo-dell-intervento-coronarico-percutaneo-per-l-angina-stabile/
https://gpcardio.org/it/2023-12-28_strategia-trasfusionale-restrittiva-o-liberale-nell-infarto-miocardico-e-nell-anemia/
https://gpcardio.org/it/2024-01-02_linea-guida-acc-aha-accp-hrs-2023-per-la-diagnosi-e-la-gestione-della-fibrillazione-atriale/
https://gpcardio.org/it/2024-01-02_linea-guida-acc-aha-accp-hrs-2023-per-la-diagnosi-e-la-gestione-della-fibrillazione-atriale/
https://gpcardio.org/it/2024-01-11_apixaban-per-la-prevenzione-dell-ictus-nella-fibrillazione-atriale-subclinica/
https://gpcardio.org/it/2024-01-18_esiti-a-lungo-termine-della-resincronizzazione-defibrillazione-nell-insufficienza-cardiaca/
https://gpcardio.org/it/2024-02-13_i-monitor-emodinamici-impiantabili-migliorano-la-sopravvivenza-nei-pazienti-con-insufficienza-cardiaca-e-frazione-di-eiezione-ridotta/
https://gpcardio.org/it/2024-02-20_sicurezza-ed-efficacia-della-monoterapia-con-ticagrelor-in-pazienti-con-sindromi-coronariche-acute-sottoposti-a-intervento-coronarico-percutaneo/
https://gpcardio.org/it/2024-02-20_sospensione-dell-aspirina-entro-1-mese-dallo-stenting-per-la-monoterapia-con-ticagrelor-nella-sindrome-coronarica-acuta/
https://gpcardio.org/it/2024-02-20_una-strategia-senza-aspirina-rispetto-a-una-strategia-antiaggregante-doppia-per-lo-stenting-coronarico/
https://gpcardio.org/it/2024-03-01_impatto-dell-acido-bempedoico-sul-totale-degli-eventi-cardiovascolari/
https://gpcardio.org/it/2024-03-02_impianto-di-stent-coronarico-a-rilascio-di-farmaco-guidato-da-imaging-intravascolare/
https://gpcardio.org/it/2024-03-18_cambiamento-globale-dal-sottopeso-al-predominio-dell-obesita-in-tre-decenni-attraverso-le-generazioni/
https://gpcardio.org/it/2024-03-26_anticoagulanti-orali-diretti-per-la-prevenzione-dell-ictus-in-pazienti-con-fibrillazione-atriale-rilevata-da-dispositivo/
https://gpcardio.org/it/2024-04-01_impianto-di-valvola-aortica-transcatetere-o-chirurgico/
https://gpcardio.org/it/2024-04-02_stratify-hf-una-collaborazione-europea-per-sviluppare-un-sistema-di-supporto-basato-sull-ia-per-la-stratificazione-del-rischio-e-la-diagnosi-precoce-dell-insufficienza-cardiaca/
https://gpcardio.org/it/2024-04-07_gamification-e-incentivi-economici-per-aumentare-l-attivita-fisica-nei-pazienti-a-rischio-cardiovascolare-elevato/
https://gpcardio.org/it/2024-04-08_app-web-efficace-nel-determinare-l-accesso-alle-statine-senza-prescrizione/
https://gpcardio.org/it/2024-04-08_un-programma-potenziato-di-gestione-remota-dei-farmaci-aumenta-le-prescrizioni-di-gdmt-nei-pazienti-con-t2d-ad-alto-rischio-cv-o-renale/
https://gpcardio.org/it/2024-04-16_percorso-decisionale-di-consenso-di-esperti-acc-2024-per-il-trattamento-dell-insufficienza-cardiaca-a-frazione-di-eiezione-ridotta/
https://gpcardio.org/it/2024-04-18_beta-bloccanti-dopo-infarto-miocardico-e-frazione-di-eiezione-preservata/
https://gpcardio.org/it/2024-04-18_pompa-a-flusso-microassiale-o-terapia-standard-nello-shock-cardiogeno-correlato-a-infarto/
https://gpcardio.org/it/2024-04-18_semaglutide-in-pazienti-con-insufficienza-cardiaca-correlata-all-obesita-e-diabete-di-tipo-2/
https://gpcardio.org/it/2024-04-25_empagliflozin-dopo-infarto-miocardico-acuto/
https://gpcardio.org/it/2024-04-25_pci-completa-guidata-da-ffr-o-pci-limitata-alla-sola-lesione-colpevole-in-pazienti-con-infarto-miocardico/
https://gpcardio.org/it/2024-04-27_semaglutide-rispetto-al-placebo-in-persone-con-insufficienza-cardiaca-correlata-all-obesita-a-frazione-di-eiezione-preservata/
https://gpcardio.org/it/2024-05-01_monoterapia-con-ticagrelor-o-clopidogrel-rispetto-alla-duplice-terapia-antiaggregante-dopo-intervento-coronarico-percutaneo/
https://gpcardio.org/it/2024-05-02_infusioni-di-apolipoproteina-a1-ed-esiti-cardiovascolari-dopo-infarto-miocardico-acuto/
https://gpcardio.org/it/2024-05-04_intervento-coronarico-percutaneo-preventivo-rispetto-alla-sola-terapia-medica-ottimale-per-il-trattamento-di-placche-coronariche-aterosclerotiche-vulnerabili-prevent/
https://gpcardio.org/it/2024-05-04_stratifyhf-supporto-alla-medicina-generale-nella-diagnosi-precoce-dell-insufficienza-cardiaca/
https://gpcardio.org/it/2024-05-06_l-azione-di-ricerca-e-innovazione-stratifyhf/
https://gpcardio.org/it/2024-05-11_intervento-coronarico-percutaneo-guidato-da-ecografia-intravascolare-rispetto-a-guidato-da-angiografia-nelle-sindromi-coronariche-acute-ivus-acs/
https://gpcardio.org/it/2024-05-11_ticagrelor-da-solo-rispetto-a-ticagrelor-piu-aspirina-dal-mese-1-al-mese-12-dopo-intervento-coronarico-percutaneo-in-pazienti-con-sindrome-coronarica-acuta-ultimate-dapt/
https://gpcardio.org/it/2024-05-16_andexanet-per-l-emorragia-intracerebrale-acuta-associata-a-inibitori-del-fattore-xa/
https://gpcardio.org/it/2024-05-16_olezarsen-pancreatite-acuta-e-sindrome-da-chilomicronemia-familiare/
https://gpcardio.org/it/2024-05-16_olezarsen-per-l-ipertrigliceridemia-in-pazienti-ad-alto-rischio-cardiovascolare/
https://gpcardio.org/it/2024-05-30_riduzione-intensiva-della-pressione-arteriosa-somministrata-in-ambulanza-nell-ictus-iperacuto/
https://gpcardio.org/it/2024-06-01_trattamento-dell-ipertensione-arteriosa-polmonare/
https://gpcardio.org/it/2024-06-04_inibitori-del-cotrasportatore-sodio-glucosio-tipo-2-ed-eventi-cardiovascolari-avversi-maggiori/
https://gpcardio.org/it/2024-06-04_migliorare-la-valutazione-del-rischio-di-cvd-integrare-il-rischio-genetico-per-una-predizione-migliore/
https://gpcardio.org/it/2024-06-06_tavi-autoespandibile-o-espandibile-con-palloncino-in-pazienti-con-anulus-aortico-piccolo/
https://gpcardio.org/it/2024-06-14_gestione-invasiva-rispetto-a-conservativa-di-pazienti-anziani-con-sindrome-coronarica-acuta-senza-sopraslivellamento-del-tratto-st/
https://gpcardio.org/it/2024-06-25_rivisitare-la-razza-e-il-beneficio-del-blocco-del-ras-nell-insufficienza-cardiaca/
https://gpcardio.org/it/2024-07-01_plozasiran-aro-apoc3-per-l-ipertrigliceridemia-grave/
https://gpcardio.org/it/2024-07-11_effetti-della-semaglutide-sulla-malattia-renale-cronica-in-pazienti-con-diabete-di-tipo-2/
https://gpcardio.org/it/2024-07-13_colchicina-a-lungo-termine-per-la-prevenzione-di-eventi-vascolari-ricorrenti-nell-ictus-non-cardioembolico-convince/
https://gpcardio.org/it/2024-07-20_riduzione-della-pressione-arteriosa-sistolica-a-meno-di-120-mm-hg-rispetto-a-meno-di-140-mm-hg-in-pazienti-ad-alto-rischio-cardiovascolare-con-e-senza-diabete-o-pregresso-ictus/
https://gpcardio.org/it/2024-08-24_semaglutide-ed-esiti-cardiovascolari-in-pazienti-con-obesita-e-insufficienza-cardiaca-prevalente/
https://gpcardio.org/it/2024-09-01_monoterapia-con-ticagrelor-nella-sindrome-coronarica-acuta/
https://gpcardio.org/it/2024-09-04_prospettive-globali-dallo-studio-interaspire-mappatura-della-prevalenza-della-lipoproteina-a-nella-cardiopatia-coronarica-in-sei-regioni-oms/
https://gpcardio.org/it/2024-09-07_semaglutide-rispetto-a-placebo-in-pazienti-con-insufficienza-cardiaca-a-frazione-di-eiezione-lievemente-ridotta-o-preservata/
https://gpcardio.org/it/2024-09-12_plozasiran-un-agente-a-interferenza-dell-rna-diretto-contro-apoc3-per-l-iperlipidemia-mista/
https://gpcardio.org/it/2024-09-12_zodasiran-una-terapia-a-rnai-diretta-contro-angptl3-per-l-iperlipidemia-mista/
https://gpcardio.org/it/2024-09-14_supporto-circolatorio-meccanico-temporaneo-nello-shock-cardiogeno-correlato-a-infarto/
https://gpcardio.org/it/2024-09-21_antagonisti-del-recettore-dei-mineralcorticoidi-nell-insufficienza-cardiaca/
https://gpcardio.org/it/2024-09-24_aggiornamento-mirato-2024-del-percorso-decisionale-di-consenso-degli-esperti-dell-acc-sulla-valutazione-clinica-la-gestione-e-la-traiettoria-dei-pazienti-ospedalizzati-con-insufficienza-cardiaca/
https://gpcardio.org/it/2024-09-29_linee-guida-esc-2024-per-la-gestione-della-fibrillazione-atriale-sviluppate-in-collaborazione-con-la-european-association-for-cardio-thoracic-surgery-eacts/
https://gpcardio.org/it/2024-10-07_linee-guida-esc-2024-per-la-gestione-della-pressione-arteriosa-elevata-e-dell-ipertensione/
https://gpcardio.org/it/2024-10-07_semaglutide-e-pressione-arteriosa/
https://gpcardio.org/it/2024-10-10_interruzione-o-continuazione-del-betabloccante-dopo-infarto-miocardico/
https://gpcardio.org/it/2024-10-22_effetti-della-semaglutide-sugli-esiti-di-insufficienza-cardiaca-nel-diabete-e-nella-malattia-renale-cronica-nello-studio-flow/
https://gpcardio.org/it/2024-10-24_finerenone-nell-insufficienza-cardiaca-a-frazione-di-eiezione-lievemente-ridotta-o-preservata/
https://gpcardio.org/it/2024-10-29_giudizio-di-ospedalizzazioni-e-decessi-nello-studio-ironman-sul-ferro-endovenoso-per-l-insufficienza-cardiaca/
https://gpcardio.org/it/2024-11-05_rivascolarizzazione-completa-rispetto-a-rivascolarizzazione-limitata-alla-lesione-colpevole-in-pazienti-anziani-con-infarto-miocardico-con-sopraslivellamento-del-tratto-st/
https://gpcardio.org/it/2024-11-07_strategia-di-trattamento-invasivo-per-pazienti-anziani-con-infarto-miocardico/
https://gpcardio.org/it/2024-11-09_rapporto-di-flusso-quantitativo-rispetto-alla-riserva-di-flusso-frazionale-per-guidare-la-rivascolarizzazione-coronarica-favor-iii-europe/
https://gpcardio.org/it/2024-11-14_riparazione-transcatetere-rispetto-alla-chirurgia-della-valvola-mitrale-per-l-insufficienza-mitralica-secondaria/
https://gpcardio.org/it/2024-11-14_riparazione-valvolare-transcatetere-nell-insufficienza-cardiaca-con-insufficienza-mitralica-da-moderata-a-severa/
https://gpcardio.org/it/2024-11-19_effetto-dello-screening-per-la-fibrillazione-atriale-non-diagnosticata-sulla-prevenzione-dell-ictus/
https://gpcardio.org/it/2024-11-26_esiti-cardiovascolari-renali-e-di-sicurezza-con-agonisti-del-recettore-glp-1-da-soli-e-in-combinazione-con-inibitori-di-sglt2-nel-diabete-di-tipo-2/
https://gpcardio.org/it/2024-12-12_pci-in-pazienti-sottoposti-a-impianto-transcatetere-di-valvola-aortica/
https://gpcardio.org/it/2024-12-14_il-ruolo-vitale-della-medicina-generale-nel-promuovere-la-salute-cardiovascolare/
https://gpcardio.org/it/2025-01-02_asundexian-rispetto-ad-apixaban-in-pazienti-con-fibrillazione-atriale/
https://gpcardio.org/it/2025-01-07_efficacia-e-sicurezza-di-finerenone-lungo-l-intero-spettro-della-frazione-di-eiezione-nell-insufficienza-cardiaca-a-frazione-di-eiezione-lievemente-ridotta-o-preservata/
https://gpcardio.org/it/2025-01-09_plozasiran-per-la-gestione-della-chilomicronemia-persistente-e-del-rischio-di-pancreatite/
https://gpcardio.org/it/2025-01-09_sostituzione-valvolare-transcatetere-nell-insufficienza-tricuspidale-severa/
https://gpcardio.org/it/2025-01-14_riparazione-transcatetere-edge-to-edge-per-l-insufficienza-tricuspidale-isolata-severa/
https://gpcardio.org/it/2025-01-21_intervento-precoce-in-pazienti-con-stenosi-aortica-severa-asintomatica-e-fibrosi-miocardica/
https://gpcardio.org/it/2025-01-21_muvalaplin-orale-per-la-riduzione-della-lipoproteina-a/
https://gpcardio.org/it/2025-01-23_abelacimab-rispetto-a-rivaroxaban-in-pazienti-con-fibrillazione-atriale/
https://gpcardio.org/it/2025-01-25_gestione-guidata-da-angiografia-coronarica-tc-in-pazienti-con-dolore-toracico-stabile/
https://gpcardio.org/it/2025-01-30_continuazione-rispetto-a-interruzione-dell-anticoagulazione-orale-durante-il-tavi/
https://gpcardio.org/it/2025-01-30_tirzepatide-nell-insufficienza-cardiaca-con-frazione-di-eiezione-preservata-e-obesita/
https://gpcardio.org/it/2025-02-13_colchicina-nell-infarto-miocardico-acuto/
https://gpcardio.org/it/2025-02-13_spironolattone-di-routine-nell-infarto-miocardico-acuto/
https://gpcardio.org/it/2025-02-20_ablazione-transcatetere-o-farmaci-antiaritmici-per-la-tachicardia-ventricolare/
https://gpcardio.org/it/2025-03-11_sostituzione-valvolare-aortica-transcatetere-in-pazienti-con-insufficienza-cardiaca-sistolica-e-stenosi-aortica-moderata/
https://gpcardio.org/it/2025-03-15_studio-sui-fattori-di-rischio-cardiovascolare-e-l-utilizzo-della-medicina-generale-in-spagna/
https://gpcardio.org/it/2025-03-16_prevenzione-primaria-della-malattia-cardiovascolare-aterosclerotica-ascvd-nella-medicina-generale-una-revisione-sistematica-delle-linee-guida/
https://gpcardio.org/it/2025-03-17_differenze-e-tendenze-di-genere-nella-gestione-del-rischio-cardiovascolare-risultati-da-uno-studio-di-medicina-generale-a-lungo-termine/
https://gpcardio.org/it/2025-03-25_anticoagulazione-e-terapia-antiaggregante-per-la-fibrillazione-atriale-e-la-coronaropatia-stabile/
https://gpcardio.org/it/2025-03-25_differenze-di-eta-e-sesso-nell-efficacia-dei-trattamenti-per-il-diabete-di-tipo-2/
https://gpcardio.org/it/2025-03-25_terapia-antitrombotica-per-minimizzare-gli-eventi-totali-dopo-sca-o-pci-nella-fibrillazione-atriale/
https://gpcardio.org/it/2025-03-27_controllo-intensivo-della-pressione-arteriosa-in-pazienti-con-diabete-di-tipo-2/
https://gpcardio.org/it/2025-03-28_soluzione-per-inalazione-di-flecainide-acetato-per-la-cardioversione-della-fibrillazione-atriale-sintomatica-di-recente-insorgenza/
https://gpcardio.org/it/2025-04-01_efficacia-e-sicurezza-degli-inibitori-dell-aldosterone-sintasi-per-l-ipertensione/
https://gpcardio.org/it/2025-04-01_linea-guida-acc-aha-2025-per-la-gestione-dei-pazienti-con-sindromi-coronariche-acute/
https://gpcardio.org/it/2025-04-01_metanalisi-di-sotagliflozin-un-inibitore-duale-del-cotrasportatore-sodio-glucosio-1-2-per-l-insufficienza-cardiaca-nel-diabete-di-tipo-2/
https://gpcardio.org/it/2025-04-03_chiusura-dell-auricola-sinistra-dopo-ablazione-per-fibrillazione-atriale/
https://gpcardio.org/it/2025-04-07_empagliflozin-nell-ipertensione-resistente-e-nell-insufficienza-cardiaca-con-frazione-di-eiezione-preservata/
https://gpcardio.org/it/2025-04-07_inibitori-del-cotrasportatore-sodio-glucosio-di-tipo-2-e-diabete-di-nuova-insorgenza-nella-malattia-cardiovascolare-o-renale/
https://gpcardio.org/it/2025-04-10_dapagliflozin-in-pazienti-sottoposti-a-impianto-transcatetere-di-valvola-aortica/
https://gpcardio.org/it/2025-04-10_presentiamo-gpcardio-colmare-il-divario-nell-assistenza-cardiovascolare/
https://gpcardio.org/it/2025-04-17_ablazione-a-campo-pulsato-o-con-criopallone-per-la-fibrillazione-atriale-parossistica/
https://gpcardio.org/it/2025-05-03_semaglutide-e-capacita-di-deambulazione-in-persone-con-arteriopatia-periferica-sintomatica-e-diabete-di-tipo-2-stride/
https://gpcardio.org/it/2025-05-08_efficacia-e-sicurezza-di-lorundrostat-in-pazienti-con-ipertensione-non-controllata/
https://gpcardio.org/it/2025-05-13_effetto-dell-empagliflozin-sui-meccanismi-che-guidano-l-eritropoiesi-e-la-mobilizzazione-del-ferro-in-pazienti-con-insufficienza-cardiaca/
https://gpcardio.org/it/2025-05-13_interazione-tra-malattia-renale-cronica-ed-effetti-del-tirzepatide-in-pazienti-con-insufficienza-cardiaca-frazione-di-eiezione-preservata-e-obesita/
https://gpcardio.org/it/2025-05-17_combinazione-a-dose-fissa-di-obicetrapib-ed-ezetimibe-per-la-riduzione-del-colesterolo-ldl-tandem/
https://gpcardio.org/it/2025-05-29_semaglutide-orale-ed-esiti-cardiovascolari-nel-diabete-di-tipo-2-ad-alto-rischio/
https://gpcardio.org/it/2025-06-01_intervento-coronarico-percutaneo-guidato-da-ffr-rispetto-al-bypass-aortocoronarico-in-pazienti-con-diabete/
https://gpcardio.org/it/2025-06-01_nuovo-acceleratore-metabolico-controllato-per-la-hfpef-correlata-all-obesita/
https://gpcardio.org/it/2025-06-01_studio-randomizzato-per-valutare-il-peggioramento-della-funzione-renale-con-l-aggiunta-di-dapagliflozin-per-l-insufficienza-cardiaca-acuta-scompensata/
https://gpcardio.org/it/2025-06-03_un-inibitore-orale-di-pcsk9-per-il-trattamento-dell-ipercolesterolemia/
https://gpcardio.org/it/2025-06-10_carbossimaltosio-ferrico-endovenoso-nell-insufficienza-cardiaca-con-carenza-di-ferro/
https://gpcardio.org/it/2025-06-10_linea-guida-acc-aha-2025-per-la-gestione-dei-pazienti-con-sindromi-coronariche-acute/
https://gpcardio.org/it/2025-06-10_semaglutide-orale-ed-esiti-cardiovascolari-in-persone-con-diabete-di-tipo-2-in-base-all-uso-di-sglt2i/
https://gpcardio.org/it/2025-06-13_l-impatto-della-fragilita-sull-efficacia-del-controllo-intensivo-della-pressione-arteriosa-nei-pazienti-con-diabete-di-tipo-2/
https://gpcardio.org/it/2025-06-17_inibizione-del-fattore-xi-ad-azione-prolungata-e-sanguinamento-periprocedurale/
https://gpcardio.org/it/2025-06-17_spironolattone-rispetto-ad-amiloride-per-l-ipertensione-resistente/
https://gpcardio.org/it/2025-06-17_tempistica-dei-farmaci-antipertensivi-ed-eventi-cardiovascolari-e-morte/
https://gpcardio.org/it/2025-07-01_gpcardio-epccs-entra-a-far-parte-di-each-la-european-alliance-for-cardiovascular-health/
https://gpcardio.org/it/2025-07-01_prevalenza-quasi-universale-dell-adiposita-centrale-nell-insufficienza-cardiaca-con-frazione-di-eiezione-preservata/
https://gpcardio.org/it/2025-07-01_trattamento-aggiuntivo-con-zilebesiran-per-l-ipertensione-controllata-in-modo-inadeguato/
https://gpcardio.org/it/2025-07-03_sicurezza-ed-efficacia-di-obicetrapib-in-pazienti-ad-alto-rischio-cardiovascolare/
https://gpcardio.org/it/2025-07-05_collaborazione-sulla-tempistica-ottimale-dell-anticoagulazione-dopo-ictus-ischemico-e-fibrillazione-atriale/
https://gpcardio.org/it/2025-07-07_colchicina-per-la-prevenzione-secondaria-degli-eventi-vascolari/
https://gpcardio.org/it/2025-07-07_studi-a-lungo-termine-sulla-colchicina-per-la-prevenzione-secondaria-degli-eventi-vascolari/
https://gpcardio.org/it/2025-07-08_ablazione-transcatetere-rispetto-alla-modifica-dello-stile-di-vita-con-farmaci-antiaritmici-per-il-trattamento-della-fibrillazione-atriale/
https://gpcardio.org/it/2025-07-10_gpcardio-e-la-ncd-academy-dell-acc-uniscono-le-forze-per-rafforzare-la-medicina-generale-nella-prevenzione-della-malattia-cardiovascolare/
https://gpcardio.org/it/2025-07-12_amycretin-un-nuovo-agonista-unimolecolare-dei-recettori-del-glp-1-e-dell-amilina-somministrato-per-via-sottocutanea/
https://gpcardio.org/it/2025-07-12_sicurezza-tollerabilita-farmacocinetica-e-farmacodinamica-dell-agonista-first-in-class-dei-recettori-del-glp-1-e-dell-amilina-amycretin/
https://gpcardio.org/it/2025-07-15_esito-a-10-anni-della-rivascolarizzazione-completa-o-della-sola-arteria-dell-infarto-nello-stemi-con-malattia-multivasale/
https://gpcardio.org/it/2025-07-22_cooperative-pfa/
https://gpcardio.org/it/2025-07-28_benefici-a-lungo-termine-dell-atorvastatina-sull-incidenza-di-eventi-cardiovascolari/
https://gpcardio.org/it/2025-07-29_cvd-e-medicina-generale-la-necessita-delle-indicazioni-pratiche-epccs/
https://gpcardio.org/it/2025-07-29_impatto-dell-indice-di-massa-corporea-dell-adiposita-centrale-e-della-perdita-di-peso-sui-benefici-di-tirzepatide-nella-hfpef/
https://gpcardio.org/it/2025-08-05_abelacimab-rispetto-a-rivaroxaban-in-pazienti-con-fibrillazione-atriale-in-terapia-antiaggregante-piastrinica/
https://gpcardio.org/it/2025-08-05_inibitore-del-cotrasportatore-sodio-glucosio-di-tipo-2-con-e-senza-antagonista-dell-aldosterone-per-lo-scompenso-cardiaco-con-frazione-di-eiezione-preservata/
https://gpcardio.org/it/2025-08-05_lorundrostat-in-partecipanti-con-ipertensione-non-controllata-e-ipertensione-resistente-al-trattamento/
https://gpcardio.org/it/2025-08-12_esiti-nei-pazienti-anziani-dopo-il-passaggio-a-un-anticoagulante-piu-recente-o-il-mantenimento-del-warfarin/
https://gpcardio.org/it/2025-08-14_cagrilintide-e-semaglutide-co-somministrati-in-adulti-con-sovrappeso-o-obesita/
https://gpcardio.org/it/2025-08-21_intervento-coronarico-percutaneo-preventivo-per-placche-coronariche-aterosclerotiche-vulnerabili-non-limitanti-il-flusso-nel-diabete/
https://gpcardio.org/it/2025-08-30_efficacia-nella-riduzione-della-pressione-arteriosa-dei-farmaci-antipertensivi-e-delle-loro-combinazioni/
https://gpcardio.org/it/2025-09-01_costo-efficacia-di-apixaban-rispetto-ad-aspirina-per-la-riduzione-della-tromboembolia-in-pazienti-ad-alto-rischio-con-fibrillazione-atriale-rilevata-da-dispositivo/
https://gpcardio.org/it/2025-09-01_diabete-e-obesita-ed-effetto-del-trattamento-del-controllo-precoce-del-ritmo-rispetto-alla-cura-abituale-in-pazienti-con-fibrillazione-atriale/
https://gpcardio.org/it/2025-09-01_stimolazione-del-sistema-di-conduzione-rispetto-alla-stimolazione-biventricolare-per-la-resincronizzazione-cardiaca/
https://gpcardio.org/it/2025-09-02_cura-medica-ottimale-e-rivascolarizzazione-miocardica-guidata-dalla-capacita-di-flusso-coronarico-rispetto-alla-cura-abituale-per-la-coronaropatia-cronica/
https://gpcardio.org/it/2025-09-02_lo-screening-remoto-della-fibrillazione-atriale-nella-medicina-generale-mediante-cerotto-ecg-mostra-benefici-modesti/
https://gpcardio.org/it/2025-09-05_riduzioni-della-pressione-arteriosa-con-baxdrostat-nei-pazienti-con-ipertensione-non-controllata-o-resistente/
https://gpcardio.org/it/2025-09-09_influenza-del-diabete-di-tipo-2-sugli-effetti-di-tirzepatide-in-pazienti-con-scompenso-cardiaco-a-frazione-di-eiezione-preservata-e-obesita/
https://gpcardio.org/it/2025-09-11_riabilitazione-multidominio-per-pazienti-anziani-con-infarto-miocardico/
https://gpcardio.org/it/2025-09-11_una-nuova-linea-guida-raccomanda-un-nuovo-approccio-per-valutare-il-rischio-cardiovascolare-e-raggiungere-gli-obiettivi-terapeutici-per-i-livelli-lipidici/
https://gpcardio.org/it/2025-09-13_beta-bloccanti-dopo-infarto-miocardico-con-frazione-di-eiezione-lievemente-ridotta/
https://gpcardio.org/it/2025-09-16_2025-aha-acc-guideline-for-the-prevention-detection-evaluation-and-management-of-high-blood-pressure-in-adults/
https://gpcardio.org/it/2025-09-16_affrontare-l-impatto-cardiovascolare-duraturo-del-covid-19-nuove-linee-guida-per-la-medicina-generale/
https://gpcardio.org/it/2025-09-18_orforglipron-un-agonista-orale-del-recettore-del-glp-1-a-piccola-molecola-nel-diabete-di-tipo-2-precoce/
https://gpcardio.org/it/2025-09-20_effetto-di-evolocumab-sulla-pervieta-del-graft-venoso-safeno-dopo-intervento-di-bypass-coronarico-newton-cabg-cardiolink-5/
https://gpcardio.org/it/2025-09-21_introduzione-e-impatto-della-cmr-su-pazienti-e-sistemi-sanitari/
https://gpcardio.org/it/2025-09-24_principali-cambiamenti-nella-guida-clinica-per-la-gestione-della-pressione-arteriosa-e-dei-lipidi/
https://gpcardio.org/it/2025-09-25_digitossina-in-pazienti-con-scompenso-cardiaco-e-frazione-di-eiezione-ridotta/
https://gpcardio.org/it/2025-09-28_perche-e-importante-riconoscere-e-gestire-la-malattia-renale-cronica-ckd/
https://gpcardio.org/it/2025-10-01_2025-aha-acc-guideline-for-the-prevention-detection-evaluation-and-management-of-high-blood-pressure-in-adults/
https://gpcardio.org/it/2025-10-01_nessuna-evidenza-a-sostegno-di-vitamine-o-integratori-per-abbassare-il-colesterolo-ldl-e-ridurre-il-rischio-cardiovascolare/
https://gpcardio.org/it/2025-10-01_sollievo-della-congestione-polmonare-mediante-l-aggiunta-di-dapagliflozin-al-diuretico-dell-ansa-endovenoso-in-pazienti-con-scompenso-cardiaco-acuto/
https://gpcardio.org/it/2025-10-07_impatto-di-obicetrapib-sugli-eventi-cardiovascolari-avversi-maggiori-in-pazienti-ad-alto-rischio/
https://gpcardio.org/it/2025-10-07_la-relazione-tra-obesita-e-malattia-renale-cronica/
https://gpcardio.org/it/2025-10-07_occlusione-dell-auricola-atriale-sinistra-in-pazienti-con-malattia-renale-allo-stadio-terminale/
https://gpcardio.org/it/2025-10-09_efficacia-e-sicurezza-di-baxdrostat-nell-ipertensione-non-controllata-e-resistente/
https://gpcardio.org/it/2025-10-14_interruzione-a-lungo-termine-dell-anticoagulazione-dopo-ablazione-transcatetere-per-fibrillazione-atriale/
https://gpcardio.org/it/2025-10-14_somministrazione-di-eparina-al-primo-contatto-medico-rispetto-a-immediatamente-prima-dell-intervento-coronarico-percutaneo-primario/
https://gpcardio.org/it/2025-10-23_aspirina-in-pazienti-con-sindrome-coronarica-cronica-in-trattamento-con-anticoagulazione-orale/
https://gpcardio.org/it/2025-10-27_sostituzione-valvolare-aortica-transcatetere-o-chirurgica-in-pazienti-a-basso-rischio-a-7-anni/
https://gpcardio.org/it/2025-10-27_unire-la-consapevolezza-su-cuore-e-ictus-piu-forti-insieme/
https://gpcardio.org/it/2025-10-28_controllo-intensivo-della-pressione-arteriosa-in-pazienti-anziani-con-ipertensione/
https://gpcardio.org/it/2025-10-28_effetto-del-controllo-intensivo-della-pressione-arteriosa-sull-ictus/
https://gpcardio.org/it/2025-10-28_pci-immediata-o-differita-della-lesione-non-colpevole-nell-infarto-miocardico/
https://gpcardio.org/it/2025-11-01_sicurezza-dell-inibizione-del-fattore-xi-con-abelacimab-nella-fibrillazione-atriale-in-base-alla-funzione-renale/
https://gpcardio.org/it/2025-11-04_2025-aha-acc-guideline-for-the-prevention-detection-evaluation-and-management-of-high-blood-pressure-in-adults/
https://gpcardio.org/it/2025-11-06_orforglipron-un-agonista-orale-del-recettore-del-glp-1-a-piccola-molecola-per-il-trattamento-dell-obesita/
https://gpcardio.org/it/2025-11-09_un-inibitore-di-pcsk9-previene-il-primo-infarto-o-ictus-nei-pazienti-ad-alto-rischio/
https://gpcardio.org/it/2025-11-10_vaccino-antinfluenzale-ad-alto-dosaggio-rispetto-a-dosaggio-standard-ed-esiti-cardiovascolari-negli-adulti-anziani/
https://gpcardio.org/it/2025-11-11_decaf-una-tazza-di-caffe-al-giorno-potrebbe-prevenire-il-ritorno-della-fibrillazione-atriale/
https://gpcardio.org/it/2025-11-13_beta-bloccanti-dopo-infarto-miocardico-in-pazienti-senza-insufficienza-cardiaca/
https://gpcardio.org/it/2025-11-13_beta-bloccanti-dopo-infarto-miocardico-senza-frazione-di-eiezione-ridotta/
https://gpcardio.org/it/2025-11-18_dapagliflozin-in-pazienti-ospedalizzati-per-insufficienza-cardiaca/
https://gpcardio.org/it/2025-11-18_dichiarazione-scientifica-acc-2025-sulla-gestione-dell-obesita-negli-adulti-con-insufficienza-cardiaca/
https://gpcardio.org/it/2025-11-18_effetti-cardiovascolari-e-tollerabilita-degli-agonisti-del-recettore-del-glp-1/
https://gpcardio.org/it/2025-11-21_il-consiglio-epccs-lancia-gpcardio-come-impegno-a-sostegno-della-medicina-generale/
https://gpcardio.org/it/2025-11-25_punteggi-di-rischio-abc-af-basati-su-biomarcatori-per-un-trattamento-personalizzato-volto-a-ridurre-l-ictus-o-la-morte-nella-fibrillazione-atriale/
https://gpcardio.org/it/2025-12-01_sanguinamento-maggiore-con-apixaban-rispetto-ad-aspirina/
https://gpcardio.org/it/2025-12-01_studio-sulla-riduzione-aggressiva-dei-fattori-di-rischio-nella-fibrillazione-atriale-implicazioni-per-gli-esiti-dell-ablazione/
https://gpcardio.org/it/2025-12-13_rivascolarizzazione-completa-rispetto-alla-rivascolarizzazione-limitata-alla-sola-lesione-colpevole-nell-infarto-miocardico-acuto-complete-revascularisation-trialists-collaboration/
https://gpcardio.org/it/2025-12-16_effetto-a-lungo-termine-degli-icd-nell-insufficienza-cardiaca-non-ischemica-con-frazione-di-eiezione-ridotta/
https://gpcardio.org/it/2025-12-16_trattamento-farmacologico-dell-insufficienza-cardiaca-con-frazione-di-eiezione-ridotta/
https://gpcardio.org/it/2025-12-18_esiti-cardiovascolari-con-tirzepatide-rispetto-a-dulaglutide-nel-diabete-di-tipo-2/
https://gpcardio.org/it/2025-12-18_improve-dice-uno-studio-in-aperto-di-fase-2a-in-due-parti-che-valuta-la-sicurezza-e-l-efficacia-di-ninerafaxstat-in-pazienti-con-sindromi-cardiometaboliche/
https://gpcardio.org/it/2025-12-18_linea-guida-acc-aha-2025-per-la-gestione-degli-adulti-con-cardiopatia-congenita/
https://gpcardio.org/it/2025-12-19_l-ue-lancia-l-ambizioso-safe-hearts-plan-una-nuova-tabella-di-marcia-per-la-salute-cardiovascolare/
https://gpcardio.org/it/2025-12-20_orforglipron-un-agonista-orale-del-recettore-del-glp-1-a-piccola-molecola-per-il-trattamento-dell-obesita-in-persone-con-diabete-di-tipo-2-attain-2/
https://gpcardio.org/it/2025-12-23_anticoagulazione-a-breve-termine-rispetto-alla-doppia-terapia-antiaggregante-piastrinica-per-la-prevenzione-della-trombosi-del-dispositivo-dopo-chiusura-dell-auricola-sinistra/
https://gpcardio.org/it/2026-01-06_l-oms-pubblica-una-linea-guida-globale-sull-uso-dei-farmaci-glp-1-per-il-trattamento-dell-obesita/
https://gpcardio.org/it/2026-01-06_spesa-alimentare-secondo-il-modello-dash-ed-effetti-sulla-pressione-arteriosa/
https://gpcardio.org/it/2026-01-07_i-linfociti-t-cxcr6-guidano-la-miocardite-da-inibitori-del-checkpoint-immunitario/
https://gpcardio.org/it/2026-01-10_la-nicotina-e-il-sistema-cardiovascolare-informazioni-chiave-per-la-medicina-generale/
https://gpcardio.org/it/2026-01-12_efficacia-e-sicurezza-del-trattamento-con-basse-dosi-di-spironolattone-in-pazienti-con-iperaldosteronismo-primario/
https://gpcardio.org/it/2026-01-13_efficacia-e-sicurezza-dell-inibitore-orale-di-pcsk9-enlicitide-in-adulti-con-ipercolesterolemia-familiare-eterozigote/
https://gpcardio.org/it/2026-01-14_agonisti-del-recettore-di-tipo-glucagone-e-farmaci-di-nuova-generazione-basati-sulle-incretine/
https://gpcardio.org/it/2026-01-15_barriere-socioeconomiche-e-strutturali-nell-affrontare-l-obesita-nelle-comunita/
https://gpcardio.org/it/2026-01-19_l-ictus-identificato-come-la-seconda-causa-principale-di-morte-per-malattia-cardiovascolare-e-un-importante-fattore-di-disabilita-acquisita-a-lungo-termine/
https://gpcardio.org/it/2026-01-20_fattori-di-stress-ambientale-e-salute-cardiovascolare/
https://gpcardio.org/it/2026-01-20_inibitori-di-sglt2-ed-esiti-renali-in-base-alla-velocita-di-filtrazione-glomerulare-e-all-albuminuria/
https://gpcardio.org/it/2026-01-20_triplice-rispetto-a-duplice-terapia-ipolipemizzante-nella-sindrome-coronarica-acuta/
https://gpcardio.org/it/2026-01-21_statistiche-2026-su-malattie-cardiache-e-ictus/
https://gpcardio.org/it/2026-01-22_gestione-responsabile-dei-farmaci-per-gli-inibitori-del-ras-e-gli-inibitori-di-sglt2-nella-malattia-renale-cronica/
https://gpcardio.org/it/2026-01-22_terapia-antitrombotica-dopo-ablazione-con-catetere-efficace-per-fibrillazione-atriale/
https://gpcardio.org/it/2026-01-27_colchicina-nelle-sindromi-coronariche-acute/
https://gpcardio.org/it/2026-01-27_monoterapia-con-inibitore-potente-del-p2y12-rispetto-a-dapt-dopo-pci-in-pazienti-con-e-senza-stemi/
https://gpcardio.org/it/2026-01-28_linea-guida-di-pratica-clinica-kdigo-2026-sull-anemia-nella-malattia-renale-cronica-ckd/
https://gpcardio.org/it/2026-01-29_carico-di-allenamento-derivato-da-dispositivi-indossabili-e-aterosclerosi-coronarica-in-atleti-di-mezza-eta-e-anziani-e-controlli-fisicamente-attivi/
https://gpcardio.org/it/2026-01-29_carico-sintomatico-e-prevenzione-secondaria-in-pazienti-con-disfunzione-sistolica-ventricolare-sinistra-dopo-infarto-miocardico-acuto/
https://gpcardio.org/it/2026-01-29_gestione-guidata-da-un-team-multidisciplinare-della-stenosi-aortica-grave/
https://gpcardio.org/it/2026-01-29_olezarsen-per-la-gestione-dell-ipertrigliceridemia-grave-e-del-rischio-di-pancreatite/
https://gpcardio.org/it/2026-01-30_eventi-embolici-sistemici-nella-fibrillazione-atriale/
https://gpcardio.org/it/2026-02-01_cagrisema-riduce-la-pressione-arteriosa-negli-adulti-con-sovrappeso-o-obesita/
https://gpcardio.org/it/2026-02-01_effetti-cardiovascolari-renali-di-dapagliflozin-in-pazienti-a-rischio-cardiovascolare-con-o-senza-diabete-di-tipo-2/
https://gpcardio.org/it/2026-02-01_esiti-dopo-il-cambio-del-test-della-troponina-cardiaca-nella-sca/
https://gpcardio.org/it/2026-02-01_semaglutide-e-ospedalizzazioni-in-pazienti-con-obesita-e-malattia-cardiovascolare-accertata/
https://gpcardio.org/it/2026-02-01_β-bloccanti-dopo-infarto-miocardico-in-pazienti-con-frazione-di-eiezione-preservata/
https://gpcardio.org/it/2026-02-02_uso-di-inibitori-di-sglt2-ed-esiti-cardiorenali-nel-diabete-di-tipo-2-con-cirrosi-epatica/
https://gpcardio.org/it/2026-02-03_attivita-fisica-e-rischio-di-eventi-avversi-nella-fibrillazione-atriale/
https://gpcardio.org/it/2026-02-03_dapagliflozin-per-ridurre-la-recidiva-precoce-dopo-ablazione-con-catetere-per-fibrillazione-atriale/
https://gpcardio.org/it/2026-02-03_gestione-attuale-della-fibrillazione-atriale-in-pazienti-con-cancro-l-indagine-2025-dell-european-heart-rhythm-association/
https://gpcardio.org/it/2026-02-03_semaglutide-come-terapia-aggiuntiva-all-ablazione-con-catetere-nella-fibrillazione-atriale-parossistica-correlata-all-obesita/
https://gpcardio.org/it/2026-02-03_semaglutide-rispetto-a-tirzepatide-in-pazienti-con-obesita-e-hfpef/
https://gpcardio.org/it/2026-02-04_gli-stetoscopi-digitali-con-ia-superano-lo-screening-tradizionale-per-la-vhd-significativa/
https://gpcardio.org/it/2026-02-05_efimosfermina-alfa-bos-580-una-volta-al-mese-in-persone-con-steatoepatite-associata-a-disfunzione-metabolica-con-fibrosi-f2-o-f3/
https://gpcardio.org/it/2026-02-05_la-base-ereditaria-della-malattia-coronarica/
https://gpcardio.org/it/2026-02-05_tenecteplase-per-via-endovenosa-per-l-ictus-ischemico-acuto-entro-24-ore-dovuto-a-occlusione-dell-arteria-basilare/
https://gpcardio.org/it/2026-02-05_tenecteplase-rispetto-al-trattamento-medico-standard-per-l-occlusione-dell-arteria-basilare-entro-24-ore-trace-5/
https://gpcardio.org/it/2026-02-05_uno-studio-controllato-con-placebo-dell-inibitore-orale-di-pcsk9-enlicitide/
https://gpcardio.org/it/2026-02-06_agonisti-del-recettore-del-peptide-simile-al-glucagone-ed-esiti-renali-nell-era-della-medicina-personalizzata/
https://gpcardio.org/it/2026-02-06_la-resistenza-all-insulina-compromette-la-via-del-pentoso-fosfato-e-compromette-il-recupero-miocardico-mediato-da-dispositivi-di-assistenza-ventricolare-sinistra-lvad-in-pazienti-obesi-con-insufficien/
https://gpcardio.org/it/2026-02-06_la-variante-rs671-dell-aldeide-deidrogenasi-2-potenzia-l-attivazione-piastrinica-e-la-trombosi-arteriosa/
https://gpcardio.org/it/2026-02-06_parlare-con-i-pazienti-delle-statine-perche-la-maggior-parte-dei-sintomi-riportati-non-e-causale/
https://gpcardio.org/it/2026-02-09_aterosclerosi-coronarica-in-pazienti-con-cancro-e-sopravvissuti/
https://gpcardio.org/it/2026-02-10_ematopoiesi-clonale-e-le-sue-implicazioni-cardiovascolari/
https://gpcardio.org/it/2026-02-10_infarto-miocardico-spontaneo-dopo-rivascolarizzazione-del-tronco-comune/
https://gpcardio.org/it/2026-02-10_nuove-terapie-farmacologiche-per-l-ipertensione/
https://gpcardio.org/it/2026-02-10_rischi-di-cancro-renale-e-uroteliale-con-inibitori-di-sglt2-rispetto-agli-agonisti-del-recettore-del-glp-1-nel-diabete-di-tipo-2/
https://gpcardio.org/it/2026-02-10_valutazione-e-gestione-dell-amiloidosi-cardiaca-da-transtiretina/
https://gpcardio.org/it/2026-02-11_criteri-per-valutare-l-utilita-predittiva-e-clinica-di-nuovi-modelli-biomarcatori-e-strumenti-per-il-rischio-di-malattia-cardiovascolare/
https://gpcardio.org/it/2026-02-11_dosaggio-dell-aspirina-dopo-sindrome-coronarica-acuta-con-sospetta-resistenza-all-aspirina/
https://gpcardio.org/it/2026-02-11_miglioramento-degli-esiti-dell-ablazione-della-fibrillazione-atriale-mediante-interventi-integrati-e-personalizzati-sullo-stile-di-vita/
https://gpcardio.org/it/2026-02-11_vericiguat-e-mortalita-nell-insufficienza-cardiaca-con-frazione-di-eiezione-ridotta/
https://gpcardio.org/it/2026-02-12_associazioni-prospettiche-di-obesita-e-gravita-dell-obesita-con-9-esiti-cardiovascolari/
https://gpcardio.org/it/2026-02-12_utilita-prognostica-della-risonanza-magnetica-cardiaca-da-stress-con-perfusione-in-pazienti-con-malattia-coronarica-nota-o-sospetta-e-test-da-sforzo-non-conclusivo/
https://gpcardio.org/it/2026-02-13_uso-di-farmaci-nefroprotettivi-durante-l-allattamento/
https://gpcardio.org/it/2026-02-16_nuovi-marcatori-proteomici-plasmatici-e-rischio-di-tromboembolismo-venoso/
https://gpcardio.org/it/2026-02-16_trattamento-anticoagulante-precoce-rispetto-a-tardivo-dopo-ictus-ischemico-acuto-con-fibrillazione-atriale/
https://gpcardio.org/it/2026-02-17_albuminuria-o-proteinuria-nella-malattia-glomerulare-e-nella-ckd-quale-utilizzare/
https://gpcardio.org/it/2026-02-18_beta-bloccanti-dopo-l-infarto-miocardico/
https://gpcardio.org/it/2026-02-18_terapia-genica-per-la-cistinosi-nefropatica/
https://gpcardio.org/it/2026-02-19_disturbi-della-conduzione-dopo-impianto-transcatetere-di-valvola-aortica/
https://gpcardio.org/it/2026-02-19_interazione-cardiovascolare-renale-metabolica-in-pazienti-con-fibrillazione-atriale-in-trattamento-con-anticoagulanti-orali-diretti/
https://gpcardio.org/it/2026-02-19_linea-guida-2026-dell-aha-acc-per-la-valutazione-e-la-gestione-dell-embolia-polmonare-acuta-negli-adulti/
https://gpcardio.org/it/2026-02-19_prevenzione-secondaria-dopo-ictus-ischemico/
https://gpcardio.org/it/2026-02-19_sostituzione-della-valvola-aortica-transcatetere-o-chirurgica-in-pazienti-a-basso-rischio-a-7-anni/
https://gpcardio.org/it/2026-02-20_previsione-migliorata-del-rischio-di-malattia-cardiovascolare-mediante-modelli-integrati-di-apprendimento-automatico/
https://gpcardio.org/it/2026-02-21_pelacarsen-e-aferesi-della-lipoproteina-a-nella-prevenzione-secondaria/
https://gpcardio.org/it/2026-02-22_costo-efficacia-degli-inibitori-del-cotrasportatore-sodio-glucosio-di-tipo-2-e-degli-agonisti-del-recettore-del-peptide-1-simile-al-glucagone-in-pazienti-con-alto-rischio-cardiovascolare-e-diabete-di/
https://gpcardio.org/it/2026-02-23_attivita-fisica-definita-mediante-accelerometria-e-qualita-della-vita-nella-cardiomiopatia-ipertrofica/
https://gpcardio.org/it/2026-02-23_effetto-di-semaglutide-su-covid-19-e-altre-infezioni/
https://gpcardio.org/it/2026-02-23_il-diabete-aumenta-il-rischio-di-insufficienza-cardiaca-nella-miocardite/
https://gpcardio.org/it/2026-02-23_immunoadsorbimento-nella-cardiomiopatia-dilatativa/
https://gpcardio.org/it/2026-02-23_l-anno-nella-medicina-cardiovascolare-2025/
https://gpcardio.org/it/2026-02-23_mitigazione-del-rischio-di-disfunzione-renale-dopo-trapianto-cardiaco-e-approcci-terapeutici/
https://gpcardio.org/it/2026-02-23_primary-care-adherence-to-heart-failure-guidelines-in-post-discharge-evaluation-routine-management-pathfinder/
https://gpcardio.org/it/2026-02-24_eventi-embolici-sistemici-nella-fibrillazione-atriale/
https://gpcardio.org/it/2026-02-24_malnutrizione-e-cachessia-nei-pazienti-ospedalizzati-con-condizioni-cardiache-acute/
https://gpcardio.org/it/2026-02-24_rischio-di-ospedalizzazione-per-insufficienza-cardiaca-con-agonisti-del-recettore-del-glp-1-rispetto-agli-inibitori-di-dpp-4-o-agli-inibitori-di-sglt2-in-pazienti-con-diabete-di-tipo-2/
https://gpcardio.org/it/2026-02-25_associazioni-combinate-degli-agonisti-del-recettore-del-glp-1-e-di-uno-stile-di-vita-sano-con-gli-esiti-cardiovascolari-in-individui-con-diabete-di-tipo-2/
https://gpcardio.org/it/2026-02-25_esiti-dell-insufficienza-cardiaca-con-frazione-di-eiezione-ridotta-lievemente-ridotta-o-preservata/
https://gpcardio.org/it/2026-02-25_previsione-del-carico-di-malattia-cardiovascolare-e-ictus-nelle-donne-negli-stati-uniti-fino-al-2050/
https://gpcardio.org/it/2026-02-25_rivaroxaban-a-basso-dosaggio-per-prevenire-la-trombosi-ventricolare-sinistra-dopo-infarto-miocardico-anteriore/
https://gpcardio.org/it/2026-02-26_controllo-intensivo-della-pressione-arteriosa-e-funzione-cognitiva/
https://gpcardio.org/it/2026-02-27_benefici-cardiorenali-additivi-della-terapia-combinata-con-finerenone-e-inibitore-di-sglt2-nella-ckd-diabetica/
https://gpcardio.org/it/2026-02-27_il-carico-di-macrofagi-della-placca-carotidea-e-i-marcatori-di-macrofagi-infiammatori-associati-ai-lipidi-predicono-eventi-cardiovascolari-avversi-maggiori-secondari-dopo-endoarteriectomia/
https://gpcardio.org/it/2026-02-27_inibizione-di-sglt2-in-pazienti-con-diabete-di-tipo-2-e-ckd-con-deterioramento-della-velocita-di-filtrazione-glomerulare-stimata-a-20-ml-min-1-73-m/
https://gpcardio.org/it/2026-02-27_passaggio-da-warfarin-ad-anticoagulanti-orali-diretti-in-pazienti-asiatici-anziani-fragili-con-fibrillazione-atriale/
https://gpcardio.org/it/2026-02-28_insufficienza-cardiaca-negli-anziani/
https://gpcardio.org/it/2026-03-01_abelacimab-rispetto-a-rivaroxaban-in-individui-anziani-con-fibrillazione-atriale/
https://gpcardio.org/it/2026-03-01_confronto-degli-algoritmi-a-0-1-ora-dell-european-society-of-cardiology-e-della-troponina-ad-alta-sensibilita-nella-valutazione-di-pazienti-con-sospetta-sindrome-coronarica-acuta-algoritmi-a-0-2-o-0-3/
https://gpcardio.org/it/2026-03-01_effetto-del-baduanjin-sulla-pressione-arteriosa-in-individui-con-pressione-arteriosa-normale-alta/
https://gpcardio.org/it/2026-03-01_esiti-a-sei-anni-dopo-sostituzione-transcatetere-rispetto-a-chirurgica-della-valvola-aortica-in-pazienti-a-basso-rischio-con-stenosi-aortica/
https://gpcardio.org/it/2026-03-01_impatto-del-trattamento-precoce-ritardato-o-interrotto-nei-bambini-con-ipercolesterolemia-familiare/
https://gpcardio.org/it/2026-03-01_journal-club/
https://gpcardio.org/it/2026-03-01_linea-guida-2026-sull-embolia-polmonare-acuta-a-colpo-d-occhio/
https://gpcardio.org/it/2026-03-01_screening-cardiaco-nei-giovani/
https://gpcardio.org/it/2026-03-01_screening-cardiaco-per-condizioni-associate-alla-morte-cardiaca-improvvisa/
https://gpcardio.org/it/2026-03-01_tempistica-dei-benefici-cardiovascolari-e-renali-di-finerenone-nell-insufficienza-cardiaca-e-nella-malattia-renale-cronica-con-diabete-di-tipo-2/
https://gpcardio.org/it/2026-03-01_un-po-di-confidence-tanto-necessaria-per-combattere-il-paradosso-rischio-trattamento-nella-malattia-renale-cronica/
https://gpcardio.org/it/2026-03-01_vaccinazione-antinfluenzale-ad-alto-dosaggio-nella-malattia-cardiovascolare-aterosclerotica/
https://gpcardio.org/it/2026-03-02_il-rumore-notturno-del-traffico-stradale-stressa-il-cuore-e-i-vasi-sanguigni/
https://gpcardio.org/it/2026-03-02_profilo-di-rischio-peggiore-numero-di-graft-e-mortalita-ospedaliera-ma-sopravvivenza-tardiva-accettabile-nelle-donne-sottoposte-a-chirurgia-coronarica/
https://gpcardio.org/it/2026-03-03_quantificazione-del-metabolismo-energetico-del-muscolo-scheletrico-durante-l-esercizio-nell-insufficienza-cardiaca-con-frazione-di-eiezione-preservata-mediante-spettroscopia-a-risonanza-magnetica-del/
https://gpcardio.org/it/2026-03-03_terapia-genica-di-base-editing-in-vivo-per-l-ipercolesterolemia-familiare-eterozigote/
https://gpcardio.org/it/2026-03-03_validazione-emodinamica-invasiva-di-uno-strumento-ecocardiografico-di-intelligenza-artificiale-per-il-rilevamento-dell-insufficienza-cardiaca-con-frazione-di-eiezione-preservata/
https://gpcardio.org/it/2026-03-04_aspirina-dopo-pci-nelle-sindromi-coronariche-acute/
https://gpcardio.org/it/2026-03-04_finerenone-per-la-malattia-renale-diabetica-nel-diabete-di-tipo-1-una-risposta-raffinata/
https://gpcardio.org/it/2026-03-04_interazione-tra-eta-e-sesso-con-la-pressione-arteriosa-clinica-e-ambulatoriale-e-la-mortalita/
https://gpcardio.org/it/2026-03-04_obiettivi-di-pressione-arteriosa-nella-gestione-dell-ipertensione/
https://gpcardio.org/it/2026-03-05_anticoagulante-orale-ad-azione-diretta-o-antagonista-della-vitamina-k-per-il-paziente-anziano-fragile-con-fibrillazione-atriale/
https://gpcardio.org/it/2026-03-05_finerenone-nel-diabete-di-tipo-1-e-nella-malattia-renale-cronica/
https://gpcardio.org/it/2026-03-05_l-inibitore-orale-di-pcsk9-enlicitide-riduce-i-livelli-di-colesterolo-ldl-in-uno-studio-di-fase-2/
https://gpcardio.org/it/2026-03-05_semaglutide-nell-arteriopatia-periferica-e-nel-diabete-in-base-alla-gravita-basale-della-malattia-e-all-eta/
https://gpcardio.org/it/2026-03-06_malattia-renale-e-insufficienza-cardiaca/
https://gpcardio.org/it/2026-03-07_effetto-del-baxdrostat-sulla-pressione-arteriosa-ambulatoriale-in-pazienti-con-ipertensione-resistente-bax24/
https://gpcardio.org/it/2026-03-07_effetto-di-baxdrostat-sulla-pressione-arteriosa-ambulatoriale-nei-pazienti-con-ipertensione-resistente-bax24/
https://gpcardio.org/it/2026-03-07_fibrillazione-atriale/
https://gpcardio.org/it/2026-03-09_differenze-nel-decorso-della-malattia-comorbidita-e-mortalita-nella-cardiomiopatia-ipertrofica-sarcomerica-e-non-sarcomerica/
https://gpcardio.org/it/2026-03-09_il-semaglutide-promuove-il-flusso-di-cellule-progenitrici-derivate-dal-midollo-osseo-verso-un-profilo-antinfiammatorio-e-pro-rigenerativo-nei-pazienti-ad-alto-rischio/
https://gpcardio.org/it/2026-03-09_obiettivi-e-trattamenti-per-la-gestione-dell-ldl-c-nella-medicina-generale/
https://gpcardio.org/it/2026-03-10_lp-a-e-tempo-di-iniziare-a-misurarlo-nella-medicina-generale/
https://gpcardio.org/it/2026-03-10_screening-genetico-per-la-fh-razionale-ed-esperienza/
https://gpcardio.org/it/2026-03-11_trigliceridi-un-marcatore-di-rischio-o-un-obiettivo-per-il-rischio-cv/
https://gpcardio.org/it/2026-03-12_indicazioni-esc-su-cvd-e-salute-mentale-nella-medicina-generale/
https://gpcardio.org/it/2026-03-12_rischio-cardiovascolare-metabolico-in-menopausa/
https://gpcardio.org/it/2026-03-12_sovradosaggio-off-label-della-terapia-antitrombotica-con-edoxaban-in-pazienti-con-fibrillazione-atriale-e-malattia-coronarica-stabile/
https://gpcardio.org/it/2026-03-13_gestione-dell-ipertensione-difficile-da-controllare-cosa-c-e-di-nuovo/
https://gpcardio.org/it/2026-03-13_insufficienza-cardiaca-nella-medicina-generale-riconoscimento-precoce-e-avvio-della-gdmt/
https://gpcardio.org/it/2026-03-13_la-necessita-del-coinvolgimento-del-medico-di-famiglia-nel-mondo-dell-advocacy/
https://gpcardio.org/it/2026-03-13_linea-guida-acc-aha-2026-sulla-gestione-della-dislipidemia/
https://gpcardio.org/it/2026-03-14_il-polso-della-medicina-generale-summit-epccs-2026/
https://gpcardio.org/it/2026-03-16_utilizzo-del-punteggio-di-calcio-coronarico-negli-individui-con-lipoproteina-a-elevata/
https://gpcardio.org/it/2026-03-20_anamnesi-degli-esiti-avversi-della-gravidanza-nel-corso-della-vita-e-rischio-cardiovascolare/
https://gpcardio.org/it/2026-03-20_evidenza-del-mondo-reale-con-dapagliflozin-nell-insufficienza-cardiaca-con-frazione-di-eiezione-ridotta-nell-europa-centrale-e-orientale-e-nella-regione-baltica-studio-evolution-hf-cee-ba/
https://gpcardio.org/it/2026-03-20_l-impatto-delle-indicazioni-epccs-sulla-farmacoterapia-in-ucraina/
https://gpcardio.org/it/2026-03-22_aggiornamento-delle-linee-guida-sull-ipertensione-in-turchia/
https://gpcardio.org/it/2026-03-22_gestione-del-rischio-cardiovascolare-in-polonia/
https://gpcardio.org/it/2026-03-22_screening-per-la-cvd-in-grecia/
https://gpcardio.org/it/2026-03-23_terapia-medica-guidata-dalle-linee-guida-nella-ckd-il-ruolo-cruciale-della-medicina-generale/
https://gpcardio.org/it/2026-03-24_gestione-della-ckd-nella-medicina-generale/
https://gpcardio.org/it/2026-03-24_indice-trigliceridi-glucosio-e-mortalita-nei-pazienti-critici-con-sindrome-cardiorenale-metabolica-stadio-4/
https://gpcardio.org/it/2026-03-24_infiammazione-sistemica-e-recidiva-dopo-ictus-correlato-a-fibrillazione-atriale/
https://gpcardio.org/it/2026-03-24_screening-e-stratificazione-del-rischio-nella-ckd-il-ruolo-cruciale-della-medicina-generale/
https://gpcardio.org/it/2026-03-25_ereditabilita-e-malattia-cardiovascolare-nella-prole-adulta-di-madri-con-disturbo-ipertensivo-della-gravidanza/
https://gpcardio.org/it/2026-03-25_gestione-degli-agonisti-dei-recettori-del-peptide-glucagone-simile-1-e-degli-inibitori-del-cotrasportatore-sodio-glucosio-2-nella-pratica-clinica/
https://gpcardio.org/it/2026-03-25_ruolo-dell-imaging-da-provocazione-e-da-sforzo-per-l-identificazione-dei-candidati-agli-inibitori-della-miosina-cardiaca/
https://gpcardio.org/it/2026-03-26_chiusura-dell-appendice-atriale-sinistra-o-terapia-medica-nella-fibrillazione-atriale/
https://gpcardio.org/it/2026-03-26_impronta-dell-obesita-senescente-nel-cancro-al-seno/
https://gpcardio.org/it/2026-03-26_nuovi-meccanismi-dei-fattori-di-rischio-cardiovascolare-metabolico-e-opportunita-terapeutiche/
https://gpcardio.org/it/2026-03-26_terapia-di-editing-genetico-nelle-malattie-cardiovascolari/
https://gpcardio.org/it/2026-03-27_endotipizzazione-approfondita-del-danno-renale-nel-diabete-di-tipo-2/
https://gpcardio.org/it/2026-03-27_malattia-renale/
https://gpcardio.org/it/2026-03-27_ottimizzazione-dei-valori-di-soglia-di-inclusione-per-nt-probnp-negli-studi-clinici-randomizzati-sull-insufficienza-cardiaca/
https://gpcardio.org/it/2026-03-28_sindrome-da-carenza-del-canale-di-rilascio-del-calcio-in-pazienti-diagnosticati-con-fibrillazione-ventricolare-idiopatica-e-in-deceduti-classificati-come-morte-improvvisa-inspiegabile-nel-giovane/
https://gpcardio.org/it/2026-03-29_chiusura-dell-appendice-atriale-sinistra-o-anticoagulazione-per-la-fibrillazione-atriale/
https://gpcardio.org/it/2026-03-29_evolocumab-riduce-del-31-il-rischio-di-primo-evento-cardiovascolare-maggiore-nei-pazienti-senza-aterosclerosi-significativa/
https://gpcardio.org/it/2026-03-29_fibrinolisi-facilitata-dagli-ultrasuoni-e-diretta-dal-catetere-per-l-embolia-polmonare-acuta/
https://gpcardio.org/it/2026-03-29_raggiungimento-intensivo-del-target-di-colesterolo-ldl-nei-pazienti-con-malattia-cardiovascolare-aterosclerotica/
https://gpcardio.org/it/2026-03-30_lo-studio-sugli-effetti-del-liraglutide-nella-fibrillazione-atriale-leaf/
https://gpcardio.org/it/2026-04-10_il-progetto-ue-nextgen-fa-progredire-la-cardiologia-personalizzata-integrando-dati-genomici-e-clinici-nei-modelli-di-ia/
https://gpcardio.org/it/2026-04-15_l-insufficienza-cardiaca-e-comune-nelle-persone-con-fibrillazione-atriale-rilevata-durante-lo-screening/
https://gpcardio.org/it/2026-04-17_evolocumab-per-ridurre-il-primo-evento-cardiovascolare-maggiore-nei-pazienti-senza-aterosclerosi-significativa-nota-e-con-diabete/
https://gpcardio.org/it/2026-04-17_variazioni-acute-della-gfre-e-la-loro-mediazione-nella-riduzione-dell-albuminuria-con-empagliflozin-e-finerenone/
https://gpcardio.org/it/2026-04-17_volume-rispetto-all-intensita-dell-attivita-fisica-e-rischio-di-malattie-croniche-cardiovascolari-e-non-cardiovascolari/
https://gpcardio.org/it/2026-04-18_agonisti-del-recettore-del-peptide-1-simile-al-glucagone-per-la-prevenzione-degli-eventi-di-insufficienza-cardiaca-nel-diabete-di-tipo-2-e-o-obesita/
https://gpcardio.org/it/2026-04-18_differenze-di-sesso-nella-sindrome-cardiorenale-metabolica/
https://gpcardio.org/it/2026-04-18_lipoproteina-a-e-trombosi-venosa-embolica-incidente-nelle-donne-pre-e-postmenopausali-e-negli-uomini/
https://gpcardio.org/it/2026-04-19_impatto-dei-test-genetici-sui-pazienti-con-ipercolesterolemia-familiare-fh-sugli-eventi-cardiovascolari-avversi-lo-studio-del-registro-hokuriku-plus-sull-ipercolesterolemia-familiare/
https://gpcardio.org/it/2026-04-20_lp-a-ha-effetti-specifici-sulla-malattia-coronarica-indipendenti-dal-ldl-c/
https://gpcardio.org/it/2026-04-21_dispositivi-indossabili-e-salute-cardiovascolare/
https://gpcardio.org/it/2026-04-22_linea-guida-acc-aha-aacvpr-abc-acpm-ada-ags-apha-aspc-nla-pcna-sulla-gestione-della-dislipidemia/
https://gpcardio.org/it/2026-04-22_memantina-per-le-contrazioni-atriali-premature/
https://gpcardio.org/it/2026-04-22_somministrazione-preospedaliera-di-eparina-nei-pazienti-con-stemi-sottoposti-a-pci-primaria/
https://gpcardio.org/it/2026-04-23_effetto-dell-inibizione-di-apoc3-con-olezarsen-sull-aterosclerosi-coronarica/
https://gpcardio.org/it/2026-04-23_rivaroxaban-a-basso-dosaggio-per-prevenire-la-trombosi-ventricolare-sinistra-dopo-infarto-miocardico-anteriore/
https://gpcardio.org/it/2026-04-24_due-studi-che-confrontano-la-stimolazione-del-sistema-di-conduzione-e-la-stimolazione-biventricolare/
https://gpcardio.org/it/2026-04-24_fasi-della-sindrome-cardiorenale-metabolica-caratteristiche-ecocardiografiche-e-rischio-di-insufficienza-cardiaca/
https://gpcardio.org/it/2026-04-24_linee-guida-nutrizionali-2026-per-migliorare-la-salute-cardiovascolare/
https://gpcardio.org/it/2026-04-25_il-ruolo-del-supporto-della-stimolazione-atriale-nella-terapia-di-risincronizzazione-cardiaca/
https://gpcardio.org/it/2026-04-25_sotatercept-per-l-ipertensione-polmonare-combinata-post-e-precapillare-associata-a-insufficienza-cardiaca/
https://gpcardio.org/it/2026-04-26_valutazione-del-rischio-di-malattia-cardiovascolare-a-lungo-termine-in-gravidanza/
https://gpcardio.org/it/2026-04-27_rilevazione-ecocardiografica-automatizzata-delle-cardiopatie-congenite-mediante-intelligenza-artificiale/
https://gpcardio.org/it/2026-04-28_prevenzione-precoce-degli-ateromi/
https://gpcardio.org/it/2026-04-30_tre-agenti-antipertensivi-a-basso-dosaggio-in-un-unico-compresse-dopo-emorragia-intracerebrale/
https://gpcardio.org/it/2026-05-01_radioablazione-stereotassica-per-la-tachicardia-ventricolare-refrattaria/
https://gpcardio.org/it/2026-05-02_blocco-del-sistema-raas-nel-rene-nel-ciclo-di-vita-standard-di-trattamento/
https://gpcardio.org/it/2026-05-03_screening-cardiovascolare-non-invasivo-multimodale-e-risultati-specifici-per-sesso/
https://gpcardio.org/it/2026-05-04_continuazione-rispetto-all-interruzione-della-terapia-anticoagulante-orale-diretta-dopo-un-ictus-nonostante-il-trattamento/
https://gpcardio.org/it/2026-05-05_ampio-periodo-di-interruzione-del-trattamento-correlato-alla-gravidanza-nelle-donne-con-ipercolesterolemia-familiare/
https://gpcardio.org/it/2026-05-05_differenze-di-sesso-nel-trattamento-farmacologico-dell-insufficienza-cardiaca/
https://gpcardio.org/it/2026-05-06_fattori-di-rischio-di-malattia-cardiovascolare-aterosclerotica-negli-individui-con-ipercolesterolemia-familiare-eterozigote/
https://gpcardio.org/it/2026-05-07_riparazione-combinata-percutanea-edge-to-edge-della-valvola-mitrale-e-tricuspide-o-riparazione-edge-to-edge-della-sola-valvola-tricuspide-in-caso-di-insufficienza-mitrale-moderata/
https://gpcardio.org/it/2026-05-08_funzione-renale-e-rischio-di-insufficienza-cardiaca-negli-adulti-anziani/
https://gpcardio.org/it/2026-05-08_rischi-di-ictus-e-sanguinamento-con-anticoagulanti-orali-diretti-nella-fibrillazione-atriale-non-valvolare/
https://gpcardio.org/it/2026-05-09_impianto-di-defibrillatore-sottocutaneo-con-o-senza-test-di-defibrillazione/
https://gpcardio.org/it/2026-05-10_digossina-a-basso-dosaggio-nei-pazienti-con-insufficienza-cardiaca-con-frazione-di-eiezione-ridotta-o-lievemente-ridotta/
https://gpcardio.org/it/2026-05-10_digossina-in-pazienti-con-cardiopatia-reumatica-sintomatica/
https://gpcardio.org/it/2026-05-10_efficacia-della-terapia-medica-raccomandata-dalle-linee-guida-in-base-all-uso-di-digossina/
https://gpcardio.org/it/2026-05-10_inibitore-del-recettore-dell-angiotensina-e-della-neprilisina-nell-insufficienza-cardiaca-con-frazione-di-eiezione-preservata-e-insufficienza-mitralica-secondaria/
https://gpcardio.org/it/2026-05-10_l-inibitore-del-microrna-cdr132l-nei-pazienti-con-frazione-di-eiezione-del-ventricolo-sinistro-ridotta-dopo-infarto-miocardico/
https://gpcardio.org/it/2026-05-10_sospensione-in-cieco-del-trattamento-randomizzato-con-digossina-a-basso-dosaggio-o-placebo-in-pazienti-con-insufficienza-cardiaca/
https://gpcardio.org/it/2026-05-11_attivita-fisica-nelle-cardiomiopatie-pediatriche/
https://gpcardio.org/it/2026-05-11_malattia-cardiovascolare-nella-malattia-falciforme/
https://gpcardio.org/it/2026-05-11_misure-antropometriche-dell-adiposita-e-peptidi-natriuretici-nello-screening-dell-insufficienza-cardiaca/
https://gpcardio.org/it/2026-05-11_prevalenza-e-predittori-di-elevato-rischio-infiammatorio-nei-sottotipi-di-insufficienza-cardiaca/
https://gpcardio.org/it/2026-05-11_subcut-hf-ii-il-furosemide-sottocutaneo-domiciliare-riduce-i-giorni-di-ospedalizzazione-rispetto-al-furosemide-endovenoso-ospedaliero-in-pazienti-ricoverati-con-edema-associato-a-insufficienza-cardiac/
https://gpcardio.org/it/2026-05-11_tumore-incidente-nell-insufficienza-cardiaca-nell-infarto-miocardico-o-in-entrambi/
https://gpcardio.org/it/2026-05-12_la-prevalenza-globale-dell-insufficienza-cardiaca-supera-ora-i-600-milioni-di-persone-dalle-congetture-alle-evidenze/
https://gpcardio.org/it/2026-05-12_predittori-degli-esiti-a-lungo-termine-nella-cardiomiopatia-ipertrofica/
https://gpcardio.org/it/2026-05-12_sotatercept-per-l-ipertensione-polmonare-post-e-precapillare-combinata-associata-a-insufficienza-cardiaca/
https://gpcardio.org/it/2026-05-15_prevenzione-secondaria-dopo-chirurgia-di-bypass-coronarico/
https://gpcardio.org/it/2026-05-15_studio-prospettico-multicentrico-di-un-anno-nel-mondo-reale-sull-efficacia-e-la-sicurezza-del-vericiguat-in-spagna/
https://gpcardio.org/it/2026-05-18_verso-controlli-cardiovascolari-completi-in-tutta-europa/
https://gpcardio.org/it/2026-05-19_atlas-of-cardiology-persistono-disuguaglianze-evitabili-nel-peso-e-nell-assistenza-della-malattia-cardiovascolare/
https://gpcardio.org/it/2026-05-25_editing-di-basi-in-vivo-di-pcsk9-con-verve-102-per-l-ipercolesterolemia/
https://gpcardio.org/it/2026-05-27_ablazione-a-campo-pulsato-per-il-trattamento-interventistico-della-fibrillazione-atriale-una-dichiarazione-scientifica-dell-european-heart-rhythm-association-ehra-della-esc-della-heart-rhythm-society/
https://gpcardio.org/it/2026-05-27_agonisti-del-recettore-del-peptide-glucagone-simile-1-nei-pazienti-con-insufficienza-cardiaca-con-frazione-di-eiezione-ridotta/
https://gpcardio.org/it/2026-05-28_centri-cardiaci-femminili/
https://gpcardio.org/it/2026-05-28_gli-inibitori-del-sglt2-sono-associati-a-una-riduzione-del-volume-e-dello-spessore-del-tessuto-adiposo-epicardico/
https://gpcardio.org/it/2026-05-29_fisiopatologia-prevenzione-e-gestione-dell-ostruzione-microvascolare-coronarica/
https://gpcardio.org/it/2026-05-31_il-rene-al-centro/
https://gpcardio.org/it/2026-06-01_meccanismi-fisiopatologici-condivisi-tra-diabete-e-malattia-della-valvola-aortica-calcifica/
https://gpcardio.org/it/2026-06-01_sovrapposizione-renale-diabetica-nell-ipertensione-polmonare-arteriosa/
https://gpcardio.org/it/2026-06-02_epidemiologia-dell-embolia-polmonare/
https://gpcardio.org/it/2026-06-02_esiti-dello-studio-betami-danblock-confrontati-con-una-popolazione-nazionale-norvegese-con-infarto-miocardico/
https://gpcardio.org/it/2026-06-02_obicetrapib-e-i-livelli-di-lipoproteina-a-nei-pazienti-ad-alto-rischio-cardiovascolare/
https://gpcardio.org/it/2026-06-03_ipercolesterolemia-familiare-nei-bambini-e-negli-adolescenti/
https://gpcardio.org/it/2026-06-03_livelli-di-lipoproteina-a-rischio-di-eventi-cardiovascolari-e-beneficio-di-evolocumab/
https://gpcardio.org/it/2026-06-04_cliniche-lipidologiche-in-tutto-il-mondo/
https://gpcardio.org/it/2026-06-04_effetti-del-semaglutide-su-mortalita-esiti-cardiovascolari-e-renali-lungo-il-continuum-cardiorenale-metabolico/
https://gpcardio.org/it/2026-06-05_riduzione-prevista-degli-eventi-cardiovascolari-avversi-maggiori-tra-gli-adulti-statunitensi-ad-alto-rischio-con-diabete-di-tipo-2-idonei-al-trattamento-con-semaglutide-orale/
https://gpcardio.org/it/2026-06-07_sindrome-di-alport-autosomica-dominante/
https://gpcardio.org/it/2026-06-09_modifiche-della-composizione-corporea-nei-pazienti-in-terapia-con-agonisti-del-recettore-del-glp-1-sottoposti-a-un-programma-intensivo-di-riabilitazione-cardiaca/
https://gpcardio.org/it/2026-06-10_additivi-alimentari-conservanti-ipertensione-e-malattie-cardiovascolari/
https://gpcardio.org/it/2026-06-10_risultati-primari-del-registro-salamander/
https://gpcardio.org/it/2026-06-11_l-unita-sanitaria-mobile-che-effettua-attivita-di-outreach-nelle-comunita-urbane-socialmente-svantaggiate-rileva-fattori-di-rischio-cardiometabolici-non-controllati/
https://gpcardio.org/it/2026-06-11_modalita-e-dosaggi-ottimali-di-esercizio-per-la-riduzione-della-pressione-arteriosa-negli-adulti-con-preipertensione-e-ipertensione-consolidata/
https://gpcardio.org/it/2026-06-12_abbassamento-del-colesterolo-delle-lipoproteine-a-bassa-densita-con-inclisiran-piu-le-cure-abituali-nel-recente-sindrome-coronarica-acuta/
https://gpcardio.org/it/2026-06-13_effetto-di-diversi-tipi-di-legumi-integrali-sui-target-lipidici-terapeutici-consolidati-per-la-riduzione-del-rischio-cardiovascolare/
https://gpcardio.org/it/2026-06-13_societa-europea-di-cardiologia/
https://gpcardio.org/it/2026-06-15_analisi-di-costo-efficacia-e-di-impatto-sul-budget-del-tirzepatide-nell-insufficienza-cardiaca-con-frazione-di-eiezione-preservata-e-obesita-nel-sistema-sanitario-tedesco/
https://gpcardio.org/it/2026-06-15_efficacia-clinica-degli-inibitori-del-cotrasportatore-sodio-glucosio-2-nei-pazienti-anziani-ricoverati-per-insufficienza-cardiaca-con-frazione-di-eiezione-ridotta/
https://gpcardio.org/it/2026-06-15_efficacia-comparativa-dei-singoli-inibitori-del-cotrasportatore-sodio-glucosico-2-sugli-esiti-cardiovascolari-nel-diabete-di-tipo-2-con-rischio-cardiovascolare-moderato/
https://gpcardio.org/it/2026-06-16_associazione-tra-modelli-dietetici-e-rischio-genetico-con-malattia-cardiovascolare-nei-sopravvissuti-al-cancro-del-uk-biobank/
https://gpcardio.org/it/2026-06-17_associazione-dipendente-dall-eta-tra-insufficienza-cardiaca-e-rischio-di-ictus-nella-fibrillazione-atriale/
https://gpcardio.org/it/2026-06-17_ipercolesterolemia-familiare-omozigote/
https://gpcardio.org/it/2026-06-19_imaging-intracoronarico-per-l-intervento-coronarico-percutaneo-del-tronco-sinistro/
https://gpcardio.org/it/2026-06-19_laroprovstat-il-primo-inibitore-di-pcsk9-orale-a-piccola-molecola-per-il-trattamento-dell-ipercolesterolemia/
https://gpcardio.org/it/2026-06-20_bersagli-farmacologici-per-la-modifica-lipidica-e-il-rischio-di-diabete-di-tipo-2/
https://gpcardio.org/it/2026-06-20_rischio-cardiovascolare-lipidico-oltre-il-colesterolo-ldl/
https://gpcardio.org/it/2026-06-21_studio-prospettico-multicentrico-su-un-anno-in-condizioni-di-pratica-clinica-reale-sull-efficacia-e-la-sicurezza-del-vericiguat-in-spagna/
https://gpcardio.org/it/2026-06-24_esiti-dopo-un-primo-infarto-miocardico-acuto-in-pazienti-con-o-senza-cardiopatia-congenita/
https://gpcardio.org/it/2026-06-25_esiti-a-1-anno-nella-pratica-reale-con-l-otturatore-amulet-dallo-studio-emerge-laa-post-approvazione/
https://gpcardio.org/it/2026-06-25_intervento-in-cieco-del-trattamento-randomizzato-con-digossina-a-basso-dosaggio-o-placebo-nei-pazienti-con-insufficienza-cardiaca/
https://gpcardio.org/it/2026-06-27_gestione-dell-insufficienza-cardiaca-nella-medicina-generale-al-di-fuori-dell-orario-di-apertura/
https://gpcardio.org/it/2026-06-29_embolia-coronarica-in-fibrillazione-atriale/
https://gpcardio.org/it/2026-06-30_indice-di-interazione-dieta-microbiota-intestinale-e-rischio-di-insufficienza-cardiaca-nel-diabete-e-prediabete/
https://gpcardio.org/it/2026-07-01_anticoagulanti-orali-diretti-fans-selettivi-cox-2-e-sanguinamento-gastrointestinale-nella-fibrillazione-atriale/
https://gpcardio.org/it/2026-07-02_ablazione-a-campo-pulsato-versus-fittizio-per-il-trattamento-della-fibrillazione-atriale/
https://gpcardio.org/it/2026-07-02_incidenza-reale-della-disfunzione-cardiaca-correlata-alla-terapia-antitumorale-in-una-coorte-ampia-diversificata-e-contemporanea/
https://gpcardio.org/it/2026-07-03_stima-del-rischio-assoluto-di-malattia-cardiovascolare-a-5-anni-utilizzando-cartelle-cliniche-elettroniche-raccolte-abitualmente-nei-studi-dei-medici-di-famiglia-australiani/
https://gpcardio.org/it/2026-07-03_storia-naturale-della-rigurgitazione-aortica-moderata-o-severa-asintomatica/
https://gpcardio.org/it/2026-07-05_condizione-fisica-dopo-infarto-miocardico-rispetto-ai-valori-di-riferimento-clinici/
https://gpcardio.org/it/2026-07-05_fattori-di-rischio-di-multimorbidita-delle-malattie-cardiovascolari-nello-studio-prospettico-million-women-study/
https://gpcardio.org/it/2026-07-05_fitness-cardiorespiratoria-negli-adolescenti-e-il-compromesso-tra-il-rischio-di-fibrillazione-atriale-e-i-benefici-cardiovascolari/
https://gpcardio.org/it/2026-07-06_fitness-cardiorespiratoria-negli-adolescenti-e-il-compromesso-tra-il-rischio-di-fibrillazione-atriale-e-i-benefici-cardiovascolari/
https://gpcardio.org/it/2026-07-07_apporti-dietetici-di-nitrato-vegetale-e-animale-e-variazioni-della-pressione-arteriosa-a-5-anni/
https://gpcardio.org/it/2026-07-07_cambiamenti-chiave-nelle-indicazioni-cliniche-per-la-gestione-della-pressione-arteriosa-e-dei-lipidi/
https://gpcardio.org/it/2026-07-07_endocardite-infettiva-dopo-l-impianto-di-valvola-aortica-transcatetere/
https://gpcardio.org/it/2026-07-07_la-medicina-generale-ha-un-ruolo-nella-gestione-dell-obesita-da-gatekeeper-a-leader-della-salute-della-popolazione/
https://gpcardio.org/it/2026-07-07_perche-la-malattia-renale-cronica-ckd-e-piu-importante-per-la-medicina-generale/
https://gpcardio.org/it/2026-07-08_apporti-dietetici-di-nitrato-vegetale-e-animale-e-variazioni-della-pressione-arteriosa-in-5-anni/
https://gpcardio.org/it/2026-07-08_blocco-dei-canali-del-calcio-versus-blocco-beta-per-l-ipertensione-nell-insufficienza-cardiaca-con-frazione-di-eiezione-preservata/
https://gpcardio.org/it/2026-07-08_evolocumab-nei-pazienti-con-precedente-intervento-coronarico-percutaneo-e-senza-precedente-infarto-del-miocardio/
https://gpcardio.org/it/2026-07-09_determinazione-della-soglia-fisiologica-per-l-angina-orbita-fire/
https://gpcardio.org/it/2026-07-09_inibitore-dei-recettori-dell-angiotensina-e-della-neprilisina-nell-insufficienza-cardiaca-con-frazione-di-eiezione-preservata-e-rigurgito-mitralico-secondario/
https://gpcardio.org/it/2026-07-09_la-disfunzione-diastolica-e-ugualmente-comune-nel-prediabete-e-nel-diabete-ed-e-associata-a-fattori-di-rischio-cardiometabolici-concomitanti/
https://gpcardio.org/it/2026-07-09_pressione-arteriosa-notturna-misurata-a-domicilio-al-polso-e-ipertrofia-ventricolare-sinistra/
https://gpcardio.org/it/2026-07-10_evolocumab-in-pazienti-con-precedente-intervento-coronarico-percutaneo-e-senza-precedente-infarto-miocardico/
https://gpcardio.org/it/2026-07-11_blocco-dei-canali-del-calcio-versus-blocco-beta-per-ipertensione-e-insufficienza-cardiaca-con-frazione-di-eiezione-preservata/
https://gpcardio.org/it/2026-07-11_pressione-arteriosa-notturna-misurata-a-domicilio-al-polso-e-ipertrofia-ventricolare-sinistra/
https://gpcardio.org/it/2026-07-12_determinazione-della-soglia-fisiologica-per-l-angina-orbita-fire/
https://gpcardio.org/it/2026-07-12_inibitore-dei-recettori-dell-angiotensina-e-della-neprilisina-nell-insufficienza-cardiaca-con-frazione-di-eiezione-preservata-e-rigurgito-mitralico-secondario/
https://gpcardio.org/it/2026-07-14_trombo-ventricolare-sinistro-nella-sindrome-di-takotsubo-e-infarto-miocardico-con-sopraslivellamento-del-tratto-st/
https://gpcardio.org/it/2026-07-15_la-storia-naturale-dell-ipertrofia-ventricolare-sinistra-massiva-nella-cardiomiopatia-ipertrofica-pediatrica/
https://gpcardio.org/it/2026-07-16_i-deficit-fisiologici-multiorgano-durante-l-esercizio-identificano-la-predisposizione-clinica-e-molecolare-all-insufficienza-cardiaca-con-frazione-di-eiezione-preservata/
https://gpcardio.org/it/2026-07-18_angiopatia-amiloide-cerebrale/
https://gpcardio.org/it/2026-07-18_esiti-clinici-della-pacizzazione-del-sistema-di-conduzione-rispetto-alla-pacizzazione-ventricolare-destra-nei-pazienti-con-blocco-atrioventricolare/
https://gpcardio.org/it/2026-07-18_i-miglioramenti-clinici-nell-ansia-o-nella-depressione-sono-associati-a-un-miglioramento-dell-idoneita-alla-deambulazione-dopo-un-programma-di-riabilitazione-cardiaca/
https://gpcardio.org/it/2026-07-19_abbassamento-farmacologico-della-pressione-arteriosa-per-la-prevenzione-della-malattia-cardiovascolare-e-del-decesso-in-tutto-lo-spettro-di-gravita-della-malattia-renale-cronica/
https://gpcardio.org/it/2026-07-19_trattamento-e-risultati-con-inibitori-di-pcsk9-in-pazienti-con-malattia-cardiovascolare-aterosclerotica-ma-senza-eventi-ischemici-pregressi/
https://gpcardio.org/it/2026-07-21_sviluppo-di-uno-strumento-integrato-per-la-valutazione-del-rischio-monogenico-e-poligenico-per-la-malattia-coronarica-e-la-sua-applicazione-in-una-biobanca-sanitaria-basata-sulla-comunita/
https://gpcardio.org/it/2026-07-22_gestione-e-esiti-della-fibrillazione-atriale-postoperatoria-ad-esordio-recente/
https://gpcardio.org/it/2026-07-23_i-deficit-fisiologici-multiorgano-durante-l-esercizio-identificano-la-predisposizione-clinica-e-molecolare-all-insufficienza-cardiaca-con-frazione-di-eiezione-preservata/
https://gpcardio.org/it/2026-07-23_la-storia-naturale-dell-ipertrofia-ventricolare-sinistra-massiva-nella-cardiomiopatia-ipertrofica-pediatrica/
https://gpcardio.org/it/2026-07-24_controllo-della-pressione-arteriosa-e-mortalita-tra-i-veterani-degli-stati-uniti/
https://gpcardio.org/it/2026-07-24_disfunzione-renale-e-malattia-vascolare-polmonare-nell-insufficienza-cardiaca-con-frazione-di-eiezione-preservata/
https://gpcardio.org/it/2026-07-25_lipoproteina-a-proteina-c-reattiva-ad-alta-sensibilita-e-rischio-di-ascvd-incidente-in-individui-privi-di-fattori-di-rischio-modificabili-standard/
https://gpcardio.org/it/2026-07-26_differenze-di-sesso-negli-esiti-dopo-ictus-ischemico-in-pazienti-in-terapia-anticoagulante-orale-per-fibrillazione-atriale/
https://gpcardio.org/it/2026-07-26_percorsi-assistenziali-e-risultati-dei-pazienti-dopo-la-diagnosi-recente-di-fibrillazione-atriale/
https://gpcardio.org/it/2026-07-27_fenotipizzazione-dei-pazienti-con-stenosi-aortica-a-basso-flusso-e-basso-gradiente-e-frazione-di-eiezione-preservata-sottoposti-a-tavi/
https://gpcardio.org/it/2026-07-27_valutazione-e-gestione-della-sindrome-metabolica-cardio-renale-epatica-nell-ambito-della-medicina-generale/
https://gpcardio.org/it/2026-07-28_effetto-combinato-del-livello-di-istruzione-e-del-diabete-sulla-mortalita-per-tutte-le-cause-a-1-anno-nei-pazienti-con-insufficienza-cardiaca/
https://gpcardio.org/it/2026-07-28_epidemiologia-onere-economico-e-mortalita-della-fibrillazione-atriale-in-una-regione-con-aspettativa-di-vita-molto-elevata/
https://gpcardio.org/it/2026-07-28_nuovi-reni-vecchi-rischi/
https://gpcardio.org/it/2026-07-29_gestione-lipidica-nel-diabete-di-tipo-2-e-colesterolo-non-hdl/
https://gpcardio.org/it/2026-07-29_puntura-transsettale-negli-interventi-cardiovascolari/
https://gpcardio.org/it/2026-07-29_tempistica-dell-esercizio-allineata-al-cronotipo-negli-adulti-di-mezza-eta-a-rischio-cardiometabolico/
https://gpcardio.org/it/2026-07-31_differenze-di-sesso-nella-diagnosi-nella-gestione-e-negli-esiti-dei-pazienti-con-endocardite-infettiva/
https://gpcardio.org/it/2026-07-31_esiti-precoci-e-predittori-di-mortalita-nell-endocardite-della-valvola-aortica-nativa/
https://gpcardio.org/it/2026-08-02_associazione-tra-proteina-c-reattiva-e-rischio-di-insufficienza-cardiaca-incidente-nei-sopravvissuti-al-cancro/
https://gpcardio.org/it/2026-08-02_dichiarazione-beneficio-cardiovascolare-con-il-consumo-tipico-di-caffe-segnale-di-danno-con-le-bevande-energetiche/
https://gpcardio.org/it/2026-08-02_epccs-rinnova-la-propria-identita-per-promuovere-un-assistenza-cardio-renale-metabolica-integrata-nella-medicina-generale/
https://gpcardio.org/it/2026-08-02_tendenze-in-nefrologia/
https://gpcardio.org/it/2026-08-03_documento-di-consenso-esperto-aha-acc-esc-whf/
https://gpcardio.org/it/2026-08-03_gestione-antitrombotica-nei-pazienti-con-sindrome-coronarica-cronica-in-trattamento-con-anticoagulanti-orali/
https://gpcardio.org/it/2026-08-04_fragilita-e-insufficienza-cardiaca/
https://gpcardio.org/it/2026-08-05_differenze-di-sesso-nel-controllo-del-fattore-di-rischio-e-nell-aderenza-alla-terapia-post-sca/
https://gpcardio.org/it/2026-08-06_controllo-della-pressione-arteriosa-e-mortalita-tra-i-veterani-degli-stati-uniti/
https://gpcardio.org/it/2026-08-06_la-riduzione-della-pressione-arteriosa-sistolica-e-dell-albuminuria-media-i-benefici-cardiovascolari-della-finerenone-nel-diabete-di-tipo-2-e-nella-malattia-renale-cronica/
https://gpcardio.org/it/2026-08-06_terapie-farmacologiche-combinate-basate-su-ormoni-peptidici-per-le-malattie-metaboliche-croniche/
https://gpcardio.org/it/2026-08-10_cuore-e-reni-in-una-sola-linea-guida/
https://gpcardio.org/it/2026-08-10_inibizione-del-fattore-xi/
https://gpcardio.org/it/2026-08-10_la-nuova-linea-guida-esc-sull-insufficienza-cardiaca/
https://gpcardio.org/it/2026-08-10_statine-oltre-i-settant-anni/
https://gpcardio.org/it/aggiornamenti-della-societa/
https://gpcardio.org/it/aggiornamenti-scientifici/
https://gpcardio.org/it/cvd-ckd-t2d/
https://gpcardio.org/it/each/
https://gpcardio.org/it/epccs-summit/
https://gpcardio.org/it/epccs-summit/aggiornamento-cardiorenale/
https://gpcardio.org/it/epccs-summit/gestione-dei-lipidi-nella-medicina-generale/
https://gpcardio.org/it/epccs-summit/gestione-del-rischio-cardiovascolare-in-europa-lezioni-dai-vari-paesi/
https://gpcardio.org/it/epccs-summit/il-piano-dell-ue-per-la-salute-cardiovascolare/
https://gpcardio.org/it/epccs-summit/malattie-cardiovascolari-in-popolazioni-speciali/
https://gpcardio.org/it/epccs-summit/sessione-di-aggiornamento-cardiovascolare-per-la-medicina-generale/
https://gpcardio.org/it/epccs/
https://gpcardio.org/it/epccs/societa-collegate/
https://gpcardio.org/it/esc-congress-2025/
https://gpcardio.org/it/gpcardio/
https://gpcardio.org/it/informazioni-su-epccs/
https://gpcardio.org/it/informazioni-su-ipccs/
https://gpcardio.org/it/letteratura/
https://gpcardio.org/it/letteratura/
https://gpcardio.org/it/ncd-academy/
https://gpcardio.org/it/risorse/
https://gpcardio.org/it/risorse/aggiornamenti-video/
https://gpcardio.org/it/risorse/indicazioni-per-la-pratica-clinica/
https://gpcardio.org/it/risorse/notizie-recenti/
https://gpcardio.org/it/risorse/resoconti-degli-incontri/
https://gpcardio.org/it/risorse/stratifyhf/
https://gpcardio.org/it/simposio-epccs-tenutosi-a-wonca-europe-2026-sulla-malattia-cardio-renale-metabolica/
https://gpcardio.org/it/wonca-world-2025/